https://www.humanexasignals.com/ 2026-08-16T18:43:14.839Z daily 1 https://www.humanexasignals.com/signals 2026-08-16T18:43:14.839Z hourly 0.7 https://www.humanexasignals.com/catalysts 2026-08-16T18:43:14.839Z hourly 0.7 https://www.humanexasignals.com/pricing 2026-08-16T18:43:14.839Z monthly 0.5 https://www.humanexasignals.com/contact 2026-08-16T18:43:14.839Z monthly 0.5 https://www.humanexasignals.com/partner 2026-08-16T18:43:14.839Z monthly 0.5 https://www.humanexasignals.com/privacy 2026-08-16T18:43:14.839Z yearly 0.3 https://www.humanexasignals.com/archive 2026-08-16T18:43:14.839Z daily 0.6 https://www.humanexasignals.com/api-access 2026-08-16T18:43:14.839Z monthly 0.4 https://www.humanexasignals.com/regulatory 2026-08-16T18:43:14.839Z daily 0.6 https://www.humanexasignals.com/clinical 2026-08-16T18:43:14.839Z daily 0.6 https://www.humanexasignals.com/competitive 2026-08-16T18:43:14.839Z daily 0.6 https://www.humanexasignals.com/markets 2026-08-16T18:43:14.839Z daily 0.6 https://www.humanexasignals.com/ma-watch 2026-08-16T18:43:14.839Z daily 0.6 https://www.humanexasignals.com/strategy 2026-08-16T18:43:14.839Z daily 0.6 https://www.humanexasignals.com/regulatory/fda 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/regulatory/ema 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/regulatory/mhra 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/regulatory/pmda 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/regulatory/health-canada 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/clinical/phase-i 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/clinical/phase-ii 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/clinical/phase-iii 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/clinical/readouts 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/clinical/enrollment-signals 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/competitive/pipeline-tracking 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/competitive/company-moves 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/competitive/asset-intelligence 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/competitive/landscape-reports 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/markets/pricing 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/markets/access 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/markets/commercial 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/markets/launch-tracking 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/ma-watch/licensing 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/ma-watch/acquisitions 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/ma-watch/partnerships 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/ma-watch/capital-raises 2026-08-16T18:43:14.839Z daily 0.55 https://www.humanexasignals.com/companies/aavrh10-pcca 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/companies/abbott 2026-08-16T18:43:27.467Z daily 0.8 https://www.humanexasignals.com/companies/abbvie 2026-09-18T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/acadia-pharmaceuticals 2026-08-16T18:43:27.352Z daily 0.8 https://www.humanexasignals.com/companies/acadia-pharmaceuticals-inc 2026-08-16T18:43:27.545Z daily 0.8 https://www.humanexasignals.com/companies/acadia-pharms-inc 2026-08-16T18:43:27.350Z daily 0.8 https://www.humanexasignals.com/companies/accord-biopharma 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/companies/acdp-o 2026-08-16T18:43:27.358Z daily 0.8 https://www.humanexasignals.com/companies/acertis-pharmaceuticals 2026-08-16T18:43:27.513Z daily 0.8 https://www.humanexasignals.com/companies/acne 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/companies/actavis-labs 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/companies/adlai-nortye-biopharma 2026-08-16T18:43:27.414Z daily 0.8 https://www.humanexasignals.com/companies/adlai-nortye-biopharma-co-ltd 2026-08-16T18:43:27.711Z daily 0.8 https://www.humanexasignals.com/companies/affinia-therapeutics 2026-08-16T18:43:27.479Z daily 0.8 https://www.humanexasignals.com/companies/aft-pharmaceuticals 2026-08-16T18:43:27.379Z daily 0.8 https://www.humanexasignals.com/companies/agios-pharmaceuticals 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/companies/agios-pharmaceuticals-inc 2026-08-16T18:43:27.690Z daily 0.8 https://www.humanexasignals.com/companies/ajanta-pharma 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/companies/akebia-therapeutics 2026-08-16T18:43:27.409Z daily 0.8 https://www.humanexasignals.com/companies/akero-therapeutics 2026-08-16T18:43:27.487Z daily 0.8 https://www.humanexasignals.com/companies/akero-therapeutics-inc 2026-08-16T18:43:27.760Z daily 0.8 https://www.humanexasignals.com/companies/alcon-laboratories-inc 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/companies/alcon-labs 2026-08-16T18:43:27.524Z daily 0.8 https://www.humanexasignals.com/companies/alembic-pharmaceuticals 2026-08-16T18:43:27.280Z daily 0.8 https://www.humanexasignals.com/companies/alexion-pharmaceuticals-inc 2026-08-16T18:43:27.530Z daily 0.8 https://www.humanexasignals.com/companies/alignscience-pharma 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/companies/alkem-labs 2026-08-16T18:43:27.280Z daily 0.8 https://www.humanexasignals.com/companies/allergy-therapeutics-companies 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/companies/allist-pharmaceuticals 2026-08-16T18:43:27.281Z daily 0.8 https://www.humanexasignals.com/companies/allist-pharmaceuticals-inc 2026-08-16T18:43:27.626Z daily 0.8 https://www.humanexasignals.com/companies/alnylam-pharmaceuticals 2026-08-16T18:43:27.281Z daily 0.8 https://www.humanexasignals.com/companies/alpha-biopharma 2026-08-16T18:43:27.444Z daily 0.8 https://www.humanexasignals.com/companies/alpha-biopharma-jiangsu-co-ltd 2026-08-16T18:43:27.729Z daily 0.8 https://www.humanexasignals.com/companies/alveus-therapeutics 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/companies/alveus-therapeutics-inc 2026-08-16T18:43:27.687Z daily 0.8 https://www.humanexasignals.com/companies/ambros-therapeutics 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/companies/ambros-therapeutics-inc 2026-08-16T18:43:27.629Z daily 0.8 https://www.humanexasignals.com/companies/amgen 2026-08-16T18:43:27.317Z daily 0.8 https://www.humanexasignals.com/companies/aminex-therapeutics-inc 2026-08-16T18:43:27.530Z daily 0.8 https://www.humanexasignals.com/companies/amneal-pharmaceuticals 2026-08-16T18:43:27.290Z daily 0.8 https://www.humanexasignals.com/companies/amphastar-pharmaceuticals 2026-08-16T18:43:27.537Z daily 0.8 https://www.humanexasignals.com/companies/anagram-therapeutics 2026-08-16T18:43:27.443Z daily 0.8 https://www.humanexasignals.com/companies/anagram-therapeutics-inc 2026-08-16T18:43:27.729Z daily 0.8 https://www.humanexasignals.com/companies/ani-pharmaceuticals 2026-08-16T18:43:27.335Z daily 0.8 https://www.humanexasignals.com/companies/annora-pharma 2026-08-16T18:43:27.303Z daily 0.8 https://www.humanexasignals.com/companies/anthea-pharma 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/companies/anthos-therapeutics 2026-08-16T18:43:27.424Z daily 0.8 https://www.humanexasignals.com/companies/anthos-therapeutics-inc 2026-08-16T18:43:27.718Z daily 0.8 https://www.humanexasignals.com/companies/anti-fungal 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/companies/anti-inflammatory 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/companies/anti-vegf 2026-08-16T18:43:27.448Z daily 0.8 https://www.humanexasignals.com/companies/apogee-therapeutics 2026-08-16T18:43:27.474Z daily 0.8 https://www.humanexasignals.com/companies/apogee-therapeutics-inc 2026-08-16T18:43:27.752Z daily 0.8 https://www.humanexasignals.com/companies/appco-pharma 2026-08-16T18:43:27.453Z daily 0.8 https://www.humanexasignals.com/companies/appco-pharma-llc 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/companies/aragon-pharmaceuticals 2026-08-16T18:43:27.396Z daily 0.8 https://www.humanexasignals.com/companies/aragon-pharmaceuticals-inc 2026-08-16T18:43:27.453Z daily 0.8 https://www.humanexasignals.com/companies/ascendis-pharma 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/companies/ascendis-pharma-a-s 2026-08-16T18:43:27.730Z daily 0.8 https://www.humanexasignals.com/companies/ascent-pharmaceuticals 2026-08-16T18:43:27.461Z daily 0.8 https://www.humanexasignals.com/companies/aspar-pharmaceuticals-ltd 2026-08-16T18:43:27.513Z daily 0.8 https://www.humanexasignals.com/companies/astellas-pharma 2026-08-16T18:43:27.367Z daily 0.8 https://www.humanexasignals.com/companies/astellas-pharma-global-development-inc 2026-08-16T18:43:27.583Z daily 0.8 https://www.humanexasignals.com/companies/astellas-pharma-inc 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/companies/astrazeneca 2026-10-12T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/astria-therapeutics 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/companies/astria-therapeutics-inc 2026-08-16T18:43:27.590Z daily 0.8 https://www.humanexasignals.com/companies/aur103-pharma 2026-08-16T18:43:27.543Z daily 0.8 https://www.humanexasignals.com/companies/aurobindo-pharma 2026-08-16T18:43:27.281Z daily 0.8 https://www.humanexasignals.com/companies/ausper-biopharma 2026-08-16T18:43:27.409Z daily 0.8 https://www.humanexasignals.com/companies/ausper-biopharma-co-ltd 2026-08-16T18:43:27.708Z daily 0.8 https://www.humanexasignals.com/companies/avidity-biosciences-inc 2026-08-16T18:43:27.687Z daily 0.8 https://www.humanexasignals.com/companies/azurity-pharmaceuticals 2026-08-16T18:43:27.379Z daily 0.8 https://www.humanexasignals.com/companies/bambusa-therapeutics 2026-08-16T18:43:27.428Z daily 0.8 https://www.humanexasignals.com/companies/barr 2026-08-16T18:43:27.335Z daily 0.8 https://www.humanexasignals.com/companies/barr-pharmaceuticals 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/companies/bayer 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/companies/bayer-healthcare-pharmaceuticals 2026-08-16T18:43:27.538Z daily 0.8 https://www.humanexasignals.com/companies/beijing-biostar-pharmaceuticals-co-ltd 2026-08-16T18:43:27.456Z daily 0.8 https://www.humanexasignals.com/companies/beta-agonist 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/companies/beta-blocker 2026-08-16T18:43:27.524Z daily 0.8 https://www.humanexasignals.com/companies/bg-c0979 2026-08-16T18:43:27.430Z daily 0.8 https://www.humanexasignals.com/companies/bharat-biotech 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/companies/bicara-therapeutics 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/companies/bicycle-therapeutics 2026-08-16T18:43:27.471Z daily 0.8 https://www.humanexasignals.com/companies/biocodex-sa 2026-08-16T18:43:27.467Z daily 0.8 https://www.humanexasignals.com/companies/biocon-pharma 2026-08-16T18:43:27.342Z daily 0.8 https://www.humanexasignals.com/companies/biocon-pharma-limited 2026-08-16T18:43:27.325Z daily 0.8 https://www.humanexasignals.com/companies/biocon-pharma-ltd 2026-08-16T18:43:27.336Z daily 0.8 https://www.humanexasignals.com/companies/biogen 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/companies/biohaven-therapeutics 2026-08-16T18:43:27.483Z daily 0.8 https://www.humanexasignals.com/companies/biohaven-therapeutics-ltd 2026-08-16T18:43:27.757Z daily 0.8 https://www.humanexasignals.com/companies/biomarin-pharmaceutical 2026-08-16T18:43:27.381Z daily 0.8 https://www.humanexasignals.com/companies/biontech 2026-08-16T18:43:27.389Z daily 0.8 https://www.humanexasignals.com/companies/biotech-companies-focused-on-endocrinology 2026-08-16T18:43:27.444Z daily 0.8 https://www.humanexasignals.com/companies/biotech-companies-in-reproductive-health 2026-08-16T18:43:27.440Z daily 0.8 https://www.humanexasignals.com/companies/biotech-firms-focused-on-neurotherapeutics 2026-08-16T18:43:27.354Z daily 0.8 https://www.humanexasignals.com/companies/biotech-firms-in-ophthalmology 2026-08-16T18:43:27.367Z daily 0.8 https://www.humanexasignals.com/companies/bite 2026-08-16T18:43:27.423Z daily 0.8 https://www.humanexasignals.com/companies/blossomhill-therapeutics 2026-08-16T18:43:27.416Z daily 0.8 https://www.humanexasignals.com/companies/boehringer-ingelheim 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/companies/bpi-labs 2026-08-16T18:43:27.344Z daily 0.8 https://www.humanexasignals.com/companies/brancaster-pharma-limited 2026-08-16T18:43:27.483Z daily 0.8 https://www.humanexasignals.com/companies/breckenridge-pharma 2026-08-16T18:43:27.464Z daily 0.8 https://www.humanexasignals.com/companies/breckenridge-pharmaceutical 2026-08-16T18:43:27.364Z daily 0.8 https://www.humanexasignals.com/companies/brii-biosciences-limited 2026-08-16T18:43:27.685Z daily 0.8 https://www.humanexasignals.com/companies/brillian-pharma 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/companies/bristol-laboratories-limited 2026-08-16T18:43:27.440Z daily 0.8 https://www.humanexasignals.com/companies/bristol-myers-squibb 2026-11-05T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/cadila-pharmaceuticals 2026-08-16T18:43:27.518Z daily 0.8 https://www.humanexasignals.com/companies/cardiogen-82 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/companies/cardiovascular-pharmaceutical-companies 2026-08-16T18:43:27.524Z daily 0.8 https://www.humanexasignals.com/companies/cardiovascular-therapeutics 2026-08-16T18:43:27.353Z daily 0.8 https://www.humanexasignals.com/companies/cardiovascular-therapeutics-companies 2026-08-16T18:43:27.520Z daily 0.8 https://www.humanexasignals.com/companies/casper-pharma 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/companies/casper-pharma-llc 2026-08-16T18:43:27.486Z daily 0.8 https://www.humanexasignals.com/companies/cd30-car-ebvsts 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/companies/cediprof-inc 2026-08-16T18:43:27.336Z daily 0.8 https://www.humanexasignals.com/companies/centaur-pharmaceuticals 2026-08-16T18:43:27.333Z daily 0.8 https://www.humanexasignals.com/companies/centessa-pharmaceuticals 2026-08-16T18:43:27.423Z daily 0.8 https://www.humanexasignals.com/companies/centessa-pharmaceuticals-uk-limited 2026-08-16T18:43:27.717Z daily 0.8 https://www.humanexasignals.com/companies/centocor-ortho-biotech 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/companies/checkmate-pharmaceuticals 2026-08-16T18:43:27.468Z daily 0.8 https://www.humanexasignals.com/companies/chongqing-claruvis-pharmaceutical-co-ltd 2026-08-16T18:43:27.739Z daily 0.8 https://www.humanexasignals.com/companies/cipher-pharmaceuticals 2026-08-16T18:43:27.501Z daily 0.8 https://www.humanexasignals.com/companies/cipher-pharms-inc 2026-08-16T18:43:27.503Z daily 0.8 https://www.humanexasignals.com/companies/cipla-ltd 2026-08-16T18:43:27.279Z daily 0.8 https://www.humanexasignals.com/companies/click-therapeutics 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/companies/clinical-laboratories 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/companies/cmg-pharm-co-ltd 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/companies/cogent-biosciences-inc 2026-08-16T18:43:27.718Z daily 0.8 https://www.humanexasignals.com/companies/collegium-pharma 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/companies/collegium-pharmaceutical 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/companies/competing-pharma-companies 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/companies/competing-pharmaceutical-companies 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/companies/concord-biotech 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/companies/contineum-therapeutics 2026-08-16T18:43:27.340Z daily 0.8 https://www.humanexasignals.com/companies/cope-a 2026-08-16T18:43:27.385Z daily 0.8 https://www.humanexasignals.com/companies/corcept-therapeutics 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/companies/corxel-pharmaceuticals 2026-08-16T18:43:27.519Z daily 0.8 https://www.humanexasignals.com/companies/cour-pharmaceutical 2026-08-16T18:43:27.472Z daily 0.8 https://www.humanexasignals.com/companies/cour-pharmaceutical-development-company-inc 2026-08-16T18:43:27.751Z daily 0.8 https://www.humanexasignals.com/companies/creekwood-pharmaceuticals 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/companies/crescent-pharma-limited 2026-08-16T18:43:27.425Z daily 0.8 https://www.humanexasignals.com/companies/crinetics-pharmaceuticals 2026-08-16T18:43:27.399Z daily 0.8 https://www.humanexasignals.com/companies/crinetics-pharmaceuticals-inc 2026-08-16T18:43:27.702Z daily 0.8 https://www.humanexasignals.com/companies/crispr-therapeutics 2026-08-16T18:43:27.562Z daily 0.8 https://www.humanexasignals.com/companies/cubist-pharmaceuticals 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/companies/cumberland-pharmaceuticals 2026-08-16T18:43:27.371Z daily 0.8 https://www.humanexasignals.com/companies/curaleaf-laboratories 2026-08-16T18:43:27.495Z daily 0.8 https://www.humanexasignals.com/companies/cytodyn 2026-08-16T18:43:27.799Z daily 0.8 https://www.humanexasignals.com/companies/da-302168s 2026-08-16T18:43:27.403Z daily 0.8 https://www.humanexasignals.com/companies/da-epoch-r 2026-08-16T18:43:27.511Z daily 0.8 https://www.humanexasignals.com/companies/dalcor-pharmaceuticals 2026-08-16T18:43:27.518Z daily 0.8 https://www.humanexasignals.com/companies/db-pharma 2026-08-16T18:43:27.543Z daily 0.8 https://www.humanexasignals.com/companies/deciphera-pharmaceuticals 2026-08-16T18:43:27.473Z daily 0.8 https://www.humanexasignals.com/companies/deciphera-pharmaceuticals-llc 2026-08-16T18:43:27.537Z daily 0.8 https://www.humanexasignals.com/companies/dhdds-cdg 2026-08-16T18:43:27.516Z daily 0.8 https://www.humanexasignals.com/companies/dianthus-therapeutics 2026-08-16T18:43:27.511Z daily 0.8 https://www.humanexasignals.com/companies/difgen-pharmaceuticals 2026-08-16T18:43:27.510Z daily 0.8 https://www.humanexasignals.com/companies/digital-health-therapeutics 2026-08-16T18:43:27.325Z daily 0.8 https://www.humanexasignals.com/companies/digital-therapeutics 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/companies/digital-therapeutics-companies 2026-08-16T18:43:27.338Z daily 0.8 https://www.humanexasignals.com/companies/digital-therapeutics-market 2026-08-16T18:43:27.366Z daily 0.8 https://www.humanexasignals.com/companies/dizal-pharmaceuticals 2026-08-16T18:43:27.397Z daily 0.8 https://www.humanexasignals.com/companies/doncaster-pharma-limited 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/companies/dr-reddy-s-laboratories 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/companies/dr-reddy-s-labs 2026-08-16T18:43:27.290Z daily 0.8 https://www.humanexasignals.com/companies/edenbridge-pharmaceuticals 2026-08-16T18:43:27.468Z daily 0.8 https://www.humanexasignals.com/companies/eisai-co-ltd 2026-08-16T18:43:27.470Z daily 0.8 https://www.humanexasignals.com/companies/eisai-inc 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/companies/eisai-korea-inc 2026-08-16T18:43:27.453Z daily 0.8 https://www.humanexasignals.com/companies/elevar-therapeutics 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/companies/eli-lilly 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/companies/elite-labs 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/companies/elite-labs-inc 2026-08-16T18:43:27.397Z daily 0.8 https://www.humanexasignals.com/companies/elpida-therapeutics 2026-08-16T18:43:27.426Z daily 0.8 https://www.humanexasignals.com/companies/epic-pharma 2026-08-16T18:43:27.334Z daily 0.8 https://www.humanexasignals.com/companies/epic-pharma-llc 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/companies/esjay-pharma 2026-08-16T18:43:27.345Z daily 0.8 https://www.humanexasignals.com/companies/eugia-pharma 2026-08-16T18:43:27.292Z daily 0.8 https://www.humanexasignals.com/companies/euraxi-pharma 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/companies/faron-pharmaceuticals 2026-08-16T18:43:27.393Z daily 0.8 https://www.humanexasignals.com/companies/faron-pharmaceuticals-ltd 2026-08-16T18:43:27.697Z daily 0.8 https://www.humanexasignals.com/companies/fdc-ltd 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/companies/feldan-therapeutics 2026-08-16T18:43:27.393Z daily 0.8 https://www.humanexasignals.com/companies/ferring-pharmaceuticals 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/companies/flamingo-pharma-uk-ltd 2026-08-16T18:43:27.476Z daily 0.8 https://www.humanexasignals.com/companies/flex-pharma 2026-08-16T18:43:27.392Z daily 0.8 https://www.humanexasignals.com/companies/flex-pharma-llc 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/companies/fujian-shengdi-pharmaceutical 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/companies/fujian-shengdi-pharmaceutical-co-ltd 2026-08-16T18:43:27.758Z daily 0.8 https://www.humanexasignals.com/companies/g-csf 2026-08-16T18:43:27.442Z daily 0.8 https://www.humanexasignals.com/companies/galderma-laboratories 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/companies/ganzhou-hemay-pharmaceutical-co-ltd 2026-08-16T18:43:27.545Z daily 0.8 https://www.humanexasignals.com/companies/genentech 2026-08-16T18:43:27.557Z daily 0.8 https://www.humanexasignals.com/companies/gilead 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/companies/gland-pharma 2026-08-16T18:43:27.346Z daily 0.8 https://www.humanexasignals.com/companies/glenmark-pharmaceuticals 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/companies/glp-1 2026-08-16T18:43:27.522Z daily 0.8 https://www.humanexasignals.com/companies/glycyx-therapeutics 2026-08-16T18:43:27.512Z daily 0.8 https://www.humanexasignals.com/companies/gout 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/companies/grifols-therapeutics-llc 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/companies/grin-therapeutics-inc 2026-08-16T18:43:27.502Z daily 0.8 https://www.humanexasignals.com/companies/gsk 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/companies/guangdong-hengrui-pharmaceutical-co-ltd 2026-08-16T18:43:27.414Z daily 0.8 https://www.humanexasignals.com/companies/haisco-pharmaceutical 2026-08-16T18:43:27.391Z daily 0.8 https://www.humanexasignals.com/companies/haisco-pharmaceutical-group-co-ltd 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/companies/hangzhou-sumgen-biotech 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/companies/hangzhou-sumgen-biotech-co-ltd 2026-08-16T18:43:27.639Z daily 0.8 https://www.humanexasignals.com/companies/hangzhou-zhongmei-huadong-pharmaceutical 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/companies/hangzhou-zhongmei-huadong-pharmaceutical-co-ltd 2026-08-16T18:43:27.738Z daily 0.8 https://www.humanexasignals.com/companies/hanmi-pharmaceutical-company 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/companies/hanmi-pharmaceutical-company-limited 2026-08-16T18:43:27.634Z daily 0.8 https://www.humanexasignals.com/companies/hematology-pharma-companies 2026-08-16T18:43:27.389Z daily 0.8 https://www.humanexasignals.com/companies/hemo-integra 2026-08-16T18:43:27.398Z daily 0.8 https://www.humanexasignals.com/companies/hengrui-pharma 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/companies/heritage-pharma 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/companies/heritage-pharma-avet 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/companies/hetero-labs 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/companies/hetero-labs-limited 2026-08-16T18:43:27.389Z daily 0.8 https://www.humanexasignals.com/companies/hetero-labs-ltd 2026-08-16T18:43:27.340Z daily 0.8 https://www.humanexasignals.com/companies/hikma 2026-08-16T18:43:27.292Z daily 0.8 https://www.humanexasignals.com/companies/hikma-pharma 2026-08-16T18:43:27.312Z daily 0.8 https://www.humanexasignals.com/companies/hikma-pharmaceuticals 2026-08-16T18:43:27.540Z daily 0.8 https://www.humanexasignals.com/companies/hiv-therapeutics-market-in-malaysia 2026-08-16T18:43:27.483Z daily 0.8 https://www.humanexasignals.com/companies/hiv-focused-pharma-companies 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/companies/hla-g 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/companies/hope-pharmaceuticals 2026-08-16T18:43:27.426Z daily 0.8 https://www.humanexasignals.com/companies/horizon-pharma 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/companies/horizon-therapeutics 2026-08-16T18:43:27.561Z daily 0.8 https://www.humanexasignals.com/companies/hq-spclt-pharma 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/companies/huaren-pharmaceutical 2026-08-16T18:43:27.290Z daily 0.8 https://www.humanexasignals.com/companies/hubei-bio-pharmaceutical-industrial-technological-institute-inc 2026-08-16T18:43:27.442Z daily 0.8 https://www.humanexasignals.com/companies/hypno-vr 2026-08-16T18:43:27.483Z daily 0.8 https://www.humanexasignals.com/companies/ibi-pharma 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/companies/ic-green 2026-08-16T18:43:27.464Z daily 0.8 https://www.humanexasignals.com/companies/idorsia-pharmaceuticals 2026-08-16T18:43:27.478Z daily 0.8 https://www.humanexasignals.com/companies/immunocore 2026-10-25T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/immunology-therapeutics 2026-08-16T18:43:27.423Z daily 0.8 https://www.humanexasignals.com/companies/immunomic-therapeutics 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/companies/immunomic-therapeutics-inc 2026-08-16T18:43:27.758Z daily 0.8 https://www.humanexasignals.com/companies/impax-labs 2026-08-16T18:43:27.303Z daily 0.8 https://www.humanexasignals.com/companies/impede-fx 2026-08-16T18:43:27.439Z daily 0.8 https://www.humanexasignals.com/companies/incyte-corporation 2026-08-16T18:43:27.540Z daily 0.8 https://www.humanexasignals.com/companies/indicus-pharma 2026-08-16T18:43:27.501Z daily 0.8 https://www.humanexasignals.com/companies/ingenus-pharmaceuticals 2026-08-16T18:43:27.335Z daily 0.8 https://www.humanexasignals.com/companies/integrative-research-laboratories-ab 2026-08-16T18:43:27.426Z daily 0.8 https://www.humanexasignals.com/companies/intensity-therapeutics 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/companies/intensity-therapeutics-inc 2026-08-16T18:43:27.639Z daily 0.8 https://www.humanexasignals.com/companies/intra-cellular 2026-08-16T18:43:27.357Z daily 0.8 https://www.humanexasignals.com/companies/invagen-pharmaceuticals 2026-08-16T18:43:27.312Z daily 0.8 https://www.humanexasignals.com/companies/ionis-pharmaceuticals 2026-08-20T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/ionis-pharmaceuticals-inc 2026-08-16T18:43:27.721Z daily 0.8 https://www.humanexasignals.com/companies/ionis-pharms-inc 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/companies/ipca-labs 2026-08-16T18:43:27.290Z daily 0.8 https://www.humanexasignals.com/companies/ipca-labs-ltd 2026-08-16T18:43:27.337Z daily 0.8 https://www.humanexasignals.com/companies/janssen-biotech 2026-08-16T18:43:27.530Z daily 0.8 https://www.humanexasignals.com/companies/janssen-pharmaceutical-k-k 2026-08-16T18:43:27.456Z daily 0.8 https://www.humanexasignals.com/companies/janssen-pharmaceuticals 2026-08-16T18:43:27.556Z daily 0.8 https://www.humanexasignals.com/companies/jazz-pharmaceuticals 2026-08-16T18:43:27.472Z daily 0.8 https://www.humanexasignals.com/companies/jcr-pharmaceuticals 2026-08-16T18:43:27.451Z daily 0.8 https://www.humanexasignals.com/companies/jcr-pharmaceuticals-co-ltd 2026-08-16T18:43:27.733Z daily 0.8 https://www.humanexasignals.com/companies/jiangsu-hansoh-pharma 2026-08-16T18:43:27.557Z daily 0.8 https://www.humanexasignals.com/companies/jiangsu-hansoh-pharmaceutical-co-ltd 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/companies/jiangsu-simcere-pharmaceutical-co-ltd 2026-08-16T18:43:27.514Z daily 0.8 https://www.humanexasignals.com/companies/jiangxi-kvvit-pharmaceutical 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/companies/jiangxi-kvvit-pharmaceutical-co-ltd 2026-08-16T18:43:27.707Z daily 0.8 https://www.humanexasignals.com/companies/jnj-77242113 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/companies/jnj-78934804 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/companies/jnj-79635322 2026-08-16T18:43:27.389Z daily 0.8 https://www.humanexasignals.com/companies/jnj-87562761 2026-08-16T18:43:27.456Z daily 0.8 https://www.humanexasignals.com/companies/jnj-88549968 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/companies/jnj-89402638 2026-08-16T18:43:27.390Z daily 0.8 https://www.humanexasignals.com/companies/johnson-johnson 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/companies/johnson-johnson-medical-shanghai-ltd 2026-08-16T18:43:27.678Z daily 0.8 https://www.humanexasignals.com/companies/karuna-therapeutics 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/companies/king-pharmaceuticals 2026-08-16T18:43:27.327Z daily 0.8 https://www.humanexasignals.com/companies/kiora-pharmaceuticals 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/companies/kiora-pharmaceuticals-inc 2026-08-16T18:43:27.789Z daily 0.8 https://www.humanexasignals.com/companies/kite-pharma 2026-08-16T18:43:27.463Z daily 0.8 https://www.humanexasignals.com/companies/klm-labs 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/companies/knoa-pharma 2026-08-16T18:43:27.491Z daily 0.8 https://www.humanexasignals.com/companies/kshb-biopharma 2026-08-16T18:43:27.543Z daily 0.8 https://www.humanexasignals.com/companies/l-carnitine 2026-08-16T18:43:27.487Z daily 0.8 https://www.humanexasignals.com/companies/l-citrulline 2026-08-16T18:43:27.346Z daily 0.8 https://www.humanexasignals.com/companies/l-glutamine 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/companies/l-ord 2026-08-16T18:43:27.532Z daily 0.8 https://www.humanexasignals.com/companies/larimar-therapeutics 2026-08-16T18:43:27.435Z daily 0.8 https://www.humanexasignals.com/companies/larimar-therapeutics-inc 2026-08-16T18:43:27.724Z daily 0.8 https://www.humanexasignals.com/companies/laurus-labs 2026-08-16T18:43:27.419Z daily 0.8 https://www.humanexasignals.com/companies/lb-dtk-mv 2026-08-16T18:43:27.495Z daily 0.8 https://www.humanexasignals.com/companies/leo-pharma 2026-08-16T18:43:27.448Z daily 0.8 https://www.humanexasignals.com/companies/lexicon-pharmaceuticals 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/companies/lgm-pharma 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/companies/lilly 2026-08-16T18:43:27.553Z daily 0.8 https://www.humanexasignals.com/companies/lnk-intl-inc 2026-08-16T18:43:27.342Z daily 0.8 https://www.humanexasignals.com/companies/lumos-pharma 2026-08-16T18:43:27.447Z daily 0.8 https://www.humanexasignals.com/companies/lupin 2026-08-16T18:43:27.280Z daily 0.8 https://www.humanexasignals.com/companies/lupin-ltd 2026-08-16T18:43:27.526Z daily 0.8 https://www.humanexasignals.com/companies/lupin-pharmaceuticals 2026-08-16T18:43:27.538Z daily 0.8 https://www.humanexasignals.com/companies/m-tapa 2026-08-16T18:43:27.325Z daily 0.8 https://www.humanexasignals.com/companies/macarthys-laboratories-ltd 2026-08-16T18:43:27.395Z daily 0.8 https://www.humanexasignals.com/companies/macleods-pharmaceuticals 2026-08-16T18:43:27.280Z daily 0.8 https://www.humanexasignals.com/companies/madrigal-pharmaceuticals 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/companies/mankind-pharma 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/companies/marksans-pharma 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/companies/mdma-at 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/companies/mediar-therapeutics 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/companies/menacwy-crm 2026-08-16T18:43:27.554Z daily 0.8 https://www.humanexasignals.com/companies/mental-health-pharma-companies 2026-08-16T18:43:27.385Z daily 0.8 https://www.humanexasignals.com/companies/mental-health-pharmaceutical-companies 2026-08-16T18:43:27.406Z daily 0.8 https://www.humanexasignals.com/companies/merck 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/companies/merz 2026-08-16T18:43:27.433Z daily 0.8 https://www.humanexasignals.com/companies/merz-pharmaceuticals 2026-08-16T18:43:27.479Z daily 0.8 https://www.humanexasignals.com/companies/met-4 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/companies/mex-cd1 2026-08-16T18:43:27.303Z daily 0.8 https://www.humanexasignals.com/companies/micro-labs 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/companies/micro-labs-ltd-india 2026-08-16T18:43:27.487Z daily 0.8 https://www.humanexasignals.com/companies/millennium-pharmaceuticals-inc 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/companies/mink-therapeutics 2026-08-16T18:43:27.490Z daily 0.8 https://www.humanexasignals.com/companies/mirati-therapeutics 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/companies/mirati-therapeutics-inc 2026-08-16T18:43:27.585Z daily 0.8 https://www.humanexasignals.com/companies/mirum-pharmaceuticals 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/companies/mirum-pharmaceuticals-inc 2026-08-16T18:43:27.691Z daily 0.8 https://www.humanexasignals.com/companies/moderna 2026-08-16T18:43:27.495Z daily 0.8 https://www.humanexasignals.com/companies/modernatx-inc 2026-08-16T18:43:27.767Z daily 0.8 https://www.humanexasignals.com/companies/mpp-pharma 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/companies/msn-laboratories 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/companies/msn-labs 2026-08-16T18:43:27.342Z daily 0.8 https://www.humanexasignals.com/companies/mtp-101p 2026-08-16T18:43:27.473Z daily 0.8 https://www.humanexasignals.com/companies/mylan 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/companies/mylan-labs 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/companies/mylan-labs-ltd 2026-08-16T18:43:27.343Z daily 0.8 https://www.humanexasignals.com/companies/mylife-diabetes-care-ag 2026-08-16T18:43:27.461Z daily 0.8 https://www.humanexasignals.com/companies/n-acetylcysteine 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/companies/nanjing-immunophage-biotech 2026-08-16T18:43:27.394Z daily 0.8 https://www.humanexasignals.com/companies/nanjing-immunophage-biotech-co-ltd 2026-08-16T18:43:27.698Z daily 0.8 https://www.humanexasignals.com/companies/nanjing-minova-pharmaceutical 2026-08-16T18:43:27.487Z daily 0.8 https://www.humanexasignals.com/companies/nanjing-minova-pharmaceutical-co-ltd 2026-08-16T18:43:27.760Z daily 0.8 https://www.humanexasignals.com/companies/natco-pharma 2026-08-16T18:43:27.497Z daily 0.8 https://www.humanexasignals.com/companies/nbi-1065845 2026-08-16T18:43:27.510Z daily 0.8 https://www.humanexasignals.com/companies/neurobiogen-co-ltd 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/companies/neurology-pharmaceutical-companies 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/companies/newave-pharmaceutical 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/companies/newave-pharmaceutical-inc 2026-08-16T18:43:27.639Z daily 0.8 https://www.humanexasignals.com/companies/nikang-therapeutics 2026-08-16T18:43:27.495Z daily 0.8 https://www.humanexasignals.com/companies/nikang-therapeutics-inc 2026-08-16T18:43:27.766Z daily 0.8 https://www.humanexasignals.com/companies/noom 2026-08-16T18:43:27.494Z daily 0.8 https://www.humanexasignals.com/companies/nostrum-pharmaceuticals 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/companies/nova-labs 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/companies/novartis 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/companies/novartis-pharmaceuticals 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/companies/novast-labs 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/companies/novel-labs 2026-08-16T18:43:27.508Z daily 0.8 https://www.humanexasignals.com/companies/novel-labs-inc 2026-08-16T18:43:27.503Z daily 0.8 https://www.humanexasignals.com/companies/noven-pharmaceuticals 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/companies/novitium-pharma 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/companies/novo-nordisk 2026-09-30T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/nurix-therapeutics 2026-08-16T18:43:27.466Z daily 0.8 https://www.humanexasignals.com/companies/nurix-therapeutics-inc 2026-08-16T18:43:27.743Z daily 0.8 https://www.humanexasignals.com/companies/ocuphire-pharma 2026-08-16T18:43:27.411Z daily 0.8 https://www.humanexasignals.com/companies/ocuphire-pharma-inc 2026-08-16T18:43:27.709Z daily 0.8 https://www.humanexasignals.com/companies/ocusun-ophthalmic-pharmaceutical 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/companies/ocusun-ophthalmic-pharmaceutical-guangzhou-co-ltd 2026-08-16T18:43:27.678Z daily 0.8 https://www.humanexasignals.com/companies/omega-pharma-ltd 2026-08-16T18:43:27.487Z daily 0.8 https://www.humanexasignals.com/companies/omsav-pharma 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/companies/oncology-pharma-companies 2026-08-16T18:43:27.321Z daily 0.8 https://www.humanexasignals.com/companies/oncology-pharmaceutical-companies 2026-08-16T18:43:27.333Z daily 0.8 https://www.humanexasignals.com/companies/oncology-therapeutics 2026-08-16T18:43:27.440Z daily 0.8 https://www.humanexasignals.com/companies/oncology-therapeutics-companies 2026-08-16T18:43:27.529Z daily 0.8 https://www.humanexasignals.com/companies/oncology-therapeutics-market 2026-08-16T18:43:27.441Z daily 0.8 https://www.humanexasignals.com/companies/oncology-focused-pharma-companies 2026-08-16T18:43:27.358Z daily 0.8 https://www.humanexasignals.com/companies/ono-pharmaceutical 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/companies/ono-pharmaceutical-co-ltd 2026-08-16T18:43:27.761Z daily 0.8 https://www.humanexasignals.com/companies/orbit-pharma-limited 2026-08-16T18:43:27.533Z daily 0.8 https://www.humanexasignals.com/companies/orient-pharma 2026-08-16T18:43:27.525Z daily 0.8 https://www.humanexasignals.com/companies/orion-corporation-orion-pharma 2026-08-16T18:43:27.627Z daily 0.8 https://www.humanexasignals.com/companies/osmotica-pharmaceuticals 2026-08-16T18:43:27.509Z daily 0.8 https://www.humanexasignals.com/companies/otsuka-pharmaceutical 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/companies/otsuka-pharmaceutical-development-commercialization-inc 2026-08-16T18:43:27.406Z daily 0.8 https://www.humanexasignals.com/companies/outlook-therapeutics 2026-08-16T18:43:27.354Z daily 0.8 https://www.humanexasignals.com/companies/outlook-therapeutics-inc 2026-08-16T18:43:27.359Z daily 0.8 https://www.humanexasignals.com/companies/pacira-pharmaceuticals 2026-08-16T18:43:27.525Z daily 0.8 https://www.humanexasignals.com/companies/paratek-pharmaceuticals 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/companies/pd-l1 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/companies/peri-implantitis 2026-08-16T18:43:27.389Z daily 0.8 https://www.humanexasignals.com/companies/pfizer 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-focused-on-cognitive-health 2026-08-16T18:43:27.364Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-geriatric-health 2026-08-16T18:43:27.390Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-hypertension 2026-08-16T18:43:27.427Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-infectious-diseases 2026-08-16T18:43:27.512Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-neonatal-therapeutics 2026-08-16T18:43:27.427Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-nephrology 2026-08-16T18:43:27.420Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-neurology 2026-08-16T18:43:27.358Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-obstetrics 2026-08-16T18:43:27.441Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-oncology 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-ophthalmology 2026-08-16T18:43:27.404Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-pain-management 2026-08-16T18:43:27.447Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-involved-in-oncology 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-with-heart-failure-portfolios 2026-08-16T18:43:27.532Z daily 0.8 https://www.humanexasignals.com/companies/pharmaceutical-associates 2026-08-16T18:43:27.510Z daily 0.8 https://www.humanexasignals.com/companies/pharmaceutical-companies-involved-in-infectious-diseases 2026-08-16T18:43:27.433Z daily 0.8 https://www.humanexasignals.com/companies/pharmaceutical-companies-involved-in-mental-health 2026-08-16T18:43:27.446Z daily 0.8 https://www.humanexasignals.com/companies/pharmaceutical-companies-involved-in-oncology 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/companies/pharmaceutical-companies-targeting-cardiovascular-diseases 2026-08-16T18:43:27.521Z daily 0.8 https://www.humanexasignals.com/companies/pharmaceutical-developers 2026-08-16T18:43:27.327Z daily 0.8 https://www.humanexasignals.com/companies/pip-2 2026-08-16T18:43:27.334Z daily 0.8 https://www.humanexasignals.com/companies/pmm2-cdg 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/companies/pom-pharma 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/companies/prevail-therapeutics 2026-08-16T18:43:27.424Z daily 0.8 https://www.humanexasignals.com/companies/protega-pharmaceuticals 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/companies/prs-therapeutics 2026-08-16T18:43:27.799Z daily 0.8 https://www.humanexasignals.com/companies/purdue-pharma 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/companies/qilu-pharm-co-ltd 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/companies/qilu-pharma 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/companies/qlc-biotech 2026-08-16T18:43:27.538Z daily 0.8 https://www.humanexasignals.com/companies/quadrant-pharmaceuticals 2026-08-16T18:43:27.494Z daily 0.8 https://www.humanexasignals.com/companies/quantx-biosciences-inc 2026-08-16T18:43:27.810Z daily 0.8 https://www.humanexasignals.com/companies/quell-therapeutics 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/companies/quell-therapeutics-limited 2026-08-16T18:43:27.756Z daily 0.8 https://www.humanexasignals.com/companies/r-chop 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/companies/ra-ild 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/companies/rayner-pharmaceuticals 2026-08-16T18:43:27.510Z daily 0.8 https://www.humanexasignals.com/companies/regeneron 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/companies/rein-therapeutics 2026-08-16T18:43:27.393Z daily 0.8 https://www.humanexasignals.com/companies/renibus-therapeutics 2026-08-16T18:43:27.404Z daily 0.8 https://www.humanexasignals.com/companies/renibus-therapeutics-inc 2026-08-16T18:43:27.705Z daily 0.8 https://www.humanexasignals.com/companies/rhodes-pharmaceuticals 2026-08-16T18:43:27.490Z daily 0.8 https://www.humanexasignals.com/companies/rk-pharma 2026-08-16T18:43:27.342Z daily 0.8 https://www.humanexasignals.com/companies/roche 2026-08-16T18:43:27.289Z daily 0.8 https://www.humanexasignals.com/companies/s-esp 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/companies/sagent-pharmaceuticals 2026-08-16T18:43:27.384Z daily 0.8 https://www.humanexasignals.com/companies/sandoz 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/companies/sanofi 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/companies/saptalis-pharmaceuticals 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/companies/sarepta-therapeutics 2026-08-16T18:43:27.561Z daily 0.8 https://www.humanexasignals.com/companies/sars-cov-2 2026-08-16T18:43:27.554Z daily 0.8 https://www.humanexasignals.com/companies/satellos-bioscience-inc 2026-08-16T18:43:27.629Z daily 0.8 https://www.humanexasignals.com/companies/sciegen-pharmaceuticals 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/companies/seasons-biotech 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/companies/senores-pharmaceuticals 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/companies/serpin-pharma-llc 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/companies/shandong-new-time-pharmaceutical 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/companies/shandong-new-time-pharmaceutical-co-ltd 2026-08-16T18:43:27.781Z daily 0.8 https://www.humanexasignals.com/companies/shanghai-ark-biopharma 2026-08-16T18:43:27.368Z daily 0.8 https://www.humanexasignals.com/companies/shanghai-aucyun-pharmaceuticals 2026-08-16T18:43:27.419Z daily 0.8 https://www.humanexasignals.com/companies/shanghai-haiyan-pharmaceutical 2026-08-16T18:43:27.474Z daily 0.8 https://www.humanexasignals.com/companies/shanghai-junshi-bioscience-co-ltd 2026-08-16T18:43:27.589Z daily 0.8 https://www.humanexasignals.com/companies/shanghai-microport-endovascular-medtech-group-co-ltd 2026-08-16T18:43:27.698Z daily 0.8 https://www.humanexasignals.com/companies/shr-a1811 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/companies/sichuan-baili-pharmaceutical 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/companies/sichuan-baili-pharmaceutical-co-ltd 2026-08-16T18:43:27.359Z daily 0.8 https://www.humanexasignals.com/companies/sichuan-credit-pharmaceutical-co-ltd 2026-08-16T18:43:27.461Z daily 0.8 https://www.humanexasignals.com/companies/solid-biosciences-inc 2026-08-16T18:43:27.681Z daily 0.8 https://www.humanexasignals.com/companies/sound-pharmaceuticals 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/companies/sound-pharmaceuticals-incorporated 2026-08-16T18:43:27.757Z daily 0.8 https://www.humanexasignals.com/companies/spectrum-pharmaceuticals 2026-08-16T18:43:27.391Z daily 0.8 https://www.humanexasignals.com/companies/spectrum-pharmaceuticals-inc 2026-08-16T18:43:27.696Z daily 0.8 https://www.humanexasignals.com/companies/stemline-therapeutics 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/companies/sterling-pharmaceuticals-ltd 2026-08-16T18:43:27.511Z daily 0.8 https://www.humanexasignals.com/companies/strides-pharma 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/companies/strides-pharma-intl 2026-08-16T18:43:27.492Z daily 0.8 https://www.humanexasignals.com/companies/sumitomo-pharma 2026-08-16T18:43:27.421Z daily 0.8 https://www.humanexasignals.com/companies/sumitomo-pharma-america-inc 2026-08-16T18:43:27.717Z daily 0.8 https://www.humanexasignals.com/companies/sun-pharma 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/companies/sun-pharma-canada 2026-08-16T18:43:27.344Z daily 0.8 https://www.humanexasignals.com/companies/sun-pharma-japan-limited 2026-08-16T18:43:27.750Z daily 0.8 https://www.humanexasignals.com/companies/sun-pharmaceutical-industries 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/companies/sunshine-lake-pharma 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/companies/surge-therapeutics 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/companies/syha-pharmaceuticals 2026-08-16T18:43:27.545Z daily 0.8 https://www.humanexasignals.com/companies/symvivo 2026-08-16T18:43:27.798Z daily 0.8 https://www.humanexasignals.com/companies/takeda 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/companies/tarix-pharmaceuticals 2026-08-16T18:43:27.406Z daily 0.8 https://www.humanexasignals.com/companies/taro 2026-08-16T18:43:27.334Z daily 0.8 https://www.humanexasignals.com/companies/taro-pharmaceuticals 2026-08-16T18:43:27.451Z daily 0.8 https://www.humanexasignals.com/companies/tasly-pharmaceutical 2026-08-16T18:43:27.400Z daily 0.8 https://www.humanexasignals.com/companies/tasly-pharmaceutical-group-co-ltd 2026-08-16T18:43:27.702Z daily 0.8 https://www.humanexasignals.com/companies/teikoku-pharma-usa 2026-08-16T18:43:27.466Z daily 0.8 https://www.humanexasignals.com/companies/teikoku-pharma-usa-inc 2026-08-16T18:43:27.743Z daily 0.8 https://www.humanexasignals.com/companies/teva 2026-08-16T18:43:27.280Z daily 0.8 https://www.humanexasignals.com/companies/teva-branded-pharmaceutical-products-r-d-llc 2026-08-16T18:43:27.787Z daily 0.8 https://www.humanexasignals.com/companies/teva-pharmaceuticals 2026-08-16T18:43:27.529Z daily 0.8 https://www.humanexasignals.com/companies/teva-pharmaceuticals-inc 2026-08-16T18:43:27.541Z daily 0.8 https://www.humanexasignals.com/companies/thea-pharma 2026-08-16T18:43:27.557Z daily 0.8 https://www.humanexasignals.com/companies/th-a-pharma 2026-08-16T18:43:27.801Z daily 0.8 https://www.humanexasignals.com/companies/tim-3 2026-08-16T18:43:27.434Z daily 0.8 https://www.humanexasignals.com/companies/torrent-pharmaceuticals 2026-08-16T18:43:27.329Z daily 0.8 https://www.humanexasignals.com/companies/tqb-biopharma 2026-08-16T18:43:27.543Z daily 0.8 https://www.humanexasignals.com/companies/travere-therapeutics 2026-08-16T18:43:27.373Z daily 0.8 https://www.humanexasignals.com/companies/tris-pharma 2026-08-16T18:43:27.492Z daily 0.8 https://www.humanexasignals.com/companies/tslpr-cart 2026-08-16T18:43:27.327Z daily 0.8 https://www.humanexasignals.com/companies/tyra-biosciences-inc 2026-08-16T18:43:27.742Z daily 0.8 https://www.humanexasignals.com/companies/ucb-biopharma 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/companies/ucb-biopharma-srl 2026-08-16T18:43:27.627Z daily 0.8 https://www.humanexasignals.com/companies/umedica-labs 2026-08-16T18:43:27.321Z daily 0.8 https://www.humanexasignals.com/companies/unique-pharmaceutical-laboratories 2026-08-16T18:43:27.394Z daily 0.8 https://www.humanexasignals.com/companies/united-therapeutics 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/companies/upsher-smith-labs 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/companies/ux-da001 2026-08-16T18:43:27.337Z daily 0.8 https://www.humanexasignals.com/companies/vanda-pharmaceuticals 2026-08-16T18:43:27.346Z daily 0.8 https://www.humanexasignals.com/companies/vera-therapeutics 2026-08-16T18:43:27.434Z daily 0.8 https://www.humanexasignals.com/companies/vertex-pharmaceuticals 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/companies/vertex-pharmaceuticals-incorporated 2026-08-16T18:43:27.740Z daily 0.8 https://www.humanexasignals.com/companies/veterinary-pharmaceutical-companies 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/companies/veterinary-pharmaceuticals 2026-08-16T18:43:27.378Z daily 0.8 https://www.humanexasignals.com/companies/viridian-therapeutics 2026-08-16T18:43:27.473Z daily 0.8 https://www.humanexasignals.com/companies/viridian-therapeutics-inc 2026-08-16T18:43:27.769Z daily 0.8 https://www.humanexasignals.com/companies/wanbangde-pharmaceutical-group 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/companies/wanbangde-pharmaceutical-group-co-ltd 2026-08-16T18:43:27.629Z daily 0.8 https://www.humanexasignals.com/companies/watson-labs 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/companies/watson-labs-inc 2026-08-16T18:43:27.292Z daily 0.8 https://www.humanexasignals.com/companies/watson-labs-teva 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/companies/women-s-health-pharma-companies 2026-08-16T18:43:27.398Z daily 0.8 https://www.humanexasignals.com/companies/xmab541 2026-08-16T18:43:27.289Z daily 0.8 https://www.humanexasignals.com/companies/xyone-therapeutics 2026-08-16T18:43:27.493Z daily 0.8 https://www.humanexasignals.com/companies/xyone-therapeutics-inc 2026-08-16T18:43:27.764Z daily 0.8 https://www.humanexasignals.com/companies/zealand-pharma 2026-08-16T18:43:27.501Z daily 0.8 https://www.humanexasignals.com/companies/zenocutuzumab-zbco 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/companies/zydus-pharmaceuticals 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/18f-dpa-714 2026-08-16T18:43:27.634Z daily 0.8 https://www.humanexasignals.com/assets/11c-armi 2026-08-16T18:43:27.709Z daily 0.8 https://www.humanexasignals.com/assets/18f-aipf-1026 2026-08-16T18:43:27.736Z daily 0.8 https://www.humanexasignals.com/assets/18f-fdopa 2026-08-16T18:43:27.761Z daily 0.8 https://www.humanexasignals.com/assets/18f-fluciclovine 2026-08-16T18:43:27.687Z daily 0.8 https://www.humanexasignals.com/assets/4-component-strep 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/8-chloroadenosine 2026-08-16T18:43:27.785Z daily 0.8 https://www.humanexasignals.com/assets/a350-anesthesia-machine 2026-08-16T18:43:27.594Z daily 0.8 https://www.humanexasignals.com/assets/aarxion-anda-hlding 2026-08-16T18:43:27.602Z daily 0.8 https://www.humanexasignals.com/assets/aavb-039 2026-08-16T18:43:27.509Z daily 0.8 https://www.humanexasignals.com/assets/ab-3028 2026-08-16T18:43:27.640Z daily 0.8 https://www.humanexasignals.com/assets/abaloparatide 2026-08-16T18:43:27.371Z daily 0.8 https://www.humanexasignals.com/assets/abbv-706 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/abbv-722 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/assets/abbv-932 2026-08-16T18:43:27.535Z daily 0.8 https://www.humanexasignals.com/assets/abcl575 2026-08-16T18:43:27.520Z daily 0.8 https://www.humanexasignals.com/assets/abelacimab 2026-08-16T18:43:27.424Z daily 0.8 https://www.humanexasignals.com/assets/abemaciclib 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/assets/abhai-llc 2026-08-16T18:43:27.612Z daily 0.8 https://www.humanexasignals.com/assets/abiomed 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/abiraterone-acetate 2026-08-16T18:43:27.704Z daily 0.8 https://www.humanexasignals.com/assets/abrocitinib 2026-08-16T18:43:27.444Z daily 0.8 https://www.humanexasignals.com/assets/absorica 2026-08-16T18:43:27.289Z daily 0.8 https://www.humanexasignals.com/assets/absorica-ld 2026-08-16T18:43:27.794Z daily 0.8 https://www.humanexasignals.com/assets/accord 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/assets/acelity 2026-08-16T18:43:27.542Z daily 0.8 https://www.humanexasignals.com/assets/acer-001 2026-08-16T18:43:27.312Z daily 0.8 https://www.humanexasignals.com/assets/acetazolamide 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/assets/acetazolamide-sodium 2026-08-16T18:43:27.617Z daily 0.8 https://www.humanexasignals.com/assets/aciclovir 2026-08-16T18:43:27.434Z daily 0.8 https://www.humanexasignals.com/assets/acp-001 2026-08-16T18:43:27.445Z daily 0.8 https://www.humanexasignals.com/assets/acp-204 2026-08-16T18:43:27.545Z daily 0.8 https://www.humanexasignals.com/assets/acp-501 2026-08-16T18:43:27.504Z daily 0.8 https://www.humanexasignals.com/assets/acs-dobfar 2026-08-16T18:43:27.644Z daily 0.8 https://www.humanexasignals.com/assets/actavis 2026-08-16T18:43:27.375Z daily 0.8 https://www.humanexasignals.com/assets/actavis-mid-atlantic 2026-08-16T18:43:27.731Z daily 0.8 https://www.humanexasignals.com/assets/actelion 2026-08-16T18:43:27.307Z daily 0.8 https://www.humanexasignals.com/assets/active-psoriatic 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/assets/acupuncture 2026-08-16T18:43:27.447Z daily 0.8 https://www.humanexasignals.com/assets/acyclovir 2026-08-16T18:43:27.445Z daily 0.8 https://www.humanexasignals.com/assets/adagrasib 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/assets/adapalene 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/assets/adapting 2026-08-16T18:43:27.446Z daily 0.8 https://www.humanexasignals.com/assets/adempas 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/assets/adequan-canine 2026-08-16T18:43:27.573Z daily 0.8 https://www.humanexasignals.com/assets/adhera 2026-08-16T18:43:27.358Z daily 0.8 https://www.humanexasignals.com/assets/adjuvant-chemotherapy 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/adrenalin 2026-08-16T18:43:27.386Z daily 0.8 https://www.humanexasignals.com/assets/adults-aged 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/advancements 2026-08-16T18:43:27.325Z daily 0.8 https://www.humanexasignals.com/assets/advances 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/adx-038 2026-08-16T18:43:27.317Z daily 0.8 https://www.humanexasignals.com/assets/afatinib 2026-08-16T18:43:27.408Z daily 0.8 https://www.humanexasignals.com/assets/aficamten 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/afimkibart 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/assets/afinitor 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/afinitor-disperz 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/aflibercept 2026-08-16T18:43:27.343Z daily 0.8 https://www.humanexasignals.com/assets/afrezza 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/aftx-201 2026-08-16T18:43:27.479Z daily 0.8 https://www.humanexasignals.com/assets/agile 2026-08-16T18:43:27.499Z daily 0.8 https://www.humanexasignals.com/assets/agios 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/assets/agn-151586 2026-08-16T18:43:27.492Z daily 0.8 https://www.humanexasignals.com/assets/ahb-171 2026-08-16T18:43:27.409Z daily 0.8 https://www.humanexasignals.com/assets/ai 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/aim 2026-08-16T18:43:27.329Z daily 0.8 https://www.humanexasignals.com/assets/aim-cd5l 2026-08-16T18:43:27.805Z daily 0.8 https://www.humanexasignals.com/assets/airsupra 2026-08-16T18:43:27.350Z daily 0.8 https://www.humanexasignals.com/assets/ajanta 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/assets/ajovy 2026-08-16T18:43:27.485Z daily 0.8 https://www.humanexasignals.com/assets/akebia 2026-08-16T18:43:27.409Z daily 0.8 https://www.humanexasignals.com/assets/akkermansia 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/albuterol-sulfate 2026-08-16T18:43:27.620Z daily 0.8 https://www.humanexasignals.com/assets/alcon 2026-08-16T18:43:27.360Z daily 0.8 https://www.humanexasignals.com/assets/alecensa 2026-08-16T18:43:27.534Z daily 0.8 https://www.humanexasignals.com/assets/alectinib 2026-08-16T18:43:27.424Z daily 0.8 https://www.humanexasignals.com/assets/alembic 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/assets/alendronate-sodium 2026-08-16T18:43:27.612Z daily 0.8 https://www.humanexasignals.com/assets/alexion 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/alfuzosin-hydrochloride 2026-08-16T18:43:27.809Z daily 0.8 https://www.humanexasignals.com/assets/alhemo 2026-08-16T18:43:27.357Z daily 0.8 https://www.humanexasignals.com/assets/alimatravir 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/alkermes 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/allergy 2026-08-16T18:43:27.540Z daily 0.8 https://www.humanexasignals.com/assets/allopurinol 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/assets/allurion 2026-08-16T18:43:27.429Z daily 0.8 https://www.humanexasignals.com/assets/almaject 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/almus 2026-08-16T18:43:27.513Z daily 0.8 https://www.humanexasignals.com/assets/aln-2232 2026-08-16T18:43:27.373Z daily 0.8 https://www.humanexasignals.com/assets/aln-6222 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/alpelisib 2026-08-16T18:43:27.340Z daily 0.8 https://www.humanexasignals.com/assets/altace-ramipril 2026-08-16T18:43:27.327Z daily 0.8 https://www.humanexasignals.com/assets/altered 2026-08-16T18:43:27.485Z daily 0.8 https://www.humanexasignals.com/assets/alv-100 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/assets/alvelestat-mph966 2026-08-16T18:43:27.327Z daily 0.8 https://www.humanexasignals.com/assets/alvogen 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/amantadine-hydrochloride 2026-08-16T18:43:27.649Z daily 0.8 https://www.humanexasignals.com/assets/amazon 2026-08-16T18:43:27.522Z daily 0.8 https://www.humanexasignals.com/assets/ambient-shipping 2026-08-16T18:43:27.520Z daily 0.8 https://www.humanexasignals.com/assets/ambtx-01 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/assets/american 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/amg-691 2026-08-16T18:43:27.786Z daily 0.8 https://www.humanexasignals.com/assets/amino 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/amivantamab 2026-08-16T18:43:27.303Z daily 0.8 https://www.humanexasignals.com/assets/amivas 2026-08-16T18:43:27.373Z daily 0.8 https://www.humanexasignals.com/assets/amlodipine-besylate 2026-08-16T18:43:27.652Z daily 0.8 https://www.humanexasignals.com/assets/ammoxetine-hydrochloride 2026-08-16T18:43:27.726Z daily 0.8 https://www.humanexasignals.com/assets/amneal 2026-08-16T18:43:27.290Z daily 0.8 https://www.humanexasignals.com/assets/amo959 2026-08-16T18:43:27.364Z daily 0.8 https://www.humanexasignals.com/assets/ampicillin 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/amvuttra 2026-08-16T18:43:27.562Z daily 0.8 https://www.humanexasignals.com/assets/amxt-1501 2026-08-16T18:43:27.789Z daily 0.8 https://www.humanexasignals.com/assets/an4035 2026-08-16T18:43:27.414Z daily 0.8 https://www.humanexasignals.com/assets/an9025 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/analysis 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/anda213093 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/assets/anda217477 2026-08-16T18:43:27.357Z daily 0.8 https://www.humanexasignals.com/assets/anda219207 2026-08-16T18:43:27.419Z daily 0.8 https://www.humanexasignals.com/assets/anda219413 2026-08-16T18:43:27.541Z daily 0.8 https://www.humanexasignals.com/assets/anda220197 2026-08-16T18:43:27.419Z daily 0.8 https://www.humanexasignals.com/assets/anda220465 2026-08-16T18:43:27.398Z daily 0.8 https://www.humanexasignals.com/assets/anda220499 2026-08-16T18:43:27.416Z daily 0.8 https://www.humanexasignals.com/assets/anda220639 2026-08-16T18:43:27.540Z daily 0.8 https://www.humanexasignals.com/assets/anda220724 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/anesthesia 2026-08-16T18:43:27.558Z daily 0.8 https://www.humanexasignals.com/assets/ang003 2026-08-16T18:43:27.443Z daily 0.8 https://www.humanexasignals.com/assets/ani 2026-08-16T18:43:27.335Z daily 0.8 https://www.humanexasignals.com/assets/anifrolumab 2026-08-16T18:43:27.448Z daily 0.8 https://www.humanexasignals.com/assets/anrs 2026-08-16T18:43:27.675Z daily 0.8 https://www.humanexasignals.com/assets/anthea 2026-08-16T18:43:27.463Z daily 0.8 https://www.humanexasignals.com/assets/antitumor-immunity 2026-08-16T18:43:27.496Z daily 0.8 https://www.humanexasignals.com/assets/anvisa 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/aortic-stenosis 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/assets/apalutamide 2026-08-16T18:43:27.396Z daily 0.8 https://www.humanexasignals.com/assets/apg777 2026-08-16T18:43:27.474Z daily 0.8 https://www.humanexasignals.com/assets/apixaban 2026-08-16T18:43:27.494Z daily 0.8 https://www.humanexasignals.com/assets/apoquel 2026-08-16T18:43:27.472Z daily 0.8 https://www.humanexasignals.com/assets/apotex 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/assets/appco 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/assets/aquamin 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/assets/aquatic 2026-08-16T18:43:27.397Z daily 0.8 https://www.humanexasignals.com/assets/arcutis 2026-08-16T18:43:27.450Z daily 0.8 https://www.humanexasignals.com/assets/argatroban 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/argenx 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/assets/argenx-bv 2026-08-16T18:43:27.580Z daily 0.8 https://www.humanexasignals.com/assets/aripiprazole 2026-08-16T18:43:27.429Z daily 0.8 https://www.humanexasignals.com/assets/arn-509 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/asciminib 2026-08-16T18:43:27.343Z daily 0.8 https://www.humanexasignals.com/assets/asp1570 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/asp2138 2026-08-16T18:43:27.375Z daily 0.8 https://www.humanexasignals.com/assets/asp2246 2026-08-16T18:43:27.470Z daily 0.8 https://www.humanexasignals.com/assets/aspirin 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/aspiro 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/assets/astellas 2026-08-16T18:43:27.356Z daily 0.8 https://www.humanexasignals.com/assets/astx727 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/atebimetinib 2026-08-16T18:43:27.437Z daily 0.8 https://www.humanexasignals.com/assets/atezolizumab 2026-08-16T18:43:27.343Z daily 0.8 https://www.humanexasignals.com/assets/atogepant 2026-08-16T18:43:27.422Z daily 0.8 https://www.humanexasignals.com/assets/atomoxetine 2026-08-16T18:43:27.476Z daily 0.8 https://www.humanexasignals.com/assets/atomoxetine-hydrochloride 2026-08-16T18:43:27.623Z daily 0.8 https://www.humanexasignals.com/assets/atorvastatin 2026-08-16T18:43:27.619Z daily 0.8 https://www.humanexasignals.com/assets/atovaquone 2026-08-16T18:43:27.519Z daily 0.8 https://www.humanexasignals.com/assets/atrasentan 2026-08-16T18:43:27.420Z daily 0.8 https://www.humanexasignals.com/assets/atropine 2026-08-16T18:43:27.422Z daily 0.8 https://www.humanexasignals.com/assets/atropine-sulfate 2026-08-16T18:43:27.656Z daily 0.8 https://www.humanexasignals.com/assets/atv-1601 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/assets/aucta 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/aurobindo 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/auson 2026-08-16T18:43:27.525Z daily 0.8 https://www.humanexasignals.com/assets/avapro 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/avelumab 2026-08-16T18:43:27.367Z daily 0.8 https://www.humanexasignals.com/assets/avet-lifesciences 2026-08-16T18:43:27.661Z daily 0.8 https://www.humanexasignals.com/assets/avidity 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/assets/avutometinib 2026-08-16T18:43:27.697Z daily 0.8 https://www.humanexasignals.com/assets/avyxa-holdings 2026-08-16T18:43:27.758Z daily 0.8 https://www.humanexasignals.com/assets/axelios-1 2026-08-16T18:43:27.591Z daily 0.8 https://www.humanexasignals.com/assets/axitinib 2026-08-16T18:43:27.499Z daily 0.8 https://www.humanexasignals.com/assets/axsome 2026-08-16T18:43:27.340Z daily 0.8 https://www.humanexasignals.com/assets/ayvakit 2026-08-16T18:43:27.561Z daily 0.8 https://www.humanexasignals.com/assets/azacitidine 2026-08-16T18:43:27.470Z daily 0.8 https://www.humanexasignals.com/assets/azathioprine 2026-08-16T18:43:27.381Z daily 0.8 https://www.humanexasignals.com/assets/azd0120 2026-08-16T18:43:27.378Z daily 0.8 https://www.humanexasignals.com/assets/azd0516 2026-08-16T18:43:27.352Z daily 0.8 https://www.humanexasignals.com/assets/azd1043 2026-08-16T18:43:27.335Z daily 0.8 https://www.humanexasignals.com/assets/azd4512 2026-08-16T18:43:27.394Z daily 0.8 https://www.humanexasignals.com/assets/azd4954 2026-08-16T18:43:27.408Z daily 0.8 https://www.humanexasignals.com/assets/azd5004 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/azd5148 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/azd6234 2026-08-16T18:43:27.359Z daily 0.8 https://www.humanexasignals.com/assets/azd6793 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/azd7442 2026-08-16T18:43:27.425Z daily 0.8 https://www.humanexasignals.com/assets/azd9574 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/azd9829 2026-08-16T18:43:27.462Z daily 0.8 https://www.humanexasignals.com/assets/azelastine-hydrochloride 2026-08-16T18:43:27.693Z daily 0.8 https://www.humanexasignals.com/assets/azurity 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/b 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/b-braun 2026-08-16T18:43:27.677Z daily 0.8 https://www.humanexasignals.com/assets/baclofen 2026-08-16T18:43:27.513Z daily 0.8 https://www.humanexasignals.com/assets/bakuchiol 2026-08-16T18:43:27.436Z daily 0.8 https://www.humanexasignals.com/assets/bal0891 2026-08-16T18:43:27.542Z daily 0.8 https://www.humanexasignals.com/assets/baricitinib 2026-08-16T18:43:27.395Z daily 0.8 https://www.humanexasignals.com/assets/baroque 2026-08-16T18:43:27.345Z daily 0.8 https://www.humanexasignals.com/assets/barr 2026-08-16T18:43:27.607Z daily 0.8 https://www.humanexasignals.com/assets/barrett 2026-08-16T18:43:27.391Z daily 0.8 https://www.humanexasignals.com/assets/bausch 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/assets/baxdrostat 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/assets/baxfendy 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/baxter 2026-08-16T18:43:27.303Z daily 0.8 https://www.humanexasignals.com/assets/bay2862789 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/bbt001 2026-08-16T18:43:27.428Z daily 0.8 https://www.humanexasignals.com/assets/bcb-276 2026-08-16T18:43:27.468Z daily 0.8 https://www.humanexasignals.com/assets/bcl6 2026-08-16T18:43:27.523Z daily 0.8 https://www.humanexasignals.com/assets/bd 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/bd2-llc 2026-08-16T18:43:27.745Z daily 0.8 https://www.humanexasignals.com/assets/bdsi 2026-08-16T18:43:27.769Z daily 0.8 https://www.humanexasignals.com/assets/be-pharms 2026-08-16T18:43:27.604Z daily 0.8 https://www.humanexasignals.com/assets/beatrix 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/belantamab 2026-08-16T18:43:27.753Z daily 0.8 https://www.humanexasignals.com/assets/belbuca 2026-08-16T18:43:27.499Z daily 0.8 https://www.humanexasignals.com/assets/beloteca 2026-08-16T18:43:27.416Z daily 0.8 https://www.humanexasignals.com/assets/belvarafenib 2026-08-16T18:43:27.463Z daily 0.8 https://www.humanexasignals.com/assets/belzutifan 2026-08-16T18:43:27.340Z daily 0.8 https://www.humanexasignals.com/assets/benzylpenicillin-benzathine 2026-08-16T18:43:27.811Z daily 0.8 https://www.humanexasignals.com/assets/beone-medicines 2026-08-16T18:43:27.580Z daily 0.8 https://www.humanexasignals.com/assets/beqalzi 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/assets/berobenatide 2026-08-16T18:43:27.552Z daily 0.8 https://www.humanexasignals.com/assets/besremi 2026-08-16T18:43:27.477Z daily 0.8 https://www.humanexasignals.com/assets/betamethasone 2026-08-16T18:43:27.478Z daily 0.8 https://www.humanexasignals.com/assets/bevacizumab 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/bexmarilimab 2026-08-16T18:43:27.393Z daily 0.8 https://www.humanexasignals.com/assets/bezuclastinib 2026-08-16T18:43:27.423Z daily 0.8 https://www.humanexasignals.com/assets/bg-75202 2026-08-16T18:43:27.371Z daily 0.8 https://www.humanexasignals.com/assets/bgb-16673 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/bgb-43395 2026-08-16T18:43:27.431Z daily 0.8 https://www.humanexasignals.com/assets/bgb-45035 2026-08-16T18:43:27.533Z daily 0.8 https://www.humanexasignals.com/assets/bh3120 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/bhutan 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/bhv-1300 2026-08-16T18:43:27.483Z daily 0.8 https://www.humanexasignals.com/assets/bhv-3000 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/assets/bi 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/biib080 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/biib141-omaveloxolone 2026-08-16T18:43:27.431Z daily 0.8 https://www.humanexasignals.com/assets/biktarvy 2026-08-16T18:43:27.309Z daily 0.8 https://www.humanexasignals.com/assets/bimekizumab 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/binimetinib 2026-08-16T18:43:27.495Z daily 0.8 https://www.humanexasignals.com/assets/biobank 2026-08-16T18:43:27.554Z daily 0.8 https://www.humanexasignals.com/assets/biocodex 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/bionpharma 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/assets/bizengri 2026-08-16T18:43:27.423Z daily 0.8 https://www.humanexasignals.com/assets/bla761298 2026-08-16T18:43:27.349Z daily 0.8 https://www.humanexasignals.com/assets/bla761376 2026-08-16T18:43:27.325Z daily 0.8 https://www.humanexasignals.com/assets/bla761460 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/assets/bla761530 2026-08-16T18:43:27.473Z daily 0.8 https://www.humanexasignals.com/assets/black 2026-08-16T18:43:27.462Z daily 0.8 https://www.humanexasignals.com/assets/bladder-control 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/assets/blinatumomab 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/assets/blood-cancers 2026-08-16T18:43:27.327Z daily 0.8 https://www.humanexasignals.com/assets/blu-5937 2026-08-16T18:43:27.545Z daily 0.8 https://www.humanexasignals.com/assets/bms-986435 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/bms-986504 2026-08-16T18:43:27.502Z daily 0.8 https://www.humanexasignals.com/assets/bnt323 2026-08-16T18:43:27.543Z daily 0.8 https://www.humanexasignals.com/assets/bnt324 2026-08-16T18:43:27.389Z daily 0.8 https://www.humanexasignals.com/assets/bnt327 2026-08-16T18:43:27.561Z daily 0.8 https://www.humanexasignals.com/assets/boehringer 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/bomedemstat 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/assets/bosentan 2026-08-16T18:43:27.371Z daily 0.8 https://www.humanexasignals.com/assets/bostal 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/boston 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/bosutinib 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/assets/botensilimab 2026-08-16T18:43:27.458Z daily 0.8 https://www.humanexasignals.com/assets/botox 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/bpl-003 2026-08-16T18:43:27.413Z daily 0.8 https://www.humanexasignals.com/assets/bracco 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/assets/braftovi 2026-08-16T18:43:27.553Z daily 0.8 https://www.humanexasignals.com/assets/brancaster 2026-08-16T18:43:27.483Z daily 0.8 https://www.humanexasignals.com/assets/brave 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/breckenridge 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/brentuximab 2026-08-16T18:43:27.428Z daily 0.8 https://www.humanexasignals.com/assets/brenzavvy 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/brexafemme 2026-08-16T18:43:27.356Z daily 0.8 https://www.humanexasignals.com/assets/brii-835 2026-08-16T18:43:27.685Z daily 0.8 https://www.humanexasignals.com/assets/brilinta 2026-08-16T18:43:27.331Z daily 0.8 https://www.humanexasignals.com/assets/brimonidine-tartrate 2026-08-16T18:43:27.621Z daily 0.8 https://www.humanexasignals.com/assets/brincidofovir 2026-08-16T18:43:27.433Z daily 0.8 https://www.humanexasignals.com/assets/bristol 2026-08-16T18:43:27.449Z daily 0.8 https://www.humanexasignals.com/assets/bristol-myers 2026-08-16T18:43:27.290Z daily 0.8 https://www.humanexasignals.com/assets/brivaracetam 2026-08-16T18:43:27.290Z daily 0.8 https://www.humanexasignals.com/assets/brodalumab 2026-08-16T18:43:27.719Z daily 0.8 https://www.humanexasignals.com/assets/bruceine 2026-08-16T18:43:27.380Z daily 0.8 https://www.humanexasignals.com/assets/bsafe 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/bst-236 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/assets/bt7480 2026-08-16T18:43:27.471Z daily 0.8 https://www.humanexasignals.com/assets/btl-043 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/assets/budesonide 2026-08-16T18:43:27.478Z daily 0.8 https://www.humanexasignals.com/assets/budesonide-and-formoterol-fumarate-dihydrate 2026-08-16T18:43:27.676Z daily 0.8 https://www.humanexasignals.com/assets/budget 2026-08-16T18:43:27.528Z daily 0.8 https://www.humanexasignals.com/assets/bulevirtide 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/assets/buloxibutid 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/bupivacaine 2026-08-16T18:43:27.508Z daily 0.8 https://www.humanexasignals.com/assets/bupivacaine-hydrochloride 2026-08-16T18:43:27.564Z daily 0.8 https://www.humanexasignals.com/assets/buprenorphine 2026-08-16T18:43:27.489Z daily 0.8 https://www.humanexasignals.com/assets/buprenorphine-hydrochloride 2026-08-16T18:43:27.682Z daily 0.8 https://www.humanexasignals.com/assets/bupropion-hydrochloride 2026-08-16T18:43:27.606Z daily 0.8 https://www.humanexasignals.com/assets/buspirone-hydrochloride 2026-08-16T18:43:27.682Z daily 0.8 https://www.humanexasignals.com/assets/butrans 2026-08-16T18:43:27.499Z daily 0.8 https://www.humanexasignals.com/assets/cab-ula 2026-08-16T18:43:27.784Z daily 0.8 https://www.humanexasignals.com/assets/caba-201 2026-08-16T18:43:27.443Z daily 0.8 https://www.humanexasignals.com/assets/cabg 2026-08-16T18:43:27.695Z daily 0.8 https://www.humanexasignals.com/assets/cabotegravir 2026-08-16T18:43:27.417Z daily 0.8 https://www.humanexasignals.com/assets/cabozantinib 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/cadila 2026-08-16T18:43:27.518Z daily 0.8 https://www.humanexasignals.com/assets/cadonilimab 2026-08-16T18:43:27.404Z daily 0.8 https://www.humanexasignals.com/assets/calcipotriene 2026-08-16T18:43:27.679Z daily 0.8 https://www.humanexasignals.com/assets/calcium-acetate 2026-08-16T18:43:27.662Z daily 0.8 https://www.humanexasignals.com/assets/calderasib 2026-08-16T18:43:27.547Z daily 0.8 https://www.humanexasignals.com/assets/camizestrant 2026-08-16T18:43:27.551Z daily 0.8 https://www.humanexasignals.com/assets/canagliflozin 2026-08-16T18:43:27.360Z daily 0.8 https://www.humanexasignals.com/assets/canakinumab 2026-08-16T18:43:27.448Z daily 0.8 https://www.humanexasignals.com/assets/cangrelor 2026-08-16T18:43:27.375Z daily 0.8 https://www.humanexasignals.com/assets/capecitabine 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/assets/capivasertib 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/assets/caplin 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/assets/caplyta 2026-08-16T18:43:27.357Z daily 0.8 https://www.humanexasignals.com/assets/capture 2026-08-16T18:43:27.433Z daily 0.8 https://www.humanexasignals.com/assets/capvaxive 2026-08-16T18:43:27.536Z daily 0.8 https://www.humanexasignals.com/assets/carbamazepine 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/assets/carbidopa 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/carboplatin 2026-08-16T18:43:27.338Z daily 0.8 https://www.humanexasignals.com/assets/carboprost-tromethamine 2026-08-16T18:43:27.642Z daily 0.8 https://www.humanexasignals.com/assets/cardiff 2026-08-16T18:43:27.541Z daily 0.8 https://www.humanexasignals.com/assets/cardiology 2026-08-16T18:43:27.539Z daily 0.8 https://www.humanexasignals.com/assets/carestations 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/carfilzomib 2026-08-16T18:43:27.379Z daily 0.8 https://www.humanexasignals.com/assets/carmustine 2026-08-16T18:43:27.513Z daily 0.8 https://www.humanexasignals.com/assets/carnegie 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/casdatifan 2026-08-16T18:43:27.560Z daily 0.8 https://www.humanexasignals.com/assets/casgevy 2026-08-16T18:43:27.476Z daily 0.8 https://www.humanexasignals.com/assets/catalent 2026-08-16T18:43:27.480Z daily 0.8 https://www.humanexasignals.com/assets/cavhanza 2026-08-16T18:43:27.392Z daily 0.8 https://www.humanexasignals.com/assets/cbd 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/ccl2 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/ccr7 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/ccta 2026-08-16T18:43:27.365Z daily 0.8 https://www.humanexasignals.com/assets/cd19-car-t-cells 2026-08-16T18:43:27.748Z daily 0.8 https://www.humanexasignals.com/assets/cdds 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/assets/cefazolin 2026-08-16T18:43:27.532Z daily 0.8 https://www.humanexasignals.com/assets/cefixime 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/celecoxib 2026-08-16T18:43:27.381Z daily 0.8 https://www.humanexasignals.com/assets/celltrion 2026-08-16T18:43:27.450Z daily 0.8 https://www.humanexasignals.com/assets/cemiplimab 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/cenobamate 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/assets/cenpi 2026-08-16T18:43:27.465Z daily 0.8 https://www.humanexasignals.com/assets/center-for-neuroscience-and-regenerative-medicine 2026-08-16T18:43:27.729Z daily 0.8 https://www.humanexasignals.com/assets/cephalexin 2026-08-16T18:43:27.525Z daily 0.8 https://www.humanexasignals.com/assets/cervavac 2026-08-16T18:43:27.698Z daily 0.8 https://www.humanexasignals.com/assets/cetirizine-hydrochloride 2026-08-16T18:43:27.563Z daily 0.8 https://www.humanexasignals.com/assets/cetrelimab 2026-08-16T18:43:27.346Z daily 0.8 https://www.humanexasignals.com/assets/cetrorelix-acetate 2026-08-16T18:43:27.735Z daily 0.8 https://www.humanexasignals.com/assets/cetuximab 2026-08-16T18:43:27.447Z daily 0.8 https://www.humanexasignals.com/assets/cevostamab 2026-08-16T18:43:27.472Z daily 0.8 https://www.humanexasignals.com/assets/chaf1a 2026-08-16T18:43:27.342Z daily 0.8 https://www.humanexasignals.com/assets/challenges 2026-08-16T18:43:27.429Z daily 0.8 https://www.humanexasignals.com/assets/characterization 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/chartwell 2026-08-16T18:43:27.499Z daily 0.8 https://www.humanexasignals.com/assets/chemoimmunotherapy 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/assets/cheplapharm 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/assets/chidamide 2026-08-16T18:43:27.536Z daily 0.8 https://www.humanexasignals.com/assets/chiesi 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/assets/chimeric 2026-08-16T18:43:27.469Z daily 0.8 https://www.humanexasignals.com/assets/china 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/assets/chlorhexidine 2026-08-16T18:43:27.325Z daily 0.8 https://www.humanexasignals.com/assets/chlorthalidone 2026-08-16T18:43:27.447Z daily 0.8 https://www.humanexasignals.com/assets/chronic-hbv 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/chronic-kidney 2026-08-16T18:43:27.437Z daily 0.8 https://www.humanexasignals.com/assets/cibinqo 2026-08-16T18:43:27.444Z daily 0.8 https://www.humanexasignals.com/assets/ciclopirox 2026-08-16T18:43:27.344Z daily 0.8 https://www.humanexasignals.com/assets/ciltacabtagene 2026-08-16T18:43:27.309Z daily 0.8 https://www.humanexasignals.com/assets/cipla 2026-08-16T18:43:27.281Z daily 0.8 https://www.humanexasignals.com/assets/ciprofloxacin-hydrochloride 2026-08-16T18:43:27.613Z daily 0.8 https://www.humanexasignals.com/assets/circular 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/assets/citruslabs 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/cladribine 2026-08-16T18:43:27.336Z daily 0.8 https://www.humanexasignals.com/assets/claseprubart 2026-08-16T18:43:27.511Z daily 0.8 https://www.humanexasignals.com/assets/cldn18-2-positive-advanced-gastric-cancers 2026-08-16T18:43:27.583Z daily 0.8 https://www.humanexasignals.com/assets/cleerly 2026-08-16T18:43:27.433Z daily 0.8 https://www.humanexasignals.com/assets/cleminorexton 2026-08-16T18:43:27.423Z daily 0.8 https://www.humanexasignals.com/assets/cleocin 2026-08-16T18:43:27.309Z daily 0.8 https://www.humanexasignals.com/assets/clindamycin-phosphate 2026-08-16T18:43:27.692Z daily 0.8 https://www.humanexasignals.com/assets/clinical 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/clinical-development-teams 2026-08-16T18:43:27.706Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guideline-committees 2026-08-16T18:43:27.648Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guideline-organizations 2026-08-16T18:43:27.708Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guidelines 2026-08-16T18:43:27.580Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guidelines-for-pas-management 2026-08-16T18:43:27.697Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guidelines-for-pe-management 2026-08-16T18:43:27.679Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guidelines-on-amino-acid-use 2026-08-16T18:43:27.774Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guidelines-organizations 2026-08-16T18:43:27.755Z daily 0.8 https://www.humanexasignals.com/assets/clinical-practice-guidelines 2026-08-16T18:43:27.651Z daily 0.8 https://www.humanexasignals.com/assets/clinical-practices 2026-08-16T18:43:27.660Z daily 0.8 https://www.humanexasignals.com/assets/clinical-practices-in-gynecology 2026-08-16T18:43:27.670Z daily 0.8 https://www.humanexasignals.com/assets/clinical-practitioners 2026-08-16T18:43:27.776Z daily 0.8 https://www.humanexasignals.com/assets/clinical-research-institutions 2026-08-16T18:43:27.672Z daily 0.8 https://www.humanexasignals.com/assets/clinical-research-organizations 2026-08-16T18:43:27.569Z daily 0.8 https://www.humanexasignals.com/assets/clinical-researchers 2026-08-16T18:43:27.790Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-designs 2026-08-16T18:43:27.632Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-nct06631391 2026-08-16T18:43:27.567Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-networks 2026-08-16T18:43:27.567Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-organizations 2026-08-16T18:43:27.567Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-programs 2026-08-16T18:43:27.565Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-recruitment 2026-08-16T18:43:27.731Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-sponsors 2026-08-16T18:43:27.567Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-stakeholders 2026-08-16T18:43:27.668Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-teams 2026-08-16T18:43:27.594Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trials 2026-08-16T18:43:27.710Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trials-network-for-lyme-and-other-tick-borne-diseases 2026-08-16T18:43:27.679Z daily 0.8 https://www.humanexasignals.com/assets/clomiphene-citrate 2026-08-16T18:43:27.646Z daily 0.8 https://www.humanexasignals.com/assets/clomiphene-citrate-brands 2026-08-16T18:43:27.615Z daily 0.8 https://www.humanexasignals.com/assets/clonazepam 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/assets/cmp-001 2026-08-16T18:43:27.548Z daily 0.8 https://www.humanexasignals.com/assets/cmr 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/cngof 2026-08-16T18:43:27.516Z daily 0.8 https://www.humanexasignals.com/assets/cnp-103 2026-08-16T18:43:27.472Z daily 0.8 https://www.humanexasignals.com/assets/cobenfy 2026-11-05T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/codeine-sulfate 2026-08-16T18:43:27.776Z daily 0.8 https://www.humanexasignals.com/assets/cognitive 2026-08-16T18:43:27.341Z daily 0.8 https://www.humanexasignals.com/assets/colchicine 2026-08-16T18:43:27.526Z daily 0.8 https://www.humanexasignals.com/assets/colestipol-hydrochloride 2026-08-16T18:43:27.681Z daily 0.8 https://www.humanexasignals.com/assets/columbia 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/columvi 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/combination-immunotherapy 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/assets/comparative 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/competitive-move 2026-08-16T18:43:27.576Z daily 0.8 https://www.humanexasignals.com/assets/compound 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/concerns 2026-08-16T18:43:27.379Z daily 0.8 https://www.humanexasignals.com/assets/concerta 2026-08-16T18:43:27.556Z daily 0.8 https://www.humanexasignals.com/assets/continuation 2026-08-16T18:43:27.465Z daily 0.8 https://www.humanexasignals.com/assets/conzip 2026-08-16T18:43:27.501Z daily 0.8 https://www.humanexasignals.com/assets/copaxone 2026-08-16T18:43:27.452Z daily 0.8 https://www.humanexasignals.com/assets/copd-exacerbations 2026-08-16T18:43:27.417Z daily 0.8 https://www.humanexasignals.com/assets/copd-patients 2026-08-16T18:43:27.513Z daily 0.8 https://www.humanexasignals.com/assets/cor-1167 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/assets/cordelia 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/assets/corticosteroids 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/cosentyx 2026-08-16T18:43:27.366Z daily 0.8 https://www.humanexasignals.com/assets/cosopt-pf 2026-08-16T18:43:27.801Z daily 0.8 https://www.humanexasignals.com/assets/cost-effectiveness 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/covac-2 2026-08-16T18:43:27.554Z daily 0.8 https://www.humanexasignals.com/assets/covid-19 2026-08-16T18:43:27.543Z daily 0.8 https://www.humanexasignals.com/assets/covid-19-symptoms 2026-08-16T18:43:27.357Z daily 0.8 https://www.humanexasignals.com/assets/cpap 2026-08-16T18:43:27.417Z daily 0.8 https://www.humanexasignals.com/assets/cpg7909 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/assets/crescent 2026-08-16T18:43:27.425Z daily 0.8 https://www.humanexasignals.com/assets/crestor 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/assets/crinetics 2026-08-16T18:43:27.399Z daily 0.8 https://www.humanexasignals.com/assets/crlx101 2026-08-16T18:43:27.535Z daily 0.8 https://www.humanexasignals.com/assets/cry2 2026-08-16T18:43:27.325Z daily 0.8 https://www.humanexasignals.com/assets/crysvita 2026-08-16T18:43:27.361Z daily 0.8 https://www.humanexasignals.com/assets/csl300 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/ctx130 2026-08-16T18:43:27.562Z daily 0.8 https://www.humanexasignals.com/assets/cu-20101 2026-08-16T18:43:27.554Z daily 0.8 https://www.humanexasignals.com/assets/culturally 2026-08-16T18:43:27.420Z daily 0.8 https://www.humanexasignals.com/assets/curaleaf 2026-08-16T18:43:27.495Z daily 0.8 https://www.humanexasignals.com/assets/curevo 2026-08-16T18:43:27.548Z daily 0.8 https://www.humanexasignals.com/assets/cx11-tablets 2026-08-16T18:43:27.782Z daily 0.8 https://www.humanexasignals.com/assets/cycle 2026-08-16T18:43:27.450Z daily 0.8 https://www.humanexasignals.com/assets/cyclobenzaprine-hydrochloride 2026-08-16T18:43:27.783Z daily 0.8 https://www.humanexasignals.com/assets/cyclophosphamide 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/assets/cyclosporine 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/cytarabine 2026-08-16T18:43:27.358Z daily 0.8 https://www.humanexasignals.com/assets/d-serine 2026-08-16T18:43:27.375Z daily 0.8 https://www.humanexasignals.com/assets/dabogratinib 2026-08-16T18:43:27.464Z daily 0.8 https://www.humanexasignals.com/assets/dabrafenib 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/assets/daiichi 2026-08-16T18:43:27.375Z daily 0.8 https://www.humanexasignals.com/assets/daito 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/assets/dalbavancin 2026-08-16T18:43:27.408Z daily 0.8 https://www.humanexasignals.com/assets/dalcetrapib 2026-08-16T18:43:27.518Z daily 0.8 https://www.humanexasignals.com/assets/dalfampridine 2026-08-16T18:43:27.364Z daily 0.8 https://www.humanexasignals.com/assets/dana-farber 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/dapagliflozin 2026-08-16T18:43:27.279Z daily 0.8 https://www.humanexasignals.com/assets/dapirolizumab 2026-08-16T18:43:27.666Z daily 0.8 https://www.humanexasignals.com/assets/dapsone 2026-08-16T18:43:27.419Z daily 0.8 https://www.humanexasignals.com/assets/dapt 2026-08-16T18:43:27.415Z daily 0.8 https://www.humanexasignals.com/assets/daratumumab 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/assets/daridorexant 2026-08-16T18:43:27.413Z daily 0.8 https://www.humanexasignals.com/assets/darolutamide 2026-08-16T18:43:27.452Z daily 0.8 https://www.humanexasignals.com/assets/darzalex 2026-08-16T18:43:27.530Z daily 0.8 https://www.humanexasignals.com/assets/datopotamab 2026-08-16T18:43:27.573Z daily 0.8 https://www.humanexasignals.com/assets/datroway 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/assets/datscan 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/dcc-3116 2026-08-16T18:43:27.534Z daily 0.8 https://www.humanexasignals.com/assets/decnupaz 2026-08-16T18:43:27.396Z daily 0.8 https://www.humanexasignals.com/assets/defect 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/assets/deflazacort 2026-08-16T18:43:27.557Z daily 0.8 https://www.humanexasignals.com/assets/delamanid 2026-08-16T18:43:27.406Z daily 0.8 https://www.humanexasignals.com/assets/delgocitinib 2026-08-16T18:43:27.448Z daily 0.8 https://www.humanexasignals.com/assets/dementia 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/assets/demerol 2026-08-16T18:43:27.501Z daily 0.8 https://www.humanexasignals.com/assets/depakote 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/depemokimab 2026-08-16T18:43:27.524Z daily 0.8 https://www.humanexasignals.com/assets/dermatology 2026-08-16T18:43:27.538Z daily 0.8 https://www.humanexasignals.com/assets/desmopressin-acetate 2026-08-16T18:43:27.707Z daily 0.8 https://www.humanexasignals.com/assets/desogestrel 2026-08-16T18:43:27.433Z daily 0.8 https://www.humanexasignals.com/assets/deucravacitinib 2026-08-16T18:43:27.334Z daily 0.8 https://www.humanexasignals.com/assets/deuruxolitinib 2026-08-16T18:43:27.471Z daily 0.8 https://www.humanexasignals.com/assets/deutetrabenazine 2026-08-16T18:43:27.325Z daily 0.8 https://www.humanexasignals.com/assets/development 2026-08-16T18:43:27.522Z daily 0.8 https://www.humanexasignals.com/assets/dexamethasone 2026-08-16T18:43:27.388Z daily 0.8 https://www.humanexasignals.com/assets/dexamethasone-sodium-phosphate 2026-08-16T18:43:27.688Z daily 0.8 https://www.humanexasignals.com/assets/dexmedetomidine 2026-08-16T18:43:27.343Z daily 0.8 https://www.humanexasignals.com/assets/dexmedetomidine-hydrochloride 2026-08-16T18:43:27.662Z daily 0.8 https://www.humanexasignals.com/assets/diacomit 2026-08-16T18:43:27.367Z daily 0.8 https://www.humanexasignals.com/assets/diagnosing-anterior 2026-08-16T18:43:27.400Z daily 0.8 https://www.humanexasignals.com/assets/diagnosing-helicobacter 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/assets/diazepam 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/diclofenac-potassium 2026-08-16T18:43:27.784Z daily 0.8 https://www.humanexasignals.com/assets/diclofenac-sodium 2026-08-16T18:43:27.807Z daily 0.8 https://www.humanexasignals.com/assets/dicyclomine-hydrochloride 2026-08-16T18:43:27.689Z daily 0.8 https://www.humanexasignals.com/assets/digital 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/digoxin 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/dii235 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/dilaudid 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/assets/diltiazem-hydrochloride 2026-08-16T18:43:27.692Z daily 0.8 https://www.humanexasignals.com/assets/dinutuximab 2026-08-16T18:43:27.546Z daily 0.8 https://www.humanexasignals.com/assets/dipg 2026-08-16T18:43:27.582Z daily 0.8 https://www.humanexasignals.com/assets/diphenhydramine-hydrochloride 2026-08-16T18:43:27.623Z daily 0.8 https://www.humanexasignals.com/assets/dipyidamole 2026-08-16T18:43:27.486Z daily 0.8 https://www.humanexasignals.com/assets/disc-1459 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/assets/disco 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/assets/discovery 2026-08-16T18:43:27.469Z daily 0.8 https://www.humanexasignals.com/assets/dispepril 2026-08-16T18:43:27.793Z daily 0.8 https://www.humanexasignals.com/assets/divalproex-sodium 2026-08-16T18:43:27.606Z daily 0.8 https://www.humanexasignals.com/assets/divarasib 2026-08-16T18:43:27.422Z daily 0.8 https://www.humanexasignals.com/assets/dmamcl 2026-08-16T18:43:27.415Z daily 0.8 https://www.humanexasignals.com/assets/dn022150 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/assets/dna 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/dnth103 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/assets/docosanol 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/dofetilide 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/assets/dolutegravir 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/assets/domperidone 2026-08-16T18:43:27.390Z daily 0.8 https://www.humanexasignals.com/assets/donanemab 2026-08-16T18:43:27.544Z daily 0.8 https://www.humanexasignals.com/assets/donidalorsen 2026-08-20T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/dopamine 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/assets/dostarlimab 2026-08-16T18:43:27.342Z daily 0.8 https://www.humanexasignals.com/assets/dotinurad 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/assets/doxepin-hydrochloride 2026-08-16T18:43:27.619Z daily 0.8 https://www.humanexasignals.com/assets/doxorubicin 2026-08-16T18:43:27.307Z daily 0.8 https://www.humanexasignals.com/assets/doxorubicin-hydrochloride 2026-08-16T18:43:27.642Z daily 0.8 https://www.humanexasignals.com/assets/doxorubicin-hydrochloride-liposomal 2026-08-16T18:43:27.606Z daily 0.8 https://www.humanexasignals.com/assets/doxycycline 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/assets/doxycycline-hyclate 2026-08-16T18:43:27.603Z daily 0.8 https://www.humanexasignals.com/assets/draeger 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/dreem 2026-08-16T18:43:27.527Z daily 0.8 https://www.humanexasignals.com/assets/dsg2 2026-08-16T18:43:27.454Z daily 0.8 https://www.humanexasignals.com/assets/dulce 2026-08-16T18:43:27.527Z daily 0.8 https://www.humanexasignals.com/assets/duloxetine-hydrochloride 2026-08-16T18:43:27.800Z daily 0.8 https://www.humanexasignals.com/assets/dupilumab 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/assets/dupixent 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/assets/durezol 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/assets/durvalumab 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/duvakitug 2026-08-16T18:43:27.553Z daily 0.8 https://www.humanexasignals.com/assets/dzd8586 2026-08-16T18:43:27.470Z daily 0.8 https://www.humanexasignals.com/assets/early 2026-08-16T18:43:27.461Z daily 0.8 https://www.humanexasignals.com/assets/eccentric 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/assets/economic 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/eculizumab 2026-08-16T18:43:27.468Z daily 0.8 https://www.humanexasignals.com/assets/edaravone 2026-08-16T18:43:27.360Z daily 0.8 https://www.humanexasignals.com/assets/edinburgh 2026-08-16T18:43:27.535Z daily 0.8 https://www.humanexasignals.com/assets/efficacy 2026-08-16T18:43:27.385Z daily 0.8 https://www.humanexasignals.com/assets/efgartigimod 2026-08-16T18:43:27.372Z daily 0.8 https://www.humanexasignals.com/assets/efruxifermin 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/assets/eg-70 2026-08-16T18:43:27.681Z daily 0.8 https://www.humanexasignals.com/assets/ei-1071 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/eisai 2026-08-16T18:43:27.375Z daily 0.8 https://www.humanexasignals.com/assets/elafibranor 2026-08-16T18:43:27.727Z daily 0.8 https://www.humanexasignals.com/assets/elecoglipron 2026-08-16T18:43:27.502Z daily 0.8 https://www.humanexasignals.com/assets/elevidys 2026-08-16T18:43:27.561Z daily 0.8 https://www.humanexasignals.com/assets/elinest 2026-08-16T18:43:27.416Z daily 0.8 https://www.humanexasignals.com/assets/eliquis 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/assets/elranatamab 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/elrexfio 2026-08-16T18:43:27.547Z daily 0.8 https://www.humanexasignals.com/assets/eltrombopag-olamine 2026-08-16T18:43:27.577Z daily 0.8 https://www.humanexasignals.com/assets/eluxadoline 2026-08-16T18:43:27.388Z daily 0.8 https://www.humanexasignals.com/assets/emavusertib 2026-08-16T18:43:27.352Z daily 0.8 https://www.humanexasignals.com/assets/emerging 2026-08-16T18:43:27.528Z daily 0.8 https://www.humanexasignals.com/assets/emgality 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/empagliflozin 2026-08-16T18:43:27.309Z daily 0.8 https://www.humanexasignals.com/assets/emraclidine 2026-09-18T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/encorafenib 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/assets/encube 2026-08-16T18:43:27.312Z daily 0.8 https://www.humanexasignals.com/assets/endocrinology 2026-08-16T18:43:27.547Z daily 0.8 https://www.humanexasignals.com/assets/endoscopic 2026-08-16T18:43:27.388Z daily 0.8 https://www.humanexasignals.com/assets/endotronix 2026-08-16T18:43:27.392Z daily 0.8 https://www.humanexasignals.com/assets/enflonsia 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/engene 2026-08-16T18:43:27.368Z daily 0.8 https://www.humanexasignals.com/assets/enhanced 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/enhertu 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/enicepatide 2026-08-16T18:43:27.511Z daily 0.8 https://www.humanexasignals.com/assets/enlicitide 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/assets/enspryng 2026-08-16T18:43:27.386Z daily 0.8 https://www.humanexasignals.com/assets/entrectinib 2026-08-16T18:43:27.510Z daily 0.8 https://www.humanexasignals.com/assets/enummo 2026-08-16T18:43:27.427Z daily 0.8 https://www.humanexasignals.com/assets/envafolimab 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/assets/enzalutamide 2026-08-16T18:43:27.366Z daily 0.8 https://www.humanexasignals.com/assets/ep102 2026-08-16T18:43:27.343Z daily 0.8 https://www.humanexasignals.com/assets/epcoritamab 2026-08-16T18:43:27.442Z daily 0.8 https://www.humanexasignals.com/assets/ephedrine-sulfate 2026-08-16T18:43:27.616Z daily 0.8 https://www.humanexasignals.com/assets/epidiolex 2026-08-16T18:43:27.486Z daily 0.8 https://www.humanexasignals.com/assets/epilepsy 2026-08-16T18:43:27.537Z daily 0.8 https://www.humanexasignals.com/assets/epinephrine 2026-08-16T18:43:27.391Z daily 0.8 https://www.humanexasignals.com/assets/eplontersen-sodium 2026-08-16T18:43:27.683Z daily 0.8 https://www.humanexasignals.com/assets/eptinezumab 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/assets/epysqli 2026-08-16T18:43:27.733Z daily 0.8 https://www.humanexasignals.com/assets/erbitux 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/erdafitinib 2026-08-16T18:43:27.456Z daily 0.8 https://www.humanexasignals.com/assets/erleada 2026-08-16T18:43:27.733Z daily 0.8 https://www.humanexasignals.com/assets/erlotinib 2026-08-16T18:43:27.341Z daily 0.8 https://www.humanexasignals.com/assets/erw316 2026-08-16T18:43:27.368Z daily 0.8 https://www.humanexasignals.com/assets/erythropoietin 2026-08-16T18:43:27.352Z daily 0.8 https://www.humanexasignals.com/assets/escitalopram 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/assets/esketamine 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/assets/eslicarbazepine-acetate 2026-08-16T18:43:27.605Z daily 0.8 https://www.humanexasignals.com/assets/esomeprazole 2026-08-16T18:43:27.402Z daily 0.8 https://www.humanexasignals.com/assets/establishment 2026-08-16T18:43:27.536Z daily 0.8 https://www.humanexasignals.com/assets/estradiol-and-norethindrone-acetate 2026-08-16T18:43:27.620Z daily 0.8 https://www.humanexasignals.com/assets/estrogen 2026-08-16T18:43:27.475Z daily 0.8 https://www.humanexasignals.com/assets/etbx-071 2026-08-16T18:43:27.427Z daily 0.8 https://www.humanexasignals.com/assets/etcamah 2026-08-16T18:43:27.380Z daily 0.8 https://www.humanexasignals.com/assets/ethicon 2026-08-16T18:43:27.397Z daily 0.8 https://www.humanexasignals.com/assets/etodolac 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/assets/eugia 2026-08-16T18:43:27.292Z daily 0.8 https://www.humanexasignals.com/assets/european 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/evaluating 2026-08-16T18:43:27.333Z daily 0.8 https://www.humanexasignals.com/assets/evaluation 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/assets/everolimus 2026-08-16T18:43:27.449Z daily 0.8 https://www.humanexasignals.com/assets/evolocumab 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/exelixis 2026-08-16T18:43:27.307Z daily 0.8 https://www.humanexasignals.com/assets/exosomes 2026-08-16T18:43:27.385Z daily 0.8 https://www.humanexasignals.com/assets/expanded 2026-08-16T18:43:27.354Z daily 0.8 https://www.humanexasignals.com/assets/exparel 2026-08-16T18:43:27.421Z daily 0.8 https://www.humanexasignals.com/assets/exploratory 2026-08-16T18:43:27.337Z daily 0.8 https://www.humanexasignals.com/assets/exploring 2026-08-16T18:43:27.386Z daily 0.8 https://www.humanexasignals.com/assets/extended-release-buprenorphine 2026-08-16T18:43:27.762Z daily 0.8 https://www.humanexasignals.com/assets/extrovis 2026-08-16T18:43:27.366Z daily 0.8 https://www.humanexasignals.com/assets/eye201 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/assets/eyevansys 2026-08-16T18:43:27.408Z daily 0.8 https://www.humanexasignals.com/assets/eylea 2026-08-16T18:43:27.665Z daily 0.8 https://www.humanexasignals.com/assets/ezetimibe 2026-08-16T18:43:27.529Z daily 0.8 https://www.humanexasignals.com/assets/ezplaz 2026-08-16T18:43:27.354Z daily 0.8 https://www.humanexasignals.com/assets/f-18-sodium-fluoride 2026-08-16T18:43:27.645Z daily 0.8 https://www.humanexasignals.com/assets/fabhalta 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/assets/famotidine 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/assets/farapulse 2026-08-16T18:43:27.373Z daily 0.8 https://www.humanexasignals.com/assets/faricimab 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/assets/farxiga 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/fasenra 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/assets/fcgr2b 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/fda 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/fda-review 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/assets/feasibility 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/febuxostat 2026-08-16T18:43:27.416Z daily 0.8 https://www.humanexasignals.com/assets/feldan 2026-08-16T18:43:27.393Z daily 0.8 https://www.humanexasignals.com/assets/felzartamab 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/assets/fenebrutinib 2026-08-16T18:43:27.546Z daily 0.8 https://www.humanexasignals.com/assets/fenofibrate 2026-08-16T18:43:27.483Z daily 0.8 https://www.humanexasignals.com/assets/ferring 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/assets/fertility 2026-08-16T18:43:27.541Z daily 0.8 https://www.humanexasignals.com/assets/fexofenadine-hydrochloride 2026-08-16T18:43:27.804Z daily 0.8 https://www.humanexasignals.com/assets/ficus 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/filspari-sparsentan 2026-08-16T18:43:27.800Z daily 0.8 https://www.humanexasignals.com/assets/financial 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/finasteride 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/assets/finerenone 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/assets/fingolimod-hydrochloride 2026-08-16T18:43:27.574Z daily 0.8 https://www.humanexasignals.com/assets/finotonlimab 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/fintepla 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/assets/fioricet-with-codeine 2026-08-16T18:43:27.769Z daily 0.8 https://www.humanexasignals.com/assets/firmonertinib 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/assets/fkc289 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/flamingo 2026-08-16T18:43:27.477Z daily 0.8 https://www.humanexasignals.com/assets/fld-103 2026-08-16T18:43:27.697Z daily 0.8 https://www.humanexasignals.com/assets/flecainide-acetate 2026-08-16T18:43:27.677Z daily 0.8 https://www.humanexasignals.com/assets/flonoltinib 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/assets/florida 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/assets/fluconazole 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/fludarabine-phosphate 2026-08-16T18:43:27.611Z daily 0.8 https://www.humanexasignals.com/assets/fluorescein-sodium 2026-08-16T18:43:27.668Z daily 0.8 https://www.humanexasignals.com/assets/fluorescite 2026-08-16T18:43:27.524Z daily 0.8 https://www.humanexasignals.com/assets/fluoropyrimidine 2026-08-16T18:43:27.519Z daily 0.8 https://www.humanexasignals.com/assets/fluoxetine 2026-08-16T18:43:27.442Z daily 0.8 https://www.humanexasignals.com/assets/fluoxetine-hydrochloride 2026-08-16T18:43:27.780Z daily 0.8 https://www.humanexasignals.com/assets/flurbiprofen 2026-08-16T18:43:27.292Z daily 0.8 https://www.humanexasignals.com/assets/flutamide 2026-08-16T18:43:27.544Z daily 0.8 https://www.humanexasignals.com/assets/fluticasone-propionate 2026-08-16T18:43:27.658Z daily 0.8 https://www.humanexasignals.com/assets/fluvoxamine-maleate 2026-08-16T18:43:27.613Z daily 0.8 https://www.humanexasignals.com/assets/fmt 2026-08-16T18:43:27.438Z daily 0.8 https://www.humanexasignals.com/assets/folfox 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/assets/folfox8 2026-08-16T18:43:27.547Z daily 0.8 https://www.humanexasignals.com/assets/formulation 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/forteo 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/fosaprepitant-dimeglumine 2026-08-16T18:43:27.437Z daily 0.8 https://www.humanexasignals.com/assets/fosfomycin-tromethamine 2026-08-16T18:43:27.601Z daily 0.8 https://www.humanexasignals.com/assets/fostamatinib 2026-08-16T18:43:27.491Z daily 0.8 https://www.humanexasignals.com/assets/foundayo 2026-08-16T18:43:27.502Z daily 0.8 https://www.humanexasignals.com/assets/fremanezumab 2026-08-16T18:43:27.529Z daily 0.8 https://www.humanexasignals.com/assets/fresenius 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/frontotemporal-dementia 2026-08-16T18:43:27.331Z daily 0.8 https://www.humanexasignals.com/assets/fruquintinib 2026-08-16T18:43:27.536Z daily 0.8 https://www.humanexasignals.com/assets/ftir 2026-08-16T18:43:27.309Z daily 0.8 https://www.humanexasignals.com/assets/fulvestrant 2026-08-16T18:43:27.411Z daily 0.8 https://www.humanexasignals.com/assets/furmonertinib 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/assets/furosemide 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/fusobacterium 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/fycompa 2026-08-16T18:43:27.753Z daily 0.8 https://www.humanexasignals.com/assets/gabapentin 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/gadavist 2026-08-16T18:43:27.345Z daily 0.8 https://www.humanexasignals.com/assets/gadobutrol 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/gadoterate-meglumine 2026-08-16T18:43:27.603Z daily 0.8 https://www.humanexasignals.com/assets/galderma 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/galectin-3 2026-08-16T18:43:27.405Z daily 0.8 https://www.humanexasignals.com/assets/galleri 2026-08-16T18:43:27.435Z daily 0.8 https://www.humanexasignals.com/assets/garzulys 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/gastroenterology 2026-08-16T18:43:27.536Z daily 0.8 https://www.humanexasignals.com/assets/gaze-contingent 2026-08-16T18:43:27.387Z daily 0.8 https://www.humanexasignals.com/assets/gazyva 2026-08-16T18:43:27.546Z daily 0.8 https://www.humanexasignals.com/assets/gcar1 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/assets/gdc-1261 2026-08-16T18:43:27.427Z daily 0.8 https://www.humanexasignals.com/assets/gdc-7035 2026-08-16T18:43:27.392Z daily 0.8 https://www.humanexasignals.com/assets/gds-23 2026-08-16T18:43:27.421Z daily 0.8 https://www.humanexasignals.com/assets/ge 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/geistlich 2026-08-16T18:43:27.389Z daily 0.8 https://www.humanexasignals.com/assets/gemcitabine 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/gemcitabine-hydrochloride 2026-08-16T18:43:27.686Z daily 0.8 https://www.humanexasignals.com/assets/general 2026-08-16T18:43:27.558Z daily 0.8 https://www.humanexasignals.com/assets/genetic 2026-08-16T18:43:27.532Z daily 0.8 https://www.humanexasignals.com/assets/genex 2026-08-16T18:43:27.404Z daily 0.8 https://www.humanexasignals.com/assets/genmab 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/genrix 2026-08-16T18:43:27.357Z daily 0.8 https://www.humanexasignals.com/assets/genzyme 2026-08-16T18:43:27.381Z daily 0.8 https://www.humanexasignals.com/assets/gerofit 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/assets/geron 2026-08-16T18:43:27.372Z daily 0.8 https://www.humanexasignals.com/assets/gi 2026-08-16T18:43:27.398Z daily 0.8 https://www.humanexasignals.com/assets/gilotrif 2026-08-16T18:43:27.417Z daily 0.8 https://www.humanexasignals.com/assets/gilteritinib 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/assets/giredestrant 2026-08-16T18:43:27.545Z daily 0.8 https://www.humanexasignals.com/assets/gland 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/glaucoma-underway 2026-08-16T18:43:27.404Z daily 0.8 https://www.humanexasignals.com/assets/gleevec 2026-08-16T18:43:27.385Z daily 0.8 https://www.humanexasignals.com/assets/glenmark 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/assets/glioblastoma 2026-08-16T18:43:27.421Z daily 0.8 https://www.humanexasignals.com/assets/glipizide 2026-08-16T18:43:27.289Z daily 0.8 https://www.humanexasignals.com/assets/glm101 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/glofitamab 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/assets/glpg5101 2026-08-16T18:43:27.317Z daily 0.8 https://www.humanexasignals.com/assets/glucantime 2026-08-16T18:43:27.366Z daily 0.8 https://www.humanexasignals.com/assets/glucosamine 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/glyburide-and-metformin-hydrochloride 2026-08-16T18:43:27.732Z daily 0.8 https://www.humanexasignals.com/assets/gohibic 2026-08-16T18:43:27.456Z daily 0.8 https://www.humanexasignals.com/assets/golidocitinib 2026-08-16T18:43:27.397Z daily 0.8 https://www.humanexasignals.com/assets/grail 2026-08-16T18:43:27.350Z daily 0.8 https://www.humanexasignals.com/assets/granules 2026-08-16T18:43:27.309Z daily 0.8 https://www.humanexasignals.com/assets/grifols 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/assets/gs-4321 2026-08-16T18:43:27.662Z daily 0.8 https://www.humanexasignals.com/assets/gs-4571 2026-08-16T18:43:27.681Z daily 0.8 https://www.humanexasignals.com/assets/gsh 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/gsk4425689a 2026-08-16T18:43:27.345Z daily 0.8 https://www.humanexasignals.com/assets/guangdong 2026-08-16T18:43:27.462Z daily 0.8 https://www.humanexasignals.com/assets/guidance 2026-08-16T18:43:27.533Z daily 0.8 https://www.humanexasignals.com/assets/guizhi-shaoyao-zhimu 2026-08-16T18:43:27.380Z daily 0.8 https://www.humanexasignals.com/assets/guselkumab 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/assets/gx03 2026-08-16T18:43:27.434Z daily 0.8 https://www.humanexasignals.com/assets/h 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/hadlima 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/assets/haleon 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/assets/haloperidol 2026-08-16T18:43:27.486Z daily 0.8 https://www.humanexasignals.com/assets/heart-failure 2026-08-16T18:43:27.532Z daily 0.8 https://www.humanexasignals.com/assets/heartfelt 2026-08-16T18:43:27.532Z daily 0.8 https://www.humanexasignals.com/assets/hec116094 2026-08-16T18:43:27.433Z daily 0.8 https://www.humanexasignals.com/assets/hematology 2026-08-16T18:43:27.551Z daily 0.8 https://www.humanexasignals.com/assets/heparin-sodium 2026-08-16T18:43:27.615Z daily 0.8 https://www.humanexasignals.com/assets/hepatitis 2026-08-16T18:43:27.424Z daily 0.8 https://www.humanexasignals.com/assets/hepatology 2026-08-16T18:43:27.549Z daily 0.8 https://www.humanexasignals.com/assets/hepcludex 2026-08-16T18:43:27.399Z daily 0.8 https://www.humanexasignals.com/assets/hepzato 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/her2-positive 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/assets/herceptin 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/assets/herceptin-hylecta 2026-08-16T18:43:27.573Z daily 0.8 https://www.humanexasignals.com/assets/heritage 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/assets/hesperidin 2026-08-16T18:43:27.524Z daily 0.8 https://www.humanexasignals.com/assets/hetlioz 2026-08-16T18:43:27.346Z daily 0.8 https://www.humanexasignals.com/assets/hexavalent 2026-08-16T18:43:27.493Z daily 0.8 https://www.humanexasignals.com/assets/hezato 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/hhs-barda 2026-08-16T18:43:27.637Z daily 0.8 https://www.humanexasignals.com/assets/hibiwash 2026-08-16T18:43:27.495Z daily 0.8 https://www.humanexasignals.com/assets/hibrow-hlthcare 2026-08-16T18:43:27.621Z daily 0.8 https://www.humanexasignals.com/assets/hifu 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/high-dose 2026-08-16T18:43:27.429Z daily 0.8 https://www.humanexasignals.com/assets/high-intensity 2026-08-16T18:43:27.532Z daily 0.8 https://www.humanexasignals.com/assets/histotripsy 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/hoffmann-la 2026-08-16T18:43:27.396Z daily 0.8 https://www.humanexasignals.com/assets/hologic 2026-08-16T18:43:27.477Z daily 0.8 https://www.humanexasignals.com/assets/hope-initiates 2026-08-16T18:43:27.448Z daily 0.8 https://www.humanexasignals.com/assets/hospira 2026-08-16T18:43:27.317Z daily 0.8 https://www.humanexasignals.com/assets/hpv 2026-08-16T18:43:27.350Z daily 0.8 https://www.humanexasignals.com/assets/hpv-positive 2026-08-16T18:43:27.554Z daily 0.8 https://www.humanexasignals.com/assets/hrs-5041 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/hrs-7450 2026-08-16T18:43:27.758Z daily 0.8 https://www.humanexasignals.com/assets/hrs-8797 2026-08-16T18:43:27.421Z daily 0.8 https://www.humanexasignals.com/assets/humanwell 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/assets/humira 2026-08-16T18:43:27.438Z daily 0.8 https://www.humanexasignals.com/assets/hutchmed 2026-08-16T18:43:27.410Z daily 0.8 https://www.humanexasignals.com/assets/hyaluronic 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/assets/hydrochlorothiazide 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/assets/hydrocortisone-sodium-succinate 2026-08-16T18:43:27.609Z daily 0.8 https://www.humanexasignals.com/assets/hydromorphone 2026-08-16T18:43:27.372Z daily 0.8 https://www.humanexasignals.com/assets/hydromorphone-hydrochloride 2026-08-16T18:43:27.761Z daily 0.8 https://www.humanexasignals.com/assets/hydroxyzine-hydrochloride 2026-08-16T18:43:27.625Z daily 0.8 https://www.humanexasignals.com/assets/hympavzi 2026-08-16T18:43:27.549Z daily 0.8 https://www.humanexasignals.com/assets/hyoscine-butyl-bromide 2026-08-16T18:43:27.696Z daily 0.8 https://www.humanexasignals.com/assets/hyperlipidemia 2026-08-16T18:43:27.548Z daily 0.8 https://www.humanexasignals.com/assets/hypophosphatasia 2026-08-16T18:43:27.558Z daily 0.8 https://www.humanexasignals.com/assets/i3-pharms 2026-08-16T18:43:27.616Z daily 0.8 https://www.humanexasignals.com/assets/ianalumab 2026-08-16T18:43:27.439Z daily 0.8 https://www.humanexasignals.com/assets/iap 2026-08-16T18:43:27.514Z daily 0.8 https://www.humanexasignals.com/assets/iberdomide 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/assets/ibi3002 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/ibrance 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/assets/ibrutinib 2026-08-16T18:43:27.354Z daily 0.8 https://www.humanexasignals.com/assets/ibuprofen 2026-08-16T18:43:27.381Z daily 0.8 https://www.humanexasignals.com/assets/ibuzatrelvir 2026-08-16T18:43:27.441Z daily 0.8 https://www.humanexasignals.com/assets/icahn 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/icotyde 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/identifying-unstable 2026-08-16T18:43:27.520Z daily 0.8 https://www.humanexasignals.com/assets/idorsia 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/idvynso 2026-08-16T18:43:27.364Z daily 0.8 https://www.humanexasignals.com/assets/ifinatamab 2026-08-16T18:43:27.596Z daily 0.8 https://www.humanexasignals.com/assets/ifinatamab-deruxtecan 2026-08-16T18:43:27.436Z daily 0.8 https://www.humanexasignals.com/assets/ilumya 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/assets/imatinib 2026-08-16T18:43:27.473Z daily 0.8 https://www.humanexasignals.com/assets/imbioray 2026-08-16T18:43:27.469Z daily 0.8 https://www.humanexasignals.com/assets/imfinzi 2026-10-12T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/immuno-oncology 2026-08-16T18:43:27.428Z daily 0.8 https://www.humanexasignals.com/assets/immunology 2026-08-16T18:43:27.540Z daily 0.8 https://www.humanexasignals.com/assets/immunomedics 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/assets/immunostimulatory 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/immunotherapy 2026-08-16T18:43:27.438Z daily 0.8 https://www.humanexasignals.com/assets/impact 2026-08-16T18:43:27.346Z daily 0.8 https://www.humanexasignals.com/assets/impax 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/assets/improving-quality 2026-08-16T18:43:27.385Z daily 0.8 https://www.humanexasignals.com/assets/imuldosa 2026-08-16T18:43:27.530Z daily 0.8 https://www.humanexasignals.com/assets/imvt-1402 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/assets/imzokitug 2026-08-16T18:43:27.467Z daily 0.8 https://www.humanexasignals.com/assets/inavolisib 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/inbrija 2026-08-16T18:43:27.433Z daily 0.8 https://www.humanexasignals.com/assets/inca33890 2026-08-16T18:43:27.684Z daily 0.8 https://www.humanexasignals.com/assets/incyte 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/assets/indicus 2026-08-16T18:43:27.501Z daily 0.8 https://www.humanexasignals.com/assets/indivior 2026-08-16T18:43:27.340Z daily 0.8 https://www.humanexasignals.com/assets/infants 2026-08-16T18:43:27.429Z daily 0.8 https://www.humanexasignals.com/assets/infliximab 2026-08-16T18:43:27.394Z daily 0.8 https://www.humanexasignals.com/assets/influenza 2026-08-16T18:43:27.546Z daily 0.8 https://www.humanexasignals.com/assets/infrastructure 2026-08-16T18:43:27.406Z daily 0.8 https://www.humanexasignals.com/assets/inhaled 2026-08-16T18:43:27.390Z daily 0.8 https://www.humanexasignals.com/assets/inhaled-azacytidine 2026-08-16T18:43:27.640Z daily 0.8 https://www.humanexasignals.com/assets/inhaled-cromolyn-sodium 2026-08-16T18:43:27.752Z daily 0.8 https://www.humanexasignals.com/assets/innovation 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/innovative 2026-08-16T18:43:27.450Z daily 0.8 https://www.humanexasignals.com/assets/inotuzumab 2026-08-16T18:43:27.474Z daily 0.8 https://www.humanexasignals.com/assets/inqovi 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/assets/inrebic 2026-08-16T18:43:27.379Z daily 0.8 https://www.humanexasignals.com/assets/inserm-umr-s-942-mascot 2026-08-16T18:43:27.756Z daily 0.8 https://www.humanexasignals.com/assets/insights 2026-08-16T18:43:27.365Z daily 0.8 https://www.humanexasignals.com/assets/insmed 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/insomnia 2026-08-16T18:43:27.358Z daily 0.8 https://www.humanexasignals.com/assets/insulet 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/insulin-glargine 2026-08-16T18:43:27.640Z daily 0.8 https://www.humanexasignals.com/assets/integrating 2026-08-16T18:43:27.469Z daily 0.8 https://www.humanexasignals.com/assets/intensity 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/intermediate-amd 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/assets/intismeran 2026-08-16T18:43:27.513Z daily 0.8 https://www.humanexasignals.com/assets/intramuscular 2026-08-16T18:43:27.404Z daily 0.8 https://www.humanexasignals.com/assets/intranasal 2026-08-16T18:43:27.329Z daily 0.8 https://www.humanexasignals.com/assets/intraoperative 2026-08-16T18:43:27.441Z daily 0.8 https://www.humanexasignals.com/assets/intrathecal 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/intrathecal-morphine 2026-08-16T18:43:27.651Z daily 0.8 https://www.humanexasignals.com/assets/inventia 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/invokamet-xr 2026-08-16T18:43:27.630Z daily 0.8 https://www.humanexasignals.com/assets/invokana 2026-08-16T18:43:27.632Z daily 0.8 https://www.humanexasignals.com/assets/ionetix 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/assets/ionis 2026-08-16T18:43:27.428Z daily 0.8 https://www.humanexasignals.com/assets/iparomlimab 2026-08-16T18:43:27.384Z daily 0.8 https://www.humanexasignals.com/assets/ipg7236 2026-08-16T18:43:27.394Z daily 0.8 https://www.humanexasignals.com/assets/ipilimumab 2026-08-16T18:43:27.498Z daily 0.8 https://www.humanexasignals.com/assets/ipsc-derived 2026-08-16T18:43:27.521Z daily 0.8 https://www.humanexasignals.com/assets/ipsen 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/iptacopan 2026-08-16T18:43:27.510Z daily 0.8 https://www.humanexasignals.com/assets/irbesartan 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/assets/irs2 2026-08-16T18:43:27.400Z daily 0.8 https://www.humanexasignals.com/assets/isatuximab 2026-08-16T18:43:27.373Z daily 0.8 https://www.humanexasignals.com/assets/islatravir 2026-08-16T18:43:27.386Z daily 0.8 https://www.humanexasignals.com/assets/isolating-microbiota 2026-08-16T18:43:27.441Z daily 0.8 https://www.humanexasignals.com/assets/isometric 2026-08-16T18:43:27.505Z daily 0.8 https://www.humanexasignals.com/assets/isotretinoin 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/istx 2026-08-16T18:43:27.751Z daily 0.8 https://www.humanexasignals.com/assets/itepekimab 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/assets/iti-1001 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/assets/itovebi 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/itraconazole 2026-08-16T18:43:27.362Z daily 0.8 https://www.humanexasignals.com/assets/ivarmacitinib 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/iveacare 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/ivonescimab 2026-08-16T18:43:27.331Z daily 0.8 https://www.humanexasignals.com/assets/jab-21822 2026-08-16T18:43:27.281Z daily 0.8 https://www.humanexasignals.com/assets/jakafi 2026-08-16T18:43:27.689Z daily 0.8 https://www.humanexasignals.com/assets/jakafi-xr 2026-08-16T18:43:27.573Z daily 0.8 https://www.humanexasignals.com/assets/janssen 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/assets/japet 2026-08-16T18:43:27.504Z daily 0.8 https://www.humanexasignals.com/assets/jardiance 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/assets/jaypirca 2026-08-16T18:43:27.498Z daily 0.8 https://www.humanexasignals.com/assets/jaypirca-pirtobrutinib 2026-08-16T18:43:27.553Z daily 0.8 https://www.humanexasignals.com/assets/jdq443 2026-08-16T18:43:27.471Z daily 0.8 https://www.humanexasignals.com/assets/jideytro 2026-08-16T18:43:27.360Z daily 0.8 https://www.humanexasignals.com/assets/jl19001-injection 2026-08-16T18:43:27.639Z daily 0.8 https://www.humanexasignals.com/assets/johnson 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/assets/jr-446 2026-08-16T18:43:27.733Z daily 0.8 https://www.humanexasignals.com/assets/js212 2026-08-16T18:43:27.452Z daily 0.8 https://www.humanexasignals.com/assets/junel-fe 2026-08-16T18:43:27.498Z daily 0.8 https://www.humanexasignals.com/assets/jyseleca-filgotinib-maleate 2026-08-16T18:43:27.736Z daily 0.8 https://www.humanexasignals.com/assets/kadcyla 2026-08-16T18:43:27.547Z daily 0.8 https://www.humanexasignals.com/assets/kaiser 2026-08-16T18:43:27.428Z daily 0.8 https://www.humanexasignals.com/assets/kaletra 2026-08-16T18:43:27.359Z daily 0.8 https://www.humanexasignals.com/assets/karuna 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/assets/karyopharm 2026-08-16T18:43:27.361Z daily 0.8 https://www.humanexasignals.com/assets/kazakh 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/assets/kazano 2026-08-16T18:43:27.290Z daily 0.8 https://www.humanexasignals.com/assets/kds2010 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/assets/ketamine 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/assets/ketoconazole 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/assets/keverprazan 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/keytruda 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/keytruda-qlex 2026-08-16T18:43:27.579Z daily 0.8 https://www.humanexasignals.com/assets/kibra 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/assets/kif18a 2026-08-16T18:43:27.512Z daily 0.8 https://www.humanexasignals.com/assets/kimmtrak 2026-10-25T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/kio-301 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/kisqali 2026-08-16T18:43:27.442Z daily 0.8 https://www.humanexasignals.com/assets/kisunla 2026-08-16T18:43:27.442Z daily 0.8 https://www.humanexasignals.com/assets/kite-363 2026-08-16T18:43:27.463Z daily 0.8 https://www.humanexasignals.com/assets/kk2223 2026-08-16T18:43:27.463Z daily 0.8 https://www.humanexasignals.com/assets/kln-1010 2026-08-16T18:43:27.395Z daily 0.8 https://www.humanexasignals.com/assets/knack 2026-08-16T18:43:27.360Z daily 0.8 https://www.humanexasignals.com/assets/knee-repair 2026-08-16T18:43:27.331Z daily 0.8 https://www.humanexasignals.com/assets/kombiglyze-xr 2026-08-16T18:43:27.630Z daily 0.8 https://www.humanexasignals.com/assets/koselugo 2026-08-16T18:43:27.307Z daily 0.8 https://www.humanexasignals.com/assets/kramer 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/assets/krystexxa 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/kshb002 2026-08-16T18:43:27.543Z daily 0.8 https://www.humanexasignals.com/assets/kunkui 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/labetalol-hydrochloride 2026-08-16T18:43:27.813Z daily 0.8 https://www.humanexasignals.com/assets/lacosamide 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/assets/lactiplantibacillus 2026-08-16T18:43:27.420Z daily 0.8 https://www.humanexasignals.com/assets/lactobacillus 2026-08-16T18:43:27.528Z daily 0.8 https://www.humanexasignals.com/assets/lactulose 2026-08-16T18:43:27.371Z daily 0.8 https://www.humanexasignals.com/assets/lamotrigine 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/langlara 2026-08-16T18:43:27.437Z daily 0.8 https://www.humanexasignals.com/assets/lantheus 2026-08-16T18:43:27.360Z daily 0.8 https://www.humanexasignals.com/assets/large-tumors 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/larimar 2026-08-16T18:43:27.435Z daily 0.8 https://www.humanexasignals.com/assets/laser 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/launch 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/assets/laurus 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/assets/lavender 2026-08-16T18:43:27.402Z daily 0.8 https://www.humanexasignals.com/assets/lazcluze 2026-08-16T18:43:27.725Z daily 0.8 https://www.humanexasignals.com/assets/lazertinib 2026-08-16T18:43:27.663Z daily 0.8 https://www.humanexasignals.com/assets/lbl-024 2026-08-16T18:43:27.477Z daily 0.8 https://www.humanexasignals.com/assets/leading 2026-08-16T18:43:27.336Z daily 0.8 https://www.humanexasignals.com/assets/lebrikizumab 2026-08-16T18:43:27.526Z daily 0.8 https://www.humanexasignals.com/assets/lecigon 2026-08-16T18:43:27.647Z daily 0.8 https://www.humanexasignals.com/assets/leflunomide 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/lenalidomide 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/lenvatinib 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/assets/leqembi 2026-08-16T18:43:27.385Z daily 0.8 https://www.humanexasignals.com/assets/leqselvi 2026-08-16T18:43:27.449Z daily 0.8 https://www.humanexasignals.com/assets/letrozole 2026-08-16T18:43:27.487Z daily 0.8 https://www.humanexasignals.com/assets/leuprolide-acetate 2026-08-16T18:43:27.617Z daily 0.8 https://www.humanexasignals.com/assets/levetiracetam 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/levocarnitine 2026-08-16T18:43:27.445Z daily 0.8 https://www.humanexasignals.com/assets/levocetirizine 2026-08-16T18:43:27.416Z daily 0.8 https://www.humanexasignals.com/assets/levofloxacin 2026-08-16T18:43:27.485Z daily 0.8 https://www.humanexasignals.com/assets/levomilnacipran-hydrochloride 2026-08-16T18:43:27.621Z daily 0.8 https://www.humanexasignals.com/assets/levonorgestrel 2026-08-16T18:43:27.337Z daily 0.8 https://www.humanexasignals.com/assets/levorphanol-tartrate 2026-08-16T18:43:27.622Z daily 0.8 https://www.humanexasignals.com/assets/levothyroxine-sodium 2026-08-16T18:43:27.608Z daily 0.8 https://www.humanexasignals.com/assets/licensed 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/lidocaine 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/liebria 2026-08-16T18:43:27.366Z daily 0.8 https://www.humanexasignals.com/assets/lifitegrast 2026-08-16T18:43:27.414Z daily 0.8 https://www.humanexasignals.com/assets/light 2026-08-16T18:43:27.341Z daily 0.8 https://www.humanexasignals.com/assets/linaclotide 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/assets/linagliptin 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/assets/linezolid 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/assets/linvoseltamab 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/linzagolix 2026-08-16T18:43:27.424Z daily 0.8 https://www.humanexasignals.com/assets/linzess 2026-08-16T18:43:27.309Z daily 0.8 https://www.humanexasignals.com/assets/lipfendra 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/assets/lipitor 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/assets/liposomal 2026-08-16T18:43:27.356Z daily 0.8 https://www.humanexasignals.com/assets/liposomal-bupivacaine 2026-08-16T18:43:27.674Z daily 0.8 https://www.humanexasignals.com/assets/lipus 2026-08-16T18:43:27.555Z daily 0.8 https://www.humanexasignals.com/assets/liq861 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/lirafigratinib 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/assets/liraglutide 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/assets/lisaftoclax 2026-08-16T18:43:27.461Z daily 0.8 https://www.humanexasignals.com/assets/litfulo 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/litifilimab-biib059 2026-08-16T18:43:27.421Z daily 0.8 https://www.humanexasignals.com/assets/litus 2026-08-16T18:43:27.477Z daily 0.8 https://www.humanexasignals.com/assets/livalozet 2026-08-16T18:43:27.334Z daily 0.8 https://www.humanexasignals.com/assets/livmarli 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/assets/lmp744 2026-08-16T18:43:27.453Z daily 0.8 https://www.humanexasignals.com/assets/lnf2105 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/assets/lnk001 2026-08-16T18:43:27.414Z daily 0.8 https://www.humanexasignals.com/assets/local 2026-08-16T18:43:27.399Z daily 0.8 https://www.humanexasignals.com/assets/long-read 2026-08-16T18:43:27.505Z daily 0.8 https://www.humanexasignals.com/assets/long-term 2026-08-16T18:43:27.391Z daily 0.8 https://www.humanexasignals.com/assets/longitudinal 2026-08-16T18:43:27.312Z daily 0.8 https://www.humanexasignals.com/assets/loperamide-hydrochloride-2-mg-orodispersible-tablets 2026-08-16T18:43:27.811Z daily 0.8 https://www.humanexasignals.com/assets/loratadine-and-pseudoephedrine-sulfate 2026-08-16T18:43:27.604Z daily 0.8 https://www.humanexasignals.com/assets/lorazepam 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/assets/lorbrena 2026-08-16T18:43:27.553Z daily 0.8 https://www.humanexasignals.com/assets/lorlatinib 2026-08-16T18:43:27.485Z daily 0.8 https://www.humanexasignals.com/assets/losartan-potassium 2026-08-16T18:43:27.526Z daily 0.8 https://www.humanexasignals.com/assets/lotilaner 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/low-level 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/assets/lt 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/assets/lti-03 2026-08-16T18:43:27.393Z daily 0.8 https://www.humanexasignals.com/assets/lum-201 2026-08-16T18:43:27.447Z daily 0.8 https://www.humanexasignals.com/assets/lum-iva 2026-08-16T18:43:27.779Z daily 0.8 https://www.humanexasignals.com/assets/lundbeck 2026-08-16T18:43:27.413Z daily 0.8 https://www.humanexasignals.com/assets/lunsumio 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/assets/lupron 2026-08-16T18:43:27.333Z daily 0.8 https://www.humanexasignals.com/assets/lupus-nephritis 2026-08-16T18:43:27.441Z daily 0.8 https://www.humanexasignals.com/assets/lurasidone-hydrochloride 2026-08-16T18:43:27.605Z daily 0.8 https://www.humanexasignals.com/assets/lurbinectedin 2026-08-16T18:43:27.521Z daily 0.8 https://www.humanexasignals.com/assets/lutikizumab 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/lyl273 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/lynozyfic 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/assets/lynparza 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/lytenava 2026-08-16T18:43:27.359Z daily 0.8 https://www.humanexasignals.com/assets/m 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/assets/m-a-partnership 2026-08-16T18:43:27.566Z daily 0.8 https://www.humanexasignals.com/assets/machine 2026-08-16T18:43:27.393Z daily 0.8 https://www.humanexasignals.com/assets/macitentan 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/assets/macrilen 2026-08-16T18:43:27.359Z daily 0.8 https://www.humanexasignals.com/assets/madrigal 2026-08-16T18:43:27.358Z daily 0.8 https://www.humanexasignals.com/assets/maged4 2026-08-16T18:43:27.532Z daily 0.8 https://www.humanexasignals.com/assets/magnesium-sulfate 2026-08-16T18:43:27.631Z daily 0.8 https://www.humanexasignals.com/assets/magnesium-sulfate-products 2026-08-16T18:43:27.804Z daily 0.8 https://www.humanexasignals.com/assets/magrolimab 2026-08-16T18:43:27.461Z daily 0.8 https://www.humanexasignals.com/assets/mainpointe 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/assets/mallinckrodt 2026-08-16T18:43:27.525Z daily 0.8 https://www.humanexasignals.com/assets/managed 2026-08-16T18:43:27.530Z daily 0.8 https://www.humanexasignals.com/assets/mankind 2026-08-16T18:43:27.325Z daily 0.8 https://www.humanexasignals.com/assets/manufacturing 2026-08-16T18:43:27.395Z daily 0.8 https://www.humanexasignals.com/assets/mar002 2026-08-16T18:43:27.342Z daily 0.8 https://www.humanexasignals.com/assets/marstacimab 2026-08-16T18:43:27.519Z daily 0.8 https://www.humanexasignals.com/assets/mas825 2026-08-16T18:43:27.438Z daily 0.8 https://www.humanexasignals.com/assets/masitinib 2026-08-16T18:43:27.545Z daily 0.8 https://www.humanexasignals.com/assets/masld 2026-08-16T18:43:27.555Z daily 0.8 https://www.humanexasignals.com/assets/massachusetts 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/assets/mastelli 2026-08-16T18:43:27.519Z daily 0.8 https://www.humanexasignals.com/assets/mavacamten 2026-08-16T18:43:27.529Z daily 0.8 https://www.humanexasignals.com/assets/mavenclad 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/mavyret 2026-08-16T18:43:27.375Z daily 0.8 https://www.humanexasignals.com/assets/mayzent 2026-08-16T18:43:27.443Z daily 0.8 https://www.humanexasignals.com/assets/mazdutide 2026-08-16T18:43:27.496Z daily 0.8 https://www.humanexasignals.com/assets/mbd2 2026-08-16T18:43:27.485Z daily 0.8 https://www.humanexasignals.com/assets/mdd-us 2026-08-16T18:43:27.646Z daily 0.8 https://www.humanexasignals.com/assets/medi5752 2026-08-16T18:43:27.545Z daily 0.8 https://www.humanexasignals.com/assets/medline 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/medtronic 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/assets/medunik 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/assets/meitheal 2026-08-16T18:43:27.334Z daily 0.8 https://www.humanexasignals.com/assets/mekinist 2026-08-16T18:43:27.327Z daily 0.8 https://www.humanexasignals.com/assets/melanoma 2026-08-16T18:43:27.451Z daily 0.8 https://www.humanexasignals.com/assets/memantine 2026-08-16T18:43:27.336Z daily 0.8 https://www.humanexasignals.com/assets/memoptic 2026-08-16T18:43:27.353Z daily 0.8 https://www.humanexasignals.com/assets/meperidine-hydrochloride 2026-08-16T18:43:27.647Z daily 0.8 https://www.humanexasignals.com/assets/meropenem 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/mesna 2026-08-16T18:43:27.800Z daily 0.8 https://www.humanexasignals.com/assets/metabolic 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/metastatic-hurthle-cell 2026-08-16T18:43:27.453Z daily 0.8 https://www.humanexasignals.com/assets/metformin 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/assets/metformin-hydrochloride 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/assets/methadone-hydrochloride 2026-08-16T18:43:27.613Z daily 0.8 https://www.humanexasignals.com/assets/methadone-hydrochloride-intensol 2026-08-16T18:43:27.760Z daily 0.8 https://www.humanexasignals.com/assets/methapharm 2026-08-16T18:43:27.519Z daily 0.8 https://www.humanexasignals.com/assets/methotrexate-sodium 2026-08-16T18:43:27.583Z daily 0.8 https://www.humanexasignals.com/assets/methylergonovine-maleate 2026-08-16T18:43:27.715Z daily 0.8 https://www.humanexasignals.com/assets/methylphenidate 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/assets/methylphenidate-hydrochloride 2026-08-16T18:43:27.668Z daily 0.8 https://www.humanexasignals.com/assets/methylprednisolone 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/methylprednisolone-acetate 2026-08-16T18:43:27.800Z daily 0.8 https://www.humanexasignals.com/assets/methylprednisolone-sodium-succinate 2026-08-16T18:43:27.791Z daily 0.8 https://www.humanexasignals.com/assets/mettl3 2026-08-16T18:43:27.360Z daily 0.8 https://www.humanexasignals.com/assets/mezagitamab 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/mezofy 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/assets/mgd019 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/mhra 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/assets/mi078 2026-08-16T18:43:27.487Z daily 0.8 https://www.humanexasignals.com/assets/mi078-capsules 2026-08-16T18:43:27.760Z daily 0.8 https://www.humanexasignals.com/assets/michigan 2026-08-16T18:43:27.344Z daily 0.8 https://www.humanexasignals.com/assets/microbiota 2026-08-16T18:43:27.440Z daily 0.8 https://www.humanexasignals.com/assets/microneedle 2026-08-16T18:43:27.485Z daily 0.8 https://www.humanexasignals.com/assets/microperimetry 2026-08-16T18:43:27.493Z daily 0.8 https://www.humanexasignals.com/assets/midazolam 2026-08-16T18:43:27.554Z daily 0.8 https://www.humanexasignals.com/assets/mikart 2026-08-16T18:43:27.503Z daily 0.8 https://www.humanexasignals.com/assets/milnacipran-hydrochloride 2026-08-16T18:43:27.612Z daily 0.8 https://www.humanexasignals.com/assets/milpharm 2026-08-16T18:43:27.472Z daily 0.8 https://www.humanexasignals.com/assets/minocycline-hydrochloride 2026-08-16T18:43:27.650Z daily 0.8 https://www.humanexasignals.com/assets/minoxidil 2026-08-16T18:43:27.425Z daily 0.8 https://www.humanexasignals.com/assets/mir-6833-3p 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/mirabegron 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/assets/mirdametinib 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/mirena 2026-08-16T18:43:27.414Z daily 0.8 https://www.humanexasignals.com/assets/mirikizumab 2026-08-16T18:43:27.527Z daily 0.8 https://www.humanexasignals.com/assets/mirtazapine 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/assets/mirvetuximab-soravtansine 2026-08-16T18:43:27.626Z daily 0.8 https://www.humanexasignals.com/assets/mitapivat 2026-08-16T18:43:27.512Z daily 0.8 https://www.humanexasignals.com/assets/mivelsiran 2026-08-16T18:43:27.321Z daily 0.8 https://www.humanexasignals.com/assets/mizagliflozin 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/mk-1045 2026-08-16T18:43:27.509Z daily 0.8 https://www.humanexasignals.com/assets/mk-1403 2026-08-16T18:43:27.716Z daily 0.8 https://www.humanexasignals.com/assets/mk-2214 2026-08-16T18:43:27.585Z daily 0.8 https://www.humanexasignals.com/assets/mk-2870 2026-08-16T18:43:27.753Z daily 0.8 https://www.humanexasignals.com/assets/mk-3543 2026-08-16T18:43:27.630Z daily 0.8 https://www.humanexasignals.com/assets/mk-8748 2026-08-16T18:43:27.740Z daily 0.8 https://www.humanexasignals.com/assets/ml261 2026-08-16T18:43:27.489Z daily 0.8 https://www.humanexasignals.com/assets/mmv055 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/mobile 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/modeling 2026-08-16T18:43:27.472Z daily 0.8 https://www.humanexasignals.com/assets/moderate 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/assets/monofer 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/assets/moodivate 2026-08-16T18:43:27.555Z daily 0.8 https://www.humanexasignals.com/assets/morphine-sulfate 2026-08-16T18:43:27.621Z daily 0.8 https://www.humanexasignals.com/assets/morphine-sulfate-injection 2026-08-16T18:43:27.609Z daily 0.8 https://www.humanexasignals.com/assets/morphine-sulfate-products 2026-08-16T18:43:27.772Z daily 0.8 https://www.humanexasignals.com/assets/mosunetuzumab 2026-08-16T18:43:27.346Z daily 0.8 https://www.humanexasignals.com/assets/mother-daughter-des 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/mounjaro 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/assets/mount 2026-08-16T18:43:27.404Z daily 0.8 https://www.humanexasignals.com/assets/movement-disorders 2026-08-16T18:43:27.480Z daily 0.8 https://www.humanexasignals.com/assets/moxifloxacin 2026-08-16T18:43:27.475Z daily 0.8 https://www.humanexasignals.com/assets/moxifloxacin-hydrochloride 2026-08-16T18:43:27.689Z daily 0.8 https://www.humanexasignals.com/assets/mri 2026-08-16T18:43:27.405Z daily 0.8 https://www.humanexasignals.com/assets/mrna-4157 2026-08-16T18:43:27.559Z daily 0.8 https://www.humanexasignals.com/assets/mrna-lnp 2026-08-16T18:43:27.512Z daily 0.8 https://www.humanexasignals.com/assets/mtx-439 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/multicenter 2026-08-16T18:43:27.452Z daily 0.8 https://www.humanexasignals.com/assets/multiple-sclerosis 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/mundipharma 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/assets/musculoskeletal 2026-08-16T18:43:27.558Z daily 0.8 https://www.humanexasignals.com/assets/music 2026-08-16T18:43:27.446Z daily 0.8 https://www.humanexasignals.com/assets/muvalaplin 2026-08-16T18:43:27.387Z daily 0.8 https://www.humanexasignals.com/assets/mwx205 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/mycophenolate-mofetil 2026-08-16T18:43:27.343Z daily 0.8 https://www.humanexasignals.com/assets/mycophenolate-mofetil-hydrochloride 2026-08-16T18:43:27.665Z daily 0.8 https://www.humanexasignals.com/assets/mycophenolate-sodium 2026-08-16T18:43:27.610Z daily 0.8 https://www.humanexasignals.com/assets/mydayis 2026-08-16T18:43:27.362Z daily 0.8 https://www.humanexasignals.com/assets/myfortic 2026-08-16T18:43:27.341Z daily 0.8 https://www.humanexasignals.com/assets/myval 2026-08-16T18:43:27.447Z daily 0.8 https://www.humanexasignals.com/assets/nalfurafine 2026-08-16T18:43:27.520Z daily 0.8 https://www.humanexasignals.com/assets/nalfurafine-hydrochloride 2026-08-16T18:43:27.783Z daily 0.8 https://www.humanexasignals.com/assets/naproxen 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/naproxen-sodium 2026-08-16T18:43:27.619Z daily 0.8 https://www.humanexasignals.com/assets/narlumosbart 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/assets/natamycin 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/assets/natco 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/natural 2026-08-16T18:43:27.349Z daily 0.8 https://www.humanexasignals.com/assets/navitrux 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/assets/navlimetostat 2026-08-16T18:43:27.493Z daily 0.8 https://www.humanexasignals.com/assets/nccih 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/assets/nci 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/assets/nd0612 2026-08-16T18:43:27.430Z daily 0.8 https://www.humanexasignals.com/assets/nda-220482 2026-08-16T18:43:27.804Z daily 0.8 https://www.humanexasignals.com/assets/nda021314 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/nda217379 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/nda219627 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/assets/nda220442 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/nda220482 2026-08-16T18:43:27.391Z daily 0.8 https://www.humanexasignals.com/assets/nebivolol-hydrochloride 2026-08-16T18:43:27.615Z daily 0.8 https://www.humanexasignals.com/assets/nebulised 2026-08-16T18:43:27.292Z daily 0.8 https://www.humanexasignals.com/assets/nemtabrutinib 2026-08-16T18:43:27.438Z daily 0.8 https://www.humanexasignals.com/assets/neoadjuvant 2026-08-16T18:43:27.465Z daily 0.8 https://www.humanexasignals.com/assets/neostigmine 2026-08-16T18:43:27.399Z daily 0.8 https://www.humanexasignals.com/assets/nephron 2026-08-16T18:43:27.307Z daily 0.8 https://www.humanexasignals.com/assets/nerandomilast 2026-08-16T18:43:27.444Z daily 0.8 https://www.humanexasignals.com/assets/neratinib 2026-08-16T18:43:27.441Z daily 0.8 https://www.humanexasignals.com/assets/netarsudil 2026-08-16T18:43:27.343Z daily 0.8 https://www.humanexasignals.com/assets/network 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/network-guided 2026-08-16T18:43:27.440Z daily 0.8 https://www.humanexasignals.com/assets/neulasta 2026-08-16T18:43:27.317Z daily 0.8 https://www.humanexasignals.com/assets/neupogen 2026-08-16T18:43:27.381Z daily 0.8 https://www.humanexasignals.com/assets/neurocrine 2026-08-16T18:43:27.510Z daily 0.8 https://www.humanexasignals.com/assets/neurology 2026-08-16T18:43:27.549Z daily 0.8 https://www.humanexasignals.com/assets/neuron 2026-08-16T18:43:27.521Z daily 0.8 https://www.humanexasignals.com/assets/neuropathy 2026-08-16T18:43:27.537Z daily 0.8 https://www.humanexasignals.com/assets/neurovalens 2026-08-16T18:43:27.462Z daily 0.8 https://www.humanexasignals.com/assets/nevro 2026-08-16T18:43:27.491Z daily 0.8 https://www.humanexasignals.com/assets/ngenla 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/assets/nhlbi 2026-08-16T18:43:27.354Z daily 0.8 https://www.humanexasignals.com/assets/niaaa 2026-08-16T18:43:27.499Z daily 0.8 https://www.humanexasignals.com/assets/niaid 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/nicardipine 2026-08-16T18:43:27.506Z daily 0.8 https://www.humanexasignals.com/assets/nicardipine-hydrochloride 2026-08-16T18:43:27.606Z daily 0.8 https://www.humanexasignals.com/assets/nice 2026-08-16T18:43:27.782Z daily 0.8 https://www.humanexasignals.com/assets/niddk 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/assets/nigeria 2026-08-16T18:43:27.452Z daily 0.8 https://www.humanexasignals.com/assets/nih 2026-08-16T18:43:27.342Z daily 0.8 https://www.humanexasignals.com/assets/nilotinib-hydrochloride 2026-08-16T18:43:27.734Z daily 0.8 https://www.humanexasignals.com/assets/nimh 2026-08-16T18:43:27.411Z daily 0.8 https://www.humanexasignals.com/assets/ninds 2026-08-16T18:43:27.506Z daily 0.8 https://www.humanexasignals.com/assets/nintedanib 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/nipocalimab 2026-08-16T18:43:27.390Z daily 0.8 https://www.humanexasignals.com/assets/niraparib 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/nirmatrelvir-ritonavir 2026-08-16T18:43:27.734Z daily 0.8 https://www.humanexasignals.com/assets/nirsevimab 2026-08-16T18:43:27.511Z daily 0.8 https://www.humanexasignals.com/assets/nitazoxanide 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/nitroglycerin 2026-08-16T18:43:27.434Z daily 0.8 https://www.humanexasignals.com/assets/nivolumab 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/nizoral 2026-08-16T18:43:27.437Z daily 0.8 https://www.humanexasignals.com/assets/nkt5097 2026-08-16T18:43:27.495Z daily 0.8 https://www.humanexasignals.com/assets/nmr 2026-08-16T18:43:27.528Z daily 0.8 https://www.humanexasignals.com/assets/non-inferiority 2026-08-16T18:43:27.483Z daily 0.8 https://www.humanexasignals.com/assets/northwestern 2026-08-16T18:43:27.459Z daily 0.8 https://www.humanexasignals.com/assets/norvir-ritonavir 2026-08-16T18:43:27.359Z daily 0.8 https://www.humanexasignals.com/assets/norwich 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/assets/nostrum 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/assets/notch 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/novel 2026-08-16T18:43:27.309Z daily 0.8 https://www.humanexasignals.com/assets/novitium 2026-08-16T18:43:27.450Z daily 0.8 https://www.humanexasignals.com/assets/novobiocin 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/assets/novocure 2026-08-16T18:43:27.544Z daily 0.8 https://www.humanexasignals.com/assets/novugen 2026-08-16T18:43:27.356Z daily 0.8 https://www.humanexasignals.com/assets/nsp13-inhibitors 2026-08-16T18:43:27.568Z daily 0.8 https://www.humanexasignals.com/assets/nucresiran 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/nucynta 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/assets/nucynta-er 2026-08-16T18:43:27.764Z daily 0.8 https://www.humanexasignals.com/assets/nulibry 2026-08-16T18:43:27.307Z daily 0.8 https://www.humanexasignals.com/assets/numb 2026-08-16T18:43:27.569Z daily 0.8 https://www.humanexasignals.com/assets/nuplazid 2026-08-16T18:43:27.350Z daily 0.8 https://www.humanexasignals.com/assets/nurix 2026-08-16T18:43:27.466Z daily 0.8 https://www.humanexasignals.com/assets/nurosym 2026-08-16T18:43:27.528Z daily 0.8 https://www.humanexasignals.com/assets/nurtec-odt 2026-08-16T18:43:27.654Z daily 0.8 https://www.humanexasignals.com/assets/nutritional 2026-08-16T18:43:27.512Z daily 0.8 https://www.humanexasignals.com/assets/nuzyra 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/nx-5948 2026-08-16T18:43:27.743Z daily 0.8 https://www.humanexasignals.com/assets/nyvepria 2026-08-16T18:43:27.309Z daily 0.8 https://www.humanexasignals.com/assets/nyxol 2026-08-16T18:43:27.411Z daily 0.8 https://www.humanexasignals.com/assets/oav101 2026-08-16T18:43:27.428Z daily 0.8 https://www.humanexasignals.com/assets/obecabtagene 2026-08-16T18:43:27.506Z daily 0.8 https://www.humanexasignals.com/assets/obesity 2026-08-16T18:43:27.398Z daily 0.8 https://www.humanexasignals.com/assets/obinutuzumab 2026-08-16T18:43:27.425Z daily 0.8 https://www.humanexasignals.com/assets/ocrelizumab 2026-08-16T18:43:27.289Z daily 0.8 https://www.humanexasignals.com/assets/ocrevus 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/assets/ocrevus-zunovo 2026-08-16T18:43:27.592Z daily 0.8 https://www.humanexasignals.com/assets/octapharma 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/assets/ocu500 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/assets/odm-208 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/ojjaara 2026-08-16T18:43:27.379Z daily 0.8 https://www.humanexasignals.com/assets/olanzapine 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/olaparib 2026-08-16T18:43:27.341Z daily 0.8 https://www.humanexasignals.com/assets/oliceridine 2026-08-16T18:43:27.506Z daily 0.8 https://www.humanexasignals.com/assets/olumiant 2026-08-16T18:43:27.449Z daily 0.8 https://www.humanexasignals.com/assets/olutasidenib 2026-08-16T18:43:27.352Z daily 0.8 https://www.humanexasignals.com/assets/olympus 2026-08-16T18:43:27.440Z daily 0.8 https://www.humanexasignals.com/assets/omega 2026-08-16T18:43:27.487Z daily 0.8 https://www.humanexasignals.com/assets/omeprazole 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/assets/onapgo 2026-08-16T18:43:27.449Z daily 0.8 https://www.humanexasignals.com/assets/onc206 2026-08-16T18:43:27.337Z daily 0.8 https://www.humanexasignals.com/assets/oncology 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/ondansetron-hydrochloride 2026-08-16T18:43:27.665Z daily 0.8 https://www.humanexasignals.com/assets/ondexxya 2026-08-16T18:43:27.449Z daily 0.8 https://www.humanexasignals.com/assets/onesource-specialty 2026-08-16T18:43:27.620Z daily 0.8 https://www.humanexasignals.com/assets/ons-5010 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/assets/ontruzant 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/opdivo 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/assets/opdivo-nivolumab 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/opdivo-qvantig 2026-08-16T18:43:27.650Z daily 0.8 https://www.humanexasignals.com/assets/opdualag 2026-08-16T18:43:27.476Z daily 0.8 https://www.humanexasignals.com/assets/ophthalmology 2026-08-16T18:43:27.540Z daily 0.8 https://www.humanexasignals.com/assets/opioid 2026-08-16T18:43:27.523Z daily 0.8 https://www.humanexasignals.com/assets/optimizing 2026-08-16T18:43:27.441Z daily 0.8 https://www.humanexasignals.com/assets/optune 2026-08-16T18:43:27.454Z daily 0.8 https://www.humanexasignals.com/assets/opzelura 2026-09-05T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/oral-nirmatrelvir-ritonavir 2026-08-16T18:43:27.790Z daily 0.8 https://www.humanexasignals.com/assets/oral7 2026-08-16T18:43:27.653Z daily 0.8 https://www.humanexasignals.com/assets/orbit 2026-08-16T18:43:27.533Z daily 0.8 https://www.humanexasignals.com/assets/orelabrutinib 2026-08-16T18:43:27.544Z daily 0.8 https://www.humanexasignals.com/assets/orenitram 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/orforglipron 2026-08-16T18:43:27.533Z daily 0.8 https://www.humanexasignals.com/assets/organon 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/orgovyx 2026-08-16T18:43:27.422Z daily 0.8 https://www.humanexasignals.com/assets/orion 2026-08-16T18:43:27.344Z daily 0.8 https://www.humanexasignals.com/assets/orserdu 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/assets/orzeyful 2026-08-16T18:43:27.317Z daily 0.8 https://www.humanexasignals.com/assets/oseltamivir 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/osimertinib 2026-08-16T18:43:27.359Z daily 0.8 https://www.humanexasignals.com/assets/osteoarthritis-knee 2026-08-16T18:43:27.403Z daily 0.8 https://www.humanexasignals.com/assets/other 2026-08-16T18:43:27.566Z daily 0.8 https://www.humanexasignals.com/assets/otsuka 2026-08-16T18:43:27.340Z daily 0.8 https://www.humanexasignals.com/assets/otud5 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/oxaydo 2026-08-16T18:43:27.494Z daily 0.8 https://www.humanexasignals.com/assets/oxcarbazepine 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/oxycet 2026-08-16T18:43:27.494Z daily 0.8 https://www.humanexasignals.com/assets/oxycodone-hydrochloride 2026-08-16T18:43:27.565Z daily 0.8 https://www.humanexasignals.com/assets/oxymorphone-hydrochloride 2026-08-16T18:43:27.489Z daily 0.8 https://www.humanexasignals.com/assets/oxytocin 2026-08-16T18:43:27.467Z daily 0.8 https://www.humanexasignals.com/assets/ozempic 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/pa5346-ocular-implant 2026-08-16T18:43:27.705Z daily 0.8 https://www.humanexasignals.com/assets/paclitaxel 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/assets/pacritinib 2026-08-16T18:43:27.456Z daily 0.8 https://www.humanexasignals.com/assets/padcev 2026-08-16T18:43:27.563Z daily 0.8 https://www.humanexasignals.com/assets/palbociclib 2026-08-16T18:43:27.312Z daily 0.8 https://www.humanexasignals.com/assets/paliperidone 2026-08-16T18:43:27.327Z daily 0.8 https://www.humanexasignals.com/assets/palsonify 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/assets/panitumumab-irdye800 2026-08-16T18:43:27.741Z daily 0.8 https://www.humanexasignals.com/assets/papaverine-hydrochloride-injection 2026-08-16T18:43:27.574Z daily 0.8 https://www.humanexasignals.com/assets/paratek-pharms 2026-08-16T18:43:27.713Z daily 0.8 https://www.humanexasignals.com/assets/paresthesia-free-spinal 2026-08-16T18:43:27.312Z daily 0.8 https://www.humanexasignals.com/assets/parexel 2026-08-16T18:43:27.362Z daily 0.8 https://www.humanexasignals.com/assets/paricalcitol 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/assets/parlodel 2026-08-16T18:43:27.449Z daily 0.8 https://www.humanexasignals.com/assets/paromlimab 2026-08-16T18:43:27.540Z daily 0.8 https://www.humanexasignals.com/assets/paroxetine 2026-08-16T18:43:27.555Z daily 0.8 https://www.humanexasignals.com/assets/paroxetine-hydrochloride 2026-08-16T18:43:27.601Z daily 0.8 https://www.humanexasignals.com/assets/patients 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/assets/patients-requiring-precision-medicine 2026-08-16T18:43:27.571Z daily 0.8 https://www.humanexasignals.com/assets/patritumab 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/assets/pavblu 2026-08-16T18:43:27.453Z daily 0.8 https://www.humanexasignals.com/assets/pazopanib 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/pcv15 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/assets/pediatric-high-grade 2026-08-16T18:43:27.502Z daily 0.8 https://www.humanexasignals.com/assets/pediatric-patients 2026-08-16T18:43:27.530Z daily 0.8 https://www.humanexasignals.com/assets/pegfilgrastim 2026-08-16T18:43:27.331Z daily 0.8 https://www.humanexasignals.com/assets/pembrolizumab 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/assets/pemigatinib 2026-08-16T18:43:27.389Z daily 0.8 https://www.humanexasignals.com/assets/pentoxifylline 2026-08-16T18:43:27.534Z daily 0.8 https://www.humanexasignals.com/assets/peptostreptococcus 2026-08-16T18:43:27.435Z daily 0.8 https://www.humanexasignals.com/assets/perampanel 2026-08-16T18:43:27.537Z daily 0.8 https://www.humanexasignals.com/assets/percocet 2026-08-16T18:43:27.490Z daily 0.8 https://www.humanexasignals.com/assets/percodan 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/assets/perjeta 2026-08-16T18:43:27.362Z daily 0.8 https://www.humanexasignals.com/assets/perphenazine 2026-08-16T18:43:27.336Z daily 0.8 https://www.humanexasignals.com/assets/petosemtamab 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/assets/pg2 2026-08-16T18:43:27.453Z daily 0.8 https://www.humanexasignals.com/assets/ph-health 2026-08-16T18:43:27.609Z daily 0.8 https://www.humanexasignals.com/assets/pha130 2026-08-16T18:43:27.762Z daily 0.8 https://www.humanexasignals.com/assets/pharmacyclics 2026-08-16T18:43:27.704Z daily 0.8 https://www.humanexasignals.com/assets/pharmobedient 2026-08-16T18:43:27.494Z daily 0.8 https://www.humanexasignals.com/assets/phase 2026-08-16T18:43:27.281Z daily 0.8 https://www.humanexasignals.com/assets/phenoxymethylpenicillin 2026-08-16T18:43:27.440Z daily 0.8 https://www.humanexasignals.com/assets/phentermine-hydrochloride 2026-08-16T18:43:27.661Z daily 0.8 https://www.humanexasignals.com/assets/phenylephrine-hydrochloride 2026-08-16T18:43:27.801Z daily 0.8 https://www.humanexasignals.com/assets/phesgo 2026-08-16T18:43:27.311Z daily 0.8 https://www.humanexasignals.com/assets/phytonadione 2026-08-16T18:43:27.405Z daily 0.8 https://www.humanexasignals.com/assets/pilot 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/assets/pimicotinib 2026-08-16T18:43:27.521Z daily 0.8 https://www.humanexasignals.com/assets/pimozide 2026-08-16T18:43:27.373Z daily 0.8 https://www.humanexasignals.com/assets/pipe-791 2026-08-16T18:43:27.340Z daily 0.8 https://www.humanexasignals.com/assets/pipeline-update 2026-08-16T18:43:27.565Z daily 0.8 https://www.humanexasignals.com/assets/piposertib 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/pirepemat 2026-08-16T18:43:27.426Z daily 0.8 https://www.humanexasignals.com/assets/pirfenidone 2026-08-16T18:43:27.365Z daily 0.8 https://www.humanexasignals.com/assets/piroxicam 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/assets/pirtobrutinib 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/assets/pit565 2026-08-16T18:43:27.459Z daily 0.8 https://www.humanexasignals.com/assets/pitolisant-hydrochloride 2026-08-16T18:43:27.563Z daily 0.8 https://www.humanexasignals.com/assets/pixxoscan 2026-08-16T18:43:27.450Z daily 0.8 https://www.humanexasignals.com/assets/platinum 2026-08-16T18:43:27.354Z daily 0.8 https://www.humanexasignals.com/assets/plerixafor 2026-08-16T18:43:27.494Z daily 0.8 https://www.humanexasignals.com/assets/pluvicto 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/assets/plx038 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/pn-ha 2026-08-16T18:43:27.782Z daily 0.8 https://www.humanexasignals.com/assets/pokonza 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/assets/polycythemia-vera 2026-08-16T18:43:27.372Z daily 0.8 https://www.humanexasignals.com/assets/pomalidomide 2026-08-16T18:43:27.353Z daily 0.8 https://www.humanexasignals.com/assets/pomalyst 2026-08-16T18:43:27.356Z daily 0.8 https://www.humanexasignals.com/assets/ponlimsi-denosumab 2026-08-16T18:43:27.403Z daily 0.8 https://www.humanexasignals.com/assets/postpartum-depression 2026-08-16T18:43:27.509Z daily 0.8 https://www.humanexasignals.com/assets/potassium-competitive-acid-blockers 2026-08-16T18:43:27.762Z daily 0.8 https://www.humanexasignals.com/assets/pou2f2 2026-08-16T18:43:27.440Z daily 0.8 https://www.humanexasignals.com/assets/poziotinib 2026-08-16T18:43:27.353Z daily 0.8 https://www.humanexasignals.com/assets/ppmt 2026-08-16T18:43:27.351Z daily 0.8 https://www.humanexasignals.com/assets/ppsv23 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/pragma 2026-08-16T18:43:27.317Z daily 0.8 https://www.humanexasignals.com/assets/pramipexole 2026-08-16T18:43:27.420Z daily 0.8 https://www.humanexasignals.com/assets/prasinezumab 2026-08-16T18:43:27.699Z daily 0.8 https://www.humanexasignals.com/assets/pravastatin-sodium 2026-08-16T18:43:27.605Z daily 0.8 https://www.humanexasignals.com/assets/prednisolone 2026-08-16T18:43:27.454Z daily 0.8 https://www.humanexasignals.com/assets/prednisone 2026-08-16T18:43:27.451Z daily 0.8 https://www.humanexasignals.com/assets/preempt 2026-08-16T18:43:27.502Z daily 0.8 https://www.humanexasignals.com/assets/pregabalin 2026-08-16T18:43:27.384Z daily 0.8 https://www.humanexasignals.com/assets/prevent 2026-08-16T18:43:27.523Z daily 0.8 https://www.humanexasignals.com/assets/prevnar-20 2026-08-16T18:43:27.572Z daily 0.8 https://www.humanexasignals.com/assets/pridopidine 2026-08-16T18:43:27.555Z daily 0.8 https://www.humanexasignals.com/assets/priftin 2026-08-16T18:43:27.511Z daily 0.8 https://www.humanexasignals.com/assets/procizumab 2026-08-16T18:43:27.443Z daily 0.8 https://www.humanexasignals.com/assets/prod-development 2026-08-16T18:43:27.625Z daily 0.8 https://www.humanexasignals.com/assets/progress 2026-08-16T18:43:27.524Z daily 0.8 https://www.humanexasignals.com/assets/project 2026-08-16T18:43:27.438Z daily 0.8 https://www.humanexasignals.com/assets/prolia 2026-08-16T18:43:27.498Z daily 0.8 https://www.humanexasignals.com/assets/promising 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/assets/propionic-acidemia 2026-08-16T18:43:27.348Z daily 0.8 https://www.humanexasignals.com/assets/propofol 2026-08-16T18:43:27.408Z daily 0.8 https://www.humanexasignals.com/assets/propranolol-hydrochloride 2026-08-16T18:43:27.621Z daily 0.8 https://www.humanexasignals.com/assets/prospective 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/prostaglandins 2026-08-16T18:43:27.390Z daily 0.8 https://www.humanexasignals.com/assets/protein 2026-08-16T18:43:27.424Z daily 0.8 https://www.humanexasignals.com/assets/provepharm-sas 2026-08-16T18:43:27.714Z daily 0.8 https://www.humanexasignals.com/assets/prs-ck-storm 2026-08-16T18:43:27.799Z daily 0.8 https://www.humanexasignals.com/assets/prucalopride 2026-08-16T18:43:27.346Z daily 0.8 https://www.humanexasignals.com/assets/prucalopride-succinate 2026-08-16T18:43:27.619Z daily 0.8 https://www.humanexasignals.com/assets/prx5 2026-08-16T18:43:27.459Z daily 0.8 https://www.humanexasignals.com/assets/psilocybin 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/psilocybin-assisted 2026-08-16T18:43:27.390Z daily 0.8 https://www.humanexasignals.com/assets/psma-617 2026-08-16T18:43:27.793Z daily 0.8 https://www.humanexasignals.com/assets/psma-pet-ct 2026-08-16T18:43:27.706Z daily 0.8 https://www.humanexasignals.com/assets/psp 2026-08-16T18:43:27.474Z daily 0.8 https://www.humanexasignals.com/assets/psychiatry 2026-08-16T18:43:27.548Z daily 0.8 https://www.humanexasignals.com/assets/pt010 2026-08-16T18:43:27.467Z daily 0.8 https://www.humanexasignals.com/assets/ptsd 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/pulmonary-arterial 2026-08-16T18:43:27.394Z daily 0.8 https://www.humanexasignals.com/assets/pulmonology 2026-08-16T18:43:27.544Z daily 0.8 https://www.humanexasignals.com/assets/pumitamig 2026-08-16T18:43:27.502Z daily 0.8 https://www.humanexasignals.com/assets/purinergic 2026-08-16T18:43:27.512Z daily 0.8 https://www.humanexasignals.com/assets/purixan 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/assets/pvp 2026-08-16T18:43:27.385Z daily 0.8 https://www.humanexasignals.com/assets/qel-005 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/assets/qilu 2026-08-16T18:43:27.672Z daily 0.8 https://www.humanexasignals.com/assets/qilu-pharm-hainan 2026-08-16T18:43:27.806Z daily 0.8 https://www.humanexasignals.com/assets/qivigy 2026-08-16T18:43:27.334Z daily 0.8 https://www.humanexasignals.com/assets/ql1706 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/assets/qlc5508 2026-08-16T18:43:27.538Z daily 0.8 https://www.humanexasignals.com/assets/qlonilik 2026-08-16T18:43:27.341Z daily 0.8 https://www.humanexasignals.com/assets/qsymia 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/qtern 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/quagen 2026-08-16T18:43:27.312Z daily 0.8 https://www.humanexasignals.com/assets/quality 2026-08-16T18:43:27.370Z daily 0.8 https://www.humanexasignals.com/assets/quetiapine 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/assets/qufeng 2026-08-16T18:43:27.378Z daily 0.8 https://www.humanexasignals.com/assets/quinacrine-hydrochloride 2026-08-16T18:43:27.796Z daily 0.8 https://www.humanexasignals.com/assets/qx-4533 2026-08-16T18:43:27.810Z daily 0.8 https://www.humanexasignals.com/assets/rabeprazole-sodium 2026-08-16T18:43:27.782Z daily 0.8 https://www.humanexasignals.com/assets/rademikibart 2026-08-16T18:43:27.508Z daily 0.8 https://www.humanexasignals.com/assets/radiomedix 2026-08-16T18:43:27.526Z daily 0.8 https://www.humanexasignals.com/assets/radius 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/ralinepag 2026-08-16T18:43:27.453Z daily 0.8 https://www.humanexasignals.com/assets/raloxifene 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/raltitrexed 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/assets/rambo 2026-08-16T18:43:27.365Z daily 0.8 https://www.humanexasignals.com/assets/ramelteon 2026-08-16T18:43:27.371Z daily 0.8 https://www.humanexasignals.com/assets/ramipril 2026-08-16T18:43:27.292Z daily 0.8 https://www.humanexasignals.com/assets/rand 2026-08-16T18:43:27.711Z daily 0.8 https://www.humanexasignals.com/assets/ranibizumab 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/ranitidine 2026-08-16T18:43:27.394Z daily 0.8 https://www.humanexasignals.com/assets/ranluspec 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/ravulizumab 2026-08-16T18:43:27.530Z daily 0.8 https://www.humanexasignals.com/assets/rayner 2026-08-16T18:43:27.510Z daily 0.8 https://www.humanexasignals.com/assets/rbm15b 2026-08-16T18:43:27.458Z daily 0.8 https://www.humanexasignals.com/assets/rbms1 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/rct 2026-08-16T18:43:27.346Z daily 0.8 https://www.humanexasignals.com/assets/real-world 2026-08-16T18:43:27.430Z daily 0.8 https://www.humanexasignals.com/assets/recakimab 2026-08-16T18:43:27.485Z daily 0.8 https://www.humanexasignals.com/assets/recombinant 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/assets/reconnect 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/assets/recurrent-gynecologic 2026-08-16T18:43:27.506Z daily 0.8 https://www.humanexasignals.com/assets/reducose 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/assets/registry 2026-08-16T18:43:27.393Z daily 0.8 https://www.humanexasignals.com/assets/regn13335 2026-08-16T18:43:27.513Z daily 0.8 https://www.humanexasignals.com/assets/regulatory-agencies 2026-08-16T18:43:27.566Z daily 0.8 https://www.humanexasignals.com/assets/regulatory-approval 2026-08-16T18:43:27.562Z daily 0.8 https://www.humanexasignals.com/assets/relapsed-solid 2026-08-16T18:43:27.435Z daily 0.8 https://www.humanexasignals.com/assets/remdesivir 2026-08-16T18:43:27.455Z daily 0.8 https://www.humanexasignals.com/assets/remibrutinib 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/remifentanil-hydrochloride 2026-08-16T18:43:27.729Z daily 0.8 https://www.humanexasignals.com/assets/remzistotug 2026-08-16T18:43:27.391Z daily 0.8 https://www.humanexasignals.com/assets/renalytix 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/assets/renata 2026-08-16T18:43:27.516Z daily 0.8 https://www.humanexasignals.com/assets/renew-pharms 2026-08-16T18:43:27.742Z daily 0.8 https://www.humanexasignals.com/assets/repaglinide 2026-08-16T18:43:27.292Z daily 0.8 https://www.humanexasignals.com/assets/repatha 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/assets/resmed 2026-08-16T18:43:27.341Z daily 0.8 https://www.humanexasignals.com/assets/resmetirom 2026-08-16T18:43:27.405Z daily 0.8 https://www.humanexasignals.com/assets/respiratory 2026-08-16T18:43:27.558Z daily 0.8 https://www.humanexasignals.com/assets/restoregi 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/assets/ret 2026-08-16T18:43:27.519Z daily 0.8 https://www.humanexasignals.com/assets/retatrutide 2026-08-16T18:43:27.557Z daily 0.8 https://www.humanexasignals.com/assets/retevmo 2026-08-16T18:43:27.408Z daily 0.8 https://www.humanexasignals.com/assets/retifanlimab 2026-08-16T18:43:27.439Z daily 0.8 https://www.humanexasignals.com/assets/revefenacin 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/assets/review 2026-08-16T18:43:27.422Z daily 0.8 https://www.humanexasignals.com/assets/revlimid 2026-08-16T18:43:27.353Z daily 0.8 https://www.humanexasignals.com/assets/revtorpyk 2026-08-16T18:43:27.408Z daily 0.8 https://www.humanexasignals.com/assets/rextovy 2026-08-16T18:43:27.532Z daily 0.8 https://www.humanexasignals.com/assets/rexulti 2026-08-16T18:43:27.663Z daily 0.8 https://www.humanexasignals.com/assets/rezdiffra 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/ribociclib 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/assets/riconpharma 2026-08-16T18:43:27.398Z daily 0.8 https://www.humanexasignals.com/assets/riconpharma-llc 2026-08-16T18:43:27.608Z daily 0.8 https://www.humanexasignals.com/assets/rifampin 2026-08-16T18:43:27.450Z daily 0.8 https://www.humanexasignals.com/assets/rifapentine 2026-08-16T18:43:27.349Z daily 0.8 https://www.humanexasignals.com/assets/rigshospitalet 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/riluzole 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/rimactane 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/rimegepant 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/rinvoq 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/riociguat 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/assets/riomet-er 2026-08-16T18:43:27.628Z daily 0.8 https://www.humanexasignals.com/assets/risankizumab 2026-08-16T18:43:27.506Z daily 0.8 https://www.humanexasignals.com/assets/risdiplam 2026-08-16T18:43:27.536Z daily 0.8 https://www.humanexasignals.com/assets/risedronate-sodium 2026-08-16T18:43:27.782Z daily 0.8 https://www.humanexasignals.com/assets/risendronate-sodium 2026-08-16T18:43:27.624Z daily 0.8 https://www.humanexasignals.com/assets/rising 2026-08-16T18:43:27.479Z daily 0.8 https://www.humanexasignals.com/assets/risperidone 2026-08-16T18:43:27.331Z daily 0.8 https://www.humanexasignals.com/assets/ritlecitinib 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/ritodrine 2026-08-16T18:43:27.415Z daily 0.8 https://www.humanexasignals.com/assets/rituximab 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/rivaroxaban 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/rna 2026-08-16T18:43:27.476Z daily 0.8 https://www.humanexasignals.com/assets/rocbrutinib 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/rocuronium-bromide 2026-08-16T18:43:27.708Z daily 0.8 https://www.humanexasignals.com/assets/romvimza-vimselitinib 2026-08-16T18:43:27.473Z daily 0.8 https://www.humanexasignals.com/assets/ropivacaine 2026-08-16T18:43:27.366Z daily 0.8 https://www.humanexasignals.com/assets/rosemont 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/assets/rosuvastatin 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/rotarix 2026-08-16T18:43:27.469Z daily 0.8 https://www.humanexasignals.com/assets/roxadustat 2026-08-16T18:43:27.367Z daily 0.8 https://www.humanexasignals.com/assets/roxicet 2026-08-16T18:43:27.510Z daily 0.8 https://www.humanexasignals.com/assets/roxicodone 2026-08-16T18:43:27.501Z daily 0.8 https://www.humanexasignals.com/assets/rozanolixizumab 2026-08-16T18:43:27.518Z daily 0.8 https://www.humanexasignals.com/assets/rsv 2026-08-16T18:43:27.496Z daily 0.8 https://www.humanexasignals.com/assets/rtme 2026-08-16T18:43:27.680Z daily 0.8 https://www.humanexasignals.com/assets/rubicon 2026-08-16T18:43:27.497Z daily 0.8 https://www.humanexasignals.com/assets/ruxolitinib 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/ryaltris 2026-08-16T18:43:27.723Z daily 0.8 https://www.humanexasignals.com/assets/ryz401 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/saba-ilac-sanayive 2026-08-16T18:43:27.618Z daily 0.8 https://www.humanexasignals.com/assets/sacituzumab 2026-08-16T18:43:27.572Z daily 0.8 https://www.humanexasignals.com/assets/sacubitril-valsartan 2026-08-16T18:43:27.644Z daily 0.8 https://www.humanexasignals.com/assets/safety 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/safety-signal 2026-08-16T18:43:27.564Z daily 0.8 https://www.humanexasignals.com/assets/safusidenib 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/sagent 2026-08-16T18:43:27.384Z daily 0.8 https://www.humanexasignals.com/assets/sal0140 2026-08-16T18:43:27.554Z daily 0.8 https://www.humanexasignals.com/assets/salvia 2026-08-16T18:43:27.378Z daily 0.8 https://www.humanexasignals.com/assets/saninova 2026-08-16T18:43:27.462Z daily 0.8 https://www.humanexasignals.com/assets/saphnelo 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/sapien-3 2026-08-16T18:43:27.672Z daily 0.8 https://www.humanexasignals.com/assets/sarclisa 2026-08-16T18:43:27.419Z daily 0.8 https://www.humanexasignals.com/assets/sat-3247 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/satralizumab 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/sava 2026-08-16T18:43:27.475Z daily 0.8 https://www.humanexasignals.com/assets/saxagliptin 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/assets/saxenda 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/sbrt 2026-08-16T18:43:27.521Z daily 0.8 https://www.humanexasignals.com/assets/sbt777101 2026-08-16T18:43:27.461Z daily 0.8 https://www.humanexasignals.com/assets/scb0020160 2026-08-16T18:43:27.470Z daily 0.8 https://www.humanexasignals.com/assets/schizophrenia 2026-08-16T18:43:27.302Z daily 0.8 https://www.humanexasignals.com/assets/scomara 2026-08-16T18:43:27.379Z daily 0.8 https://www.humanexasignals.com/assets/scopolamine 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/scotiaderm 2026-08-16T18:43:27.487Z daily 0.8 https://www.humanexasignals.com/assets/scpharmaceuticals 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/assets/seagen 2026-08-16T18:43:27.396Z daily 0.8 https://www.humanexasignals.com/assets/sec61g 2026-08-16T18:43:27.496Z daily 0.8 https://www.humanexasignals.com/assets/segluromet 2026-08-16T18:43:27.289Z daily 0.8 https://www.humanexasignals.com/assets/selexipag 2026-08-16T18:43:27.367Z daily 0.8 https://www.humanexasignals.com/assets/selinexor 2026-08-16T18:43:27.329Z daily 0.8 https://www.humanexasignals.com/assets/selpercatinib 2026-08-16T18:43:27.420Z daily 0.8 https://www.humanexasignals.com/assets/selumetinib 2026-08-16T18:43:27.539Z daily 0.8 https://www.humanexasignals.com/assets/selution 2026-08-16T18:43:27.297Z daily 0.8 https://www.humanexasignals.com/assets/semaglutide 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/septin9 2026-08-16T18:43:27.405Z daily 0.8 https://www.humanexasignals.com/assets/serostim 2026-08-16T18:43:27.408Z daily 0.8 https://www.humanexasignals.com/assets/sertraline-hydrochloride 2026-08-16T18:43:27.614Z daily 0.8 https://www.humanexasignals.com/assets/servier 2026-08-16T18:43:27.406Z daily 0.8 https://www.humanexasignals.com/assets/severe-alopecia 2026-08-16T18:43:27.378Z daily 0.8 https://www.humanexasignals.com/assets/severe-harm 2026-08-16T18:43:27.448Z daily 0.8 https://www.humanexasignals.com/assets/severe-pneumonia 2026-08-16T18:43:27.491Z daily 0.8 https://www.humanexasignals.com/assets/sg301 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/assets/sgt-003 2026-08-16T18:43:27.681Z daily 0.8 https://www.humanexasignals.com/assets/shandong 2026-08-16T18:43:27.408Z daily 0.8 https://www.humanexasignals.com/assets/shape 2026-08-16T18:43:27.439Z daily 0.8 https://www.humanexasignals.com/assets/shenzhen 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/assets/shikonin 2026-08-16T18:43:27.530Z daily 0.8 https://www.humanexasignals.com/assets/shingrix 2026-08-16T18:43:27.317Z daily 0.8 https://www.humanexasignals.com/assets/shionogi 2026-08-16T18:43:27.391Z daily 0.8 https://www.humanexasignals.com/assets/shock 2026-08-16T18:43:27.383Z daily 0.8 https://www.humanexasignals.com/assets/shorla 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/shr-1703 2026-08-16T18:43:27.414Z daily 0.8 https://www.humanexasignals.com/assets/shr-8068 2026-08-16T18:43:27.442Z daily 0.8 https://www.humanexasignals.com/assets/shuangcheng 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/assets/sibeprenlimab 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/assets/sickle-cell 2026-08-16T18:43:27.336Z daily 0.8 https://www.humanexasignals.com/assets/sigvotatug-vedotin 2026-08-16T18:43:27.513Z daily 0.8 https://www.humanexasignals.com/assets/siliqu-brodalumab 2026-08-16T18:43:27.327Z daily 0.8 https://www.humanexasignals.com/assets/silkworm 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/sim0689 2026-08-16T18:43:27.514Z daily 0.8 https://www.humanexasignals.com/assets/simtriyo 2026-08-16T18:43:27.355Z daily 0.8 https://www.humanexasignals.com/assets/simvastatin 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/sintilimab 2026-08-16T18:43:27.282Z daily 0.8 https://www.humanexasignals.com/assets/sitagliptin 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/assets/skov3 2026-08-16T18:43:27.465Z daily 0.8 https://www.humanexasignals.com/assets/skyrizi 2026-08-16T18:43:27.472Z daily 0.8 https://www.humanexasignals.com/assets/slc22a4 2026-08-16T18:43:27.522Z daily 0.8 https://www.humanexasignals.com/assets/sobi 2026-08-16T18:43:27.689Z daily 0.8 https://www.humanexasignals.com/assets/sodium 2026-08-16T18:43:27.358Z daily 0.8 https://www.humanexasignals.com/assets/sodium-bicarbonate 2026-08-16T18:43:27.582Z daily 0.8 https://www.humanexasignals.com/assets/sodium-butabarbital 2026-08-16T18:43:27.603Z daily 0.8 https://www.humanexasignals.com/assets/sodium-thiosulfate 2026-08-16T18:43:27.656Z daily 0.8 https://www.humanexasignals.com/assets/sodium-zirconium-cyclosilicate 2026-08-16T18:43:27.603Z daily 0.8 https://www.humanexasignals.com/assets/solid 2026-08-16T18:43:27.368Z daily 0.8 https://www.humanexasignals.com/assets/soliris 2026-08-16T18:43:27.637Z daily 0.8 https://www.humanexasignals.com/assets/solriamfetol-hydrochloride 2026-08-16T18:43:27.514Z daily 0.8 https://www.humanexasignals.com/assets/somane 2026-08-16T18:43:27.389Z daily 0.8 https://www.humanexasignals.com/assets/somapacitan 2026-08-16T18:43:27.508Z daily 0.8 https://www.humanexasignals.com/assets/somerset 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/assets/sonazine 2026-08-16T18:43:27.372Z daily 0.8 https://www.humanexasignals.com/assets/sonazoid 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/sonesitatug 2026-08-16T18:43:27.365Z daily 0.8 https://www.humanexasignals.com/assets/sonrotoclax 2026-08-16T18:43:27.452Z daily 0.8 https://www.humanexasignals.com/assets/sorafenib 2026-08-16T18:43:27.445Z daily 0.8 https://www.humanexasignals.com/assets/sotagliflozin 2026-08-16T18:43:27.299Z daily 0.8 https://www.humanexasignals.com/assets/sotalol-hydrochloride 2026-08-16T18:43:27.729Z daily 0.8 https://www.humanexasignals.com/assets/sotatercept 2026-08-16T18:43:27.345Z daily 0.8 https://www.humanexasignals.com/assets/sotyktu 2026-08-16T18:43:27.733Z daily 0.8 https://www.humanexasignals.com/assets/south 2026-08-16T18:43:27.557Z daily 0.8 https://www.humanexasignals.com/assets/sp16 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/assets/specgx-llc 2026-08-16T18:43:27.622Z daily 0.8 https://www.humanexasignals.com/assets/spectrum 2026-08-16T18:43:27.391Z daily 0.8 https://www.humanexasignals.com/assets/spesolimab 2026-08-16T18:43:27.523Z daily 0.8 https://www.humanexasignals.com/assets/spg50 2026-08-16T18:43:27.426Z daily 0.8 https://www.humanexasignals.com/assets/spi-1005 2026-08-16T18:43:27.482Z daily 0.8 https://www.humanexasignals.com/assets/spiriva 2026-08-16T18:43:27.537Z daily 0.8 https://www.humanexasignals.com/assets/spironolactone 2026-08-16T18:43:27.303Z daily 0.8 https://www.humanexasignals.com/assets/sporanox 2026-08-16T18:43:27.723Z daily 0.8 https://www.humanexasignals.com/assets/spravato 2026-08-16T18:43:27.556Z daily 0.8 https://www.humanexasignals.com/assets/springworks 2026-08-16T18:43:27.381Z daily 0.8 https://www.humanexasignals.com/assets/srg-514 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/assets/steglatro 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/assets/steglujan 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/stelara 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/assets/steriscience 2026-08-16T18:43:27.518Z daily 0.8 https://www.humanexasignals.com/assets/sterling 2026-08-16T18:43:27.511Z daily 0.8 https://www.humanexasignals.com/assets/stira 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/assets/strattera 2026-08-16T18:43:27.450Z daily 0.8 https://www.humanexasignals.com/assets/streams 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/stryker 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/study 2026-08-16T18:43:27.281Z daily 0.8 https://www.humanexasignals.com/assets/subvenite 2026-08-16T18:43:27.378Z daily 0.8 https://www.humanexasignals.com/assets/sugammadex 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/assets/sugammadex-sodium 2026-08-16T18:43:27.345Z daily 0.8 https://www.humanexasignals.com/assets/sumatriptan 2026-08-16T18:43:27.625Z daily 0.8 https://www.humanexasignals.com/assets/sun-pharm 2026-08-16T18:43:27.780Z daily 0.8 https://www.humanexasignals.com/assets/sun-pharm-industries 2026-08-16T18:43:27.650Z daily 0.8 https://www.humanexasignals.com/assets/sunitinib 2026-08-16T18:43:27.406Z daily 0.8 https://www.humanexasignals.com/assets/sunny 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/assets/sunshine 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/assets/surabgene-lomparvovec 2026-08-16T18:43:27.498Z daily 0.8 https://www.humanexasignals.com/assets/surovatamig 2026-08-16T18:43:27.440Z daily 0.8 https://www.humanexasignals.com/assets/surufatinib 2026-08-16T18:43:27.435Z daily 0.8 https://www.humanexasignals.com/assets/survodutide 2026-08-16T18:43:27.506Z daily 0.8 https://www.humanexasignals.com/assets/susvimo 2026-08-16T18:43:27.378Z daily 0.8 https://www.humanexasignals.com/assets/suvorexant 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/assets/suzetrigine 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/assets/swedish 2026-08-16T18:43:27.496Z daily 0.8 https://www.humanexasignals.com/assets/sx-682 2026-08-16T18:43:27.766Z daily 0.8 https://www.humanexasignals.com/assets/syha1813 2026-08-16T18:43:27.545Z daily 0.8 https://www.humanexasignals.com/assets/symbicort 2026-08-16T18:43:27.462Z daily 0.8 https://www.humanexasignals.com/assets/symbicort-aerosphere 2026-08-16T18:43:27.670Z daily 0.8 https://www.humanexasignals.com/assets/synjardy 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/assets/sys6010 2026-08-16T18:43:27.497Z daily 0.8 https://www.humanexasignals.com/assets/systematic 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/syt-510 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/tace 2026-08-16T18:43:27.423Z daily 0.8 https://www.humanexasignals.com/assets/tacrolimus 2026-08-16T18:43:27.330Z daily 0.8 https://www.humanexasignals.com/assets/tadalafil 2026-08-16T18:43:27.315Z daily 0.8 https://www.humanexasignals.com/assets/tagitanlimab 2026-08-16T18:43:27.417Z daily 0.8 https://www.humanexasignals.com/assets/taiwan 2026-08-16T18:43:27.417Z daily 0.8 https://www.humanexasignals.com/assets/tak-360 2026-08-16T18:43:27.365Z daily 0.8 https://www.humanexasignals.com/assets/talazoparib 2026-08-16T18:43:27.413Z daily 0.8 https://www.humanexasignals.com/assets/talquetamab 2026-08-16T18:43:27.406Z daily 0.8 https://www.humanexasignals.com/assets/talvey 2026-08-16T18:43:27.658Z daily 0.8 https://www.humanexasignals.com/assets/talzenna 2026-08-16T18:43:27.381Z daily 0.8 https://www.humanexasignals.com/assets/tamoxifen-citrate 2026-08-16T18:43:27.797Z daily 0.8 https://www.humanexasignals.com/assets/tamsulosin-hydrochloride 2026-08-16T18:43:27.656Z daily 0.8 https://www.humanexasignals.com/assets/taohe 2026-08-16T18:43:27.375Z daily 0.8 https://www.humanexasignals.com/assets/tapentadol-hydrochloride 2026-08-16T18:43:27.766Z daily 0.8 https://www.humanexasignals.com/assets/tar-200 2026-08-16T18:43:27.307Z daily 0.8 https://www.humanexasignals.com/assets/tarceva 2026-08-16T18:43:27.317Z daily 0.8 https://www.humanexasignals.com/assets/targeted-therapies 2026-08-16T18:43:27.428Z daily 0.8 https://www.humanexasignals.com/assets/targeting 2026-08-16T18:43:27.528Z daily 0.8 https://www.humanexasignals.com/assets/tarlatamab 2026-08-16T18:43:27.553Z daily 0.8 https://www.humanexasignals.com/assets/tasly 2026-08-16T18:43:27.400Z daily 0.8 https://www.humanexasignals.com/assets/tazemetostat 2026-08-16T18:43:27.476Z daily 0.8 https://www.humanexasignals.com/assets/tecentriq 2026-08-16T18:43:27.313Z daily 0.8 https://www.humanexasignals.com/assets/teclistamab 2026-08-16T18:43:27.382Z daily 0.8 https://www.humanexasignals.com/assets/tecvayli 2026-08-16T18:43:27.657Z daily 0.8 https://www.humanexasignals.com/assets/tegretol 2026-08-16T18:43:27.407Z daily 0.8 https://www.humanexasignals.com/assets/teikoku 2026-08-16T18:43:27.466Z daily 0.8 https://www.humanexasignals.com/assets/telemedicine 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/assets/telemonitoring 2026-08-16T18:43:27.409Z daily 0.8 https://www.humanexasignals.com/assets/teleo 2026-08-16T18:43:27.394Z daily 0.8 https://www.humanexasignals.com/assets/telerehabilitation 2026-08-16T18:43:27.455Z daily 0.8 https://www.humanexasignals.com/assets/temozolomide 2026-08-16T18:43:27.527Z daily 0.8 https://www.humanexasignals.com/assets/tenofovir-alafenamide-fumarate 2026-08-16T18:43:27.715Z daily 0.8 https://www.humanexasignals.com/assets/tepezza 2026-08-16T18:43:27.561Z daily 0.8 https://www.humanexasignals.com/assets/teprotumumab 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/assets/tern-701 2026-08-16T18:43:27.547Z daily 0.8 https://www.humanexasignals.com/assets/tersera 2026-08-16T18:43:27.333Z daily 0.8 https://www.humanexasignals.com/assets/terumo 2026-08-16T18:43:27.357Z daily 0.8 https://www.humanexasignals.com/assets/tetracycline-hydrochloride 2026-08-16T18:43:27.744Z daily 0.8 https://www.humanexasignals.com/assets/tetravi 2026-08-16T18:43:27.342Z daily 0.8 https://www.humanexasignals.com/assets/tev-53408 2026-08-16T18:43:27.534Z daily 0.8 https://www.humanexasignals.com/assets/tev-56286 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/assets/tezepelumab 2026-08-16T18:43:27.541Z daily 0.8 https://www.humanexasignals.com/assets/tgfa 2026-08-16T18:43:27.568Z daily 0.8 https://www.humanexasignals.com/assets/thalidomide 2026-08-16T18:43:27.669Z daily 0.8 https://www.humanexasignals.com/assets/thalomid 2026-08-16T18:43:27.739Z daily 0.8 https://www.humanexasignals.com/assets/the-0504 2026-08-16T18:43:27.349Z daily 0.8 https://www.humanexasignals.com/assets/thiamine-hydrochloride 2026-08-16T18:43:27.653Z daily 0.8 https://www.humanexasignals.com/assets/thyroglobulin 2026-08-16T18:43:27.360Z daily 0.8 https://www.humanexasignals.com/assets/thyroid 2026-08-16T18:43:27.454Z daily 0.8 https://www.humanexasignals.com/assets/tianhuang 2026-08-16T18:43:27.378Z daily 0.8 https://www.humanexasignals.com/assets/ticagrelor 2026-08-16T18:43:27.283Z daily 0.8 https://www.humanexasignals.com/assets/tigit 2026-08-16T18:43:27.434Z daily 0.8 https://www.humanexasignals.com/assets/tiocystin 2026-08-16T18:43:27.388Z daily 0.8 https://www.humanexasignals.com/assets/tioprinin 2026-08-16T18:43:27.486Z daily 0.8 https://www.humanexasignals.com/assets/tiopronin 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/tirzepatide 2026-08-16T18:43:27.494Z daily 0.8 https://www.humanexasignals.com/assets/tislelizumab 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/assets/tivozanib 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/assets/tocilizumab 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/assets/tofacitinib 2026-08-16T18:43:27.520Z daily 0.8 https://www.humanexasignals.com/assets/tofacitinib-citrate 2026-08-16T18:43:27.575Z daily 0.8 https://www.humanexasignals.com/assets/tolebrutinib 2026-08-16T18:43:27.559Z daily 0.8 https://www.humanexasignals.com/assets/tolmar 2026-08-16T18:43:27.331Z daily 0.8 https://www.humanexasignals.com/assets/tolvaptan 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/assets/tomivosertib 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/assets/topiramate 2026-08-16T18:43:27.307Z daily 0.8 https://www.humanexasignals.com/assets/toripalimab 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/assets/torrent 2026-08-16T18:43:27.329Z daily 0.8 https://www.humanexasignals.com/assets/torsemide 2026-08-16T18:43:27.337Z daily 0.8 https://www.humanexasignals.com/assets/tovorafenib-day101 2026-08-16T18:43:27.305Z daily 0.8 https://www.humanexasignals.com/assets/tozorakimab 2026-08-16T18:43:27.502Z daily 0.8 https://www.humanexasignals.com/assets/tp-anda-holdings 2026-08-16T18:43:27.606Z daily 0.8 https://www.humanexasignals.com/assets/tpst-1495 2026-08-16T18:43:27.445Z daily 0.8 https://www.humanexasignals.com/assets/tpx-115 2026-08-16T18:43:27.535Z daily 0.8 https://www.humanexasignals.com/assets/tqb2868 2026-08-16T18:43:27.543Z daily 0.8 https://www.humanexasignals.com/assets/tqc3927 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/assets/tr115 2026-08-16T18:43:27.553Z daily 0.8 https://www.humanexasignals.com/assets/traditional 2026-08-16T18:43:27.380Z daily 0.8 https://www.humanexasignals.com/assets/traditional-chinese-medicine 2026-08-16T18:43:27.635Z daily 0.8 https://www.humanexasignals.com/assets/tramadol-hydrochloride 2026-08-16T18:43:27.622Z daily 0.8 https://www.humanexasignals.com/assets/tramadol-hydrochloride-and-acetaminophen 2026-08-16T18:43:27.760Z daily 0.8 https://www.humanexasignals.com/assets/transplantation 2026-08-16T18:43:27.359Z daily 0.8 https://www.humanexasignals.com/assets/trastuzumab 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/travere 2026-08-16T18:43:27.556Z daily 0.8 https://www.humanexasignals.com/assets/trb-061 2026-08-16T18:43:27.291Z daily 0.8 https://www.humanexasignals.com/assets/treating-refractory 2026-08-16T18:43:27.542Z daily 0.8 https://www.humanexasignals.com/assets/tregzi 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/assets/tremfya 2026-08-16T18:43:27.698Z daily 0.8 https://www.humanexasignals.com/assets/tremfya-guselkumab 2026-08-16T18:43:27.641Z daily 0.8 https://www.humanexasignals.com/assets/tretinoin 2026-08-16T18:43:27.539Z daily 0.8 https://www.humanexasignals.com/assets/trexall 2026-08-16T18:43:27.306Z daily 0.8 https://www.humanexasignals.com/assets/trial 2026-08-16T18:43:27.281Z daily 0.8 https://www.humanexasignals.com/assets/trial-update 2026-08-16T18:43:27.562Z daily 0.8 https://www.humanexasignals.com/assets/triapine 2026-08-16T18:43:27.336Z daily 0.8 https://www.humanexasignals.com/assets/triastek 2026-08-16T18:43:27.485Z daily 0.8 https://www.humanexasignals.com/assets/trichodermin 2026-08-16T18:43:27.390Z daily 0.8 https://www.humanexasignals.com/assets/trodelvy 2026-08-28T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/trofinetide 2026-08-16T18:43:27.536Z daily 0.8 https://www.humanexasignals.com/assets/trontinemab 2026-08-16T18:43:27.450Z daily 0.8 https://www.humanexasignals.com/assets/truqap 2026-08-16T18:43:27.550Z daily 0.8 https://www.humanexasignals.com/assets/trutakna 2026-08-16T18:43:27.434Z daily 0.8 https://www.humanexasignals.com/assets/truvada 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/tryngolza 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/assets/tsha-105 2026-08-16T18:43:27.379Z daily 0.8 https://www.humanexasignals.com/assets/tuberculosis 2026-08-16T18:43:27.412Z daily 0.8 https://www.humanexasignals.com/assets/tuberculosis-detection 2026-08-16T18:43:27.420Z daily 0.8 https://www.humanexasignals.com/assets/tucatinib 2026-08-16T18:43:27.332Z daily 0.8 https://www.humanexasignals.com/assets/tudriqev 2026-08-16T18:43:27.322Z daily 0.8 https://www.humanexasignals.com/assets/tulisokibart 2026-08-16T18:43:27.518Z daily 0.8 https://www.humanexasignals.com/assets/tvt 2026-08-16T18:43:27.362Z daily 0.8 https://www.humanexasignals.com/assets/tyenne 2026-08-16T18:43:27.308Z daily 0.8 https://www.humanexasignals.com/assets/tylenol 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/assets/tyra-300 2026-08-16T18:43:27.493Z daily 0.8 https://www.humanexasignals.com/assets/tyruko 2026-08-16T18:43:27.360Z daily 0.8 https://www.humanexasignals.com/assets/tyvaso 2026-08-16T18:43:27.557Z daily 0.8 https://www.humanexasignals.com/assets/tzield 2026-08-16T18:43:27.365Z daily 0.8 https://www.humanexasignals.com/assets/tzield-teplizumab 2026-08-16T18:43:27.522Z daily 0.8 https://www.humanexasignals.com/assets/ubamatamab 2026-08-16T18:43:27.365Z daily 0.8 https://www.humanexasignals.com/assets/ube2c 2026-08-16T18:43:27.449Z daily 0.8 https://www.humanexasignals.com/assets/ubiquitination 2026-08-16T18:43:27.525Z daily 0.8 https://www.humanexasignals.com/assets/ubrogepant 2026-08-16T18:43:27.316Z daily 0.8 https://www.humanexasignals.com/assets/ubt251 2026-08-16T18:43:27.488Z daily 0.8 https://www.humanexasignals.com/assets/ucb 2026-08-16T18:43:27.369Z daily 0.8 https://www.humanexasignals.com/assets/ucla 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/ulixertinib 2026-08-16T18:43:27.352Z daily 0.8 https://www.humanexasignals.com/assets/ultomiris 2026-09-01T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/umedica 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/unichem 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/assets/unique 2026-08-16T18:43:27.443Z daily 0.8 https://www.humanexasignals.com/assets/universal 2026-08-16T18:43:27.509Z daily 0.8 https://www.humanexasignals.com/assets/university 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/updated 2026-08-16T18:43:27.415Z daily 0.8 https://www.humanexasignals.com/assets/us-antibiotics 2026-08-16T18:43:27.676Z daily 0.8 https://www.humanexasignals.com/assets/ustekinumab 2026-08-16T18:43:27.423Z daily 0.8 https://www.humanexasignals.com/assets/utebzi 2026-08-16T18:43:27.515Z daily 0.8 https://www.humanexasignals.com/assets/va 2026-08-16T18:43:27.512Z daily 0.8 https://www.humanexasignals.com/assets/vabysmo 2026-08-16T18:43:27.547Z daily 0.8 https://www.humanexasignals.com/assets/valacyclovir-hydrochloride 2026-08-16T18:43:27.624Z daily 0.8 https://www.humanexasignals.com/assets/valneva 2026-08-16T18:43:27.287Z daily 0.8 https://www.humanexasignals.com/assets/valsartan 2026-08-16T18:43:27.290Z daily 0.8 https://www.humanexasignals.com/assets/vancomycin-hydrochloride 2026-08-16T18:43:27.604Z daily 0.8 https://www.humanexasignals.com/assets/vanflyta 2026-08-16T18:43:27.347Z daily 0.8 https://www.humanexasignals.com/assets/vantas 2026-08-16T18:43:27.331Z daily 0.8 https://www.humanexasignals.com/assets/vardenafil-hydrochloride 2026-08-16T18:43:27.284Z daily 0.8 https://www.humanexasignals.com/assets/varenicline 2026-08-16T18:43:27.536Z daily 0.8 https://www.humanexasignals.com/assets/varenicline-tartrate 2026-08-16T18:43:27.617Z daily 0.8 https://www.humanexasignals.com/assets/variceal-bleeding 2026-08-16T18:43:27.444Z daily 0.8 https://www.humanexasignals.com/assets/various-products 2026-08-16T18:43:27.496Z daily 0.8 https://www.humanexasignals.com/assets/vas-101 2026-08-16T18:43:27.393Z daily 0.8 https://www.humanexasignals.com/assets/vasopressin 2026-08-16T18:43:27.334Z daily 0.8 https://www.humanexasignals.com/assets/vax-31 2026-08-16T18:43:27.460Z daily 0.8 https://www.humanexasignals.com/assets/vc005 2026-08-16T18:43:27.400Z daily 0.8 https://www.humanexasignals.com/assets/veklury 2026-08-16T18:43:27.457Z daily 0.8 https://www.humanexasignals.com/assets/veklury-remdesivir 2026-08-16T18:43:27.341Z daily 0.8 https://www.humanexasignals.com/assets/vemagal 2026-08-16T18:43:27.336Z daily 0.8 https://www.humanexasignals.com/assets/venclexta 2026-08-16T18:43:27.310Z daily 0.8 https://www.humanexasignals.com/assets/venetoclax 2026-08-16T18:43:27.303Z daily 0.8 https://www.humanexasignals.com/assets/venetoclax-dexamethasone 2026-08-16T18:43:27.531Z daily 0.8 https://www.humanexasignals.com/assets/venglustat 2026-08-16T18:43:27.507Z daily 0.8 https://www.humanexasignals.com/assets/venlafaxine 2026-08-16T18:43:27.411Z daily 0.8 https://www.humanexasignals.com/assets/vepdegestant 2026-08-16T18:43:27.434Z daily 0.8 https://www.humanexasignals.com/assets/vepdegestrant 2026-08-16T18:43:27.339Z daily 0.8 https://www.humanexasignals.com/assets/verapamil-hydrochloride 2026-08-16T18:43:27.644Z daily 0.8 https://www.humanexasignals.com/assets/vericiguat 2026-08-16T18:43:27.365Z daily 0.8 https://www.humanexasignals.com/assets/verity 2026-08-16T18:43:27.473Z daily 0.8 https://www.humanexasignals.com/assets/verve-102 2026-08-16T18:43:27.549Z daily 0.8 https://www.humanexasignals.com/assets/verzenio 2026-08-16T18:43:27.385Z daily 0.8 https://www.humanexasignals.com/assets/vesomni 2026-08-16T18:43:27.494Z daily 0.8 https://www.humanexasignals.com/assets/veverimer 2026-08-16T18:43:27.404Z daily 0.8 https://www.humanexasignals.com/assets/vevye 2026-08-16T18:43:27.324Z daily 0.8 https://www.humanexasignals.com/assets/viatris 2026-08-16T18:43:27.514Z daily 0.8 https://www.humanexasignals.com/assets/viberzi 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/viloxazine-hydrochloride 2026-08-16T18:43:27.669Z daily 0.8 https://www.humanexasignals.com/assets/vimseltinib 2026-08-16T18:43:27.537Z daily 0.8 https://www.humanexasignals.com/assets/vir-2218 2026-08-16T18:43:27.496Z daily 0.8 https://www.humanexasignals.com/assets/virologically-suppressed 2026-08-16T18:43:27.523Z daily 0.8 https://www.humanexasignals.com/assets/virtual 2026-08-16T18:43:27.352Z daily 0.8 https://www.humanexasignals.com/assets/vistapharm 2026-08-16T18:43:27.500Z daily 0.8 https://www.humanexasignals.com/assets/visugromab 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/assets/vitamin 2026-08-16T18:43:27.483Z daily 0.8 https://www.humanexasignals.com/assets/vitiligo 2026-08-16T18:43:27.425Z daily 0.8 https://www.humanexasignals.com/assets/vivus-llc 2026-08-16T18:43:27.733Z daily 0.8 https://www.humanexasignals.com/assets/vixarelimab 2026-08-16T18:43:27.475Z daily 0.8 https://www.humanexasignals.com/assets/vnx-202 2026-08-16T18:43:27.506Z daily 0.8 https://www.humanexasignals.com/assets/voclosporin 2026-08-16T18:43:27.295Z daily 0.8 https://www.humanexasignals.com/assets/vonjo 2026-08-16T18:43:27.379Z daily 0.8 https://www.humanexasignals.com/assets/voriconazole 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/votoplam 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/vrdn-003 2026-08-16T18:43:27.499Z daily 0.8 https://www.humanexasignals.com/assets/vtp-1000 2026-08-16T18:43:27.343Z daily 0.8 https://www.humanexasignals.com/assets/vv913 2026-08-16T18:43:27.413Z daily 0.8 https://www.humanexasignals.com/assets/vyvanse 2026-08-16T18:43:27.361Z daily 0.8 https://www.humanexasignals.com/assets/vyvgart 2026-08-16T18:43:27.323Z daily 0.8 https://www.humanexasignals.com/assets/washington 2026-08-16T18:43:27.475Z daily 0.8 https://www.humanexasignals.com/assets/watchman-flx 2026-08-16T18:43:27.634Z daily 0.8 https://www.humanexasignals.com/assets/watson 2026-08-16T18:43:27.293Z daily 0.8 https://www.humanexasignals.com/assets/web-based 2026-08-16T18:43:27.522Z daily 0.8 https://www.humanexasignals.com/assets/wedelolactone 2026-08-16T18:43:27.475Z daily 0.8 https://www.humanexasignals.com/assets/wegovy 2026-08-16T18:43:27.334Z daily 0.8 https://www.humanexasignals.com/assets/weight 2026-08-16T18:43:27.522Z daily 0.8 https://www.humanexasignals.com/assets/welireg 2026-08-16T18:43:27.533Z daily 0.8 https://www.humanexasignals.com/assets/wezlana 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/assets/winrevair 2026-08-16T18:43:27.285Z daily 0.8 https://www.humanexasignals.com/assets/wp205 2026-08-16T18:43:27.286Z daily 0.8 https://www.humanexasignals.com/assets/wrist-ankle 2026-08-16T18:43:27.454Z daily 0.8 https://www.humanexasignals.com/assets/wuxi 2026-08-16T18:43:27.664Z daily 0.8 https://www.humanexasignals.com/assets/x-linked-retinitis 2026-08-16T18:43:27.304Z daily 0.8 https://www.humanexasignals.com/assets/xaluritamig 2026-08-16T18:43:27.536Z daily 0.8 https://www.humanexasignals.com/assets/xeljanz 2026-08-16T18:43:27.294Z daily 0.8 https://www.humanexasignals.com/assets/xeljanz-xr 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/xelstrym 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/assets/xen63 2026-08-16T18:43:27.535Z daily 0.8 https://www.humanexasignals.com/assets/xencor 2026-08-16T18:43:27.289Z daily 0.8 https://www.humanexasignals.com/assets/xeomin 2026-08-16T18:43:27.755Z daily 0.8 https://www.humanexasignals.com/assets/xiao-chai-hu-tang 2026-08-16T18:43:27.296Z daily 0.8 https://www.humanexasignals.com/assets/xigduo-xr 2026-08-16T18:43:27.630Z daily 0.8 https://www.humanexasignals.com/assets/xiromed 2026-08-16T18:43:27.384Z daily 0.8 https://www.humanexasignals.com/assets/xofluza 2026-08-16T18:43:27.534Z daily 0.8 https://www.humanexasignals.com/assets/xolair 2026-08-16T18:43:27.300Z daily 0.8 https://www.humanexasignals.com/assets/xtampza-er 2026-08-16T18:43:27.762Z daily 0.8 https://www.humanexasignals.com/assets/xtandi 2026-08-16T18:43:27.673Z daily 0.8 https://www.humanexasignals.com/assets/xttrium 2026-08-16T18:43:27.354Z daily 0.8 https://www.humanexasignals.com/assets/xtx301 2026-08-16T18:43:27.509Z daily 0.8 https://www.humanexasignals.com/assets/xya02 2026-08-16T18:43:27.493Z daily 0.8 https://www.humanexasignals.com/assets/xyzal-allergy-24hr 2026-08-16T18:43:27.703Z daily 0.8 https://www.humanexasignals.com/assets/yaopharma 2026-08-16T18:43:27.525Z daily 0.8 https://www.humanexasignals.com/assets/yartemlea 2026-08-16T18:43:27.484Z daily 0.8 https://www.humanexasignals.com/assets/yervoy 2026-08-16T18:43:27.517Z daily 0.8 https://www.humanexasignals.com/assets/yh32364 2026-08-16T18:43:27.328Z daily 0.8 https://www.humanexasignals.com/assets/yiling 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/assets/yonsa 2026-08-16T18:43:27.319Z daily 0.8 https://www.humanexasignals.com/assets/yorvipath 2026-08-16T18:43:27.318Z daily 0.8 https://www.humanexasignals.com/assets/ytb323 2026-08-16T18:43:27.481Z daily 0.8 https://www.humanexasignals.com/assets/yy001 2026-08-16T18:43:27.458Z daily 0.8 https://www.humanexasignals.com/assets/yzj-4729 2026-08-16T18:43:27.458Z daily 0.8 https://www.humanexasignals.com/assets/yzj-5053 2026-08-16T18:43:27.474Z daily 0.8 https://www.humanexasignals.com/assets/zalifrelimab 2026-08-16T18:43:27.298Z daily 0.8 https://www.humanexasignals.com/assets/zanidatamab 2026-08-16T18:43:27.472Z daily 0.8 https://www.humanexasignals.com/assets/zanthoxylum 2026-08-16T18:43:27.374Z daily 0.8 https://www.humanexasignals.com/assets/zanubrutinib 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/assets/zanzalintinib 2026-08-16T18:43:27.390Z daily 0.8 https://www.humanexasignals.com/assets/zasocitinib 2026-08-16T18:43:27.527Z daily 0.8 https://www.humanexasignals.com/assets/zaynich 2026-08-16T18:43:27.301Z daily 0.8 https://www.humanexasignals.com/assets/zegalogue 2026-08-16T18:43:27.501Z daily 0.8 https://www.humanexasignals.com/assets/zegfrovy 2026-08-16T18:43:27.424Z daily 0.8 https://www.humanexasignals.com/assets/zen-3694 2026-08-16T18:43:27.485Z daily 0.8 https://www.humanexasignals.com/assets/zenara 2026-08-16T18:43:27.345Z daily 0.8 https://www.humanexasignals.com/assets/zeprumetostat 2026-08-16T18:43:27.350Z daily 0.8 https://www.humanexasignals.com/assets/zerbaxa 2026-08-16T18:43:27.320Z daily 0.8 https://www.humanexasignals.com/assets/zevtera 2026-08-16T18:43:27.473Z daily 0.8 https://www.humanexasignals.com/assets/ziac 2026-08-16T18:43:27.672Z daily 0.8 https://www.humanexasignals.com/assets/zidesamtinib 2026-08-16T18:43:27.376Z daily 0.8 https://www.humanexasignals.com/assets/ziextenzo 2026-08-16T18:43:27.321Z daily 0.8 https://www.humanexasignals.com/assets/zilebesiran 2026-08-16T18:43:27.281Z daily 0.8 https://www.humanexasignals.com/assets/zilovertamab 2026-08-16T18:43:27.796Z daily 0.8 https://www.humanexasignals.com/assets/ziprasidone-hydrochloride 2026-08-16T18:43:27.674Z daily 0.8 https://www.humanexasignals.com/assets/ziresovir 2026-08-16T18:43:27.368Z daily 0.8 https://www.humanexasignals.com/assets/zithromax 2026-08-16T18:43:27.384Z daily 0.8 https://www.humanexasignals.com/assets/zituvimet 2026-08-16T18:43:27.288Z daily 0.8 https://www.humanexasignals.com/assets/zoc2017217 2026-08-16T18:43:27.363Z daily 0.8 https://www.humanexasignals.com/assets/zoladex 2026-08-16T18:43:27.428Z daily 0.8 https://www.humanexasignals.com/assets/zolbetuximab 2026-08-16T18:43:27.377Z daily 0.8 https://www.humanexasignals.com/assets/zolpidem-tartrate 2026-08-16T18:43:27.650Z daily 0.8 https://www.humanexasignals.com/assets/zongertinib 2026-08-16T18:43:27.326Z daily 0.8 https://www.humanexasignals.com/assets/zorifertinib 2026-08-16T18:43:27.444Z daily 0.8 https://www.humanexasignals.com/assets/zuranolone 2026-08-16T18:43:27.366Z daily 0.8 https://www.humanexasignals.com/assets/zyban 2026-08-16T18:43:27.361Z daily 0.8 https://www.humanexasignals.com/assets/zydus 2026-08-16T18:43:27.303Z daily 0.8 https://www.humanexasignals.com/assets/zyla 2026-08-16T18:43:27.621Z daily 0.8 https://www.humanexasignals.com/assets/zynyz 2026-08-16T18:43:27.645Z daily 0.8 https://www.humanexasignals.com/assets/zyogreen 2026-08-16T18:43:27.418Z daily 0.8 https://www.humanexasignals.com/assets/zyvox 2026-08-16T18:43:27.526Z daily 0.8 https://www.humanexasignals.com/indications/acute-cardiovascular-disease 2026-08-16T18:43:27.480Z weekly 0.7 https://www.humanexasignals.com/indications/acute-coronary-syndrome 2026-08-16T18:43:27.415Z weekly 0.7 https://www.humanexasignals.com/indications/acute-leukemia 2026-08-16T18:43:27.520Z weekly 0.7 https://www.humanexasignals.com/indications/acute-lymphoblastic-leukemia 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/indications/acute-myeloid-leukemia 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/indications/acute-promyelocytic-leukemia 2026-08-16T18:43:27.461Z weekly 0.7 https://www.humanexasignals.com/indications/acute-respiratory-distress-syndrome 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/indications/acute-respiratory-distress-syndrome-ards 2026-08-16T18:43:27.346Z weekly 0.7 https://www.humanexasignals.com/indications/adolescent-and-young-adult-cancer 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/indications/adrenocortical-carcinoma 2026-08-16T18:43:27.358Z weekly 0.7 https://www.humanexasignals.com/indications/alagille-syndrome 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/indications/alcohol-use-disorder 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/indications/alzheimer-s-disease 2026-08-16T18:43:27.301Z weekly 0.7 https://www.humanexasignals.com/indications/alzheimer-s-disease-subcutaneous 2026-08-16T18:43:27.559Z weekly 0.7 https://www.humanexasignals.com/indications/alzheimer-s-psychosis 2026-11-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/anal-cancer 2026-08-16T18:43:27.493Z weekly 0.7 https://www.humanexasignals.com/indications/androgen-excess-disorders 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/indications/anemia 2026-08-16T18:43:27.352Z weekly 0.7 https://www.humanexasignals.com/indications/anxiety-disorders 2026-08-16T18:43:27.335Z weekly 0.7 https://www.humanexasignals.com/indications/asthma 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/indications/atherosclerotic-disease 2026-08-16T18:43:27.433Z weekly 0.7 https://www.humanexasignals.com/indications/autism-spectrum-disorder 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/indications/autoimmune-disease 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/indications/autoimmune-diseases 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/indications/autoimmune-disorders 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/indications/autoimmune-dry-eye-disease 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/indications/autoinflammatory-disorders 2026-08-16T18:43:27.448Z weekly 0.7 https://www.humanexasignals.com/indications/autoinflammatory-syndromes 2026-08-16T18:43:27.438Z weekly 0.7 https://www.humanexasignals.com/indications/autonomic-nervous-system-disorders 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/indications/axial-spondyloarthritis 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/indications/b-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.474Z weekly 0.7 https://www.humanexasignals.com/indications/b-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.350Z weekly 0.7 https://www.humanexasignals.com/indications/b-cell-acute-lymphoblastic-leukemia-b-all 2026-08-16T18:43:27.475Z weekly 0.7 https://www.humanexasignals.com/indications/b-cell-lymphoma 2026-08-16T18:43:27.303Z weekly 0.7 https://www.humanexasignals.com/indications/b-cell-non-hodgkin-lymphoma 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/indications/b-cell-non-hodgkin-s-lymphoma 2026-08-16T18:43:27.399Z weekly 0.7 https://www.humanexasignals.com/indications/basal-cell-carcinoma 2026-08-16T18:43:27.393Z weekly 0.7 https://www.humanexasignals.com/indications/behavioral-disorders 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/indications/biliary-tract-cancer 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/indications/binge-eating-disorder 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/indications/bipolar-disorder 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/indications/bladder-cancer 2026-08-16T18:43:27.307Z weekly 0.7 https://www.humanexasignals.com/indications/bladder-pain-syndrome 2026-08-16T18:43:27.411Z weekly 0.7 https://www.humanexasignals.com/indications/blood-cancers 2026-08-16T18:43:27.304Z weekly 0.7 https://www.humanexasignals.com/indications/bone-cancer 2026-08-16T18:43:27.486Z weekly 0.7 https://www.humanexasignals.com/indications/borderline-personality-disorder 2026-08-16T18:43:27.467Z weekly 0.7 https://www.humanexasignals.com/indications/braf-mutant-melanoma 2026-08-16T18:43:27.472Z weekly 0.7 https://www.humanexasignals.com/indications/brain-cancer 2026-08-16T18:43:27.502Z weekly 0.7 https://www.humanexasignals.com/indications/breast-cancer 2026-08-16T18:43:27.293Z weekly 0.7 https://www.humanexasignals.com/indications/burkitt-lymphoma 2026-08-16T18:43:27.342Z weekly 0.7 https://www.humanexasignals.com/indications/cancer-cachexia 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/indications/cancer-care 2026-08-16T18:43:27.447Z weekly 0.7 https://www.humanexasignals.com/indications/cancer-genetics 2026-08-16T18:43:27.423Z weekly 0.7 https://www.humanexasignals.com/indications/cancer-vaccines 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/indications/cancer-related-fatigue 2026-08-16T18:43:27.531Z weekly 0.7 https://www.humanexasignals.com/indications/cardiovascular-disease 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/indications/carpal-tunnel-syndrome 2026-08-16T18:43:27.492Z weekly 0.7 https://www.humanexasignals.com/indications/cd30-positive-lymphoma 2026-08-16T18:43:27.451Z weekly 0.7 https://www.humanexasignals.com/indications/celiac-disease 2026-08-16T18:43:27.343Z weekly 0.7 https://www.humanexasignals.com/indications/cervical-and-vaginal-cancer 2026-08-16T18:43:27.547Z weekly 0.7 https://www.humanexasignals.com/indications/cervical-cancer 2026-08-16T18:43:27.309Z weekly 0.7 https://www.humanexasignals.com/indications/charcot-marie-tooth-disease 2026-08-16T18:43:27.534Z weekly 0.7 https://www.humanexasignals.com/indications/cholangiocarcinoma 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-fatigue-syndrome 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-hepatitis-b 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-hepatitis-d 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-kidney-disease 2026-08-16T18:43:27.381Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-liver-disease 2026-08-16T18:43:27.549Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-lymphocytic-leukemia 2026-08-16T18:43:27.418Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-myeloid-leukemia 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-myelomonocytic-leukemia 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-non-cancer-pain 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-obstructive-pulmonary-disease 2026-08-16T18:43:27.559Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-obstructive-pulmonary-disease-copd 2026-08-16T18:43:27.521Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-respiratory-disease 2026-08-16T18:43:27.471Z weekly 0.7 https://www.humanexasignals.com/indications/clear-cell-renal-cell-carcinoma 2026-08-16T18:43:27.561Z weekly 0.7 https://www.humanexasignals.com/indications/cns-lymphoma 2026-08-16T18:43:27.387Z weekly 0.7 https://www.humanexasignals.com/indications/colon-cancer 2026-08-16T18:43:27.402Z weekly 0.7 https://www.humanexasignals.com/indications/colorectal-cancer 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/indications/complement-mediated-kidney-disease 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/indications/congenital-disorders-of-glycosylation 2026-08-16T18:43:27.516Z weekly 0.7 https://www.humanexasignals.com/indications/connective-tissue-disorders 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/indications/copd 2026-08-16T18:43:27.292Z weekly 0.7 https://www.humanexasignals.com/indications/coronary-artery-disease 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/indications/covid-19 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/indications/covid-19-vaccine 2026-08-16T18:43:27.351Z weekly 0.7 https://www.humanexasignals.com/indications/crohn-s-disease 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/indications/cystic-fibrosis 2026-08-16T18:43:27.469Z weekly 0.7 https://www.humanexasignals.com/indications/developmental-disorders 2026-08-16T18:43:27.429Z weekly 0.7 https://www.humanexasignals.com/indications/developmental-language-disorder 2026-08-16T18:43:27.404Z weekly 0.7 https://www.humanexasignals.com/indications/diabetes 2026-08-16T18:43:27.280Z weekly 0.7 https://www.humanexasignals.com/indications/diabetes-insipidus 2026-08-16T18:43:27.408Z weekly 0.7 https://www.humanexasignals.com/indications/diabetic-kidney-disease 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/indications/diffuse-large-b-cell-lymphoma 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/indications/digestive-cancers 2026-08-16T18:43:27.360Z weekly 0.7 https://www.humanexasignals.com/indications/disruptive-mood-dysregulation-disorder 2026-08-16T18:43:27.478Z weekly 0.7 https://www.humanexasignals.com/indications/dry-eye-disease 2026-08-16T18:43:27.414Z weekly 0.7 https://www.humanexasignals.com/indications/duchenne-muscular-dystrophy-ambulatory 2026-08-16T18:43:27.561Z weekly 0.7 https://www.humanexasignals.com/indications/eating-disorders 2026-08-16T18:43:27.483Z weekly 0.7 https://www.humanexasignals.com/indications/electrolyte-disorders 2026-08-16T18:43:27.360Z weekly 0.7 https://www.humanexasignals.com/indications/endometrial-cancer 2026-08-16T18:43:27.337Z weekly 0.7 https://www.humanexasignals.com/indications/endometrial-cancer-1l 2026-08-16T18:43:27.559Z weekly 0.7 https://www.humanexasignals.com/indications/epilepsy 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/indications/er-positive-breast-cancer 2026-08-16T18:43:27.551Z weekly 0.7 https://www.humanexasignals.com/indications/esophageal-cancer 2026-08-16T18:43:27.293Z weekly 0.7 https://www.humanexasignals.com/indications/esophageal-squamous-cell-carcinoma 2026-08-16T18:43:27.452Z weekly 0.7 https://www.humanexasignals.com/indications/fabry-disease 2026-08-16T18:43:27.507Z weekly 0.7 https://www.humanexasignals.com/indications/fatty-liver-disease 2026-08-16T18:43:27.423Z weekly 0.7 https://www.humanexasignals.com/indications/fibrosing-interstitial-lung-disease 2026-08-16T18:43:27.442Z weekly 0.7 https://www.humanexasignals.com/indications/fibrosis 2026-08-16T18:43:27.365Z weekly 0.7 https://www.humanexasignals.com/indications/follicular-lymphoma 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/indications/gallbladder-cancer 2026-08-16T18:43:27.530Z weekly 0.7 https://www.humanexasignals.com/indications/gambling-disorder 2026-08-16T18:43:27.331Z weekly 0.7 https://www.humanexasignals.com/indications/gastric-cancer 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/indications/gastroesophageal-adenocarcinoma 2026-08-16T18:43:27.362Z weekly 0.7 https://www.humanexasignals.com/indications/gastroesophageal-cancer 2026-08-16T18:43:27.448Z weekly 0.7 https://www.humanexasignals.com/indications/gastrointestinal-cancers 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/indications/gaucher-disease 2026-08-16T18:43:27.424Z weekly 0.7 https://www.humanexasignals.com/indications/gaucher-disease-and-parkinsonism 2026-08-16T18:43:27.521Z weekly 0.7 https://www.humanexasignals.com/indications/generalized-myasthenia-gravis-pediatric 2026-09-01T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/genetic-disorders 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/indications/gestational-diabetes 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/indications/gi-cancers 2026-08-16T18:43:27.475Z weekly 0.7 https://www.humanexasignals.com/indications/graves-disease 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/indications/grin-related-neurodevelopmental-disorder 2026-08-16T18:43:27.502Z weekly 0.7 https://www.humanexasignals.com/indications/growth-disorders 2026-08-16T18:43:27.381Z weekly 0.7 https://www.humanexasignals.com/indications/gynecologic-cancer 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/indications/hairy-cell-leukemia 2026-08-16T18:43:27.336Z weekly 0.7 https://www.humanexasignals.com/indications/head-and-neck-cancer 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/indications/head-and-neck-squamous-cell-carcinoma 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/indications/heart-disease 2026-08-16T18:43:27.522Z weekly 0.7 https://www.humanexasignals.com/indications/hepatitis 2026-08-16T18:43:27.308Z weekly 0.7 https://www.humanexasignals.com/indications/hepatitis-b 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/indications/hepatitis-c 2026-08-16T18:43:27.359Z weekly 0.7 https://www.humanexasignals.com/indications/hepatitis-d 2026-08-16T18:43:27.424Z weekly 0.7 https://www.humanexasignals.com/indications/hepatitis-delta 2026-08-16T18:43:27.338Z weekly 0.7 https://www.humanexasignals.com/indications/hepatocellular-carcinoma 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/indications/her2-positive-endometrial-cancer 2026-08-16T18:43:27.545Z weekly 0.7 https://www.humanexasignals.com/indications/her2-positive-breast-cancer 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/indications/her2-positive-esophagogastric-adenocarcinoma 2026-08-16T18:43:27.473Z weekly 0.7 https://www.humanexasignals.com/indications/her2-positive-gastric-cancer 2026-08-16T18:43:27.519Z weekly 0.7 https://www.humanexasignals.com/indications/her2-positive-upper-tract-urothelial-carcinoma 2026-08-16T18:43:27.418Z weekly 0.7 https://www.humanexasignals.com/indications/hereditary-angioedema 2026-08-20T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/hodgkin-lymphoma 2026-08-16T18:43:27.428Z weekly 0.7 https://www.humanexasignals.com/indications/hormone-receptor-positive-breast-cancer 2026-08-16T18:43:27.549Z weekly 0.7 https://www.humanexasignals.com/indications/hpv-related-cancers 2026-08-16T18:43:27.436Z weekly 0.7 https://www.humanexasignals.com/indications/hr-her2-breast-cancer 2026-08-28T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/huntington-s-disease 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/indications/idiopathic-pulmonary-fibrosis 2026-08-16T18:43:27.302Z weekly 0.7 https://www.humanexasignals.com/indications/igg4-related-disease 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/indications/infectious-disease 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/indications/infectious-diseases 2026-08-16T18:43:27.359Z weekly 0.7 https://www.humanexasignals.com/indications/inflammatory-bowel-disease 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/indications/inflammatory-disease 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/indications/inflammatory-disorders 2026-08-16T18:43:27.460Z weekly 0.7 https://www.humanexasignals.com/indications/influenza 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/indications/inherited-retinal-diseases 2026-08-16T18:43:27.394Z weekly 0.7 https://www.humanexasignals.com/indications/interstitial-lung-disease 2026-08-16T18:43:27.484Z weekly 0.7 https://www.humanexasignals.com/indications/intrahepatic-cholangiocarcinoma 2026-08-16T18:43:27.442Z weekly 0.7 https://www.humanexasignals.com/indications/iron-deficiency-anemia 2026-08-16T18:43:27.380Z weekly 0.7 https://www.humanexasignals.com/indications/juvenile-idiopathic-arthritis 2026-08-16T18:43:27.418Z weekly 0.7 https://www.humanexasignals.com/indications/kidney-cancer 2026-08-16T18:43:27.440Z weekly 0.7 https://www.humanexasignals.com/indications/kidney-stone-disease 2026-08-16T18:43:27.490Z weekly 0.7 https://www.humanexasignals.com/indications/knee-osteoarthritis 2026-08-16T18:43:27.417Z weekly 0.7 https://www.humanexasignals.com/indications/kras-g12c-non-small-cell-lung-cancer 2026-08-16T18:43:27.476Z weekly 0.7 https://www.humanexasignals.com/indications/kras-g12c-nsclc 2026-08-16T18:43:27.476Z weekly 0.7 https://www.humanexasignals.com/indications/kras-g12c-positive-non-small-cell-lung-cancer 2026-08-16T18:43:27.433Z weekly 0.7 https://www.humanexasignals.com/indications/leukemia 2026-08-16T18:43:27.443Z weekly 0.7 https://www.humanexasignals.com/indications/liver-cancer 2026-08-16T18:43:27.329Z weekly 0.7 https://www.humanexasignals.com/indications/liver-fibrosis 2026-08-16T18:43:27.530Z weekly 0.7 https://www.humanexasignals.com/indications/long-covid 2026-08-16T18:43:27.349Z weekly 0.7 https://www.humanexasignals.com/indications/lung-adenocarcinoma 2026-08-16T18:43:27.380Z weekly 0.7 https://www.humanexasignals.com/indications/lung-cancer 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/indications/lung-fibrosis 2026-08-16T18:43:27.441Z weekly 0.7 https://www.humanexasignals.com/indications/lupus-and-rheumatoid-arthritis 2026-08-16T18:43:27.509Z weekly 0.7 https://www.humanexasignals.com/indications/lyme-disease 2026-08-16T18:43:27.301Z weekly 0.7 https://www.humanexasignals.com/indications/lymphoma 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/indications/major-depressive-disorder 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/indications/mantle-cell-lymphoma 2026-08-16T18:43:27.354Z weekly 0.7 https://www.humanexasignals.com/indications/melanoma 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/indications/melanoma-adjuvant 2026-08-16T18:43:27.559Z weekly 0.7 https://www.humanexasignals.com/indications/meniere-s-disease 2026-08-16T18:43:27.482Z weekly 0.7 https://www.humanexasignals.com/indications/merkel-cell-carcinoma 2026-08-16T18:43:27.372Z weekly 0.7 https://www.humanexasignals.com/indications/metabolic-disorders 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/indications/metabolic-dysfunction-associated-steatohepatitis 2026-08-16T18:43:27.405Z weekly 0.7 https://www.humanexasignals.com/indications/metastatic-colorectal-and-gastric-cancer 2026-08-16T18:43:27.390Z weekly 0.7 https://www.humanexasignals.com/indications/mitral-valve-disease 2026-08-16T18:43:27.362Z weekly 0.7 https://www.humanexasignals.com/indications/mood-disorders 2026-08-16T18:43:27.406Z weekly 0.7 https://www.humanexasignals.com/indications/movement-disorders 2026-08-16T18:43:27.337Z weekly 0.7 https://www.humanexasignals.com/indications/multiple-myeloma-earlier-line 2026-08-16T18:43:27.560Z weekly 0.7 https://www.humanexasignals.com/indications/multiple-sclerosis 2026-08-16T18:43:27.559Z weekly 0.7 https://www.humanexasignals.com/indications/musculoskeletal-disorders 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/indications/myelodysplastic-syndrome 2026-08-16T18:43:27.520Z weekly 0.7 https://www.humanexasignals.com/indications/myelodysplastic-syndromes 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/indications/myelodysplastic-syndromes-and-acute-myeloid-leukemia 2026-08-16T18:43:27.485Z weekly 0.7 https://www.humanexasignals.com/indications/myelofibrosis 2026-08-16T18:43:27.372Z weekly 0.7 https://www.humanexasignals.com/indications/myeloid-cancer 2026-08-16T18:43:27.426Z weekly 0.7 https://www.humanexasignals.com/indications/nasopharyngeal-carcinoma 2026-08-16T18:43:27.287Z weekly 0.7 https://www.humanexasignals.com/indications/neurodegenerative-diseases 2026-08-16T18:43:27.379Z weekly 0.7 https://www.humanexasignals.com/indications/neurodegenerative-disorders 2026-08-16T18:43:27.367Z weekly 0.7 https://www.humanexasignals.com/indications/neurodevelopmental-disorders 2026-08-16T18:43:27.526Z weekly 0.7 https://www.humanexasignals.com/indications/neuroendocrine-cancers 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/indications/neuroendocrine-carcinomas 2026-08-16T18:43:27.345Z weekly 0.7 https://www.humanexasignals.com/indications/neuroimmune-diseases 2026-08-16T18:43:27.523Z weekly 0.7 https://www.humanexasignals.com/indications/niemann-pick-disease 2026-08-16T18:43:27.388Z weekly 0.7 https://www.humanexasignals.com/indications/niemann-pick-type-c-disease 2026-08-16T18:43:27.420Z weekly 0.7 https://www.humanexasignals.com/indications/non-hodgkin-lymphoma 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/indications/non-small-cell-lung-cancer 2026-08-16T18:43:27.298Z weekly 0.7 https://www.humanexasignals.com/indications/nontuberculous-mycobacterial-lung-disease 2026-08-16T18:43:27.390Z weekly 0.7 https://www.humanexasignals.com/indications/nras-mutant-melanoma 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/indications/nrg1-fusion-positive-cholangiocarcinoma 2026-08-16T18:43:27.547Z weekly 0.7 https://www.humanexasignals.com/indications/nsclc 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/indications/obesity 2026-09-30T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/obesity-and-type-2-diabetes 2026-08-16T18:43:27.398Z weekly 0.7 https://www.humanexasignals.com/indications/obsessive-compulsive-disorder-ocd 2026-08-16T18:43:27.377Z weekly 0.7 https://www.humanexasignals.com/indications/ocular-surface-diseases 2026-08-16T18:43:27.436Z weekly 0.7 https://www.humanexasignals.com/indications/opioid-use-disorder 2026-08-16T18:43:27.400Z weekly 0.7 https://www.humanexasignals.com/indications/oral-cancer 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/indications/oropharyngeal-cancer 2026-08-16T18:43:27.554Z weekly 0.7 https://www.humanexasignals.com/indications/oropharyngeal-squamous-cell-carcinoma 2026-08-16T18:43:27.315Z weekly 0.7 https://www.humanexasignals.com/indications/osteoarthritis 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/indications/ovarian-cancer 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/indications/pancreatic-adenocarcinoma 2026-08-16T18:43:27.437Z weekly 0.7 https://www.humanexasignals.com/indications/pancreatic-cancer 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/indications/pancreatic-disorders 2026-08-16T18:43:27.451Z weekly 0.7 https://www.humanexasignals.com/indications/pancreatic-ductal-adenocarcinoma 2026-08-16T18:43:27.287Z weekly 0.7 https://www.humanexasignals.com/indications/parkinson-s-disease 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-anxiety-disorders 2026-08-16T18:43:27.387Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-b-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.377Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-bipolar-disorder 2026-08-16T18:43:27.535Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-cancer 2026-08-16T18:43:27.439Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-cancers 2026-08-16T18:43:27.466Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-demyelinating-diseases 2026-08-16T18:43:27.528Z weekly 0.7 https://www.humanexasignals.com/indications/periodontal-disease 2026-08-16T18:43:27.490Z weekly 0.7 https://www.humanexasignals.com/indications/peripheral-arterial-disease 2026-08-16T18:43:27.459Z weekly 0.7 https://www.humanexasignals.com/indications/peripheral-artery-disease 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/indications/pik3ca-mutant-breast-cancer 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/indications/pilonidal-sinus-disease 2026-08-16T18:43:27.415Z weekly 0.7 https://www.humanexasignals.com/indications/pneumococcal-disease 2026-08-16T18:43:27.429Z weekly 0.7 https://www.humanexasignals.com/indications/polycystic-kidney-disease 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/indications/polycystic-ovary-syndrome 2026-08-16T18:43:27.532Z weekly 0.7 https://www.humanexasignals.com/indications/pompe-disease 2026-08-16T18:43:27.381Z weekly 0.7 https://www.humanexasignals.com/indications/prostate-cancer 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/indications/psoriasis 2026-08-16T18:43:27.319Z weekly 0.7 https://www.humanexasignals.com/indications/psoriasis-and-autoimmune-diseases 2026-08-16T18:43:27.423Z weekly 0.7 https://www.humanexasignals.com/indications/psoriasis-and-eczema 2026-08-16T18:43:27.334Z weekly 0.7 https://www.humanexasignals.com/indications/psoriatic-arthritis 2026-08-16T18:43:27.305Z weekly 0.7 https://www.humanexasignals.com/indications/psoriatic-arthritis-and-ankylosing-spondylitis 2026-08-16T18:43:27.362Z weekly 0.7 https://www.humanexasignals.com/indications/psychosis-spectrum-disorders 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/indications/ptsd-and-substance-use-disorder 2026-08-16T18:43:27.385Z weekly 0.7 https://www.humanexasignals.com/indications/pulmonary-fibrosis 2026-08-16T18:43:27.378Z weekly 0.7 https://www.humanexasignals.com/indications/rare-blood-disorders 2026-08-16T18:43:27.477Z weekly 0.7 https://www.humanexasignals.com/indications/rare-cancers 2026-08-16T18:43:27.416Z weekly 0.7 https://www.humanexasignals.com/indications/rare-disease 2026-08-16T18:43:27.301Z weekly 0.7 https://www.humanexasignals.com/indications/rare-diseases 2026-08-16T18:43:27.294Z weekly 0.7 https://www.humanexasignals.com/indications/rare-genetic-disorders 2026-08-16T18:43:27.398Z weekly 0.7 https://www.humanexasignals.com/indications/rectal-cancer 2026-08-16T18:43:27.367Z weekly 0.7 https://www.humanexasignals.com/indications/renal-cell-carcinoma 2026-08-16T18:43:27.286Z weekly 0.7 https://www.humanexasignals.com/indications/renal-fibrosis 2026-08-16T18:43:27.385Z weekly 0.7 https://www.humanexasignals.com/indications/respiratory-disease 2026-08-16T18:43:27.487Z weekly 0.7 https://www.humanexasignals.com/indications/ret-fusion-positive-lung-cancer 2026-08-16T18:43:27.550Z weekly 0.7 https://www.humanexasignals.com/indications/retinal-diseases 2026-08-16T18:43:27.367Z weekly 0.7 https://www.humanexasignals.com/indications/retinal-disorders 2026-08-16T18:43:27.363Z weekly 0.7 https://www.humanexasignals.com/indications/rett-syndrome 2026-08-16T18:43:27.536Z weekly 0.7 https://www.humanexasignals.com/indications/rheumatoid-arthritis 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/indications/runx1-familial-platelet-disorder 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/indications/schizophrenia 2026-09-18T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/sclc 2026-08-16T18:43:27.521Z weekly 0.7 https://www.humanexasignals.com/indications/sickle-cell-anemia 2026-08-16T18:43:27.359Z weekly 0.7 https://www.humanexasignals.com/indications/sickle-cell-disease 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/indications/skin-cancer 2026-08-16T18:43:27.545Z weekly 0.7 https://www.humanexasignals.com/indications/skin-disorders 2026-08-16T18:43:27.421Z weekly 0.7 https://www.humanexasignals.com/indications/skin-melanoma 2026-08-16T18:43:27.498Z weekly 0.7 https://www.humanexasignals.com/indications/sleep-disorders 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/indications/sleep-disordered-breathing 2026-08-16T18:43:27.440Z weekly 0.7 https://www.humanexasignals.com/indications/sleep-wake-disorders 2026-08-16T18:43:27.508Z weekly 0.7 https://www.humanexasignals.com/indications/sll-and-related-lymphomas 2026-08-16T18:43:27.439Z weekly 0.7 https://www.humanexasignals.com/indications/small-cell-lung-cancer 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/indications/small-cell-lung-cancer-limited-stage 2026-10-12T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/solid-tumors-pd-l1-vegf-bispecific 2026-08-16T18:43:27.561Z weekly 0.7 https://www.humanexasignals.com/indications/squamous-cell-carcinoma 2026-08-16T18:43:27.349Z weekly 0.7 https://www.humanexasignals.com/indications/stage-iii-colon-cancer 2026-08-16T18:43:27.559Z weekly 0.7 https://www.humanexasignals.com/indications/stargardt-disease 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/indications/stiff-person-syndrome 2026-08-16T18:43:27.334Z weekly 0.7 https://www.humanexasignals.com/indications/still-s-disease 2026-08-16T18:43:27.438Z weekly 0.7 https://www.humanexasignals.com/indications/stimulant-use-disorder 2026-08-16T18:43:27.462Z weekly 0.7 https://www.humanexasignals.com/indications/stomach-adenocarcinoma 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/indications/substance-use-disorder 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/indications/substance-use-disorders 2026-08-16T18:43:27.346Z weekly 0.7 https://www.humanexasignals.com/indications/systemic-juvenile-idiopathic-arthritis 2026-08-16T18:43:27.396Z weekly 0.7 https://www.humanexasignals.com/indications/systemic-mastocytosis-earlier-line 2026-08-16T18:43:27.561Z weekly 0.7 https://www.humanexasignals.com/indications/t-cell-lymphoma 2026-08-16T18:43:27.318Z weekly 0.7 https://www.humanexasignals.com/indications/t-cell-non-hodgkin-lymphoma 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/indications/t-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.521Z weekly 0.7 https://www.humanexasignals.com/indications/temporomandibular-joint-disorders 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/indications/thoracic-cancer 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/indications/thymoma-and-thymic-carcinoma 2026-08-16T18:43:27.367Z weekly 0.7 https://www.humanexasignals.com/indications/thyroid-cancer 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/indications/thyroid-carcinoma 2026-08-16T18:43:27.513Z weekly 0.7 https://www.humanexasignals.com/indications/thyroid-disorders 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/indications/thyroid-eye-disease 2026-08-16T18:43:27.293Z weekly 0.7 https://www.humanexasignals.com/indications/thyroid-eye-disease-subcutaneous 2026-08-16T18:43:27.561Z weekly 0.7 https://www.humanexasignals.com/indications/triple-negative-breast-cancer 2026-08-16T18:43:27.288Z weekly 0.7 https://www.humanexasignals.com/indications/type-1-diabetes 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/indications/type-2-diabetes 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/indications/type-2-diabetes-mellitus 2026-08-16T18:43:27.368Z weekly 0.7 https://www.humanexasignals.com/indications/type-i-diabetes 2026-08-16T18:43:27.522Z weekly 0.7 https://www.humanexasignals.com/indications/type-ii-diabetes 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/indications/urea-cycle-disorder 2026-08-16T18:43:27.436Z weekly 0.7 https://www.humanexasignals.com/indications/urea-cycle-disorders 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/indications/urothelial-cancer 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/indications/urothelial-carcinoma 2026-08-16T18:43:27.464Z weekly 0.7 https://www.humanexasignals.com/indications/uterine-cancer 2026-08-16T18:43:27.336Z weekly 0.7 https://www.humanexasignals.com/indications/uveal-melanoma 2026-08-16T18:43:27.514Z weekly 0.7 https://www.humanexasignals.com/indications/uveal-melanoma-adjuvant 2026-10-25T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/valvular-heart-disease 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/indications/vitiligo-pediatric 2026-09-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/voice-disorders 2026-08-16T18:43:27.455Z weekly 0.7 https://www.humanexasignals.com/indications/von-willebrand-disease 2026-08-16T18:43:27.319Z weekly 0.7 https://www.humanexasignals.com/indications/wheezing-diseases 2026-08-16T18:43:27.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/23 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/23-inhibitor 2026-08-16T18:43:27.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/5-alpha-reductase-inhibitor 2026-08-16T18:43:27.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/6-inhibitor 2026-08-16T18:43:27.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/abdominal-aortic-aneurysm 2026-08-16T18:43:27.393Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ace-inhibitor 2026-08-16T18:43:27.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ace-inhibitors 2026-08-16T18:43:27.533Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acne 2026-08-16T18:43:27.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acromegaly 2026-08-16T18:43:27.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acs 2026-08-16T18:43:27.518Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/actinic-keratosis 2026-08-16T18:43:27.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acupuncture 2026-08-16T18:43:27.422Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-cardiovascular-disease 2026-08-16T18:43:27.480Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-coronary-syndrome 2026-08-16T18:43:27.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-hypoxemic-respiratory-failure 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-ischemic-stroke 2026-08-16T18:43:27.400Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-kidney-injury 2026-08-16T18:43:27.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-leukemia 2026-08-16T18:43:27.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-lung-injury 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-lymphoblastic-leukemia 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-myeloid-leukemia 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-myocardial-infarction 2026-08-16T18:43:27.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-pancreatitis 2026-08-16T18:43:27.394Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-promyelocytic-leukemia 2026-08-16T18:43:27.461Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-renal-failure 2026-08-16T18:43:27.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-respiratory-distress-syndrome 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-respiratory-distress-syndrome-ards 2026-08-16T18:43:27.346Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-respiratory-failure 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adc 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adc-and-bispecific-antibody 2026-08-16T18:43:27.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction 2026-08-16T18:43:27.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-alcohol-dependence 2026-08-16T18:43:27.776Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-alcohol-use-disorder 2026-08-16T18:43:27.769Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-digital-health 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-glp-1-receptor-agonist 2026-08-16T18:43:27.765Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-neuromodulation 2026-08-16T18:43:27.730Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-nicotine 2026-08-16T18:43:27.707Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-opioid-dependence 2026-08-16T18:43:27.682Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-opioid-use-disorder 2026-08-16T18:43:27.747Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-opioids 2026-08-16T18:43:27.585Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-psilocybin 2026-08-16T18:43:27.589Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-smoking-cessation 2026-08-16T18:43:27.793Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-stimulant-use-disorder 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-substance-use-disorders 2026-08-16T18:43:27.759Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-medicine 2026-08-16T18:43:27.483Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-medicine-opioid-use-disorder 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adenomyosis 2026-08-16T18:43:27.424Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adhd 2026-08-16T18:43:27.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adhesion-prevention 2026-08-16T18:43:27.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adolescent-and-young-adult-cancer 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adrenal-insufficiency 2026-08-16T18:43:27.497Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adrenocortical-carcinoma 2026-08-16T18:43:27.358Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/advanced-care-planning 2026-08-16T18:43:27.479Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aesthetic-medicine 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aesthetic-treatments 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/age-related-macular-degeneration 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aging 2026-08-16T18:43:27.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aging-metformin 2026-08-16T18:43:27.747Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ai-decision-support 2026-08-16T18:43:27.464Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ai-diagnostics 2026-08-16T18:43:27.400Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ai-in-diagnostics 2026-08-16T18:43:27.522Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ai-in-drug-development 2026-08-16T18:43:27.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/akt-inhibitor 2026-08-16T18:43:27.306Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/al-amyloidosis 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alagille-syndrome 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alcohol-dependence 2026-08-16T18:43:27.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alcohol-use-disorder 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aldosterone-antagonist 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alk-inhibitor 2026-08-16T18:43:27.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/allergy 2026-08-16T18:43:27.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/allergy-anaphylaxis 2026-08-16T18:43:27.774Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/allergy-antihistamine 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/allergy-antihistamine-and-decongestant 2026-08-16T18:43:27.604Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/allergy-food-allergy 2026-08-16T18:43:27.710Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/allergy-nasal-spray 2026-08-16T18:43:27.693Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alopecia-areata 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alopecia-areata-and-vitiligo 2026-08-16T18:43:27.425Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alpha-1-antitrypsin-deficiency 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alpha-1-blocker 2026-08-16T18:43:27.318Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/als 2026-08-16T18:43:27.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alzheimer-s-disease 2026-08-16T18:43:27.301Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/amino-acid-supplement 2026-08-16T18:43:27.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aml 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/amyloidosis 2026-08-16T18:43:27.531Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/amyotrophic-lateral-sclerosis 2026-08-16T18:43:27.545Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/amyotrophic-lateral-sclerosis-als 2026-08-16T18:43:27.523Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anal-cancer 2026-08-16T18:43:27.493Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/analgesia 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/analgesia-postoperative-pain 2026-08-16T18:43:27.738Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/analgesic 2026-08-16T18:43:27.339Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/analgesics 2026-08-16T18:43:27.376Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anaphylaxis 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/androgen-excess-disorders 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/androgen-receptor-inhibitor 2026-08-16T18:43:27.356Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anemia 2026-08-16T18:43:27.352Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-dexmedetomidine 2026-08-16T18:43:27.665Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-injectable 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-ketamine 2026-08-16T18:43:27.773Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-local-anesthetic 2026-08-16T18:43:27.677Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-local-anesthetics 2026-08-16T18:43:27.624Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-medical-devices 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-monitoring 2026-08-16T18:43:27.786Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-neuromuscular-blockade 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-neuromuscular-blocker 2026-08-16T18:43:27.624Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-opioid 2026-08-16T18:43:27.729Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-opioids 2026-08-16T18:43:27.805Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-pain-management 2026-08-16T18:43:27.646Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-regional-anesthesia 2026-08-16T18:43:27.775Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-respiratory-management 2026-08-16T18:43:27.675Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-reversal-agent 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-sedation 2026-08-16T18:43:27.721Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-sedative 2026-08-16T18:43:27.575Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-surgical-procedures 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesiology 2026-08-16T18:43:27.354Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesiology-general-anesthesia 2026-08-16T18:43:27.672Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesiology-pain-management 2026-08-16T18:43:27.774Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesiology-pediatric-pain-management 2026-08-16T18:43:27.711Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesiology-pediatric-surgery 2026-08-16T18:43:27.799Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesiology-postoperative-nausea-and-vomiting 2026-08-16T18:43:27.736Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aneurysm 2026-08-16T18:43:27.476Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/angina 2026-08-16T18:43:27.434Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anti-fungal 2026-08-16T18:43:27.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anti-il-33-mab 2026-08-16T18:43:27.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anti-infective-agents 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anti-inflammatory 2026-08-16T18:43:27.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anti-vegf 2026-08-16T18:43:27.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antianginal 2026-08-16T18:43:27.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiarrhythmic 2026-08-16T18:43:27.330Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibacterial 2026-08-16T18:43:27.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibiotic 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibiotic-prophylaxis 2026-08-16T18:43:27.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibiotic-resistance 2026-08-16T18:43:27.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibiotic-therapy 2026-08-16T18:43:27.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibiotics 2026-08-16T18:43:27.344Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibody-drug-conjugate 2026-08-16T18:43:27.484Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticholinergic 2026-08-16T18:43:27.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticoagulant 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticoagulants 2026-08-16T18:43:27.504Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticoagulation 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticonvulsant 2026-08-16T18:43:27.315Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antidepressant 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antidiarrheal 2026-08-16T18:43:27.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiemetic 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiepileptic 2026-08-16T18:43:27.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antifibrinolytic 2026-08-16T18:43:27.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antifungal 2026-08-16T18:43:27.301Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antihistamine 2026-08-16T18:43:27.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antihistamine-and-decongestant 2026-08-16T18:43:27.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antihypertensive 2026-08-16T18:43:27.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antimalarial 2026-08-16T18:43:27.373Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antimetabolite 2026-08-16T18:43:27.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antimicrobial 2026-08-16T18:43:27.419Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antineoplastic 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiparasitic 2026-08-16T18:43:27.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiplatelet 2026-08-16T18:43:27.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiplatelet-therapy 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antipsychotic 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiretroviral 2026-08-16T18:43:27.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiseptic 2026-08-16T18:43:27.354Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antispasmodic 2026-08-16T18:43:27.380Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antitubercular 2026-08-16T18:43:27.498Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antitumor 2026-08-16T18:43:27.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antitumor-agents 2026-08-16T18:43:27.351Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antitussive 2026-08-16T18:43:27.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiviral 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anxiety 2026-08-16T18:43:27.483Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anxiety-non-pharmacological-intervention 2026-08-16T18:43:27.758Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anxiety-disorders 2026-08-16T18:43:27.335Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anxiolytic 2026-08-16T18:43:27.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aortic-aneurysm 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aortic-aneurysms 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aortic-dissection 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aortic-stenosis 2026-08-16T18:43:27.418Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aphasia 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ascites 2026-08-16T18:43:27.449Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/assisted-reproductive-technology 2026-08-16T18:43:27.464Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/asthma 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/atherosclerosis 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/atherosclerotic-disease 2026-08-16T18:43:27.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/atopic-dermatitis 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/atrial-fibrillation 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/atrial-fibrillation-and-heart-failure 2026-08-16T18:43:27.412Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/atropine 2026-08-16T18:43:27.477Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/attr-cm 2026-08-16T18:43:27.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autism-spectrum-disorder 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune 2026-08-16T18:43:27.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-corticosteroid 2026-08-16T18:43:27.640Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-type-1-diabetes 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-disease 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-diseases 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-diseases-car-t-cell-therapy 2026-08-16T18:43:27.651Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-disorders 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-dry-eye-disease 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoinflammatory-disorders 2026-08-16T18:43:27.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoinflammatory-syndromes 2026-08-16T18:43:27.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autonomic-nervous-system-disorders 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/axial-spondyloarthritis 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.474Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-inhibition 2026-08-16T18:43:27.371Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-cell-acute-lymphoblastic-leukemia-b-all 2026-08-16T18:43:27.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-cell-lymphoma 2026-08-16T18:43:27.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-cell-malignancies 2026-08-16T18:43:27.551Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-cell-non-hodgkin-lymphoma 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-cell-non-hodgkin-s-lymphoma 2026-08-16T18:43:27.399Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bacterial-infections 2026-08-16T18:43:27.537Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/barrett-s-esophagus 2026-08-16T18:43:27.485Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/basal-cell-carcinoma 2026-08-16T18:43:27.393Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bcl-2-inhibitor 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bcr-abl1-inhibition 2026-08-16T18:43:27.547Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/behavioral-disorders 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/behavioral-intervention 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/behavioral-interventions 2026-08-16T18:43:27.555Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/benign-prostatic-hyperplasia 2026-08-16T18:43:27.355Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/benzodiazepine 2026-08-16T18:43:27.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/beta-blocker 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/beta-agonist 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biguanide 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biliary-tract-cancer 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/binge-eating-disorder 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biologic 2026-08-16T18:43:27.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biologic-therapy 2026-08-16T18:43:27.453Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biologics 2026-08-16T18:43:27.524Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biologics-drug-delivery 2026-08-16T18:43:27.785Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biomarker-discovery 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biomarker-research 2026-08-16T18:43:27.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biomarkers 2026-08-16T18:43:27.355Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biosimilar 2026-08-16T18:43:27.348Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bipolar-disorder 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bispecific-antibodies 2026-08-16T18:43:27.553Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bispecific-t-cell-engager 2026-08-16T18:43:27.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bisphosphonate 2026-08-16T18:43:27.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bite 2026-08-16T18:43:27.423Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bladder-cancer 2026-08-16T18:43:27.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bladder-pain-syndrome 2026-08-16T18:43:27.411Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/blood-cancers 2026-08-16T18:43:27.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/blood-transfusion 2026-08-16T18:43:27.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-cancer 2026-08-16T18:43:27.486Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-health 2026-08-16T18:43:27.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-health-bisphosphonate 2026-08-16T18:43:27.612Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-health-osteoporosis 2026-08-16T18:43:27.683Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-metabolism 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-metastases 2026-08-16T18:43:27.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-regeneration 2026-08-16T18:43:27.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-sarcoma 2026-08-16T18:43:27.390Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/borderline-personality-disorder 2026-08-16T18:43:27.467Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bordetella-pertussis 2026-08-16T18:43:27.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/botulinum-toxin 2026-08-16T18:43:27.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bowel-care 2026-08-16T18:43:27.399Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bph 2026-08-16T18:43:27.329Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bradyarrhythmias 2026-08-16T18:43:27.491Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/braf 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/braf-mutant-melanoma 2026-08-16T18:43:27.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/brain-cancer 2026-08-16T18:43:27.502Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/brain-injury 2026-08-16T18:43:27.354Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/brain-metastases 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/brain-tumors 2026-08-16T18:43:27.352Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/breast 2026-08-16T18:43:27.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/breast-cancer 2026-08-16T18:43:27.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/breast-reconstruction 2026-08-16T18:43:27.425Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/breast-tumors 2026-08-16T18:43:27.543Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bronchial-challenge-test 2026-08-16T18:43:27.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bronchial-provocation-testing 2026-08-16T18:43:27.529Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bronchodilator 2026-08-16T18:43:27.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bronchopulmonary-dysplasia 2026-08-16T18:43:27.427Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/btk-degrader 2026-08-16T18:43:27.551Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/btk-inhibitor 2026-08-16T18:43:27.403Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/burkitt-lymphoma 2026-08-16T18:43:27.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cadasil 2026-08-16T18:43:27.488Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/calcium-channel-blocker 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/calcium-supplement 2026-08-16T18:43:27.336Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cancer-cachexia 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cancer-care 2026-08-16T18:43:27.447Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cancer-genetics 2026-08-16T18:43:27.423Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cancer-vaccines 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cancer-related-fatigue 2026-08-16T18:43:27.531Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/canine-and-equine 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cannabinoid 2026-08-16T18:43:27.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cannabinoids 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/car-nk-cell-therapy 2026-08-16T18:43:27.404Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/car-t-cell-therapy 2026-08-16T18:43:27.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/car-nk-cells 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/car-t 2026-08-16T18:43:27.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/carbonic-anhydrase-inhibitor 2026-08-16T18:43:27.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiac-repolarization 2026-08-16T18:43:27.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiac-safety 2026-08-16T18:43:27.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiogenic-shock 2026-08-16T18:43:27.539Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-ace-inhibitors 2026-08-16T18:43:27.594Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-acute-cardiovascular-disease 2026-08-16T18:43:27.756Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-acute-coronary-syndrome 2026-08-16T18:43:27.712Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-acute-kidney-injury 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-acute-myocardial-infarction 2026-08-16T18:43:27.723Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-antiarrhythmic 2026-08-16T18:43:27.609Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-anticoagulants 2026-08-16T18:43:27.772Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-anticoagulation 2026-08-16T18:43:27.588Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-antihypertensive 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-antiplatelet 2026-08-16T18:43:27.575Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-antiplatelet-therapy 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-aortic-aneurysm 2026-08-16T18:43:27.774Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-aortic-stenosis 2026-08-16T18:43:27.715Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-atrial-fibrillation 2026-08-16T18:43:27.634Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-atrial-fibrillation-and-heart-failure 2026-08-16T18:43:27.710Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-attr-cm 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-beta-agonist 2026-08-16T18:43:27.615Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-beta-blocker 2026-08-16T18:43:27.621Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-biomarker-research 2026-08-16T18:43:27.727Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-bradyarrhythmias 2026-08-16T18:43:27.763Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-calcium-channel-blocker 2026-08-16T18:43:27.704Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-cardiac-repolarization 2026-08-16T18:43:27.681Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-cardiac-safety 2026-08-16T18:43:27.723Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-cardiogenic-shock 2026-08-16T18:43:27.595Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-catheters 2026-08-16T18:43:27.579Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-cholesterol-management 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-coronary-artery-disease 2026-08-16T18:43:27.636Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-delirium-prevention 2026-08-16T18:43:27.813Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-device-therapy 2026-08-16T18:43:27.796Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-diabetes 2026-08-16T18:43:27.752Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-digital-health 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-diuretic 2026-08-16T18:43:27.609Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-dyslipidemia 2026-08-16T18:43:27.658Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-electrolyte-replacement 2026-08-16T18:43:27.781Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-electrophysiology 2026-08-16T18:43:27.643Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-endothelin-receptor-antagonist 2026-08-16T18:43:27.684Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-fabry-disease 2026-08-16T18:43:27.774Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-gene-therapy 2026-08-16T18:43:27.755Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-disease 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-failure 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-pump 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-pump-devices 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-transplantation 2026-08-16T18:43:27.752Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-hypercholesterolemia 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-hypertension 2026-08-16T18:43:27.600Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-hypertrophic-cardiomyopathy 2026-08-16T18:43:27.788Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-imaging 2026-08-16T18:43:27.753Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-infective-endocarditis 2026-08-16T18:43:27.767Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-interventional-devices 2026-08-16T18:43:27.757Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-intraoperative-monitoring 2026-08-16T18:43:27.701Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-ischemia 2026-08-16T18:43:27.631Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-ldl-c-lowering 2026-08-16T18:43:27.652Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-lipid-management 2026-08-16T18:43:27.763Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-lipid-lowering-therapy 2026-08-16T18:43:27.660Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-lipoprotein-a 2026-08-16T18:43:27.683Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-medical-device 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-medical-devices 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-microvascular-health 2026-08-16T18:43:27.785Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-mineralocorticoid-receptor-antagonist 2026-08-16T18:43:27.647Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-mitral-valve-disease 2026-08-16T18:43:27.677Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-myocardial-infarction 2026-08-16T18:43:27.636Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-pah 2026-08-16T18:43:27.793Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-pcsk9-inhibitor 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-peripheral-arterial-disease 2026-08-16T18:43:27.750Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-pulmonary-arterial-hypertension 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-pulmonary-hypertension 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-radiopharmaceutical 2026-08-16T18:43:27.649Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-rehabilitation 2026-08-16T18:43:27.754Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-stenting 2026-08-16T18:43:27.767Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-sudden-cardiac-death 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-surgical-intervention 2026-08-16T18:43:27.814Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-surgical-procedures 2026-08-16T18:43:27.722Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-transcatheter-aortic-valve-implantation 2026-08-16T18:43:27.629Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-transcatheter-aortic-valve-replacement 2026-08-16T18:43:27.731Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-valvular-heart-disease 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-venous-thromboembolism 2026-08-16T18:43:27.658Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-abdominal-aortic-aneurysm 2026-08-16T18:43:27.698Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-ace-inhibitor 2026-08-16T18:43:27.603Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-acs 2026-08-16T18:43:27.781Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-aldosterone-antagonist 2026-08-16T18:43:27.615Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-alpha-1-blocker 2026-08-16T18:43:27.608Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-aneurysm 2026-08-16T18:43:27.753Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-angina 2026-08-16T18:43:27.724Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-antianginal 2026-08-16T18:43:27.606Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-anticholinergic 2026-08-16T18:43:27.609Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-anticoagulant 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-antihypertensive 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-antiplatelet 2026-08-16T18:43:27.657Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-aortic-aneurysms 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-aortic-dissection 2026-08-16T18:43:27.742Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-atherosclerosis 2026-08-16T18:43:27.686Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-atherosclerotic-disease 2026-08-16T18:43:27.723Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-beta-blocker 2026-08-16T18:43:27.615Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-beta-agonist 2026-08-16T18:43:27.645Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-calcium-channel-blocker 2026-08-16T18:43:27.611Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-cholesterol-management 2026-08-16T18:43:27.606Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-combination-therapy 2026-08-16T18:43:27.640Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-diuretic 2026-08-16T18:43:27.610Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-dyslipidemia 2026-08-16T18:43:27.708Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-gene-editing 2026-08-16T18:43:27.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-heart-failure 2026-08-16T18:43:27.652Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-hypercholesterolemia 2026-08-16T18:43:27.788Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-hypertension 2026-08-16T18:43:27.607Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-injectable 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-lipid-management 2026-08-16T18:43:27.681Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-lipid-regulation 2026-08-16T18:43:27.615Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-lipoprotein-a 2026-08-16T18:43:27.694Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-medical-devices 2026-08-16T18:43:27.579Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-monoclonal-antibody 2026-08-16T18:43:27.729Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-omega-3-fatty-acids 2026-08-16T18:43:27.758Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-pcsk9-inhibition 2026-08-16T18:43:27.597Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-pcsk9-inhibitor 2026-08-16T18:43:27.707Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-peripheral-arterial-disease 2026-08-16T18:43:27.740Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-peripheral-artery-disease 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-pulmonary-arterial-hypertension 2026-08-16T18:43:27.778Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-rehabilitation 2026-08-16T18:43:27.756Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-statin 2026-08-16T18:43:27.605Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-vasopressor 2026-08-16T18:43:27.625Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-disease 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-disease-digital-health 2026-08-16T18:43:27.651Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-disease-nutritional-assessment 2026-08-16T18:43:27.777Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-disease-observational-study 2026-08-16T18:43:27.743Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-disease-pneumonia 2026-08-16T18:43:27.738Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/care-strategy 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/carpal-tunnel-syndrome 2026-08-16T18:43:27.492Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cartilage-regeneration 2026-08-16T18:43:27.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cataract 2026-08-16T18:43:27.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cataracts 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/catheterization 2026-08-16T18:43:27.554Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/catheters 2026-08-16T18:43:27.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cd123-targeted-therapy 2026-08-16T18:43:27.462Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cd3-bispecific-antibody 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cd30-positive-lymphoma 2026-08-16T18:43:27.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cdk-inhibitor 2026-08-16T18:43:27.427Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cdk4 2026-08-16T18:43:27.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cdk7-inhibition 2026-08-16T18:43:27.425Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/celiac-disease 2026-08-16T18:43:27.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cell-therapy 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cerebral-palsy 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cerebral-palsy-and-muscular-dystrophy 2026-08-16T18:43:27.491Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cervical-and-vaginal-cancer 2026-08-16T18:43:27.547Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cervical-cancer 2026-08-16T18:43:27.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cervical-health 2026-08-16T18:43:27.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cgrp-antibody 2026-08-16T18:43:27.529Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cgrp-inhibitor 2026-08-16T18:43:27.482Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cgvhd 2026-08-16T18:43:27.522Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/charcot-marie-tooth-disease 2026-08-16T18:43:27.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/checkpoint-inhibitor 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chemotherapy 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chemotherapy-adjunct 2026-08-16T18:43:27.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chemotherapy-support 2026-08-16T18:43:27.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chemotherapy-induced-peripheral-neuropathy 2026-08-16T18:43:27.412Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cholangiocarcinoma 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cholestasis 2026-08-16T18:43:27.421Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cholesterol-management 2026-08-16T18:43:27.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-anal-fissure 2026-08-16T18:43:27.497Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-coccydynia 2026-08-16T18:43:27.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-cough 2026-08-16T18:43:27.545Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-fatigue-syndrome 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-hepatitis-b 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-hepatitis-d 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-kidney-disease 2026-08-16T18:43:27.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-liver-disease 2026-08-16T18:43:27.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-low-back-pain 2026-08-16T18:43:27.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-lymphocytic-leukemia 2026-08-16T18:43:27.418Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-myeloid-leukemia 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-myelomonocytic-leukemia 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-non-cancer-pain 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-obstructive-pulmonary-disease-copd 2026-08-16T18:43:27.521Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-pain 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-pain-management 2026-08-16T18:43:27.404Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-respiratory-disease 2026-08-16T18:43:27.471Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-rhinosinusitis-with-nasal-polyps 2026-08-16T18:43:27.518Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-spontaneous-urticaria 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-thromboembolic-pulmonary-hypertension 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-venous-insufficiency 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cirrhosis 2026-08-16T18:43:27.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cll 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/clostridioides-difficile 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/clostridioides-difficile-infection 2026-08-16T18:43:27.452Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cns 2026-08-16T18:43:27.468Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cns-cough-suppressant 2026-08-16T18:43:27.745Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cns-lymphoma 2026-08-16T18:43:27.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cns-metastases 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cns-tumors 2026-08-16T18:43:27.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cochlear-implant 2026-08-16T18:43:27.490Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cognitive-impairment 2026-08-16T18:43:27.402Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cold-sores 2026-08-16T18:43:27.371Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/colon-cancer 2026-08-16T18:43:27.402Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/colorectal-cancer 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/combination-analgesic 2026-08-16T18:43:27.501Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/combination-analgesics 2026-08-16T18:43:27.494Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/combination-immunotherapy 2026-08-16T18:43:27.319Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/combination-therapy 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/complement-inhibition 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/complement-inhibitor 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/complement-mediated-kidney-disease 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/compounding 2026-08-16T18:43:27.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/congenital-adrenal-hyperplasia 2026-08-16T18:43:27.399Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/congenital-disorders-of-glycosylation 2026-08-16T18:43:27.516Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/connective-tissue-disorders 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/constipation 2026-08-16T18:43:27.346Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/continuous-glucose-monitoring 2026-08-16T18:43:27.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/contraception 2026-08-16T18:43:27.359Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/contraception-hormonal 2026-08-16T18:43:27.697Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/contraceptive 2026-08-16T18:43:27.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/contrast-agent 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/copd 2026-08-16T18:43:27.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/coronary-artery-disease 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/coronavirus 2026-08-16T18:43:27.445Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/corticosteroid 2026-08-16T18:43:27.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/corticosteroids 2026-08-16T18:43:27.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cortisol-regulation 2026-08-16T18:43:27.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cough-and-cold 2026-08-16T18:43:27.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cough-and-cold-antitussive 2026-08-16T18:43:27.681Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cough-suppressant 2026-08-16T18:43:27.468Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/covid-19 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/covid-19-vaccine 2026-08-16T18:43:27.351Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cox-2-inhibitor 2026-08-16T18:43:27.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/critical-care 2026-08-16T18:43:27.358Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/critical-care-catheterization 2026-08-16T18:43:27.798Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/critical-care-sepsis 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/crohn-s-disease 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cutaneous-angiosarcoma 2026-08-16T18:43:27.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cystic-fibrosis 2026-08-16T18:43:27.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cystinosis 2026-08-16T18:43:27.388Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cystinuria 2026-08-16T18:43:27.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cytokine-modulation 2026-08-16T18:43:27.554Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/data-analytics 2026-08-16T18:43:27.462Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/data-collection 2026-08-16T18:43:27.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/de-quervain-tenosynovitis 2026-08-16T18:43:27.399Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/deep-brain-stimulation 2026-08-16T18:43:27.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/delirium-prevention 2026-08-16T18:43:27.505Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dementia 2026-08-16T18:43:27.329Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dementia-care 2026-08-16T18:43:27.358Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dementia-with-lewy-bodies 2026-08-16T18:43:27.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dendrimer-based-therapy 2026-08-16T18:43:27.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dental 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dental-bone-regeneration 2026-08-16T18:43:27.678Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dental-oral-care 2026-08-16T18:43:27.654Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dental-peri-implantitis 2026-08-16T18:43:27.807Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dental-periodontitis 2026-08-16T18:43:27.647Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dentistry 2026-08-16T18:43:27.490Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dentistry-periodontal-disease 2026-08-16T18:43:27.812Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/depression 2026-08-16T18:43:27.301Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology 2026-09-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-acne 2026-08-16T18:43:27.575Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-actinic-keratosis 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-aesthetic-medicine 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-aesthetic-treatments 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-alopecia-areata 2026-08-16T18:43:27.658Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-alopecia-areata-and-vitiligo 2026-08-16T18:43:27.719Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-anti-fungal 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-antibiotic 2026-08-16T18:43:27.645Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-antifungal 2026-08-16T18:43:27.666Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-atopic-dermatitis 2026-08-16T18:43:27.579Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-autoimmune-disease 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-autoimmune-diseases 2026-08-16T18:43:27.791Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-autoimmune-disorders 2026-08-16T18:43:27.703Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-chronic-spontaneous-urticaria 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-cold-sores 2026-08-16T18:43:27.684Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-corticosteroid 2026-08-16T18:43:27.613Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-exosome-therapy 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-hidradenitis-suppurativa 2026-08-16T18:43:27.706Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-il-23 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-incontinence-associated-dermatitis 2026-08-16T18:43:27.799Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-infantile-hemangiomas 2026-08-16T18:43:27.725Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-jak-inhibitor 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-keloids 2026-08-16T18:43:27.753Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-nonsegmental-vitiligo 2026-08-16T18:43:27.686Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-pde4-inhibition 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-psoriasis 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-psoriasis-and-eczema 2026-08-16T18:43:27.581Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-scar-management 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-skin-aging 2026-08-16T18:43:27.667Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-skin-damage 2026-08-16T18:43:27.760Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-skin-disorders 2026-08-16T18:43:27.716Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-skin-hydration 2026-08-16T18:43:27.782Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-small-molecule 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-stem-cell-therapy 2026-08-16T18:43:27.796Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-topical-anti-inflammatory 2026-08-16T18:43:27.733Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-topical-antiviral 2026-08-16T18:43:27.609Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-topical-corticosteroid 2026-08-16T18:43:27.756Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-topical-immunomodulator 2026-08-16T18:43:27.756Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-topical-retinoid 2026-08-16T18:43:27.616Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-topical-steroid 2026-08-16T18:43:27.602Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-transdermal-delivery 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-vascular-tumors 2026-08-16T18:43:27.748Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-vitiligo 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/developmental-disorders 2026-08-16T18:43:27.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/developmental-language-disorder 2026-08-16T18:43:27.404Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/device 2026-08-16T18:43:27.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/device-therapy 2026-08-16T18:43:27.542Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dexmedetomidine 2026-08-16T18:43:27.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes 2026-08-16T18:43:27.279Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-behavioral-intervention 2026-08-16T18:43:27.666Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-combination-therapy 2026-08-16T18:43:27.602Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-continuous-glucose-monitoring 2026-08-16T18:43:27.594Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-digital-health 2026-08-16T18:43:27.662Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-dpp-4-inhibitor 2026-08-16T18:43:27.642Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-dpp-4-inhibitor-biguanide 2026-08-16T18:43:27.628Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-dpp-4-inhibitor-and-biguanide 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-drug-interaction 2026-08-16T18:43:27.710Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-glp-1 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-glp-1-agonist 2026-08-16T18:43:27.631Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-glp-1-receptor-agonist 2026-08-16T18:43:27.704Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-insulin 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-insulin-combination-therapy 2026-08-16T18:43:27.640Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-insulin-delivery 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-lifestyle-intervention 2026-08-16T18:43:27.697Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-neuropathy 2026-08-16T18:43:27.793Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-oral-hypoglycemic 2026-08-16T18:43:27.601Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-oral-hypoglycemic-agent 2026-08-16T18:43:27.601Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-oral-hypoglycemics 2026-08-16T18:43:27.603Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-pharmacokinetics 2026-08-16T18:43:27.716Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-sglt-2-inhibitor 2026-08-16T18:43:27.639Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-sglt2-inhibitor 2026-08-16T18:43:27.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-sglt2-inhibitor-dpp-4-inhibitor 2026-08-16T18:43:27.584Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-sglt2-inhibitor-metformin 2026-08-16T18:43:27.630Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-sglt2-inhibitor-and-biguanide 2026-08-16T18:43:27.600Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-sglt2-inhibitor-and-dpp-4-inhibitor 2026-08-16T18:43:27.601Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-sglt2-inhibitor-biguanide 2026-08-16T18:43:27.628Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-insipidus 2026-08-16T18:43:27.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetic-kidney-disease 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetic-macular-edema 2026-08-16T18:43:27.558Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetic-macular-oedema 2026-08-16T18:43:27.493Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetic-retinopathy 2026-08-16T18:43:27.413Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diagnostic-agent 2026-08-16T18:43:27.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diagnostic-imaging 2026-08-16T18:43:27.318Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diagnostics 2026-08-16T18:43:27.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diagnostics-biomarkers 2026-08-16T18:43:27.673Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diagnostics-and-multiple-sclerosis 2026-08-16T18:43:27.546Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dialysis 2026-08-16T18:43:27.453Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dietary-supplements 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diffuse-large-b-cell-lymphoma 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/digestive-cancers 2026-08-16T18:43:27.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/digital-health 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/digital-pathology 2026-08-16T18:43:27.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/digital-therapeutics 2026-08-16T18:43:27.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/disruptive-mood-dysregulation-disorder 2026-08-16T18:43:27.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diuretic 2026-08-16T18:43:27.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dlbcl 2026-08-16T18:43:27.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dll3 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dmard 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dna-repair-inhibition 2026-08-16T18:43:27.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dopamine-agonist 2026-08-16T18:43:27.449Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dpp-4-inhibitor 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dpp-4-inhibitor-and-biguanide 2026-08-16T18:43:27.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug 2026-08-16T18:43:27.373Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-absorption 2026-08-16T18:43:27.362Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-delivery 2026-08-16T18:43:27.412Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-development 2026-08-16T18:43:27.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-interaction 2026-08-16T18:43:27.412Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-labeling 2026-08-16T18:43:27.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-manufacturing 2026-08-16T18:43:27.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-safety 2026-08-16T18:43:27.558Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dry-age-related-macular-degeneration 2026-08-16T18:43:27.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dry-eye 2026-08-16T18:43:27.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dry-eye-disease 2026-08-16T18:43:27.414Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dsrct 2026-08-16T18:43:27.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/duchenne-muscular-dystrophy 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dyslipidemia 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dysmenorrhea 2026-08-16T18:43:27.425Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dysphagia 2026-08-16T18:43:27.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/early-detection 2026-08-16T18:43:27.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/early-gi-neoplasia 2026-08-16T18:43:27.393Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/eating-disorders 2026-08-16T18:43:27.483Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ecmo 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/egfr-inhibitor 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/egfr-targeted-therapies 2026-08-16T18:43:27.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/electrolyte-disorders 2026-08-16T18:43:27.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/electrolyte-imbalance 2026-08-16T18:43:27.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/electrolyte-imbalance-calcium-supplement 2026-08-16T18:43:27.610Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/electrolyte-imbalance-injectable 2026-08-16T18:43:27.641Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/electrolyte-imbalance-magnesium-supplement 2026-08-16T18:43:27.804Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/electrolyte-replacement 2026-08-16T18:43:27.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/electrolyte-replenisher 2026-08-16T18:43:27.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/electrophysiology 2026-08-16T18:43:27.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/emergency-medicine 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/emergency-medicine-anaphylaxis 2026-08-16T18:43:27.605Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/emergency-medicine-data-analytics 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/emergency-medicine-epinephrine 2026-08-16T18:43:27.614Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrine-tumors 2026-08-16T18:43:27.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-acromegaly 2026-08-16T18:43:27.664Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-adrenal-insufficiency 2026-08-16T18:43:27.768Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-androgen-excess-disorders 2026-08-16T18:43:27.679Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-bone-health 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-bone-metabolism 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-congenital-adrenal-hyperplasia 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-corticosteroid 2026-08-16T18:43:27.609Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-cortisol-regulation 2026-08-16T18:43:27.682Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-diabetes 2026-08-16T18:43:27.634Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-diabetes-insipidus 2026-08-16T18:43:27.707Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-dopamine-agonist 2026-08-16T18:43:27.623Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-electrolyte-disorders 2026-08-16T18:43:27.676Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-gestational-diabetes 2026-08-16T18:43:27.650Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glp-1 2026-08-16T18:43:27.597Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glp-1-agonist 2026-08-16T18:43:27.588Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glp-1-agonists 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glp-1-receptor-agonist 2026-08-16T18:43:27.636Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glp-1-gip-agonist 2026-08-16T18:43:27.777Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glycemic-control 2026-08-16T18:43:27.649Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-graves-disease 2026-08-16T18:43:27.691Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-growth-hormone-deficiency 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hormonal-therapies 2026-08-16T18:43:27.758Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hormonal-therapy 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hormone-replacement 2026-08-16T18:43:27.581Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hormone-replacement-therapy 2026-08-16T18:43:27.646Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hypercalcemia 2026-08-16T18:43:27.779Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hypertension 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hypertriglyceridemia 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hypophosphatemia 2026-08-16T18:43:27.676Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-obesity 2026-08-16T18:43:27.584Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-obesity-and-type-2-diabetes 2026-08-16T18:43:27.701Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-osteoporosis 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-pcos 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-pheochromocytoma 2026-08-16T18:43:27.684Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-polycystic-ovary-syndrome 2026-08-16T18:43:27.790Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-primary-aldosteronism 2026-08-16T18:43:27.738Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-rare-genetic-disorders 2026-08-16T18:43:27.701Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-reproductive-health 2026-08-16T18:43:27.726Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-testosterone-deficiency 2026-08-16T18:43:27.747Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-thyroid-disorders 2026-08-16T18:43:27.608Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-type-1-diabetes 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-type-2-diabetes 2026-08-16T18:43:27.598Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-type-2-diabetes-mellitus 2026-08-16T18:43:27.681Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-type-i-diabetes 2026-08-16T18:43:27.594Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-type-ii-diabetes 2026-08-16T18:43:27.774Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-vitamin-d-analog 2026-08-16T18:43:27.780Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endometrial-cancer 2026-08-16T18:43:27.337Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endometrial-hyperplasia 2026-08-16T18:43:27.414Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endometriosis 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endoscopic-procedure 2026-08-16T18:43:27.540Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endothelin-receptor-antagonist 2026-08-16T18:43:27.371Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ent 2026-08-16T18:43:27.402Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ent-surgical-intervention 2026-08-16T18:43:27.704Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/enzyme-replacement-therapy 2026-08-16T18:43:27.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/eosinophilic-esophagitis 2026-08-16T18:43:27.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/epidemiology 2026-08-16T18:43:27.471Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/epilepsy 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/epinephrine 2026-08-16T18:43:27.386Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/epstein-barr-virus 2026-08-16T18:43:27.417Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/er-positive-breast-cancer 2026-08-16T18:43:27.551Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/erectile-dysfunction 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/erythropoietic-protoporphyria-epp 2026-08-16T18:43:27.376Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/eskd 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/esophageal-cancer 2026-08-16T18:43:27.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/esophageal-squamous-cell-carcinoma 2026-08-16T18:43:27.452Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/essential-thrombocythemia 2026-08-16T18:43:27.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/estrogen-receptor-modulator 2026-08-16T18:43:27.339Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ewing-sarcoma 2026-08-16T18:43:27.517Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/exercise-intervention 2026-08-16T18:43:27.376Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/exosome-therapy 2026-08-16T18:43:27.407Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/eye-drops 2026-08-16T18:43:27.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ezh2-inhibitor 2026-08-16T18:43:27.553Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fabry-disease 2026-08-16T18:43:27.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/familial-adenomatous-polyposis 2026-08-16T18:43:27.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/familial-mediterranean-fever 2026-08-16T18:43:27.466Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fatty-liver-disease 2026-08-16T18:43:27.423Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/femur-fractures 2026-08-16T18:43:27.447Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fertility 2026-08-16T18:43:27.541Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fertility-preservation 2026-08-16T18:43:27.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fgfr-inhibitor 2026-08-16T18:43:27.515Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fibromyalgia 2026-08-16T18:43:27.306Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fibrosing-interstitial-lung-disease 2026-08-16T18:43:27.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fibrosis 2026-08-16T18:43:27.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/flt3-inhibitor 2026-08-16T18:43:27.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/focal-segmental-glomerulosclerosis 2026-08-16T18:43:27.409Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/follicular-lymphoma 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/food-allergy 2026-08-16T18:43:27.412Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/friedreich-s-ataxia 2026-08-16T18:43:27.435Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/friedrich-s-ataxia 2026-08-16T18:43:27.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/frontotemporal-dementia 2026-08-16T18:43:27.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/functional-dyspepsia 2026-08-16T18:43:27.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fungal-infections 2026-08-16T18:43:27.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fungal-keratitis 2026-08-16T18:43:27.306Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gallbladder-cancer 2026-08-16T18:43:27.530Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gambling-disorder 2026-08-16T18:43:27.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastric-cancer 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-acupuncture 2026-08-16T18:43:27.772Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-acute-pancreatitis 2026-08-16T18:43:27.699Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-ai-in-diagnostics 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-antidiarrheal 2026-08-16T18:43:27.811Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-antiemetic 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-antispasmodic 2026-08-16T18:43:27.689Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-barrett-s-esophagus 2026-08-16T18:43:27.759Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-bowel-care 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-celiac-disease 2026-08-16T18:43:27.665Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-chronic-anal-fissure 2026-08-16T18:43:27.767Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-constipation 2026-08-16T18:43:27.611Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-crohn-s-disease 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-device 2026-08-16T18:43:27.700Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-drug-absorption 2026-08-16T18:43:27.677Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-drug-delivery 2026-08-16T18:43:27.710Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-early-gi-neoplasia 2026-08-16T18:43:27.698Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-enzyme-replacement-therapy 2026-08-16T18:43:27.729Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-eosinophilic-esophagitis 2026-08-16T18:43:27.679Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-familial-adenomatous-polyposis 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-functional-dyspepsia 2026-08-16T18:43:27.793Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-h2-antagonist 2026-08-16T18:43:27.609Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-hyperkalemia 2026-08-16T18:43:27.603Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-ibs-c 2026-08-16T18:43:27.585Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-ibs-d 2026-08-16T18:43:27.634Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-il-23-inhibitors 2026-08-16T18:43:27.722Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-ileostomy-management 2026-08-16T18:43:27.657Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-inflammatory-bowel-disease 2026-08-16T18:43:27.652Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-laxative 2026-08-16T18:43:27.620Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-linaclotide 2026-08-16T18:43:27.645Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-microbiota-therapy 2026-08-16T18:43:27.751Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-neuromodulation 2026-08-16T18:43:27.634Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-pancreatic-disorders 2026-08-16T18:43:27.734Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-proton-pump-inhibitor 2026-08-16T18:43:27.620Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-regenerative-therapy 2026-08-16T18:43:27.780Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-sedation 2026-08-16T18:43:27.690Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-ulcerative-colitis 2026-08-16T18:43:27.590Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroesophageal-adenocarcinoma 2026-08-16T18:43:27.362Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroesophageal-cancer 2026-08-16T18:43:27.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastrointestinal-cancers 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastrointestinal-stromal-tumor 2026-08-16T18:43:27.473Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gaucher-disease 2026-08-16T18:43:27.424Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gaucher-disease-and-parkinsonism 2026-08-16T18:43:27.521Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gene-editing 2026-08-16T18:43:27.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gene-regulation 2026-08-16T18:43:27.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gene-therapy 2026-08-16T18:43:27.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gene-therapy-rare-diseases 2026-08-16T18:43:27.696Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general 2026-08-16T18:43:27.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-ai-in-drug-development 2026-08-16T18:43:27.783Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-drug-development 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-drug-safety 2026-08-16T18:43:27.814Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-and-metabolism 2026-08-16T18:43:27.424Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-anesthesia 2026-08-16T18:43:27.354Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-medicine 2026-08-16T18:43:27.465Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-medicine-injectable 2026-08-16T18:43:27.804Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/generic-drug 2026-08-16T18:43:27.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-congenital-disorders-of-glycosylation 2026-08-16T18:43:27.780Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-enzyme-replacement-therapy 2026-08-16T18:43:27.772Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-fabry-disease 2026-08-16T18:43:27.814Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-gaucher-disease 2026-08-16T18:43:27.718Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-gene-therapy 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-mucopolysaccharidosis 2026-08-16T18:43:27.733Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-pmm2-cdg 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-pompe-disease 2026-08-16T18:43:27.690Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-risk-assessment 2026-08-16T18:43:27.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-testing 2026-08-16T18:43:27.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetics 2026-08-16T18:43:27.466Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetics-familial-mediterranean-fever 2026-08-16T18:43:27.743Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetics-gene-therapy 2026-08-16T18:43:27.780Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genomics 2026-08-16T18:43:27.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genomics-sequencing-technology 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/geographic-atrophy 2026-08-16T18:43:27.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/geriatric-assessment 2026-08-16T18:43:27.400Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/geriatrics 2026-08-16T18:43:27.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/geriatrics-aging 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/geriatrics-muscle-strengthening 2026-08-16T18:43:27.696Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gestational-diabetes 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gi-cancers 2026-08-16T18:43:27.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gip-agonist 2026-08-16T18:43:27.511Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gip-receptor-agonist-and-amylin-analog 2026-08-16T18:43:27.551Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gist 2026-08-16T18:43:27.423Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glaucoma 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glioblastoma 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glioma 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glp-1 2026-08-16T18:43:27.326Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glp-1-agonist 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glp-1-agonists 2026-08-16T18:43:27.502Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glp-1-receptor-agonist 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glp-1-receptor-agonists 2026-08-16T18:43:27.416Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glycemic-control 2026-08-16T18:43:27.319Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gnrh-antagonist 2026-08-16T18:43:27.348Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gout 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/graves-disease 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/grin-related-neurodevelopmental-disorder 2026-08-16T18:43:27.502Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/growth-disorders 2026-08-16T18:43:27.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/growth-hormone-deficiency 2026-08-16T18:43:27.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gut-microbiome 2026-08-16T18:43:27.502Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecologic-cancer 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecological-procedures 2026-08-16T18:43:27.516Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecology 2026-08-16T18:43:27.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecology-adhesion-prevention 2026-08-16T18:43:27.670Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecology-dysmenorrhea 2026-08-16T18:43:27.719Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecology-endometrial-hyperplasia 2026-08-16T18:43:27.586Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecology-endometriosis 2026-08-16T18:43:27.773Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecology-inflammatory-disease 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/h2-antagonist 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/haemophilia-a 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hairy-cell-leukemia 2026-08-16T18:43:27.336Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ham 2026-08-16T18:43:27.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hbv-co-infection 2026-08-16T18:43:27.406Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hcc 2026-08-16T18:43:27.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hdac-inhibitor 2026-08-16T18:43:27.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/head-and-neck-cancer 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/head-and-neck-squamous-cell-carcinoma 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/headache 2026-08-16T18:43:27.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hearing-loss 2026-08-16T18:43:27.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-disease 2026-08-16T18:43:27.522Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-failure 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-pump 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-pump-devices 2026-08-16T18:43:27.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-transplantation 2026-08-16T18:43:27.474Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematologic-malignancies 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematologic-malignancies-cell-therapy 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematologic-malignancies-and-solid-tumors 2026-08-16T18:43:27.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematological-malignancies 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-acute-leukemia-myelodysplastic-syndrome 2026-08-16T18:43:27.783Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-acute-myeloid-leukemia 2026-08-16T18:43:27.662Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-acute-promyelocytic-leukemia 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-al-amyloidosis 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-aml 2026-08-16T18:43:27.638Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-amyloidosis 2026-08-16T18:43:27.789Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-anemia 2026-08-16T18:43:27.671Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-anticoagulant 2026-08-16T18:43:27.733Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-antifibrinolytic 2026-08-16T18:43:27.669Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-antimetabolite 2026-08-16T18:43:27.691Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-autoimmune-disorders 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-autoinflammatory-syndromes 2026-08-16T18:43:27.726Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-b-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.671Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-blood-cancers 2026-08-16T18:43:27.641Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-blood-transfusion 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-btk-degrader 2026-08-16T18:43:27.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-car-t 2026-08-16T18:43:27.592Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-car-t-cell-therapy 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-cd123-targeted-therapy 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-cgvhd 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-chemotherapy 2026-08-16T18:43:27.685Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-chronic-myeloid-leukemia 2026-08-16T18:43:27.635Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-chronic-myelomonocytic-leukemia 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-cll 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-cll-sll 2026-08-16T18:43:27.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-cll-sll-and-related-lymphomas 2026-08-16T18:43:27.727Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-complement-inhibitor 2026-08-16T18:43:27.584Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-erythropoietic-protoporphyria-epp 2026-08-16T18:43:27.687Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-essential-thrombocythemia 2026-08-16T18:43:27.630Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-gene-therapy 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-genetic-disorders 2026-08-16T18:43:27.659Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-haemophilia-a-b 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-hemochromatosis 2026-08-16T18:43:27.643Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-hemophilia 2026-08-16T18:43:27.737Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-hemophilia-a-b 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-idh-inhibition 2026-08-16T18:43:27.748Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-immune-thrombocytopenia 2026-08-16T18:43:27.671Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-immune-thrombocytopenic-purpura 2026-08-16T18:43:27.790Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-immunotherapy 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-iron-deficiency-anemia 2026-08-16T18:43:27.575Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-iron-replacement 2026-08-16T18:43:27.642Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-jak-inhibitor 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-jak2-inhibition 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-langerhans-cell-histiocytosis 2026-08-16T18:43:27.642Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-leukemia 2026-08-16T18:43:27.729Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-mastocytosis 2026-08-16T18:43:27.772Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-monoclonal-antibody 2026-08-16T18:43:27.593Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-multiple-myeloma 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-myelodysplastic-syndromes 2026-08-16T18:43:27.686Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-myelodysplastic-syndromes-and-acute-myeloid-leukemia 2026-08-16T18:43:27.759Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-myelofibrosis 2026-08-16T18:43:27.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-myeloproliferative-neoplasms 2026-08-16T18:43:27.637Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-neutropenia 2026-08-16T18:43:27.581Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-paroxysmal-nocturnal-hemoglobinuria 2026-08-16T18:43:27.776Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-paroxysmal-nocturnal-hemoglobinuria-pnh 2026-08-16T18:43:27.746Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-plasma-products 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-plasma-derived-products 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-plasma-derived-therapies 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-polycythemia-vera 2026-08-16T18:43:27.629Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-pyruvate-kinase-deficiency 2026-08-16T18:43:27.690Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-rare-blood-disorders 2026-08-16T18:43:27.754Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-rna-targeted-therapy 2026-08-16T18:43:27.721Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-runx1-familial-platelet-disorder 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-sickle-cell-anemia 2026-08-16T18:43:27.675Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-sickle-cell-disease 2026-08-16T18:43:27.686Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-spleen-tyrosine-kinase-inhibitor 2026-08-16T18:43:27.623Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-stem-cell-transplantation 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-systemic-al-amyloidosis 2026-08-16T18:43:27.734Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-telomerase-inhibitor 2026-08-16T18:43:27.752Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-thalassemia 2026-08-16T18:43:27.777Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-thrombocytopenia 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-thrombotic-microangiopathy 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-venous-thromboembolism 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-vitamin-k 2026-08-16T18:43:27.608Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-von-willebrand-disease 2026-08-16T18:43:27.649Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hemochromatosis 2026-08-16T18:43:27.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hemodialysis 2026-08-16T18:43:27.326Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hemophilia 2026-08-16T18:43:27.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hemophilia-a 2026-08-16T18:43:27.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatitis 2026-08-16T18:43:27.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatitis-antiviral 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatitis-b 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatitis-c 2026-08-16T18:43:27.359Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatitis-c-antiviral 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatitis-d 2026-08-16T18:43:27.424Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatitis-delta 2026-08-16T18:43:27.338Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatocellular-carcinoma 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology 2026-08-16T18:43:27.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-alagille-syndrome-progressive-familial-intrahepatic-cholestasis 2026-08-16T18:43:27.691Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-alcohol-use-disorder 2026-08-16T18:43:27.657Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-antiviral 2026-08-16T18:43:27.585Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-ascites 2026-08-16T18:43:27.732Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-chronic-hepatitis-b 2026-08-16T18:43:27.678Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-chronic-hepatitis-d 2026-08-16T18:43:27.767Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-chronic-liver-disease 2026-08-16T18:43:27.598Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-cirrhosis 2026-08-16T18:43:27.588Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-fatty-liver-disease 2026-08-16T18:43:27.718Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-glp-1-agonist 2026-08-16T18:43:27.590Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-herbal-medicine 2026-08-16T18:43:27.584Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-imaging 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-liver-fibrosis 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-liver-transplantation 2026-08-16T18:43:27.645Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-masld 2026-08-16T18:43:27.799Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-metabolic-dysfunction-associated-steatohepatitis 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-nafld-and-dermatology-psoriatic-arthritis 2026-08-16T18:43:27.661Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-nash-mash 2026-08-16T18:43:27.760Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-primary-biliary-cholangitis 2026-08-16T18:43:27.727Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-rare-disease 2026-08-16T18:43:27.743Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-sepsis-induced-liver-injury 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-vasopressor 2026-08-16T18:43:27.786Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-alterations 2026-08-16T18:43:27.379Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-inhibitor 2026-08-16T18:43:27.462Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-endometrial-cancer 2026-08-16T18:43:27.545Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-breast-cancer 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-esophagogastric-adenocarcinoma 2026-08-16T18:43:27.473Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-gastric-cancer 2026-08-16T18:43:27.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-solid-tumours 2026-08-16T18:43:27.558Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-upper-tract-urothelial-carcinoma 2026-08-16T18:43:27.418Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-targeted-therapy 2026-08-16T18:43:27.315Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-solid-tumors 2026-08-16T18:43:27.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/herbal-medicine 2026-08-16T18:43:27.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hereditary-angioedema 2026-08-16T18:43:27.481Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hereditary-hemorrhagic-telangiectasia 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hereditary-transthyretin-amyloidosis 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hernia-repair 2026-08-16T18:43:27.344Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/herpes-zoster 2026-08-16T18:43:27.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hidradenitis-suppurativa 2026-08-16T18:43:27.406Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/high-grade-glioma 2026-08-16T18:43:27.352Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hiv 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hiv-and-contraception 2026-08-16T18:43:27.557Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hiv-prevention 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hiv-1 2026-08-16T18:43:27.547Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hiv-related-malignancies 2026-08-16T18:43:27.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hodgkin-lymphoma 2026-08-16T18:43:27.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormonal 2026-08-16T18:43:27.393Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormonal-therapies 2026-08-16T18:43:27.485Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormonal-therapy 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormone-receptor-positive-breast-cancer 2026-08-16T18:43:27.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormone-replacement 2026-08-16T18:43:27.334Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormone-replacement-therapy 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormone-therapy 2026-08-16T18:43:27.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hpv 2026-08-16T18:43:27.394Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hpv-vaccination 2026-08-16T18:43:27.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hpv-vaccine 2026-08-16T18:43:27.468Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hpv-related-cancers 2026-08-16T18:43:27.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/huntington-s-disease 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypercalcemia 2026-08-16T18:43:27.514Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypercholesterolemia 2026-08-16T18:43:27.410Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hyperkalemia 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypertension 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypertriglyceridemia 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypertrophic-cardiomyopathy 2026-08-16T18:43:27.529Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypophosphatasia 2026-08-16T18:43:27.558Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypophosphatemia 2026-08-16T18:43:27.361Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypoxemic-respiratory-distress 2026-08-16T18:43:27.392Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ibs-c 2026-08-16T18:43:27.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ibs-d 2026-08-16T18:43:27.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/idh-inhibition 2026-08-16T18:43:27.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/idiopathic-pulmonary-fibrosis 2026-08-16T18:43:27.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/iga-nephropathy 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/igg4-related-disease 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-1-inhibition 2026-08-16T18:43:27.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-12 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-13 2026-08-16T18:43:27.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-17 2026-08-16T18:43:27.327Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-23 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-23-inhibitors 2026-08-16T18:43:27.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-4 2026-08-16T18:43:27.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-5 2026-08-16T18:43:27.524Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-6-inhibitor 2026-08-16T18:43:27.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ileostomy-management 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/image-guided-therapy 2026-08-16T18:43:27.555Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/imaging 2026-08-16T18:43:27.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/imaging-contrast-agent 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/imaging-agent 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/imaging-biomarker 2026-08-16T18:43:27.327Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/imaging-techniques 2026-08-16T18:43:27.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-checkpoint-inhibitor 2026-08-16T18:43:27.517Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-checkpoint-inhibitors 2026-08-16T18:43:27.344Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-response 2026-08-16T18:43:27.417Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-therapy 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-thrombocytopenia 2026-08-16T18:43:27.352Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-thrombocytopenic-purpura 2026-08-16T18:43:27.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-mobilizing-t-cell-receptors 2026-08-16T18:43:27.544Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immuno-oncology 2026-08-16T18:43:27.518Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunodeficiency 2026-08-16T18:43:27.435Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunoglobulin-a-nephropathy 2026-08-16T18:43:27.452Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-allergy 2026-08-16T18:43:27.672Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-anti-inflammatory 2026-08-16T18:43:27.635Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-asthma 2026-08-16T18:43:27.639Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-autoimmune-disease 2026-08-16T18:43:27.629Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-autoimmune-diseases 2026-08-16T18:43:27.756Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-autoimmune-disorders 2026-08-16T18:43:27.587Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-autoinflammatory-disorders 2026-08-16T18:43:27.732Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-axial-spondyloarthritis 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-biosimilar 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-complement-inhibition 2026-08-16T18:43:27.585Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-corticosteroid 2026-08-16T18:43:27.605Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-gene-therapy 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-genetic-disorders 2026-08-16T18:43:27.791Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-hereditary-angioedema 2026-08-16T18:43:27.590Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-igg4-related-disease 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-12-23 2026-08-16T18:43:27.649Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-12-23-inhibitor 2026-08-16T18:43:27.682Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-17 2026-08-16T18:43:27.583Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-23 2026-08-16T18:43:27.641Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-4-il-13 2026-08-16T18:43:27.583Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-5 2026-08-16T18:43:27.785Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-6-inhibitor 2026-08-16T18:43:27.643Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-immunodeficiency 2026-08-16T18:43:27.724Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-immunosuppressant 2026-08-16T18:43:27.605Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-inflammatory-disorders 2026-08-16T18:43:27.740Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-jak-inhibitor 2026-08-16T18:43:27.575Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-jak-inhibitors 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-lupus 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-lupus-and-rheumatoid-arthritis 2026-08-16T18:43:27.775Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-lupus-nephritis 2026-08-16T18:43:27.634Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-monoclonal-antibodies 2026-08-16T18:43:27.788Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-monoclonal-antibody 2026-08-16T18:43:27.587Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-myositis 2026-08-16T18:43:27.729Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-oral-therapy 2026-08-16T18:43:27.633Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-primary-immunodeficiency 2026-08-16T18:43:27.646Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-psoriasis-and-autoimmune-diseases 2026-08-16T18:43:27.718Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-psoriatic-arthritis 2026-08-16T18:43:27.642Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-rare-disease 2026-08-16T18:43:27.765Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-renal-transplantation 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-rheumatoid-arthritis 2026-08-16T18:43:27.695Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-stem-cell-therapy 2026-08-16T18:43:27.682Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-systemic-lupus-erythematosus 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-tnf-inhibitor 2026-08-16T18:43:27.586Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-transplant-rejection 2026-08-16T18:43:27.763Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-transplantation 2026-08-16T18:43:27.609Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-type-1-diabetes 2026-08-16T18:43:27.583Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-type-1-interferonopathies 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-vaccine-development 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunomodulator 2026-08-16T18:43:27.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunosuppressant 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunotherapy 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/inclusion-body-myositis 2026-08-16T18:43:27.458Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/incontinence-associated-dermatitis 2026-08-16T18:43:27.554Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infantile-hemangiomas 2026-08-16T18:43:27.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infection-control 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infection-control-antiseptic 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infection-control-medical-devices 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infection-prevention 2026-08-16T18:43:27.514Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antibacterial 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antibiotic 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antibiotic-prophylaxis 2026-08-16T18:43:27.790Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antibiotic-resistance 2026-08-16T18:43:27.590Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antibiotic-therapy 2026-08-16T18:43:27.708Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antibiotics 2026-08-16T18:43:27.666Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antifungal 2026-08-16T18:43:27.610Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antimalarial 2026-08-16T18:43:27.684Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antimicrobial 2026-08-16T18:43:27.620Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antiparasitic 2026-08-16T18:43:27.624Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antiretroviral 2026-08-16T18:43:27.713Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antiseptic 2026-08-16T18:43:27.672Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antitubercular 2026-08-16T18:43:27.768Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antiviral 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-bacterial-infections 2026-08-16T18:43:27.793Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-bordetella-pertussis 2026-08-16T18:43:27.681Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-cell-therapy 2026-08-16T18:43:27.796Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-clostridioides-difficile 2026-08-16T18:43:27.634Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-clostridioides-difficile-infection 2026-08-16T18:43:27.734Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-coronavirus 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-covid-19 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-covid-19-vaccine 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-cytokine-modulation 2026-08-16T18:43:27.799Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-epstein-barr-virus 2026-08-16T18:43:27.713Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-fungal-infections 2026-08-16T18:43:27.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hematological-malignancies 2026-08-16T18:43:27.626Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hepatitis-b 2026-08-16T18:43:27.685Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hepatitis-c 2026-08-16T18:43:27.679Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hepatitis-delta 2026-08-16T18:43:27.662Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-herpes-zoster 2026-08-16T18:43:27.667Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hiv 2026-08-16T18:43:27.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hiv-and-contraception 2026-08-16T18:43:27.600Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hiv-prevention 2026-08-16T18:43:27.683Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hiv-1 2026-08-16T18:43:27.579Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hiv-hbv-co-infection 2026-08-16T18:43:27.706Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-influenza 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-leishmaniasis 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-listeriosis 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-long-covid 2026-08-16T18:43:27.585Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-lyme-disease 2026-08-16T18:43:27.640Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-malaria 2026-08-16T18:43:27.637Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-medical-devices 2026-08-16T18:43:27.708Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-neonatal-care 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-non-tuberculous-mycobacteria 2026-08-16T18:43:27.672Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-nontuberculous-mycobacterial-infections 2026-08-16T18:43:27.736Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-osteomyelitis 2026-08-16T18:43:27.705Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-parasitic-infections 2026-08-16T18:43:27.680Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-pneumococcal-disease 2026-08-16T18:43:27.722Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-pneumococcal-vaccination 2026-08-16T18:43:27.592Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-pneumococcal-vaccine 2026-08-16T18:43:27.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-pulmonary-nontuberculous-mycobacterial-infection 2026-08-16T18:43:27.695Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-pulmonary-tuberculosis 2026-08-16T18:43:27.634Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-respiratory-syncytial-virus 2026-08-16T18:43:27.734Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-respiratory-syncytial-virus-rsv 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-respiratory-tract-infections 2026-08-16T18:43:27.729Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-sepsis 2026-08-16T18:43:27.726Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-syphilis 2026-08-16T18:43:27.593Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-t-cell-therapy 2026-08-16T18:43:27.581Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-tuberculosis 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-tuberculosis-and-hiv 2026-08-16T18:43:27.677Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-urinary-tract-infections 2026-08-16T18:43:27.742Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-vaccine 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-vaccines 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-viral-and-bacterial-pathogens 2026-08-16T18:43:27.597Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-viral-infections 2026-08-16T18:43:27.766Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-diseases 2026-08-16T18:43:27.359Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-diseases-hepatitis-c 2026-08-16T18:43:27.675Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-diseases-hepatitis-d 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-diseases-tuberculosis 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infective-endocarditis 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/inflammatory-bowel-disease 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/inflammatory-disease 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/inflammatory-disorders 2026-08-16T18:43:27.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/influenza 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/inhalation-therapy 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/inherited-retinal-diseases 2026-08-16T18:43:27.394Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/injectable 2026-08-16T18:43:27.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/injectable-therapy 2026-08-16T18:43:27.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/injectable-vitamins 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/insulin 2026-08-16T18:43:27.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/insulin-combination-therapy 2026-08-16T18:43:27.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/insulin-delivery 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/insulin-resistance 2026-08-16T18:43:27.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/interstitial-lung-disease 2026-08-16T18:43:27.484Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/interventional-cardiology 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/interventional-cardiology-medical-devices 2026-08-16T18:43:27.639Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/interventional-devices 2026-08-16T18:43:27.482Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/interventional-procedure 2026-08-16T18:43:27.518Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/intracerebral-hemorrhage 2026-08-16T18:43:27.439Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/intracranial-aneurysms 2026-08-16T18:43:27.398Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/intracranial-hemorrhage 2026-08-16T18:43:27.416Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/intrahepatic-cholangiocarcinoma 2026-08-16T18:43:27.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/intraocular-lens 2026-08-16T18:43:27.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/intraoperative-monitoring 2026-08-16T18:43:27.398Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/iron-deficiency-anemia 2026-08-16T18:43:27.380Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/iron-replacement 2026-08-16T18:43:27.306Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ischemia 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/iv-administration 2026-08-16T18:43:27.395Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ivf 2026-08-16T18:43:27.346Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/jak-inhibitor 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/jak-inhibitors 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/jak2-inhibition 2026-08-16T18:43:27.395Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/juvenile-idiopathic-arthritis 2026-08-16T18:43:27.418Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kat6a 2026-08-16T18:43:27.371Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/keloids 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ketamine 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kidney-cancer 2026-08-16T18:43:27.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kidney-stone-disease 2026-08-16T18:43:27.490Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kidney-stones 2026-08-16T18:43:27.480Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kidney-transplant 2026-08-16T18:43:27.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/knee-osteoarthritis 2026-08-16T18:43:27.417Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/knee-pain 2026-08-16T18:43:27.435Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kras-g12c-inhibitor 2026-08-16T18:43:27.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kras-g12c-non-small-cell-lung-cancer 2026-08-16T18:43:27.476Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kras-g12c-nsclc 2026-08-16T18:43:27.476Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kras-g12c-positive-non-small-cell-lung-cancer 2026-08-16T18:43:27.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kras-inhibitor 2026-08-16T18:43:27.392Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/labor-induction 2026-08-16T18:43:27.390Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/langerhans-cell-histiocytosis 2026-08-16T18:43:27.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lateral-epicondylitis 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/laxative 2026-08-16T18:43:27.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ldl-c-lowering 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/leishmaniasis 2026-08-16T18:43:27.485Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/leukemia 2026-08-16T18:43:27.443Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/levocarnitine 2026-08-16T18:43:27.445Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lifestyle-intervention 2026-08-16T18:43:27.392Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/light-chain-cast-nephropathy 2026-08-16T18:43:27.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/linaclotide 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lipid-management 2026-08-16T18:43:27.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lipid-regulation 2026-08-16T18:43:27.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lipid-lowering-therapy 2026-08-16T18:43:27.334Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lipoprotein-a 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/listeriosis 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/liver-cancer 2026-08-16T18:43:27.468Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/liver-cancer-neurology 2026-08-16T18:43:27.329Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/liver-fibrosis 2026-08-16T18:43:27.530Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/liver-transplantation 2026-08-16T18:43:27.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/local-anesthetic 2026-08-16T18:43:27.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/local-anesthetics 2026-08-16T18:43:27.333Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/long-covid 2026-08-16T18:43:27.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/long-acting-injectable-antipsychotic 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lung-adenocarcinoma 2026-08-16T18:43:27.380Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lung-cancer 2026-08-16T18:43:27.323Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lung-fibrosis 2026-08-16T18:43:27.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lupus 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lupus-and-rheumatoid-arthritis 2026-08-16T18:43:27.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lupus-nephritis 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lyme-disease 2026-08-16T18:43:27.301Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lymphedema 2026-08-16T18:43:27.412Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lymphoma 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/magnesium-supplement 2026-08-16T18:43:27.416Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/major-depressive-disorder 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/malaria 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/male-infertility 2026-08-16T18:43:27.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/malignant-mesothelioma 2026-08-16T18:43:27.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/malignant-peritoneal-mesothelioma 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/malnutrition 2026-08-16T18:43:27.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mantle-cell-lymphoma 2026-08-16T18:43:27.354Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mash 2026-08-16T18:43:27.488Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/masld 2026-08-16T18:43:27.555Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mastocytosis 2026-08-16T18:43:27.504Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mcrc 2026-08-16T18:43:27.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mechanical-ventilation 2026-08-16T18:43:27.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/medical-device 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/medical-devices 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/medical-devices-iv-administration 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/medical-devices-vascular-access 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/medium-chain-acyl-coa-dehydrogenase-deficiency 2026-08-16T18:43:27.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/meibomian-gland-dysfunction 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mek-inhibitor 2026-08-16T18:43:27.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mek-inhibitors 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/melanoma 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/melatonin-receptor-agonist 2026-08-16T18:43:27.371Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/membranous-nephropathy 2026-08-16T18:43:27.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/meniere-s-disease 2026-08-16T18:43:27.482Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/meningioma 2026-08-16T18:43:27.454Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/menopause 2026-08-16T18:43:27.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-antidepressant 2026-08-16T18:43:27.614Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-anxiety-disorders 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-behavioral-interventions 2026-08-16T18:43:27.799Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-depression 2026-08-16T18:43:27.726Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-digital-therapeutics 2026-08-16T18:43:27.736Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-major-depressive-disorder 2026-08-16T18:43:27.666Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-psychedelics 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-ptsd 2026-08-16T18:43:27.628Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-ptsd-and-substance-use-disorder 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/merkel-cell-carcinoma 2026-08-16T18:43:27.372Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mesothelioma 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic 2026-09-30T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-amino-acid-supplement 2026-08-16T18:43:27.643Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-electrolyte-replacement 2026-08-16T18:43:27.680Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-electrolyte-replenisher 2026-08-16T18:43:27.612Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-gut-microbiome 2026-08-16T18:43:27.771Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-insulin-resistance 2026-08-16T18:43:27.688Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-levocarnitine 2026-08-16T18:43:27.618Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-medium-chain-acyl-coa-dehydrogenase-deficiency 2026-08-16T18:43:27.645Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-nash 2026-08-16T18:43:27.636Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-obesity 2026-08-16T18:43:27.634Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-oral-therapy 2026-08-16T18:43:27.699Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-urea-cycle-disorder 2026-08-16T18:43:27.725Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-urea-cycle-disorders 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-dysfunction-associated-steatohepatitis 2026-08-16T18:43:27.405Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-reprogramming 2026-08-16T18:43:27.531Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolism 2026-08-16T18:43:27.413Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolism-oral-drug-delivery 2026-08-16T18:43:27.808Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metastatic-colorectal-and-gastric-cancer 2026-08-16T18:43:27.390Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metformin 2026-08-16T18:43:27.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/microbiota-therapy 2026-08-16T18:43:27.473Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/microvascular-health 2026-08-16T18:43:27.524Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/migraine 2026-08-16T18:43:27.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mineralocorticoid-receptor-antagonist 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mitral-valve-disease 2026-08-16T18:43:27.362Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/monitoring 2026-08-16T18:43:27.524Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/monoclonal-antibodies 2026-08-16T18:43:27.351Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/monoclonal-antibody 2026-08-16T18:43:27.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mood-disorders 2026-08-16T18:43:27.406Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/movement-disorders 2026-08-16T18:43:27.337Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ms 2026-08-16T18:43:27.501Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mtor-inhibitor 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mucopolysaccharidosis 2026-08-16T18:43:27.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/multifocal-motor-neuropathy 2026-08-16T18:43:27.511Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/multiple-myeloma 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/multiple-sclerosis 2026-08-16T18:43:27.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/multiple-system-atrophy 2026-08-16T18:43:27.527Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/muscle-relaxant 2026-08-16T18:43:27.513Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/muscle-strengthening 2026-08-16T18:43:27.390Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/muscular-dystrophy 2026-08-16T18:43:27.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal-chronic-pain 2026-08-16T18:43:27.690Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal-de-quervain-tenosynovitis 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal-knee-osteoarthritis 2026-08-16T18:43:27.714Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal-knee-pain 2026-08-16T18:43:27.724Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal-lateral-epicondylitis 2026-08-16T18:43:27.805Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal-osteoarthritis 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal-disorders 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal-disorders-care-strategy 2026-08-16T18:43:27.658Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myalgic-encephalomyelitis 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myasthenia-gravis 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myelodysplastic-syndrome 2026-08-16T18:43:27.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myelodysplastic-syndromes 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myelodysplastic-syndromes-and-acute-myeloid-leukemia 2026-08-16T18:43:27.485Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myelofibrosis 2026-08-16T18:43:27.372Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myeloid-cancer 2026-08-16T18:43:27.426Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myeloproliferative-neoplasms 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myocardial-infarction 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myopia 2026-08-16T18:43:27.422Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myositis 2026-08-16T18:43:27.443Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myotonic-dystrophy-type-1 2026-08-16T18:43:27.377Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nafld-and-dermatology 2026-08-16T18:43:27.335Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/namd 2026-08-16T18:43:27.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nanomedicine 2026-08-16T18:43:27.407Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nanoparticle-therapy 2026-08-16T18:43:27.406Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/narcolepsy 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nasal-obstruction 2026-08-16T18:43:27.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nasal-spray 2026-08-16T18:43:27.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nash 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nasopharyngeal-carcinoma 2026-08-16T18:43:27.287Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nausea-and-vomiting-in-pregnancy 2026-08-16T18:43:27.524Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/necrotizing-enterocolitis 2026-08-16T18:43:27.356Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neonatal-care 2026-08-16T18:43:27.318Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neonatal-hypoxic-ischemic-encephalopathy 2026-08-16T18:43:27.504Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neonatology 2026-08-16T18:43:27.407Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neonatology-bronchopulmonary-dysplasia 2026-08-16T18:43:27.720Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neonatology-oral-care 2026-08-16T18:43:27.707Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neovascular-age-related-macular-degeneration 2026-08-16T18:43:27.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrolithiasis 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-acute-kidney-injury 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-acute-renal-failure 2026-08-16T18:43:27.694Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-anemia 2026-08-16T18:43:27.680Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-autoimmune-disease 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-chronic-kidney-disease 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-complement-inhibition 2026-08-16T18:43:27.586Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-complement-mediated-kidney-disease 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-diabetic-kidney-disease 2026-08-16T18:43:27.639Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-diagnostics 2026-08-16T18:43:27.630Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-dialysis 2026-08-16T18:43:27.735Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-drug 2026-08-16T18:43:27.684Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-eskd 2026-08-16T18:43:27.639Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-focal-segmental-glomerulosclerosis 2026-08-16T18:43:27.708Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-hemodialysis 2026-08-16T18:43:27.654Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-iga-nephropathy 2026-08-16T18:43:27.628Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-immunoglobulin-a-nephropathy 2026-08-16T18:43:27.589Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-kidney-transplant 2026-08-16T18:43:27.589Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-light-chain-cast-nephropathy 2026-08-16T18:43:27.720Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-membranous-nephropathy 2026-08-16T18:43:27.670Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-monoclonal-antibody 2026-08-16T18:43:27.594Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-pharmacokinetics 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-polycystic-kidney-disease 2026-08-16T18:43:27.628Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-pruritus 2026-08-16T18:43:27.783Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-renal-fibrosis 2026-08-16T18:43:27.693Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-renal-osteodystrophy 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-sglt2-inhibitor 2026-08-16T18:43:27.800Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-sglt2-inhibitors 2026-08-16T18:43:27.774Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-vasopressin-antagonist 2026-08-16T18:43:27.613Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroblastoma 2026-08-16T18:43:27.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurodegenerative-diseases 2026-08-16T18:43:27.379Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurodegenerative-disorders 2026-08-16T18:43:27.367Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurodevelopmental-disorders 2026-08-16T18:43:27.526Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroendocrine-cancers 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroendocrine-carcinomas 2026-08-16T18:43:27.345Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroendocrine-tumors 2026-08-16T18:43:27.358Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroendocrine-tumours 2026-08-16T18:43:27.543Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurofibromatosis-type-1 2026-08-16T18:43:27.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurogenic-bladder-overactivity 2026-08-16T18:43:27.488Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroimmune-diseases 2026-08-16T18:43:27.523Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-acute-ischemic-stroke 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-addiction 2026-08-16T18:43:27.765Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-adhd 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-alcohol-use-disorder 2026-08-16T18:43:27.636Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-als 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-alzheimer-s-disease 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-amyotrophic-lateral-sclerosis 2026-08-16T18:43:27.797Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-amyotrophic-lateral-sclerosis-als 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-anesthesia 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-anticonvulsant 2026-08-16T18:43:27.609Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antidepressant 2026-08-16T18:43:27.617Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antiemetic 2026-08-16T18:43:27.603Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antiepileptic 2026-08-16T18:43:27.605Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antihistamine 2026-08-16T18:43:27.625Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antihypertensive 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antipsychotic 2026-08-16T18:43:27.612Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antiviral 2026-08-16T18:43:27.649Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-anxiety-disorders 2026-08-16T18:43:27.682Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-anxiolytic 2026-08-16T18:43:27.605Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-aphasia 2026-08-16T18:43:27.742Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-autism-spectrum-disorder 2026-08-16T18:43:27.647Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-autoimmune-disease 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-autoimmune-diseases 2026-08-16T18:43:27.742Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-autoimmune-disorders 2026-08-16T18:43:27.585Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-autonomic-nervous-system-disorders 2026-08-16T18:43:27.651Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-benzodiazepine 2026-08-16T18:43:27.608Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-bipolar-disorder 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-botulinum-toxin 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-brain-injury 2026-08-16T18:43:27.672Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cadasil 2026-08-16T18:43:27.761Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cannabinoid 2026-08-16T18:43:27.783Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cannabinoids 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-carbonic-anhydrase-inhibitor 2026-08-16T18:43:27.617Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-carpal-tunnel-syndrome 2026-08-16T18:43:27.763Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cerebral-palsy 2026-08-16T18:43:27.637Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cerebral-palsy-and-muscular-dystrophy 2026-08-16T18:43:27.763Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cgrp-antibody 2026-08-16T18:43:27.788Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cgrp-inhibitor 2026-08-16T18:43:27.757Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-charcot-marie-tooth-disease 2026-08-16T18:43:27.791Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cognitive-impairment 2026-08-16T18:43:27.704Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cough-suppressant 2026-08-16T18:43:27.789Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-deep-brain-stimulation 2026-08-16T18:43:27.690Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-dementia-care 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-dementia-with-lewy-bodies 2026-08-16T18:43:27.691Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-depression 2026-08-16T18:43:27.606Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-developmental-language-disorder 2026-08-16T18:43:27.705Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-diagnostic-imaging 2026-08-16T18:43:27.764Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-duchenne-muscular-dystrophy 2026-08-16T18:43:27.631Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-dysphagia 2026-08-16T18:43:27.792Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-epilepsy 2026-08-16T18:43:27.637Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-fibromyalgia 2026-08-16T18:43:27.642Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-friedreich-s-ataxia 2026-08-16T18:43:27.724Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-friedrich-s-ataxia 2026-08-16T18:43:27.803Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-frontotemporal-dementia 2026-08-16T18:43:27.581Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-gambling-disorder 2026-08-16T18:43:27.657Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-gaucher-disease-and-parkinsonism 2026-08-16T18:43:27.783Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-gene-therapy 2026-08-16T18:43:27.689Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-generic-drug 2026-08-16T18:43:27.809Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-genetic-disorders 2026-08-16T18:43:27.773Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-grin-related-neurodevelopmental-disorder 2026-08-16T18:43:27.592Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-ham-tsp 2026-08-16T18:43:27.805Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-headache 2026-08-16T18:43:27.750Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-hereditary-transthyretin-amyloidosis 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-huntington-s-disease 2026-08-16T18:43:27.639Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-imaging 2026-08-16T18:43:27.709Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-imaging-agent 2026-08-16T18:43:27.683Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-imaging-biomarker 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-imaging-techniques 2026-08-16T18:43:27.748Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-inclusion-body-myositis 2026-08-16T18:43:27.739Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-infectious-disease 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-intracerebral-hemorrhage 2026-08-16T18:43:27.726Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-intracranial-aneurysms 2026-08-16T18:43:27.701Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-intracranial-hemorrhage 2026-08-16T18:43:27.713Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-long-covid 2026-08-16T18:43:27.669Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-major-depressive-disorder 2026-08-16T18:43:27.631Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-migraine 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-mood-disorders 2026-08-16T18:43:27.708Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-movement-disorders 2026-08-16T18:43:27.662Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-ms 2026-08-16T18:43:27.592Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-multifocal-motor-neuropathy 2026-08-16T18:43:27.777Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-multiple-sclerosis 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-multiple-system-atrophy 2026-08-16T18:43:27.787Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-muscle-relaxant 2026-08-16T18:43:27.623Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-muscular-dystrophy 2026-08-16T18:43:27.730Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-myalgic-encephalomyelitis-chronic-fatigue-syndrome 2026-08-16T18:43:27.645Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-myasthenia-gravis 2026-08-16T18:43:27.635Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-myotonic-dystrophy-type-1 2026-08-16T18:43:27.688Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-narcolepsy 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-neonatal-hypoxic-ischemic-encephalopathy 2026-08-16T18:43:27.772Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-neurodegenerative-diseases 2026-08-16T18:43:27.689Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-neurodegenerative-disorders 2026-08-16T18:43:27.680Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-neurodevelopmental-disorders 2026-08-16T18:43:27.786Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-neuroimmune-diseases 2026-08-16T18:43:27.785Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-niemann-pick-disease 2026-08-16T18:43:27.694Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-niemann-pick-type-c-disease 2026-08-16T18:43:27.716Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-nmosd 2026-08-16T18:43:27.694Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-obsessive-compulsive-disorder-ocd 2026-08-16T18:43:27.687Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-opioid-overdose 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-opioid-use-disorder 2026-08-16T18:43:27.703Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-pain-management 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-painful-diabetic-neuropathy 2026-08-16T18:43:27.764Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-parkinson-s-disease 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-pediatric-demyelinating-diseases 2026-08-16T18:43:27.787Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-pediatric-neurosurgery 2026-08-16T18:43:27.724Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-pet-imaging-agent 2026-08-16T18:43:27.676Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-post-acute-sequelae-of-sars-cov-2 2026-08-16T18:43:27.696Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-progressive-supranuclear-palsy-and-dementia 2026-08-16T18:43:27.752Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-psychotropic-agents 2026-08-16T18:43:27.744Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-ptsd 2026-08-16T18:43:27.673Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-rare-disease 2026-08-16T18:43:27.640Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-rett-syndrome 2026-08-16T18:43:27.793Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-rna-targeted-therapy 2026-08-16T18:43:27.590Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-schizophrenia 2026-08-16T18:43:27.631Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-sedative 2026-08-16T18:43:27.603Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-slc6a1-ndd 2026-08-16T18:43:27.740Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-sleep-disorders 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-sleep-wake-disorders 2026-08-16T18:43:27.592Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-smoking-cessation 2026-08-16T18:43:27.676Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-spinal-cord-injury 2026-08-16T18:43:27.707Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-spinal-muscular-atrophy 2026-08-16T18:43:27.721Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-status-epilepticus 2026-08-16T18:43:27.787Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-stiff-person-syndrome 2026-08-16T18:43:27.659Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-stroke 2026-08-16T18:43:27.635Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-stroke-recovery 2026-08-16T18:43:27.590Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-stroke-rehabilitation 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-substance-use-disorder 2026-08-16T18:43:27.651Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-substance-use-disorders 2026-08-16T18:43:27.699Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-tinnitus 2026-08-16T18:43:27.754Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-transthyretin-amyloidosis 2026-08-16T18:43:27.669Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-traumatic-brain-injury 2026-08-16T18:43:27.631Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-viral-infections 2026-08-16T18:43:27.723Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-wakefulness-promoting-agent 2026-08-16T18:43:27.623Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuromodulation 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuromuscular 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuromuscular-duchenne-muscular-dystrophy 2026-08-16T18:43:27.629Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuromuscular-gene-therapy 2026-08-16T18:43:27.681Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuromuscular-blockade 2026-08-16T18:43:27.344Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuromuscular-blocker 2026-08-16T18:43:27.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuropathy 2026-08-16T18:43:27.537Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuropsychiatry 2026-11-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuropsychiatry-developmental-disorders 2026-08-16T18:43:27.722Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroscience 2026-08-16T18:43:27.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroscience-alcohol-use-disorder 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroscience-depression 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroscience-schizophrenia 2026-08-16T18:43:27.636Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neutropenia 2026-08-16T18:43:27.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neutrophil-elastase-inhibition 2026-08-16T18:43:27.327Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nicotine 2026-08-16T18:43:27.407Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nicotine-receptor-agonist 2026-08-16T18:43:27.434Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nicotine-replacement-therapy 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/niemann-pick-disease 2026-08-16T18:43:27.388Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/niemann-pick-type-c-disease 2026-08-16T18:43:27.420Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nk 2026-08-16T18:43:27.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nmosd 2026-08-16T18:43:27.388Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/non-hodgkin-lymphoma 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/non-pharmacological-intervention 2026-08-16T18:43:27.483Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/non-small-cell-lung-cancer 2026-08-16T18:43:27.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/non-tuberculous-mycobacteria 2026-08-16T18:43:27.354Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nonsegmental-vitiligo 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nontuberculous-mycobacterial-infections 2026-08-16T18:43:27.454Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nontuberculous-mycobacterial-lung-disease 2026-08-16T18:43:27.390Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/not-applicable 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/not-specified 2026-08-16T18:43:27.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/not-specified-not-applicable 2026-08-16T18:43:27.711Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/not-specified-not-specified 2026-08-16T18:43:27.809Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/not-specified-oral-formulation 2026-08-16T18:43:27.805Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nras-mutant-melanoma 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nrg1-fusion-positive-cholangiocarcinoma 2026-08-16T18:43:27.547Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nsaid 2026-08-16T18:43:27.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nsclc 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutraceuticals 2026-08-16T18:43:27.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutraceuticals-vitamin-d 2026-08-16T18:43:27.752Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutrition 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutrition-vitamins 2026-08-16T18:43:27.678Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-assessment 2026-08-16T18:43:27.512Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-deficiency 2026-08-16T18:43:27.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-deficiency-vitamin-b1 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-deficiency-vitamin-b12 2026-08-16T18:43:27.616Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-supplements 2026-08-16T18:43:27.329Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-supplements-vitamin-c 2026-08-16T18:43:27.803Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-support 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-support-injectable-vitamins 2026-08-16T18:43:27.678Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-support-parenteral-nutrition 2026-08-16T18:43:27.714Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-behavioral-intervention 2026-08-16T18:43:27.766Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-combination-therapy 2026-08-16T18:43:27.606Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-device 2026-08-16T18:43:27.678Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-digital-health 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-endoscopic-procedure 2026-08-16T18:43:27.795Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1 2026-08-16T18:43:27.578Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1-agonist 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1-agonists 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1-receptor-agonist 2026-08-16T18:43:27.598Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1-receptor-agonists 2026-08-16T18:43:27.713Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1-gip-receptor-agonist-and-amylin-analog 2026-08-16T18:43:27.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-injectable-therapy 2026-08-16T18:43:27.727Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-medical-device 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-metabolic 2026-08-16T18:43:27.650Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-nanoparticle-therapy 2026-08-16T18:43:27.707Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-neuromodulation 2026-08-16T18:43:27.726Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-oral-glp-1-receptor-agonist 2026-08-16T18:43:27.598Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-oral-tablet 2026-08-16T18:43:27.782Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-peptide-therapy 2026-08-16T18:43:27.798Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-pharmacotherapy 2026-08-16T18:43:27.579Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-small-molecule 2026-08-16T18:43:27.781Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-surgical-intervention 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-triple-agonist 2026-08-16T18:43:27.598Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-and-type-2-diabetes 2026-08-16T18:43:27.398Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/observational-study 2026-08-16T18:43:27.465Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obsessive-compulsive-disorder-ocd 2026-08-16T18:43:27.377Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics 2026-08-16T18:43:27.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-ai-decision-support 2026-08-16T18:43:27.742Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-cervical-health 2026-08-16T18:43:27.670Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-chronic-pain-management 2026-08-16T18:43:27.705Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-corticosteroids 2026-08-16T18:43:27.755Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-gynecological-procedures 2026-08-16T18:43:27.780Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-labor-induction 2026-08-16T18:43:27.696Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-placenta-accreta-spectrum 2026-08-16T18:43:27.697Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-preterm-birth 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-substance-use-disorder 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-tocolytics 2026-08-16T18:43:27.712Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-uterine-fibroids 2026-08-16T18:43:27.670Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-uterotonics 2026-08-16T18:43:27.642Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstructive-sleep-apnea 2026-08-16T18:43:27.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ocd 2026-08-16T18:43:27.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ocular-inflammation 2026-08-16T18:43:27.544Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ocular-surface-diseases 2026-08-16T18:43:27.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/omega-3-fatty-acids 2026-08-16T18:43:27.484Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology 2026-10-25T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.691Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-acute-myeloid-leukemia 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-adc 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-adc-and-bispecific-antibody 2026-08-16T18:43:27.695Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-adolescent-and-young-adult-cancer 2026-08-16T18:43:27.686Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-adrenocortical-carcinoma 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-advanced-care-planning 2026-08-16T18:43:27.755Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-akt-inhibitor 2026-08-16T18:43:27.643Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-alk-inhibitor 2026-08-16T18:43:27.791Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-aml 2026-08-16T18:43:27.583Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-anal-cancer 2026-08-16T18:43:27.764Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-androgen-receptor-inhibitor 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-antibody-drug-conjugate 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-antiemetic 2026-08-16T18:43:27.604Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-antineoplastic 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-antitumor 2026-08-16T18:43:27.669Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-antitumor-agents 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.751Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.670Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-cell-acute-lymphoblastic-leukemia-b-all 2026-08-16T18:43:27.753Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-cell-lymphoma 2026-08-16T18:43:27.641Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-cell-malignancies 2026-08-16T18:43:27.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-cell-non-hodgkin-lymphoma 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-cell-non-hodgkin-s-lymphoma 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-basal-cell-carcinoma 2026-08-16T18:43:27.697Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bcl-2-inhibitor 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bcr-abl1-inhibition 2026-08-16T18:43:27.597Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-biliary-tract-cancer 2026-08-16T18:43:27.570Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-biologic 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-biologic-therapy 2026-08-16T18:43:27.735Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-biomarker-discovery 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-biomarkers 2026-08-16T18:43:27.712Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-biosimilar 2026-08-16T18:43:27.748Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bispecific-antibodies 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bispecific-t-cell-engager 2026-08-16T18:43:27.593Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bite 2026-08-16T18:43:27.586Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bladder-cancer 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bone-cancer 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bone-health 2026-08-16T18:43:27.680Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bone-metabolism 2026-08-16T18:43:27.615Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bone-metastases 2026-08-16T18:43:27.644Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bone-sarcoma 2026-08-16T18:43:27.695Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-braf-mutant-melanoma 2026-08-16T18:43:27.750Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-braf-mek-inhibitors 2026-08-16T18:43:27.767Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-brain-cancer 2026-08-16T18:43:27.771Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-brain-metastases 2026-08-16T18:43:27.639Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-brain-tumors 2026-08-16T18:43:27.671Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-breast-cancer 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-breast-tumors 2026-08-16T18:43:27.797Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-breast-ovarian-cancer 2026-08-16T18:43:27.723Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-btk-inhibitor 2026-08-16T18:43:27.704Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-burkitt-lymphoma 2026-08-16T18:43:27.593Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cancer-cachexia 2026-08-16T18:43:27.647Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cancer-care 2026-08-16T18:43:27.731Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cancer-genetics 2026-08-16T18:43:27.718Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cancer-vaccines 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cancer-related-fatigue 2026-08-16T18:43:27.790Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-car-nk-cell-therapy 2026-08-16T18:43:27.705Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-car-t-cell-therapy 2026-08-16T18:43:27.581Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-car-nk-cells 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-car-t 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cd30-positive-lymphoma 2026-08-16T18:43:27.733Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cdk-inhibitor 2026-08-16T18:43:27.720Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cdk4-6-inhibitor 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cdk7-inhibition 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cell-therapy 2026-08-16T18:43:27.644Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cervical-and-vaginal-cancer 2026-08-16T18:43:27.797Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cervical-cancer 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-checkpoint-inhibitor 2026-08-16T18:43:27.650Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-chemotherapy 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-chemotherapy-adjunct 2026-08-16T18:43:27.617Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-chemotherapy-support 2026-08-16T18:43:27.617Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-chemotherapy-induced-peripheral-neuropathy 2026-08-16T18:43:27.781Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cholangiocarcinoma 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-chronic-lymphocytic-leukemia 2026-08-16T18:43:27.715Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cll 2026-08-16T18:43:27.671Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cll-sll 2026-08-16T18:43:27.595Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cns-lymphoma 2026-08-16T18:43:27.694Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cns-metastases 2026-08-16T18:43:27.635Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cns-tumors 2026-08-16T18:43:27.596Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cognitive-impairment 2026-08-16T18:43:27.710Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-colon-cancer 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-colorectal-cancer 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-combination-immunotherapy 2026-08-16T18:43:27.649Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-combination-therapy 2026-08-16T18:43:27.588Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cutaneous-angiosarcoma 2026-08-16T18:43:27.694Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-data-collection 2026-08-16T18:43:27.783Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-dendrimer-based-therapy 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-diagnostics-and-multiple-sclerosis-btk-inhibitor 2026-08-16T18:43:27.597Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-diffuse-large-b-cell-lymphoma 2026-08-16T18:43:27.570Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-digestive-cancers 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-digital-health 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-digital-pathology 2026-08-16T18:43:27.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-dlbcl 2026-08-16T18:43:27.584Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-dll3-cd3-bispecific-antibody 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-dna-repair-inhibition 2026-08-16T18:43:27.740Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-drug-development 2026-08-16T18:43:27.587Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-dsrct 2026-08-16T18:43:27.665Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-early-detection 2026-08-16T18:43:27.670Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-egfr-inhibitor 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-egfr-targeted-therapies 2026-08-16T18:43:27.589Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-endocrine-tumors 2026-08-16T18:43:27.680Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-endometrial-cancer 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-epidemiology 2026-08-16T18:43:27.750Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-er-positive-breast-cancer 2026-08-16T18:43:27.579Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-esophageal-cancer 2026-08-16T18:43:27.632Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-esophageal-squamous-cell-carcinoma 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-estrogen-receptor-modulator 2026-08-16T18:43:27.581Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ewing-sarcoma 2026-08-16T18:43:27.593Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ezh2-inhibitor 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-familial-adenomatous-polyposis 2026-08-16T18:43:27.730Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-fertility-preservation 2026-08-16T18:43:27.774Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-fgfr-inhibitor 2026-08-16T18:43:27.780Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-flt3-inhibitor 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-follicular-lymphoma 2026-08-16T18:43:27.588Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gallbladder-cancer 2026-08-16T18:43:27.789Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gastric-cancer 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gastroesophageal-adenocarcinoma 2026-08-16T18:43:27.677Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gastroesophageal-cancer 2026-08-16T18:43:27.732Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gastrointestinal-cancers 2026-08-16T18:43:27.691Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gastrointestinal-stromal-tumor 2026-08-16T18:43:27.751Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gene-regulation 2026-08-16T18:43:27.747Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gene-therapy 2026-08-16T18:43:27.773Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-general-and-metabolism-diabetes 2026-08-16T18:43:27.718Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-genetic-risk-assessment 2026-08-16T18:43:27.657Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-genetic-testing 2026-08-16T18:43:27.691Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-genomics 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-geriatric-assessment 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gi-cancers 2026-08-16T18:43:27.753Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gist 2026-08-16T18:43:27.718Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-glioblastoma 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-glioma 2026-08-16T18:43:27.581Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gynecologic-cancer 2026-08-16T18:43:27.774Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hairy-cell-leukemia 2026-08-16T18:43:27.661Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hcc 2026-08-16T18:43:27.589Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hdac-inhibitor 2026-08-16T18:43:27.605Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-head-and-neck-cancer 2026-08-16T18:43:27.588Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-head-and-neck-cancer-prostate-cancer 2026-08-16T18:43:27.766Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-head-and-neck-squamous-cell-carcinoma 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hematologic-malignancies 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hematologic-malignancies-and-solid-tumors 2026-08-16T18:43:27.737Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hepatocellular-carcinoma 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-alterations 2026-08-16T18:43:27.689Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-inhibitor 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-endometrial-cancer 2026-08-16T18:43:27.596Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-breast-cancer 2026-08-16T18:43:27.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-esophagogastric-adenocarcinoma 2026-08-16T18:43:27.751Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-gastric-cancer 2026-08-16T18:43:27.593Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-solid-tumours 2026-08-16T18:43:27.600Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-upper-tract-urothelial-carcinoma 2026-08-16T18:43:27.586Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-targeted-therapy 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-solid-tumors 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-high-grade-glioma 2026-08-16T18:43:27.671Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hiv-related-malignancies 2026-08-16T18:43:27.740Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hodgkin-lymphoma 2026-08-16T18:43:27.587Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hormonal-therapy 2026-08-16T18:43:27.590Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hormone-receptor-positive-breast-cancer 2026-08-16T18:43:27.798Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hpv 2026-08-16T18:43:27.698Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hpv-vaccination 2026-08-16T18:43:27.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hpv-vaccine 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hpv-related-cancers 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-il-1-inhibition 2026-08-16T18:43:27.732Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-image-guided-therapy 2026-08-16T18:43:27.799Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-imaging 2026-08-16T18:43:27.630Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-imaging-agent 2026-08-16T18:43:27.714Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-imaging-biomarker 2026-08-16T18:43:27.736Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immune-checkpoint-inhibitor 2026-08-16T18:43:27.594Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immune-checkpoint-inhibitors 2026-08-16T18:43:27.666Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immune-response 2026-08-16T18:43:27.714Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immune-therapy 2026-08-16T18:43:27.658Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immune-mobilizing-t-cell-receptors 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immuno-oncology 2026-08-16T18:43:27.781Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immunomodulator 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immunotherapy 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-intrahepatic-cholangiocarcinoma 2026-08-16T18:43:27.588Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kat6a-b-inhibition 2026-08-16T18:43:27.683Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kidney-cancer 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kras-g12c-inhibitor 2026-08-16T18:43:27.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kras-g12c-non-small-cell-lung-cancer 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kras-g12c-nsclc 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kras-g12c-positive-non-small-cell-lung-cancer 2026-08-16T18:43:27.587Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kras-inhibitor 2026-08-16T18:43:27.697Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-liver-cancer 2026-08-16T18:43:27.600Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-liver-cancer-neurology-dementia 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-lung-adenocarcinoma 2026-08-16T18:43:27.689Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-lung-cancer 2026-08-16T18:43:27.652Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-lymphedema 2026-08-16T18:43:27.710Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-lymphoma 2026-08-16T18:43:27.584Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-malignant-mesothelioma 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-malignant-peritoneal-mesothelioma 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mantle-cell-lymphoma 2026-08-16T18:43:27.672Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mcrc 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-medical-devices 2026-08-16T18:43:27.625Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mek-inhibitor 2026-08-16T18:43:27.607Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-melanoma 2026-08-16T18:43:27.570Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-meningioma 2026-08-16T18:43:27.736Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mental-health 2026-08-16T18:43:27.717Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-merkel-cell-carcinoma 2026-08-16T18:43:27.684Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mesothelioma 2026-08-16T18:43:27.596Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-metabolic-reprogramming 2026-08-16T18:43:27.600Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-metastatic-colorectal-and-gastric-cancer 2026-08-16T18:43:27.695Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-monoclonal-antibodies 2026-08-16T18:43:27.670Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-monoclonal-antibody 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mtor-inhibitor 2026-08-16T18:43:27.637Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-multiple-myeloma 2026-08-16T18:43:27.570Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-myeloid-cancer 2026-08-16T18:43:27.719Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nanomedicine 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nasopharyngeal-carcinoma 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-neuroblastoma 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-neuroendocrine-cancers 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-neuroendocrine-carcinomas 2026-08-16T18:43:27.582Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-neuroendocrine-tumors 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-neuroendocrine-tumours 2026-08-16T18:43:27.797Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-neurofibromatosis-type-1 2026-08-16T18:43:27.664Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nk-t-cell-lymphoma 2026-08-16T18:43:27.595Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-non-hodgkin-lymphoma 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-non-small-cell-lung-cancer 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nras-mutant-melanoma 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nrg1-fusion-positive-cholangiocarcinoma 2026-08-16T18:43:27.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nsclc 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-oncolytic-virus-therapy 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-oral-agent 2026-08-16T18:43:27.807Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-oral-cancer 2026-08-16T18:43:27.767Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-oropharyngeal-cancer 2026-08-16T18:43:27.798Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-oropharyngeal-squamous-cell-carcinoma 2026-08-16T18:43:27.646Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-osteosarcoma 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ovarian-cancer 2026-08-16T18:43:27.570Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pain-management 2026-08-16T18:43:27.640Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-palliative-care 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pancreatic-adenocarcinoma 2026-08-16T18:43:27.596Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pancreatic-cancer 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pancreatic-ductal-adenocarcinoma 2026-08-16T18:43:27.629Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-parp-inhibitor 2026-08-16T18:43:27.685Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-parp-inhibitor-and-pi3k-inhibitor 2026-08-16T18:43:27.775Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-patient-reported-outcomes 2026-08-16T18:43:27.794Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-patient-support 2026-08-16T18:43:27.645Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pd-1-inhibition 2026-08-16T18:43:27.586Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pd-1-inhibitor 2026-08-16T18:43:27.579Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pd-1-inhibitor-and-adc 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pd-1-pd-l1-inhibitor 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pd-l1-inhibitor 2026-08-16T18:43:27.586Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric 2026-08-16T18:43:27.795Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric-b-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.584Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric-brain-tumors 2026-08-16T18:43:27.688Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric-cancer 2026-08-16T18:43:27.727Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric-cancers 2026-08-16T18:43:27.743Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric-hematology 2026-08-16T18:43:27.735Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric-neoplasms 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pharmacokinetics 2026-08-16T18:43:27.729Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-photodynamic-therapy 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pi3k-inhibitor 2026-08-16T18:43:27.576Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pik3ca-mutant-breast-cancer 2026-08-16T18:43:27.658Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-prostate-cancer 2026-08-16T18:43:27.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-proteasome-inhibitor 2026-08-16T18:43:27.575Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-psychotherapy 2026-08-16T18:43:27.695Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radiation-therapy 2026-08-16T18:43:27.664Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radioactive-drug-therapy 2026-08-16T18:43:27.736Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radioconjugate 2026-08-16T18:43:27.594Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radioligand-therapy 2026-08-16T18:43:27.647Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radiopharmaceutical 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radiotherapy 2026-08-16T18:43:27.647Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-rare-cancers 2026-08-16T18:43:27.713Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-rare-genitourinary-tumors 2026-08-16T18:43:27.762Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ras-inhibitor 2026-08-16T18:43:27.646Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ras-mutations 2026-08-16T18:43:27.711Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-rcc 2026-08-16T18:43:27.643Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-rectal-cancer 2026-08-16T18:43:27.595Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-renal-cell-carcinoma 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ret-fusion-positive-lung-cancer 2026-08-16T18:43:27.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ret-fusion-positive-tumors 2026-08-16T18:43:27.586Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ret-inhibitor 2026-08-16T18:43:27.585Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-rna-modifications 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-sarcoma 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-sclc 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-skin-cancer 2026-08-16T18:43:27.596Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-skin-melanoma 2026-08-16T18:43:27.768Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-skin-tumors 2026-08-16T18:43:27.814Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-small-cell-lung-cancer 2026-08-16T18:43:27.596Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-small-cell-sarcoma 2026-08-16T18:43:27.646Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-small-molecule 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-small-molecule-inhibitors 2026-08-16T18:43:27.654Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-small-molecule-therapeutics 2026-08-16T18:43:27.600Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-smoking-cessation 2026-08-16T18:43:27.706Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-soft-tissue-sarcoma 2026-08-16T18:43:27.599Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-solid-tumors 2026-08-16T18:43:27.595Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-solid-tumors-and-cns-tumors 2026-08-16T18:43:27.776Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-solid-tumors-and-hematology-aml 2026-08-16T18:43:27.796Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-solid-tumors-and-hematology-b-cell-non-hodgkin-lymphoma 2026-08-16T18:43:27.639Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-squamous-cell-carcinoma 2026-08-16T18:43:27.669Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-stomach-adenocarcinoma 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-supportive-care 2026-08-16T18:43:27.585Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-surgery 2026-08-16T18:43:27.790Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-surgical-care 2026-08-16T18:43:27.777Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-surgical-robotics 2026-08-16T18:43:27.744Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-survivorship 2026-08-16T18:43:27.570Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-t-cell-lymphoma 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-t-cell-non-hodgkin-lymphoma 2026-08-16T18:43:27.742Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-t-cell-therapy 2026-08-16T18:43:27.640Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-t-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.783Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-t-cell-engagers 2026-08-16T18:43:27.658Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-t-cell-malignancies 2026-08-16T18:43:27.700Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-targeted-protein-degradation 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-targeted-therapy 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-tenosynovial-giant-cell-tumor 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-thoracic-cancer 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-thymoma-and-thymic-carcinoma 2026-08-16T18:43:27.680Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-thyroid-cancer 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-thyroid-carcinoma 2026-08-16T18:43:27.778Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-til-therapy 2026-08-16T18:43:27.588Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-triple-negative-breast-cancer 2026-08-16T18:43:27.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-tumor-metastasis 2026-08-16T18:43:27.716Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-tyrosine-kinase-inhibitor 2026-08-16T18:43:27.608Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-tyrosine-kinase-inhibitors 2026-08-16T18:43:27.718Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ulk1-inhibition 2026-08-16T18:43:27.594Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-urothelial-cancer 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-urothelial-carcinoma 2026-08-16T18:43:27.742Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-uterine-cancer 2026-08-16T18:43:27.661Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-uveal-melanoma 2026-08-16T18:43:27.779Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-various-autoimmunity-various 2026-08-16T18:43:27.584Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-vegf-inhibitor 2026-08-16T18:43:27.647Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-veterinary 2026-08-16T18:43:27.717Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-viral-immunotherapy 2026-08-16T18:43:27.600Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncolytic-virus-therapy 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-age-related-macular-degeneration 2026-08-16T18:43:27.638Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-ai-diagnostics 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-anti-inflammatory 2026-08-16T18:43:27.629Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-anti-vegf 2026-08-16T18:43:27.633Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-anticholinergic 2026-08-16T18:43:27.682Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-atropine 2026-08-16T18:43:27.811Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-autoimmune-disease 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-autoimmune-dry-eye-disease 2026-08-16T18:43:27.767Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-cataract 2026-08-16T18:43:27.678Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-cataracts 2026-08-16T18:43:27.628Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diabetic-macular-edema 2026-08-16T18:43:27.814Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diabetic-macular-oedema 2026-08-16T18:43:27.765Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diabetic-retinopathy 2026-08-16T18:43:27.590Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diagnostic-agent 2026-08-16T18:43:27.668Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diagnostic-imaging 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-dry-age-related-macular-degeneration 2026-08-16T18:43:27.708Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-dry-eye 2026-08-16T18:43:27.675Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-dry-eye-disease 2026-08-16T18:43:27.711Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-eye-drops 2026-08-16T18:43:27.804Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-fungal-keratitis 2026-08-16T18:43:27.642Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-gene-therapy 2026-08-16T18:43:27.592Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-geographic-atrophy 2026-08-16T18:43:27.688Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-glaucoma 2026-08-16T18:43:27.618Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-inherited-retinal-diseases 2026-08-16T18:43:27.699Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-intraocular-lens 2026-08-16T18:43:27.730Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-meibomian-gland-dysfunction 2026-08-16T18:43:27.652Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-myopia 2026-08-16T18:43:27.717Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-namd 2026-08-16T18:43:27.665Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-neovascular-age-related-macular-degeneration 2026-08-16T18:43:27.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-ocular-inflammation 2026-08-16T18:43:27.570Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-ocular-surface-diseases 2026-08-16T18:43:27.725Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-presbyopia 2026-08-16T18:43:27.704Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-retinal-diseases 2026-08-16T18:43:27.597Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-retinal-disorders 2026-08-16T18:43:27.678Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-retinitis-pigmentosa 2026-08-16T18:43:27.678Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-retinopathy-of-prematurity 2026-08-16T18:43:27.806Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-thyroid-eye-disease 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-vision-impairment 2026-08-16T18:43:27.705Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid-combination 2026-08-16T18:43:27.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid-dependence 2026-08-16T18:43:27.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid-overdose 2026-08-16T18:43:27.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid-use-disorder 2026-08-16T18:43:27.400Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioids 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-agent 2026-08-16T18:43:27.406Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-cancer 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-care 2026-08-16T18:43:27.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-drug-delivery 2026-08-16T18:43:27.413Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-formulation 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-glp-1-receptor-agonist 2026-08-16T18:43:27.550Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-hypoglycemic 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-hypoglycemic-agent 2026-08-16T18:43:27.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-hypoglycemics 2026-08-16T18:43:27.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-surgery 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-surgery-temporomandibular-joint-disorders 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-tablet 2026-08-16T18:43:27.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-therapy 2026-08-16T18:43:27.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oropharyngeal-cancer 2026-08-16T18:43:27.554Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oropharyngeal-squamous-cell-carcinoma 2026-08-16T18:43:27.315Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-cartilage-regeneration 2026-08-16T18:43:27.657Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-femur-fractures 2026-08-16T18:43:27.731Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-osteoarthritis 2026-08-16T18:43:27.768Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-osteoporotic-vertebral-compression-fractures 2026-08-16T18:43:27.692Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-regenerative-medicine 2026-08-16T18:43:27.792Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-shoulder-surgery 2026-08-16T18:43:27.721Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-spine-surgery 2026-08-16T18:43:27.702Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-trauma 2026-08-16T18:43:27.804Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteoarthritis 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteomyelitis 2026-08-16T18:43:27.404Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteoporosis 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteoporosis-bisphosphonate 2026-08-16T18:43:27.612Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteoporosis-exercise-intervention 2026-08-16T18:43:27.687Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteoporotic-vertebral-compression-fractures 2026-08-16T18:43:27.385Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteosarcoma 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otc 2026-08-16T18:43:27.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology 2026-08-16T18:43:27.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-anti-il-33-mab 2026-08-16T18:43:27.632Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-chronic-rhinosinusitis-with-nasal-polyps 2026-08-16T18:43:27.781Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-cochlear-implant 2026-08-16T18:43:27.762Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-hearing-loss 2026-08-16T18:43:27.791Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-meniere-s-disease 2026-08-16T18:43:27.757Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-nasal-obstruction 2026-08-16T18:43:27.806Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-voice-disorders 2026-08-16T18:43:27.810Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ovarian-cancer 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/overactive-bladder 2026-08-16T18:43:27.339Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pah 2026-08-16T18:43:27.367Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management 2026-08-16T18:43:27.287Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-acupuncture 2026-08-16T18:43:27.717Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-analgesia 2026-08-16T18:43:27.651Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-analgesic 2026-08-16T18:43:27.622Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-analgesics 2026-08-16T18:43:27.575Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-anesthesia 2026-08-16T18:43:27.659Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-botulinum-toxin 2026-08-16T18:43:27.759Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-chronic-coccydynia 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-chronic-low-back-pain 2026-08-16T18:43:27.645Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-chronic-non-cancer-pain 2026-08-16T18:43:27.774Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-chronic-pain 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-combination-analgesic 2026-08-16T18:43:27.771Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-combination-analgesics 2026-08-16T18:43:27.765Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-combination-therapy 2026-08-16T18:43:27.690Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-cox-2-inhibitor 2026-08-16T18:43:27.690Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-local-anesthetic 2026-08-16T18:43:27.800Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-local-anesthetics 2026-08-16T18:43:27.610Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-medical-device 2026-08-16T18:43:27.772Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-medical-devices 2026-08-16T18:43:27.715Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-neuromodulation 2026-08-16T18:43:27.710Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-nsaid 2026-08-16T18:43:27.604Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-opioid 2026-08-16T18:43:27.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-opioid-combination 2026-08-16T18:43:27.621Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-opioids 2026-08-16T18:43:27.763Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-otc 2026-08-16T18:43:27.621Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-pediatric 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-postoperative-pain 2026-08-16T18:43:27.680Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-regional-anesthesia 2026-08-16T18:43:27.714Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-shockwave-therapy 2026-08-16T18:43:27.722Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-solvent 2026-08-16T18:43:27.617Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/painful-diabetic-neuropathy 2026-08-16T18:43:27.493Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/palliative-care 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pancreatic-adenocarcinoma 2026-08-16T18:43:27.437Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pancreatic-cancer 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pancreatic-disorders 2026-08-16T18:43:27.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pancreatic-ductal-adenocarcinoma 2026-08-16T18:43:27.287Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parasitic-infections 2026-08-16T18:43:27.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parasiticide 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parasitology 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parenteral-nutrition 2026-08-16T18:43:27.417Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parkinson-s-disease 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/paroxysmal-nocturnal-hemoglobinuria 2026-08-16T18:43:27.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/paroxysmal-nocturnal-hemoglobinuria-pnh 2026-08-16T18:43:27.468Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parp-inhibitor 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parp-inhibitor-and-pi3k-inhibitor 2026-08-16T18:43:27.508Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/patient-reported-outcomes 2026-08-16T18:43:27.538Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/patient-support 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pcos 2026-08-16T18:43:27.443Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pcsk9-inhibition 2026-08-16T18:43:27.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pcsk9-inhibitor 2026-08-16T18:43:27.326Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pd-1 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pd-1-inhibition 2026-08-16T18:43:27.413Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pd-1-inhibitor 2026-08-16T18:43:27.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pd-1-inhibitor-and-adc 2026-08-16T18:43:27.434Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pd-l1-inhibitor 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pde4-inhibition 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pde5-inhibitor 2026-08-16T18:43:27.315Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric 2026-08-16T18:43:27.522Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-anxiety-disorders 2026-08-16T18:43:27.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-b-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.377Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-bipolar-disorder 2026-08-16T18:43:27.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-brain-tumors 2026-08-16T18:43:27.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-cancer 2026-08-16T18:43:27.439Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-cancers 2026-08-16T18:43:27.466Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-demyelinating-diseases 2026-08-16T18:43:27.528Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-hematology 2026-08-16T18:43:27.452Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-neoplasms 2026-08-16T18:43:27.461Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-neurosurgery 2026-08-16T18:43:27.435Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-pain-management 2026-08-16T18:43:27.414Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-surgery 2026-08-16T18:43:27.555Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-adhd 2026-08-16T18:43:27.726Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-analgesic 2026-08-16T18:43:27.662Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-cholestasis 2026-08-16T18:43:27.717Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-ecmo 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-growth-disorders 2026-08-16T18:43:27.689Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-malnutrition 2026-08-16T18:43:27.790Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-medical-device 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-medical-devices 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-necrotizing-enterocolitis 2026-08-16T18:43:27.674Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-neonatology 2026-08-16T18:43:27.714Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-obesity 2026-08-16T18:43:27.753Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-pain-management 2026-08-16T18:43:27.618Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-respiratory-disease 2026-08-16T18:43:27.759Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-respiratory-distress 2026-08-16T18:43:27.632Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-tracheoesophageal-fistula 2026-08-16T18:43:27.732Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/peptide-therapy 2026-08-16T18:43:27.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/peri-implantitis 2026-08-16T18:43:27.390Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/periodontal-disease 2026-08-16T18:43:27.490Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/periodontitis 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/peripheral-arterial-disease 2026-08-16T18:43:27.459Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/peripheral-artery-disease 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pet-imaging-agent 2026-08-16T18:43:27.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pharmaceuticals 2026-08-16T18:43:27.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pharmaceuticals-compounding 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pharmacokinetics 2026-08-16T18:43:27.400Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pharmacotherapy 2026-08-16T18:43:27.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pheochromocytoma 2026-08-16T18:43:27.372Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/phosphate-binder 2026-08-16T18:43:27.337Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/photodynamic-therapy 2026-08-16T18:43:27.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pi3k-inhibitor 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pik3ca-mutant-breast-cancer 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pilonidal-sinus-disease 2026-08-16T18:43:27.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/placenta-accreta-spectrum 2026-08-16T18:43:27.392Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/plasma-products 2026-08-16T18:43:27.354Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/plasma-derived-products 2026-08-16T18:43:27.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/plasma-derived-therapies 2026-08-16T18:43:27.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pmm2-cdg 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pneumococcal-disease 2026-08-16T18:43:27.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pneumococcal-vaccination 2026-08-16T18:43:27.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pneumococcal-vaccine 2026-08-16T18:43:27.332Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pneumonia 2026-08-16T18:43:27.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/polycystic-kidney-disease 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/polycystic-ovary-syndrome 2026-08-16T18:43:27.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/polycythemia-vera 2026-08-16T18:43:27.287Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pompe-disease 2026-08-16T18:43:27.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/post-acute-sequelae-of-sars-cov-2 2026-08-16T18:43:27.391Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/postoperative-nausea-and-vomiting 2026-08-16T18:43:27.454Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/postoperative-pain 2026-08-16T18:43:27.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/postpartum-depression 2026-08-16T18:43:27.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/presbyopia 2026-08-16T18:43:27.402Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/preterm-birth 2026-08-16T18:43:27.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/primary-aldosteronism 2026-08-16T18:43:27.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/primary-biliary-cholangitis 2026-08-16T18:43:27.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/primary-immunodeficiency 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/progressive-familial-intrahepatic-cholestasis 2026-08-16T18:43:27.383Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/progressive-supranuclear-palsy-and-dementia 2026-08-16T18:43:27.474Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/prostacyclin-analog 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/prostate-cancer 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/proteasome-inhibitor 2026-08-16T18:43:27.379Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/proton-pump-inhibitor 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pruritus 2026-08-16T18:43:27.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psilocybin 2026-08-16T18:43:27.462Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psoriasis 2026-08-16T18:43:27.319Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psoriasis-and-autoimmune-diseases 2026-08-16T18:43:27.423Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psoriasis-and-eczema 2026-08-16T18:43:27.334Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psoriatic-arthritis 2026-08-16T18:43:27.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psoriatic-arthritis-and-ankylosing-spondylitis 2026-08-16T18:43:27.362Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychedelics 2026-08-16T18:43:27.423Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-adhd 2026-08-16T18:43:27.623Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-antidepressant 2026-08-16T18:43:27.608Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-antipsychotic 2026-08-16T18:43:27.605Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-anxiety-disorders 2026-08-16T18:43:27.661Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-autism-spectrum-disorder 2026-08-16T18:43:27.659Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-behavioral-disorders 2026-08-16T18:43:27.658Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-binge-eating-disorder 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-borderline-personality-disorder 2026-08-16T18:43:27.745Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-depression 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-dietary-supplements 2026-08-16T18:43:27.806Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-disruptive-mood-dysregulation-disorder 2026-08-16T18:43:27.755Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-eating-disorders 2026-08-16T18:43:27.758Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-long-acting-injectable-antipsychotic 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-major-depressive-disorder 2026-08-16T18:43:27.716Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-mental-health 2026-08-16T18:43:27.709Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-mood-disorders 2026-08-16T18:43:27.706Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-ocd 2026-08-16T18:43:27.681Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-pediatric-anxiety-disorders 2026-08-16T18:43:27.694Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-pediatric-bipolar-disorder 2026-08-16T18:43:27.792Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-postpartum-depression 2026-08-16T18:43:27.760Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-psychosis-spectrum-disorders 2026-08-16T18:43:27.686Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-ptsd 2026-08-16T18:43:27.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-sleep-disorders 2026-08-16T18:43:27.691Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-snri 2026-08-16T18:43:27.621Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-ssri 2026-08-16T18:43:27.601Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-stress-and-anxiety 2026-08-16T18:43:27.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-substance-use-disorders 2026-08-16T18:43:27.667Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-telehealth 2026-08-16T18:43:27.698Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-weight-management 2026-08-16T18:43:27.799Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychosis-spectrum-disorders 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychotherapy 2026-08-16T18:43:27.390Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychotropic-agents 2026-08-16T18:43:27.467Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ptsd 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ptsd-and-substance-use-disorder 2026-08-16T18:43:27.385Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-arterial-hypertension 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-arterial-hypertension-inhalation-therapy 2026-08-16T18:43:27.634Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-arterial-hypertension-oral-therapy 2026-08-16T18:43:27.643Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-arterial-hypertension-pharmacotherapy 2026-08-16T18:43:27.641Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-arterial-hypertension-prostacyclin-analog 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-arterial-hypertension-targeted-therapy 2026-08-16T18:43:27.666Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-embolism 2026-08-16T18:43:27.336Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-embolism-interventional-procedure 2026-08-16T18:43:27.782Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-fibrosis 2026-08-16T18:43:27.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-fibrosis-herbal-medicine 2026-08-16T18:43:27.688Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-hypertension 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-hypertension-biomarkers 2026-08-16T18:43:27.792Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-hypertension-prostacyclin-analog 2026-08-16T18:43:27.713Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-hypertension-rare-disease 2026-08-16T18:43:27.810Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-hypertension-rehabilitation 2026-08-16T18:43:27.695Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-nontuberculous-mycobacterial-infection 2026-08-16T18:43:27.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-tuberculosis 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-acute-lung-injury 2026-08-16T18:43:27.660Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-acute-respiratory-distress-syndrome 2026-08-16T18:43:27.682Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-acute-respiratory-distress-syndrome-ards 2026-08-16T18:43:27.667Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-acute-respiratory-failure 2026-08-16T18:43:27.645Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-chronic-thromboembolic-pulmonary-hypertension 2026-08-16T18:43:27.638Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-copd 2026-08-16T18:43:27.663Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-cystic-fibrosis 2026-08-16T18:43:27.592Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-fibrosing-interstitial-lung-disease 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-fibrosis 2026-08-16T18:43:27.679Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-idiopathic-pulmonary-fibrosis 2026-08-16T18:43:27.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-interstitial-lung-disease 2026-08-16T18:43:27.811Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-lung-fibrosis 2026-08-16T18:43:27.728Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-neonatal-care 2026-08-16T18:43:27.594Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-neutrophil-elastase-inhibition 2026-08-16T18:43:27.655Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-nontuberculous-mycobacterial-lung-disease 2026-08-16T18:43:27.696Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-obstructive-sleep-apnea 2026-08-16T18:43:27.626Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-oncology 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-pah 2026-08-16T18:43:27.574Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-pulmonary-embolism 2026-08-16T18:43:27.661Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-pulmonary-fibrosis 2026-08-16T18:43:27.772Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-pulmonary-hypertension 2026-08-16T18:43:27.596Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-respiratory-distress 2026-08-16T18:43:27.711Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-smoking-cessation 2026-08-16T18:43:27.716Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pyruvate-kinase-deficiency 2026-08-16T18:43:27.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ra-ild 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radiation-therapy 2026-08-16T18:43:27.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radioactive-drug-therapy 2026-08-16T18:43:27.453Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radioconjugate 2026-08-16T18:43:27.531Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radioligand-therapy 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radiopharmaceutical 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radiotherapy 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-blood-disorders 2026-08-16T18:43:27.477Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-cancers 2026-08-16T18:43:27.416Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-disease 2026-09-01T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-disease-enzyme-replacement-therapy 2026-08-16T18:43:27.643Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases 2026-08-16T18:43:27.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-connective-tissue-disorders 2026-08-16T18:43:27.652Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-cystinosis 2026-08-16T18:43:27.577Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-cystinuria 2026-08-16T18:43:27.633Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-enzyme-replacement-therapy 2026-08-16T18:43:27.701Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-genetic-disorders 2026-08-16T18:43:27.664Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-hereditary-hemorrhagic-telangiectasia 2026-08-16T18:43:27.647Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-hypophosphatasia 2026-08-16T18:43:27.600Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-urea-cycle-disorders 2026-08-16T18:43:27.807Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-various 2026-08-16T18:43:27.588Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-genetic-disorders 2026-08-16T18:43:27.398Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-genitourinary-tumors 2026-08-16T18:43:27.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ras-inhibitor 2026-08-16T18:43:27.315Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ras-mutations 2026-08-16T18:43:27.414Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rcc 2026-08-16T18:43:27.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rectal-cancer 2026-08-16T18:43:27.367Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/regenerative-medicine 2026-08-16T18:43:27.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/regenerative-therapy 2026-08-16T18:43:27.515Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/regional-anesthesia 2026-08-16T18:43:27.418Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/regulatory-affairs 2026-08-16T18:43:27.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/regulatory-affairs-drug-labeling 2026-08-16T18:43:27.730Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/regulatory-affairs-drug-manufacturing 2026-08-16T18:43:27.726Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rehabilitation 2026-08-16T18:43:27.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/renal 2026-08-16T18:43:27.337Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/renal-phosphate-binder 2026-08-16T18:43:27.662Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/renal-cell-carcinoma 2026-08-16T18:43:27.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/renal-fibrosis 2026-08-16T18:43:27.385Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/renal-osteodystrophy 2026-08-16T18:43:27.348Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/renal-transplantation 2026-08-16T18:43:27.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health-adenomyosis 2026-08-16T18:43:27.718Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health-assisted-reproductive-technology 2026-08-16T18:43:27.742Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health-gnrh-antagonist 2026-08-16T18:43:27.611Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health-hormonal-therapy 2026-08-16T18:43:27.615Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health-ivf 2026-08-16T18:43:27.667Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health-male-infertility 2026-08-16T18:43:27.760Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory 2026-08-16T18:43:27.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-acute-hypoxemic-respiratory-failure 2026-08-16T18:43:27.648Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-acute-lung-injury 2026-08-16T18:43:27.635Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-alpha-1-antitrypsin-deficiency 2026-08-16T18:43:27.639Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-anticholinergic 2026-08-16T18:43:27.615Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-asthma 2026-08-16T18:43:27.580Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-asthma-copd 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-bronchial-challenge-test 2026-08-16T18:43:27.782Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-bronchial-provocation-testing 2026-08-16T18:43:27.788Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-bronchodilator 2026-08-16T18:43:27.608Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-chronic-cough 2026-08-16T18:43:27.596Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-chronic-obstructive-pulmonary-disease-copd 2026-08-16T18:43:27.784Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-chronic-respiratory-disease 2026-08-16T18:43:27.750Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-copd 2026-08-16T18:43:27.589Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-cough-and-cold 2026-08-16T18:43:27.715Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-device 2026-08-16T18:43:27.578Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-hypoxemic-respiratory-distress 2026-08-16T18:43:27.697Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-mechanical-ventilation 2026-08-16T18:43:27.691Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-medical-devices 2026-08-16T18:43:27.586Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-nasal-spray 2026-08-16T18:43:27.624Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-severe-pneumonia 2026-08-16T18:43:27.591Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-ventilation 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-wheezing-diseases 2026-08-16T18:43:27.754Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-disease 2026-08-16T18:43:27.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-distress 2026-08-16T18:43:27.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-management 2026-08-16T18:43:27.358Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-syncytial-virus 2026-08-16T18:43:27.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-syncytial-virus-rsv 2026-08-16T18:43:27.318Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-tract-infections 2026-08-16T18:43:27.443Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ret-fusion-positive-lung-cancer 2026-08-16T18:43:27.550Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ret-fusion-positive-tumors 2026-08-16T18:43:27.420Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ret-inhibitor 2026-08-16T18:43:27.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/retinal-diseases 2026-08-16T18:43:27.367Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/retinal-disorders 2026-08-16T18:43:27.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/retinitis-pigmentosa 2026-08-16T18:43:27.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/retinopathy-of-prematurity 2026-08-16T18:43:27.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rett-syndrome 2026-08-16T18:43:27.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reversal-agent 2026-08-16T18:43:27.319Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatoid-arthritis 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology 2026-08-16T18:43:27.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-biologic 2026-08-16T18:43:27.797Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-dmard 2026-08-16T18:43:27.605Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-fibromyalgia 2026-08-16T18:43:27.812Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-gout 2026-08-16T18:43:27.636Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-jak-inhibitor 2026-08-16T18:43:27.685Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-juvenile-idiopathic-arthritis 2026-08-16T18:43:27.714Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-monoclonal-antibody 2026-08-16T18:43:27.741Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-osteoarthritis 2026-08-16T18:43:27.705Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-psoriatic-arthritis 2026-08-16T18:43:27.787Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-psoriatic-arthritis-and-ankylosing-spondylitis 2026-08-16T18:43:27.677Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-ra-ild 2026-08-16T18:43:27.662Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-rheumatoid-arthritis 2026-08-16T18:43:27.628Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-small-molecule 2026-08-16T18:43:27.739Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-still-s-disease 2026-08-16T18:43:27.726Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-systemic-juvenile-idiopathic-arthritis 2026-08-16T18:43:27.699Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-traditional-chinese-medicine 2026-08-16T18:43:27.689Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rna-modifications 2026-08-16T18:43:27.476Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rna-targeted-therapy 2026-08-16T18:43:27.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/runx1-familial-platelet-disorder 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sarcoma 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/scar-management 2026-08-16T18:43:27.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/schizophrenia 2026-08-16T18:43:27.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sclc 2026-08-16T18:43:27.521Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sedation 2026-08-16T18:43:27.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sedative 2026-08-16T18:43:27.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sepsis 2026-08-16T18:43:27.358Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sepsis-induced-liver-injury 2026-08-16T18:43:27.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sequencing-technology 2026-08-16T18:43:27.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/severe-pneumonia 2026-08-16T18:43:27.491Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sglt-2-inhibitor 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sglt2-inhibitor 2026-08-16T18:43:27.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sglt2-inhibitor-and-biguanide 2026-08-16T18:43:27.279Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sglt2-inhibitor-and-dpp-4-inhibitor 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sglt2-inhibitors 2026-08-16T18:43:27.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/shockwave-therapy 2026-08-16T18:43:27.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/shoulder-surgery 2026-08-16T18:43:27.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sickle-cell-anemia 2026-08-16T18:43:27.359Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sickle-cell-disease 2026-08-16T18:43:27.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-aging 2026-08-16T18:43:27.346Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-cancer 2026-08-16T18:43:27.545Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-damage 2026-08-16T18:43:27.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-disorders 2026-08-16T18:43:27.421Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-hydration 2026-08-16T18:43:27.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-melanoma 2026-08-16T18:43:27.498Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-tumors 2026-08-16T18:43:27.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/slc6a1-ndd 2026-08-16T18:43:27.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disorders 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disorders-herbal-medicine 2026-08-16T18:43:27.810Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disorders-melatonin-receptor-agonist 2026-08-16T18:43:27.621Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disorders-obstructive-sleep-apnea 2026-08-16T18:43:27.779Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disorders-sleep-disordered-breathing 2026-08-16T18:43:27.727Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-medicine 2026-08-16T18:43:27.476Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-medicine-obstructive-sleep-apnea 2026-08-16T18:43:27.753Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disordered-breathing 2026-08-16T18:43:27.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-wake-disorders 2026-08-16T18:43:27.508Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sll 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sll-and-related-lymphomas 2026-08-16T18:43:27.439Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/small-cell-lung-cancer 2026-08-16T18:43:27.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/small-cell-sarcoma 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/small-molecule 2026-08-16T18:43:27.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/small-molecule-inhibitors 2026-08-16T18:43:27.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/small-molecule-therapeutics 2026-08-16T18:43:27.493Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/smoking-cessation 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/smoking-cessation-nicotine-receptor-agonist 2026-08-16T18:43:27.617Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/smoking-cessation-nicotine-replacement-therapy 2026-08-16T18:43:27.616Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/snri 2026-08-16T18:43:27.479Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/soft-tissue-sarcoma 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/solid-tumors 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/solid-tumors-and-cns-tumors 2026-08-16T18:43:27.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/solid-tumors-and-hematology 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/solvent 2026-08-16T18:43:27.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/spinal-cord-injury 2026-08-16T18:43:27.407Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/spinal-muscular-atrophy 2026-08-16T18:43:27.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/spine-surgery 2026-08-16T18:43:27.399Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/spleen-tyrosine-kinase-inhibitor 2026-08-16T18:43:27.515Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/squamous-cell-carcinoma 2026-08-16T18:43:27.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ssri 2026-08-16T18:43:27.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/statin 2026-08-16T18:43:27.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/status-epilepticus 2026-08-16T18:43:27.527Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stem-cell-therapy 2026-08-16T18:43:27.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stem-cell-transplantation 2026-08-16T18:43:27.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stenting 2026-08-16T18:43:27.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stiff-person-syndrome 2026-08-16T18:43:27.334Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/still-s-disease 2026-08-16T18:43:27.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stimulant-use-disorder 2026-08-16T18:43:27.462Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stomach-adenocarcinoma 2026-08-16T18:43:27.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stress-and-anxiety 2026-08-16T18:43:27.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stress-urinary-incontinence 2026-08-16T18:43:27.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stroke 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stroke-recovery 2026-08-16T18:43:27.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stroke-rehabilitation 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/substance-use-disorder 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/substance-use-disorder-behavioral-intervention 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/substance-use-disorder-opioid-use-disorder 2026-08-16T18:43:27.778Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/substance-use-disorders 2026-08-16T18:43:27.346Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sudden-cardiac-death 2026-08-16T18:43:27.356Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/supportive-care 2026-08-16T18:43:27.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-anesthesia 2026-08-16T18:43:27.700Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-breast-reconstruction 2026-08-16T18:43:27.719Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-gynecology 2026-08-16T18:43:27.759Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-hernia-repair 2026-08-16T18:43:27.666Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-infection-prevention 2026-08-16T18:43:27.779Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-medical-devices 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-pain-management 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-pilonidal-sinus-disease 2026-08-16T18:43:27.808Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-thoracic 2026-08-16T18:43:27.742Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-wound-healing 2026-08-16T18:43:27.653Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgical-care 2026-08-16T18:43:27.512Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgical-intervention 2026-08-16T18:43:27.348Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgical-procedures 2026-08-16T18:43:27.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgical-robotics 2026-08-16T18:43:27.467Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/survivorship 2026-08-16T18:43:27.537Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/syphilis 2026-08-16T18:43:27.512Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/systemic-al-amyloidosis 2026-08-16T18:43:27.452Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/systemic-juvenile-idiopathic-arthritis 2026-08-16T18:43:27.396Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/systemic-lupus-erythematosus 2026-08-16T18:43:27.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/t-cell-lymphoma 2026-08-16T18:43:27.318Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/t-cell-non-hodgkin-lymphoma 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/t-cell-therapy 2026-08-16T18:43:27.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/t-cell-acute-lymphoblastic-leukemia 2026-08-16T18:43:27.521Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/t-cell-engagers 2026-08-16T18:43:27.333Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/t-cell-malignancies 2026-08-16T18:43:27.397Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/targeted-protein-degradation 2026-08-16T18:43:27.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/targeted-therapy 2026-08-16T18:43:27.345Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/telehealth 2026-08-16T18:43:27.394Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/telomerase-inhibitor 2026-08-16T18:43:27.474Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/temporomandibular-joint-disorders 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tenosynovial-giant-cell-tumor 2026-08-16T18:43:27.521Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/testosterone-deficiency 2026-08-16T18:43:27.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thalassemia 2026-08-16T18:43:27.512Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thoracic 2026-08-16T18:43:27.463Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thoracic-cancer 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thrombocytopenia 2026-08-16T18:43:27.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thrombotic-microangiopathy 2026-08-16T18:43:27.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thymoma-and-thymic-carcinoma 2026-08-16T18:43:27.367Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thyroid-cancer 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thyroid-carcinoma 2026-08-16T18:43:27.513Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thyroid-disorders 2026-08-16T18:43:27.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thyroid-eye-disease 2026-08-16T18:43:27.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/til-therapy 2026-08-16T18:43:27.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tinnitus 2026-08-16T18:43:27.477Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tnf-inhibitor 2026-08-16T18:43:27.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tocolytics 2026-08-16T18:43:27.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/topical-anti-inflammatory 2026-08-16T18:43:27.450Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/topical-antiviral 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/topical-corticosteroid 2026-08-16T18:43:27.480Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/topical-immunomodulator 2026-08-16T18:43:27.480Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/topical-retinoid 2026-08-16T18:43:27.411Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/topical-steroid 2026-08-16T18:43:27.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tracheoesophageal-fistula 2026-08-16T18:43:27.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/traditional-chinese-medicine 2026-08-16T18:43:27.380Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transcatheter-aortic-valve-implantation 2026-08-16T18:43:27.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transcatheter-aortic-valve-replacement 2026-08-16T18:43:27.447Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transdermal-delivery 2026-08-16T18:43:27.466Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transplant-rejection 2026-08-16T18:43:27.491Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transplantation 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transplantation-anti-infective-agents 2026-08-16T18:43:27.627Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transthyretin-amyloidosis 2026-08-16T18:43:27.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/trauma 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/traumatic-brain-injury 2026-08-16T18:43:27.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/triple-agonist 2026-08-16T18:43:27.550Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/triple-negative-breast-cancer 2026-08-16T18:43:27.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tsp 2026-08-16T18:43:27.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tuberculosis 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tuberculosis-and-hiv 2026-08-16T18:43:27.361Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tumor-metastasis 2026-08-16T18:43:27.421Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-1-diabetes 2026-08-16T18:43:27.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-1-interferonopathies 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-2-diabetes 2026-08-16T18:43:27.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-2-diabetes-mellitus 2026-08-16T18:43:27.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-i-diabetes 2026-08-16T18:43:27.522Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-ii-diabetes 2026-08-16T18:43:27.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tyrosine-kinase-inhibitor 2026-08-16T18:43:27.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tyrosine-kinase-inhibitors 2026-08-16T18:43:27.424Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ulcerative-colitis 2026-08-16T18:43:27.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ulk1-inhibition 2026-08-16T18:43:27.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urea-cycle-disorder 2026-08-16T18:43:27.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urea-cycle-disorders 2026-08-16T18:43:27.340Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urinary-incontinence 2026-08-16T18:43:27.414Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urinary-tract-infections 2026-08-16T18:43:27.464Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology 2026-08-16T18:43:27.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-5-alpha-reductase-inhibitor 2026-08-16T18:43:27.618Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-antimicrobial 2026-08-16T18:43:27.812Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-benign-prostatic-hyperplasia 2026-08-16T18:43:27.673Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-bladder-cancer 2026-08-16T18:43:27.681Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-bladder-pain-syndrome 2026-08-16T18:43:27.709Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-bph 2026-08-16T18:43:27.656Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-erectile-dysfunction 2026-08-16T18:43:27.601Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-kidney-stone-disease 2026-08-16T18:43:27.812Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-kidney-stones 2026-08-16T18:43:27.755Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-male-infertility 2026-08-16T18:43:27.727Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-nephrolithiasis 2026-08-16T18:43:27.626Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-neurogenic-bladder-overactivity 2026-08-16T18:43:27.761Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-overactive-bladder 2026-08-16T18:43:27.618Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-pain-management 2026-08-16T18:43:27.717Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-pde5-inhibitor 2026-08-16T18:43:27.608Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-stress-urinary-incontinence 2026-08-16T18:43:27.759Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-urinary-incontinence 2026-08-16T18:43:27.711Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urothelial-cancer 2026-08-16T18:43:27.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urothelial-carcinoma 2026-08-16T18:43:27.464Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/uterine-cancer 2026-08-16T18:43:27.336Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/uterine-fibroids 2026-08-16T18:43:27.351Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/uterotonics 2026-08-16T18:43:27.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/uveal-melanoma 2026-08-16T18:43:27.514Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vaccine 2026-08-16T18:43:27.287Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vaccine-development 2026-08-16T18:43:27.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vaccines 2026-08-16T18:43:27.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/valvular-heart-disease 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/varicose-veins 2026-08-16T18:43:27.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/various 2026-08-16T18:43:27.386Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/various-pharmaceuticals 2026-08-16T18:43:27.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/various-autoimmunity 2026-08-16T18:43:27.386Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vascular 2026-08-16T18:43:27.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vascular-chronic-venous-insufficiency 2026-08-16T18:43:27.651Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vascular-varicose-veins 2026-08-16T18:43:27.751Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vascular-access 2026-08-16T18:43:27.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vascular-tumors 2026-08-16T18:43:27.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vasopressin-antagonist 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vasopressor 2026-08-16T18:43:27.525Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vegf-inhibitor 2026-08-16T18:43:27.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/venous-thromboembolism 2026-08-16T18:43:27.333Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ventilation 2026-08-16T18:43:27.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary 2026-08-16T18:43:27.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-parasitology 2026-08-16T18:43:27.601Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-medicine 2026-08-16T18:43:27.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-medicine-allergy 2026-08-16T18:43:27.750Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-medicine-canine-and-equine 2026-08-16T18:43:27.573Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-medicine-parasitic-infections 2026-08-16T18:43:27.813Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-medicine-parasiticide 2026-08-16T18:43:27.608Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-medicine-parasitology 2026-08-16T18:43:27.808Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/viral-and-bacterial-pathogens 2026-08-16T18:43:27.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/viral-immunotherapy 2026-08-16T18:43:27.482Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/viral-infections 2026-08-16T18:43:27.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vision-impairment 2026-08-16T18:43:27.404Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitamin-b1 2026-08-16T18:43:27.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitamin-b12 2026-08-16T18:43:27.419Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitamin-c 2026-08-16T18:43:27.329Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitamin-d 2026-08-16T18:43:27.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitamin-d-analog 2026-08-16T18:43:27.515Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitamin-k 2026-08-16T18:43:27.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitamins 2026-08-16T18:43:27.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitiligo 2026-08-16T18:43:27.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/voice-disorders 2026-08-16T18:43:27.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/von-willebrand-disease 2026-08-16T18:43:27.319Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vulvodynia 2026-08-16T18:43:27.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/wakefulness-promoting-agent 2026-08-16T18:43:27.514Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/weight-management 2026-08-16T18:43:27.554Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/wheezing-diseases 2026-08-16T18:43:27.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health 2026-08-16T18:43:27.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-contraception 2026-08-16T18:43:27.614Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-contraceptive 2026-08-16T18:43:27.640Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-endometriosis 2026-08-16T18:43:27.592Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-fertility 2026-08-16T18:43:27.795Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-hormonal-therapy 2026-08-16T18:43:27.620Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-hormone-therapy 2026-08-16T18:43:27.752Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-menopause 2026-08-16T18:43:27.814Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-mental-health 2026-08-16T18:43:27.701Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-nausea-and-vomiting-in-pregnancy 2026-08-16T18:43:27.785Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-reproductive-health 2026-08-16T18:43:27.700Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-uterine-fibroids 2026-08-16T18:43:27.789Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-vulvodynia 2026-08-16T18:43:27.695Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/wound-healing 2026-08-16T18:43:27.324Z weekly 0.7 https://www.humanexasignals.com/regulatory/fda-advisory-committee 2026-08-16T18:43:27.279Z weekly 0.7 https://www.humanexasignals.com/regulatory/pdufa 2026-08-16T18:43:27.279Z weekly 0.7 https://www.humanexasignals.com/regulatory/breakthrough-designation 2026-08-16T18:43:27.279Z weekly 0.7 https://www.humanexasignals.com/regulatory/priority-review 2026-08-16T18:43:27.279Z weekly 0.7 https://www.humanexasignals.com/regulatory/fda-approval 2026-08-20T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/regulatory/ema-decision 2026-09-30T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/regulatory/nda-bla-submission 2026-08-16T18:43:27.279Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-anda-for-dapagliflozin-and-metformin-hydrochloride-receives-ap-status 2026-08-16T18:34:57.309Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-dapagliflozin-anda211541-receives-approval-from-fda 2026-08-16T18:34:36.804Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dapagliflozin-anda211545-by-alkem-labs 2026-08-16T18:34:17.446Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-dapagliflozin-anda211560-by-alembic 2026-08-16T18:33:58.311Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dapagliflozin-and-metformin-hydrochloride-by-macleods 2026-08-16T18:33:38.064Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dapagliflozin-and-metformin-hydrochloride-by-alkem-labs 2026-08-16T18:33:22.071Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-anda211579-for-dapagliflozin-and-metformin-hydrochloride-receives-ta-stat 2026-08-16T18:33:04.864Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-zydus-pharms-dapagliflozin-anda211582 2026-08-16T18:32:47.235Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-dapagliflozin-and-metformin-hydrochloride-anda211583-receives-ap-status 2026-08-16T18:32:31.759Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-anda211595-for-dapagliflozin-and-metformin-approved-by-fda 2026-08-16T18:32:19.736Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mngs-for-diagnosing-invasive-fungal-disease-in-hematological-malignanci 2026-08-16T18:32:05.737Z weekly 0.7 https://www.humanexasignals.com/signals/allist-pharmaceuticals-initiates-trial-for-jab-21822-in-nsclc-with-kras-pg12c-an 2026-08-16T18:31:52.457Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-single-tract-vs-multi-tract-nephrolithotomy-for-complex-renal-st 2026-08-16T18:31:27.928Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-trial-for-carboplatin-and-mirvetuximab-soravtansine-in-advanced 2026-08-16T18:31:15.132Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2a-trial-of-ultrasound-for-immune-modulation-in-glioblastoma 2026-08-16T18:31:02.962Z weekly 0.7 https://www.humanexasignals.com/signals/alnylam-initiates-trial-for-aln-agt01-rvr-in-hypertension-patients-pretreated-wi 2026-08-16T18:30:51.374Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-galleri-test-for-ovarian-cancer-detection-in-brca12-patients 2026-08-16T18:30:38.026Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-receives-ap-status-for-paroxetine-hydrochloride-supplement 2026-08-16T12:33:06.132Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-fda-approval-for-dapagliflozin-anda211312 2026-08-16T12:32:55.518Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-paroxetine-hydrochloride-anda091427-receives-ap-status 2026-08-16T12:32:44.342Z weekly 0.7 https://www.humanexasignals.com/signals/insmed-initiates-trial-for-tpip-in-pulmonary-hypertension-associated-with-inters 2026-08-16T12:32:22.631Z weekly 0.7 https://www.humanexasignals.com/signals/innovent-initiates-phase-iiiii-trial-of-sintilimab-for-gastric-adenocarcinoma 2026-08-16T12:32:10.952Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-trial-for-lutikizumab-in-moderate-to-severe-atopic-dermatitis 2026-08-16T12:31:58.691Z weekly 0.7 https://www.humanexasignals.com/signals/glycomine-initiates-phase-2-trial-of-glm101-for-pmm2-cdg 2026-08-16T12:31:47.970Z weekly 0.7 https://www.humanexasignals.com/signals/fkc289-phase-iii-study-initiated-for-relapsedrefractory-al-amyloidosis 2026-08-16T12:31:37.138Z weekly 0.7 https://www.humanexasignals.com/signals/alnylams-nucresiran-trial-for-hattr-pn-evaluates-efficacy-against-vutrisiran 2026-08-16T12:31:25.852Z weekly 0.7 https://www.humanexasignals.com/signals/ge-healthcare-issues-early-alert-for-infant-resuscitation-system-oxygen-delivery 2026-08-16T06:31:43.671Z weekly 0.7 https://www.humanexasignals.com/signals/ge-healthcare-issues-recall-for-carestations-due-to-ventilation-risk-in-vcv-mode 2026-08-16T06:31:33.724Z weekly 0.7 https://www.humanexasignals.com/signals/insulets-omnipod-pods-face-early-alert-due-to-insulin-leakage-issue 2026-08-16T06:31:21.462Z weekly 0.7 https://www.humanexasignals.com/signals/ucb-initiates-long-term-study-of-bimekizumab-in-active-axial-spondyloarthritis 2026-08-16T06:31:10.678Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-precision-dosing-of-anti-infectives-in-early-kidney-transplantation 2026-08-16T06:31:00.445Z weekly 0.7 https://www.humanexasignals.com/signals/icahn-school-of-medicine-initiates-trial-for-pf-07038124-in-seborrheic-dermatiti 2026-08-16T06:30:44.777Z weekly 0.7 https://www.humanexasignals.com/signals/mdma-at-study-for-ptsd-in-young-adults-initiated 2026-08-16T06:30:33.083Z weekly 0.7 https://www.humanexasignals.com/signals/stryker-initiates-pmcf-study-for-tornier-perform-reversed-monopost-system 2026-08-16T06:05:06.595Z weekly 0.7 https://www.humanexasignals.com/signals/head-to-head-trial-of-botulinum-neurotoxin-type-a-products-for-frown-lines 2026-08-16T06:04:54.396Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-ticagrelor-monotherapy-vs-ticagrelor-plus-aspirin-in-stemi-patients 2026-08-16T06:04:34.422Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-durvalumab-with-chemotherapy-for-high-risk-resectable-cholangi 2026-08-16T06:04:19.590Z weekly 0.7 https://www.humanexasignals.com/signals/fda-issues-early-alert-on-abiomeds-impella-cp-heart-pump-quality-issue 2026-08-16T00:32:30.117Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-rinvoq-upadacitinib-by-abbvie-1 2026-08-16T00:32:17.274Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-qtern-nda209091-receives-ap-status-from-fda 2026-08-16T00:32:02.464Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-eua-for-simparica-trio-to-treat-new-world-screwworm-in-dogs 2026-08-16T00:31:48.467Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-man-study-of-odm-208-in-metastatic-castration-resistant-prostate-cancer 2026-08-16T00:31:33.068Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-posluma-pet-scan-for-monitoring-prostate-cancer-post-treatment 2026-08-16T00:31:18.773Z weekly 0.7 https://www.humanexasignals.com/signals/massachusetts-general-hospital-initiates-oxytocin-study-for-binge-eating-disorde 2026-08-16T00:31:08.359Z weekly 0.7 https://www.humanexasignals.com/signals/icahn-school-of-medicine-initiates-trial-for-caox-stone-prevention-strategies 2026-08-16T00:30:56.469Z weekly 0.7 https://www.humanexasignals.com/signals/study-to-evaluate-hydrochlorothiazide-in-adpkd-patients-to-enhance-tolvaptan-eff 2026-08-16T00:30:39.722Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-smart-hand-protocol-for-hand-rehabilitation-in-rheumatoid-arthriti 2026-08-16T00:30:27.421Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-janumet-xr 2026-08-15T18:33:10.737Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-riomet-er-by-sun-pharma 2026-08-15T18:32:58.893Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-metformin-hydrochloride-by-macleods 2026-08-15T18:32:43.536Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda209882-by-laurus 2026-08-15T18:32:29.924Z weekly 0.7 https://www.humanexasignals.com/signals/teva-pharmaceuticals-receives-ap-status-for-vardenafil-hydrochloride-anda091347 2026-08-15T18:32:15.586Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-jentadueto-xr-by-boehringer-ingelheim 2026-08-15T18:32:03.057Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-synjardy-by-boehringer-ingelheim 2026-08-15T18:31:50.187Z weekly 0.7 https://www.humanexasignals.com/signals/glenmark-pharmaceuticals-submits-supplemental-application-for-metformin-hydrochl 2026-08-15T18:31:38.861Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-intraocular-pressure-during-cataract-surgery-using-active-sentry 2026-08-15T18:31:25.621Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-trial-for-abbv-706-in-relapsedrefractory-small-cell-lung-cancer 2026-08-15T18:31:15.085Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-cemiplimab-with-chemotherapy-in-sinonasal-squamous-cell-carcin 2026-08-15T18:30:55.038Z weekly 0.7 https://www.humanexasignals.com/signals/takedas-mezagitamab-study-for-iga-nephropathy-enters-phase-to-assess-efficacy-an 2026-08-15T18:30:43.054Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-arkansas-initiates-ptsd-therapy-study-for-pregnant-women-in-substa 2026-08-15T12:32:06.496Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-cabozantinib-with-chemotherapy-in-newly-diagnosed-osteosarc 2026-08-15T12:31:51.404Z weekly 0.7 https://www.humanexasignals.com/signals/merck-initiates-trial-for-mk-8527-as-monthly-prep-for-hiv-1-prevention 2026-08-15T12:31:35.685Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-winrevair-sotatercept-csrk-by-merck 2026-08-15T12:31:16.236Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-novitium-pharmas-fosfomycin-tromethamine 2026-08-15T12:31:02.995Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-hepzato-by-delcath-systems-1 2026-08-15T12:30:52.391Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-nda-for-rimactane-by-oxford-pharms 2026-08-15T12:30:40.491Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-belantamab-mafodotin-and-lenalidomide-in-newly-diagnosed-multiple-myelo 2026-08-15T06:34:34.358Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-durvalumab-and-tremelimumab-with-sbrt-for-metastatic-head-and-neck-carc 2026-08-15T06:34:14.758Z weekly 0.7 https://www.humanexasignals.com/signals/satellos-bioscience-initiates-phase-2-trial-of-sat-3247-in-pediatric-dmd-patient 2026-08-15T06:33:52.724Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-multi-antigen-t-cell-infusion-for-cns-tumors-initiated 2026-08-15T06:33:35.478Z weekly 0.7 https://www.humanexasignals.com/signals/bioequivalence-study-of-wp205-initiated-by-wanbangde-pharmaceutical 2026-08-15T06:33:15.578Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-redo-tavi-outcomes-for-transcatheter-aortic-valve-failure-launched 2026-08-15T06:32:59.930Z weekly 0.7 https://www.humanexasignals.com/signals/hla-g-identified-as-a-driver-of-growth-and-immune-suppression-in-renal-cell-carc 2026-08-15T06:32:41.543Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-durezol-by-sandoz 2026-08-15T06:32:25.009Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-opdivo-by-bristol-myers-squibb 2026-08-15T06:32:13.117Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-healthcares-metformin-hydrochloride-supplement 2026-08-15T06:32:00.949Z weekly 0.7 https://www.humanexasignals.com/signals/ajanta-pharmas-metformin-hydrochloride-anda213651-receives-ap-status 2026-08-15T06:31:46.496Z weekly 0.7 https://www.humanexasignals.com/signals/heritage-pharmas-metformin-hydrochloride-anda075978-receives-ap-status 2026-08-15T06:31:35.594Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-metformin-hydrochloride-anda205330 2026-08-15T06:31:23.061Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-ap-status-for-metformin-hydrochloride-anda075985 2026-08-15T06:31:13.009Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-metformin-hydrochloride-by-mpp-pharma 2026-08-15T06:31:01.698Z weekly 0.7 https://www.humanexasignals.com/signals/unichems-metformin-hydrochloride-anda213359-receives-ap-status 2026-08-15T06:30:52.165Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-triamcinolone-acetonide-anda220110-receives-ap-status 2026-08-15T06:30:38.484Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-metformin-hydrochloride-by-vistapharm 2026-08-15T06:05:21.358Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda077336-by-sun-pharma 2026-08-15T06:05:02.347Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-metformin-hydrochloride-by-alignscience-phar 2026-08-15T06:04:44.427Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda209993-by-qingdao-baheal-ph 2026-08-15T06:04:27.927Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda209674-by-novast-labs 2026-08-15T06:04:12.872Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-metformin-hydrochloride-by-sunshine 2026-08-15T06:03:58.444Z weekly 0.7 https://www.humanexasignals.com/signals/bionpharmas-metformin-hydrochloride-anda219151-receives-ap-status 2026-08-15T06:03:42.331Z weekly 0.7 https://www.humanexasignals.com/signals/chengdu-zenitar-initiates-phase-iia-trial-of-flonoltinib-for-polycythemia-vera-p 2026-08-15T06:03:27.617Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-tooth-extraction-impact-on-osteoradionecrosis-risk-in-npc-patients 2026-08-15T06:03:04.705Z weekly 0.7 https://www.humanexasignals.com/signals/ambros-therapeutics-initiates-phase-3-trial-of-ambtx-01-for-crps-type-1 2026-08-15T06:02:51.489Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-surgery-vs-observation-in-stage-ii-iii-nsclc-post-chemotherapy 2026-08-15T06:02:35.745Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-phase-23-trial-of-telisotuzumab-adizutecan-for-pancreatic-cance 2026-08-15T06:02:20.261Z weekly 0.7 https://www.humanexasignals.com/signals/merck-initiates-trial-for-pembrolizumab-combinations-in-advanced-ccrcc 2026-08-15T06:02:07.693Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1b-study-of-furmonertinib-in-nsclc-patients-with-exon-20-insertion-mutatio 2026-08-15T06:01:53.314Z weekly 0.7 https://www.humanexasignals.com/signals/pfizer-and-valnevas-lyme-disease-vaccine-maa-validated-by-ema 2026-08-15T06:01:42.339Z weekly 0.7 https://www.humanexasignals.com/signals/md-anderson-initiates-study-on-hp-mr-imaging-for-pancreatic-cysts 2026-08-15T00:34:56.802Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-e-sync-car-t-cells-for-egfrviii-positive-glioblastoma 2026-08-15T00:34:28.494Z weekly 0.7 https://www.humanexasignals.com/signals/merck-initiates-trial-of-bomedemstat-vs-best-available-therapy-in-essential-thro 2026-08-15T00:34:09.044Z weekly 0.7 https://www.humanexasignals.com/signals/breakbio-initiates-trial-for-combination-immunotherapy-in-triple-negative-breast 2026-08-15T00:33:49.604Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda208880-by-prinston-inc 2026-08-15T00:33:31.695Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-zituvimet-by-zydus-lifesciences 2026-08-15T00:33:12.652Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-metformin-hydrochloride-by-saptalis-pharmaceuticals 2026-08-15T00:32:57.782Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-kombiglyze-xr-by-astrazeneca 2026-08-15T00:32:38.562Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-invokamet-xr-by-janssen 2026-08-15T00:32:16.833Z weekly 0.7 https://www.humanexasignals.com/signals/nostrum-pharmaceuticals-receives-ap-status-for-metformin-hydrochloride-anda07675 2026-08-15T00:32:05.170Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-actoplus-met-by-takeda 2026-08-15T00:31:52.805Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda211052 2026-08-15T00:31:42.297Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-xigduo-xr-by-astrazeneca 2026-08-15T00:31:30.873Z weekly 0.7 https://www.humanexasignals.com/signals/renalytix-ai-initiates-real-world-study-on-kidneyintelx-assay-in-primary-care 2026-08-14T18:35:54.334Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-on-18f-dcfpyl-petct-for-high-risk-and-recurrent-prostate-cancer 2026-08-14T18:35:23.242Z weekly 0.7 https://www.humanexasignals.com/signals/genentech-initiates-study-on-subcutaneous-ocrelizumab-for-ms-patients-switching- 2026-08-14T18:34:58.811Z weekly 0.7 https://www.humanexasignals.com/signals/xencor-initiates-phase-1-trial-for-xmab541-and-xmab808-in-advanced-solid-tumors 2026-08-14T18:34:36.894Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-absorica-by-sun-pharma-1 2026-08-14T18:34:12.858Z weekly 0.7 https://www.humanexasignals.com/signals/novitium-pharmas-anda078083-for-glipizide-and-metformin-hydrochloride-approved 2026-08-14T18:33:46.607Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-segluromet-ertugliflozinmetformin 2026-08-14T18:33:27.199Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda077787-by-dr-reddys-labs 2026-08-14T18:33:11.753Z weekly 0.7 https://www.humanexasignals.com/signals/takedas-kazano-supplement-application-approved-by-fda 2026-08-14T18:32:52.083Z weekly 0.7 https://www.humanexasignals.com/signals/amneal-pharmaceuticals-receives-ap-status-for-doxycycline-hyclate-anda207289 2026-08-14T18:32:36.421Z weekly 0.7 https://www.humanexasignals.com/signals/huaren-pharmaceuticals-anda205357-for-valsartan-receives-ap-status 2026-08-14T18:32:19.140Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-metformin-hydrochloride-by-ipca-labs 2026-08-14T18:32:00.740Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-brivaracetam-anda220288-receives-ap-status-from-fda 2026-08-14T18:31:40.823Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-initiates-karxt-trial-for-adolescent-schizophrenia 2026-08-14T12:34:00.389Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-magnesium-sulfates-anti-inflammatory-effects-in-moderate-tbi-patients 2026-08-14T12:33:41.523Z weekly 0.7 https://www.humanexasignals.com/signals/trb-061-phase-1a1b-study-initiated-for-atopic-dermatitis 2026-08-14T12:33:04.343Z weekly 0.7 https://www.humanexasignals.com/signals/novo-nordisk-initiates-dosing-study-for-nnc0519-0130-in-type-2-diabetes 2026-08-14T12:32:43.832Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-application-for-olanzapine-by-dr-reddys-labs 2026-08-14T12:32:27.034Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-olanzapine-by-dr-reddys-labs 2026-08-14T12:32:07.054Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-meropenem-by-hq-spclt-pharma 2026-08-14T12:31:45.068Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-scopolamine-supplement-by-mylan-technologies 2026-08-14T12:31:34.897Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gadoterate-meglumine-under-anda219286 2026-08-14T12:31:21.723Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-fda-ap-status-for-digoxin-supplement-application 2026-08-14T12:30:58.395Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-sodium-zirconium-cyclosilicate-anda217549-receives-ap-status-from-fda 2026-08-14T12:30:45.046Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-virginia-initiates-trial-for-ischemia-detection-using-sonazoid 2026-08-14T06:35:07.717Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-tuvusertib-m1774-initiated-for-solid-tumors-by-emd-serono-and-m 2026-08-14T06:34:31.616Z weekly 0.7 https://www.humanexasignals.com/signals/psilocybin-fmri-study-initiated-for-major-depressive-disorder 2026-08-14T06:34:01.000Z weekly 0.7 https://www.humanexasignals.com/signals/hoffmann-la-roche-initiates-study-on-satralizumab-for-duchenne-muscular-dystroph 2026-08-14T06:33:34.874Z weekly 0.7 https://www.humanexasignals.com/signals/nebulised-steroids-trial-for-meconium-aspiration-syndrome-in-neonates 2026-08-14T06:33:15.949Z weekly 0.7 https://www.humanexasignals.com/signals/novo-nordisk-tests-new-oral-semaglutide-d-in-type-2-diabetes-study 2026-08-14T06:32:57.175Z weekly 0.7 https://www.humanexasignals.com/signals/dual-bronchodilator-treatment-shows-improved-ventilation-dynamics-in-copd-via-pr 2026-08-14T06:32:41.467Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-ramipril-anda-submission-receives-ap-status-from-fda 2026-08-14T06:32:26.009Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-sodium-butabarbital-anda085432-receives-ap-status-from-fda 2026-08-14T06:32:13.206Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-sodium-butabarbital-anda085418-receives-ap-status-from-fda 2026-08-14T06:31:58.469Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharmas-anda210625-for-fosaprepitant-dimeglumine-receives-ap-status 2026-08-14T06:31:45.951Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lupins-ramipril-supplement 2026-08-14T06:31:32.871Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-fosaprepitant-dimeglumine-anda209965 2026-08-14T06:31:20.112Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-receives-anda-approval-for-vancomycin-hydrochloride 2026-08-14T06:31:06.100Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-fosaprepitant-dimeglumine-anda212309 2026-08-14T06:30:51.646Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-to-repaglinide-anda207209-by-macleods-pharmaceuticals 2026-08-14T06:30:39.898Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-flurbiprofen-anda074431-by-new-heightsrx 2026-08-14T06:06:13.020Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dr-reddys-loratadine-and-pseudoephedrine-sulfate 2026-08-14T06:05:48.130Z weekly 0.7 https://www.humanexasignals.com/signals/watson-labs-receives-ap-status-for-metformin-hydrochloride-anda076818 2026-08-14T06:05:27.644Z weekly 0.7 https://www.humanexasignals.com/signals/senores-pharms-receives-ap-status-for-pravastatin-sodium-anda077491 2026-08-14T06:05:07.970Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-aurobindos-eslicarbazepine-acetate 2026-08-14T06:04:48.606Z weekly 0.7 https://www.humanexasignals.com/signals/innovent-biologics-initiates-phase-iv-trial-of-teprotumumab-for-thyroid-eye-dise 2026-08-14T06:04:30.551Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-ficerafusp-alfa-with-pembrolizumab-and-sbrt-in-hpv-negative-h 2026-08-14T06:04:06.000Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-survival-prediction-in-esophageal-squamous-cell-carcinoma-post-chemoimm 2026-08-14T06:03:43.934Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-comparing-ribociclib-with-chemotherapy-in-high-stage-breast-canc 2026-08-14T06:03:29.443Z weekly 0.7 https://www.humanexasignals.com/signals/sanofi-and-regeneron-initiate-phase-3-trial-of-itepekimab-for-chronic-rhinosinus 2026-08-14T06:03:13.223Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-firmonertinib-vs-platinum-chemotherapy-in-nsclc-with-egfr-mut 2026-08-14T06:02:57.720Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-accelerated-approval-to-iberdomide-with-daratumumab-for-multiple-myel 2026-08-14T06:02:44.090Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-invokana-canagliflozin-by-janssen 2026-08-14T00:34:26.142Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-tofacitinib-citrate-application-by-somerset-thera 2026-08-14T00:34:07.768Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-steglatro-ertugliflozin-by-merck-1 2026-08-14T00:33:45.795Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-steglujan-ertugliflozinsitagliptin-1 2026-08-14T00:33:28.271Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-anda-for-tofacitinib-citrate 2026-08-14T00:33:14.428Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-farxiga-dapagliflozin-by-astrazeneca 2026-08-14T00:33:00.855Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-tofacitinib-citrate-by-sun-pharma 2026-08-14T00:32:52.673Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-breckenridges-tofacitinib-citrate 2026-08-14T00:32:41.062Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-brenzavvy-bexagliflozin-1 2026-08-14T00:32:27.790Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-furosemide-by-epic-pharma 2026-08-14T00:32:14.709Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-evaluates-bioavailability-of-bms-986435-in-new-study 2026-08-14T00:31:58.328Z weekly 0.7 https://www.humanexasignals.com/signals/nci-initiates-trial-of-plx038-for-brain-tumors-with-mycmycn-amplifications 2026-08-14T00:31:31.981Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-oxcarbazepine-by-aucta 2026-08-13T18:35:08.541Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-nda-for-tiopronin-by-casper-pharma 2026-08-13T18:34:47.201Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-for-romidepsin-application-anda219099 2026-08-13T18:34:21.954Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplemental-approval-for-zydus-arsenic-trioxide 2026-08-13T18:34:03.390Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-ranluspec-by-lupin-limited 2026-08-13T18:33:39.646Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-original-application-for-eluxadoline-anda213511 2026-08-13T18:33:20.210Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-saxenda-liraglutide-by-novo-1 2026-08-13T18:33:02.745Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leflunomide-anda077083-by-barr 2026-08-13T18:32:42.698Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplemental-approval-for-lurasidone-hydrochloride-by-dr-reddys 2026-08-13T18:32:24.105Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-trial-for-azd5148-to-prevent-recurrent-clostridioides-diff 2026-08-13T18:32:06.403Z weekly 0.7 https://www.humanexasignals.com/signals/boston-scientifics-champion-af-trial-evaluates-watchman-flx-for-atrial-fibrillat 2026-08-13T18:31:50.688Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2b-trial-of-mizagliflozin-for-post-bariatric-hypoglycemia-initiated-by-vog 2026-08-13T18:31:36.370Z weekly 0.7 https://www.humanexasignals.com/signals/niaid-launches-phase-2-trial-for-novel-tb-treatment-regimens 2026-08-13T18:31:15.051Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-voclosporins-impact-in-lupus-nephritis-treatment-initiated 2026-08-13T18:30:58.970Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-azd9574-study-in-advanced-solid-malignancies 2026-08-13T18:30:42.884Z weekly 0.7 https://www.humanexasignals.com/signals/hanmi-initiates-phase-1-trial-of-bh3120-with-pembrolizumab-in-advanced-solid-tum 2026-08-13T12:33:51.076Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-alabama-at-birmingham-initiates-longitudinal-study-on-18fdpa-714-i 2026-08-13T12:33:17.992Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-sacral-neuromodulation-for-low-anterior-resection-syndrome-initia 2026-08-13T12:32:54.138Z weekly 0.7 https://www.humanexasignals.com/signals/liquidia-initiates-study-on-inhaled-treprostinil-for-pah-patients-switching-from 2026-08-13T12:32:32.836Z weekly 0.7 https://www.humanexasignals.com/signals/alnylam-pharmaceuticals-initiates-phase-1-trial-for-aln-6222-in-obesity 2026-08-13T12:32:09.995Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-predictors-of-response-to-ici-in-hepatocellular-carcinoma 2026-08-13T12:31:58.462Z weekly 0.7 https://www.humanexasignals.com/signals/ai-enhanced-mri-tool-for-multiple-sclerosis-treatment-monitoring-in-nhs 2026-08-13T12:31:38.738Z weekly 0.7 https://www.humanexasignals.com/signals/characterization-of-impurities-in-baloxavir-marboxil-using-2d-lc-q-tofms 2026-08-13T12:31:18.844Z weekly 0.7 https://www.humanexasignals.com/signals/xiao-chai-hu-tang-mitigates-irinotecan-induced-toxicity-in-crc-via-gut-microbiot 2026-08-13T12:31:03.657Z weekly 0.7 https://www.humanexasignals.com/signals/formulation-changes-impact-pemetrexed-infusion-stability-study-findings 2026-08-13T12:30:43.509Z weekly 0.7 https://www.humanexasignals.com/signals/medlines-convenience-kits-may-contain-non-sterile-bd-chloraprep-applicators 2026-08-13T06:33:20.794Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-on-digital-tool-for-chronic-myeloid-leukemia-patient-monitorin 2026-08-13T06:32:45.839Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-autologous-cd8-t-cells-for-leptomeningeal-melanoma 2026-08-13T06:32:17.255Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cognitive-impairment-in-bad-related-stroke-launched-by-peking-union-med 2026-08-13T06:31:58.460Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-observational-study-on-achr-antibody-positive-gmg-treatmen 2026-08-13T06:31:44.219Z weekly 0.7 https://www.humanexasignals.com/signals/chaige-qingsan-decoction-shows-dual-immunomodulatory-effects-against-influenza-a 2026-08-13T06:31:23.762Z weekly 0.7 https://www.humanexasignals.com/signals/brazils-paracelsus-project-validates-lc-msms-for-cannabinoid-analysis-in-seized- 2026-08-13T06:31:08.181Z weekly 0.7 https://www.humanexasignals.com/signals/ficus-tikoua-extract-shows-promise-in-treating-acute-lung-injury-in-mice 2026-08-13T06:30:42.448Z weekly 0.7 https://www.humanexasignals.com/signals/metabolic-profiling-of-rupestonic-acid-post-intranasal-administration-in-rats 2026-08-13T06:06:18.582Z weekly 0.7 https://www.humanexasignals.com/signals/lc-msms-assay-reveals-altered-csf-glutathione-in-cancer-patients-with-cns-metast 2026-08-13T06:05:55.793Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-iqirvo-elafibranor-by-ipsen 2026-08-13T06:05:33.597Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-saphnelo-anifrolumab-by-astrazeneca 2026-08-13T06:05:13.328Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-krystexxa-by-horizon-pharma 2026-08-13T06:04:55.963Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-argatroban-by-accord-healthcare 2026-08-13T06:04:41.576Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-psilocybin-for-alcohol-use-disorder-initiated-by-nyu-langone-he 2026-08-13T06:04:28.534Z weekly 0.7 https://www.humanexasignals.com/signals/rituximab-study-in-st-elevation-myocardial-infarction-patients-evaluates-efficac 2026-08-13T06:03:59.203Z weekly 0.7 https://www.humanexasignals.com/signals/selution-sirolimus-eluting-balloon-registry-launched-for-coronary-artery-disease 2026-08-13T06:03:41.722Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-hs-10380-safety-in-schizophrenia-patients-initiated-by-jiangsu- 2026-08-13T06:03:23.775Z weekly 0.7 https://www.humanexasignals.com/signals/genmab-initiates-phase-3-trial-of-rina-s-in-platinum-resistant-ovarian-cancer 2026-08-13T06:03:10.889Z weekly 0.7 https://www.humanexasignals.com/signals/organon-initiates-phase-3-trial-of-tapinarof-cream-for-atopic-dermatitis-in-infa 2026-08-13T06:02:56.700Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lilly-files-six-lawsuits-to-combat-retatrutide-black-market 2026-08-13T06:02:33.888Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-for-eribulin-mesylate-by-natco 2026-08-13T00:33:55.949Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-mycophenolate-mofetil-by-concord-biotech 2026-08-13T00:33:36.429Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-submits-supplemental-nda-for-afinitor-everolimus-to-fda 2026-08-13T00:33:18.744Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-ozempic-semaglutide-by-novo 2026-08-13T00:33:01.172Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-bla-for-soliris-eculizumab-by-alexion-pharmaceuticals 2026-08-13T00:32:50.782Z weekly 0.7 https://www.humanexasignals.com/signals/brave-study-investigates-adenosine-pathway-in-drug-resistant-epilepsy-and-sudep- 2026-08-13T00:32:37.062Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1b-study-of-lotilaner-shows-safety-and-mosquitocidal-activity-in-mali 2026-08-13T00:32:20.666Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-astx727-with-iadademstat-in-advanced-myeloproliferative-neopla 2026-08-13T00:32:06.095Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-dorsal-root-electrical-stimulation-for-cerebral-palsy-initiate 2026-08-13T00:31:52.999Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-phase-iib-trial-for-azd6793-in-copd-patients 2026-08-13T00:31:36.748Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-ch505-hiv-vaccine-nanoparticles-and-mrna-boosters-initiated 2026-08-13T00:31:20.415Z weekly 0.7 https://www.humanexasignals.com/signals/gsk-initiates-first-human-trial-for-4-component-strep-a-vaccine 2026-08-13T00:31:08.468Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-finotonlimab-in-rm-hnscc-treatment-in-china 2026-08-13T00:30:52.813Z weekly 0.7 https://www.humanexasignals.com/signals/keverprazan-shows-potential-over-esomeprazole-for-h-pylori-eradication-in-new-tr 2026-08-13T00:30:45.627Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-for-phytonadione-by-amneal 2026-08-12T18:33:24.057Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-ultomiris-ravulizumab-cwvz-by-alexion-p 2026-08-12T18:33:07.970Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-submits-supplemental-nda-for-afinitor-disperz-nda203985 2026-08-12T18:32:40.067Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-methylprednisolone-anda206751-1 2026-08-12T18:32:27.412Z weekly 0.7 https://www.humanexasignals.com/signals/ucla-study-on-brain-stimulation-for-pain-in-major-depressive-disorder-initiated 2026-08-12T18:32:16.002Z weekly 0.7 https://www.humanexasignals.com/signals/investigation-of-89zr-trastuzumab-petct-in-her2-positive-nsclc 2026-08-12T18:32:01.975Z weekly 0.7 https://www.humanexasignals.com/signals/agenus-initiates-phase-12-trial-of-zalifrelimab-and-balstilimab-in-advanced-soli 2026-08-12T18:31:47.271Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-for-cyclosporine-by-jiangsu-anbison 2026-08-12T12:34:29.657Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-diazepam-anda070311-receives-ap-status-from-fda 2026-08-12T12:34:12.043Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-shionogis-application-220442 2026-08-12T12:33:56.789Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-haiscos-new-drug-application-220482 2026-08-12T12:33:42.464Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-morphine-sulfate-by-fresenius-kabi-usa 2026-08-12T12:33:26.555Z weekly 0.7 https://www.humanexasignals.com/signals/bst-236-evaluated-in-adults-with-relapsed-or-refractory-aml-or-hr-mds 2026-08-12T12:33:12.036Z weekly 0.7 https://www.humanexasignals.com/signals/macutherm-study-initiated-for-intermediate-amd-using-navilas-laser-system 2026-08-12T12:33:00.618Z weekly 0.7 https://www.humanexasignals.com/signals/kazakh-academy-of-nutrition-trials-digital-dietary-intervention-with-glp-1-thera 2026-08-12T12:32:44.086Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-continuous-monitoring-post-pulmonary-endarterectomy-in-cteph 2026-08-12T12:32:32.856Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-encorafenib-and-binimetinib-in-brafv600e-mutant-nsclc-initiate 2026-08-12T12:32:19.670Z weekly 0.7 https://www.humanexasignals.com/signals/niaid-initiates-phase-1-trial-for-ebv-vaccine-in-healthy-adults 2026-08-12T12:32:07.127Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-jl19001-injection-in-advanced-solid-tumors-and-b-nhl-initiated- 2026-08-12T12:31:49.265Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-hikmas-epinephrine-application 2026-08-12T06:31:55.912Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1a1b-trial-of-sg301-for-relapsedrefractory-multiple-myeloma-initiated-by-h 2026-08-12T06:31:41.601Z weekly 0.7 https://www.humanexasignals.com/signals/grifols-initiates-study-comparing-sc-and-iv-alpha1-pi-in-alpha-1-antitrypsin-def 2026-08-12T06:31:22.515Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-sotagliflozin-by-lexicon-pharmaceuticals 2026-08-12T06:31:02.864Z weekly 0.7 https://www.humanexasignals.com/signals/medtronic-initiates-clinical-survey-for-concerto-versa-detachable-coils-to-suppo 2026-08-12T06:30:49.519Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-rosy-d-study-for-durvalumab-rollover-patients 2026-08-12T06:30:36.505Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-xolair-by-genentech 2026-08-12T06:08:02.617Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-aprocitentan-tryvio-by-idorsia 2026-08-12T06:07:42.703Z weekly 0.7 https://www.humanexasignals.com/signals/fda-snapshot-icotyde-approved-for-plaque-psoriasis 2026-08-12T06:07:21.487Z weekly 0.7 https://www.humanexasignals.com/signals/kunkui-baoshen-granule-shows-efficacy-in-diabetic-kidney-disease-via-sirt3foxo3a 2026-08-12T06:07:01.233Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-trial-for-votoplam-in-huntingtons-disease-patients 2026-08-12T06:06:36.851Z weekly 0.7 https://www.humanexasignals.com/signals/bayer-initiates-first-in-human-trial-for-bay2862789-in-advanced-solid-tumors 2026-08-12T06:06:17.590Z weekly 0.7 https://www.humanexasignals.com/signals/nuvation-bio-initiates-study-of-safusidenib-for-idh1-mutant-glioma-post-voraside 2026-08-12T06:05:58.816Z weekly 0.7 https://www.humanexasignals.com/signals/csl300-clazakizumab-phase-2b3-study-targets-cv-outcomes-in-eskd-patients-undergo 2026-08-12T06:05:44.152Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-pembrolizumab-and-sacituzumab-govitecan-hziy-in-advanced-urot 2026-08-12T06:05:25.746Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-stereotactic-radiosurgery-vs-observation-for-brain-metastases 2026-08-12T06:05:08.137Z weekly 0.7 https://www.humanexasignals.com/signals/intensity-therapeutics-initiates-int230-6-trial-for-soft-tissue-sarcomas-against 2026-08-12T06:04:44.104Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-rocbrutinib-vs-pirtobrutinib-in-rr-cllsll-initiated-by-newave-p 2026-08-12T06:04:30.122Z weekly 0.7 https://www.humanexasignals.com/signals/silkworm-pupa-powder-trial-for-alzheimers-disease-initiated 2026-08-12T00:35:20.285Z weekly 0.7 https://www.humanexasignals.com/signals/biib080-study-targets-mild-cognitive-impairment-in-alzheimers-disease 2026-08-12T00:35:01.176Z weekly 0.7 https://www.humanexasignals.com/signals/study-of-resiniferatoxin-for-severe-pain-in-advanced-cancer-patients 2026-08-12T00:34:43.621Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-jnj-88549968-in-calr-mutated-myeloproliferative-neoplasms 2026-08-12T00:34:15.431Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-isotretinoin-vs-doxycycline-for-acneiform-rash-in-cancer-patien 2026-08-12T00:34:02.330Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-zaynich-nda220787-by-wockhardt-bio-ag 2026-08-12T00:33:44.406Z weekly 0.7 https://www.humanexasignals.com/signals/fda-application-approval-for-phentermine-hydrochloride-and-topiramate-by-dr-redd 2026-08-12T00:33:28.850Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-bupropion-hydrochloride-anda211020-by-graviti-pharms 2026-08-12T00:33:13.960Z weekly 0.7 https://www.humanexasignals.com/signals/flex-pharma-receives-fda-application-approval-for-nda217379 2026-08-12T00:32:59.415Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-afrezza-by-mannkind 2026-08-12T00:32:43.700Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-oxcarbazepine-application-anda209020 2026-08-12T00:32:29.993Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-voriconazole-supplement-by-hainan-poly-pharm 2026-08-12T00:32:15.563Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-submits-supplemental-nda-for-sandimmune-cyclosporine 2026-08-12T00:32:00.779Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-widaplik-by-azurity-1 2026-08-12T00:31:49.703Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-carbidopa-and-levodopa-by-apotex 2026-08-12T00:31:35.632Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-post-treatment-lyme-disease-syndrome-and-diagnostic-criteria-developmen 2026-08-11T18:34:38.815Z weekly 0.7 https://www.humanexasignals.com/signals/study-of-inhaled-azacytidine-with-chemotherapy-and-durvalumab-in-early-stage-nsc 2026-08-11T18:34:15.067Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-trial-of-ab-3028-in-metastatic-castration-resistant-prostate-cancer-ini 2026-08-11T18:33:50.209Z weekly 0.7 https://www.humanexasignals.com/signals/buloxibutid-trial-initiated-for-idiopathic-pulmonary-fibrosis-with-efficacy-and- 2026-08-11T18:33:30.091Z weekly 0.7 https://www.humanexasignals.com/signals/click-therapeutics-initiates-ole-study-for-digital-therapeutic-in-schizophrenia 2026-08-11T18:33:07.825Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-clindamycin-phosphate-by-almaject-1 2026-08-11T18:32:51.891Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-dapagliflozin-anda211156-by-inventia 2026-08-11T18:32:37.262Z weekly 0.7 https://www.humanexasignals.com/signals/glenmark-pharmaceuticals-submits-supplemental-application-for-oxcarbazepine 2026-08-11T18:32:15.069Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-columvi-bla761309-by-genentech 2026-08-11T18:31:59.322Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-implanon-by-organon 2026-08-11T18:31:47.812Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-deflazacort-submitted-by-carnegie 2026-08-11T18:31:34.763Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-zydus-pharmaceuticals-application-220724 2026-08-11T18:31:18.250Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-darzalex-by-janssen-biotech-1 2026-08-11T18:31:07.346Z weekly 0.7 https://www.humanexasignals.com/signals/delcath-systems-hezato-nda-submission-receives-standard-review-status 2026-08-11T18:30:53.311Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-carbidopa-and-levodopa-by-rubicon-rese 2026-08-11T18:30:40.673Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-arn-509-in-advanced-castration-resistant-prostate-cancer 2026-08-11T12:34:21.227Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-cd22-car-tcell-immunotherapy-for-cd22-leukemia-and-lymphoma-ini 2026-08-11T12:34:00.368Z weekly 0.7 https://www.humanexasignals.com/signals/icosema-study-compares-weekly-insulin-icodecsemaglutide-to-daily-insulin-glargin 2026-08-11T12:33:36.852Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-divalproex-sodium-anda078790-receives-ap-status-from-fda 2026-08-11T12:33:15.473Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-oxcarbazepine-by-annora-pharma 2026-08-11T12:32:57.335Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-tremfya-guselkumab-by-janssen-biotech-1 2026-08-11T12:32:41.346Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-imfinzi-durvalumab-supplement-application-under-fda-review 2026-08-11T12:32:12.929Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-clindamycin-phosphate-by-almaject 2026-08-11T12:31:55.259Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-clindamycin-phosphate-by-almaject 2026-08-11T12:31:39.333Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplemental-approval-for-impax-labs-carbidopa-and-levodopa 2026-08-11T12:31:26.056Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-sodium-sulfate-magnesium-sulfate-and-potassium-chlo 2026-08-11T12:31:09.934Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-zydus-oxcarbazepine-supplement 2026-08-11T12:30:57.573Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda201749-by-sun-pharma-1 2026-08-11T12:30:42.184Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-of-mex-cd1-in-dialysis-for-sepsis-associated-aki 2026-08-11T06:35:20.477Z weekly 0.7 https://www.humanexasignals.com/signals/nih-study-to-evaluate-spironolactone-in-pulmonary-arterial-hypertension 2026-08-11T06:34:58.801Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-enhanced-dermatological-care-in-egfr-mutated-nsclc-with-amivantamab-and 2026-08-11T06:34:34.996Z weekly 0.7 https://www.humanexasignals.com/signals/amivantamab-and-lazertinib-study-for-egfrm-nsclc-initiated 2026-08-11T06:34:14.677Z weekly 0.7 https://www.humanexasignals.com/signals/study-to-enhance-hiv-treatment-outcomes-for-pwid-in-india 2026-08-11T06:33:55.481Z weekly 0.7 https://www.humanexasignals.com/signals/vipor-study-initiated-for-relapsedrefractory-b-cell-lymphoma 2026-08-11T06:33:40.102Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-safety-study-initiated-for-ciltacabtagene-autoleucel-cilta-cel 2026-08-11T06:33:24.493Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-jylamvo-by-shorla-1 2026-08-11T06:33:08.112Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharmas-methotrexate-sodium-anda210454-receives-ap-status-from-fda 2026-08-11T06:32:58.967Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-and-oscor-recall-catheter-introducers-due-to-leakage-risk 2026-08-11T06:32:44.210Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-levetiracetam-anda208458-by-baxter-healthcare 2026-08-11T06:32:30.348Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-tryvio-aprocitentan-by-idorsia 2026-08-11T06:32:21.002Z weekly 0.7 https://www.humanexasignals.com/signals/umedicas-anda214551-for-ranolazine-receives-approval-status-from-fda 2026-08-11T06:32:01.398Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-simvastatin-anda076685-by-watson-labs-teva 2026-08-11T06:31:48.808Z weekly 0.7 https://www.humanexasignals.com/signals/amneal-pharmaceuticals-submits-anda-for-lamotrigine 2026-08-11T06:31:35.422Z weekly 0.7 https://www.humanexasignals.com/signals/elranatamab-study-initiated-for-relapsed-multiple-myeloma-patients 2026-08-11T06:04:48.999Z weekly 0.7 https://www.humanexasignals.com/signals/amivantamab-study-in-advanced-colorectal-cancer-initiates-phase-1b-and-phase-2-t 2026-08-11T06:04:31.127Z weekly 0.7 https://www.humanexasignals.com/signals/gene-therapy-trial-for-x-linked-retinitis-pigmentosa-using-aav5-hrkprpgr-vector 2026-08-11T06:04:12.408Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-study-on-tailored-stem-cell-transplantation-for-runx1-blood-cancers 2026-08-11T06:03:55.915Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-naproxen-anda216908-by-tp-anda-holdings 2026-08-11T06:03:29.814Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-anda207944-containing-aspirin-and-dipyridamole 2026-08-11T06:03:11.313Z weekly 0.7 https://www.humanexasignals.com/signals/fresenius-kabi-usa-receives-fda-approval-for-nicardipine-hydrochloride-injection 2026-08-11T06:02:55.726Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-fenofibrate-by-bostal 2026-08-11T06:02:41.711Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-doxorubicin-hydrochloride-liposomal-by-zydus-lifescience 2026-08-11T06:02:27.454Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-doxorubicin-hydrochloride-liposomal-by-sun-pharma 2026-08-11T06:02:14.094Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-mylans-saxagliptin-and-metformin-hydrochloride 2026-08-11T06:02:05.881Z weekly 0.7 https://www.humanexasignals.com/signals/alembic-receives-ap-status-for-doxorubicin-hydrochloride-liposomal-anda219199 2026-08-11T06:01:50.752Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-doxorubicin-hydrochloride-by-qilu-pharma 2026-08-11T06:01:39.607Z weekly 0.7 https://www.humanexasignals.com/signals/insulin-icodec-study-for-type-1-diabetes-begins-enrollment 2026-08-11T00:35:07.203Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-tovorafenib-day101-for-relapsedrefractory-langerhans-cell-hist 2026-08-11T00:34:44.600Z weekly 0.7 https://www.humanexasignals.com/signals/esketamine-nasal-spray-trial-for-treatment-resistant-depression-in-korea 2026-08-11T00:34:21.565Z weekly 0.7 https://www.humanexasignals.com/signals/jnj-88545223-phase-2-study-for-active-psoriatic-arthritis-initiated 2026-08-11T00:34:08.623Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-xatmep-nda-208400-by-azurity 2026-08-11T00:33:45.742Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-linagliptin-by-teva-pharmaceuticals 2026-08-11T00:33:33.713Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-carboprost-tromethamine-application 2026-08-11T00:33:19.745Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda213343-by-accord-healthcare 2026-08-11T00:33:01.033Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda217552-by-alembic 2026-08-11T00:32:41.375Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-methotrexate-sodium-anda-approved-by-fda 2026-08-11T00:32:21.974Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-methotrexate-sodium-by-daito 2026-08-11T00:32:08.317Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplemental-approval-for-trexall-methotrexate-sodium-by-barr 2026-08-11T00:31:56.622Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-feraheme-by-azurity-1 2026-08-11T00:31:49.057Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-doxycycline-by-strides-pharma 2026-08-11T00:31:36.972Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-tdcs-efficacy-in-fibromyalgia-underway 2026-08-10T18:34:48.719Z weekly 0.7 https://www.humanexasignals.com/signals/petosemtamab-in-combination-with-pembrolizumab-for-nsclc-enters-clinical-trial 2026-08-10T18:34:09.156Z weekly 0.7 https://www.humanexasignals.com/signals/mk-1045-trial-for-rr-b-all-compares-to-blinatumomab 2026-08-10T18:33:47.951Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-cyclosporine-a-and-natamycin-for-fungal-keratitis 2026-08-10T18:33:32.051Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-cabozantinib-and-nivolumab-in-advanced-melanoma-and-head-and-n 2026-08-10T18:33:12.487Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-methotrexate-sodium-by-strides-pharma 2026-08-10T18:32:52.164Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-receives-priority-review-for-bla761460-pivekimab-sunirine-pvzy 2026-08-10T18:32:36.817Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-methotrexate-sodium-by-zydus-pharmaceuticals 2026-08-10T18:32:21.730Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-losartan-potassium-and-hydrochlorothiazide-by-hetero-lab 2026-08-10T18:32:03.930Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda216453-by-elite-labs 2026-08-10T18:31:48.213Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-submits-supplemental-nda-for-capivasertib-nda218197 2026-08-10T18:31:29.927Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda081099-by-barr-1 2026-08-10T18:31:18.984Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda210040-by-amneal-pharmaceutical 2026-08-10T18:31:06.114Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-mylans-methotrexate-sodium-supplement 2026-08-10T18:30:52.614Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-nulibry-by-sentyln-therapies 2026-08-10T18:30:41.350Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-doxorubicin-lipiodol-emulsion-in-c-tace-for-hcc 2026-08-10T12:34:06.128Z weekly 0.7 https://www.humanexasignals.com/signals/study-of-tar-200-with-cetrelimab-vs-bcg-in-high-risk-bladder-cancer 2026-08-10T12:33:29.201Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-digital-monitoring-impact-in-rcc-patients-treated-with-cabozantinib-and 2026-08-10T12:33:03.067Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-suppl-for-olanzapine-anda203708-to-fda 2026-08-10T12:32:41.364Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-koselugo-selumetinib-sulfate-by-astrazeneca 2026-08-10T12:32:22.705Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-l-glutamine-by-annora-pharma 2026-08-10T12:32:11.658Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-koselugo-selumetinib-nda219943-receives-ap-status-from-fda 2026-08-10T12:31:55.721Z weekly 0.7 https://www.humanexasignals.com/signals/nephrons-levalbuterol-hydrochloride-anda215217-receives-ap-status-from-fda 2026-08-10T12:31:38.904Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-topiramate-anda220041 2026-08-10T12:31:24.586Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-uptravi-selexipag-by-actelion 2026-08-10T12:31:11.457Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-uptravi-selexipag 2026-08-10T12:31:00.257Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-inc-submits-anda220465-for-fda-review-1 2026-08-10T12:30:42.745Z weekly 0.7 https://www.humanexasignals.com/signals/3d-mapping-shows-efficacy-in-avnrt-ablation-compared-to-conventional-methods 2026-08-10T06:33:54.294Z weekly 0.7 https://www.humanexasignals.com/signals/tar-200-and-cetrelimab-study-in-muscle-invasive-bladder-cancer-initiated 2026-08-10T06:33:34.130Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-application-for-tocilizumab-bavi-by-biogen 2026-08-10T06:32:57.873Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-imatinib-mesylate-anda-submission-by-hetero-labs 2026-08-10T06:32:42.736Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-differin-epiduo-acne-gel-nda220736-by-galderma 2026-08-10T06:32:26.803Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-daiichi-sankyos-datopotamab-deruxtecan-bla761394 2026-08-10T06:32:06.632Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-supplemental-application-for-lacosamide-1 2026-08-10T06:31:49.324Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-supplemental-application-for-lacosamide 2026-08-10T06:31:36.607Z weekly 0.7 https://www.humanexasignals.com/signals/gilead-sciences-receives-priority-review-for-bulevirtide-hepcludex-bla761468 2026-08-10T06:31:23.906Z weekly 0.7 https://www.humanexasignals.com/signals/ucbs-fintepla-nda-supplement-receives-fda-application-status 2026-08-10T06:31:11.736Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-clonazepam-application-by-rubicon-research 2026-08-10T06:30:57.239Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-dapagliflozin-and-metformin-by-sun-phar 2026-08-10T06:30:41.120Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-mcv-test-for-phlebotomy-therapy-in-hemochromatosis-patients 2026-08-10T06:08:08.189Z weekly 0.7 https://www.humanexasignals.com/signals/bhv-3000-evaluated-for-acute-migraine-treatment-in-pediatric-patients 2026-08-10T06:07:43.573Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-tyenne-by-fresenius-kabi 2026-08-10T06:07:20.035Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-original-application-for-sitagliptin-and-metformin-hydrochloride-by- 2026-08-10T06:06:56.214Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-lacosamide-by-steranco-healthcare 2026-08-10T06:06:35.976Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-cleocin-by-pfizer 2026-08-10T06:06:21.005Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-biktarvy-by-gilead-sciences 2026-08-10T06:06:05.021Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-receives-priority-review-for-linzess-supplemental-application 2026-08-10T06:05:46.796Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-original-application-for-empagliflozin-to-fda 2026-08-10T06:05:32.525Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-argatroban-by-accord-healthcare-1 2026-08-10T06:05:15.511Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-nyvepria-bla761111-by-hospira 2026-08-10T06:05:01.337Z weekly 0.7 https://www.humanexasignals.com/signals/novel-biosensor-enables-early-detection-of-cervical-cancer-using-machine-learnin 2026-08-10T06:04:39.802Z weekly 0.7 https://www.humanexasignals.com/signals/ftir-imaging-reveals-cardiorenal-crosstalk-modulated-by-sacubitrilvalsartan 2026-08-10T06:04:23.813Z weekly 0.7 https://www.humanexasignals.com/signals/ciltacabtagene-autoleucel-efficacy-study-with-alternative-lymphodepletion-regime 2026-08-10T00:32:40.617Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-xyzal-allergy-24hr 2026-08-10T00:32:29.771Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-granules-amphetamine-combination-product 2026-08-10T00:32:17.946Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-zoledronic-acid-by-eugia-pharma 2026-08-10T00:32:08.485Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-childrens-claritin-by-bayer 2026-08-10T00:31:58.172Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-brimonidine-tartrate-by-apotex 2026-08-10T00:31:48.495Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-supplemental-application-for-brimonidine-tartrate 2026-08-10T00:31:38.848Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-nebivolol-hydrochloride-supplement-by-prinston-inc 2026-08-10T00:31:31.013Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-levothyroxine-sodium-application-anda216370-by-alembic 2026-08-10T00:31:23.035Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-tyenne-bla761449-by-fresenius-kabi 2026-08-10T00:31:16.064Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-meropenem-supplement-by-acs-dobfar 2026-08-10T00:31:05.791Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-dnth103-in-generalized-myasthenia-gravis-initiated 2026-08-10T00:30:56.122Z weekly 0.7 https://www.humanexasignals.com/signals/cor-1167-shows-promise-in-worsening-heart-failure-study 2026-08-10T00:30:49.731Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-til-therapy-with-pembrolizumab-in-metastatic-melanoma-initiated 2026-08-10T00:30:43.856Z weekly 0.7 https://www.humanexasignals.com/signals/tqc3927-inhaled-powder-trial-for-copd-shows-preliminary-efficacy-and-safety 2026-08-10T00:30:37.700Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-gcar1-car-t-therapy-for-gpnmb-expressing-tumors-initiated-in-ca 2026-08-10T00:30:31.473Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-esomeprazole-magnesium-by-marksans-pharma 2026-08-09T18:33:32.173Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-venclexta-by-abbvie-1 2026-08-09T18:33:21.224Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-verapamil-hydrochloride-anda211015-1 2026-08-09T18:33:09.035Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-verapamil-hydrochloride-anda211035-1 2026-08-09T18:32:57.212Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-eplerenone-anda208283-by-breckenridge 2026-08-09T18:32:47.706Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-anda220055-by-msn-laboratories-1 2026-08-09T18:32:38.986Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lurasidone-hydrochloride-supplement-by-amneal-pharmaceut 2026-08-09T18:32:30.798Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-mirtazapine-application-anda220104-from-micro-labs 2026-08-09T18:32:23.053Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-ciprofloxacin-hydrochloride-supplement 2026-08-09T18:32:15.607Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-linaclotide-by-actavis-labs 2026-08-09T18:32:08.134Z weekly 0.7 https://www.humanexasignals.com/signals/aquamin-study-aims-to-prevent-pouchitis-in-ulcerative-colitis-patients 2026-08-09T18:32:01.523Z weekly 0.7 https://www.humanexasignals.com/signals/jnj-78934804-shows-efficacy-in-crohns-disease-compared-to-guselkumab 2026-08-09T18:31:55.443Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-automated-pulmonary-volume-assessment-in-covid-19-and-postoperative-pat 2026-08-09T18:31:49.208Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-post-exertional-symptoms-in-mecfs-and-cardiac-patients 2026-08-09T18:31:42.019Z weekly 0.7 https://www.humanexasignals.com/signals/disco-app-aims-to-mitigate-financial-toxicity-in-cancer-patients 2026-08-09T18:31:34.689Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1b-study-of-iberdomide-and-cc-99282-with-r-chop-for-lymphoma-treatment 2026-08-09T18:31:21.726Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-macitentan-by-seasons-biotech 2026-08-09T12:32:22.009Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-phesgo-bla761170-for-subcutaneous-administration 2026-08-09T12:32:13.444Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-isoproterenol-hydrochloride-application 2026-08-09T12:32:04.201Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-zynyz-bla761334-from-incyte 2026-08-09T12:31:54.642Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-herceptin-trastuzumab-by-genentech 2026-08-09T12:31:46.591Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-divalproex-sodium-by-apotex 2026-08-09T12:31:39.141Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-herceptin-hylecta 2026-08-09T12:31:32.281Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-glycopyrrolate-anda-216910 2026-08-09T12:31:26.002Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-clindamycin-phosphate-by-encube 2026-08-09T12:31:19.389Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-oxcarbazepine-by-rubicon-research 2026-08-09T12:31:12.877Z weekly 0.7 https://www.humanexasignals.com/signals/new-blinded-rct-to-assess-efficacy-of-paresthesia-free-spinal-cord-stimulation 2026-08-09T12:31:00.322Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-discarding-initial-reperfusion-blood-in-liver-transplantation-to-improv 2026-08-09T12:30:52.675Z weekly 0.7 https://www.humanexasignals.com/signals/acer-001-study-initiated-for-mcadd-in-pediatric-and-adult-patients 2026-08-09T12:30:46.191Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pet-mri-imaging-for-glioblastoma-post-surgery-safety-and-feasibility 2026-08-09T12:30:39.965Z weekly 0.7 https://www.humanexasignals.com/signals/longitudinal-study-of-hamtsp-to-assess-clinical-and-immunological-progression 2026-08-09T06:31:30.769Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-petct-vs-ultrasound-for-chronic-low-back-pain-management 2026-08-09T06:31:24.678Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-emotion-regulation-treatment-for-veterans-with-ptsd 2026-08-09T06:31:19.389Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-apomorphine-hydrochloride-nda214056-1 2026-08-09T06:07:40.510Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lurasidone-hydrochloride-supplement-by-invagen-pharmaceu 2026-08-09T06:07:28.518Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-lurasidone-hydrochloride-anda208045-receives-ap-status-1 2026-08-09T06:07:17.151Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-phytonadione-anda215820-by-dr-reddys 2026-08-09T06:07:06.670Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-palbociclib-by-dr-reddys-laboratories 2026-08-09T06:06:56.271Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tecentriq-hybreza-submission 2026-08-09T06:06:47.713Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-argatroban-by-hikma-pharma 2026-08-09T06:06:39.695Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-oxcarbazepine-supplement-by-rubicon-research 2026-08-09T06:06:32.037Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-estradiol-hrt-combined-with-herbal-supplements-for-menopausal-women 2026-08-09T06:06:22.915Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-contraception-and-menstrual-hygiene-in-patients-with-primary-immunodefi 2026-08-09T06:06:16.167Z weekly 0.7 https://www.humanexasignals.com/signals/abemaciclib-trial-initiated-for-dedifferentiated-liposarcoma 2026-08-09T06:06:08.622Z weekly 0.7 https://www.humanexasignals.com/signals/launch-of-natural-history-study-for-niemann-pick-disease-type-c-to-build-compreh 2026-08-09T06:05:56.962Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-treatment-satisfaction-for-sumavel-dosepro-in-migraine-patients 2026-08-09T06:05:49.891Z weekly 0.7 https://www.humanexasignals.com/signals/impact-of-dexamethasone-duration-on-al-amyloidosis-treatment-outcomes 2026-08-09T06:04:21.518Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-neoadjuvant-pembrolizumab-in-head-and-neck-cancer-demonstr 2026-08-09T06:04:12.889Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-clomiphene-citrate-by-ascent-pharms 2026-08-09T00:33:37.892Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-crexont-carbidopalevodopa-by-impax 2026-08-09T00:33:26.022Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-irbesartan-by-hisun-pharm 2026-08-09T00:33:15.105Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lorazepam-anda200542-by-rising-1 2026-08-09T00:33:03.804Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tecentriq-supplement-application-1 2026-08-09T00:32:53.318Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-revefenacin-by-lupin-inc 2026-08-09T00:32:44.041Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-bla761452-for-golimumab-sldi-submission 2026-08-09T00:32:35.322Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dr-reddys-venetoclax-application-anda214733 2026-08-09T00:32:25.605Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-baxfendy-baxdrostat-nda219878 2026-08-09T00:32:16.557Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tadalafil-application-anda210329-by-jubilant-generics 2026-08-09T00:32:07.618Z weekly 0.7 https://www.humanexasignals.com/signals/safety-evaluation-of-pfspz-vaccine-in-pregnant-women-in-mali-initiated 2026-08-09T00:32:01.387Z weekly 0.7 https://www.humanexasignals.com/signals/mgd019-trial-for-advanced-cervical-cancer-shows-potential-for-immunotherapy 2026-08-09T00:31:55.016Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-ondansetron-vs-lidocaine-for-pain-management-during-propofol-injection 2026-08-09T00:31:49.967Z weekly 0.7 https://www.humanexasignals.com/signals/financial-compass-trial-aims-to-alleviate-financial-hardship-in-head-and-neck-ca 2026-08-09T00:31:42.174Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-of-met-4-with-chemoradiotherapy-in-oropharyngeal-cancer 2026-08-09T00:31:37.225Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluating-an9025-for-ras-mutated-solid-tumors-initiated 2026-08-09T00:31:24.211Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-long-term-effectiveness-of-lecigon-in-advanced-parkinsons-disease 2026-08-09T00:31:17.766Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-meperidine-hydrochloride-supplement 2026-08-08T18:32:47.828Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-enhertu-supplement-application-1 2026-08-08T18:32:29.689Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplement-approval-for-levothyroxine-sodium-by-macleods 2026-08-08T18:32:16.252Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-lamotrigine-anda077420 2026-08-08T18:32:06.254Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-gabapentin-by-senores-pharms 2026-08-08T18:31:57.930Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-mavenclad-cladribine-by-emd-serono 2026-08-08T18:31:47.646Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tretinoin-anda217497-by-amneal 2026-08-08T18:31:39.060Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lurasidone-hydrochloride-by-zydus-pharms 2026-08-08T18:31:30.375Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lurasidone-hydrochloride-by-heritage-phar 2026-08-08T18:31:21.663Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-adaptive-radiotherapy-for-endometrial-and-cervical-cancer-laun 2026-08-08T18:31:13.293Z weekly 0.7 https://www.humanexasignals.com/signals/new-pet-imaging-test-for-thyroid-cancer-shows-potential-for-improved-radioactive 2026-08-08T18:31:00.776Z weekly 0.7 https://www.humanexasignals.com/signals/hyaluronic-acid-gel-enhances-periodontal-healing-in-diabetic-patients 2026-08-08T18:30:53.591Z weekly 0.7 https://www.humanexasignals.com/signals/177lulu-neob-trial-with-ribociclib-and-fulvestrant-in-er-her2-advanced-breast-ca 2026-08-08T18:30:46.833Z weekly 0.7 https://www.humanexasignals.com/signals/atv-1601-shows-promise-in-phase-2-study-for-hereditary-hemorrhagic-telangiectasi 2026-08-08T18:30:40.050Z weekly 0.7 https://www.humanexasignals.com/signals/telemedicine-nutritional-counseling-for-cancer-cachexia-in-pakistan-a-comparativ 2026-08-08T18:30:33.293Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ultramicronized-pea-for-sensory-function-in-children-with-asd 2026-08-08T18:30:27.766Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-tivozanib-by-sandoz-inc 2026-08-08T12:31:43.326Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-trimbow-by-chiesi 2026-08-08T12:31:34.947Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-finerenone-by-macleods-pharmaceuticals 2026-08-08T12:31:27.358Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-l-glutamine-application-anda219750 2026-08-08T12:31:20.308Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-gallium-ga-68-gozetotide-for-diagnostic-use-1 2026-08-08T12:31:13.812Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-ubrogepant-by-zydus-pharmaceuticals 2026-08-08T12:31:07.015Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-adx-038-targets-complement-mediated-kidney-disease 2026-08-08T12:31:00.730Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tarceva-and-radplat-in-head-and-neck-cancer-shows-promise 2026-08-08T12:30:53.889Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-digital-health-interventions-for-cardiovascular-disease-prevention-post 2026-08-08T12:30:46.889Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-metabolomics-to-predict-hfnc-failure-in-acute-hypoxemic-respiratory-fai 2026-08-08T12:30:39.683Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bci-for-upper-extremity-recovery-in-chronic-stroke-patients 2026-08-08T12:30:33.703Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ivus-vs-angiography-in-peripheral-artery-disease-revascularization 2026-08-08T06:32:11.202Z weekly 0.7 https://www.humanexasignals.com/signals/glpg5101-phase-2-study-initiated-for-non-hodgkin-lymphoma 2026-08-08T06:32:01.038Z weekly 0.7 https://www.humanexasignals.com/signals/nci-trial-evaluates-new-drug-combo-for-gvhd-prophylaxis-in-hiv-patients-undergoi 2026-08-08T06:31:50.863Z weekly 0.7 https://www.humanexasignals.com/signals/laaos-4-study-to-assess-left-atrial-appendage-occlusion-in-atrial-fibrillation-p 2026-08-08T06:31:42.535Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-recombinant-zoster-vaccine-initiated-for-adults-40 2026-08-08T06:31:28.080Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-erector-spinae-plane-block-and-trigger-point-injection-for-chroni 2026-08-08T06:31:19.841Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-eua-for-clik-extra-to-combat-new-world-screwworm-in-livestock 2026-08-08T06:31:05.074Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-takedas-orzeyful-nda-220860 2026-08-08T06:30:58.961Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-adempas-riociguat-by-bayer-healthcare-1 2026-08-08T06:30:53.104Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-umedicas-sacubitril-and-valsartan-anda219946 2026-08-08T06:30:46.740Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-neulasta-pegfilgrastim 2026-08-08T06:30:40.595Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-teriparatide-by-almaject-1 2026-08-08T06:30:35.744Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-keflex-cephalexin-by-pragma 2026-08-08T06:30:30.682Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplement-approval-for-cytarabine-by-hospira 2026-08-08T06:30:25.951Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-comparison-of-remifentanil-tci-models-eleveld-vs-minto 2026-08-08T06:03:06.107Z weekly 0.7 https://www.humanexasignals.com/signals/economic-impact-of-gbs-screening-strategies-in-france-for-neonatal-infection-pre 2026-08-08T06:02:52.214Z weekly 0.7 https://www.humanexasignals.com/signals/notch-signaling-promotes-tumor-supportive-monocyte-population-in-t-lymphoma-mode 2026-08-08T06:02:41.003Z weekly 0.7 https://www.humanexasignals.com/signals/real-world-safety-analysis-of-adcs-reveals-specific-toxicity-profiles-linked-to- 2026-08-08T06:02:29.468Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-tymlos-abaloparatide 2026-08-08T06:02:20.480Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-nintedanib-esylate-anda219926-by-macleods-pharmaceutical 2026-08-08T06:02:10.165Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-forteo-teriparatide-by-lilly-1 2026-08-08T06:02:01.332Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-bonsity-teriparatide-by-alvogen 2026-08-08T06:01:53.888Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-doxazosin-mesylate-supplement-receives-fda-ap-status 2026-08-08T06:01:46.645Z weekly 0.7 https://www.humanexasignals.com/signals/hospiras-anda072168-for-cytarabine-receives-ap-status-from-fda 2026-08-08T06:01:39.825Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-indocyanine-green-by-zydus-lifesciences 2026-08-08T06:01:33.825Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-cytarabine-anda072945-by-hospira 2026-08-08T06:01:28.207Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-yorvipath-palopegteriparatide 2026-08-08T06:01:22.862Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-sbla-for-enflonsia-to-include-high-risk-children-under-two-for-rsv-p 2026-08-08T06:01:15.749Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-cefixime-anda218691-by-fdc-ltd-1 2026-08-08T00:33:35.557Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-levocetirizine-dihydrochloride-by-macleods 2026-08-08T00:33:23.067Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-nuzyra-omadacycline-by-paratek-pharmaceuticals-1 2026-08-08T00:33:11.243Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-nuzyra-omadacycline-by-paratek-pharmaceuticals 2026-08-08T00:33:00.805Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-anda220499-by-alembic-pharmaceuticals 2026-08-08T00:32:51.134Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-amantadine-hydrochloride-supplement-by-pom-pharma 2026-08-08T00:32:42.398Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-beone-medicines-beqalzi-nda220711 2026-08-08T00:32:33.987Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-fasenra-benralizumab-by-astrazeneca-1 2026-08-08T00:32:22.206Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-yonsa-by-sun-pharma-1 2026-08-08T00:32:14.935Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-cardiogen-82-by-bracco-1 2026-08-08T00:32:08.504Z weekly 0.7 https://www.humanexasignals.com/signals/jnj-77242113-study-initiated-for-moderate-to-severe-plaque-psoriasis 2026-08-08T00:32:00.177Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-subcutaneous-amivantamab-formulation-for-egfr-mutated-nsclc 2026-08-08T00:31:54.471Z weekly 0.7 https://www.humanexasignals.com/signals/niraparib-combination-therapies-under-investigation-for-mcrpc 2026-08-08T00:31:48.565Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-reducose-shows-potential-to-improve-glycemic-control-in-obese-you 2026-08-08T00:31:41.679Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pembrolizumabquavonlimab-in-msi-hdmmr-stage-iv-colorectal-cancer 2026-08-08T00:31:34.887Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-factors-in-patients-with-low-von-willebrand-factor-levels-initi 2026-08-08T00:31:29.240Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-foscarnet-sodium-under-anda220068 2026-08-07T18:33:30.636Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-sugammadex-by-tamarang-sa 2026-08-07T18:33:14.042Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-inc-submits-anda219346-for-fda-review 2026-08-07T18:32:59.226Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-for-nicotine-polacrilex-by-dr-reddys-labs 2026-08-07T18:32:44.698Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-famotidine-anda217432-by-lupin 2026-08-07T18:32:31.642Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lamotrigine-anda078625-by-rubicon-research 2026-08-07T18:32:19.884Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-zerbaxa-supplement-nda206829 2026-08-07T18:32:07.704Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-wezlana-ustekinumab-auub-by-amgen-1 2026-08-07T18:31:48.608Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-spironolactone-anda219494-by-graviti-pharms-1 2026-08-07T18:31:38.900Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-radiotherapy-with-glofitamab-in-relapsedrefractory-dlbcl-shows-promise 2026-08-07T18:31:29.217Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tdcs-impact-on-sleep-and-mood-in-moderate-depression 2026-08-07T18:31:20.617Z weekly 0.7 https://www.humanexasignals.com/signals/ai-driven-precision-diagnosis-for-prostate-cancer-targets-psa-gray-zone 2026-08-07T18:31:12.836Z weekly 0.7 https://www.humanexasignals.com/signals/dotinurad-shows-promise-in-lowering-uric-acid-in-gout-patients-compared-to-allop 2026-08-07T18:31:05.285Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2b-trial-of-visugromab-and-nivolumab-in-metastatic-nsclc-initiated 2026-08-07T18:30:58.856Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-mirabegron-and-alpha-lipoic-acid-for-obesity-underway 2026-08-07T18:30:51.819Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vaccine-response-to-hzsu-in-sle-patients-compared-to-controls 2026-08-07T18:30:43.830Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-dichloroacetates-effect-on-brain-function-in-type-1-diabetes 2026-08-07T18:30:34.937Z weekly 0.7 https://www.humanexasignals.com/signals/cordelia-trial-evaluates-cgm-in-women-with-gestational-diabetes 2026-08-07T18:30:28.629Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-minocycline-hydrochloride-supplement-by-watson-labs 2026-08-07T12:33:34.960Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-wezlana-bla761331-by-amgen 2026-08-07T12:33:19.401Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-everolimus-by-apotex 2026-08-07T12:33:04.456Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-minocycline-hydrochloride-by-watson-labs-teva 2026-08-07T12:32:47.702Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-pyridostigmine-bromide-by-amneal-1 2026-08-07T12:32:32.224Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-opdivo-qvantig-by-bristol-myers-squibb-1 2026-08-07T12:32:21.052Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-zolpidem-tartrate-by-umedica-labs 2026-08-07T12:32:09.780Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-spironolactone-and-hydrochlorothiazide-combination 2026-08-07T12:31:59.136Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-spironolactone-anda203512-by-accord-healthcare-1 2026-08-07T12:31:49.642Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-ziextenzo-by-sandoz 2026-08-07T12:31:40.552Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-immersive-vr-for-anxiety-and-pain-management-in-evla-procedures 2026-08-07T12:31:31.828Z weekly 0.7 https://www.humanexasignals.com/signals/new-trial-evaluates-combined-biopsy-methods-for-prostate-cancer-detection 2026-08-07T12:31:23.397Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-cd19bcma-car-t-cell-therapy-in-autoimmune-diseases 2026-08-07T12:31:12.098Z weekly 0.7 https://www.humanexasignals.com/signals/mivelsiran-study-initiated-for-early-stage-down-syndrome-associated-alzheimers-d 2026-08-07T12:31:02.266Z weekly 0.7 https://www.humanexasignals.com/signals/launch-of-synovial-sarcoma-registry-to-enhance-research-and-patient-outcomes 2026-08-07T12:30:52.819Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tms-effects-in-opioid-use-disorder-decision-making-capacity 2026-08-07T12:30:44.940Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-keytruda-qlex-by-merck 2026-08-07T06:31:47.463Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-spironolactone-anda217761-by-annora-pharma-1 2026-08-07T06:31:38.687Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-oxcarbazepine-supplement-by-chartwell-rx 2026-08-07T06:31:30.275Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-keytruda-bla125514-by-merck 2026-08-07T06:31:22.484Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-opdivo-nivolumab-by-bristol-myers-squibb 2026-08-07T06:31:14.884Z weekly 0.7 https://www.humanexasignals.com/signals/intrathecal-morphine-study-aims-to-reduce-postoperative-pain-in-thoracic-surgery 2026-08-07T06:31:07.587Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-surgical-techniques-in-proximal-gastric-cancer-patients 2026-08-07T06:30:58.482Z weekly 0.7 https://www.humanexasignals.com/signals/beatrix-study-on-group-b-streptococcus-vaccine-in-pregnant-women-initiates-recru 2026-08-07T06:30:51.999Z weekly 0.7 https://www.humanexasignals.com/signals/digital-lifestyle-intervention-trial-aims-to-improve-cardiovascular-health-outco 2026-08-07T06:30:44.006Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-mr-guided-sbrt-for-oligorecurrent-prostate-cancer-initiated 2026-08-07T06:30:37.414Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-immune-metabolism-in-nsclc-patients-receiving-anti-pd-1pd-l1-therapy 2026-08-07T06:03:17.618Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-theta-burst-stimulation-in-major-depressive-disorder-using-advanced-ima 2026-08-07T06:03:06.980Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-non-invasive-bioelectronic-analytics-for-ans-function-assessment 2026-08-07T06:02:56.449Z weekly 0.7 https://www.humanexasignals.com/signals/study-aims-to-establish-new-diagnostic-threshold-for-primary-aldosteronism 2026-08-07T06:02:46.126Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-community-based-tb-preventive-therapy-delivery-initiated 2026-08-07T06:02:35.424Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-regional-radiotherapy-in-low-risk-node-positive-breast-cancer-initiated 2026-08-07T06:02:26.069Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-approves-remibrutinib-for-chronic-spontaneous-urticaria 2026-08-07T06:02:09.671Z weekly 0.7 https://www.humanexasignals.com/signals/h5n6-vaccine-shows-strong-immunogenicity-in-h5n1-primed-adults 2026-08-07T06:01:50.813Z weekly 0.7 https://www.humanexasignals.com/signals/hifu-with-pd-1-inhibitors-shows-potential-in-elderly-pancreatic-cancer-patients 2026-08-07T06:01:40.700Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-accelerated-approval-for-tudriqev-in-advanced-melanoma 2026-08-07T06:01:31.735Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-accelerated-approval-to-vusolimogene-oderparepvec-wtpg-with-nivolumab 2026-08-07T06:01:24.441Z weekly 0.7 https://www.humanexasignals.com/signals/ibi3002-safety-study-in-healthy-and-asthmatic-participants-underway 2026-08-07T00:31:48.585Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-pbm-therapy-for-chronic-pain-in-hypermobile-ehlers-danlos-syndrom 2026-08-07T00:31:41.886Z weekly 0.7 https://www.humanexasignals.com/signals/longitudinal-study-on-inflammatory-bowel-disease-to-explore-genetic-and-immune-f 2026-08-07T00:31:35.934Z weekly 0.7 https://www.humanexasignals.com/signals/ql1706-and-anlotinib-show-promise-in-advanced-lung-cancer-phase-iiiii-trial 2026-08-07T00:31:27.903Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ibii-trial-of-hai-gp-chemo-with-envafolimab-and-lenvatinib-in-unresectable 2026-08-07T00:31:21.988Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-estradiol-application-anda218214-from-encube 2026-08-06T18:33:13.197Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-carbidope-and-levodopa-supplement-application-receives-standar 2026-08-06T18:32:58.533Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-adempas-nda204819-from-bayer-healthcare 2026-08-06T18:32:45.461Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-vyvgart-supplement-application-1 2026-08-06T18:32:34.108Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-riociguat-anda211135-submission 2026-08-06T18:32:22.541Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-levetiracetam-in-sodium-chloride-by-mylan-labs 2026-08-06T18:32:11.513Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-vyvgart-hytrulo-by-argenx 2026-08-06T18:32:01.420Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-amlodipine-besylate-by-brillian-pharma-1 2026-08-06T18:31:51.433Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-bla761352-zenocutuzumab-zbco-by-merus-nv 2026-08-06T18:31:42.587Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-ocrevus-supplement-application 2026-08-06T18:31:34.135Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-transcatheter-mitral-and-tricuspid-interventions-using-cardiac-mri 2026-08-06T18:31:24.913Z weekly 0.7 https://www.humanexasignals.com/signals/vevye-ophthalmic-solution-trial-for-meibomian-gland-dysfunction-underway 2026-08-06T18:31:18.345Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-study-on-bap1-mutations-and-mesothelioma-initiated-by-nci 2026-08-06T18:31:10.962Z weekly 0.7 https://www.humanexasignals.com/signals/streams-study-to-enhance-mental-health-and-hiv-care-in-adolescents-in-uganda 2026-08-06T18:31:03.291Z weekly 0.7 https://www.humanexasignals.com/signals/abbv-706-and-atezolizumab-trial-for-small-cell-lung-cancer-initiated 2026-08-06T18:30:57.313Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sleep-impacting-mcv4-vaccine-response-in-adolescents 2026-08-06T18:30:50.647Z weekly 0.7 https://www.humanexasignals.com/signals/capra-evo-trial-evaluates-early-evolocumab-in-acute-coronary-syndrome-patients 2026-08-06T18:30:38.526Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-fluconazoles-impact-on-pf-07248144-pharmacokinetics 2026-08-06T18:30:32.387Z weekly 0.7 https://www.humanexasignals.com/signals/nci-trials-mirdametinib-and-sirolimus-in-ras-mutated-relapsed-refractory-multipl 2026-08-06T12:31:16.339Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-orzeyful-for-narcolepsy-type-1-treatment 2026-08-06T12:30:58.277Z weekly 0.7 https://www.humanexasignals.com/signals/fresenius-kabi-recalls-morphine-sulfate-injection-due-to-labeling-error 2026-08-06T12:30:51.774Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-orforglipron-calcium-by-eli-lilly 2026-08-06T12:30:43.048Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-orenitram-by-united-therapeutics 2026-08-06T12:30:34.631Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-yorvipath-palopegteriparatide 2026-08-06T12:30:28.360Z weekly 0.7 https://www.humanexasignals.com/signals/bsafe-trial-aims-to-reduce-overdose-risk-in-stimulant-users-with-fentanyl-educat 2026-08-06T06:35:13.730Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheims-bi-764532-trial-in-advanced-neuroendocrine-cancers-underwa 2026-08-06T06:34:48.466Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-oxygenated-gel-therapy-for-surgical-wound-healing-and-infection-control 2026-08-06T06:34:23.117Z weekly 0.7 https://www.humanexasignals.com/signals/ryz401-phase-2-study-initiated-for-solid-tumors-with-sstr-expression 2026-08-06T06:33:52.990Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-lyl273-in-relapsed-or-refractory-mcrc-initiated 2026-08-06T06:33:27.094Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-keflex-cephalexin 2026-08-06T06:33:06.294Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tymlos-abaloparatide 2026-08-06T06:32:47.722Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-teriparatide-by-almaject 2026-08-06T06:32:26.767Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-forteo-teriparatide-by-lilly 2026-08-06T06:32:09.014Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-carbidope-and-levodopa-by-biocon-pharma-limited 2026-08-06T06:31:52.757Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-bonsity-teriparatide 2026-08-06T06:31:36.050Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-doxycycline-hyclate-anda-submission-from-ajanta-pharma 2026-08-06T06:31:20.245Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-argatroban-in-sodium-chloride 2026-08-06T06:31:04.533Z weekly 0.7 https://www.humanexasignals.com/signals/mankind-pharmas-anda220513-for-thiamine-hydrochloride-receives-ap-status 2026-08-06T06:30:50.352Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-bla761376-application-from-dr-reddys-labs 2026-08-06T06:30:36.154Z weekly 0.7 https://www.humanexasignals.com/signals/real-world-effectiveness-and-safety-study-of-deutetrabenazine-in-huntingtons-dis 2026-08-06T06:04:58.911Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-m-tapa-vs-eoi-block-for-opioid-use-in-laparoscopic-cholecystectomy 2026-08-06T06:04:36.195Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-kios-app-for-opioid-use-disorder-effectiveness-and-implementation 2026-08-06T06:04:21.060Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-oral7-mouthwash-for-post-wisdom-tooth-surgery-healing 2026-08-06T06:03:59.038Z weekly 0.7 https://www.humanexasignals.com/signals/advancements-in-small-molecules-targeting-acidic-tumor-microenvironment-for-canc 2026-08-06T06:03:43.181Z weekly 0.7 https://www.humanexasignals.com/signals/cry2-identified-as-key-regulator-in-colorectal-cancer-immunity-and-survival-thro 2026-08-06T06:03:24.909Z weekly 0.7 https://www.humanexasignals.com/signals/cdds-shows-improved-nutritional-outcomes-in-maintenance-hemodialysis-patients 2026-08-06T06:03:09.714Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-mezofy-aripiprazole-by-cmg-pharm-co-ltd 2026-08-06T06:02:56.145Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lynozyfic-bla761400 2026-08-06T06:02:46.599Z weekly 0.7 https://www.humanexasignals.com/signals/impax-labs-anda076852-for-amphetamine-products-receives-ap-status 2026-08-06T06:02:35.882Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-keytruda-qlex-pembrolizumab 2026-08-06T06:02:16.215Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-pluvicto-by-novartis 2026-08-06T06:02:05.249Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-piroxicam-anda206152-by-micro-labs 2026-08-06T06:01:55.734Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-zongertinib-by-boehringer-ingelheim 2026-08-06T06:01:46.936Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-q2-2026-revenue-surges-48-driven-by-mounjaro-and-zepbound 2026-08-06T06:01:33.474Z weekly 0.7 https://www.humanexasignals.com/signals/merck-receives-fda-approval-for-lipfendra-first-once-daily-oral-pcsk9-inhibitor 2026-08-06T06:01:25.789Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-nurtec-odt-rimegepant-sulfate-by-pfizer 2026-08-06T00:33:35.494Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-zyprexa-relprevv-supplement-by-cheplapharm 2026-08-06T00:33:24.009Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-sitagliptin-and-metformin-hydrochloride-by-inventia-healthcar-1 2026-08-06T00:33:12.857Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-altace-ramipril-by-king-pharmaceuticals 2026-08-06T00:33:00.578Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-losartan-potassium-supplement-application-receives-standard-review-status 2026-08-06T00:32:50.996Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-paliperidone-anda205402 2026-08-06T00:32:42.373Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-hydrocortisone-sodium-succinate-by-zydus-pharmaceuticals 2026-08-06T00:32:34.323Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-siliq-brodalumab 2026-08-06T00:32:25.904Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-for-brimonidine-tartrate-by-micro-labs 2026-08-06T00:32:18.485Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-mekinist-by-novartis 2026-08-06T00:32:11.736Z weekly 0.7 https://www.humanexasignals.com/signals/novel-mri-methods-for-liver-disease-biomarkers-under-evaluation 2026-08-06T00:32:04.430Z weekly 0.7 https://www.humanexasignals.com/signals/alvelestat-mph966-trial-for-bronchiolitis-obliterans-syndrome-post-hsct-initiate 2026-08-06T00:31:53.456Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-11cztp-1-tracer-for-imaging-pde4b-in-healthy-subjects 2026-08-06T00:31:45.596Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-tslpr-cart-in-refractory-b-all-shows-promise-for-targeting-tslp 2026-08-06T00:31:37.922Z weekly 0.7 https://www.humanexasignals.com/signals/trial-to-assess-ischemic-preconditioning-for-aki-prevention-in-juxta-renal-aaa-s 2026-08-06T00:31:31.968Z weekly 0.7 https://www.humanexasignals.com/signals/neoepitope-specific-t-cell-therapy-for-blood-cancers-enters-clinical-trials 2026-08-06T00:31:26.196Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-ei-1071-shows-safety-and-tolerability-in-healthy-volunte 2026-08-05T18:30:44.119Z weekly 0.7 https://www.humanexasignals.com/signals/rimegepant-study-in-adolescents-with-frequent-migraine-begins-enrollment 2026-08-05T18:30:36.332Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-prp-vs-prf-in-tmj-surgery-outcomes 2026-08-05T12:31:46.067Z weekly 0.7 https://www.humanexasignals.com/signals/bi-764532-dose-tolerance-study-in-dll3-positive-brain-tumor-patients-initiated 2026-08-05T12:31:33.404Z weekly 0.7 https://www.humanexasignals.com/signals/cmr-enhances-surgical-decision-making-in-severe-mitral-regurgitation-patients 2026-08-05T12:31:18.788Z weekly 0.7 https://www.humanexasignals.com/signals/yh32364-trial-targets-egfr-overexpressing-solid-tumors-in-advanced-cancer-patien 2026-08-05T12:31:09.065Z weekly 0.7 https://www.humanexasignals.com/signals/bd-recalls-intraosseous-needle-sets-due-to-obturator-removal-issues 2026-08-05T12:30:52.914Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-pluvicto-lutetium-lu-177-by-novartis 2026-08-05T12:30:47.053Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-atropine-sulfate-anda219996 2026-08-05T12:30:41.136Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-docosanol-anda220017-by-klm-labs 2026-08-05T12:30:35.676Z weekly 0.7 https://www.humanexasignals.com/signals/mankind-pharmas-rosuvastatin-calcium-anda206603-receives-ap-status 2026-08-05T12:30:28.464Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-elranatamab-in-outpatients-with-relapsedrefractory-multiple-my 2026-08-05T06:33:11.066Z weekly 0.7 https://www.humanexasignals.com/signals/karxt-study-for-bipolar-i-disorder-mania-shows-potential-efficacy 2026-08-05T06:32:55.675Z weekly 0.7 https://www.humanexasignals.com/signals/vr-program-for-heart-health-education-in-breast-cancer-survivors-undergoing-trea 2026-08-05T06:32:42.131Z weekly 0.7 https://www.humanexasignals.com/signals/cbd-study-investigates-pain-relief-for-knee-osteoarthritis 2026-08-05T06:32:26.904Z weekly 0.7 https://www.humanexasignals.com/signals/innovation-passports-granted-for-liver-cancer-and-dementia-products 2026-08-05T06:32:07.542Z weekly 0.7 https://www.humanexasignals.com/signals/selinexor-shows-promise-in-high-risk-multiple-myeloma-with-xvrd-regimen 2026-08-05T06:31:56.012Z weekly 0.7 https://www.humanexasignals.com/signals/advancements-in-prostate-cancer-diagnostics-ai-and-liquid-biopsies-show-promise 2026-08-05T06:31:43.841Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheims-zongertinib-nda219042-receives-ap-status-from-fda 2026-08-05T06:31:28.768Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-rosuvastatin-calcium-supplement-application-approved-by-fda 2026-08-05T06:31:20.753Z weekly 0.7 https://www.humanexasignals.com/signals/torrents-rosuvastatin-calcium-anda-receives-approval-status 2026-08-05T06:31:13.333Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-lynozyfic-bla761400-from-regeneron 2026-08-05T06:31:06.744Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-rosuvastatin-calcium-by-alkem-labs 2026-08-05T06:30:59.610Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-ascorbic-acid-anda220172-by-stira 2026-08-05T06:30:53.371Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-fexofenadine-hydrochloride-anda220413-by-dr-reddys 2026-08-05T06:30:47.046Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-metformin-hydrochloride-by-amneal-pharmaceut 2026-08-05T06:30:39.954Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-methylprednisolone-supplement 2026-08-05T06:30:33.604Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-tamsulosin-hydrochloride-by-synthon-bv 2026-08-05T06:30:27.115Z weekly 0.7 https://www.humanexasignals.com/signals/aimcd5l-as-a-potential-immunomodulator-in-feline-injection-site-sarcoma 2026-08-05T06:03:16.107Z weekly 0.7 https://www.humanexasignals.com/signals/intranasal-rna-therapy-shows-promise-against-sars-cov-2-with-dual-targeting-appr 2026-08-05T06:03:03.888Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-carbamazepine-anda207798-by-umedica 2026-08-05T06:02:53.347Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-ruxolitinib-by-apotex 2026-08-05T06:02:43.765Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-applications-for-cellcept-mycophenolate-mofetil 2026-08-05T06:02:35.318Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tacrolimus-anda203740-by-alkem-labs 2026-08-05T06:02:27.358Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dofetilide-anda212496-by-innogenix-inc 2026-08-05T06:02:19.140Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-linezolid-anda206097 2026-08-05T06:02:11.248Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-furoscix-by-scpharmaceuticals 2026-08-05T06:02:02.207Z weekly 0.7 https://www.humanexasignals.com/signals/management-of-braf-inhibitors-in-glioma-addressing-toxicity-and-resistance 2026-08-05T06:01:48.239Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-shows-safe-co-administration-of-pcv15-and-dtap-in-infants 2026-08-05T06:01:41.059Z weekly 0.7 https://www.humanexasignals.com/signals/pfizer-raises-2026-revenue-guidance-by-500-million-amid-strong-q2-results 2026-08-05T06:01:34.534Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-anda212336-by-dr-reddys-labs 2026-08-05T00:33:30.264Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-sodium-thiosulfate-by-hope-pharms 2026-08-05T00:33:18.937Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-dolutegravir-lamivudine-and-tenofovir-disoproxil-fum 2026-08-05T00:33:07.561Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-atropine-sulfate-anda218148-by-mankind-pharma-1 2026-08-05T00:32:57.974Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-capecitabine-anda204345-by-dr-reddys 2026-08-05T00:32:47.866Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-sertraline-hydrochloride-supplement 2026-08-05T00:32:38.576Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-capecitabine-anda204741-by-amneal-pharmaceuticals 2026-08-05T00:32:31.046Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-risperidone-by-heritage-pharma 2026-08-05T00:32:24.374Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-gabapentin-anda075435-receives-ap-status-from-fda 2026-08-05T00:32:17.457Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-brilinta-ticagrelor-by-astrazeneca 2026-08-05T00:32:10.758Z weekly 0.7 https://www.humanexasignals.com/signals/hi-tacs-trial-aims-to-improve-executive-control-in-gambling-disorder-patients 2026-08-05T00:32:05.038Z weekly 0.7 https://www.humanexasignals.com/signals/new-cartilage-regeneration-platform-trial-for-knee-repair-underway 2026-08-05T00:31:58.793Z weekly 0.7 https://www.humanexasignals.com/signals/msc-exosome-therapy-shows-promise-for-frontotemporal-dementia-treatment 2026-08-05T00:31:53.587Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-screening-for-high-genetic-risk-cancer-studies 2026-08-05T00:31:45.896Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-for-simulation-free-celiac-plexus-pain-ablation-using-sbrt-shows-nov 2026-08-05T00:31:37.487Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-alendronate-sodium-by-apotex 2026-08-04T18:33:13.945Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-acetazolamide-sodium-anda200880 2026-08-04T18:32:59.171Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-bla761147-for-pegfilgrastim-pccg-by-accord-biopharma 2026-08-04T18:32:45.789Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-leuprolide-acetate-anda215336 2026-08-04T18:32:33.527Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vantas-histrelin-acetate-by-endo-operations 2026-08-04T18:32:22.212Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-eligard-kit-by-tolmar-1 2026-08-04T18:32:10.909Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-leuprolide-acetate-by-ph-health 2026-08-04T18:32:00.785Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-tecvayli-bla761291 2026-08-04T18:31:51.916Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-leuprolide-acetate-anda217957 2026-08-04T18:31:42.535Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leuprolide-acetate-anda215826-by-zydus-pharms 2026-08-04T18:31:34.880Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-ivonescimab-in-high-risk-localized-clear-cell-renal-cell-cance 2026-08-04T18:31:27.313Z weekly 0.7 https://www.humanexasignals.com/signals/iveacare-neuromodulation-system-study-for-drug-resistant-epilepsy-underway 2026-08-04T18:31:18.596Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-fecal-microbiota-transplantation-for-refractory-rheumatoid-arthritis-in 2026-08-04T18:31:09.096Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-hepatic-lipid-metabolism-in-alcohol-use-disorder-initiated 2026-08-04T18:30:54.948Z weekly 0.7 https://www.humanexasignals.com/signals/new-pneumococcal-vaccine-study-initiated-for-adults-aged-18-and-older 2026-08-04T18:30:47.692Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-biomarkers-in-aml-patients-post-stem-cell-transplantation-with-menin-in 2026-08-04T18:30:39.911Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-shock-wave-therapy-for-lateral-epicondylitis-shows-potential-benefits 2026-08-04T12:31:44.246Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-efferent-limb-stimulation-before-ileostomy-closure-to-reduce-postoperat 2026-08-04T12:31:30.655Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-syt-510-to-assess-bioavailability-and-safety-in-healthy-partici 2026-08-04T06:32:25.850Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-study-of-inavolisib-in-pik3ca-mutant-solid-tumors-and-breast-cancer 2026-08-04T06:32:18.109Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-transcranial-pulse-stimulation-for-alzheimers-disease-safety-and-effica 2026-08-04T06:32:09.644Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-fluticasone-propionatealbuterol-combination-for-asthma-exacerbation-pre 2026-08-04T06:32:02.178Z weekly 0.7 https://www.humanexasignals.com/signals/real-world-study-on-ritlecitinib-for-severe-alopecia-areata-reveals-patient-and- 2026-08-04T06:31:54.655Z weekly 0.7 https://www.humanexasignals.com/signals/mwx205-study-initiated-to-assess-safety-and-pharmacokinetics-in-dyslipidemia-pat 2026-08-04T06:31:48.431Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-palbociclib-combinations-in-hrher2-mbc-initiated-in-africa-and-middle-e 2026-08-04T06:31:41.481Z weekly 0.7 https://www.humanexasignals.com/signals/alks-2680-shows-promise-in-reducing-sleepiness-and-cataplexy-in-narcolepsy-type- 2026-08-04T06:31:34.636Z weekly 0.7 https://www.humanexasignals.com/signals/american-regent-issues-nationwide-recall-of-adequan-canine-and-im-lots 2026-08-04T06:31:23.330Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ngs-testing-to-monitor-b-all-relapse-post-cart-therapy-in-children 2026-08-04T06:04:04.031Z weekly 0.7 https://www.humanexasignals.com/signals/hrs-5041-tablets-show-promise-in-advanced-prostate-cancer-therapy 2026-08-04T06:03:44.051Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-frequent-contact-strategy-for-musculoskeletal-conditions 2026-08-04T06:03:22.460Z weekly 0.7 https://www.humanexasignals.com/signals/ro7771950-shows-promise-against-tucatinib-in-her2-positive-breast-cancer-trial 2026-08-04T06:03:08.246Z weekly 0.7 https://www.humanexasignals.com/signals/asp1570-study-in-advanced-solid-tumors-with-pembrolizumab-and-standard-therapies 2026-08-04T06:02:49.213Z weekly 0.7 https://www.humanexasignals.com/signals/semaglutide-wegovy-under-investigation-for-trichotillomania-treatment 2026-08-04T06:02:34.194Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-msept9-biomarker-for-early-detection-of-hepatocellular-carcinoma-in-cir 2026-08-04T06:02:20.953Z weekly 0.7 https://www.humanexasignals.com/signals/trial-to-assess-thromboprophylaxis-in-postpartum-women-at-intermediate-risk-for- 2026-08-04T06:02:10.916Z weekly 0.7 https://www.humanexasignals.com/signals/medline-issues-correction-for-convenience-kits-containing-recalled-lidocaine-and 2026-08-04T06:01:53.337Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-olomorasib-receives-fda-breakthrough-therapy-designation-for-advanced-pan 2026-08-04T06:01:26.890Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-eligard-kit-by-tolmar-1 2026-08-04T00:33:10.804Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leuprolide-acetate-anda212963-by-eugia-pharma 2026-08-04T00:32:55.176Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-bla-for-talvey-talquetamab-tgvs-by-janssen 2026-08-04T00:32:41.431Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-zoladex-by-tersera 2026-08-04T00:32:29.265Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-zoladex-goserelin-by-tersera 2026-08-04T00:32:16.719Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-dapagliflozin-application-from-centaur-pharmaceuticals 2026-08-04T00:32:06.001Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-lupron-by-abbvie 2026-08-04T00:31:55.795Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-sandozs-leuprolide-acetate-supplement 2026-08-04T00:31:46.574Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leuprolide-acetate-anda213829 2026-08-04T00:31:37.724Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-eligard-kit-by-tolmar 2026-08-04T00:31:29.507Z weekly 0.7 https://www.humanexasignals.com/signals/elranatamab-and-iberdomide-combination-study-in-relapsedrefractory-multiple-myel 2026-08-04T00:31:20.722Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-of-up-a-ast-for-adolescents-with-autism-and-anxietydepression 2026-08-04T00:31:12.537Z weekly 0.7 https://www.humanexasignals.com/signals/evaluating-perineural-catheter-for-postoperative-pain-in-hindfoot-surgery 2026-08-04T00:31:05.751Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-familial-platelet-disease-with-runx1-variants-launched 2026-08-04T00:30:57.605Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ctdna-and-hpv-dna-detection-in-high-risk-head-and-neck-cancer-initiated 2026-08-04T00:30:48.530Z weekly 0.7 https://www.humanexasignals.com/signals/qivigy-study-initiated-for-stiff-person-syndrome-efficacy-and-safety 2026-08-04T00:30:42.465Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-high-density-theta-burst-stimulation-hdtbs-initiated 2026-08-04T00:30:35.855Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-vasopressin-application-anda212068-by-sandoz 2026-08-03T18:33:15.915Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-vasopressin-by-sandoz 2026-08-03T18:33:04.771Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-leuprolide-acetate-by-sun-pharma 2026-08-03T18:32:53.853Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lamotrigine-supplement-application-by-taro 2026-08-03T18:32:44.795Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leuprolide-acetate-anda075471-by-meitheal 2026-08-03T18:32:35.531Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-zoladex-by-tersera-2 2026-08-03T18:32:22.981Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-eligard-kit-by-tolmar 2026-08-03T18:32:15.561Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-voriconazole-generic-by-zhejiang-novus 2026-08-03T18:32:06.338Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-wegovy-semaglutide-by-novo-1 2026-08-03T18:31:59.070Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-leucovorin-calcium-by-epic-pharma 2026-08-03T18:31:51.946Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-efficacy-of-antimicrobial-photodynamic-therapy-in-severe-periodo 2026-08-03T18:31:43.387Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-livalozet-vs-high-intensity-statins-in-elderly-cad-patients 2026-08-03T18:31:38.157Z weekly 0.7 https://www.humanexasignals.com/signals/in-vitro-study-on-pip-2-for-immune-cell-blockade-in-ards-patients 2026-08-03T18:31:27.794Z weekly 0.7 https://www.humanexasignals.com/signals/deucravacitinib-shows-promise-in-treating-psoriasis-with-eczematous-features 2026-08-03T18:31:22.329Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-wegovy-semaglutide-by-novo 2026-08-03T12:34:05.756Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-leucovorin-calcium-supplement-application-by-ingenus-pharmaceutical 2026-08-03T12:33:51.749Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-leucovorin-calcium-by-hikma-1 2026-08-03T12:33:39.231Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-leucovorin-calcium-anda072734-by-hikma-1 2026-08-03T12:33:27.873Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-leucovorin-calcium-by-hikma 2026-08-03T12:33:16.276Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-status-for-leucovorin-calcium-anda072736 2026-08-03T12:33:05.801Z weekly 0.7 https://www.humanexasignals.com/signals/ani-pharmaceuticals-receives-ap-status-for-leucovorin-calcium-supplement 2026-08-03T12:32:56.722Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-valproic-acid-supplement-by-sun-pharma 2026-08-03T12:32:48.512Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-leucovorin-calcium-supplement-application-by-barr 2026-08-03T12:32:40.362Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-leucovorin-calcium-by-barr 2026-08-03T12:32:32.472Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-co2-biomarker-for-predicting-therapy-response-in-anxiety-disorde 2026-08-03T12:32:25.598Z weekly 0.7 https://www.humanexasignals.com/signals/azd1043-study-launches-to-assess-safety-and-pharmacokinetics-in-overweight-and-o 2026-08-03T12:32:18.538Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-guselkumab-therapys-impact-on-nafld-in-psa-patients 2026-08-03T12:32:11.441Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pbmc-collection-for-t-cell-expansion-in-cancer-therapy 2026-08-03T12:31:54.751Z weekly 0.7 https://www.humanexasignals.com/signals/gene-therapy-for-sickle-cell-disease-shows-promising-safety-and-efficacy-in-36-p 2026-08-03T12:31:34.719Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-behavioral-therapy-vs-memantine-for-body-focused-repetitive-behav 2026-08-03T12:31:27.904Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-leucovorin-calcium-supplement 2026-08-03T06:32:49.835Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-calcium-gluconate-by-caplin 2026-08-03T06:32:36.923Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-bupropion-hydrochloride-by-yichang-humanwell 2026-08-03T06:32:17.370Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-levo-t-levothyroxine-sodium 2026-08-03T06:32:04.109Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gabapentin-supplement-by-zhejiang-yongtai 2026-08-03T06:31:53.151Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-ondansetron-hydrochloride-preservative-free 2026-08-03T06:31:43.185Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-perphenazine-by-zydus-pharmaceuticals 2026-08-03T06:31:33.524Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-sitagliptin-by-biocon-pharma 2026-08-03T06:31:23.307Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-anda220421-by-hetero-labs 2026-08-03T06:31:15.529Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-cladribine-and-rituximab-for-hairy-cell-leukemia 2026-08-03T06:31:07.423Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-triapine-in-uterine-cancers-shows-potential-for-enhanced-treatm 2026-08-03T06:31:00.285Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-digital-support-impact-on-multiple-myeloma-patient-quality-of-life 2026-08-03T06:30:52.904Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-echocardiographic-pap-changes-for-pulmonary-embolism-risk-stratificatio 2026-08-03T06:30:42.511Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mr-guided-adaptive-therapy-for-endometrial-cancer-initiated 2026-08-03T06:30:33.748Z weekly 0.7 https://www.humanexasignals.com/signals/exploratory-study-of-ux-da001-in-parkinsons-disease-shows-potential-for-motor-fu 2026-08-03T06:30:27.685Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-gabapentin-anda205807-receives-ap-status-from-fda 2026-08-03T06:04:02.888Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-phentermine-hydrochloride-and-topiramate 2026-08-03T06:03:52.602Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-jakafi-xr-ruxolitinib-phosphate-submission-by-incyte 2026-08-03T06:03:42.884Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-trabectedin-by-apotex-1 2026-08-03T06:03:33.359Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-propranolol-hydrochloride-application-anda203103 2026-08-03T06:03:25.026Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-dexmedetomidine-hydrochloride-nda-206628 2026-08-03T06:03:17.071Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-anda201446-for-levonorgestrel-receives-fda-ap-status 2026-08-03T06:03:09.110Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-calcium-acetate-by-chartwell-molecular 2026-08-03T06:03:02.265Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-torsemide-application-anda217239-from-micro-labs 2026-08-03T06:02:54.903Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-deutetrabenazine-by-aurobindo-pharma 2026-08-03T06:02:46.076Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-onc206-for-newly-diagnosed-and-recurrent-malignant-cns-tumors 2026-08-03T06:02:38.034Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-carboplatin-in-metastatic-prostate-cancer-with-hr-pathway-alte 2026-08-03T06:02:31.104Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-gs-4321-in-healthy-and-chronic-hepatitis-delta-participants 2026-08-03T06:02:25.064Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-environmental-effects-on-alcohol-use-disorder-behavior 2026-08-03T00:30:40.743Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-digital-health-solutions-for-type-2-diabetes-patients-initiated 2026-08-03T00:30:32.439Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-vepdegestrant-by-arvinas-operations 2026-08-02T18:33:10.428Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-childrens-advil-flavored 2026-08-02T18:32:59.329Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-mirabegron-submitted-by-deva-holding 2026-08-02T18:32:49.343Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-mycophenolate-sodium-by-yichang-humanwell 2026-08-02T18:32:40.516Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-gadobutrol-by-hengrui-pharma 2026-08-02T18:32:31.146Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplemental-approval-for-precedex-dexmedetomidine-hydrochloride 2026-08-02T18:32:24.098Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-dapagliflozin-by-sciegen-pharmaceuticals 2026-08-02T18:32:17.157Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lamotrigine-anda078982-by-granules 2026-08-02T18:32:10.141Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-fluvoxamine-maleate-by-appco 2026-08-02T18:32:03.665Z weekly 0.7 https://www.humanexasignals.com/signals/eptinezumab-shows-promise-for-migraine-prevention-in-new-study 2026-08-02T18:31:55.184Z weekly 0.7 https://www.humanexasignals.com/signals/exploratory-study-of-shr-a1811-in-her2-positive-advanced-breast-cancer 2026-08-02T18:31:47.606Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-tomivosertib-in-relapsedrefractory-aml-initiates-dose-finding 2026-08-02T18:31:39.745Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tocilizumab-and-telitacicept-for-ra-ild-treatment-initiated 2026-08-02T18:31:32.513Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-alpelisib-in-pik3ca-related-overgrowth-spectrum-initiated 2026-08-02T18:31:26.790Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-glycerol-phenylbutyrate-application-by-lupin 2026-08-02T12:32:36.798Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-lazertinib-mesylate-by-janssen-biotech 2026-08-02T12:32:25.537Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-pregabalin-application-anda219593-by-unichem 2026-08-02T12:32:14.741Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-axsomes-auvelity-nda215430 2026-08-02T12:32:04.603Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-rexulti-brexpiprazole 2026-08-02T12:31:55.619Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-sitagliptin-and-metformin-hydrochloride-combination 2026-08-02T12:31:47.412Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-perseris-kit-by-indivior-1 2026-08-02T12:31:39.736Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-methotrexate-sodium-application-anda219865 2026-08-02T12:31:32.591Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-trop2-car-nk-cells-with-belzutifan-in-pancreatic-cancer 2026-08-02T12:31:15.380Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-on-adaptive-radiation-planning-in-nsclc-to-reduce-toxicity 2026-08-02T12:31:09.292Z weekly 0.7 https://www.humanexasignals.com/signals/efgartigimod-shows-potential-as-maintenance-therapy-for-ittp-in-pilot-study 2026-08-02T12:31:03.417Z weekly 0.7 https://www.humanexasignals.com/signals/safety-and-feasibility-study-of-cd34-stem-cells-in-runx1-familial-platelet-disor 2026-08-02T12:30:54.003Z weekly 0.7 https://www.humanexasignals.com/signals/bi-3000202-tolerability-study-in-type-1-interferonopathies-initiated 2026-08-02T12:30:47.031Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-pipe-791-in-idiopathic-pulmonary-fibrosis-initiated-by-contineu 2026-08-02T12:30:38.426Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lutetium-lu-177-vipivotide-for-metastatic-prostate-cancer 2026-08-02T12:30:31.623Z weekly 0.7 https://www.humanexasignals.com/signals/study-reviews-endoscopy-reports-post-erlotinib-in-familial-adenomatous-polyposis 2026-08-02T06:31:17.162Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-olaparib-and-radium-223-in-advanced-prostate-cancer 2026-08-02T06:31:09.920Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-on-hipecs-impact-on-pd-l1-in-advanced-gastric-cancer 2026-08-02T06:31:04.401Z weekly 0.7 https://www.humanexasignals.com/signals/light-therapy-shows-promise-for-depression-in-pediatric-hsct-recipients 2026-08-02T06:30:54.932Z weekly 0.7 https://www.humanexasignals.com/signals/100-year-human-aging-study-aims-to-validate-surrogate-endpoints-in-longevity-med 2026-08-02T06:30:49.415Z weekly 0.7 https://www.humanexasignals.com/signals/resmed-issues-correction-for-astral-ventilator-due-to-electrical-component-failu 2026-08-02T06:30:39.116Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-myfortic-by-novartis 2026-08-02T06:30:33.256Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-application-for-myhibbin-by-azurity 2026-08-02T06:30:27.910Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-transcutaneous-co2-measurement-during-exercise-in-copd-and-other-condit 2026-08-02T06:03:10.505Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-lumiradx-d-dimer-assay-for-vte-diagnosis 2026-08-02T06:02:59.621Z weekly 0.7 https://www.humanexasignals.com/signals/cognitive-behavioral-intervention-study-for-type-1-diabetes-launched 2026-08-02T06:02:49.820Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictive-factors-for-thromboembolic-events-in-high-risk-polycythemia- 2026-08-02T06:02:40.528Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-goniotomy-devices-for-glaucoma-treatment-during-cataract-surgery 2026-08-02T06:02:29.631Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-veklury-remdesivir-by-gilead-sciences 2026-08-02T06:02:19.218Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-qlonilik-clonidine-hydrochloride-nda221094 2026-08-02T06:02:11.397Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-metformin-hydrochloride-anda077124 2026-08-02T06:02:05.242Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-cellcept-mycophenolate-mofetil-by-roche 2026-08-02T06:01:53.306Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-mycophenolate-mofetil-by-hikma 2026-08-02T06:01:46.731Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-mycophenolate-mofetil-anda218227-receives-ap-status 2026-08-02T06:01:40.977Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-mycophenolate-mofetil-by-hikma 2026-08-02T06:01:34.586Z weekly 0.7 https://www.humanexasignals.com/signals/budget-impact-of-dostarlimab-in-first-line-endometrial-cancer-treatment-in-saudi 2026-08-02T06:01:22.410Z weekly 0.7 https://www.humanexasignals.com/signals/chaf1a-emerges-as-biomarker-and-target-in-burkitt-lymphoma 2026-08-02T06:01:16.902Z weekly 0.7 https://www.humanexasignals.com/signals/nih-undiagnosed-diseases-network-aims-to-enhance-diagnosis-of-rare-conditions 2026-08-02T00:32:44.093Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-multivirus-ctl-for-viral-infections-post-allogeneic-sct-shows-promise 2026-08-02T00:32:32.141Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-triapine-with-radiation-for-recurrent-glioblastoma-or-astrocyto 2026-08-02T00:32:20.850Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-liver-volume-variation-impact-on-sbrt-planning-for-abdominal-malignanci 2026-08-02T00:32:09.459Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-musics-impact-on-emotion-recognition-in-depressed-elderly-population 2026-08-02T00:31:56.247Z weekly 0.7 https://www.humanexasignals.com/signals/mar002-study-initiated-for-acromegaly-treatment-evaluation 2026-08-02T00:31:47.627Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-dopamine-receptors-in-schizophrenia-using-pet-imaging 2026-08-02T00:31:40.099Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-on-neurofibromatosis-type-1-aims-to-improve-early-detection-of-maligna 2026-08-02T00:31:31.662Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-mycophenolate-sodium-by-rk-pharma 2026-08-02T00:31:24.242Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-mycophenolate-mofetil-anda217828-receives-ap-status 2026-08-02T00:31:16.534Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-mycophenolate-mofetil-anda214079-by-wuxi 2026-08-02T00:31:08.970Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-mycophenolate-sodium-anda217031-by-biocon-pharma 2026-08-02T00:31:02.144Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-lacosamide-supplement-by-msn-labs 2026-08-02T00:30:55.769Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-polyethylene-glycol-3350-anda217505 2026-08-02T00:30:49.776Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-metformin-hydrochloride-by-sun-pharma 2026-08-02T00:30:39.442Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-supplemental-application-for-mycophenolate-mofetil 2026-08-02T00:30:34.013Z weekly 0.7 https://www.humanexasignals.com/signals/fresenius-kabis-ondansetron-hydrochloride-preservative-free-receives-ap-status 2026-08-02T00:30:28.125Z weekly 0.7 https://www.humanexasignals.com/signals/asciminib-efficacy-in-real-world-cml-patients-in-second-line-treatment-assessed 2026-08-01T18:33:08.242Z weekly 0.7 https://www.humanexasignals.com/signals/real-world-study-of-aflibercept-8-mg-in-namd-to-assess-efficacy-and-safety 2026-08-01T18:32:53.791Z weekly 0.7 https://www.humanexasignals.com/signals/barinthus-biotherapeutics-initiates-first-in-human-trial-of-vtp-1000-for-celiac- 2026-08-01T18:32:41.043Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-ep102-in-advanced-solid-tumors-initiated 2026-08-01T18:32:29.107Z weekly 0.7 https://www.humanexasignals.com/signals/dexmedetomidine-administration-routes-impact-postoperative-sleep-in-thyroidectom 2026-08-01T18:32:17.910Z weekly 0.7 https://www.humanexasignals.com/signals/netarsudil-study-evaluates-trabecular-meshwork-changes-in-glaucoma-patients 2026-08-01T18:32:06.642Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-atezolizumab-with-chemo-for-relapsedrefractory-dlbcl 2026-08-01T18:31:56.289Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nivolumab-and-cabozantinib-for-mucosal-melanoma-recurrence-pre 2026-08-01T18:31:45.905Z weekly 0.7 https://www.humanexasignals.com/signals/new-clinical-study-on-advanced-desmoplastic-small-round-cell-tumor-dsrct-initiat 2026-08-01T18:31:37.197Z weekly 0.7 https://www.humanexasignals.com/signals/mylan-labs-receives-ap-status-for-mycophenolate-mofetil-hydrochloride-anda203859 2026-08-01T18:31:30.097Z weekly 0.7 https://www.humanexasignals.com/signals/fresenius-kabis-ondansetron-hydrochloride-anda076974-receives-ap-status 2026-08-01T18:31:21.819Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-mycophenolate-mofetil-by-hetero-labs 2026-08-01T18:31:14.739Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda207022-for-mycophenolate-mofetil-by-hetero-labs 2026-08-01T18:31:07.964Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-hydromorphone-hydrochloride-anda076444 2026-08-01T18:31:01.239Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-mycophenolate-mofetil-hydrochloride-supplement-application 2026-08-01T18:30:55.273Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-nda220381-from-fresenius-kabi-usa 2026-08-01T18:30:43.095Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-ruxolitinib-by-apotex-receives-standard-review-status 2026-08-01T18:30:36.751Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-of-ciclopirox-supplement-by-sun-pharma-canada 2026-08-01T18:30:30.780Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-short-course-antibiotics-for-cholangitis-aims-for-non-inferiority 2026-08-01T12:33:03.811Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-atezolizumab-and-cabozantinib-in-recurrent-glioblastoma 2026-08-01T12:32:50.704Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-iadademstat-with-atezolizumab-or-durvalumab-in-extensive-stag 2026-08-01T12:32:37.652Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-cancer-lysate-vaccine-with-n-803-for-pd-l1-negative-nsclc-post-surgery 2026-08-01T12:32:26.092Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-intermittent-fasting-with-immune-checkpoint-inhibitors-initiated 2026-08-01T12:32:14.598Z weekly 0.7 https://www.humanexasignals.com/signals/michigan-mens-diabetes-project-iii-pilot-trial-for-black-men-with-type-2-diabete 2026-08-01T12:32:05.568Z weekly 0.7 https://www.humanexasignals.com/signals/safety-and-tolerability-study-of-dapirolizumab-pegol-in-systemic-lupus-erythemat 2026-08-01T12:31:55.068Z weekly 0.7 https://www.humanexasignals.com/signals/orion-study-evaluates-mesh-position-impact-on-minimally-invasive-surgery-outcome 2026-08-01T12:31:44.531Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-mycophenolate-sodium-anda-submission-receives-ap-status 2026-08-01T12:31:36.523Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-cytarabine-by-hospira 2026-08-01T12:31:28.900Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-sugammadex-sodium-anda218727-receives-approval-status 2026-08-01T12:31:22.161Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-sugammadex-sodium-anda218728-receives-abbreviated-approval 2026-08-01T12:31:14.553Z weekly 0.7 https://www.humanexasignals.com/signals/baxter-healthcares-diazepam-anda219882-receives-approval-status 2026-08-01T12:31:08.214Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-nda219990-for-viatris-specialty 2026-08-01T12:31:01.970Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sugammadex-sodium-anda218814-by-steriscience 2026-08-01T12:30:55.469Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-sugammadex-sodium-receives-fda-approval-status 2026-08-01T12:30:42.693Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-gadavist-by-bayer-healthcare 2026-08-01T12:30:35.552Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sugammadex-sodium-anda219448-by-fresenius-kabi 2026-08-01T12:30:28.158Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-trial-for-gsk4425689a-monoclonal-antibody-initiated 2026-08-01T06:32:15.197Z weekly 0.7 https://www.humanexasignals.com/signals/merck-initiates-long-term-study-on-sotatercept-for-pulmonary-arterial-hypertensi 2026-08-01T06:32:03.871Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-st2-biomarker-for-reducing-heart-failure-readmissions 2026-08-01T06:31:52.052Z weekly 0.7 https://www.humanexasignals.com/signals/baroque-music-therapy-shows-potential-to-reduce-anxiety-in-major-depressive-diso 2026-08-01T06:31:41.973Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-atezolizumab-with-chemotherapy-for-advanced-neuroendocrine- 2026-08-01T06:31:31.307Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-sugammadex-sodium-application-from-mankind-pharma 2026-08-01T06:31:22.653Z weekly 0.7 https://www.humanexasignals.com/signals/dr-reddys-sugammadex-sodium-anda214236-receives-fda-approval 2026-08-01T06:31:14.770Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-fosaprepitant-dimeglumine-anda203939 2026-08-01T06:31:07.013Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sugammadex-sodium-anda214306-by-zenara 2026-08-01T06:30:59.508Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-fda-approval-for-sugammadex-sodium-anda214311 2026-08-01T06:30:53.456Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sugammadex-sodium-anda214319-by-sun-pharma 2026-08-01T06:30:47.903Z weekly 0.7 https://www.humanexasignals.com/signals/mylans-sugammadex-sodium-anda213915-receives-ap-status-from-fda 2026-08-01T06:30:42.739Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-sugammadex-sodium-anda214338-receives-approval-status 2026-08-01T06:30:37.428Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-glycerol-phenylbutyrate-by-esjay-pharma 2026-08-01T06:30:32.284Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-sugammadex-sodium-for-gland-pharma 2026-08-01T06:30:26.554Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-cabazitaxel-carboplatin-and-cetrelimab-for-aggressive-variant- 2026-08-01T06:04:09.118Z weekly 0.7 https://www.humanexasignals.com/signals/rct-to-evaluate-outpatient-treatment-for-adolescents-with-substance-use-and-inte 2026-08-01T06:03:54.226Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-l-citrulline-and-tadalafil-for-erectile-dysfunction-shows-potential-com 2026-08-01T06:03:38.496Z weekly 0.7 https://www.humanexasignals.com/signals/selinexor-and-radiation-therapy-trial-for-dipg-and-hgg-shows-promise 2026-08-01T06:03:20.126Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-prone-position-techniques-to-reduce-pressure-sores-in-ards-patien 2026-08-01T06:03:06.241Z weekly 0.7 https://www.humanexasignals.com/signals/mosunetuzumab-shows-promise-in-b-cell-nhl-beyond-follicular-lymphoma 2026-08-01T06:02:54.984Z weekly 0.7 https://www.humanexasignals.com/signals/impact-of-neutrophil-to-lymphocyte-ratio-on-ivf-outcomes-in-pcos-women 2026-08-01T06:02:44.059Z weekly 0.7 https://www.humanexasignals.com/signals/novel-dpp-lip-sa-composite-shows-promise-in-treating-uvb-induced-skin-photoaging 2026-08-01T06:02:35.390Z weekly 0.7 https://www.humanexasignals.com/signals/cafs-enhance-adenosine-production-in-nsclc-impeding-t-cell-response 2026-08-01T06:02:23.347Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sugammadex-sodium-under-anda214368 2026-08-01T06:02:14.594Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-prucalopride-succinate-anda219234-by-alembic 2026-08-01T06:02:06.442Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-hetlioz-tasimelteon-by-vanda-pharmaceuticals 2026-08-01T06:01:59.182Z weekly 0.7 https://www.humanexasignals.com/signals/impax-labs-receives-fda-approval-for-metformin-hydrochloride-supplement 2026-08-01T06:01:52.974Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-anda213087-for-fluticasone-propionate-and-salmeterol-xinafoate-receives-a 2026-08-01T06:01:47.045Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda209313-by-granules 2026-08-01T06:01:40.927Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-methylphenidate-by-mylan-tech-viatris 2026-08-01T06:01:34.949Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda076249 2026-08-01T06:01:30.146Z weekly 0.7 https://www.humanexasignals.com/signals/recombinant-zoster-vaccine-shows-feasibility-and-safety-in-cancer-patients-on-sy 2026-08-01T06:01:23.285Z weekly 0.7 https://www.humanexasignals.com/signals/datroway-approved-in-eu-for-metastatic-tnbc-as-first-trop2-directed-therapy 2026-08-01T06:01:17.046Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-fosaprepitant-dimeglumine-supplement-receives-fda-ap-status 2026-08-01T00:33:13.152Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-finasteride-by-sun-pharma 2026-08-01T00:32:57.364Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-nizoral-anti-dandruff-application 2026-08-01T00:32:45.065Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-fluorescein-sodium-application-anda220046 2026-08-01T00:32:32.383Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-ngenla-bla761184-from-pfizer 2026-08-01T00:32:21.216Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-vanflyta-by-daiichi-sankyo 2026-08-01T00:32:10.558Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-oxcarbazepine-by-umedica-labs 2026-08-01T00:32:00.093Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-methylphenidate-hydrochloride-by-rising 2026-08-01T00:31:49.453Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-omeprazole-by-dr-reddys 2026-08-01T00:31:41.307Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-langlara-insulin-glargine-aldy-by-sunshine-lake-phar 2026-08-01T00:31:33.097Z weekly 0.7 https://www.humanexasignals.com/signals/promising-study-on-serial-casting-for-hypertrophic-scars-in-burn-survivors 2026-08-01T00:31:19.585Z weekly 0.7 https://www.humanexasignals.com/signals/aavrh10-pcca-gene-therapy-trial-for-propionic-acidemia-initiated 2026-08-01T00:31:11.658Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bariatric-embolization-before-sleeve-gastrectomy-in-super-obese-patient 2026-08-01T00:31:02.131Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bone-loss-in-anorexia-nervosa-patients-to-assess-bone-density-and-hormo 2026-08-01T00:30:55.465Z weekly 0.7 https://www.humanexasignals.com/signals/new-study-proposes-personalized-cardiac-surveillance-for-her2-positive-breast-ca 2026-08-01T00:30:46.589Z weekly 0.7 https://www.humanexasignals.com/signals/novel-microrna-biomarker-approach-for-renal-osteodystrophy-treatment 2026-08-01T00:30:38.439Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-egfril13r2-car-t-cells-for-recurrent-high-grade-gliomas 2026-08-01T00:30:31.678Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-hadlima-by-samsung-bioepis 2026-07-31T18:32:41.944Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ta-status-for-anda213093-from-qilu-pharm-co-ltd 2026-07-31T18:32:29.047Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-carbamazepine-anda205571-by-zydus-pharmaceuticals 2026-07-31T18:32:16.569Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ta-status-for-cyclophosphamide-anda219271-by-hetero-labs 2026-07-31T18:32:04.787Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-cetrorelix-acetate-application-anda218740 2026-07-31T18:31:54.261Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-nda-for-crestor-by-astrazeneca 2026-07-31T18:31:45.135Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-original-application-for-cenobamate 2026-07-31T18:31:35.955Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ta-for-viloxazine-hydrochloride-application-anda220326 2026-07-31T18:31:27.708Z weekly 0.7 https://www.humanexasignals.com/signals/amgens-bla761298-for-pavblu-receives-ap-status-from-fda 2026-07-31T18:31:20.410Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-gabapentin-anda214957 2026-07-31T18:31:13.607Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ivig-for-neurological-symptoms-in-long-covid-patients 2026-07-31T18:31:04.109Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rifapentine-and-isoniazid-for-tb-prevention-in-children-under-13 2026-07-31T18:30:57.109Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-anterior-carpal-ligament-biopsy-for-early-detection-of-attr 2026-07-31T18:30:50.637Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-compares-proton-vs-imrt-for-endometrial-and-cervical-cancer 2026-07-31T18:30:41.081Z weekly 0.7 https://www.humanexasignals.com/signals/natural-history-study-of-squamous-cell-carcinoma-in-fanconi-anemia-initiated 2026-07-31T18:30:35.575Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-the-0504-in-solid-tumors-initiated 2026-07-31T18:30:28.856Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-dextroamphetamine-combination-products 2026-07-31T12:33:49.384Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-eltrombopag-olamine-application-by-biocon-pharma 2026-07-31T12:33:32.105Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharmas-tranexamic-acid-supplement-receives-fda-ap-status 2026-07-31T12:33:20.270Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-atorvastatin-calcium-by-sciegen-pharmaceuticals 2026-07-31T12:33:09.427Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-doxepin-hydrochloride-application-by-sun-pharma 2026-07-31T12:32:59.808Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-breztri-aerosphere-by-astrazeneca 2026-07-31T12:32:50.537Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-application-for-thalidomide-by-bristol-myers 2026-07-31T12:32:41.737Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-lenalidomide-anda210435-receives-abbreviated-approval-from-fda-1 2026-07-31T12:32:33.478Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-symbicort-aerosphere-supplement-by-astrazeneca 2026-07-31T12:32:22.311Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-blinatumomab-with-nivolumab-in-relapsed-b-all-patients 2026-07-31T12:32:12.333Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-intrauterine-stent-placement-to-prevent-adhesions-post-surgery 2026-07-31T12:32:00.597Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-tms-for-early-alzheimers-disease-shows-potential-efficacy 2026-07-31T12:31:53.090Z weekly 0.7 https://www.humanexasignals.com/signals/combination-of-rituximab-and-cyclosporine-in-membranous-nephropathy-trial-initia 2026-07-31T12:31:47.194Z weekly 0.7 https://www.humanexasignals.com/signals/mammoverse-study-to-enhance-emotional-support-for-breast-cancer-patients 2026-07-31T12:31:28.875Z weekly 0.7 https://www.humanexasignals.com/signals/study-of-pembrolizumab-plus-mk-1084-in-nsclc-with-kras-g12c-mutations 2026-07-31T12:31:20.569Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-pomalidomide-supplement-by-breckenridge 2026-07-31T06:32:44.275Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-nuplazid-supplement-nda210793 2026-07-31T06:32:32.123Z weekly 0.7 https://www.humanexasignals.com/signals/granite-study-evaluates-airsupra-vs-albuterol-for-asthma-exacerbation-risk 2026-07-31T06:32:20.924Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-investigational-agents-with-pembrolizumab-in-advanced-esophage 2026-07-31T06:32:10.278Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-long-term-effects-of-pediatric-car-t-cell-therapy-initiated 2026-07-31T06:31:59.888Z weekly 0.7 https://www.humanexasignals.com/signals/single-arm-study-of-zeprumetostat-with-glofitamab-in-relapsedrefractory-dlbcl 2026-07-31T06:31:50.439Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-uwl-detection-with-grail-galleri-for-early-cancer-diagnosis 2026-07-31T06:31:41.074Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cervical-conization-impact-on-pregnancy-outcomes 2026-07-31T06:31:32.752Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nivolumab-and-ipilimumab-in-kidney-transplant-recipients-with- 2026-07-31T06:31:25.383Z weekly 0.7 https://www.humanexasignals.com/signals/hpv-vaccine-hesitancy-among-female-students-in-china-increases-despite-improved- 2026-07-31T06:31:14.594Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-neoadjuvant-immunochemotherapys-impact-on-opioid-use-in-esophageal-canc 2026-07-31T06:31:05.464Z weekly 0.7 https://www.humanexasignals.com/signals/robotic-assisted-surgery-reduces-complications-in-bladder-cancer-patients 2026-07-31T06:30:59.103Z weekly 0.7 https://www.humanexasignals.com/signals/platelet-based-delivery-of-fluorescein-enhances-sonodynamic-therapy-in-glioblast 2026-07-31T06:30:52.811Z weekly 0.7 https://www.humanexasignals.com/signals/mobile-app-delivered-act-shows-efficacy-in-ptsd-treatment-in-china 2026-07-31T06:30:44.192Z weekly 0.7 https://www.humanexasignals.com/signals/ppmt-shows-feasibility-and-acceptability-in-ptsd-treatment-insights-for-protocol 2026-07-31T06:30:37.748Z weekly 0.7 https://www.humanexasignals.com/signals/advances-in-monoclonal-antibody-therapeutics-targeting-insulin-resistance-in-can 2026-07-31T06:30:31.006Z weekly 0.7 https://www.humanexasignals.com/signals/aficamten-approved-by-mhra-and-recommended-by-nice-for-heart-condition 2026-07-31T06:03:57.326Z weekly 0.7 https://www.humanexasignals.com/signals/dna-polymerase-theta-emerges-as-a-promising-target-for-cancer-therapy 2026-07-31T06:03:44.570Z weekly 0.7 https://www.humanexasignals.com/signals/hpv-vaccination-challenges-and-strategies-in-who-south-east-asia-region-identifi 2026-07-31T06:03:34.270Z weekly 0.7 https://www.humanexasignals.com/signals/ai-transforming-immune-checkpoint-inhibitor-research-key-trends-identified 2026-07-31T06:03:25.369Z weekly 0.7 https://www.humanexasignals.com/signals/novel-ultrasound-technique-for-managing-cystic-fibroids-during-pregnancy-shows-p 2026-07-31T06:03:17.237Z weekly 0.7 https://www.humanexasignals.com/signals/novel-rh-catalysed-method-yields-potent-antitumor-phenanthridinone-derivatives 2026-07-31T06:03:08.882Z weekly 0.7 https://www.humanexasignals.com/signals/ccr7low-treg-subset-linked-to-poor-prognosis-in-b-all 2026-07-31T06:03:01.493Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-afamitresgene-autoleucel-for-synovial-sarcoma-highlighting-tcr-ther 2026-07-31T06:02:54.028Z weekly 0.7 https://www.humanexasignals.com/signals/fusobacterium-nucleatum-adhesins-linked-to-colorectal-cancer-progression 2026-07-31T06:02:45.732Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-tumor-treating-fields-in-advanced-pancreatic-cancer-evalua 2026-07-31T06:02:37.616Z weekly 0.7 https://www.humanexasignals.com/signals/european-commission-approves-pfizer-biontech-xfg-adapted-covid-19-vaccine-for-20 2026-07-31T06:02:28.505Z weekly 0.7 https://www.humanexasignals.com/signals/pfizer-reports-positive-phase-3-results-for-litfulo-in-nonsegmental-vitiligo 2026-07-31T06:02:20.254Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lenalidomide-by-biocon-pharma 2026-07-31T00:32:39.419Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lenalidomide-anda210480-by-alvogen 2026-07-31T00:32:28.014Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lenalidomide-supplement-by-zydus-pharmaceuticals 2026-07-31T00:32:12.177Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-lenalidomide-supplement-application-from-amneal 2026-07-31T00:32:01.593Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lenalidomide-supplement-application-by-sun-pharma 2026-07-31T00:31:51.799Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-supplemental-application-for-pomalidomide-anda-210164 2026-07-31T00:31:43.132Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-prednisolone-anda219509 2026-07-31T00:31:34.331Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lenalidomide-anda217554-submission-by-deva-holding-as 2026-07-31T00:31:26.333Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-nuplazid-supplemental-application 2026-07-31T00:31:19.353Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-erythropoietins-impact-on-hepcidin-levels-in-healthy-volunteers 2026-07-31T00:31:10.543Z weekly 0.7 https://www.humanexasignals.com/signals/virtual-reality-for-cognitive-remediation-in-elderly-patients-with-depression 2026-07-31T00:31:04.121Z weekly 0.7 https://www.humanexasignals.com/signals/mezagitamab-study-initiated-for-chronic-primary-immune-thrombocytopenia 2026-07-31T00:30:56.893Z weekly 0.7 https://www.humanexasignals.com/signals/efficacy-study-of-olutasidenib-and-temozolomide-in-idh1-mutant-high-grade-glioma 2026-07-31T00:30:48.180Z weekly 0.7 https://www.humanexasignals.com/signals/azd0516-study-for-metastatic-prostate-cancer-initiated 2026-07-31T00:30:39.559Z weekly 0.7 https://www.humanexasignals.com/signals/ulixertinib-trial-aims-to-assess-blood-brain-barrier-penetration-in-gliomas 2026-07-31T00:30:33.350Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-gluten-free-vs-mediterranean-diets-in-rheumatoid-arthritis-launched 2026-07-30T18:30:40.287Z weekly 0.7 https://www.humanexasignals.com/signals/emavusertib-zanubrutinib-study-targets-cll-anticancer-activity 2026-07-30T18:30:33.922Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-revlimid-by-bristol-myers-squibb-1 2026-07-30T12:33:26.812Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-lenalidomide-anda-submission-from-torrent 2026-07-30T12:33:11.635Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-lenalidomide-anda214618-receives-fda-ap-status 2026-07-30T12:32:56.447Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-pomalidomide-by-hetero-labs 2026-07-30T12:32:41.520Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharma-submits-supplemental-application-for-pomalidomide-anda210249 2026-07-30T12:32:27.530Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-ticagrelor-application-anda208539-by-micro-labs 2026-07-30T12:32:15.660Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lenalidomide-by-arrow-international 2026-07-30T12:32:04.115Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-pomalidomide-by-teva-pharmaceuticals 2026-07-30T12:31:53.738Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-pomalidomide-supplement-by-mylan 2026-07-30T12:31:44.867Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lenalidomide-anda217265-by-qilu 2026-07-30T12:31:34.868Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-poziotinib-in-nsclc-with-egfrher2-mutations-underway 2026-07-30T12:31:26.440Z weekly 0.7 https://www.humanexasignals.com/signals/memoptic-trial-aims-to-preserve-vision-in-open-angle-glaucoma-patients 2026-07-30T12:31:17.570Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-iv-vs-oral-aspirin-in-healthy-adults 2026-07-30T12:31:10.062Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-multimorbidity-and-polypharmacy-in-hiv-patients-in-basque-country 2026-07-30T12:31:03.567Z weekly 0.7 https://www.humanexasignals.com/signals/expanded-access-study-for-bulevirtide-in-chronic-hepatitis-delta-virus-infection 2026-07-30T12:30:53.035Z weekly 0.7 https://www.humanexasignals.com/signals/remibrutinib-shows-promise-in-peanut-allergy-trial 2026-07-30T12:30:42.331Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tavi-without-balloon-predilatation-shows-potential-for-improved-outcome 2026-07-30T12:30:35.836Z weekly 0.7 https://www.humanexasignals.com/signals/ibrutinib-and-rituximab-show-promise-in-relapsedrefractory-mantle-cell-lymphoma 2026-07-30T12:30:28.355Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-anesthetic-effects-on-brain-connectivity-and-consciousness-monitoring 2026-07-30T06:32:24.128Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ntm-treatment-toxicity-in-cancer-patients-highlights-treatment-gaps 2026-07-30T06:32:11.931Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-psychotherapy-for-ptsd-in-hiv-patients 2026-07-30T06:32:01.289Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-focused-ultrasound-for-recovery-after-severe-brain-injury-initiated 2026-07-30T06:31:50.836Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-chronic-pain-patient-preferences-for-medication-side-effects 2026-07-30T06:31:41.052Z weekly 0.7 https://www.humanexasignals.com/signals/nhlbi-launches-map-heart-study-to-analyze-heart-failure-phenotypes 2026-07-30T06:31:31.958Z weekly 0.7 https://www.humanexasignals.com/signals/fda-licenses-first-ever-freeze-dried-plasma-product-in-the-us 2026-07-30T06:31:22.800Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-metformin-hydrochloride-anda207427 2026-07-30T06:31:13.237Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lamotrigine-anda206382-submission-by-sciegen-pharmaceuticals 2026-07-30T06:31:05.953Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-diazepam-anda220365-receives-approval-status-from-fda 2026-07-30T06:30:58.300Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda202306 2026-07-30T06:30:51.582Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-dyna-hex-2-by-xttrium 2026-07-30T06:30:45.401Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-nda-for-ziac-by-teva 2026-07-30T06:30:38.848Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lytenava-bla761320-from-outlook-therapeutics 2026-07-30T06:30:33.502Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-dyna-hex-4-by-xttrium 2026-07-30T06:30:26.836Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-insulin-infusion-methods-for-glycemic-variability-in-icu-patient 2026-07-30T06:04:50.309Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-neoadjuvant-vs-adjuvant-stereotactic-radiotherapy-for-brain-metastases 2026-07-30T06:04:36.480Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rtms-for-ptsd-in-veterans-aims-to-understand-mechanisms-of-action 2026-07-30T06:04:23.986Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ibii-trial-of-olaparib-with-azd2014-or-azd5363-in-recurrent-endometrial-an 2026-07-30T06:04:11.572Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-lai-mmv055-and-mmv371-in-healthy-participants-initiated 2026-07-30T06:03:59.673Z weekly 0.7 https://www.humanexasignals.com/signals/duke-university-trials-lattice-radiation-therapy-for-large-tumors 2026-07-30T06:03:47.391Z weekly 0.7 https://www.humanexasignals.com/signals/regeneron-initiates-study-on-linvoseltamab-for-high-risk-monoclonal-gammopathy 2026-07-30T06:03:30.336Z weekly 0.7 https://www.humanexasignals.com/signals/comparative-study-of-water-vapor-therapy-vs-bipolar-enucleation-for-bph 2026-07-30T06:03:20.427Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-otsukas-simtriyo-centanafadine-1 2026-07-30T06:03:11.728Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-rezdiffra-resmetirom-by-madrigal-1 2026-07-30T06:03:03.332Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-avapro-by-sanofi 2026-07-30T06:02:55.790Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-bla-for-garzulys-insulin-aspart-fsan-by-emerge-bioscience 2026-07-30T06:02:47.982Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-meridian-biosciences-nda021314-1 2026-07-30T06:02:40.647Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-brexafemme-ibrexafungerp-by-glaxosmith 2026-07-30T06:02:34.379Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-xtandi-enzalutamide-1 2026-07-30T06:02:28.337Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-metformin-hydrochloride-anda077064-by-zydus-pharms-usa 2026-07-30T06:02:22.346Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-biocons-topiramate-anda220943 2026-07-30T06:02:15.832Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharmas-lenalidomide-anda213885-receives-ap-status-from-fda 2026-07-30T00:32:51.969Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-lenalidomide-supplement-application-from-novugen 2026-07-30T00:32:38.634Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-lenalidomide-supplement-application-from-apotex 2026-07-30T00:32:27.412Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lenalidomide-anda213912-by-mylan 2026-07-30T00:32:16.561Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-lenalidomide-supplement-application-by-hetero-labs 2026-07-30T00:32:05.774Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lenalidomide-by-dr-reddys-1 2026-07-30T00:31:56.511Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-lenalidomide-anda213165-receives-ap-status-from-fda-1 2026-07-30T00:31:46.887Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-pomalyst-by-bristol 2026-07-30T00:31:38.454Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-lenalidomide-anda214398-receives-fda-approval-status 2026-07-30T00:31:29.257Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-fingolimod-hydrochloride-application-by-alembic 2026-07-30T00:31:20.279Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-nirs-for-early-diagnosis-of-nec-in-neonates 2026-07-30T00:31:10.482Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predicting-sudden-cardiac-death-risk-in-patients-with-moderate-lvef 2026-07-30T00:31:01.687Z weekly 0.7 https://www.humanexasignals.com/signals/liposomal-bupivacaine-may-enhance-analgesia-in-hip-fracture-surgery 2026-07-30T00:30:54.632Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-endografts-for-aortic-aneurysms-by-baptist-health-and-collaborators 2026-07-30T00:30:47.804Z weekly 0.7 https://www.humanexasignals.com/signals/novo-nordisk-initiates-post-marketing-surveillance-for-alhemo-in-haemophilia-pat 2026-07-30T00:30:40.687Z weekly 0.7 https://www.humanexasignals.com/signals/personalized-treatment-approach-for-malignant-peritoneal-mesothelioma-under-inve 2026-07-30T00:30:34.088Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-haloperidol-and-lorazepam-for-agitated-delirium-in-advanced 2026-07-30T00:30:27.350Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-thalidomide-application-anda213267 2026-07-29T18:33:10.054Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gabapentin-anda214956-by-ascent-pharm-inc 2026-07-29T18:32:56.362Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-caplyta-lumateperone-tosylate 2026-07-29T18:32:42.881Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-ziprasidone-hydrochloride 2026-07-29T18:32:28.566Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-saphnelo-anifrolimab-fnia-by-astrazeneca 2026-07-29T18:32:16.232Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-topiramate-anda079162-by-invagen-pharmaceuticals 2026-07-29T18:32:05.277Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-anda217477-by-hainan-poly-pharm 2026-07-29T18:31:54.480Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-electronic-symptom-monitoring-for-palliative-care-in-thoracic-cancer-pa 2026-07-29T18:31:44.377Z weekly 0.7 https://www.humanexasignals.com/signals/lumiradx-uk-limited-evaluates-poc-test-for-covid-19-symptoms 2026-07-29T18:31:35.832Z weekly 0.7 https://www.humanexasignals.com/signals/genrix-initiates-phase-ibii-trial-for-gr2301-in-vitiligo-patients 2026-07-29T18:31:27.786Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-resistance-mechanisms-in-metastatic-castration-resistant-prostate-cance 2026-07-29T18:31:18.963Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-gr2301-injection-by-genrix-initiated-in-healthy-adults 2026-07-29T18:31:11.571Z weekly 0.7 https://www.humanexasignals.com/signals/ai-vs-radiologist-in-prostate-cancer-detection-the-primer-trial 2026-07-29T18:31:03.754Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-icu-acquired-weakness-and-cardiovascular-impairment-in-sepsis-patients 2026-07-29T18:30:53.006Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-systemic-lidocaine-to-adductor-canal-block-in-knee-surgery 2026-07-29T18:30:47.041Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ib-trial-of-m3814-with-lutetium-lu-177-dotatate-for-pancreatic-neuroendocr 2026-07-29T18:30:41.206Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-durvalumab-and-olaparib-with-radiation-for-unresectable-pancrea 2026-07-29T18:30:35.650Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-dyna-hex-2-by-xttrium 2026-07-29T18:30:27.997Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bdnf-levels-and-atrial-cardiomyopathy-in-af-ablation-patients 2026-07-29T12:35:05.899Z weekly 0.7 https://www.humanexasignals.com/signals/adhera-healths-acdp-o-study-targets-obesity-in-youth-with-chronic-conditions 2026-07-29T12:34:46.895Z weekly 0.7 https://www.humanexasignals.com/signals/nci-initiates-trial-for-preoperative-radiation-therapy-in-recurrent-abdominal-ad 2026-07-29T12:34:30.758Z weekly 0.7 https://www.humanexasignals.com/signals/web-based-cbt-for-insomnia-in-dementia-caregivers-a-new-study-launch 2026-07-29T12:34:15.239Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-oxygenation-strategies-for-obese-patients-during-intubation 2026-07-29T12:34:01.177Z weekly 0.7 https://www.humanexasignals.com/signals/sodium-bicarbonate-shows-promise-in-severe-metabolic-acidosis-with-acute-kidney- 2026-07-29T12:33:48.990Z weekly 0.7 https://www.humanexasignals.com/signals/myelomatch-trial-compares-venetoclax-combinations-in-intermediate-risk-aml 2026-07-29T12:33:27.229Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-otsukas-simtriyo-centanafadine 2026-07-29T12:33:09.542Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-rezdiffra-resmetirom-by-madrigal 2026-07-29T12:32:58.953Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-avapro-by-sanofi 2026-07-29T12:32:49.456Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-meridian-biosciences-nda021314 2026-07-29T12:32:40.699Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-brexafemme-ibrexafungerp-by-glaxosmithkline 2026-07-29T12:32:21.990Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-xtandi-enzalutamide 2026-07-29T12:32:13.177Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-ziac-by-teva 2026-07-29T12:31:53.323Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lytenava-bla761320-for-use 2026-07-29T12:31:42.413Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-macrilen-by-aeterna-zentaris 2026-07-29T12:31:34.860Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-bl-b01d1-with-osimertinib-in-egfr-mutant-nsclc-initiated 2026-07-29T06:33:36.970Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-study-on-azd6234-and-azd9550-impact-on-oral-contraceptive-pharmacok 2026-07-29T06:33:24.677Z weekly 0.7 https://www.humanexasignals.com/signals/trial-initiated-for-cbd-effects-on-alzheimers-disease-biomarkers 2026-07-29T06:32:57.077Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-outcomes-of-transplantation-vs-standard-care-in-sickle-cell-anemia-ass 2026-07-29T06:32:47.619Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-liver-transplantation-in-hcv-hiv-coinfected-patients-launched 2026-07-29T06:32:38.417Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-kaletra-by-abbvie 2026-07-29T06:32:29.244Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-norvir-ritonavir-by-abbvie 2026-07-29T06:32:19.686Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-original-approval-for-fludarabine-phosphate-by-hisun-pharm 2026-07-29T06:32:11.767Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-metformin-hydrochloride-by-amneal-pharmaceuticals 2026-07-29T06:32:03.990Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-furoscix-by-scpharmaceuticals 2026-07-29T06:31:56.375Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tyruko-natalizumab-sztn 2026-07-29T06:31:50.001Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-revlimid-by-bristol-myers-squibb 2026-07-29T06:31:44.086Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-zydus-edaravone-anda218349 2026-07-29T06:31:36.289Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-verapamil-hydrochloride-by-knack 2026-07-29T06:31:29.884Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-jideytro-zidesamtinib-for-nuvalent-inc 2026-07-29T06:31:24.080Z weekly 0.7 https://www.humanexasignals.com/signals/alcons-pmcf-study-on-tears-naturale-eye-drops-for-dry-eye-symptoms 2026-07-29T06:04:14.026Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-non-contrast-ct-for-opportunistic-breast-cancer-screening-initiated 2026-07-29T06:04:00.229Z weekly 0.7 https://www.humanexasignals.com/signals/nivolumab-added-to-standard-treatment-in-advanced-stomachesophageal-cancer-trial 2026-07-29T06:03:47.477Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-myocardial-injury-in-rapid-atrial-fibrillation-patients 2026-07-29T06:03:35.575Z weekly 0.7 https://www.humanexasignals.com/signals/14-3-3-proteins-linked-to-therapy-resistance-in-digestive-cancers 2026-07-29T06:03:11.242Z weekly 0.7 https://www.humanexasignals.com/signals/peptide-1-shows-antiproliferative-activity-against-non-small-cell-lung-cancer-vi 2026-07-29T06:03:01.505Z weekly 0.7 https://www.humanexasignals.com/signals/thyroglobulin-antibody-positivity-linked-to-delayed-absorption-post-microwave-ab 2026-07-29T06:02:52.158Z weekly 0.7 https://www.humanexasignals.com/signals/study-protocol-for-hfnc-in-sedated-endoscopy-for-high-risk-osa-patients 2026-07-29T06:02:43.192Z weekly 0.7 https://www.humanexasignals.com/signals/trial-protocol-for-hypertonic-glucose-vs-insulin-dextrose-in-hyperkalaemia-manag 2026-07-29T06:02:33.496Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-metformin-hydrochloride-anda090692-receives-ap-status-from-fda 2026-07-29T06:02:24.806Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-neuraceq-by-lantheus 2026-07-29T06:02:10.873Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-aurobindos-bupropion-hydrochloride 2026-07-29T06:02:03.828Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-canagliflozin-by-teva-pharmaceuticals 2026-07-29T06:01:56.664Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-augmentin-875-submission 2026-07-29T06:01:49.817Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-zyban-by-glaxosmithkline 2026-07-29T06:01:41.446Z weekly 0.7 https://www.humanexasignals.com/signals/finotonlimab-plus-bevacizumab-unlikely-cost-effective-vs-sorafenib-for-hcc-in-ch 2026-07-29T06:01:33.383Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-budesonide-and-formoterol-fumarate-dihydrate 2026-07-29T00:33:48.545Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-glycerol-phenylbutyrate-by-navinta-llc 2026-07-29T00:33:36.145Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vyvanse-nda-208510-from-takeda 2026-07-29T00:33:24.242Z weekly 0.7 https://www.humanexasignals.com/signals/karyopharms-xpovio-selinexor-nda212306-receives-approval-status-from-fda 2026-07-29T00:33:11.039Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-vyvanse-by-takeda 2026-07-29T00:33:01.140Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-olmesartan-medoxomil-and-hydrochlorothiaz 2026-07-29T00:32:51.857Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-valsartan-and-hydrochlorothiazide-by-sciegen-pharms 2026-07-29T00:32:42.043Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-crysvita-bla761068 2026-07-29T00:32:33.311Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-adderall-xr-10-by-takeda 2026-07-29T00:32:25.736Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-alendronate-sodium-by-impax-labs 2026-07-29T00:32:17.766Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-alcohol-reduction-in-tb-and-hiv-patients-in-india 2026-07-29T00:32:11.013Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-gemini-periop-gc-study-targets-locally-advanced-gastroesophageal-ad 2026-07-29T00:32:02.871Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-pf-08049820-study-examines-absorption-variability-in-healthy-adults 2026-07-29T00:31:55.702Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-study-on-itraconazoles-effect-on-pf-08642534-pharmacokinetics 2026-07-29T00:31:49.560Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-serum-metrnl-levels-in-psa-and-as-patients-to-explore-biomarker-potenti 2026-07-29T00:31:27.273Z weekly 0.7 https://www.humanexasignals.com/signals/tvt-registry-launches-mitral-module-to-monitor-tmvr-outcomes 2026-07-29T00:31:21.418Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-perjeta-pertuzumab-by-genentech 2026-07-28T18:33:08.190Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-mydayis-by-takeda 2026-07-28T18:32:52.685Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-metro-iv-by-b-braun 2026-07-28T18:32:40.099Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-albuterol-sulfate-anda219409-receives-fda-approval-status 2026-07-28T18:32:27.700Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-escitalopram-oxalate-application-by-micro-labs 2026-07-28T18:32:16.167Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-bupivacaine-hydrochloride-by-anthea-pharma 2026-07-28T18:32:05.033Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-flecainide-acetate-by-omsav-pharma 2026-07-28T18:31:55.200Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplemental-application-approval-for-dupixent-bla761055 2026-07-28T18:31:46.305Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-quetiapine-fumarate-anda206252-by-accord-healthcare 2026-07-28T18:31:37.810Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-pantoprazole-sodium-anda219973-1 2026-07-28T18:31:29.617Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-iv-iron-therapy-for-hfpef-patients-with-iron-deficiency-initiated 2026-07-28T18:31:21.107Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-faricimab-vs-fluocinolone-for-radiation-retinopathy-prevention 2026-07-28T18:31:12.751Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-n-acetylcysteine-shows-promise-for-retinitis-pigmentosa 2026-07-28T18:31:03.270Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-paclitaxel-and-cixutumumab-in-metastatic-esophageal-cancer 2026-07-28T18:30:56.336Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-magnesium-membrane-for-alveolar-ridge-reconstruction-in-dental-implants 2026-07-28T18:30:49.752Z weekly 0.7 https://www.humanexasignals.com/signals/johnson-johnson-initiates-5-year-safety-study-for-mentor-breast-implants-in-chin 2026-07-28T18:30:42.343Z weekly 0.7 https://www.humanexasignals.com/signals/safety-and-effectiveness-study-of-igballoon-for-obesity-treatment-initiated 2026-07-28T18:30:35.184Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-of-zoc2017217-for-age-related-cataract-shows-efficacy-and-safety-eva 2026-07-28T18:30:28.835Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-indocyanine-green-by-renew-pharms 2026-07-28T12:32:38.776Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-estradiol-and-norethindrone-acetate 2026-07-28T12:32:26.904Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-tolvaptan-by-alkem-labs 2026-07-28T12:32:15.809Z weekly 0.7 https://www.humanexasignals.com/signals/fda-review-status-for-pediatric-multiple-vitamins-injection-by-apotex-1 2026-07-28T12:32:03.291Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-valsartan-anda218897-by-laurus-1 2026-07-28T12:31:54.128Z weekly 0.7 https://www.humanexasignals.com/signals/fda-review-status-for-pediatric-multiple-vitamins-injection-by-apotex 2026-07-28T12:31:43.603Z weekly 0.7 https://www.humanexasignals.com/signals/impax-labs-receives-fda-approval-for-methylphenidate-hydrochloride-supplement 2026-07-28T12:31:34.772Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levetiracetam-supplement-by-strides-pharma-1 2026-07-28T12:31:26.087Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-dalfampridine-by-accord-healthcare 2026-07-28T12:31:18.355Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-timing-of-withdrawal-from-long-term-antiviral-treatment-for-chronic-hep 2026-07-28T12:31:05.215Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-physical-activitys-impact-on-self-esteem-in-alzheimers-patients 2026-07-28T12:30:57.210Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-combining-focal-prostate-ablation-with-androgen-deprivation-therapy 2026-07-28T12:30:51.089Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vte-prevention-in-hip-and-knee-arthroplasty-comparing-aspirin-and-rivar 2026-07-28T12:30:43.642Z weekly 0.7 https://www.humanexasignals.com/signals/natural-history-study-of-excess-androgen-in-genetic-conditions 2026-07-28T12:30:34.875Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-phase-ibii-study-of-amo959-in-mcrpc-with-aaa617-and-arpi 2026-07-28T12:30:28.662Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-idvynso-containing-doravirine-and-islatravir-1 2026-07-28T06:35:20.772Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-neurodevelopmental-outcomes-after-in-utero-lyme-disease-exposure-launch 2026-07-28T06:35:13.565Z weekly 0.7 https://www.humanexasignals.com/signals/takedas-tak-360-trial-for-narcolepsy-type-1-underway 2026-07-28T06:35:02.252Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-aars-reliability-for-surgical-indication-in-nasal-obstruction 2026-07-28T06:30:33.229Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tzield-teplizumab-supplement-1 2026-07-28T06:02:45.252Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-vericiguat-by-torrent-pharmaceuticals 2026-07-28T06:02:36.118Z weekly 0.7 https://www.humanexasignals.com/signals/rambo-trial-evaluates-pulmonary-rehabilitations-impact-post-pulmonary-embolism 2026-07-28T06:02:26.474Z weekly 0.7 https://www.humanexasignals.com/signals/nih-study-to-evaluate-hepatitis-c-virus-infection-in-blood-donors 2026-07-28T06:02:16.160Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-esophageal-string-test-for-eosinophilic-esophagitis-in-african-populati 2026-07-28T06:02:07.301Z weekly 0.7 https://www.humanexasignals.com/signals/ccta-may-enhance-risk-stratification-for-atrial-fibrillation-ablation-outcomes 2026-07-28T06:01:58.918Z weekly 0.7 https://www.humanexasignals.com/signals/regeneron-initiates-trial-for-ubamatamab-and-regn7075-in-advanced-nsclc 2026-07-28T06:01:51.205Z weekly 0.7 https://www.humanexasignals.com/signals/american-regent-issues-nationwide-recall-of-papaverine-hydrochloride-injection-d 2026-07-28T06:01:41.732Z weekly 0.7 https://www.humanexasignals.com/signals/insights-into-precision-therapy-for-colorectal-cancer-targeting-key-molecular-pa 2026-07-28T06:01:32.773Z weekly 0.7 https://www.humanexasignals.com/signals/ultomiris-phase-iii-trial-fails-to-meet-primary-endpoint-in-hsct-tma 2026-07-28T06:01:21.468Z weekly 0.7 https://www.humanexasignals.com/signals/sonesitatug-vedotin-shows-significant-survival-benefit-in-advanced-gastric-cance 2026-07-28T06:01:14.401Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-pirfenidone-receives-fda-approval-status-update 2026-07-28T00:32:37.451Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-biogens-zuranolone-zurzuvae 2026-07-28T00:32:25.198Z weekly 0.7 https://www.humanexasignals.com/signals/sandozs-enzalutamide-anda216068-receives-approval-status-from-fda 2026-07-28T00:32:14.526Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-canagliflozin-application-by-aurobindo-pharma 2026-07-28T00:32:03.767Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-calcipotriene-by-glenmark 2026-07-28T00:31:53.661Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-cosentyx-secukinumab-by-novartis 2026-07-28T00:31:45.086Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-carbamazepine-anda219072-by-yichang-humanwell-1 2026-07-28T00:31:35.429Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-lamotrigine-supplement-application-from-glenmark 2026-07-28T00:31:27.443Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-sodium-acetate-application-anda220274-by-extrovis 2026-07-28T00:31:20.030Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-on-new-screening-methods-for-high-risk-breast-cancer-women 2026-07-28T00:31:13.211Z weekly 0.7 https://www.humanexasignals.com/signals/gaia-ag-trials-digital-health-app-liebria-for-primary-hypertension 2026-07-28T00:31:05.727Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-glucantime-alone-vs-with-co2-laser-for-cutaneous-leishmaniasis 2026-07-28T00:30:59.170Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-acpa-and-ra-origins-aims-to-uncover-lung-inflammation-links 2026-07-28T00:30:52.836Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ropivacaine-plus-triamcinolone-for-postoperative-pain-relief-after-vats 2026-07-28T00:30:41.768Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-study-on-molecular-analysis-of-endocrine-neoplasms 2026-07-28T00:30:29.103Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-cosentyx-supplement-application 2026-07-27T18:33:35.343Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-valproic-acid-by-quagen 2026-07-27T18:33:18.611Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-selexipag-application-anda214055 2026-07-27T18:33:04.368Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-anda211182-by-hetero-labs 2026-07-27T18:32:50.773Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-brimonidine-tartrate-application-anda220398-by-mankind-pharma 2026-07-27T18:32:38.942Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-methotrexate-sodium-by-alembic 2026-07-27T18:32:26.403Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-zoledronic-acid-by-mylan-labs-1 2026-07-27T18:32:13.743Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-diacomit-stiripentol 2026-07-27T18:32:03.401Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-glycerol-phenylbutyrate-receives-fda-submission-approval 2026-07-27T18:31:54.567Z weekly 0.7 https://www.humanexasignals.com/signals/study-comparing-tatme-and-rtme-for-low-rectal-cancer-initiated-by-sun-yat-sen-un 2026-07-27T18:31:40.021Z weekly 0.7 https://www.humanexasignals.com/signals/avelumab-shows-promise-in-treating-relapsed-thymoma-and-thymic-carcinoma-post-ch 2026-07-27T18:31:31.326Z weekly 0.7 https://www.humanexasignals.com/signals/ai-study-to-enhance-diagnostic-accuracy-in-retinal-imaging 2026-07-27T18:31:18.562Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-links-chronic-hypoxia-to-multiple-system-atrophy-risk-in-han-chin 2026-07-27T18:31:09.819Z weekly 0.7 https://www.humanexasignals.com/signals/roxadustat-study-for-anemia-in-children-with-chronic-kidney-disease-initiated-by 2026-07-27T18:31:01.889Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cbt-i-efficacy-in-adolescents-with-adhd-initiated 2026-07-27T18:30:50.946Z weekly 0.7 https://www.humanexasignals.com/signals/solid-biosciences-initiates-sgt-003-gene-therapy-study-for-duchenne-muscular-dys 2026-07-27T18:30:44.329Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-cd20-car-t-cell-therapy-for-relapsedrefractory-b-cell-lymphom 2026-07-27T18:30:36.197Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-hbm-based-education-for-rop-screening-in-premature-infants-parents 2026-07-27T12:31:14.215Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-firmonertinib-for-egfr-mutated-nsclc-adjusted-by-ctdna-changes 2026-07-27T12:31:06.869Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-imagery-rescripting-vs-exposure-for-ocd-by-kings-college-london 2026-07-27T12:30:59.142Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-interdisciplinary-program-to-enhance-quality-of-life-in-fibromyalgia-pa 2026-07-27T12:30:52.917Z weekly 0.7 https://www.humanexasignals.com/signals/ziresovir-tqt-study-initiated-by-shanghai-ark-biopharma 2026-07-27T12:30:44.318Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-phase-iii-trial-for-erw316-in-hrher2-breast-cancer 2026-07-27T12:30:38.532Z weekly 0.7 https://www.humanexasignals.com/signals/engene-initiates-legend-study-of-eg-70-in-bcg-unresponsive-nmibc-patients 2026-07-27T12:30:31.018Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-colestipol-hydrochloride-supplement-by-impax-labs 2026-07-27T06:35:07.059Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-aurobindos-dextromethorphan-polistirex-application 2026-07-27T06:33:46.358Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-glycerol-phenylbutyrate-anda219540-1 2026-07-27T06:33:25.045Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-long-term-safety-study-for-ruxolitinib-and-panobinostat-combi 2026-07-27T06:33:03.159Z weekly 0.7 https://www.humanexasignals.com/signals/study-aims-to-characterize-malt-lymphoma-for-better-diagnosis-and-treatment 2026-07-27T06:32:43.051Z weekly 0.7 https://www.humanexasignals.com/signals/ruxolitinib-trial-for-apeced-associated-alopecia-areata-underway 2026-07-27T06:32:24.778Z weekly 0.7 https://www.humanexasignals.com/signals/study-to-establish-bordetella-pertussis-infection-model-in-healthy-adults 2026-07-27T06:32:06.432Z weekly 0.7 https://www.humanexasignals.com/signals/gileads-gs-4571-study-targets-safety-and-pharmacokinetics-in-t2dm-and-obesity 2026-07-27T06:31:49.167Z weekly 0.7 https://www.humanexasignals.com/signals/ravulizumab-study-in-chinese-adults-with-generalized-myasthenia-gravis-initiated 2026-07-27T06:31:31.485Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-flt3-inhibitors-immunological-impact-post-hsct-in-aml-patients 2026-07-27T06:31:15.024Z weekly 0.7 https://www.humanexasignals.com/signals/shenzhen-geno-immune-initiates-trial-on-cfmscs-for-immune-related-disorders 2026-07-27T06:31:00.615Z weekly 0.7 https://www.humanexasignals.com/signals/ucb-biopharmas-staccato-alprazolam-trial-targets-prolonged-seizures-in-patients- 2026-07-27T06:30:44.363Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-inqovi-by-taiho-oncology 2026-07-27T06:30:29.775Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-atropine-sulfate-application-anda219013-by-edenbridge-pharms 2026-07-27T06:05:31.990Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-buprenorphine-and-naloxone-from-dr-reddys-labs 2026-07-27T06:05:16.019Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dexmedetomidine-hydrochloride-by-baxter-healthcare 2026-07-27T06:04:57.991Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sodium-bicarbonate-application-anda220788 2026-07-27T06:04:44.611Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-stelara-by-janssen-biotech-1 2026-07-27T06:04:31.656Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-buspirone-hydrochloride-by-oxford-pharms 2026-07-27T06:04:17.104Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-overview-for-anda215575-by-qilu-pharm-hainan 2026-07-27T06:04:04.889Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-alendronate-sodium-supplement-application-approved-by-fda 2026-07-27T06:03:52.000Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-ondansetron-hydrochloride-preservative-free-supplement 2026-07-27T06:03:42.219Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-stelara-ustekinumab-by-centocor-ortho-biotech 2026-07-27T06:03:32.021Z weekly 0.7 https://www.humanexasignals.com/signals/karuna-therapeutics-initiates-trial-for-karxt-in-schizophrenia-with-food-effect- 2026-07-27T06:03:22.376Z weekly 0.7 https://www.humanexasignals.com/signals/ketoconazole-trial-for-mild-autonomous-cortisol-secretion-shows-potential-to-low 2026-07-27T06:03:12.942Z weekly 0.7 https://www.humanexasignals.com/signals/medtronics-percept-pc-dbs-study-for-treatment-resistant-depression-initiated 2026-07-27T06:03:02.398Z weekly 0.7 https://www.humanexasignals.com/signals/low-level-infrared-light-therapy-shows-promise-for-autism-spectrum-disorder 2026-07-27T06:02:53.070Z weekly 0.7 https://www.humanexasignals.com/signals/bgb-16673-study-initiated-for-rr-cllsll-vs-investigators-choice 2026-07-27T06:02:44.665Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-rituximab-lenalidomide-and-ibrutinib-in-follicular-lymphoma 2026-07-27T06:02:34.678Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-fcv-and-pcv-in-moderate-to-severe-ards-initiated 2026-07-27T06:02:23.913Z weekly 0.7 https://www.humanexasignals.com/signals/galderma-rd-evaluates-safety-of-restylane-lyft-for-chin-augmentation 2026-07-27T06:02:15.013Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-68ga-rgd-pet-ct-for-keloid-diagnosis-and-treatment-evaluation 2026-07-27T00:31:06.212Z weekly 0.7 https://www.humanexasignals.com/signals/telemedicine-pilot-study-to-enhance-diabetes-self-management-in-emerging-adults 2026-07-27T00:31:00.014Z weekly 0.7 https://www.humanexasignals.com/signals/columbia-university-launches-effectiveness-trial-for-wingsprep-combination 2026-07-27T00:30:54.300Z weekly 0.7 https://www.humanexasignals.com/signals/mayo-clinic-trial-on-cbt-for-quality-of-life-in-stage-iii-iv-melanoma-patients 2026-07-27T00:30:48.713Z weekly 0.7 https://www.humanexasignals.com/signals/laser-acupuncture-trial-for-improving-body-shape-in-women-with-type-2-diabetes 2026-07-27T00:30:41.151Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-study-on-dii235-for-elevated-lipoproteina 2026-07-27T00:30:35.300Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-diacomit-stiripentol-by-biocodex 2026-07-26T18:32:42.211Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-ontruzant-bla761100-by-samsung-bioepis 2026-07-26T18:32:30.375Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-ondansetron-hydrochloride-supplement 2026-07-26T18:32:19.407Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-datscan-nda022454-by-ge-healthcare 2026-07-26T18:32:09.282Z weekly 0.7 https://www.humanexasignals.com/signals/genentechs-itovebi-nda219249-submission-receives-ap-status 2026-07-26T18:32:00.032Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-eplontersen-sodium-autoinjector-receives-ap-status-from-fda 2026-07-26T18:31:51.666Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-glycerol-phenylbutyrate-by-teva-pharmaceuticals 2026-07-26T18:31:42.436Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-alendronate-sodium-anda206387-by-ipca-labs 2026-07-26T18:31:35.181Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-ramelteon-anda-215243-by-micro-labs 2026-07-26T18:31:28.211Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-canagliflozin-by-apotex-1 2026-07-26T18:31:21.555Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-evaluates-chemo-and-chemo-immunotherapy-for-advanced-head-and-nec 2026-07-26T18:31:14.429Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-clonal-evolution-in-follicular-lymphoma-by-nci 2026-07-26T18:31:08.270Z weekly 0.7 https://www.humanexasignals.com/signals/b2227-vs-vraylar-pharmacokinetics-study-in-schizophrenia-launched 2026-07-26T18:31:00.947Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-abaloparatides-impact-on-bone-quality-in-osteoporotic-patients 2026-07-26T18:30:54.979Z weekly 0.7 https://www.humanexasignals.com/signals/beone-medicines-initiates-study-of-bg-75202-in-advanced-solid-tumors 2026-07-26T18:30:49.203Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-chw-support-to-enhance-palliative-care-in-advanced-cancer-patients 2026-07-26T18:30:38.552Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-lactulose-by-cumberland-pharmaceuticals 2026-07-26T12:32:41.583Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-bosentan-by-zydus-pharms 2026-07-26T12:32:28.264Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-abreva-docosanol-by-haleon 2026-07-26T12:32:16.419Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-milnacipran-hydrochloride 2026-07-26T12:32:06.176Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-saptalis-sonazine-chlorpromazine-hydrochloride 2026-07-26T12:31:55.673Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-milnacipran-hydrochloride-by-amneal-pharmaceuticals 2026-07-26T12:31:44.958Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-bosentan-anda207110-by-watson-labs 2026-07-26T12:31:36.083Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-rytelo-imetelstat-sodium-by-geron 2026-07-26T12:31:27.551Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-danziten-nilotinib-tartrate-1 2026-07-26T12:31:19.802Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-lamotrigine-by-alembic-pharmaceuticals 2026-07-26T12:31:12.858Z weekly 0.7 https://www.humanexasignals.com/signals/study-aims-to-improve-diagnosis-and-treatment-of-pheochromocytoma 2026-07-26T12:31:05.995Z weekly 0.7 https://www.humanexasignals.com/signals/efgartigimod-trial-initiated-for-igg4-related-disease-treatment 2026-07-26T12:30:58.541Z weekly 0.7 https://www.humanexasignals.com/signals/incytes-inca33890-safety-study-in-advanced-solid-tumors-initiated 2026-07-26T12:30:52.567Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-hydromorphone-in-multimodal-analgesia-for-knee-arthroplasty 2026-07-26T12:30:44.582Z weekly 0.7 https://www.humanexasignals.com/signals/astx727-and-retifanlimab-dlwr-trial-for-advanced-merkel-cell-cancer-initiated 2026-07-26T12:30:38.793Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-bomedemstat-trial-for-polycythemia-vera-aims-to-improve-treatment-outcome 2026-07-26T12:30:32.643Z weekly 0.7 https://www.humanexasignals.com/signals/niaid-study-on-hiv-pathogenesis-using-human-blood-cells 2026-07-26T12:30:27.065Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lurasidone-hydrochloride-anda208055 2026-07-26T06:32:12.837Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-spravato-esketamine 2026-07-26T06:32:02.426Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-artesunate-by-amivas-1 2026-07-26T06:31:52.905Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-traveres-filspari-sparsentan 2026-07-26T06:31:43.953Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-pimozide-application-anda219897-from-novitium-pharma 2026-07-26T06:31:35.704Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-for-olmesartan-medoxomil-and-hydrochlorothiazide-by-micro-l 2026-07-26T06:31:27.568Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-to-methylprednisolone-anda204072-from-tianjin-tianyao 2026-07-26T06:31:20.418Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lamotrigine-anda078947-by-torrent-pharmaceuticals 2026-07-26T06:31:13.544Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-concerta-by-janssen-pharmaceuticals 2026-07-26T06:31:06.787Z weekly 0.7 https://www.humanexasignals.com/signals/registry-launched-to-evaluate-farapulse-pfa-technology-for-atrial-fibrillation 2026-07-26T06:30:57.908Z weekly 0.7 https://www.humanexasignals.com/signals/johnson-johnsons-varipulse-catheter-study-targets-paroxysmal-atrial-fibrillation 2026-07-26T06:30:47.783Z weekly 0.7 https://www.humanexasignals.com/signals/alnylams-aln-2232-undergoing-evaluation-for-obesity-treatment 2026-07-26T06:30:41.180Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictors-of-drug-resistant-epilepsy-in-children-initiated 2026-07-26T06:30:34.604Z weekly 0.7 https://www.humanexasignals.com/signals/isatuximab-evaluated-in-stem-cell-transplant-for-multiple-myeloma-and-lymphoma 2026-07-26T06:30:28.669Z weekly 0.7 https://www.humanexasignals.com/signals/fda-updates-boxed-warnings-for-jak-inhibitors-due-to-serious-risks 2026-07-26T06:03:19.342Z weekly 0.7 https://www.humanexasignals.com/signals/lenalidomide-being-studied-for-treatment-of-adult-histiocyte-disorders 2026-07-26T06:03:04.993Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-post-marketing-surveillance-for-lynparza-in-south-korea 2026-07-26T06:02:55.104Z weekly 0.7 https://www.humanexasignals.com/signals/brii-biosciences-initiates-study-on-brii-835-and-brii-179-for-chronic-hbv-infect 2026-07-26T06:02:46.458Z weekly 0.7 https://www.humanexasignals.com/signals/post-marketing-surveillance-for-xeljanz-xr-to-evaluate-safety-in-rheumatoid-arth 2026-07-26T06:02:37.325Z weekly 0.7 https://www.humanexasignals.com/signals/study-aims-to-identify-blood-biomarkers-for-obstructive-sleep-apnea 2026-07-26T06:02:25.546Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-study-on-myelodysplastic-syndromes-to-enhance-treatment-options 2026-07-26T06:02:18.060Z weekly 0.7 https://www.humanexasignals.com/signals/zanthoxylum-nitidum-shows-multi-target-anti-hcc-mechanisms-via-network-pharmacol 2026-07-26T06:02:00.230Z weekly 0.7 https://www.humanexasignals.com/signals/nanovaccines-show-superior-efficacy-over-ampicillin-in-preventing-neonatal-liste 2026-07-26T06:01:53.144Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-semaglutide-surgery-and-lifestyle-for-weight-management-in-endome 2026-07-26T06:01:46.682Z weekly 0.7 https://www.humanexasignals.com/signals/histotripsy-shows-promise-for-noninvasive-treatment-of-renal-cell-carcinoma 2026-07-26T06:01:40.858Z weekly 0.7 https://www.humanexasignals.com/signals/compound-kushen-injection-inhibits-immune-evasion-in-hepatocellular-carcinoma-vi 2026-07-26T06:01:34.531Z weekly 0.7 https://www.humanexasignals.com/signals/h-pylori-variants-linked-to-wnt-catenin-signaling-in-stomach-adenocarcinoma-prog 2026-07-26T06:01:25.880Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-access-plans-for-alimatravir-in-hiv-prep-targeting-low-income-countries 2026-07-26T06:01:20.543Z weekly 0.7 https://www.humanexasignals.com/signals/edgeease-pmam-system-trial-evaluates-mood-and-sleep-quality-in-healthy-adults 2026-07-26T00:30:42.850Z weekly 0.7 https://www.humanexasignals.com/signals/daiichi-sankyo-trials-triple-therapy-for-coronary-atherosclerosis-without-events 2026-07-26T00:30:37.905Z weekly 0.7 https://www.humanexasignals.com/signals/blood-sampling-study-for-sickle-cell-disease-research-initiated-by-niddk 2026-07-26T00:30:32.931Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-hiv-1-replication-during-long-term-antiretroviral-therapy-initiated 2026-07-26T00:30:27.567Z weekly 0.7 https://www.humanexasignals.com/signals/fda-warns-of-serious-liver-injury-risk-with-mavyret-zepatier-and-vosevi-in-advan 2026-07-25T18:32:21.559Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-rinvoq-upadacitinib-by-abbvie 2026-07-25T18:32:11.020Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-cangrelor-for-market-release 2026-07-25T18:32:04.541Z weekly 0.7 https://www.humanexasignals.com/signals/incytes-ruxolitinib-cream-shows-promise-for-pediatric-nonsegmental-vitiligo 2026-07-25T18:31:58.797Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-hybrid-intervention-for-financial-and-health-needs-in-aya-cancer-surviv 2026-07-25T18:31:52.579Z weekly 0.7 https://www.humanexasignals.com/signals/eisai-initiates-study-on-algorithms-for-intracerebral-hemorrhage-and-seizures-in 2026-07-25T18:31:47.181Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sonda-visual-field-test-for-patients-with-supra-sellar-tumors 2026-07-25T18:31:39.901Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-m3t01-monotherapy-and-combination-therapy-in-solid-tumors 2026-07-25T18:31:27.657Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dalbavancin-hydrochloride-anda219604 2026-07-25T12:31:35.096Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-childrens-allegra-hives-1 2026-07-25T12:31:28.471Z weekly 0.7 https://www.humanexasignals.com/signals/actavis-inc-submits-supplement-for-gemcitabine-hydrochloride-anda204549 2026-07-25T12:31:17.037Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-augmentin-875-supplement-application 2026-07-25T12:31:10.647Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-methylphenidate-hydrochloride-anda206932 2026-07-25T12:31:04.288Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-minnesota-trials-cognitive-strategies-in-early-psychosis-with-moda 2026-07-25T12:30:54.548Z weekly 0.7 https://www.humanexasignals.com/signals/astellas-pharma-initiates-trial-of-asp2138-for-her2-negative-gastric-cancer 2026-07-25T12:30:47.469Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-improving-hypertension-medication-adherence-in-hiv-patients 2026-07-25T12:30:40.376Z weekly 0.7 https://www.humanexasignals.com/signals/nci-trials-b7-h3-car-t-cell-therapy-for-refractory-small-cell-lung-cancer 2026-07-25T12:30:34.646Z weekly 0.7 https://www.humanexasignals.com/signals/taohe-chengqi-decoction-shows-potential-in-treating-acute-pelvic-inflammatory-di 2026-07-25T06:32:06.930Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-zidesamtinib-for-ros1-positive-non-small-cell-lung-cancer 2026-07-25T06:31:54.751Z weekly 0.7 https://www.humanexasignals.com/signals/sunny-pharmtech-issues-recall-of-cyclophosphamide-injection-due-to-contamination 2026-07-25T06:31:46.059Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-nonprescription-acetaminophen-and-naproxen-combination-for-pa 2026-07-25T06:31:36.012Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-issues-guidance-on-safe-use-of-glp-1-weight-loss-medicines 2026-07-25T06:31:28.039Z weekly 0.7 https://www.humanexasignals.com/signals/alveus-therapeutics-initiates-alv-100-study-for-obesity-and-type-2-diabetes 2026-07-25T06:31:16.586Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-bl-b01d1-with-pd-1-antibody-in-advanced-lung-cancer-and-other- 2026-07-25T06:31:09.915Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-resistance-training-intensity-for-osteoporosis-management 2026-07-25T06:31:02.867Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vr-directed-therapy-for-pain-management-in-ibd-patients 2026-07-25T06:30:55.302Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-18f-fluciclovine-petct-for-improved-detection-in-multiple-myeloma 2026-07-25T06:30:48.536Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-study-of-disc-1459-for-epp-shows-safety-and-efficacy-potential 2026-07-25T06:30:41.810Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-gabapentin-anda217995-by-rising 2026-07-25T06:30:32.011Z weekly 0.7 https://www.humanexasignals.com/signals/watson-labs-receives-ap-status-for-ciprofloxacin-hydrochloride-anda076794 2026-07-25T06:30:26.347Z weekly 0.7 https://www.humanexasignals.com/signals/novel-plc-snedds-enhances-oral-bioavailability-of-cannabidiol-significantly 2026-07-25T06:05:10.270Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-ciprofloxacin-hydrochloride-by-hikma 2026-07-25T06:04:48.653Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-anda-for-adapalene-and-benzoyl-peroxide 2026-07-25T06:04:30.117Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-fluvoxamine-maleate-anda220447-by-zydus-pharms 2026-07-25T06:04:12.326Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-camcevi-etm-by-accord 2026-07-25T06:03:56.086Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-bupropion-hydrochloride-anda216051-receives-ap-status 2026-07-25T06:03:40.958Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tevas-tolvaptan-anda216933 2026-07-25T06:03:27.369Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-dr-reddys-allopurinol-anda071587 2026-07-25T06:03:14.291Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-acanya-by-bausch 2026-07-25T06:03:02.173Z weekly 0.7 https://www.humanexasignals.com/signals/florida-ascent-study-evaluates-patient-navigator-for-cancer-care-improvement 2026-07-25T06:02:49.108Z weekly 0.7 https://www.humanexasignals.com/signals/neurophysiological-study-on-dbs-in-ocd-patients-to-inform-neuromodulation-strate 2026-07-25T06:02:37.669Z weekly 0.7 https://www.humanexasignals.com/signals/zanubrutinib-plus-anti-cd20-shows-promise-in-rr-follicular-and-marginal-zone-lym 2026-07-25T06:02:27.469Z weekly 0.7 https://www.humanexasignals.com/signals/zolbetuximab-in-combination-with-chemotherapy-for-advanced-biliary-tract-cancers 2026-07-25T06:02:17.970Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-mosunetuzumab-in-cll-patients-post-btki-treatment 2026-07-25T06:02:09.314Z weekly 0.7 https://www.humanexasignals.com/signals/new-trial-for-pediatric-b-cell-all-aims-to-improve-survival-rates 2026-07-25T06:02:00.455Z weekly 0.7 https://www.humanexasignals.com/signals/avidity-biosciences-initiates-phase-3-study-for-del-desiran-in-myotonic-dystroph 2026-07-25T06:01:52.419Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-srg-514-in-triple-negative-breast-cancer-undergoing-surgery 2026-07-25T06:01:44.260Z weekly 0.7 https://www.humanexasignals.com/signals/comparative-study-of-raltitrexed-and-oxaliplatin-in-metastatic-colorectal-cancer 2026-07-25T06:01:37.683Z weekly 0.7 https://www.humanexasignals.com/signals/narlumosbart-with-sbrt-shows-promise-in-nsclc-with-bone-metastases-in-new-phase- 2026-07-25T06:01:31.002Z weekly 0.7 https://www.humanexasignals.com/signals/chmp-recommends-eu-approval-of-roches-susvimo-for-neovascular-amd 2026-07-25T06:01:23.340Z weekly 0.7 https://www.humanexasignals.com/signals/chmp-recommends-eu-approval-of-roches-susvimo-for-namd-treatment 2026-07-25T06:01:16.936Z weekly 0.7 https://www.humanexasignals.com/signals/memantine-pilot-study-for-cognitive-protection-in-pediatric-brain-tumor-patients 2026-07-25T00:31:30.501Z weekly 0.7 https://www.humanexasignals.com/signals/genentechs-opregen-study-targets-geographic-atrophy-in-amd-with-subretinal-deliv 2026-07-25T00:31:24.202Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-ly4005130-trial-for-severe-alopecia-areata-underway 2026-07-25T00:31:18.109Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-phase-1b2-trial-of-azd0120-for-relapsedrefractory-multiple 2026-07-25T00:31:08.357Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-subvenite-lamotrigine-by-owp-pharms 2026-07-25T00:31:02.224Z weekly 0.7 https://www.humanexasignals.com/signals/fresenius-kabi-usa-receives-ap-status-for-dexamethasone-sodium-phosphate-anda209 2026-07-25T00:30:56.469Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-gabapentin-by-zydus-pharmaceuticals 2026-07-25T00:30:51.171Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-pregabalin-anda211687-submission-from-alvogen 2026-07-25T00:30:42.595Z weekly 0.7 https://www.humanexasignals.com/signals/qufeng-xuanbi-formula-shows-potential-in-treating-allergic-asthma-via-immune-met 2026-07-24T18:30:43.478Z weekly 0.7 https://www.humanexasignals.com/signals/tianhuang-formula-shows-potential-in-addressing-central-insulin-resistance 2026-07-24T18:30:37.130Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-mechanism-of-herbal-extracts-in-treating-acute-lung-injury-in-poul 2026-07-24T12:30:57.701Z weekly 0.7 https://www.humanexasignals.com/signals/salvia-miltiorrhiza-shows-promise-in-treating-pulmonary-fibrosis-through-fibrobl 2026-07-24T12:30:47.421Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-camcevi-etm-leuprolide-mesylate 2026-07-24T12:30:40.987Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-anda-submission-for-canagliflozin-receives-ta-status 2026-07-24T12:30:34.940Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-pitolisant-hydrochloride-by-novitium-pharma 2026-07-24T12:30:29.005Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheims-zongertinib-trial-targets-advanced-cancers-with-her2-alter 2026-07-24T06:32:30.127Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-tsha-105-in-slc13a5-citrate-transporter-disorder-initiated 2026-07-24T06:32:12.443Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tripterygium-glycosides-tablets-reveals-anti-inflammatory-potential 2026-07-24T06:31:53.001Z weekly 0.7 https://www.humanexasignals.com/signals/concerns-raised-over-hepatotoxicity-of-epimedium-brevicornu-maxim 2026-07-24T06:31:35.555Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-ojjaara-momelotinib-dihydrochloride-by-glaxosmithklin 2026-07-24T06:31:26.565Z weekly 0.7 https://www.humanexasignals.com/signals/torrents-moxifloxacin-hydrochloride-anda-receives-approval-status 2026-07-24T06:31:17.535Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-vonjo-pacritinib-citrate 2026-07-24T06:31:10.067Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-doxycycline-hyclate-anda210527-by-alembic 2026-07-24T06:31:02.310Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-jakafi-ruxolitinib-phosphate-by-incyte 2026-07-24T06:30:56.279Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-carfilzomib-by-msn 2026-07-24T06:30:49.992Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-inrebic-fedratinib-hydrochloride 2026-07-24T06:30:43.996Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-scomara-sirolimus-by-aft-pharmaceuticals 2026-07-24T06:30:37.948Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-edaravone-by-azurity-pharmaceuticals 2026-07-24T06:30:32.148Z weekly 0.7 https://www.humanexasignals.com/signals/torrent-pharmaceuticals-receives-ap-status-for-metformin-hydrochloride-anda07922 2026-07-24T06:30:26.251Z weekly 0.7 https://www.humanexasignals.com/signals/bruceine-d-shows-potential-to-overcome-egfr-tki-resistance-in-lung-adenocarcinom 2026-07-24T06:04:32.147Z weekly 0.7 https://www.humanexasignals.com/signals/traditional-chinese-medicine-shows-promise-in-treating-cerebral-ischemia-reperfu 2026-07-24T06:04:18.252Z weekly 0.7 https://www.humanexasignals.com/signals/guizhi-shaoyao-zhimu-decoction-modulates-il-17r-mapk-pathway-in-rheumatoid-arthr 2026-07-24T06:04:02.468Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-methadone-hydrochloride-anda212093-by-lannett-co-inc 2026-07-24T06:03:47.990Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dicyclomine-hydrochloride-anda216515 2026-07-24T06:03:37.329Z weekly 0.7 https://www.humanexasignals.com/signals/torrents-metformin-hydrochloride-anda090014-receives-ap-status 2026-07-24T06:03:26.459Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-doxepin-hydrochloride-by-mylan 2026-07-24T06:03:16.904Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-ferric-carboxymaltose-by-mylan 2026-07-24T06:03:07.607Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-ferric-carboxymaltose-by-mylan-labs 2026-07-24T06:02:58.158Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-ferric-carboxymaltose-for-mylans-anda217076 2026-07-24T06:02:49.407Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-ubrogepant-application-by-msn-laboratories 2026-07-24T06:02:41.898Z weekly 0.7 https://www.humanexasignals.com/signals/fda-workshop-on-glp-1-generic-drug-pathway-highlights-development-considerations 2026-07-24T06:02:34.828Z weekly 0.7 https://www.humanexasignals.com/signals/pola-r-chp-shows-promise-in-treating-cd5-positive-dlbcl-predicts-patient-outcome 2026-07-24T06:02:28.323Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-retatrutide-shows-significant-weight-loss-in-phase-3-obesity-trials 2026-07-24T06:02:21.650Z weekly 0.7 https://www.humanexasignals.com/signals/etcamah-approved-in-eu-for-1st-line-advanced-er-breast-cancer 2026-07-24T06:02:14.539Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-talzenna-plus-xtandi-in-metastatic-prostate-cance 2026-07-24T06:02:06.568Z weekly 0.7 https://www.humanexasignals.com/signals/biomarins-study-on-growth-in-children-with-idiopathic-short-stature-underway 2026-07-24T00:32:30.925Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-thyroid-hormones-in-severe-ckd-stages-g4-g5-initiated 2026-07-24T00:32:07.542Z weekly 0.7 https://www.humanexasignals.com/signals/pembrolizumab-trial-for-small-cell-carcinoma-of-ovary-hypercalcemic-type 2026-07-24T00:31:45.887Z weekly 0.7 https://www.humanexasignals.com/signals/genzyme-launches-global-registry-for-pompe-disease-to-enhance-patient-care-and-r 2026-07-24T00:31:37.396Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-sitagliptin-phosphate-by-dr-reddys-labs 2026-07-24T00:31:28.443Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-ogsiveo-nirogacestat-hydro-bromide 2026-07-24T00:31:20.499Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-desvenlafaxine-succinate-by-platinum 2026-07-24T00:31:13.609Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-celecoxib-by-alembic 2026-07-24T00:31:06.875Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-rosuvastatin-calcium-by-macleods 2026-07-24T00:30:59.189Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-ibuprofen-and-famotidine-by-alkem-labs 2026-07-24T00:30:53.165Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-neupogen-by-amgen 2026-07-24T00:30:46.818Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-azathioprine-supplement-by-rising 2026-07-24T00:30:41.202Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-diclofenac-sodium-anda076152-receives-ap-status 2026-07-24T00:30:35.394Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-lisdexamfetamine-dimesylate-supplement-receives-fda-acceptance 2026-07-24T00:30:28.381Z weekly 0.7 https://www.humanexasignals.com/signals/agios-initiates-trial-of-mitapivat-in-pediatric-pkd-patients-with-no-transfusion 2026-07-23T18:33:47.408Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-music-therapys-effects-in-chronic-neck-pain-rehabilitation 2026-07-23T18:33:29.481Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-mk-1045-under-investigation-for-non-hodgkin-lymphoma-treatment 2026-07-23T18:33:15.352Z weekly 0.7 https://www.humanexasignals.com/signals/reconnect-study-evaluates-deep-brain-stimulation-for-chronic-disorders-of-consci 2026-07-23T18:33:02.305Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-topical-anesthesia-to-propofol-ketamine-for-gi-endoscopy 2026-07-23T18:32:50.098Z weekly 0.7 https://www.humanexasignals.com/signals/red-light-therapy-trial-for-dementia-with-lewy-bodies-shows-potential-for-cognit 2026-07-23T18:32:30.215Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-online-tool-to-enhance-cascade-screening-for-lynch-syndrome 2026-07-23T18:32:18.544Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ib-trial-of-teclistamab-and-iberdomide-in-relapsedrefractory-multiple-myel 2026-07-23T18:32:05.846Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-maryland-evaluates-suvorexant-for-reducing-drug-demand 2026-07-23T18:31:55.423Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-diaphragm-dysfunction-during-mechanical-ventilation-initiated 2026-07-23T18:31:45.640Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-rosuvastatin-calcium-by-sun-pharma 2026-07-23T18:31:37.499Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-purixan-by-nova-labs 2026-07-23T18:31:29.004Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-rosuvastatin-calcium-by-sciegen-pharmaceuticals 2026-07-23T18:31:21.669Z weekly 0.7 https://www.humanexasignals.com/signals/ajanta-pharma-submits-anda-for-sitagliptin-and-metformin-hydrochloride-1 2026-07-23T18:31:14.037Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-ilumya-tildrakizumab-by-sun-pharma 2026-07-23T18:31:06.821Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-pheburane-nda216513-by-medunik 2026-07-23T18:30:59.810Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-novartis-fabhalta-ipacopan-hydrochloride 2026-07-23T18:30:48.889Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-rezzayo-rezafungin-acetate 2026-07-23T18:30:42.513Z weekly 0.7 https://www.humanexasignals.com/signals/sandozs-gabapentin-anda075428-receives-abbreviated-approval 2026-07-23T18:30:35.172Z weekly 0.7 https://www.humanexasignals.com/signals/immunovants-imvt-1402-enters-phase-2b-for-graves-disease-treatment 2026-07-23T12:32:33.724Z weekly 0.7 https://www.humanexasignals.com/signals/mirum-pharmaceuticals-evaluates-livmarli-in-long-term-study-for-alagille-syndrom 2026-07-23T12:32:16.211Z weekly 0.7 https://www.humanexasignals.com/signals/shock-wave-therapy-trial-for-knee-osteoarthritis-shows-potential-for-clinical-pr 2026-07-23T12:32:03.606Z weekly 0.7 https://www.humanexasignals.com/signals/patritumab-deruxtecan-study-initiated-for-advanced-gastrointestinal-cancers 2026-07-23T12:31:52.982Z weekly 0.7 https://www.humanexasignals.com/signals/inotuzumab-ozogamicin-combined-with-chemotherapy-shows-promise-in-acute-lymphobl 2026-07-23T12:31:43.147Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-hydrocortisone-anda218298-by-rising 2026-07-23T12:31:20.835Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-metformin-hydrochloride-anda077060-by-zydus-lifesciences 2026-07-23T12:31:13.274Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-zydus-lifesciences-metformin-hydrochloride-anda077078 2026-07-23T12:31:06.208Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-aurobindos-etodolac-anda214872 2026-07-23T12:30:58.810Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-diltiazem-hydrochloride-by-novast-labs 2026-07-23T12:30:53.019Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-acetazolamide-supplement-by-heritage-pharma 2026-07-23T12:30:46.192Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-metformin-hydrochloride-by-actavis-elizabeth 2026-07-23T12:30:40.353Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-pregabalin-supplement-application-anda209357-from-msn 2026-07-23T12:30:33.643Z weekly 0.7 https://www.humanexasignals.com/signals/torrent-pharmaceuticals-receives-ap-status-for-metformin-hydrochloride-anda07771 2026-07-23T12:30:27.995Z weekly 0.7 https://www.humanexasignals.com/signals/trial-to-assess-recruitment-methods-for-type-1-diabetes-screening 2026-07-23T06:31:39.198Z weekly 0.7 https://www.humanexasignals.com/signals/iparomlimab-and-tovorilimab-combined-with-bevacizumab-in-advanced-ovarian-cancer 2026-07-23T06:31:31.040Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-metformin-hydrochloride-anda075961-from-watson-labs 2026-07-23T06:31:22.793Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-watson-labs-metformin-hydrochloride-supplement 2026-07-23T06:31:15.556Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-metformin-hydrochloride-by-actavis-elizabeth 2026-07-23T06:31:08.341Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-applications-for-zyban-by-glaxosmithkline 2026-07-23T06:30:59.794Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-zithromax-by-pfizer 2026-07-23T06:30:53.666Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-norethindrone-acetate-and-ethinyl-estradiol 2026-07-23T06:30:47.516Z weekly 0.7 https://www.humanexasignals.com/signals/sagent-pharmaceuticals-clindamycin-phosphate-anda090108-receives-ap-status 2026-07-23T06:30:41.992Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-clindamycin-phosphate-anda090109 2026-07-23T06:30:36.795Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-zithromax-by-pfizer 2026-07-23T06:30:31.386Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-engineered-dendritic-cell-vaccines-for-multiple-myeloma-initiated 2026-07-23T06:04:21.446Z weekly 0.7 https://www.humanexasignals.com/signals/pvp-with-pedicle-screw-fixation-shows-superior-outcomes-in-elderly-osteoporotic- 2026-07-23T06:03:57.658Z weekly 0.7 https://www.humanexasignals.com/signals/post-icu-ptsd-intervention-shows-potential-for-improving-quality-of-life 2026-07-23T06:03:43.618Z weekly 0.7 https://www.humanexasignals.com/signals/exosomes-in-renal-fibrosis-dual-roles-and-therapeutic-potential 2026-07-23T06:03:31.235Z weekly 0.7 https://www.humanexasignals.com/signals/efficacy-of-cope-a-for-ptsd-and-sud-in-young-people-demonstrated-in-rct 2026-07-23T06:03:19.861Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-leqembi-supplement-application-1 2026-07-23T06:03:07.272Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-gleevec-imatinib-mesylate 2026-07-23T06:02:56.573Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-argatroban-by-fresenius-kabi 2026-07-23T06:02:44.193Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-verzenio-abemaciclib 2026-07-23T06:02:34.847Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-buprenorphine-hydrochloride-by-rubicon-research 2026-07-23T06:02:25.415Z weekly 0.7 https://www.humanexasignals.com/signals/zydus-pharms-receives-ap-status-for-dexmedetomidine-hydrochloride-anda206798 2026-07-23T06:02:17.640Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-novitiums-tramadol-hydrochloride 2026-07-23T06:02:10.044Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-adrenalin-epinephrine 2026-07-23T06:01:57.504Z weekly 0.7 https://www.humanexasignals.com/signals/exploring-m6a-modification-as-therapeutic-target-in-osteosarcoma 2026-07-23T06:01:48.055Z weekly 0.7 https://www.humanexasignals.com/signals/islatravir-and-lenacapavir-show-sustained-virologic-suppression-in-phase-3-hiv-t 2026-07-23T06:01:38.751Z weekly 0.7 https://www.humanexasignals.com/signals/roche-reports-strong-h1-2026-sales-growth-and-multiple-fda-priority-reviews-1 2026-07-23T06:01:32.487Z weekly 0.7 https://www.humanexasignals.com/signals/roche-reports-strong-h1-2026-sales-and-multiple-fda-priority-reviews 2026-07-23T06:01:24.893Z weekly 0.7 https://www.humanexasignals.com/signals/roche-reports-strong-h1-2026-sales-growth-and-multiple-fda-priority-reviews 2026-07-23T06:01:14.278Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-qtern-dapagliflozinsaxagliptin 2026-07-23T00:32:56.466Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-steglujan-ertugliflozinsitagliptin 2026-07-23T00:32:43.284Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-steglatro-ertugliflozin-by-merck 2026-07-23T00:32:31.090Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-farxiga-dapagliflozin 2026-07-23T00:32:20.388Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-anda-for-tofacitinib-citrate-receives-ap-status 2026-07-23T00:32:09.708Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-tofacitinib-citrate-by-sun-pharma 2026-07-23T00:31:59.215Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-azelastine-hydrochloride-and-fluticasone-propionate 2026-07-23T00:31:50.169Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-anda-for-tofacitinib-citrate-fda-review-ongoing 2026-07-23T00:31:41.939Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-breckenridges-tofacitinib-citrate-application 2026-07-23T00:31:33.476Z weekly 0.7 https://www.humanexasignals.com/signals/heritage-pharmas-sertraline-hydrochloride-anda077345-receives-ap-status 2026-07-23T00:31:24.849Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-study-on-surzetoclax-for-relapsedrefractory-multiple-myeloma 2026-07-23T00:31:17.180Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-muvalaplin-trial-targets-cardiovascular-risk-in-high-lipoproteina-pat 2026-07-23T00:31:09.171Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-smartphone-based-heart-sound-analysis-using-ai 2026-07-23T00:31:01.623Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-lenalidomide-and-nivolumab-in-primary-cns-lymphoma 2026-07-23T00:30:55.711Z weekly 0.7 https://www.humanexasignals.com/signals/pembrolizumab-and-lenvatinib-trial-for-unresectable-cutaneous-angiosarcoma-initi 2026-07-23T00:30:48.475Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-buteyko-breathing-techniques-impact-on-childhood-asthma-control 2026-07-23T00:30:42.436Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-piiinp-and-urinary-ngal-as-biomarkers-for-renal-function-recovery 2026-07-23T00:30:37.556Z weekly 0.7 https://www.humanexasignals.com/signals/gaze-contingent-music-therapy-augmentation-of-cbt-for-pediatric-anxiety-trial-in 2026-07-23T00:30:29.255Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda217298 2026-07-22T18:32:46.955Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-brenzavvy-bexagliflozin 2026-07-22T18:32:31.705Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-vasopressin-in-dextrose-5-by-dr-reddys 2026-07-22T18:32:19.886Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-argatroban-in-dextrose-by-sandoz 2026-07-22T18:32:09.787Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-invokana-canagliflozin-by-janssen 2026-07-22T18:32:00.481Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-tofacitinib-citrate-by-micro-labs 2026-07-22T18:31:52.196Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda220137 2026-07-22T18:31:44.358Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-oxcarbazepine-anda215332 2026-07-22T18:31:35.621Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-tiocystin-by-casper-pharma 2026-07-22T18:31:28.129Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-romidepsin-anda219099-by-amneal 2026-07-22T18:31:20.815Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rtms-and-olfactory-training-for-parkinsons-disease-shows-promise 2026-07-22T18:31:07.988Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-biomarkers-for-niemann-pick-disease-type-c-progression 2026-07-22T18:31:01.573Z weekly 0.7 https://www.humanexasignals.com/signals/alexions-ravulizumab-shows-promise-in-pediatric-nmosd-study 2026-07-22T18:30:49.080Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-liposomal-bupivacaine-and-dexamethasone-for-postoperative-pain-c 2026-07-22T18:30:36.756Z weekly 0.7 https://www.humanexasignals.com/signals/endoscopic-duodenal-therapy-shows-promise-for-early-type-2-dm-treatment 2026-07-22T18:30:30.075Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-arsenic-trioxide-anda206228 2026-07-22T12:33:16.246Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-bla-for-ranluspec-by-lupin-limited 2026-07-22T12:33:00.748Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-anda213511-for-eluxadoline-receives-ap-status 2026-07-22T12:32:46.249Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-saxenda-liraglutide-by-novo 2026-07-22T12:32:33.345Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-leflunomide-by-barr 2026-07-22T12:32:21.625Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-furosemide-by-epic-pharma 2026-07-22T12:32:11.142Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lurasidone-hydrochloride-anda208047-by-dr-reddys 2026-07-22T12:32:00.902Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-eribulin-mesylate-by-natco 2026-07-22T12:31:51.695Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-submits-anda-for-pemigatinib-seeking-fda-approval 2026-07-22T12:31:43.236Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-anda220866-by-hetero-labs-limited 2026-07-22T12:31:34.646Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-diagnostic-methods-for-pulmonary-nontuberculous-mycobacterial-infection 2026-07-22T12:31:27.394Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-c1q-binding-hla-antibodies-and-platelet-transfusion-response 2026-07-22T12:31:20.002Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-pci-vs-cabg-in-diabetic-patients-with-three-vessel-cad 2026-07-22T12:31:12.307Z weekly 0.7 https://www.humanexasignals.com/signals/vexus-protocol-study-aims-to-improve-hemodialysis-patient-outcomes 2026-07-22T12:31:04.631Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-on-124-i-petct-dosimetry-in-high-risk-differentiated-thyroid-cance 2026-07-22T12:30:58.773Z weekly 0.7 https://www.humanexasignals.com/signals/jnj-79635322-dose-escalation-study-in-multiple-myeloma-shows-promising-combinati 2026-07-22T12:30:52.733Z weekly 0.7 https://www.humanexasignals.com/signals/biontechs-bnt324-and-bnt327-combination-therapy-in-advanced-lung-cancer-under-in 2026-07-22T12:30:47.039Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-aerobic-exercise-benefits-for-pulmonary-hypertension-patients 2026-07-22T12:30:40.927Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-focal-shock-wave-therapy-for-vulvodynia-shows-promise 2026-07-22T12:30:34.652Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-treatment-of-peri-implantitis-with-soft-tissue-augmentation-initiated 2026-07-22T06:32:05.041Z weekly 0.7 https://www.humanexasignals.com/signals/metformin-trial-post-lvad-implantation-to-assess-cardiac-function-improvement 2026-07-22T06:31:59.071Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ethnic-differences-in-adipose-tissue-dysfunction-and-type-2-diabetes-ri 2026-07-22T06:31:51.015Z weekly 0.7 https://www.humanexasignals.com/signals/jnj-89402638-phase-2-study-initiated-for-metastatic-colorectal-and-gastric-cance 2026-07-22T06:31:44.030Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-zanzalintinib-in-advanced-bone-sarcomas-initiated 2026-07-22T06:31:37.737Z weekly 0.7 https://www.humanexasignals.com/signals/psilocybin-assisted-psychotherapy-trial-for-advanced-cancer-patients-launched 2026-07-22T06:31:30.125Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-optimizes-therapy-for-her2-breast-cancer-patients-post-surgery 2026-07-22T06:02:27.627Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-flexor-hallucis-longus-training-impact-on-geriatric-balance-and-falls 2026-07-22T06:02:19.993Z weekly 0.7 https://www.humanexasignals.com/signals/domperidone-updated-with-new-contraindication-for-phaeochromocytoma-patients 2026-07-22T06:02:04.354Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-approves-first-lower-carbon-beclometasone-inhalers-for-asthma 2026-07-22T06:01:55.897Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-hyoscine-butyl-bromide-and-prostaglandins-for-labor-induction 2026-07-22T06:01:47.378Z weekly 0.7 https://www.humanexasignals.com/signals/vivacity-mg3-study-reveals-high-healthcare-costs-in-generalized-myasthenia-gravi 2026-07-22T06:01:40.255Z weekly 0.7 https://www.humanexasignals.com/signals/trichodermin-shows-potent-anti-glioblastoma-effects-enhancing-temozolomide-effic 2026-07-22T06:01:31.773Z weekly 0.7 https://www.humanexasignals.com/signals/inhaled-3-hypertonic-saline-shows-promise-for-antibiotic-nave-ntm-lung-disease 2026-07-22T06:01:24.676Z weekly 0.7 https://www.humanexasignals.com/signals/car-t-cell-therapy-for-all-emerging-research-trends-and-focus-areas-identified 2026-07-22T06:01:15.815Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-mycophenolate-mofetil-anda218566-by-concord-biotech 2026-07-22T00:33:18.128Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-afinitor-everolimus-by-novartis 2026-07-22T00:33:02.533Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-ozempic-semaglutide 2026-07-22T00:32:48.307Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-ultomiris-ravulizumab-cwvz 2026-07-22T00:32:34.820Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-zydus-lifesciences-fluorescein-sodium-application 2026-07-22T00:32:21.620Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-amneals-phytonadione-anda217734 2026-07-22T00:32:08.614Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-methylprednisolone-anda206751 2026-07-22T00:31:58.812Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-diazepam-by-hikma 2026-07-22T00:31:41.754Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-xocova-ensitrelvir-by-shionogi 2026-07-22T00:31:32.631Z weekly 0.7 https://www.humanexasignals.com/signals/mayo-clinics-sos5c-trial-explores-ai-and-minimally-invasive-methods-for-barretts 2026-07-22T00:31:23.156Z weekly 0.7 https://www.humanexasignals.com/signals/spectrum-pharmaceuticals-evaluates-eflapegrastim-in-pediatric-cancer-patients 2026-07-22T00:31:14.958Z weekly 0.7 https://www.humanexasignals.com/signals/peer-support-study-aims-to-enhance-adherence-in-ms-patients 2026-07-22T00:31:06.262Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-pembrolizumab-for-neurological-symptoms-post-covid-19 2026-07-22T00:30:52.901Z weekly 0.7 https://www.humanexasignals.com/signals/exelixis-initiates-trial-for-xb628-and-zanzalintinib-in-advanced-solid-tumors 2026-07-22T00:30:45.188Z weekly 0.7 https://www.humanexasignals.com/signals/gsk-initiates-first-time-in-human-study-of-remzistotug-for-advanced-solid-tumors 2026-07-22T00:30:35.647Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-safety-follow-up-for-seattle-childrens-gene-therapy-products-initiated 2026-07-22T00:30:28.508Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda220482-from-haisco-pharmaceutical-for-review 2026-07-21T18:34:24.383Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-morphine-sulfate-by-fresenius-kabi-usa 2026-07-21T18:34:10.026Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-epinephrine-anda220562-receives-abbreviated-approval-from-fda 2026-07-21T18:33:55.312Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-zaynich-nda-submission-by-wockhardt-bio-ag 2026-07-21T18:33:42.128Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-phentermine-hydrochloride-and-topiramate-by-dr-reddys-l 2026-07-21T18:32:39.227Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-bupropion-hydrochloride-by-graviti-pharms 2026-07-21T18:32:26.752Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-cavhanza-nilotinib-by-flex-pharma 2026-07-21T18:32:14.165Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-afrezza-by-mannkind 2026-07-21T18:32:02.290Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-oxcarbazepine-anda209020 2026-07-21T18:31:48.515Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-voriconazole-by-hainan-poly-pharm 2026-07-21T18:31:34.899Z weekly 0.7 https://www.humanexasignals.com/signals/ai-lifestyle-coach-study-for-type-2-diabetes-shows-potential-for-remote-manageme 2026-07-21T18:31:26.234Z weekly 0.7 https://www.humanexasignals.com/signals/ketamine-trial-for-long-covid-symptoms-shows-promise-for-fatigue-and-brain-fog 2026-07-21T18:31:15.858Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-study-of-gdc-7035-in-advanced-solid-tumors-with-kras-g12d-mutation 2026-07-21T18:31:07.812Z weekly 0.7 https://www.humanexasignals.com/signals/endotronix-initiates-proactive-hf-2-trial-for-cordella-system-in-heart-failure-p 2026-07-21T18:30:59.513Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-endometrial-cavity-post-conservative-management-in-pas-patients 2026-07-21T18:30:52.697Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-high-flow-oxygen-therapy-for-hypoxemic-respiratory-distress-initiated 2026-07-21T18:30:43.626Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ib-study-of-avutometinib-defactinib-and-everolimus-in-ras-mutant-endometri 2026-07-21T18:30:29.217Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-sandimmune-by-novartis 2026-07-21T12:32:52.980Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-oxcarbazepine-by-glenmark-pharmaceuticals 2026-07-21T12:32:40.706Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-widaplik-by-azurity 2026-07-21T12:32:28.990Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-hepzato-by-delcath-systems 2026-07-21T12:32:18.631Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-carbidope-and-levodopa-supplement-by-rubicon-research-1 2026-07-21T12:32:09.005Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-dapagliflozin-by-inventia-1 2026-07-21T12:31:58.781Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-columvi-glofitamab-gxbm 2026-07-21T12:31:48.261Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-deflazacort-anda220709-by-carnegie 2026-07-21T12:31:40.184Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-implanon-by-organon 2026-07-21T12:31:32.253Z weekly 0.7 https://www.humanexasignals.com/signals/faron-pharmaceuticals-initiates-phase-iib-trial-of-bexmarilimab-in-higher-risk-m 2026-07-21T12:31:19.403Z weekly 0.7 https://www.humanexasignals.com/signals/feldan-therapeutics-initiates-fld-103-trial-for-basal-cell-carcinoma 2026-07-21T12:31:10.230Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-launches-ai-study-for-lung-cancer-risk-stratification 2026-07-21T12:31:01.303Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ctdnas-predictive-value-in-nsclc-patients-treated-with-icis 2026-07-21T12:30:54.850Z weekly 0.7 https://www.humanexasignals.com/signals/machine-learning-model-developed-to-differentiate-diabetic-kidney-disease-in-typ 2026-07-21T12:30:43.200Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-endoscopic-submucosal-dissection-for-early-gi-neoplasia-launched-in-the 2026-07-21T12:30:36.756Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-anda220724-by-zydus-pharmaceuticals 2026-07-21T06:32:50.148Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-darzalex-daratumumab 2026-07-21T06:32:36.762Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-divalproex-sodium-supplement-receives-fda-ap-status 2026-07-21T06:32:23.318Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-oxcarbazepine-by-annora-pharma 2026-07-21T06:32:10.802Z weekly 0.7 https://www.humanexasignals.com/signals/registry-study-for-minos-stent-graft-in-abdominal-aortic-aneurysm-treatment-laun 2026-07-21T06:31:59.081Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-vas-101-gel-for-improved-curcumin-absorption-in-sickle-cell-dis 2026-07-21T06:31:48.093Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-mrna-hiv-vaccines-dv700p-rna-and-dv701b11-rna-initiated 2026-07-21T06:31:36.197Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-lti-03-in-idiopathic-pulmonary-fibrosis-patients-initiated-by-r 2026-07-21T06:31:25.256Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-study-of-ro7566802-in-combination-with-atezolizumab-for-solid-tumors 2026-07-21T06:31:08.178Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3b-study-of-cervavac-vaccine-in-women-living-with-hiv-initiated 2026-07-21T06:30:58.036Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sotatercept-study-for-pulmonary-arterial-hypertension-launches-in-india 2026-07-21T06:30:46.188Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-phase-iii-study-of-azd4512-in-b-cell-non-hodgkin-lymphoma 2026-07-21T06:30:36.999Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-tremfya-guselkumab-by-janssen-biotech 2026-07-21T06:03:48.989Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-imfinzi-durvalumab-by-astrazeneca 2026-07-21T06:03:35.577Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-ipg7236-and-toripalimab-in-advanced-solid-tumors-initiated 2026-07-21T06:03:12.097Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-teleo-virtual-therapy-platform-for-youth-psychotherapy-engagem 2026-07-21T06:02:59.780Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-dopamine-release-in-cocaine-use-disorders-using-pet-imaging 2026-07-21T06:02:47.738Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheims-bi-764198-trial-focuses-on-safety-and-pharmacokinetics 2026-07-21T06:02:37.552Z weekly 0.7 https://www.humanexasignals.com/signals/janssen-launches-global-registry-for-inherited-retinal-diseases 2026-07-21T06:02:27.314Z weekly 0.7 https://www.humanexasignals.com/signals/infliximab-trial-for-acute-pancreatitis-shows-potential-efficacy 2026-07-21T06:02:17.041Z weekly 0.7 https://www.humanexasignals.com/signals/unique-pharmaceutical-laboratories-recalls-cetirizine-hydrochloride-due-to-ranit 2026-07-21T06:02:06.589Z weekly 0.7 https://www.humanexasignals.com/signals/manufacturing-issue-with-xaggitin-xl-tablets-reported-by-martindale-pharma 2026-07-21T06:01:56.037Z weekly 0.7 https://www.humanexasignals.com/signals/baxter-faces-early-alert-over-intravascular-administration-set-air-bubble-issue 2026-07-21T06:01:48.002Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-q1-2026-revenue-up-56-raises-full-year-guidance 2026-07-21T06:01:34.881Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-to-acquire-ajax-therapeutics-for-myelofibrosis-and-polycythemia-vera 2026-07-21T06:01:27.566Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-to-acquire-kelonia-therapeutics-for-in-vivo-car-t-cell-therapy-advancement 2026-07-21T06:01:19.004Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-clindamycin-phosphate-supplement-by-almaject-2 2026-07-21T00:33:00.311Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-clindamycin-phosphate-supplement-by-almaject-1 2026-07-21T00:32:48.130Z weekly 0.7 https://www.humanexasignals.com/signals/impax-labs-receives-ap-status-for-carbidope-and-levodopa-supplement 2026-07-21T00:32:36.433Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-oxcarbazepine-anda211747 2026-07-21T00:32:25.153Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lupins-sodium-sulfate-magnesium-sulfate-and-potassium-ch 2026-07-21T00:32:14.596Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-supplemental-anda-for-carbidopa-and-levodopa 2026-07-21T00:32:05.283Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-clindamycin-phosphate-supplement-by-almaject 2026-07-21T00:31:56.898Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-feraheme-by-azurity 2026-07-21T00:31:48.615Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-xatmep-methotrexate-sodium 2026-07-21T00:31:37.499Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-methotrexate-sodium-anda217552-receives-ap-status-from-fda 2026-07-21T00:31:29.917Z weekly 0.7 https://www.humanexasignals.com/signals/janssens-apalutamide-study-targets-mcrpc-in-chinese-patients 2026-07-21T00:31:21.876Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-baricitinib-evaluated-for-safety-in-pediatric-sjia-patients 2026-07-21T00:31:02.159Z weekly 0.7 https://www.humanexasignals.com/signals/brentuximab-vedotin-and-pembrolizumab-trial-for-metastatic-cancers-initiated 2026-07-21T00:30:44.548Z weekly 0.7 https://www.humanexasignals.com/signals/hoffmann-la-roches-prasinezumab-trial-targets-early-stage-parkinsons-disease 2026-07-21T00:30:36.547Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda213343 2026-07-20T18:33:30.338Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-methotrexate-sodium-by-hikma 2026-07-20T18:33:16.283Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda213362 2026-07-20T18:33:02.505Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-trexall-methotrexate-sodium-by-barr 2026-07-20T18:32:46.386Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-doxycycline-anda202778-by-strides-pharma 2026-07-20T18:32:34.545Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-methotrexate-sodium-by-strides-pharma 2026-07-20T18:32:22.837Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-abbvies-bla761460-decnupaz 2026-07-20T18:32:07.214Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-methotrexate-sodium-supplement 2026-07-20T18:31:57.365Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-carboprost-tromethamine-anda219529 2026-07-20T18:31:47.448Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-linagliptin-by-teva-pharmaceuticals 2026-07-20T18:31:38.793Z weekly 0.7 https://www.humanexasignals.com/signals/efficacy-study-of-apalutamide-in-high-risk-prostate-cancer-underway 2026-07-20T18:31:30.212Z weekly 0.7 https://www.humanexasignals.com/signals/aquatic-hiit-trial-for-parkinsons-disease-shows-potential-benefits 2026-07-20T18:31:22.514Z weekly 0.7 https://www.humanexasignals.com/signals/ethicons-rethink-reflux-registry-to-assess-long-term-safety-of-linx-device 2026-07-20T18:31:14.495Z weekly 0.7 https://www.humanexasignals.com/signals/golidocitinib-pilot-study-in-mycosis-fungoides-and-t-lgll-initiated 2026-07-20T18:31:06.471Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sleep-interventions-impact-on-alzheimers-disease-progression 2026-07-20T18:30:59.647Z weekly 0.7 https://www.humanexasignals.com/signals/nci-and-lantheus-test-pmsa-based-pet-imaging-for-high-risk-prostate-cancer 2026-07-20T18:30:43.638Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pvi-predictors-in-laparoscopic-hysterectomy-to-enhance-fluid-management 2026-07-20T18:30:35.875Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluates-ai-communication-aid-in-prostate-cancer-care 2026-07-20T18:30:28.453Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-losartan-potassium-and-hydrochlorothiazide-anda219869 2026-07-20T12:33:44.646Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda216453 2026-07-20T12:33:28.914Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-capivasertib-nda218197-receives-ap-status-from-fda 2026-07-20T12:33:13.784Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda081099-by-barr 2026-07-20T12:32:59.539Z weekly 0.7 https://www.humanexasignals.com/signals/amneal-pharmaceuticals-receives-ap-status-for-methotrexate-sodium-anda210040 2026-07-20T12:32:46.051Z weekly 0.7 https://www.humanexasignals.com/signals/mylans-methotrexate-sodium-anda081235-receives-abbreviated-approval 2026-07-20T12:32:34.618Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methotrexate-sodium-anda201749-by-sun-pharma 2026-07-20T12:32:22.941Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-jylamvo-by-shorla 2026-07-20T12:32:11.931Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharmas-methotrexate-sodium-anda210454-receives-ap-status 2026-07-20T12:32:00.746Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-koselugo-selumetinib 2026-07-20T12:31:50.375Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-adaptive-sbrt-for-localized-prostate-cancer-initiated 2026-07-20T12:31:32.629Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-probiotics-and-prebiotics-for-obesity-in-prader-willi-syndrome-children 2026-07-20T12:31:23.294Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-stent-assisted-coil-embolization-for-acute-intracranial-aneurysms 2026-07-20T12:31:06.764Z weekly 0.7 https://www.humanexasignals.com/signals/gi-windows-inc-initiates-study-on-duodenum-to-ileal-diversion-for-type-2-diabete 2026-07-20T12:30:59.019Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-hemo-integra-for-intraoperative-hemodynamic-monitoring-in-cardiac 2026-07-20T12:30:51.751Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mental-health-outcomes-post-pregnancy-loss-in-denmark 2026-07-20T12:30:44.416Z weekly 0.7 https://www.humanexasignals.com/signals/amgens-maritime-2-extension-trial-evaluates-maridebart-cafraglutide-for-obesity- 2026-07-20T12:30:36.090Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-l-glutamine-anda219722-by-annora-pharma 2026-07-20T06:33:53.460Z weekly 0.7 https://www.humanexasignals.com/signals/nephrons-levalbuterol-hydrochloride-anda215217-receives-approval-status 2026-07-20T06:33:36.368Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-topiramate-anda220041-by-riconpharma 2026-07-20T06:33:19.854Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-nulibry-by-sentyln-therapies 2026-07-20T06:33:04.019Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-olanzapine-anda203708-receives-ap-status-from-fda 2026-07-20T06:32:47.545Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-uptravi-selexipag 2026-07-20T06:32:33.085Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-imatinib-mesylate-by-hetero-labs 2026-07-20T06:32:19.580Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-inc-submits-anda220465-for-fda-review 2026-07-20T06:32:06.740Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-tofidence-tocilizumab-bavi 2026-07-20T06:31:54.844Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-differin-epiduo-acne-gel-for-acne-treatment 2026-07-20T06:31:44.043Z weekly 0.7 https://www.humanexasignals.com/signals/strykers-mild-procedure-study-to-assess-medicare-beneficiary-outcomes 2026-07-20T06:31:33.410Z weekly 0.7 https://www.humanexasignals.com/signals/crinetics-pharmaceuticals-initiates-pediatric-cah-study-for-atumelnant 2026-07-20T06:31:23.229Z weekly 0.7 https://www.humanexasignals.com/signals/local-corticosteroid-injection-shows-promise-over-surgery-for-de-quervain-tenosy 2026-07-20T06:31:13.780Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-study-on-transdermal-delivery-of-neostigmine-for-bowel-care-in-sci-patie 2026-07-20T06:31:05.180Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-retrolaminar-blocks-impact-on-opioid-use-in-spine-surgery 2026-07-20T06:30:53.527Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ibii-study-of-glofitamab-with-atezolizumab-or-polatuzumab-in-b-cell-nhl 2026-07-20T06:30:45.780Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-mk-2214-trial-aims-to-slow-tau-spread-in-early-alzheimers-disease 2026-07-20T06:30:36.531Z weekly 0.7 https://www.humanexasignals.com/signals/janssens-apalutamide-study-targets-high-risk-prostate-cancer-pre-radical-prostat 2026-07-20T06:30:28.413Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-lacosamide-anda209224-receives-ap-status-from-fda 2026-07-20T06:06:13.633Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-lacosamide-anda204994-receives-ap-status-from-fda 2026-07-20T06:05:52.173Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-datopotamab-deruxtecan-supplement 2026-07-20T06:05:32.390Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-bla761468-hepcludex-by-gilead-sciences 2026-07-20T06:05:15.352Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-fintepla-fenfluramine-by-ucb 2026-07-20T06:04:58.120Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-anda220143-by-hetero-labs 2026-07-20T06:04:43.814Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-dapagliflozin-and-metformin-hydrochlori 2026-07-20T06:04:29.588Z weekly 0.7 https://www.humanexasignals.com/signals/hoffmann-la-roche-evaluates-petrelintide-and-enicepatide-in-obesity-trial 2026-07-20T06:04:15.118Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-vc005-tablets-in-renal-impairment-shows-safety-and-pharmacokine 2026-07-20T06:04:01.553Z weekly 0.7 https://www.humanexasignals.com/signals/new-ai-framework-for-diagnosing-anterior-segment-diseases-in-clinical-trial 2026-07-20T06:03:48.488Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-intra-arterial-cooling-infusion-in-acute-ischemic-stroke-initiated 2026-07-20T06:03:38.325Z weekly 0.7 https://www.humanexasignals.com/signals/study-targets-maternal-mortality-in-native-mothers-through-integrated-care-model 2026-07-20T06:03:28.306Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-rochester-launches-egap-study-for-older-cancer-patients 2026-07-20T06:03:19.406Z weekly 0.7 https://www.humanexasignals.com/signals/tasly-pharma-trials-qishen-yiqi-pills-for-chronic-heart-failure 2026-07-20T06:03:09.447Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-far-infrared-rays-and-tens-for-head-and-neck-cancer-patients 2026-07-20T06:03:01.054Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-proton-sfrt-and-standard-radiation-for-retroperitoneal-soft-t 2026-07-20T06:02:52.948Z weekly 0.7 https://www.humanexasignals.com/signals/study-identifies-key-genes-and-potential-therapies-in-myasthenia-gravis-via-lipi 2026-07-20T06:02:42.257Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-crisaborole-ointment-and-laser-therapy-for-non-segmental-vitiligo 2026-07-20T06:02:35.203Z weekly 0.7 https://www.humanexasignals.com/signals/gut-microbiota-dynamics-linked-to-opioid-use-disorder-in-mouse-model 2026-07-20T06:02:27.012Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-sitagliptin-and-metformin-hydrochloride-by-mankind-pharma 2026-07-20T00:32:04.862Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-tyenne-tocilizumab-aazg 2026-07-20T00:31:54.965Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-cleocin-clindamycin-palmitate-hydrochloride 2026-07-20T00:31:46.336Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-biktarvy-by-gilead-sciences 2026-07-20T00:31:38.549Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-linzess-by-abbvie 2026-07-20T00:31:30.632Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-anda-for-empagliflozin 2026-07-20T00:31:22.640Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-lacosamide-by-steranco-healthcare 2026-07-20T00:31:15.011Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-argatroban-by-accord-healthcare 2026-07-20T00:31:07.508Z weekly 0.7 https://www.humanexasignals.com/signals/genmab-initiates-phase-2-trial-of-rina-s-for-non-small-cell-lung-cancer 2026-07-20T00:30:59.281Z weekly 0.7 https://www.humanexasignals.com/signals/genmabs-gen1042-trial-evaluates-anti-tumor-activity-in-solid-tumors 2026-07-20T00:30:51.657Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-missouri-columbia-launches-naloxone-training-initiative-to-combat- 2026-07-20T00:30:46.409Z weekly 0.7 https://www.humanexasignals.com/signals/fda-mandates-compliance-for-imported-heparin-sodium-with-usp-specifications 2026-07-20T00:30:28.375Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-nyvepria-pegfilgrastim-apgf 2026-07-19T18:32:58.051Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-clonazepam-anda216988-from-rubicon-research 2026-07-19T18:32:43.182Z weekly 0.7 https://www.humanexasignals.com/signals/granules-anda217027-for-amphetamine-products-receives-fda-approval 2026-07-19T18:32:30.667Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-xyzal-allergy-24hr-supplement-application 2026-07-19T18:32:17.957Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharma-submits-supplemental-application-for-zoledronic-acid-anda209125 2026-07-19T18:32:06.331Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-childrens-claritin 2026-07-19T18:31:55.737Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-brimonidine-tartrate-by-apotex 2026-07-19T18:31:45.366Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-anda-for-brimonidine-tartrate 2026-07-19T18:31:35.279Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-levothyroxine-sodium-anda216370-by-alembic 2026-07-19T18:31:26.384Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-laser-blended-vision-and-monovision-lasik-for-presbyopia 2026-07-19T18:31:17.645Z weekly 0.7 https://www.humanexasignals.com/signals/epcoritamab-trial-in-japanese-rr-b-cell-nhl-shows-safety-and-efficacy-potential 2026-07-19T18:31:09.343Z weekly 0.7 https://www.humanexasignals.com/signals/ai-enhanced-mri-techniques-may-improve-prostate-cancer-diagnosis 2026-07-19T18:31:00.795Z weekly 0.7 https://www.humanexasignals.com/signals/lavender-aromatherapy-trial-for-cognitive-function-in-older-adults-with-mci 2026-07-19T18:30:53.853Z weekly 0.7 https://www.humanexasignals.com/signals/yale-university-launches-pragmatic-trial-for-colorectal-cancer-screening-adheren 2026-07-19T18:30:46.138Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-real-world-use-of-darolutamide-in-metastatic-hormone-sensitive-prostate 2026-07-19T18:30:39.975Z weekly 0.7 https://www.humanexasignals.com/signals/study-initiated-to-develop-exosomal-microrna-biomarker-for-colon-cancer-staging 2026-07-19T18:30:30.769Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-nebivolol-hydrochloride-anda212682 2026-07-19T12:32:56.922Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-meropenem-by-acs-dobfar 2026-07-19T12:32:44.100Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-tyenne-tocilizumab-aazg-by-fresenius-kabi 2026-07-19T12:32:31.916Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-venclexta-by-abbvie 2026-07-19T12:32:20.851Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-esomeprazole-magnesium-by-marksans-pharma 2026-07-19T12:32:10.499Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-verapamil-hydrochloride-anda211015 2026-07-19T12:32:00.098Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-verapamil-hydrochloride-anda211035 2026-07-19T12:31:50.981Z weekly 0.7 https://www.humanexasignals.com/signals/breckenridges-eplerenone-anda208283-receives-abbreviated-approval 2026-07-19T12:31:42.704Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-anda220055-by-msn-laboratories 2026-07-19T12:31:34.838Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplement-approval-for-lurasidone-hydrochloride-by-amneal-pharmaceut 2026-07-19T12:31:27.388Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-superficial-cervical-block-to-reduce-opioid-use-in-cervical-disc 2026-07-19T12:31:20.336Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-on-ire-system-for-adenotonsillar-hypertrophy-in-children 2026-07-19T12:31:13.541Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-deep-brain-stimulations-impact-on-eye-function-in-parkinsons-disease 2026-07-19T12:31:04.757Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-ly3457263-trial-in-type-2-diabetes-shows-potential-against-semaglutid 2026-07-19T12:30:58.093Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-safety-and-efficacy-study-of-ibrutinib-initiated-by-janssen 2026-07-19T12:30:50.744Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-eloralintide-shows-promise-for-osteoarthritis-knee-pain-in-obese-pati 2026-07-19T12:30:43.619Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-initiates-dose-exploration-study-of-bi-1831169-with-anti-pd 2026-07-19T12:30:36.837Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-study-of-da-302168s-for-overweightobesity-initiated-in-china 2026-07-19T12:30:30.270Z weekly 0.7 https://www.humanexasignals.com/signals/teva-reports-labelling-error-for-ponlimsi-denosumab-60mg-injection 2026-07-19T06:32:43.536Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-linaclotide-anda-submission-by-actavis-labs 2026-07-19T06:32:29.999Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-macitentan-by-seasons-biotech 2026-07-19T06:32:19.042Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-mirtazapine-anda220104-by-micro-labs 2026-07-19T06:32:09.064Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-isoproterenol-hydrochloride-anda220299 2026-07-19T06:31:57.954Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-zynyz-retifanlimab-dlwr-by-incyte 2026-07-19T06:31:49.236Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-herceptin-hylecta-supplement-application 2026-07-19T06:31:41.185Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-divalproex-sodium-supplement-by-apotex 2026-07-19T06:31:32.507Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-glycopyrrolate-anda216910-by-quagen 2026-07-19T06:31:25.090Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-clindamycin-phosphate-by-encube 2026-07-19T06:31:18.828Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-thio-and-cadonilimab-for-resectable-hepatocellular-carcinoma-launched 2026-07-19T06:31:12.407Z weekly 0.7 https://www.humanexasignals.com/signals/mount-sinai-launches-pilot-study-on-chemotherapy-vs-surgery-for-stage-iiiii-rect 2026-07-19T06:31:03.446Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-chronic-post-cesarean-pain-under-eras-protocol 2026-07-19T06:30:57.377Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-on-brain-stimulation-for-vision-impairment-shows-potential-for-mobil 2026-07-19T06:30:48.499Z weekly 0.7 https://www.humanexasignals.com/signals/polyactivas-pa5346-ocular-implant-trial-for-glaucoma-underway 2026-07-19T06:30:42.249Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-cd70car-nk-cells-in-dlbcl-and-hodgkin-lymphoma-initiated 2026-07-19T06:30:32.265Z weekly 0.7 https://www.humanexasignals.com/signals/genex-with-gentamicin-trial-for-osteomyelitis-shows-promise-in-surgical-treatmen 2026-07-19T06:30:26.507Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-study-of-js001sc-in-advanced-nasopharyngeal-carcinoma-shows-focus-on-saf 2026-07-19T06:03:15.822Z weekly 0.7 https://www.humanexasignals.com/signals/astellas-pharmas-asp5541-phase-2-study-in-advanced-prostate-cancer-underway 2026-07-19T06:03:06.818Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-basis-of-developmental-language-disorder-launched 2026-07-19T06:02:59.697Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-chronic-post-surgical-pain-following-video-assisted-thoracic-surgery-la 2026-07-19T06:02:51.802Z weekly 0.7 https://www.humanexasignals.com/signals/renibus-therapeutics-initiates-long-term-study-of-veverimer-for-ckd-and-metaboli 2026-07-19T06:02:42.900Z weekly 0.7 https://www.humanexasignals.com/signals/novel-cmcceo2-nanocarriers-enhance-quercetin-delivery-in-lung-cancer-cells 2026-07-19T06:02:35.125Z weekly 0.7 https://www.humanexasignals.com/signals/intramuscular-pdx-models-show-high-engraftment-for-gastric-cancer-drug-testing 2026-07-19T06:02:28.022Z weekly 0.7 https://www.humanexasignals.com/signals/septin9-methylation-in-ctdna-predicts-mrd-in-colorectal-cancer-patients-post-sur 2026-07-19T06:02:14.670Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-mri-and-petct-in-prostate-cancer-staging-reevaluated-with- 2026-07-19T06:02:07.786Z weekly 0.7 https://www.humanexasignals.com/signals/resmetirom-rezdiffra-approved-for-mash-treatment-in-adults 2026-07-19T00:34:11.357Z weekly 0.7 https://www.humanexasignals.com/signals/novel-imaging-biomarker-ppat-thickness-predicts-prostate-cancer-in-gray-zone-pat 2026-07-19T00:33:53.670Z weekly 0.7 https://www.humanexasignals.com/signals/galectin-3pd-l1-cecs-identified-as-immunosuppressive-drivers-in-tnbc 2026-07-19T00:33:33.099Z weekly 0.7 https://www.humanexasignals.com/signals/study-links-neoadjuvant-immunochemotherapy-to-postoperative-ahrf-risk-in-thoraci 2026-07-19T00:33:15.913Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-phesgo-supplement-for-genentechs-combination-therapy 2026-07-19T00:33:00.592Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-lurasidone-hydrochloride-anda208045-receives-ap-status 2026-07-19T00:32:47.125Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-apomorphine-hydrochloride-nda214056 2026-07-19T00:32:32.671Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lurasidone-hydrochloride-anda208028 2026-07-19T00:32:21.683Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-dr-reddys-phytonadione-anda215820 2026-07-19T00:32:08.951Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-palbociclib-by-dr-reddys-laboratories 2026-07-19T00:31:58.070Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-argatroban-by-hikma-pharma 2026-07-19T00:31:48.522Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tecentriq-hybreza-supplement-application 2026-07-19T00:31:40.041Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-oxcarbazepine-anda207717-submission 2026-07-19T00:31:31.622Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-clomiphene-citrate-anda220673-by-ascent-pharms 2026-07-19T00:31:23.267Z weekly 0.7 https://www.humanexasignals.com/signals/otsukas-opc-167832-trial-for-drug-susceptible-tb-shows-promise-against-standard- 2026-07-19T00:31:13.787Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tes-ti-to-modulate-sleep-spindles-in-schizophrenia-spectrum-disorders 2026-07-19T00:31:05.966Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-124i-cg250-petct-for-early-detection-of-therapy-response-in-metastatic- 2026-07-19T00:30:57.680Z weekly 0.7 https://www.humanexasignals.com/signals/gsks-bepirovirsen-study-targets-hivhbv-co-infection-efficacy-and-safety 2026-07-19T00:30:50.502Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-remibrutinib-in-hidradenitis-suppurativa-underway 2026-07-19T00:30:28.189Z weekly 0.7 https://www.humanexasignals.com/signals/nanjing-immunophage-initiates-phase-12a-trial-for-ipg7236-in-advanced-solid-tumo 2026-07-18T18:31:23.079Z weekly 0.7 https://www.humanexasignals.com/signals/infrastructure-proposal-for-mhealth-interventions-in-cancer-patient-smoking-cess 2026-07-18T18:31:10.704Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-perimenopause-related-mood-disorders-examines-hormonal-impact 2026-07-18T18:30:56.900Z weekly 0.7 https://www.humanexasignals.com/signals/mayo-clinic-trial-on-health-coaching-for-thyroid-cancer-survivors 2026-07-18T18:30:49.776Z weekly 0.7 https://www.humanexasignals.com/signals/vorasidenib-and-temozolomide-combination-study-in-idh-mutant-glioma-initiated 2026-07-18T18:30:43.980Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-biospecimen-study-to-enhance-immunotherapy-research 2026-07-18T18:30:36.062Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-cilta-cel-and-talquetamab-combinations-with-daratumumab-in-multi 2026-07-18T18:30:30.056Z weekly 0.7 https://www.humanexasignals.com/signals/zno-nanoparticles-from-pomegranate-husk-show-promise-in-obesity-management 2026-07-18T12:33:56.508Z weekly 0.7 https://www.humanexasignals.com/signals/novel-mof-pzno-nanocomposite-shows-promise-for-targeted-cancer-therapy 2026-07-18T12:33:42.804Z weekly 0.7 https://www.humanexasignals.com/signals/exosomes-as-promising-candidates-for-dermatological-and-oncological-treatments 2026-07-18T12:33:31.556Z weekly 0.7 https://www.humanexasignals.com/signals/dn022150-trial-initiated-for-advanced-pancreatic-cancer-with-kras-g12d-mutation 2026-07-18T12:33:17.854Z weekly 0.7 https://www.humanexasignals.com/signals/eccentric-training-vs-standard-strength-training-in-spinal-cord-injury-rehabilit 2026-07-18T12:33:07.486Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-oral-care-in-vlbw-infants-to-address-oral-dysbiosis 2026-07-18T12:32:58.378Z weekly 0.7 https://www.humanexasignals.com/signals/miratis-adagrasib-plus-pembrolizumab-trial-for-nsclc-shows-promise 2026-07-18T12:32:47.336Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-oral-nicotine-pouches-impact-on-craving-and-brain-response 2026-07-18T12:32:39.105Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-ketamine-induced-phbold-in-healthy-volunteers 2026-07-18T12:32:28.014Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-oral-pcsk9-inhibitor-lipfendra-for-high-cholesterol 2026-07-18T12:32:11.541Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-recalls-14fr-low-profile-introducer-kits-due-to-thrombus-risk 2026-07-18T12:32:03.438Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplementary-application-for-stelara-by-centocor-ortho-biotech 2026-07-18T12:31:55.991Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-enlicitide-by-merck-sharp-and-dohme 2026-07-18T12:31:49.774Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-tegretol-carbamazepine-by-novartis 2026-07-18T12:31:43.348Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-endometrin-by-ferring 2026-07-18T12:31:36.730Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-repatha-evolocumab-by-amgen 2026-07-18T12:31:30.966Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-desmopressin-acetate-by-ferring-pharmaceuticals 2026-07-18T12:31:24.565Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-rocuronium-bromide-by-fresenius-kabi 2026-07-18T12:31:18.534Z weekly 0.7 https://www.humanexasignals.com/signals/dalbavancin-vs-standard-therapy-in-endocarditis-a-comparative-study 2026-07-18T06:32:53.516Z weekly 0.7 https://www.humanexasignals.com/signals/bright-trial-pembrolizumab-and-radiation-therapy-for-muscle-invasive-bladder-can 2026-07-18T06:32:39.755Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-azd4954-study-evaluates-safety-and-pharmacokinetics-in-healthy-adul 2026-07-18T06:32:26.354Z weekly 0.7 https://www.humanexasignals.com/signals/eyevansys-initiates-trial-for-pst-611-in-dry-amd-assessing-safety-and-tolerabili 2026-07-18T06:32:14.680Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-pembrolizumab-study-targets-japanese-pediatric-and-adult-cancer-patients 2026-07-18T06:32:02.761Z weekly 0.7 https://www.humanexasignals.com/signals/viiv-healthcare-initiates-first-in-human-trial-for-antiretroviral-vh4770359 2026-07-18T06:31:53.526Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-azd0120-phase-i-study-in-multiple-myeloma-initiated 2026-07-18T06:31:44.044Z weekly 0.7 https://www.humanexasignals.com/signals/niaid-initiates-phase-ab-trial-for-experimental-h1n1-influenza-vaccine-bpl-1357 2026-07-18T06:31:36.094Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-propofol-anda220857-by-anthea-pharma 2026-07-18T06:31:27.784Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-retevmo-selpercatinib 2026-07-18T06:31:19.896Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-anda-for-afatinib-dimaleate-fda-review-in-progress 2026-07-18T06:31:13.064Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-afatinib-dimaleate-anda210750 2026-07-18T06:31:06.188Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-revtorpyk-gedatolisib-for-celcuity-inc 2026-07-18T06:30:59.697Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-serostim-by-emd-serono 2026-07-18T06:30:53.161Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-brivaracetam-anda219766-by-shandong 2026-07-18T06:30:43.382Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lamotrigine-anda219677-by-taro 2026-07-18T06:30:38.199Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-alprazolam-anda213204-by-unichem 2026-07-18T06:30:32.732Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-lithium-carbonate-anda-receives-approval-status-from-fda 2026-07-18T06:30:26.885Z weekly 0.7 https://www.humanexasignals.com/signals/akebia-therapeutics-initiates-phase-2-trial-of-praliciguat-for-fsgs 2026-07-18T06:03:38.682Z weekly 0.7 https://www.humanexasignals.com/signals/shionogis-s-892216-study-targets-renal-impairment-pharmacokinetics 2026-07-18T06:03:24.552Z weekly 0.7 https://www.humanexasignals.com/signals/ausper-biopharma-initiates-ahb-171-trial-for-chronic-hepatitis-b 2026-07-18T06:03:13.636Z weekly 0.7 https://www.humanexasignals.com/signals/telemonitoring-program-shows-promise-for-copd-management 2026-07-18T06:03:02.962Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-dressing-strategies-to-prevent-marsi-in-cvcs 2026-07-18T06:02:47.181Z weekly 0.7 https://www.humanexasignals.com/signals/il-37-shows-protective-role-in-inflammatory-bowel-disease-and-colitis-associated 2026-07-18T06:02:36.943Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-oxcarbazepine-by-kanchan-healthcare 2026-07-18T06:02:27.254Z weekly 0.7 https://www.humanexasignals.com/signals/hospiras-heparin-sodium-anda090571-receives-ap-status-from-fda 2026-07-18T06:02:19.216Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-irbesartan-anda077205-by-chartwell-molecular 2026-07-18T06:02:06.723Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-eltrombopag-olamine-anda209938-receives-approval 2026-07-18T06:01:58.757Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-choline-fenofibrate-by-macleods-pharmaceuticals 2026-07-18T06:01:50.409Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-micro-labs-choline-fenofibrate-anda213450 2026-07-18T06:01:43.604Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-heparin-sodium-anda088100-from-hospira 2026-07-18T06:01:36.081Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-hospiras-heparin-sodium-preservative-free 2026-07-18T06:01:28.611Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-fabhalta-iptacopan-gains-fda-approval-for-primary-igan-treatment 2026-07-18T06:01:21.601Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-lipfendra-approved-as-first-oral-pcsk9-inhibitor-for-hypercholesterolemia 2026-07-18T06:01:14.248Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-crexont-by-impax 2026-07-18T00:32:55.135Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lorazepam-anda200542-by-rising 2026-07-18T00:32:41.917Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-irbesartan-anda206194-by-hisun-pharm 2026-07-18T00:32:30.734Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tecentriq-supplement-application 2026-07-18T00:32:19.508Z weekly 0.7 https://www.humanexasignals.com/signals/lupin-inc-submits-anda-for-revefenacin-to-fda 2026-07-18T00:32:08.885Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-bla-for-immgolis-golimumab-sldi-by-accord-biopharma 2026-07-18T00:31:58.864Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dr-reddys-venetoclax-anda214733 2026-07-18T00:31:49.595Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-baxfendy-baxdrostat-by-astrazeneca 2026-07-18T00:31:41.262Z weekly 0.7 https://www.humanexasignals.com/signals/jubilant-generics-receives-fda-approval-for-tadalafil-anda210329 2026-07-18T00:31:33.044Z weekly 0.7 https://www.humanexasignals.com/signals/hutchmed-initiates-study-on-food-and-ppi-effects-on-hmpl-760-pharmacokinetics 2026-07-18T00:31:23.309Z weekly 0.7 https://www.humanexasignals.com/signals/ocuphire-pharma-initiates-trial-for-nyxol-in-presbyopia-with-adjunctive-pilocarp 2026-07-18T00:31:09.531Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-study-on-durvalumab-and-tremelimumab-in-hcc-with-tace 2026-07-18T00:30:55.436Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-on-culturally-tailored-exercise-program-for-hispanics-with-knee-oa 2026-07-18T00:30:48.891Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-non-invasive-vagus-nerve-stimulation-for-ptsd-underway 2026-07-18T00:30:42.521Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-micrornas-as-biomarkers-for-suicidality-in-adolescents 2026-07-18T00:30:35.790Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-l-ornithine-l-aspartate-and-n-acetylcysteine-in-hrher2-advance 2026-07-18T00:30:28.594Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-enhertu-supplement-application 2026-07-17T18:34:59.162Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levothyroxine-sodium-anda211417 2026-07-17T18:34:44.569Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lamotrigine-anda077420-by-rising 2026-07-17T18:34:31.884Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-oxcarbazepine-by-rubicon-research 2026-07-17T18:34:18.624Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-mavenclad-by-emd-serono 2026-07-17T18:34:08.669Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-amneals-tretinoin-anda217497 2026-07-17T18:33:58.438Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-submits-anda-for-tivozanib-marking-a-new-generic-entry 2026-07-17T18:33:46.048Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-trimbow-nda219622-by-chiesi 2026-07-17T18:33:34.734Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-exercise-impact-on-mental-health-in-psychiatric-inpatients-initiated-by 2026-07-17T18:33:25.628Z weekly 0.7 https://www.humanexasignals.com/signals/nimh-initiates-pet-imaging-study-with-new-tracer-11c-armi-for-brain-research 2026-07-17T18:33:17.588Z weekly 0.7 https://www.humanexasignals.com/signals/venlafaxine-shows-promise-in-treating-bladder-pain-syndrome-with-behavioral-inte 2026-07-17T18:32:28.511Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-real-world-study-on-pluvicto-in-metastatic-crpc-patients 2026-07-17T18:32:03.528Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-respiratory-training-in-lower-extremity-lymphedema-initiated-by-toros-u 2026-07-17T18:31:55.868Z weekly 0.7 https://www.humanexasignals.com/signals/medtronics-study-on-left-bundle-branch-optimized-crt-for-heart-failure-outcomes 2026-07-17T18:31:40.288Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-ly4178256-tolerance-study-in-healthy-participants-initiated 2026-07-17T12:31:19.124Z weekly 0.7 https://www.humanexasignals.com/signals/detect-study-aims-to-identify-asymptomatic-atherosclerosis-prevalence-and-risk-f 2026-07-17T12:31:10.947Z weekly 0.7 https://www.humanexasignals.com/signals/ai-model-for-predicting-neoadjuvant-chemo-response-in-advanced-gastric-cancer 2026-07-17T12:31:02.122Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-azd5004-study-evaluates-drug-interaction-with-mitiglinide-and-piogl 2026-07-17T12:30:53.371Z weekly 0.7 https://www.humanexasignals.com/signals/rph-002-shows-comparable-efficacy-to-erbitux-in-head-and-neck-cancer-trial 2026-07-17T12:30:44.467Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-integrated-care-for-atrial-fibrillation-and-heart-failure-in-rural-chin 2026-07-17T12:30:36.452Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-electroacupuncture-and-exercise-for-chemotherapy-induced-peripheral-neu 2026-07-17T06:32:35.991Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-maternal-diet-impact-on-infant-peanut-and-egg-allergy-development 2026-07-17T06:32:27.316Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rivaroxabans-effects-in-peripheral-artery-disease-initiated 2026-07-17T06:32:19.909Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2a-trial-of-riluzole-for-cancer-related-cognitive-impairment-initiated 2026-07-17T06:32:13.174Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tavns-for-postoperative-pain-management-in-thoracoscopic-surgery 2026-07-17T06:31:54.852Z weekly 0.7 https://www.humanexasignals.com/signals/dietary-butyrate-enhances-anti-pd-1-efficacy-in-nsclc-via-gut-microbiome-modulat 2026-07-17T06:31:46.963Z weekly 0.7 https://www.humanexasignals.com/signals/enhanced-intestinal-delivery-of-volatile-phytotherapeutics-via-self-microemulsif 2026-07-17T06:31:38.484Z weekly 0.7 https://www.humanexasignals.com/signals/ivarmacitinib-shows-early-response-linked-to-long-term-efficacy-in-atopic-dermat 2026-07-17T06:31:28.631Z weekly 0.7 https://www.humanexasignals.com/signals/b-braun-medical-recalls-spinal-anesthesia-kits-due-to-bupivacaine-hydrochloride- 2026-07-17T06:03:27.666Z weekly 0.7 https://www.humanexasignals.com/signals/link-between-graves-disease-and-prostate-cancer-explored-through-bioinformatics 2026-07-17T06:03:14.236Z weekly 0.7 https://www.humanexasignals.com/signals/bcg-vaccine-intravenous-administration-shows-superior-efficacy-over-traditional- 2026-07-17T06:03:04.419Z weekly 0.7 https://www.humanexasignals.com/signals/ccl2timp1-axis-identified-as-key-driver-in-glioblastomas-immunosuppressive-micro 2026-07-17T06:02:44.938Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-to-acquire-ataibeckley-to-enhance-treatment-resistant-depression-therapies 2026-07-17T06:02:31.856Z weekly 0.7 https://www.humanexasignals.com/signals/merck-to-present-new-data-on-hiv-treatment-options-at-aids-2026 2026-07-17T06:02:23.266Z weekly 0.7 https://www.humanexasignals.com/signals/keytruda-shows-significant-pfs-improvement-in-dmmr-endometrial-cancer-in-phase-3 2026-07-17T06:02:13.243Z weekly 0.7 https://www.humanexasignals.com/signals/vv913-food-effect-study-initiated-by-vigonvita-life-sciences 2026-07-17T00:31:20.001Z weekly 0.7 https://www.humanexasignals.com/signals/daridorexant-trial-targets-insomnia-and-alcohol-use-disorder 2026-07-17T00:31:12.184Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-on-hyperpolarized-imaging-for-cns-lymphoma-shows-feasibility 2026-07-17T00:31:04.333Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-anesthesia-methods-for-pain-management-in-diabetic-retinopathy-la 2026-07-17T00:30:57.493Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-rapid-autopsy-program-for-small-cell-lung-cancer-initiated 2026-07-17T00:30:48.507Z weekly 0.7 https://www.humanexasignals.com/signals/eptinezumab-trial-for-pediatric-migraine-participants-initiated-by-lundbeck 2026-07-17T00:30:42.437Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-study-on-met-concordance-in-treatment-nave-nsclc 2026-07-17T00:30:35.234Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sacituzumab-govitecan-and-talazoparib-in-metastatic-breast-cancer 2026-07-17T00:30:29.121Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-finerenone-by-macleods-pharmaceuticals 2026-07-16T18:32:29.773Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-l-glutamine-anda219750-by-renova-pharms 2026-07-16T18:32:13.696Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-application-for-lurasidone-hydrochloride-by-zydus 2026-07-16T18:32:02.223Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-gallium-ga-68-gozetotide-for-diagnostic-use 2026-07-16T18:31:51.555Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-ubrogepant-by-zydus-pharmaceuticals 2026-07-16T18:31:40.784Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-cefixime-anda218691-by-fdc-ltd 2026-07-16T18:31:32.629Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-optimal-oxygen-saturation-levels-for-children-with-respiratory-distress 2026-07-16T18:31:24.310Z weekly 0.7 https://www.humanexasignals.com/signals/adlai-nortye-initiates-trial-for-an4035-in-ras-mutated-advanced-cancers 2026-07-16T18:31:11.754Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-perfusion-index-vs-surgical-pleth-index-for-pediatric-caudal-block-effe 2026-07-16T18:31:02.337Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-elidah-device-for-urinary-incontinence-post-prostate-cancer-treatment 2026-07-16T18:30:55.525Z weekly 0.7 https://www.humanexasignals.com/signals/bausch-lombs-fixed-dose-combo-for-dry-eye-disease-undergoes-safety-and-efficacy- 2026-07-16T18:30:45.828Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-eua-for-ivermectin-liquid-to-prevent-new-world-screwworm-in-horses 2026-07-16T18:30:32.561Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-behavioral-economics-to-enhance-art-adherence-in-hiv-patients 2026-07-16T12:31:56.647Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-stereotactic-boost-for-recurrent-head-and-neck-cancer-initiated 2026-07-16T12:31:46.262Z weekly 0.7 https://www.humanexasignals.com/signals/bayers-mirena-investigated-for-nonatypical-endometrial-hyperplasia-treatment 2026-07-16T12:31:37.393Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-lnk001-in-advanced-clear-cell-renal-cell-carcinoma-initiated 2026-07-16T12:31:28.297Z weekly 0.7 https://www.humanexasignals.com/signals/guangdong-hengrui-pharma-compares-delivery-methods-for-shr-1703-in-healthy-parti 2026-07-16T12:31:19.715Z weekly 0.7 https://www.humanexasignals.com/signals/resmed-astral-ventilators-face-serious-electrical-component-failure-risk 2026-07-16T12:31:03.534Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-gleevec-imatinib-mesylate-by-novartis 2026-07-16T12:30:56.316Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-leqembi-supplement-application 2026-07-16T12:30:48.879Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-zithromax-azithromycin 2026-07-16T12:30:42.551Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-zithromax-by-pfizer-1 2026-07-16T12:30:34.141Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-zithromax-azithromycin-by-pfizer 2026-07-16T12:30:27.975Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-laser-ablation-vs-crystallized-phenol-for-pilonidal-sinus-disease 2026-07-16T06:33:49.679Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-strengthens-warnings-for-botulinum-toxin-type-a-products-due-to-botulism-ca 2026-07-16T06:33:29.713Z weekly 0.7 https://www.humanexasignals.com/signals/updated-warnings-on-botulinum-toxin-type-a-products-due-to-iatrogenic-botulism-r 2026-07-16T06:33:13.413Z weekly 0.7 https://www.humanexasignals.com/signals/characterization-of-pi4kpipk-alterations-in-solid-tumors-for-biomarker-developme 2026-07-16T06:32:55.230Z weekly 0.7 https://www.humanexasignals.com/signals/dmamcl-induces-ferroptosis-in-neuroblastoma-targeting-hmox1-and-steap3 2026-07-16T06:32:42.506Z weekly 0.7 https://www.humanexasignals.com/signals/dapt-duration-post-pci-no-cardiovascular-benefit-increased-bleeding-in-ckd-patie 2026-07-16T06:32:29.473Z weekly 0.7 https://www.humanexasignals.com/signals/declining-trends-in-ritodrine-prescriptions-among-pregnant-women-in-japan 2026-07-16T06:32:18.021Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-shows-safety-and-enhanced-immunogenicity-of-mrna-1010-influenza-va 2026-07-16T06:32:03.822Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-argatroban-by-fresenius-kabi 2026-07-16T06:31:53.952Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-verzenio-abemaciclib 2026-07-16T06:31:42.037Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-childrens-zyrtec-hives 2026-07-16T06:31:32.409Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-zithromax-by-pfizer 2026-07-16T06:31:22.170Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-rilpivirine-hydrochloride-anda219788 2026-07-16T06:31:09.173Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-fda-approval-for-metformin-hydrochloride-supplement 2026-07-16T06:31:00.274Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-buprenorphine-hydrochloride-by-rubicon-research 2026-07-16T06:30:52.971Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-iloprost-anda214997-by-beloteca 2026-07-16T06:30:45.412Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-elinest-anda091105-by-novast-labs 2026-07-16T06:30:37.056Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-anda218552-by-apotex 2026-07-16T06:01:43.623Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-original-application-for-magnesium-sulfate-by-square-pharms-plc 2026-07-16T06:01:35.370Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sodium-bicarbonate-anda219089-by-milla-pharms 2026-07-16T06:01:24.291Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levocetirizine-dihydrochloride-anda205564 2026-07-16T00:33:34.719Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-nuzyra-omadacycline-tosylate 2026-07-16T00:33:16.724Z weekly 0.7 https://www.humanexasignals.com/signals/alembic-pharmaceuticals-submits-anda220499-for-fda-review 2026-07-16T00:33:02.334Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-amantadine-hydrochloride-anda210215 2026-07-16T00:32:48.019Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-beqalzi-sonrotoclax-nda220711 2026-07-16T00:32:34.064Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-fasenra-benralizumab-by-astrazeneca 2026-07-16T00:32:21.674Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-yonsa-by-sun-pharma 2026-07-16T00:32:10.236Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-cardiogen-82-by-bracco 2026-07-16T00:31:59.210Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-foscarnet-sodium-anda220068-by-caplin 2026-07-16T00:31:48.823Z weekly 0.7 https://www.humanexasignals.com/signals/febuxostat-evaluated-for-intracranial-hemorrhage-treatment-in-clinical-study 2026-07-16T00:31:37.838Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-glp-1-agonists-and-lifestyle-changes-in-obese-adolescents 2026-07-16T00:31:27.673Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-bh-30643-in-nsclc-with-egfrher2-mutations-initiated-by-blossom 2026-07-16T00:31:18.713Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-registry-for-very-rare-childhood-cancers-to-inform-future-treatment 2026-07-16T00:31:06.267Z weekly 0.7 https://www.humanexasignals.com/signals/reset-copd-study-to-develop-early-warning-model-for-copd-exacerbations 2026-07-16T00:30:58.412Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-mutations-in-chronic-active-epstein-barr-disease-launched 2026-07-16T00:30:50.951Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cognitive-rehabilitation-in-adult-lower-grade-gliomas-launched 2026-07-16T00:30:43.222Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-missouri-initiates-study-on-lymphatic-pain-and-lymphedema-manageme 2026-07-16T00:30:31.622Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-dextrose-5-in-plastic-container 2026-07-15T18:35:42.304Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-spironolactone-anda219494-by-graviti-pharms 2026-07-15T18:35:24.736Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-wezlana-ustekinumab-auub-by-amgen 2026-07-15T18:35:10.098Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-anda-for-everolimus-fda-review-in-progress 2026-07-15T18:34:16.350Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-watson-labs-minocycline-hydrochloride 2026-07-15T18:34:02.027Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-pyridostigmine-bromide-by-amneal 2026-07-15T18:33:51.088Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-opdivo-qvantig-by-bristol-myers-squibb 2026-07-15T18:33:39.287Z weekly 0.7 https://www.humanexasignals.com/signals/umedica-labs-receives-fda-approval-for-zolpidem-tartrate-anda220717 2026-07-15T18:32:48.158Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-sacituzumab-tirumotecan-and-tagitanlimab-in-advanced-esophagea 2026-07-15T18:32:36.007Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-shingrix-vaccine-response-in-hiv-patients-and-healthy-controls 2026-07-15T18:32:21.650Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-on-immune-suppressor-cells-in-cancer-patients-pre-and-post-chemotherap 2026-07-15T18:32:07.131Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-study-on-cabotegravir-plus-rilpivirine-effectiveness-in-hiv-patients 2026-07-15T18:31:57.606Z weekly 0.7 https://www.humanexasignals.com/signals/digital-rehabilitation-program-for-knee-osteoarthritis-using-ai-and-wearable-tec 2026-07-15T18:31:38.876Z weekly 0.7 https://www.humanexasignals.com/signals/cpap-trial-aims-to-reduce-bronchopulmonary-dysplasia-in-premature-infants 2026-07-15T18:31:24.692Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-generics-of-gilotrif-afatinib-tablets 2026-07-15T12:32:26.284Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-gedatolisib-with-fulvestrant-for-hr-positive-her2-negative-breast-c 2026-07-15T12:32:15.323Z weekly 0.7 https://www.humanexasignals.com/signals/baxter-issues-correction-for-volera-positive-pressure-breathing-devices-due-to-a 2026-07-15T12:31:59.692Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-axillary-block-and-analgesic-truncal-blocks-for-wrist-surgery 2026-07-15T12:31:50.542Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pain-mechanisms-in-juvenile-arthritis-launched-by-washington-university 2026-07-15T12:31:39.936Z weekly 0.7 https://www.humanexasignals.com/signals/biontechs-mrna-mpox-vaccine-candidate-enters-clinical-trial-phase 2026-07-15T12:31:18.535Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-keytruda-qlex-supplement-application-2 2026-07-15T12:31:04.526Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-padcev-supplemental-application 2026-07-15T12:30:52.614Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-xelstrym-by-noven-pharmaceuticals 2026-07-15T12:30:43.516Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-zyogreen-by-provepharm-sas 2026-07-15T12:30:33.348Z weekly 0.7 https://www.humanexasignals.com/signals/benefit-risk-assessment-of-dupilumab-vs-upadacitinib-in-atopic-dermatitis 2026-07-15T06:33:57.145Z weekly 0.7 https://www.humanexasignals.com/signals/otsuka-initiates-trial-for-sibeprenlimab-in-iga-nephropathy 2026-07-15T06:33:42.399Z weekly 0.7 https://www.humanexasignals.com/signals/economic-analysis-of-early-vs-delayed-therapy-in-cllsll-patients 2026-07-15T06:33:23.926Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-allogeneic-cd30car-ebvsts-in-relapsedrefractory-lymphomas 2026-07-15T06:32:58.838Z weekly 0.7 https://www.humanexasignals.com/signals/tislelizumab-and-disitamab-vedotin-show-promise-in-neoadjuvant-therapy-for-her2- 2026-07-15T06:32:47.479Z weekly 0.7 https://www.humanexasignals.com/signals/btl-043-and-btl-899-devices-show-promise-in-alleviating-back-pain 2026-07-15T06:32:38.156Z weekly 0.7 https://www.humanexasignals.com/signals/ai-based-echocardiography-trial-for-aortic-stenosis-launched-by-caption-health 2026-07-15T06:32:29.165Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-tuxarin-er-by-mainpointe 2026-07-15T06:32:19.337Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-keytruda-supplemental-application 2026-07-15T06:32:11.194Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-tenofovir-alafenamide-fumarate-by-laurus-labs 2026-07-15T06:32:02.813Z weekly 0.7 https://www.humanexasignals.com/signals/ajanta-pharma-submits-anda-for-sitagliptin-and-metformin-hydrochloride 2026-07-15T06:31:55.332Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nintedanib-application-from-glenmark-pharmaceuticals 2026-07-15T06:31:49.188Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-nintedanib-esylate-anda218472 2026-07-15T06:31:43.325Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-sodium-bicarbonate-by-amneal-eu-ltd 2026-07-15T06:31:35.787Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-sarclisa-isatuximab-irfc-by-sanofi 2026-07-15T06:31:29.854Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-cyancobalamin-anda219820-by-aspiro 2026-07-15T06:31:24.249Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-methylergomovine-maleate-by-amneal-pharmaceuticals 2026-07-15T06:31:18.578Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dapsone-anda218335-by-macleods-pharmaceuticals 2026-07-15T06:05:10.287Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methylergonovine-maleate-anda211919 2026-07-15T06:04:51.842Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-ephedrine-sulfate-anda216740-by-baxter-healthcare 2026-07-15T06:04:34.866Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-oxcarbazepine-by-hetero-labs 2026-07-15T06:04:19.275Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-anda220197-by-aizant-drug-research-solutions 2026-07-15T06:04:03.436Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-anda219207-by-shanghai-aucyun-pharmaceuticals 2026-07-15T06:03:50.475Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-inc-submits-anda220086-for-fda-review 2026-07-15T06:03:37.754Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-pramipexole-vs-escitalopram-for-mdd-in-hiv-patients 2026-07-15T06:03:22.765Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-study-of-sacituzumab-govitecan-and-berzosertib-in-small-cell-lung-canc 2026-07-15T06:03:06.767Z weekly 0.7 https://www.humanexasignals.com/signals/alcon-initiates-post-approval-study-for-hydrus-microstent-malposition-rates 2026-07-15T06:02:55.579Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nivolumab-and-ipilimumab-in-dmmr-recurrent-endometrial-carcino 2026-07-15T06:02:46.002Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-follow-up-study-on-gene-therapy-adverse-events-in-pediatric-oncology 2026-07-15T06:02:34.325Z weekly 0.7 https://www.humanexasignals.com/signals/lactiplantibacillus-plantarum-wjl-enhances-low-protein-diet-efficacy-in-chronic- 2026-07-15T06:02:26.061Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-nizubaglustat-for-niemann-pick-type-c-disease-initiated 2026-07-15T06:02:17.439Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-phase-iii-trial-of-atrasentan-in-pediatric-igan-patients 2026-07-15T06:02:07.869Z weekly 0.7 https://www.humanexasignals.com/signals/culturally-adapted-snacktivity-program-trial-for-copd-patients-launched 2026-07-15T06:01:59.807Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-study-on-her2-altered-metastatic-breast-cancer-treatment-pa 2026-07-15T06:01:51.247Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-selpercatinib-for-ret-fusion-positive-solid-tumors 2026-07-15T06:01:43.879Z weekly 0.7 https://www.humanexasignals.com/signals/roches-elecsys-igra-tb-test-receives-ce-mark-for-tuberculosis-detection-1 2026-07-15T06:01:35.191Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-to-roches-gazyvagazyvaro-for-primary-membranous-nephr-1 2026-07-15T06:01:28.572Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-to-roches-gazyvagazyvaro-for-primary-membranous-nephr 2026-07-15T06:01:21.514Z weekly 0.7 https://www.humanexasignals.com/signals/gds-23-niosomes-enhance-vitamin-c-delivery-and-antioxidant-uptake-in-skin 2026-07-15T00:34:19.723Z weekly 0.7 https://www.humanexasignals.com/signals/ucb-nk-cells-enhance-anti-gd2-therapy-efficacy-in-neuroblastoma 2026-07-15T00:34:04.592Z weekly 0.7 https://www.humanexasignals.com/signals/tfpi2s-dual-role-in-tumor-metastasis-implications-for-targeted-therapy 2026-07-15T00:33:50.379Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-spironolactone-anda203512-by-accord-healthcare 2026-07-15T00:33:32.306Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-ziextenzo-by-sandoz 2026-07-15T00:33:20.473Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-keytruda-qlex-supplement-application-1 2026-07-15T00:33:09.490Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-spironolactone-anda217761-by-annora-pharma 2026-07-15T00:32:56.123Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-oxcarbazepine-by-chartwell-rx 2026-07-15T00:32:45.596Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-keytruda-pembrolizumab-by-merck 2026-07-15T00:32:36.909Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-opdivo-nivolumab-by-bristol-myers-squibb 2026-07-15T00:32:28.004Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pain-reporting-in-women-with-non-metastatic-breast-cancer-during-chemot 2026-07-15T00:32:13.690Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-mk-1403-trial-targets-type-2-diabetes-and-hscrp-levels 2026-07-15T00:32:01.088Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mhealth-smoking-cessation-for-african-americans-with-hivaids-initiated 2026-07-15T00:31:53.849Z weekly 0.7 https://www.humanexasignals.com/signals/biogens-litifilimab-biib059-study-targets-active-cutaneous-lupus-erythematosus 2026-07-15T00:31:42.415Z weekly 0.7 https://www.humanexasignals.com/signals/machine-learning-study-aims-to-diagnose-cholestasis-in-newborns-using-parent-pro 2026-07-15T00:31:36.128Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mental-health-services-for-older-cancer-patients-launched 2026-07-15T00:31:29.441Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-reck-vs-exparel-for-pain-management-in-robotic-nephrectomy 2026-07-15T00:31:22.926Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-study-of-hrs-8797-initiated-by-chengdu-suncadia-medicine 2026-07-14T18:31:47.601Z weekly 0.7 https://www.humanexasignals.com/signals/sumitomo-pharma-initiates-observational-study-on-orgovyx-in-prostate-cancer-pati 2026-07-14T18:31:27.341Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-inc-submits-anda219346-for-review-by-fda 2026-07-14T12:34:20.547Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-sugammadex-by-tamarang-sa 2026-07-14T12:33:28.150Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-famotidine-anda217432-receives-abbreviated-approval-from-fda 2026-07-14T12:33:09.431Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lamotrigine-anda078625-by-rubicon-research 2026-07-14T12:32:53.973Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-nicotine-polacrilex-by-dr-reddys-labs 2026-07-14T12:32:40.189Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-zerbaxa-supplement-by-cubist-pharmaceuticals 2026-07-14T12:32:26.427Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-estradiol-anda218214-by-encube 2026-07-14T12:32:11.876Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-levetiracetam-in-sodium-chloride-by-mylan-labs 2026-07-14T12:32:00.350Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-riociguat-by-msn 2026-07-14T12:31:49.101Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-amlodipine-besylate-by-brillian-pharma 2026-07-14T12:31:39.281Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-evaluates-remibrutinib-for-secondary-progressive-multiple-sclerosis 2026-07-14T12:31:29.127Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-atogepant-study-shows-real-world-effectiveness-for-migraine-prevention 2026-07-14T12:31:19.784Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-thread-embedding-acupuncture-for-chronic-low-back-pain-initiated 2026-07-14T12:31:09.507Z weekly 0.7 https://www.humanexasignals.com/signals/intranasal-insulin-shows-potential-for-treating-ptsd-symptoms 2026-07-14T12:30:59.326Z weekly 0.7 https://www.humanexasignals.com/signals/ohio-state-university-trials-atropine-for-delaying-nearsightedness-in-children 2026-07-14T12:30:51.296Z weekly 0.7 https://www.humanexasignals.com/signals/divarasib-study-in-untreated-advanced-nsclc-shows-promise-for-safety-and-efficac 2026-07-14T12:30:43.894Z weekly 0.7 https://www.humanexasignals.com/signals/cleminorexton-study-for-narcolepsy-type-1-and-type-2-initiated-by-centessa-pharm 2026-07-14T12:30:36.862Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-quality-of-life-recovery-in-cervical-cancer-patients-post-radiotherapy 2026-07-14T12:30:28.999Z weekly 0.7 https://www.humanexasignals.com/signals/tace-with-qs-gmp-shows-promise-for-canine-lower-urinary-tract-carcinomas 2026-07-14T06:32:38.614Z weekly 0.7 https://www.humanexasignals.com/signals/human-factors-study-validates-bmab-1200-autoinjector-for-ustekinumab-delivery 2026-07-14T06:32:25.995Z weekly 0.7 https://www.humanexasignals.com/signals/ai-driven-insights-on-gut-microbiomes-role-in-colorectal-cancer-therapy 2026-07-14T06:32:10.083Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-bizengri-supplement-by-merus-nv 2026-07-14T06:32:00.340Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-ocrevus-supplemental-application 2026-07-14T06:31:51.126Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-vyvgart-hytrulo-supplement-by-argenx 2026-07-14T06:31:41.745Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-nurtec-odt-by-pfizer 2026-07-14T06:31:32.830Z weekly 0.7 https://www.humanexasignals.com/signals/fda-supports-development-of-psychedelic-drugs-for-mental-health 2026-07-14T06:31:22.539Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-at-home-starting-dose-for-leqembi-in-alzheimers-treatment 2026-07-14T06:31:12.862Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-on-genetic-variants-in-cancer-patients-with-immunologic-disorders 2026-07-14T06:31:04.773Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-outpatient-ultrasound-for-early-diagnosis-of-fatty-liver 2026-07-14T06:30:57.502Z weekly 0.7 https://www.humanexasignals.com/signals/sitagliptin-combined-with-gemcitabine-and-paclitaxel-in-pdac-patients 2026-07-14T06:30:50.206Z weekly 0.7 https://www.humanexasignals.com/signals/expanded-access-program-for-bezuclastinib-and-sunitinib-in-gist-patients 2026-07-14T06:30:40.968Z weekly 0.7 https://www.humanexasignals.com/signals/medtronic-recalls-harmony-delivery-catheter-due-to-detachment-risk 2026-07-14T06:05:14.113Z weekly 0.7 https://www.humanexasignals.com/signals/anthos-and-novartis-initiate-lilac-timi-76-trial-for-abelacimab-in-high-risk-af- 2026-07-14T06:04:57.961Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-trial-of-ly3884961-for-gaucher-disease-initiated-by-prevail-therapeutic 2026-07-14T06:04:39.993Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-dapagliflozin-approved-for-heart-failure-real-world-study-launched- 2026-07-14T06:04:26.350Z weekly 0.7 https://www.humanexasignals.com/signals/linzagolix-evaluated-for-adenomyosis-and-recurrent-implantation-failure-in-new-s 2026-07-14T06:04:15.563Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-evaluates-18f-fet-petct-for-glioma-diagnosis 2026-07-14T06:03:20.913Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-initiates-phase-3-trial-for-karxt-karx-ec-in-alzheimers-agi 2026-07-14T06:03:10.852Z weekly 0.7 https://www.humanexasignals.com/signals/neladalkib-nvl-655-shows-promise-in-phase-3-trial-for-alk-positive-nsclc 2026-07-14T06:02:59.678Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-lecigon-in-parkinsons-disease-targets-neuropsychiatric-sympto 2026-07-14T06:02:48.085Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-licenses-novel-egfr-inhibitor-zegfrovy-for-lung-cancer 2026-07-14T06:02:38.193Z weekly 0.7 https://www.humanexasignals.com/signals/roche-launches-first-fully-automated-cobas-hdv-test-for-hepatitis-d-diagnosis 2026-07-14T06:02:27.762Z weekly 0.7 https://www.humanexasignals.com/signals/roche-launches-first-fully-automated-hdv-test-to-enhance-diagnosis-and-monitorin 2026-07-14T06:02:14.361Z weekly 0.7 https://www.humanexasignals.com/signals/exploring-bmx-as-target-for-cancer-therapy-mechanisms-and-inhibitors 2026-07-14T00:34:23.429Z weekly 0.7 https://www.humanexasignals.com/signals/protein-palmitoylation-linked-to-disease-pathogenesis-and-therapeutic-opportunit 2026-07-14T00:33:33.009Z weekly 0.7 https://www.humanexasignals.com/signals/novel-cdk7-inhibitor-7a-shows-potent-antitumor-activity-in-colorectal-cancer-mod 2026-07-14T00:33:17.723Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-anda216537-for-carbidope-and-levodopa-receives-ap-status 2026-07-14T00:33:01.528Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-adempas-riociguat-by-bayer-healthcare 2026-07-14T00:32:48.017Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-vyvgart-supplement-application 2026-07-14T00:32:35.937Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-mekinist-trametinib-by-novartis 2026-07-14T00:32:24.570Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-zyprexa-relprevv-by-cheplapharm 2026-07-14T00:32:12.689Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-sitagliptin-and-metformin-hydrochloride-by-inventia-healthc 2026-07-14T00:32:01.426Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-paliperidone-anda205402-by-i3-pharms 2026-07-14T00:31:49.713Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-hydrocortisone-sodium-succinate-by-zydus-pharms 2026-07-14T00:31:40.047Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-obinutuzumab-combinations-in-relapsedrefractory-follicular-lym 2026-07-14T00:31:31.280Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-evaluates-gemcitabine-carboplatin-and-lenalidomide-for-urothelial-canc 2026-07-14T00:31:21.565Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sujok-therapy-for-primary-dysmenorrhea-shows-potential-benefits 2026-07-14T00:31:13.247Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-dark-adaptation-for-early-detection-of-age-related-macular-degeneration 2026-07-14T00:31:05.237Z weekly 0.7 https://www.humanexasignals.com/signals/dren-bio-initiates-phase-1b-trial-of-dr-01-for-alopecia-areata-and-vitiligo 2026-07-14T00:30:56.695Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-immune-function-in-brca12-mutation-carriers-initiated 2026-07-14T00:30:47.821Z weekly 0.7 https://www.humanexasignals.com/signals/discovery-trial-evaluates-azd7442-for-covid-19-in-hospitalized-adults 2026-07-14T00:30:40.424Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-minoxidils-impact-on-flap-viability-in-breast-reconstruction 2026-07-14T00:30:28.663Z weekly 0.7 https://www.humanexasignals.com/signals/crescent-pharma-recalls-ramipril-25mg-due-to-packaging-error 2026-07-13T18:33:59.064Z weekly 0.7 https://www.humanexasignals.com/signals/crescent-pharma-recalls-ramipril-25-mg-capsules-due-to-packaging-error 2026-07-13T18:33:43.686Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-brimonidine-tartrate-anda218558-by-micro-labs 2026-07-13T18:33:27.560Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-brodalumab-siliq-by-valeant 2026-07-13T18:33:14.832Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-sodium-thiosulfate-by-hope-pharmaceutical 2026-07-13T18:33:02.546Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-dr-reddys-capecitabine-anda204345 2026-07-13T18:32:51.730Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-dolutegravir-lamivudine-and-tenofovir-disoproxil-fumarate 2026-07-13T18:32:06.971Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-atropine-sulfate-anda218148-by-mankind-pharma 2026-07-13T18:31:56.780Z weekly 0.7 https://www.humanexasignals.com/signals/heritage-pharmas-sertraline-hydrochloride-anda-submission-receives-ap-status 2026-07-13T18:31:44.257Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-risperidone-by-heritage-pharma 2026-07-13T18:31:35.416Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-inhaled-nitric-oxides-impact-on-copd-patients-breathing-efficiency 2026-07-13T18:31:18.633Z weekly 0.7 https://www.humanexasignals.com/signals/myelomatch-screening-study-to-enhance-treatment-matching-for-myeloid-cancer-pati 2026-07-13T18:31:07.905Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-dna-guided-therapy-for-high-residual-risk-er-her-2-negative-br 2026-07-13T18:30:52.143Z weekly 0.7 https://www.humanexasignals.com/signals/elpida-therapeutics-initiates-melpida-trial-for-spg50-using-aav9-gene-therapy 2026-07-13T18:30:44.427Z weekly 0.7 https://www.humanexasignals.com/signals/nci-initiates-trial-for-aza-tdc-in-advanced-solid-tumors 2026-07-13T18:30:36.668Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2b-study-of-pirepemat-shows-promise-for-reducing-falls-in-parkinsons-patie 2026-07-13T18:30:29.513Z weekly 0.7 https://www.humanexasignals.com/signals/amneal-pharmaceuticals-submits-supplemental-anda-for-capecitabine 2026-07-13T12:33:08.303Z weekly 0.7 https://www.humanexasignals.com/signals/teva-pharmaceuticals-receives-ap-status-for-gabapentin-supplement 2026-07-13T12:32:55.962Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-brilinta-ticagrelor 2026-07-13T12:32:44.553Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-alendronate-sodium-by-rising 2026-07-13T12:32:02.875Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-acetazolamide-sodium-by-mylan 2026-07-13T12:31:52.730Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-bla-for-ennumo-pegfilgrastim-pccg-by-accord-biopharma 2026-07-13T12:31:43.329Z weekly 0.7 https://www.humanexasignals.com/signals/study-aims-to-improve-diagnosis-of-primary-aldosteronism-using-lc-msms 2026-07-13T12:31:33.562Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-palbociclib-in-cancers-with-ccnd-amplifications-shows-potentia 2026-07-13T12:31:24.752Z weekly 0.7 https://www.humanexasignals.com/signals/ai-models-to-predict-bronchopulmonary-dysplasia-in-preterm-infants-a-retrospecti 2026-07-13T12:31:12.012Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-lung-disease-prevalence-in-early-rheumatoid-arthritis-patients 2026-07-13T12:30:56.174Z weekly 0.7 https://www.humanexasignals.com/signals/il-15-superagonist-n-803-combined-with-vaccine-etbx-071-in-recurrent-prostate-ca 2026-07-13T12:30:46.497Z weekly 0.7 https://www.humanexasignals.com/signals/genentechs-gdc-1261-study-targets-advanced-prostate-cancer-safety-and-activity 2026-07-13T12:30:33.388Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-tecvayli-by-janssen-biotech 2026-07-13T06:34:50.260Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leuprolide-acetate-anda215336-by-amneal 2026-07-13T06:34:31.441Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leuprolide-acetate-anda217957 2026-07-13T06:34:20.134Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-to-zydus-leuprolide-acetate-anda215826 2026-07-13T06:34:08.614Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-applications-for-eligard-kit 2026-07-13T06:33:58.222Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharmas-leuprolide-acetate-anda-submission-receives-ap-status 2026-07-13T06:33:48.769Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-zoladex-by-tersera-1 2026-07-13T06:33:37.898Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-plasma-exchange-vs-daratumumab-for-light-chain-cast-nephropathy 2026-07-13T06:33:23.898Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-bbt001-in-atopic-dermatitis-patients-initiated-by-bambusa-thera 2026-07-13T06:33:12.782Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-long-term-follow-up-study-for-oav101-in-spinal-muscular-atrop 2026-07-13T06:33:03.207Z weekly 0.7 https://www.humanexasignals.com/signals/machine-learning-model-predicts-refractive-error-in-myopic-adults 2026-07-13T06:32:54.306Z weekly 0.7 https://www.humanexasignals.com/signals/kaiser-permanente-trials-educational-video-to-improve-ltbi-treatment-completion 2026-07-13T06:30:29.829Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-zoladex-by-tersera 2026-07-13T06:06:08.596Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-bowen-therapy-and-mcgill-exercises-for-chronic-low-back-pain-initiated 2026-07-13T06:05:51.233Z weekly 0.7 https://www.humanexasignals.com/signals/ionis-pharmaceuticals-evaluates-sapablursen-in-polycythemia-vera-patients 2026-07-13T06:05:31.518Z weekly 0.7 https://www.humanexasignals.com/signals/mri-and-multiomics-integration-for-precision-treatment-in-luminal-breast-cancer 2026-07-13T06:04:43.128Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-d-0120-and-allopurinol-in-gout-by-inventisbio 2026-07-13T06:04:28.221Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-rilvegostomig-study-targets-advanced-solid-tumors-with-subcutaneous 2026-07-13T06:04:14.470Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-biceps-tenodesis-techniques-in-patients-without-rotator-cuff-tear 2026-07-13T06:03:22.692Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-low-dose-remimazolam-for-emergence-agitation-in-oral-surgery 2026-07-13T06:03:01.237Z weekly 0.7 https://www.humanexasignals.com/signals/gut-microbiotas-role-in-colorectal-cancer-insights-for-targeted-therapies 2026-07-13T06:02:42.901Z weekly 0.7 https://www.humanexasignals.com/signals/brentuximab-vedotin-shows-effectiveness-over-standard-chemotherapy-in-relapsed-h 2026-07-13T06:02:24.013Z weekly 0.7 https://www.humanexasignals.com/signals/challenges-and-strategies-in-nanomedicine-based-cancer-immunotherapy 2026-07-13T00:36:00.025Z weekly 0.7 https://www.humanexasignals.com/signals/lytacs-a-new-strategy-to-combat-cancer-drug-resistance 2026-07-13T00:35:38.669Z weekly 0.7 https://www.humanexasignals.com/signals/high-dose-quadrivalent-influenza-vaccine-shows-superior-immunogenicity-in-young- 2026-07-13T00:35:20.343Z weekly 0.7 https://www.humanexasignals.com/signals/allurion-gastric-balloon-safety-update-risks-of-obstruction-and-perforation 2026-07-13T00:35:02.354Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-lupron-by-abbvie 2026-07-13T00:34:13.881Z weekly 0.7 https://www.humanexasignals.com/signals/centaur-pharmaceuticals-submits-anda-for-dapagliflozin 2026-07-13T00:33:57.522Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-leuprolide-acetate-anda213829 2026-07-13T00:33:43.126Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-fda-approval-for-vasopressin-anda212069 2026-07-13T00:33:30.507Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-fda-approval-for-vasopressin-anda212068 2026-07-13T00:33:16.007Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leuprolide-acetate-anda078885-by-sun-pharma 2026-07-13T00:33:05.261Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lamotrigine-anda079204-by-taro 2026-07-13T00:32:53.927Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leuprolide-acetate-anda075471 2026-07-13T00:32:43.693Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-vantas-by-endo-operations 2026-07-13T00:32:34.406Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-treatment-options-for-major-depressive-disorder-with-trd-initiated 2026-07-13T00:32:26.001Z weekly 0.7 https://www.humanexasignals.com/signals/pfizer-initiates-study-on-new-pneumococcal-vaccine-for-infants 2026-07-13T00:32:17.316Z weekly 0.7 https://www.humanexasignals.com/signals/longitudinal-study-on-pubertys-impact-on-neuropsychiatric-disorders 2026-07-13T00:32:08.370Z weekly 0.7 https://www.humanexasignals.com/signals/real-world-study-of-il-23-inhibitors-in-active-crohns-disease-launched 2026-07-13T00:31:58.722Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-shockwave-therapy-for-non-specific-low-back-pain-underway 2026-07-13T00:31:49.341Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-factors-influencing-emergency-contraceptive-efficacy 2026-07-13T00:31:41.259Z weekly 0.7 https://www.humanexasignals.com/signals/neuroderms-nd0612-study-evaluates-safety-and-pharmacokinetics-in-parkinsons-dise 2026-07-13T00:31:31.490Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leuprolide-acetate-anda217437 2026-07-12T18:33:26.698Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-leucovorin-calcium-by-ingenus-pharmaceuticals 2026-07-12T18:33:13.959Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-leucovorin-calcium-anda072736-receives-ap-status-from-fda 2026-07-12T18:33:00.922Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-leucovorin-calcium-anda072733-receives-abbreviated-approval 2026-07-12T18:32:15.350Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-leucovorin-calcium-anda072734-by-hikma 2026-07-12T18:32:05.619Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-leucovorin-calcium-anda072735-receives-abbreviated-approval 2026-07-12T18:31:54.771Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-valproic-acid-anda091037-by-sun-pharma 2026-07-12T18:31:46.238Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-leucovorin-calcium-supplement-application 2026-07-12T18:31:35.255Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-leucovorin-calcium-anda071199-by-barr 2026-07-12T18:31:26.156Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ventilation-during-cpb-in-cardiac-surgery-to-assess-lung-outcomes 2026-07-12T18:31:15.231Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-glp-1-ras-and-exercise-training-in-obesity-patients-launched 2026-07-12T18:31:07.116Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-bg-c0979-in-advanced-solid-tumors-initiated 2026-07-12T18:30:58.646Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-dabrafenib-and-trametinib-in-braf-v600-mutant-high-grade-gliom 2026-07-12T18:30:49.747Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-continuous-glucose-monitoring-for-postpartum-screening-initiated 2026-07-12T18:30:40.293Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-tislelizumab-in-msi-h-or-dmmr-solid-tumors-by-beigene 2026-07-12T18:30:31.590Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-shows-comparable-immunogenicity-of-gsks-investigational-mmrv-vacc 2026-07-12T12:35:17.471Z weekly 0.7 https://www.humanexasignals.com/signals/lncrna-ac0084063-enhances-docetaxel-sensitivity-in-breast-cancer-via-cuproptosis 2026-07-12T12:34:24.549Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-leucovorin-calcium-anda213929 2026-07-12T12:34:07.145Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-voriconazole-anda220078-by-zhejiang-novus 2026-07-12T12:33:51.134Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-wegovy-semaglutide 2026-07-12T12:33:36.357Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-to-epic-pharmas-leucovorin-calcium-supplement 2026-07-12T12:33:23.408Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-calcium-gluconate-by-caplin 2026-07-12T12:33:11.075Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lorazepam-anda200217-by-rising 2026-07-12T12:32:59.886Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-bupropion-hydrochloride-by-yichang-humanwell 2026-07-12T12:32:49.621Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-levo-t-by-cediprof-inc 2026-07-12T12:32:10.132Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-sitagliptin-by-biocon-pharma 2026-07-12T12:31:59.793Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-study-of-gemcitabinenab-paclitaxel-and-radiation-in-advanced-pancreatic 2026-07-12T12:31:44.193Z weekly 0.7 https://www.humanexasignals.com/signals/beone-medicines-initiates-trial-for-bg-75098-in-advanced-solid-tumors 2026-07-12T12:31:34.080Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-cannabidiol-for-alcohol-withdrawal-symptoms-initiated 2026-07-12T12:31:15.221Z weekly 0.7 https://www.humanexasignals.com/signals/biogen-initiates-observational-study-on-omaveloxolones-effects-during-pregnancy- 2026-07-12T12:31:04.114Z weekly 0.7 https://www.humanexasignals.com/signals/gsks-bepirovirsen-study-evaluates-cardiac-conduction-impact-in-healthy-volunteer 2026-07-12T12:30:55.732Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-erector-spinae-plane-block-for-pain-control-in-spinal-surgery 2026-07-12T12:30:48.434Z weekly 0.7 https://www.humanexasignals.com/signals/text-messaging-improves-adherence-to-oral-chemotherapy-in-all-patients 2026-07-12T12:30:32.847Z weekly 0.7 https://www.humanexasignals.com/signals/hetero-labs-submits-anda220421-for-vemagal-with-standard-review-priority 2026-07-12T06:33:52.667Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-gabapentin-anda205807-receives-approval-status-from-fda 2026-07-12T06:33:38.112Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-jakafi-xr-for-incyte-corp 2026-07-12T06:33:23.536Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplemental-approval-for-phentermine-hydrochloride-and-topiramate 2026-07-12T06:33:09.621Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda203103-for-propranolol-hydrochloride-by-ipca-labs 2026-07-12T06:32:58.250Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-trabectedin-by-apotex 2026-07-12T06:32:47.417Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-dexmedetomidine-hydrochloride 2026-07-12T06:32:36.844Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-anda201446-for-levonorgestrel-receives-standard-review-status 2026-07-12T06:31:55.057Z weekly 0.7 https://www.humanexasignals.com/signals/divarasib-study-targets-kras-g12c-positive-nsclc-post-chemoimmunotherapy 2026-07-12T06:31:41.973Z weekly 0.7 https://www.humanexasignals.com/signals/niaid-launches-study-on-natural-history-of-tuberculosis-with-active-recruitment 2026-07-12T06:31:32.636Z weekly 0.7 https://www.humanexasignals.com/signals/capture-ami-trial-evaluates-mechanical-thrombectomy-in-stemi-patients 2026-07-12T06:31:24.503Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-of-brincidofovir-for-treating-progressive-multifocal-leukoencephalop 2026-07-12T06:31:16.880Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-osimertinib-for-nsclc-with-egfr-exon-20-mutations 2026-07-12T06:31:08.057Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-on-high-risk-breastovarian-cancer-families-to-enhance-genetic-understa 2026-07-12T06:30:54.133Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-quadro-iliac-plane-block-for-pain-control-post-lumbar-microdiscectomy 2026-07-12T06:30:44.875Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-inbrija-levodopa-by-merz 2026-07-12T06:30:37.900Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-desogestrel-and-ethinyl-estradiol-anda219670 2026-07-12T06:30:30.551Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictors-of-recurrence-in-papillary-thyroid-carcinoma-initiated 2026-07-12T06:06:15.659Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-herpesvirus-reactivation-in-hiv-infected-women-initiating-art 2026-07-12T06:05:57.581Z weekly 0.7 https://www.humanexasignals.com/signals/cleerlys-cad-staging-system-trial-aims-to-reduce-cardiovascular-events 2026-07-12T06:05:41.576Z weekly 0.7 https://www.humanexasignals.com/signals/single-cell-analysis-reveals-immune-evasion-pathways-in-thyroid-cancer-metastasi 2026-07-12T06:04:54.363Z weekly 0.7 https://www.humanexasignals.com/signals/hpv-vaccination-shows-moderate-effectiveness-in-women-aged-18-45-in-china 2026-07-12T06:04:39.262Z weekly 0.7 https://www.humanexasignals.com/signals/hec116094-shows-potent-activity-as-pb2-inhibitor-against-influenza-a-virus 2026-07-12T06:04:26.853Z weekly 0.7 https://www.humanexasignals.com/signals/efficacy-of-il-17-inhibitors-after-il-23-failure-in-psoriasis-patients 2026-07-12T06:04:13.945Z weekly 0.7 https://www.humanexasignals.com/signals/immune-profiling-in-dmmrmsi-h-crc-reveals-prognostic-insights-and-immunotherapeu 2026-07-12T06:04:01.386Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-dimethyl-sulfoxide-anda220173 2026-07-12T06:03:49.187Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-morphine-sulfate-anda213892-by-quagen 2026-07-12T06:03:39.538Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-sporanox-itraconazole-by-janssen 2026-07-12T06:03:29.449Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-trutakna-bla761486-by-vera-therapeutics 2026-07-12T06:03:20.527Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-ryaltris-by-glenmark 2026-07-12T06:03:11.194Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-varenicline-tartrate-anda219382-by-somerset-therap-llc 2026-07-12T06:03:02.054Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-nitrogycerin-anda214565-by-padagis-israel 2026-07-12T06:02:50.689Z weekly 0.7 https://www.humanexasignals.com/signals/granules-india-receives-ap-status-for-metformin-hydrochloride-anda090564 2026-07-12T06:02:41.694Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-aciclovir-anda215669-by-hetero-labs 2026-07-12T06:02:34.058Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-keytruda-and-keytruda-qlex-for-muscle-invasive-bladder-cancer 2026-07-12T06:02:24.431Z weekly 0.7 https://www.humanexasignals.com/signals/ebv-reprograms-immune-escape-in-nasopharyngeal-carcinoma-impacting-immunotherapy 2026-07-12T00:35:07.892Z weekly 0.7 https://www.humanexasignals.com/signals/gx03-shows-promise-in-reducing-severity-of-s-aureus-induced-dermatitis-in-murine 2026-07-12T00:34:49.103Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-calcium-acetate-anda202420-by-chartwell-molecular 2026-07-12T00:34:31.258Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-torsemide-anda217239-by-micro-labs 2026-07-12T00:34:13.914Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-deutetrabenazine-by-aurobindo-pharma 2026-07-12T00:33:57.392Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-childrens-advil-ibuprofen-by-haleon 2026-07-12T00:33:41.516Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-vepdegestant-by-arvinas-operations 2026-07-12T00:33:26.331Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-childrens-advil-flavored-supplement-by-haleon-1 2026-07-12T00:32:37.012Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-mirabegron-anda219941-by-deva-holding-as 2026-07-12T00:32:24.392Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-mycophenolate-sodium-by-yichang-humanwell 2026-07-12T00:32:13.120Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-gadobutrol-by-hengrui-pharma 2026-07-12T00:32:01.210Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-precedex-dexmedetomidine-hydrochloride 2026-07-12T00:31:50.494Z weekly 0.7 https://www.humanexasignals.com/signals/galleri-test-trial-in-nhs-aims-to-reduce-late-stage-cancer-diagnoses 2026-07-12T00:31:41.572Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pediatric-extradural-hematoma-outcomes-post-head-injury 2026-07-12T00:31:29.598Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-plant-derived-cfa-for-knee-pain-shows-promise-for-joint-health 2026-07-12T00:31:21.299Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-methocarbamol-for-pain-management-in-hernia-repair 2026-07-12T00:31:11.616Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-factors-in-severe-combined-immunodeficiency-scid 2026-07-12T00:31:01.408Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-evaluates-radiation-therapy-plus-cisplatin-for-head-and-neck-canc 2026-07-12T00:30:53.672Z weekly 0.7 https://www.humanexasignals.com/signals/il-12-gemys-trial-for-relapsed-solid-tumors-initiated-by-nci 2026-07-12T00:30:46.081Z weekly 0.7 https://www.humanexasignals.com/signals/larimar-therapeutics-evaluates-nomlabofusp-in-pediatric-friedreichs-ataxia-trial 2026-07-12T00:30:37.431Z weekly 0.7 https://www.humanexasignals.com/signals/surufatinib-combination-trial-for-high-risk-pancreatic-cancer-initiated 2026-07-12T00:30:29.859Z weekly 0.7 https://www.humanexasignals.com/signals/peptostreptococcus-as-a-potential-biomarker-and-therapeutic-target-in-colorectal 2026-07-11T18:34:12.021Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-gabapentin-anda213603-by-zhejiang-yongtai 2026-07-11T18:33:48.982Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-ondansetron-hydrochloride-preservative-free-1 2026-07-11T18:33:08.252Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-perphenazine-supplement 2026-07-11T18:32:56.364Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-dapagliflozin-by-sciegen-pharmaceuticals 2026-07-11T18:32:46.379Z weekly 0.7 https://www.humanexasignals.com/signals/granules-lamotrigine-anda078982-receives-approval-status 2026-07-11T18:32:36.857Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-fluvoxamine-maleate-by-appco 2026-07-11T18:32:26.858Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-pregabalin-anda219593-by-unichem 2026-07-11T18:32:17.571Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-auvelity-by-axsome 2026-07-11T18:31:38.029Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-glycerol-phenylbutyrate-receives-fda-approval-status 2026-07-11T18:31:28.947Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lazcluze-lazertinib-mesylate 2026-07-11T18:31:18.135Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sacituzumab-tirumotecan-in-tnbc-shows-potential-in-combination-with-pembr 2026-07-11T18:31:10.421Z weekly 0.7 https://www.humanexasignals.com/signals/merck-and-daiichi-sankyo-trial-of-ifinatamab-deruxtecan-in-advanced-esophageal-c 2026-07-11T18:30:54.495Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictive-biomarkers-for-visual-outcomes-in-ocular-surface-diseases 2026-07-11T18:30:44.372Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vibratory-anesthesia-for-pain-management-in-corticosteroid-injections 2026-07-11T18:30:37.080Z weekly 0.7 https://www.humanexasignals.com/signals/safety-assessment-of-propranolol-for-infantile-hemangiomas-highlights-cardiovasc 2026-07-11T12:35:20.941Z weekly 0.7 https://www.humanexasignals.com/signals/advancements-and-challenges-in-hpv-vaccine-development-for-cancer-treatment 2026-07-11T12:34:55.510Z weekly 0.7 https://www.humanexasignals.com/signals/identification-of-bakuchiol-as-potent-bacterial-neuraminidase-inhibitor-from-pso 2026-07-11T12:34:38.549Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-rexulti-brexpiprazole-submission 2026-07-11T12:34:23.110Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-anda-for-sitagliptin-and-metformin-hydrochloride 2026-07-11T12:34:08.284Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-perseris-kit-by-indivior 2026-07-11T12:33:26.456Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-methotrexate-sodium-anda219865-by-hetero-labs 2026-07-11T12:33:13.927Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-anda-for-fosaprepitant-dimeglumine-receives-ap-status-from-fda 2026-07-11T12:33:02.262Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-finasteride-by-sun-pharma 2026-07-11T12:32:47.021Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-nizoral-anti-dandruff 2026-07-11T12:32:36.998Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-fluorescein-sodium-by-bpi-labs 2026-07-11T12:32:27.325Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-omeprazole-anda207740-by-dr-reddys 2026-07-11T12:31:51.940Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-bla-for-langlara-by-sunshine-lake-pharma 2026-07-11T12:31:42.163Z weekly 0.7 https://www.humanexasignals.com/signals/atebimetinib-gnp-study-for-metastatic-pancreatic-adenocarcinoma-initiated 2026-07-11T12:31:27.108Z weekly 0.7 https://www.humanexasignals.com/signals/ucbs-dapirolizumab-pegol-shows-promise-in-systemic-lupus-erythematosus-study 2026-07-11T12:31:18.377Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-integrating-behavioral-therapy-in-primary-care-for-adhd-in-underserved- 2026-07-11T12:31:02.591Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-prebiotic-diet-to-enhance-immunotherapy-response-in-melanoma 2026-07-11T12:30:54.644Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-partial-enteral-nutrition-augmenting-therapy-in-active-crohns-disease 2026-07-11T12:30:45.760Z weekly 0.7 https://www.humanexasignals.com/signals/nimh-study-on-adolescent-depression-aims-to-enhance-treatment-understanding 2026-07-11T12:30:38.319Z weekly 0.7 https://www.humanexasignals.com/signals/nanotechnology-advances-in-podocyte-injury-repair-for-chronic-kidney-diseases 2026-07-11T06:35:14.107Z weekly 0.7 https://www.humanexasignals.com/signals/impact-of-pcom-on-hormonal-response-to-gnrh-in-functional-hypothalamic-amenorrhe 2026-07-11T06:35:02.146Z weekly 0.7 https://www.humanexasignals.com/signals/fmt-shows-promise-in-restoring-gut-microbiome-in-antibiotic-treated-sepsis-patie 2026-07-11T06:34:50.521Z weekly 0.7 https://www.humanexasignals.com/signals/immunotherapy-shows-promise-in-treating-soft-tissue-sarcoma-with-combination-str 2026-07-11T06:34:08.533Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-hadlima-adalimumab-biosimilar 2026-07-11T06:33:57.953Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-methylphenidate-hydrochloride-anda205756 2026-07-11T06:33:48.050Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-carbamazepine-anda205571 2026-07-11T06:33:39.404Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-cyclophosphamide-by-hetero-labs-limited 2026-07-11T06:33:31.136Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nemtabrutinib-with-car-t-cell-therapy-in-relapsedrefractory-cl 2026-07-11T06:33:19.071Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-brain-stimulations-impact-on-food-intake-and-weight-loss 2026-07-11T06:33:10.476Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-tobacco-treatment-strategies-for-cancer-survivors 2026-07-11T06:32:48.393Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-allogeneic-stem-cell-transplant-for-vexas-syndrome-initiated 2026-07-11T06:32:41.694Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-phase-ii-trial-of-mas825-for-stills-disease 2026-07-11T06:32:33.814Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bioelectrical-impedance-analysis-in-colorectal-cancer-surgery 2026-07-11T06:30:28.680Z weekly 0.7 https://www.humanexasignals.com/signals/ai-model-enhances-stas-detection-in-nsclc-for-improved-diagnostic-accuracy 2026-07-11T06:04:53.085Z weekly 0.7 https://www.humanexasignals.com/signals/project-orbis-aims-to-accelerate-cancer-drug-approvals 2026-07-11T06:04:28.938Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-pembrolizumab-combinations-for-muscle-invasive-bladder-cancer 2026-07-11T06:04:09.198Z weekly 0.7 https://www.humanexasignals.com/signals/fda-proposes-streamlined-registration-for-distributed-drug-manufacturing 2026-07-11T06:03:55.586Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-isatuximab-irfc-subcutaneous-injection-for-multiple-myeloma 2026-07-11T06:03:42.624Z weekly 0.7 https://www.humanexasignals.com/signals/interfant-21-study-on-blinatumomab-for-infants-with-kmt2a-rearranged-all 2026-07-11T06:03:29.800Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-ammoxetine-hydrochloride-in-hepatic-impairment-patients 2026-07-11T06:03:17.730Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-remifentanil-and-dexmedetomidine-for-blood-pressure-control-in-ich-pati 2026-07-11T06:02:37.098Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-evaluates-surgery-vs-high-dose-radiation-for-limited-metastati 2026-07-11T06:02:25.745Z weekly 0.7 https://www.humanexasignals.com/signals/gsks-mo-rez-evaluated-in-1l-maintenance-for-hrd-ovarian-cancer-in-behold-ovarian 2026-07-11T06:02:14.703Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-palliative-care-integration-in-pediatric-oncology-phase-1-trials 2026-07-11T06:02:03.025Z weekly 0.7 https://www.humanexasignals.com/signals/shape-memory-medical-initiates-pivotal-trial-for-impede-fx-in-abdominal-aortic-a 2026-07-11T06:01:54.564Z weekly 0.7 https://www.humanexasignals.com/signals/natural-history-study-of-mbl-and-cllsll-to-identify-disease-progression-markers 2026-07-11T06:01:43.903Z weekly 0.7 https://www.humanexasignals.com/signals/digital-tomosynthesis-mammography-shows-promise-in-breast-cancer-screening 2026-07-11T06:01:34.169Z weekly 0.7 https://www.humanexasignals.com/signals/post-marketing-study-shows-cholera-vaccine-reduces-diarrhea-incidence-in-childre 2026-07-11T06:01:26.126Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-padcev-plus-keytruda-for-muscle-invasive-bladder-cancer-treatment 2026-07-11T06:01:16.022Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-star15-combination-therapy-for-metastatic-colorectal-cancer 2026-07-11T00:31:55.306Z weekly 0.7 https://www.humanexasignals.com/signals/study-to-develop-risk-prediction-model-for-medication-related-osteonecrosis-of-t 2026-07-11T00:31:19.403Z weekly 0.7 https://www.humanexasignals.com/signals/beone-medicines-initiates-study-of-bgb-16673-in-cllsll-patients-post-btk-and-bcl 2026-07-11T00:31:11.742Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pain-neuroscience-education-for-chronic-pain-shows-need-for-biomechanic 2026-07-11T00:31:03.040Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-tolerability-study-of-ianalumab-with-tpo-ra-in-itp-patients 2026-07-11T00:30:55.947Z weekly 0.7 https://www.humanexasignals.com/signals/novo-nordisks-nnc0487-0111-trial-targets-obesity-in-sleep-apnoea-patients 2026-07-11T00:30:49.174Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-dopaminergic-pathway-in-sleep-breathing-disorders-initiated 2026-07-11T00:30:42.125Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-plasma-tumor-dna-as-predictor-in-early-stage-breast-cancer-treatment 2026-07-11T00:30:28.828Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-laboratories-recalls-phenoxymethylpenicillin-due-to-labeling-issues 2026-07-10T18:32:20.800Z weekly 0.7 https://www.humanexasignals.com/signals/surufatinib-plus-folfoxfolfiri-shows-potential-in-mcrc-second-line-therapy 2026-07-10T18:32:09.851Z weekly 0.7 https://www.humanexasignals.com/signals/fda-alerts-on-non-sterile-bd-chloraprep-applicators-in-medline-convenience-kits 2026-07-10T18:31:58.414Z weekly 0.7 https://www.humanexasignals.com/signals/pou2f2-identified-as-a-key-oncogenic-and-immunomodulatory-factor-in-kidney-cance 2026-07-10T18:31:49.773Z weekly 0.7 https://www.humanexasignals.com/signals/microbiota-and-metabolites-influence-immunotherapy-response-in-triple-negative-b 2026-07-10T18:31:40.046Z weekly 0.7 https://www.humanexasignals.com/signals/mt-nd1-mutation-linked-to-male-infertility-in-chinese-population 2026-07-10T18:31:31.297Z weekly 0.7 https://www.humanexasignals.com/signals/ipsen-initiates-trial-of-elafibranor-for-primary-biliary-cholangitis-in-patients 2026-07-10T18:31:18.753Z weekly 0.7 https://www.humanexasignals.com/signals/network-guided-tms-trial-for-alzheimers-behavioral-symptoms-initiated 2026-07-10T18:31:11.059Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-phoenixin-14-levels-in-infants-of-diabetic-mothers 2026-07-10T18:31:04.076Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-evaluates-surovatamig-for-cllsll-consolidation-therapy 2026-07-10T18:30:57.084Z weekly 0.7 https://www.humanexasignals.com/signals/comparative-study-of-ai-vs-narrow-band-imaging-for-ibd-cancer-surveillance 2026-07-10T18:30:50.512Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-study-on-malignant-mesothelioma-for-tissue-procurement-and-natural- 2026-07-10T18:30:43.650Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-rfa-techniques-for-chronic-coccydynia-pain-relief 2026-07-10T18:30:36.646Z weekly 0.7 https://www.humanexasignals.com/signals/intraoperative-fluid-exposure-affects-early-bowel-recovery-in-colorectal-cancer- 2026-07-10T12:31:08.487Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheims-nerandomilast-trial-for-lung-fibrosis-in-autoimmune-diseas 2026-07-10T12:31:00.188Z weekly 0.7 https://www.humanexasignals.com/signals/regeneron-initiates-dose-escalation-study-of-bispecific-antibodies-for-lupus-nep 2026-07-10T12:30:52.891Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-ibuzatrelvir-study-targets-high-risk-covid-19-patients 2026-07-10T12:30:45.670Z weekly 0.7 https://www.humanexasignals.com/signals/digital-health-intervention-for-young-adult-cancer-survivors-under-study 2026-07-10T12:30:35.560Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-bw-41012-by-shanghai-argo-biopharmaceutical-co 2026-07-10T06:31:24.129Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-neratinib-and-palbociclib-in-her2-solid-tumors-initiated 2026-07-10T06:31:12.569Z weekly 0.7 https://www.humanexasignals.com/signals/biomarker-guided-care-improves-outcomes-in-nulliparous-pregnancies-at-risk-for-p 2026-07-10T06:31:00.969Z weekly 0.7 https://www.humanexasignals.com/signals/novel-ala-hpo-hybrids-show-enhanced-efficacy-in-photodynamic-therapy-for-superfi 2026-07-10T06:30:51.886Z weekly 0.7 https://www.humanexasignals.com/signals/optimizing-estradiol-levels-for-menopausal-health-implications-for-hormone-thera 2026-07-10T06:30:40.764Z weekly 0.7 https://www.humanexasignals.com/signals/elranatamab-shows-robust-efficacy-and-favorable-safety-in-relapsedrefractory-mul 2026-07-10T06:05:18.356Z weekly 0.7 https://www.humanexasignals.com/signals/new-workflow-for-isolating-microbiota-from-pancreatic-tumors-and-duodenum 2026-07-10T06:05:00.086Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-reviews-safety-of-five-plasma-derived-products-for-vcjd-risk 2026-07-10T06:04:45.735Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-approves-uk-plasma-donations-for-key-medicinal-products 2026-07-10T06:04:30.416Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-hw211026-for-actinic-keratosis-initiated 2026-07-10T06:03:51.113Z weekly 0.7 https://www.humanexasignals.com/signals/ft-ir-spectroscopy-identifies-non-invasive-biomarkers-for-kidney-cancer-detectio 2026-07-10T06:03:39.180Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheims-nerandomilast-trial-for-fibrosing-ild-shows-potential-for- 2026-07-10T06:02:56.926Z weekly 0.7 https://www.humanexasignals.com/signals/study-comparing-single-dose-vs-divided-dose-g-csf-for-stem-cell-mobilization 2026-07-10T06:02:43.332Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-hal-pdt-vs-surgery-for-high-grade-squamous-intraepithelial-les 2026-07-10T06:02:32.507Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-shr-8068-adebrelimab-and-bevacizumab-in-hepatocellular-carcinom 2026-07-10T06:02:23.112Z weekly 0.7 https://www.humanexasignals.com/signals/pembrolizumab-plus-enzalutamide-trial-in-mcrpc-shows-promise-for-overall-surviva 2026-07-10T06:02:11.973Z weekly 0.7 https://www.humanexasignals.com/signals/epcoritamab-lenalidomide-and-rituximab-outperforms-chemoimmunotherapy-in-rr-foll 2026-07-10T06:02:02.371Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-presents-new-alzheimers-diagnostic-and-therapeutic-data-at-aaic-2026 2026-07-10T06:01:49.145Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-tislelizumab-and-lenvatinib-in-unresectable-intrahepatic-chol 2026-07-10T06:01:37.596Z weekly 0.7 https://www.humanexasignals.com/signals/traditional-chinese-medicine-enhances-efficacy-of-immune-checkpoint-inhibitors 2026-07-10T00:33:27.413Z weekly 0.7 https://www.humanexasignals.com/signals/fluoxetine-janus-dendrimer-shows-potent-anticancer-activity-against-mcf-7-cells 2026-07-10T00:33:11.726Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-rinvoq-lq-by-abbvie 2026-07-10T00:32:46.013Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-kisqali-femara-co-packaged-product 2026-07-10T00:32:29.399Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-application-for-rivaroxaban-by-mankind-pharma 2026-07-10T00:32:17.600Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-nda-for-fetroja-by-shionogi 2026-07-10T00:31:40.861Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-reproductive-axis-maturation-in-post-menarchal-girls-and-pcos-risk 2026-07-10T00:31:31.391Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-chemoimmunotherapy-with-dc-vaccines-for-recurrent-ovarian-cance 2026-07-10T00:31:22.868Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-burden-of-hospitalized-patients-with-respiratory-tract-infections-in-du 2026-07-10T00:31:13.754Z weekly 0.7 https://www.humanexasignals.com/signals/sanaria-inc-initiates-pfspz-larc2-vaccine-trial-for-women-in-mali 2026-07-10T00:31:06.043Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-to-collect-samples-for-hairy-cell-leukemia-and-immunotoxin-development 2026-07-10T00:30:58.332Z weekly 0.7 https://www.humanexasignals.com/signals/cabaletta-bio-initiates-reset-myositis-trial-for-caba-201-in-inflammatory-myopat 2026-07-10T00:30:49.934Z weekly 0.7 https://www.humanexasignals.com/signals/anagram-therapeutics-initiates-phase-2-trial-for-ang003-in-exocrine-pancreatic-i 2026-07-10T00:30:43.341Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-study-on-alpelisib-and-fulvestrant-for-advanced-hr-breast-can 2026-07-10T00:30:36.928Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-traumatic-brain-injury-pathogenesis-and-outcomes-by-ninds 2026-07-10T00:30:29.159Z weekly 0.7 https://www.humanexasignals.com/signals/procizumab-shows-safety-and-tolerability-in-first-in-human-trial-for-cardiogenic 2026-07-09T18:34:27.861Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-kisqali-supplement-by-novartis 2026-07-09T18:34:12.222Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-mayzent-siponimod-by-novartis 2026-07-09T18:33:16.227Z weekly 0.7 https://www.humanexasignals.com/signals/zydus-pharms-submits-anda-for-metformin-hydrochloride-and-sitagliptin-phosphate 2026-07-09T18:33:03.734Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-adapalene-anda219565-by-unique 2026-07-09T18:32:52.091Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-remifentanil-hydrochloride-by-fresenius-kabi 2026-07-09T18:32:14.614Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-sotalol-hydrochloride-anda207428 2026-07-09T18:32:03.422Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-xeljanz-tofacitinib-citrate 2026-07-09T18:31:52.804Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-cibinqo-abrocitinib-by-pfizer 2026-07-09T18:31:43.664Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-soliris-eculizumab-by-alexion-pharmaceuti 2026-07-09T18:31:34.223Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-xeljanz-xr-by-pfizer 2026-07-09T18:31:26.088Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pharmacokinetics-and-drug-side-effects-by-nci 2026-07-09T18:31:16.905Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-text-based-monitoring-for-ibd-outcomes-and-patient-empowerment 2026-07-09T18:31:08.176Z weekly 0.7 https://www.humanexasignals.com/signals/4d-flow-mri-study-aims-to-improve-risk-stratification-for-variceal-bleeding-in-c 2026-07-09T18:31:00.879Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-study-of-14czorifertinib-shows-promising-safety-and-pharmacokinetics 2026-07-09T18:30:52.665Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pcsk9-and-pd-1-inhibitors-in-locally-advanced-rectal-cancer 2026-07-09T18:30:46.230Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-follow-up-study-on-hematopoietic-stem-cell-transplantation-and-therapi 2026-07-09T18:30:39.161Z weekly 0.7 https://www.humanexasignals.com/signals/correlative-study-on-epcoritamab-in-cll-and-richter-syndrome-by-nhlbi 2026-07-09T18:30:29.681Z weekly 0.7 https://www.humanexasignals.com/signals/abrocitinib-shows-sustained-disease-control-in-atopic-dermatitis-post-treatment 2026-07-09T12:35:09.864Z weekly 0.7 https://www.humanexasignals.com/signals/novel-compound-ag3-shows-promise-for-targeting-p53-y220c-mutation-in-gastric-can 2026-07-09T12:34:51.984Z weekly 0.7 https://www.humanexasignals.com/signals/amneals-anda217288-for-brimonidine-tartrate-and-timolol-maleate-receives-ap-stat 2026-07-09T12:34:07.728Z weekly 0.7 https://www.humanexasignals.com/signals/fda-adopts-uniform-12-digit-national-drug-code-format 2026-07-09T12:33:51.419Z weekly 0.7 https://www.humanexasignals.com/signals/nerandomilast-jascayd-approved-for-idiopathic-and-progressive-pulmonary-fibrosis 2026-07-09T12:33:36.067Z weekly 0.7 https://www.humanexasignals.com/signals/niddk-launches-genetic-study-on-insulin-resistance-and-diabetes 2026-07-09T12:32:54.458Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-biomarkers-in-fragile-sarcolemmal-muscular-dystrophy-launched 2026-07-09T12:32:39.926Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-traditional-chinese-medicine-patch-for-cancer-related-fatigue-in-radiot 2026-07-09T12:32:27.550Z weekly 0.7 https://www.humanexasignals.com/signals/alcons-trifocal-iol-study-compares-visual-outcomes-with-clareon-panoptix-pro 2026-07-09T12:32:17.635Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-combining-immunotherapy-and-thermal-therapy-in-her2-negative-breast- 2026-07-09T12:32:01.223Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-ultrasound-guided-cervical-plexus-block-for-vns-surgery-analgesia 2026-07-09T12:31:51.527Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2b-study-of-jx-594-in-advanced-liver-cancer-patients-failing-sorafenib 2026-07-09T12:31:41.359Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-iberdomide-in-relapsed-neuroblastoma-shows-potential-efficacy 2026-07-09T12:31:31.271Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-elocon-mometasone-furoate 2026-07-09T12:31:22.793Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-levothyroxine-sodium-by-fresenius-kabi 2026-07-09T12:31:15.733Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-finasteride-anda090121 2026-07-09T12:31:04.652Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-tranexamic-acid-by-micro-labs 2026-07-09T12:30:58.442Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-finasteride-anda076511-receives-abbreviated-approval-from-fda 2026-07-09T12:30:51.751Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-levocarnitine-anda217896-by-baxter-healthcare 2026-07-09T12:30:45.822Z weekly 0.7 https://www.humanexasignals.com/signals/novitium-pharmas-aciclovir-anda212252-receives-ap-status-from-fda 2026-07-09T12:30:39.674Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-aciclovir-anda216331-receives-ap-status-from-fda 2026-07-09T12:30:28.865Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-tpst-1495-in-familial-adenomatous-polyposis-patients 2026-07-09T06:35:01.471Z weekly 0.7 https://www.humanexasignals.com/signals/ascendis-pharmas-acp-001-shows-promise-in-weekly-growth-hormone-therapy-for-ghd 2026-07-09T06:34:42.869Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-diabetes-care-improvement-for-breast-cancer-patients 2026-07-09T06:34:25.887Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rtms-for-methamphetamine-abuse-in-methadone-patients-launched 2026-07-09T06:34:10.415Z weekly 0.7 https://www.humanexasignals.com/signals/advances-in-nsp13-helicase-inhibitors-for-broad-spectrum-anti-coronavirus-therap 2026-07-09T06:33:55.227Z weekly 0.7 https://www.humanexasignals.com/signals/adapting-stair-nt-for-polysubstance-users-in-opioid-treatment-programs 2026-07-09T06:33:15.255Z weekly 0.7 https://www.humanexasignals.com/signals/advancements-in-single-cell-and-spatial-transcriptomics-for-pancreatic-cancer-in 2026-07-09T06:33:02.498Z weekly 0.7 https://www.humanexasignals.com/signals/hpv-vaccination-shows-high-efficacy-against-cancer-and-precancer-outcomes 2026-07-09T06:32:49.151Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-risperidone-by-actavis-labs 2026-07-09T06:32:38.629Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-finasteride-anda076437-by-dr-reddys-labs 2026-07-09T06:32:28.166Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-acyclovir-anda212718-by-chartwell-rx 2026-07-09T06:32:18.316Z weekly 0.7 https://www.humanexasignals.com/signals/actavis-mid-atlantics-aciclovir-anda074738-receives-ap-status 2026-07-09T06:32:08.175Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-capecitabine-by-reliance-life 2026-07-09T06:31:31.331Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-acyclovir-anda213951-by-vistapharm 2026-07-09T06:31:21.838Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-verapamil-hydrochloride-anda078306 2026-07-09T06:31:12.264Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-finasteride-anda078341-receives-ap-status 2026-07-09T06:31:03.776Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-brivaracetam-anda219952-by-sciegen-pharmaceuticals 2026-07-09T06:30:56.205Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-acetazolamide-sodium-anda040089-receives-ap-status-from-fda 2026-07-09T06:30:47.076Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-adze1c-in-advanced-melanoma-shows-promise 2026-07-09T06:30:37.618Z weekly 0.7 https://www.humanexasignals.com/signals/music-therapy-may-alleviate-pain-and-distress-in-lung-cancer-surgery-patients 2026-07-09T06:30:29.564Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-chlorthalidone-anda212229-by-macleods-pharmaceuticals 2026-07-09T06:06:06.703Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda217934-for-brimonidine-tartrate-and-timolol-maleate 2026-07-09T06:05:50.058Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-fda-approval-for-liraglutide-anda212972 2026-07-09T06:05:34.480Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-capecitabine-anda210203-by-hetero-labs 2026-07-09T06:05:21.139Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-suppl-for-alfuzosin-hydrochloride-anda079060 2026-07-09T06:05:08.098Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-anda-for-azelastine-hydrochloride-and-fluticasone-propionate 2026-07-09T06:04:57.179Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cyberknife-for-melanoma-brain-metastasis-aims-to-improve-treatment-stra 2026-07-09T06:04:43.537Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-study-on-outcomes-and-risks-of-rare-cns-tumors 2026-07-09T06:04:32.797Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-provides-standard-cancer-care-for-non-trial-patients 2026-07-09T06:04:22.944Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-evaluates-docetaxel-cetuximab-with-atezolizumab-in-high-risk-h 2026-07-09T06:03:47.064Z weekly 0.7 https://www.humanexasignals.com/signals/stryker-initiates-clinical-evaluation-of-femoral-nail-gt-for-femur-fractures 2026-07-09T06:03:04.648Z weekly 0.7 https://www.humanexasignals.com/signals/select-tavr-trial-to-compare-myval-and-evolut-valves-in-borderline-annuli-patien 2026-07-09T06:02:55.053Z weekly 0.7 https://www.humanexasignals.com/signals/acupuncture-trial-for-heel-pain-syndrome-shows-promise-in-pain-relief-and-functi 2026-07-09T06:02:45.866Z weekly 0.7 https://www.humanexasignals.com/signals/lumos-pharma-initiates-phase-3-extension-study-for-lum-201-in-pediatric-growth-h 2026-07-09T06:02:37.403Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-wainua-fails-primary-endpoint-in-attr-cm-phase-iii-trial 2026-07-09T06:02:18.093Z weekly 0.7 https://www.humanexasignals.com/signals/roches-elecsys-igra-tb-test-receives-ce-mark-for-tuberculosis-detection 2026-07-09T06:02:08.257Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-launches-consultation-for-earlier-licensing-of-rare-disease-therapies 2026-07-09T00:35:08.892Z weekly 0.7 https://www.humanexasignals.com/signals/risk-of-severe-harm-from-incorrect-blood-transfusion-administration-sets 2026-07-09T00:34:51.278Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-anifrolumab-study-for-systemic-lupus-erythematosus-underway 2026-07-09T00:34:35.486Z weekly 0.7 https://www.humanexasignals.com/signals/city-of-hope-initiates-liquid-biopsy-study-for-early-colorectal-cancer-detection 2026-07-09T00:34:19.769Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-canakinumab-in-high-risk-former-smokers-launched 2026-07-09T00:34:04.224Z weekly 0.7 https://www.humanexasignals.com/signals/natural-history-study-of-trisomy-8-associated-autoinflammatory-disease-launched 2026-07-09T00:33:44.172Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-on-mindfulness-based-diabetes-education-for-rural-black-adults 2026-07-09T00:33:31.167Z weekly 0.7 https://www.humanexasignals.com/signals/fast-go-study-evaluates-physical-function-in-gastroesophageal-cancer-patients-un 2026-07-09T00:33:19.403Z weekly 0.7 https://www.humanexasignals.com/signals/single-af-trial-evaluates-doacs-in-intermediate-stroke-risk-atrial-fibrillation- 2026-07-09T00:33:08.061Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-tracheoscopy-techniques-in-neonates-with-tracheoesophageal-fistul 2026-07-09T00:32:58.248Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-intraocular-pressure-after-aflibercept-007ml-injection 2026-07-09T00:32:48.299Z weekly 0.7 https://www.humanexasignals.com/signals/leo-pharmas-delgocitinib-nda219155-receives-ap-status-from-fda 2026-07-09T00:31:49.232Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-zydus-glyburide-and-metformin-hydrochloride 2026-07-09T00:31:39.157Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-olumiant-baricitinib-by-eli-lilly 2026-07-09T00:31:29.657Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-parlodel-by-esjay-pharma 2026-07-09T00:31:20.483Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-rivaroxaban-generic-by-micro-labs 2026-07-09T00:31:11.573Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-opzelura-ruxolitinib-phosphate-by-incyte 2026-07-09T00:31:02.535Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-onapgo-apomorphine-hydrochloride 2026-07-09T00:30:54.178Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-hetero-labs-naproxen-anda215776 2026-07-09T00:30:38.724Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-leqselvi-deuruxolitinib-phosphate-by-sun-pharma 2026-07-09T00:30:31.119Z weekly 0.7 https://www.humanexasignals.com/signals/case-study-melanoma-patient-with-brain-metastases-and-dvt-managed-with-immunothe 2026-07-08T18:34:19.829Z weekly 0.7 https://www.humanexasignals.com/signals/ube2c-identified-as-a-key-driver-in-pancreatic-cancer-via-pi3kaktmtor-pathway 2026-07-08T18:34:01.784Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-large-volume-paracentesis-and-tips-for-ascites-relief 2026-07-08T18:33:40.065Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-evaluates-pomalidomide-outcomes-in-relapsedrefractory-multi 2026-07-08T18:32:54.627Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-investigates-safety-of-ondexxya-iv-injection-in-real-world-use 2026-07-08T18:32:35.165Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-sotyktu-deucravacitinib-by-bristol 2026-07-08T18:31:45.303Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-everolimus-anda219464 2026-07-08T18:31:35.757Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-pfizers-ritlecitinib-tosylate-litfulo 2026-07-08T18:31:27.128Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-qsymia-supplemental-application-by-vivus-llc 2026-07-08T18:31:18.072Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-erleada-apalutamide 2026-07-08T18:31:10.233Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-bla761340-by-samsung-bioepis 2026-07-08T18:31:02.275Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-pixxoscan-gadobutrol-by-ge-healthcare 2026-07-08T18:30:54.239Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-status-update-for-abanta-apixaban-by-azurity 2026-07-08T18:30:47.861Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-zoryve-roflumilast-by-arcutis 2026-07-08T18:30:39.928Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-prucalopride-succinate-by-micro-labs 2026-07-08T18:30:29.981Z weekly 0.7 https://www.humanexasignals.com/signals/quantx-biosciences-initiates-qx-4533-safety-study-in-healthy-participants 2026-07-08T12:32:08.858Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-bla761333-by-amgen-for-eculizumab-aeeb 2026-07-08T12:31:49.109Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-truxima-rituximab-abbs 2026-07-08T12:31:38.663Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-novitium-pharmas-rifampin-anda219918 2026-07-08T12:31:27.309Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-hepzato-by-delcath-systems 2026-07-08T12:31:15.315Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-omeprazole-magnesium-by-marksans-pharma 2026-07-08T12:31:06.898Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-strattera-by-lilly 2026-07-08T12:30:59.158Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-posaconazole-by-apotex 2026-07-08T12:30:52.149Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-tascenso-odt 2026-07-08T12:30:45.208Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-carbidopa-levodopa-by-zydus-pharms 2026-07-08T12:30:38.429Z weekly 0.7 https://www.humanexasignals.com/signals/novitium-pharmas-tramadol-hydrochloride-anda219647-receives-ap-status 2026-07-08T12:30:30.256Z weekly 0.7 https://www.humanexasignals.com/signals/innovative-mri-methods-for-characterizing-heart-failure-with-preserved-ejection- 2026-07-08T06:34:42.310Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sepsis-associated-acute-lung-injury-from-hypervirulent-klebsiella-pneum 2026-07-08T06:34:27.161Z weekly 0.7 https://www.humanexasignals.com/signals/hoffmann-la-roche-initiates-trial-for-trontinemab-in-early-symptomatic-alzheimer 2026-07-08T06:34:08.227Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-jr-446-for-mps-iiib-initiated-by-jcr-pharmaceuticals 2026-07-08T06:33:53.036Z weekly 0.7 https://www.humanexasignals.com/signals/novel-remote-rehab-technique-for-parkinsons-disease-in-veterans 2026-07-08T06:33:39.320Z weekly 0.7 https://www.humanexasignals.com/signals/brentuximab-vedotin-study-in-cd30-positive-lymphoma-launched-by-takeda 2026-07-08T06:33:28.137Z weekly 0.7 https://www.humanexasignals.com/signals/shionogis-s-337395-trial-targets-high-risk-rsv-patients 2026-07-08T06:32:49.354Z weekly 0.7 https://www.humanexasignals.com/signals/mayo-clinic-study-on-secretins-effect-on-pancreatic-fluid-composition 2026-07-08T06:32:36.437Z weekly 0.7 https://www.humanexasignals.com/signals/economic-review-of-nirmatrelvirritonavir-for-covid-19-health-outcomes 2026-07-08T06:32:25.731Z weekly 0.7 https://www.humanexasignals.com/signals/preclinical-snap-til-therapy-shows-promise-for-broader-cancer-treatment-efficacy 2026-07-08T06:32:15.403Z weekly 0.7 https://www.humanexasignals.com/signals/mylans-metformin-hydrochloride-anda200690-receives-ap-status-from-fda 2026-07-08T06:32:05.254Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-nilotinib-hydrochloride-anda219134-receives-ap-status-from-fda 2026-07-08T06:31:53.911Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-carbamazepine-anda215591-by-zhejiang-jiuzhou 2026-07-08T06:31:20.174Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-prednisone-anda218035-by-dr-reddys 2026-07-08T06:31:12.243Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-sitagliptin-and-metformin-hydrochloride-by-inventia-healthcar 2026-07-08T06:31:04.846Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-azelaic-acid-by-taro-pharmaceuticals 2026-07-08T06:30:50.611Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-introvale-anda079064-by-xiromed 2026-07-08T06:30:42.954Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-naproxen-by-novitium-pharma 2026-07-08T06:30:36.300Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-tofacitinib-citrate-by-sciegen-pharmaceutica 2026-07-08T06:30:29.328Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-naproxen-sodium-anda212199-by-sciegen-pharmaceuticals 2026-07-08T06:04:55.427Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-sufentanil-citrate-anda074534-by-hospira 2026-07-08T06:04:40.884Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-mylans-ferric-carboxymaltose-anda217076 2026-07-08T06:04:25.652Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-columvi-glofitamab-gxbm-by-genentech 2026-07-08T06:04:12.748Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-copaxone-glatiramer-acetate 2026-07-08T06:03:51.271Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-exl01-to-prevent-clostridioides-difficile-infection-recurrenc 2026-07-08T06:03:05.053Z weekly 0.7 https://www.humanexasignals.com/signals/study-to-enhance-hydroxyurea-adoption-for-sickle-cell-disease-in-nigeria 2026-07-08T06:02:52.967Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ibii-trial-of-sonrotoclax-and-bcma-bispecific-antibody-in-systemic-al-amyl 2026-07-08T06:02:41.682Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-trutakna-for-proteinuria-in-primary-iga-nephropathy 2026-07-08T06:02:04.050Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-js212-plus-js111-in-egfr-mutant-nsclc-initiated-by-shanghai-ju 2026-07-08T06:01:45.512Z weekly 0.7 https://www.humanexasignals.com/signals/bayers-study-on-darolutamide-in-advanced-prostate-cancer-to-assess-real-world-ef 2026-07-08T06:01:34.465Z weekly 0.7 https://www.humanexasignals.com/signals/multicenter-trial-comparing-surgery-and-systemic-therapy-in-stage-iv-breast-canc 2026-07-08T06:01:25.621Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-becotatug-vedotin-with-tislelizumab-and-lenvatinib-in-advanced 2026-07-08T06:01:17.842Z weekly 0.7 https://www.humanexasignals.com/signals/catch-up-vaccination-safe-and-effective-in-children-with-kaposiform-hemangioendo 2026-07-08T00:35:18.572Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-cetrorelix-acetate-by-epic-pharma 2026-07-08T00:35:00.310Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-crestor-rosuvastatin-calcium 2026-07-08T00:34:44.490Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-vanflyta-quizartinib 2026-07-08T00:34:04.091Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-ngenla-somatrogon-ghla 2026-07-08T00:33:48.840Z weekly 0.7 https://www.humanexasignals.com/signals/umedica-labs-receives-fda-approval-for-oxcarbazepine-anda218341 2026-07-08T00:33:35.113Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-pavblu-aflibercept-ayyh-from-amgen 2026-07-08T00:33:21.282Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-aurobindos-application-for-cenobamate 2026-07-08T00:33:09.392Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-viloxazine-hydrochloride-by-appco-pharma 2026-07-08T00:32:58.676Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-dextroamphetamine-and-amphetamine-combination-products 2026-07-08T00:32:48.466Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-eculizumab-aagh-by-samsung-bioepis 2026-07-08T00:32:39.577Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ava-use-in-continuous-renal-replacement-therapy-to-reduce-catheter-risk 2026-07-08T00:32:07.346Z weekly 0.7 https://www.humanexasignals.com/signals/united-therapeutics-ralinepag-shows-potential-in-improving-exercise-capacity-in- 2026-07-08T00:31:58.134Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mycap-app-for-monitoring-radiation-dermatitis-in-head-and-neck-cancer-p 2026-07-08T00:31:49.351Z weekly 0.7 https://www.humanexasignals.com/signals/teclistamab-combination-study-in-multiple-myeloma-initiated-by-janssen 2026-07-08T00:31:17.411Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-lmp744-in-recurrent-glioblastoma-shows-potential-for-new-treatm 2026-07-08T00:31:09.330Z weekly 0.7 https://www.humanexasignals.com/signals/pg2-study-to-evaluate-survival-benefits-in-early-breast-cancer-patients-undergoi 2026-07-08T00:30:58.681Z weekly 0.7 https://www.humanexasignals.com/signals/eisai-initiates-post-marketing-study-of-jyseleca-in-korea-to-assess-safety-and-e 2026-07-08T00:30:49.732Z weekly 0.7 https://www.humanexasignals.com/signals/177lu-dota-eb-tate-trial-for-metastatic-hurthle-cell-thyroid-cancer-initiated 2026-07-08T00:30:40.784Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-jnj-56021927-and-abiraterone-in-metastatic-prostate-cancer 2026-07-08T00:30:29.725Z weekly 0.7 https://www.humanexasignals.com/signals/tgfa-identified-as-key-regulator-in-cervical-cancer-progression-via-dsg2-interac 2026-07-07T18:35:07.087Z weekly 0.7 https://www.humanexasignals.com/signals/thyroid-cancer-exosomal-spp1-drives-macrophage-m2-polarization-and-tumor-progres 2026-07-07T18:34:47.962Z weekly 0.7 https://www.humanexasignals.com/signals/linezolid-shows-potential-as-adjunctive-treatment-for-ntm-infections-in-immunode 2026-07-07T18:34:28.858Z weekly 0.7 https://www.humanexasignals.com/signals/wrist-ankle-acupuncture-shows-promise-for-preventing-postoperative-nausea-in-hig 2026-07-07T18:34:11.093Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-biocons-eltrombopag-olamine-under-anda220660 2026-07-07T18:33:54.663Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharmas-tranexamic-acid-supplement-application-receives-ap-status-from-fda 2026-07-07T18:33:40.323Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-gabapentin-anda214957-by-ascent-pharm 2026-07-07T18:33:27.457Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-atorvastatin-calcium-supplement 2026-07-07T18:32:53.673Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-doxepin-hydrochloride-anda213919-by-sun-pharma 2026-07-07T18:32:42.407Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-supplemental-anda-for-pomalidomide 2026-07-07T18:32:06.621Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-prednisolone-anda219509-by-tp-anda-holdings 2026-07-07T18:31:57.153Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-nuplazid-by-acadia-pharms 2026-07-07T18:31:47.304Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-lenalidomide-supplement-by-alvogen 2026-07-07T18:31:38.840Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-lenalidomide-by-biocon-pharma 2026-07-07T18:31:29.884Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-of-optune-for-recurrent-atypical-and-anaplastic-meningioma-initiated 2026-07-07T18:31:16.901Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-18f-aipf-1026-petct-in-mao-a-related-diseases 2026-07-07T18:31:07.986Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-gamified-mobile-app-for-depression-shows-promise-in-reducing-sympt 2026-07-07T18:30:59.992Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheims-bi-764198-trial-examines-formulation-impact-on-bioavailabi 2026-07-07T18:30:51.976Z weekly 0.7 https://www.humanexasignals.com/signals/merck-and-daiichi-sankyo-launch-escc-combination-therapy-study-with-pembrolizuma 2026-07-07T18:30:46.153Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-supersense-proprioceptive-rehabilitation-in-parkinsons-disease 2026-07-07T18:30:38.931Z weekly 0.7 https://www.humanexasignals.com/signals/janssen-initiates-rollover-study-for-long-term-safety-in-multiple-cancers 2026-07-07T18:30:31.413Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-gender-disparities-in-voice-outcomes-post-laryngectomy-at-uc-davis 2026-07-07T12:31:22.900Z weekly 0.7 https://www.humanexasignals.com/signals/telerehabilitation-vs-face-to-face-care-in-hemophilia-patients-a-comparative-stu 2026-07-07T12:31:14.766Z weekly 0.7 https://www.humanexasignals.com/signals/janssens-guselkumab-compared-to-risankizumab-in-crohns-disease-study-initiated 2026-07-07T12:31:03.248Z weekly 0.7 https://www.humanexasignals.com/signals/janssens-amivantamab-study-in-advanced-nsclc-evaluates-safety-and-efficacy 2026-07-07T12:30:43.445Z weekly 0.7 https://www.humanexasignals.com/signals/novel-bispecific-t-cell-engagers-show-promise-against-egfr-resistance-in-cancer 2026-07-07T06:34:40.932Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lenalidomide-by-zydus-pharmaceuticals 2026-07-07T06:34:21.577Z weekly 0.7 https://www.humanexasignals.com/signals/fda-authorizes-baricitinib-and-remdesivir-combination-for-covid-19-treatment 2026-07-07T06:33:34.121Z weekly 0.7 https://www.humanexasignals.com/signals/fda-warns-of-drug-interaction-reducing-remdesivir-effectiveness-in-covid-19-trea 2026-07-07T06:33:17.254Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-emergency-use-authorization-for-remdesivir-in-severe-covid-19-cases 2026-07-07T06:33:03.644Z weekly 0.7 https://www.humanexasignals.com/signals/fda-authorizes-gohibic-vilobelimab-for-covid-19-treatment 2026-07-07T06:32:49.575Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1b2-study-of-jnj-90014496-for-b-cell-non-hodgkin-lymphoma-initiated-by-jan 2026-07-07T06:32:05.468Z weekly 0.7 https://www.humanexasignals.com/signals/janssen-initiates-study-on-erdafitinib-intravesical-delivery-for-bladder-cancer- 2026-07-07T06:31:49.573Z weekly 0.7 https://www.humanexasignals.com/signals/jnj-87562761-phase-2-study-initiated-for-relapsedrefractory-multiple-myeloma 2026-07-07T06:31:36.648Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-biomarkers-for-predicting-recurrence-in-colorectal-cancer-launched 2026-07-07T06:31:24.233Z weekly 0.7 https://www.humanexasignals.com/signals/pacritinib-trial-for-myelodysplastic-syndromes-in-adults-and-children-initiated- 2026-07-07T06:31:14.323Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-rtms-trial-for-knee-arthritis-pain-and-depression-shows-promise 2026-07-07T06:30:55.994Z weekly 0.7 https://www.humanexasignals.com/signals/bayers-study-on-arpi-use-in-mhspc-patients-in-australia-aims-to-inform-clinical- 2026-07-07T06:30:44.934Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-utidelones-efficacy-in-her-2-negative-advanced-breast-cancer 2026-07-07T06:04:29.441Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-lisaftoclax-and-pirtobrutinib-in-relapsed-mantle-cell-lymphoma 2026-07-07T06:04:14.806Z weekly 0.7 https://www.humanexasignals.com/signals/janssens-amivantamab-and-docetaxel-combo-in-nsclc-enters-phase-12-trials 2026-07-07T06:04:01.213Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cardiovascular-disease-progression-post-pneumonia-and-covid-19-infectio 2026-07-07T06:03:46.387Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ibii-study-of-becotatugvedotin-with-gemcitabine-in-advanced-pdac 2026-07-07T06:03:34.090Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-roflumilast-cream-03-shows-promise-for-plaque-psoriasis 2026-07-07T06:02:58.414Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-afimkibart-shows-promise-for-moderately-to-severely-active-cr 2026-07-07T06:02:46.831Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-toripalimab-and-lenvatinib-for-advanced-hcc-initiated 2026-07-07T06:02:36.990Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-phase-iii-trial-of-baxdrostat-in-primary-aldosteronism-underway 2026-07-07T06:02:04.782Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-veklury-as-first-treatment-for-covid-19 2026-07-07T06:01:47.111Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-present-new-alzheimers-data-including-trontinemab-and-ptau217-blood-tes 2026-07-07T06:01:35.255Z weekly 0.7 https://www.humanexasignals.com/signals/roche-presents-new-alzheimers-data-at-aaic-2026-highlighting-trontinemab-and-blo 2026-07-07T06:01:22.425Z weekly 0.7 https://www.humanexasignals.com/signals/circular-rnas-as-potential-biomarkers-in-cancer-diagnosis-and-prognosis 2026-07-07T00:34:03.373Z weekly 0.7 https://www.humanexasignals.com/signals/kibra-identified-as-a-tumor-suppressor-in-osteosarcoma-via-wnt-catenin-inhibitio 2026-07-07T00:33:51.238Z weekly 0.7 https://www.humanexasignals.com/signals/rbm15bfoxm1aurkatpx2-axis-identified-as-key-driver-in-endometrial-cancer-progres 2026-07-07T00:33:38.541Z weekly 0.7 https://www.humanexasignals.com/signals/amneals-lenalidomide-anda216213-receives-abbreviated-approval 2026-07-07T00:33:19.164Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lenalidomide-by-accord-healthcare 2026-07-07T00:32:44.465Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-lenalidomide-anda210435-receives-abbreviated-approval-from-fda 2026-07-07T00:32:32.930Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-nda-for-revlimid-by-bristol-myers-squibb 2026-07-07T00:32:18.242Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-pomalidomide-by-hetero-labs 2026-07-07T00:31:45.497Z weekly 0.7 https://www.humanexasignals.com/signals/eugia-pharma-receives-ap-status-for-pomalidomide-supplement 2026-07-07T00:31:36.894Z weekly 0.7 https://www.humanexasignals.com/signals/teva-pharmaceuticals-submits-supplemental-application-for-pomalidomide 2026-07-07T00:31:22.629Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-botensilimab-balstilimab-in-chemo-refractory-colorectal-cancer 2026-07-07T00:31:09.486Z weekly 0.7 https://www.humanexasignals.com/signals/yzj-4729-shows-promise-in-phase-trial-for-postoperative-pain-relief 2026-07-07T00:31:00.592Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-non-invasive-median-nerve-stimulation-for-atrial-fibrillation-post-abla 2026-07-07T00:30:53.955Z weekly 0.7 https://www.humanexasignals.com/signals/apt-comparison-study-to-evaluate-atogepant-vs-topiramate-and-propranolol-for-mig 2026-07-07T00:30:46.614Z weekly 0.7 https://www.humanexasignals.com/signals/digital-biomarkers-for-monitoring-limb-function-in-inclusion-body-myositis 2026-07-07T00:30:39.889Z weekly 0.7 https://www.humanexasignals.com/signals/chongqing-claruvis-initiates-study-on-yy001-for-glabellar-lines 2026-07-07T00:30:33.721Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lenalidomide-by-qilu 2026-07-06T18:36:08.491Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-lenalidomide-anda217281-submission-from-novugen 2026-07-06T18:36:00.047Z weekly 0.7 https://www.humanexasignals.com/signals/psilocybin-therapy-shows-promise-for-depression-in-parkinsons-disease 2026-07-06T18:35:50.928Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-dexmedetomidine-vs-magnesium-sulphate-for-thoracotomy-pain-management 2026-07-06T18:35:41.206Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-ascending-dose-study-of-pit565-for-rheumatoid-arthritis 2026-07-06T18:35:33.442Z weekly 0.7 https://www.humanexasignals.com/signals/sonocloud-9-enhances-carboplatin-delivery-in-recurrent-glioblastoma-trial 2026-07-06T18:35:25.701Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-laparoscopic-techniques-for-gastric-cancer-quality-of-life 2026-07-06T18:33:28.962Z weekly 0.7 https://www.humanexasignals.com/signals/northwestern-university-trials-behavioral-treatments-for-narcolepsy-related-nigh 2026-07-06T18:31:28.579Z weekly 0.7 https://www.humanexasignals.com/signals/type-2-diabetes-remission-in-gynecologic-oncology-patients-post-weight-loss-prot 2026-07-06T12:35:17.876Z weekly 0.7 https://www.humanexasignals.com/signals/prx5-identified-as-key-regulator-in-colorectal-cancer-stem-cell-formation 2026-07-06T12:34:31.160Z weekly 0.7 https://www.humanexasignals.com/signals/new-orthotopic-model-reveals-cd8-t-cell-dysfunction-in-colorectal-cancer-immunot 2026-07-06T12:34:14.499Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lenalidomide-by-apotex 2026-07-06T12:33:58.592Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-lenalidomide-supplement-application-by-mylan 2026-07-06T12:33:45.654Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lenalidomide-by-dr-reddys 2026-07-06T12:33:23.660Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-lenalidomide-anda213165-receives-ap-status-from-fda 2026-07-06T12:33:08.133Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-lenalidomide-anda214398-receives-abbreviated-approval 2026-07-06T12:32:33.984Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-breztri-aerosphere 2026-07-06T12:32:23.860Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-thalidomide-thalomid 2026-07-06T12:32:14.355Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-pomalidomide-supplement-by-breckenridge 2026-07-06T12:31:44.092Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-symbicort-aerosphere 2026-07-06T12:31:35.338Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictors-of-major-adverse-limb-events-after-iliac-stenting 2026-07-06T12:31:25.922Z weekly 0.7 https://www.humanexasignals.com/signals/intranasal-and-iv-oxytocin-study-for-pain-relief-shows-potential 2026-07-06T12:31:16.018Z weekly 0.7 https://www.humanexasignals.com/signals/eye201mk-8748-trial-initiated-for-neovascular-amd-treatment-comparison 2026-07-06T12:31:08.670Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-on-specimen-collections-from-hiv-and-kshv-patients 2026-07-06T12:30:57.712Z weekly 0.7 https://www.humanexasignals.com/signals/corcept-initiates-study-of-nenocorilant-with-nivolumab-in-advanced-solid-tumors 2026-07-06T12:30:49.785Z weekly 0.7 https://www.humanexasignals.com/signals/vertex-pharmaceuticals-evaluates-suzetrigines-pk-with-efavirenz-in-healthy-parti 2026-07-06T12:30:38.649Z weekly 0.7 https://www.humanexasignals.com/signals/teva-initiates-trial-for-tev-56286-assessing-pharmacokinetics-and-safety 2026-07-06T06:32:13.188Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-novobiocin-targets-cancer-with-dna-repair-gene-alterations 2026-07-06T06:31:39.199Z weekly 0.7 https://www.humanexasignals.com/signals/gerofit-exercise-intervention-study-for-sickle-cell-disease-shows-promise 2026-07-06T06:31:04.393Z weekly 0.7 https://www.humanexasignals.com/signals/vaxcyte-initiates-study-on-vax-31-for-adults-over-50-with-prior-pneumococcal-vac 2026-07-06T06:30:43.091Z weekly 0.7 https://www.humanexasignals.com/signals/outlook-therapeutics-initiates-trial-for-ons-5010-in-neovascular-amd 2026-07-06T06:30:32.150Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-thalidomide-anda213267-by-natco-1 2026-07-06T06:06:17.732Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-caplyta-lumateperone-by-intra-cellular 2026-07-06T06:05:39.011Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-ziprasidone-hydrochloride-by-chartwell-rx 2026-07-06T06:05:04.791Z weekly 0.7 https://www.humanexasignals.com/signals/ucb-biopharma-initiates-slc6a1-ndd-natural-history-study-to-inform-future-clinic 2026-07-06T06:04:50.582Z weekly 0.7 https://www.humanexasignals.com/signals/niaid-launches-study-on-inflammatory-disorders-with-long-term-follow-up 2026-07-06T06:04:12.790Z weekly 0.7 https://www.humanexasignals.com/signals/boston-medical-center-study-on-ultrasound-for-heart-failure-management 2026-07-06T06:03:34.579Z weekly 0.7 https://www.humanexasignals.com/signals/biogens-felzartamab-study-targets-isolated-microvascular-inflammation-in-kidney- 2026-07-06T06:03:22.918Z weekly 0.7 https://www.humanexasignals.com/signals/early-feasibility-study-of-unibe-hybrid-closed-loop-insulin-delivery-in-type-1-d 2026-07-06T06:03:09.409Z weekly 0.7 https://www.humanexasignals.com/signals/magrolimab-and-pembrolizumab-combination-study-in-hodgkin-lymphoma-initiated 2026-07-06T06:02:39.373Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-cd19cd22-car-t-cells-in-pediatric-b-cell-malignancies 2026-07-06T06:02:18.365Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-bla-for-anifrolumab-by-astrazeneca 2026-07-06T00:35:11.271Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-gabapentin-by-ascent-pharmaceuticals 2026-07-06T00:34:39.871Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-topiramate-supplement-by-invagen-pharmaceuticals 2026-07-06T00:34:30.077Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-anda207974-for-fingolimod-hydrochloride-receives-approval 2026-07-06T00:34:19.701Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-anda217477-by-hainan-poly-pharm 2026-07-06T00:34:10.242Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-eczema-treatments-and-skin-bacteria-launches 2026-07-06T00:33:56.926Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-panitumumab-irdye800-for-pediatric-tumor-detection-in-neurosurgery 2026-07-06T00:33:22.172Z weekly 0.7 https://www.humanexasignals.com/signals/first-human-study-of-sbt777101-in-rheumatoid-arthritis-by-sonoma-biotherapeutics 2026-07-06T00:33:10.693Z weekly 0.7 https://www.humanexasignals.com/signals/lisaftoclax-evaluated-for-preventing-differentiation-syndrome-in-apl-patients 2026-07-06T00:33:01.779Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-ltbi-screening-methods-in-hiv-patients-in-liberia 2026-07-06T00:32:51.919Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-semiconductor-headbands-for-cognitive-impairment-in-cancer-patients 2026-07-06T00:32:41.421Z weekly 0.7 https://www.humanexasignals.com/signals/saninova-tablets-study-assesses-dose-proportionality-and-pk-linearity 2026-07-06T00:30:29.930Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-induction-plus-consolidation-vs-consolidation-only-in-nsclc-immun 2026-07-05T18:34:46.445Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-budesonide-and-formoterol-fumarate-dihydrate-receives-fda-approval 2026-07-05T18:34:28.945Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-vyvanse-by-takeda 2026-07-05T18:33:41.049Z weekly 0.7 https://www.humanexasignals.com/signals/karyopharms-xpovio-selinexor-nda-supplement-receives-approval-from-fda 2026-07-05T18:33:26.438Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-olmesartan-medoxomil-and-hydrochlorothiazide-anda207037 2026-07-05T18:33:11.719Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda204687-for-valsartan-and-hydrochlorothiazide 2026-07-05T18:32:56.239Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-crysvita-burosumab-twza 2026-07-05T18:32:44.918Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-perjeta-by-genentech 2026-07-05T18:32:30.814Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-metro-iv-in-plastic-container-by-b-braun 2026-07-05T18:31:58.393Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-phase-iii-trial-of-azd9829-for-cd123-hematological-maligna 2026-07-05T18:31:48.506Z weekly 0.7 https://www.humanexasignals.com/signals/yale-university-develops-culturally-adapted-cm-for-black-adults-with-stimulant-u 2026-07-05T18:31:37.194Z weekly 0.7 https://www.humanexasignals.com/signals/guangdong-provincial-peoples-hospital-launches-big-data-centre-in-emergency-medi 2026-07-05T18:31:06.470Z weekly 0.7 https://www.humanexasignals.com/signals/psilocybin-shows-promise-in-preventing-relapse-in-alcohol-use-disorder-with-depr 2026-07-05T18:30:56.052Z weekly 0.7 https://www.humanexasignals.com/signals/neurovalens-initiates-vens-trial-for-adolescent-anxiety-treatment 2026-07-05T18:30:45.636Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-glutamine-and-thalidomide-for-radiation-induced-oral-mucositis 2026-07-05T18:30:36.554Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-abi-detection-in-pediatric-ecmo-patients-using-ultrawide-mri 2026-07-05T18:30:28.145Z weekly 0.7 https://www.humanexasignals.com/signals/genentechs-belvarafenib-trial-in-nras-mutant-advanced-melanoma-initiated 2026-07-05T18:30:20.921Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-ruxolitinib-in-chronic-myelomonocytic-leukemia-shows-potential- 2026-07-05T18:30:12.337Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-albuterol-sulfate-anda219409-receives-ap-status-from-fda 2026-07-05T12:34:37.686Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-escitalopram-oxalate-by-micro-labs 2026-07-05T12:34:27.078Z weekly 0.7 https://www.humanexasignals.com/signals/anthea-pharmas-bupivacaine-hydrochloride-anda220493-receives-ap-status 2026-07-05T12:34:17.468Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-flecainide-acetate-anda218093-by-omsav-pharma 2026-07-05T12:34:08.491Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-dupixent-dupilumab 2026-07-05T12:33:57.667Z weekly 0.7 https://www.humanexasignals.com/signals/kite-363-phase-1-study-initiated-for-autoimmune-neurologic-diseases 2026-07-05T12:33:39.699Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-modified-antegrade-cerebral-perfusion-in-aortic-dissection-surgery 2026-07-05T12:33:31.902Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-optibio-tool-for-medication-reduction-in-rheumatoid-arthritis 2026-07-05T12:33:24.500Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-language-recovery-in-aphasia-investigates-treatment-effects 2026-07-05T12:33:17.119Z weekly 0.7 https://www.humanexasignals.com/signals/real-world-study-on-donge-brand-ejiao-yuanjiang-for-sleep-improvement 2026-07-05T12:30:24.966Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-car-t-cells-with-chlorotoxin-for-mmp2-recurrent-glioblastoma 2026-07-05T12:30:17.595Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-social-feedbacks-impact-on-intracranial-eeg-in-epilepsy-patients 2026-07-05T06:31:31.118Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-intraoperative-chest-tube-removal-in-thoracoscopic-wedge-resection 2026-07-05T06:31:21.386Z weekly 0.7 https://www.humanexasignals.com/signals/kyowa-kirin-initiates-first-in-human-trial-for-kk2223-in-t-cell-non-hodgkin-lymp 2026-07-05T06:30:46.198Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-nivolumab-and-ipilimumab-for-advanced-melanoma-initiated 2026-07-05T06:30:36.548Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-integrons-to-reduce-broad-spectrum-antibiotic-use-in-utis 2026-07-05T06:30:28.107Z weekly 0.7 https://www.humanexasignals.com/signals/nci-trials-cd19cd22-car-t-cells-for-refractory-b-cell-malignancies-in-young-pati 2026-07-05T06:30:20.434Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-ais-impact-on-clinician-confidence-in-preterm-birth-risk-assessm 2026-07-05T06:30:10.120Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-pantoprazole-sodium-anda219973 2026-07-05T06:05:59.747Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-ic-green-by-renew-pharms 2026-07-05T06:05:38.828Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-valsartan-anda218897-by-laurus 2026-07-05T06:05:24.696Z weekly 0.7 https://www.humanexasignals.com/signals/impax-labs-receives-ap-for-methylphenidate-hydrochloride-anda205105 2026-07-05T06:05:10.951Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levetiracetam-supplement-by-strides-pharma 2026-07-05T06:04:59.400Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda078324-for-estradiol-and-norethindrone-acetate 2026-07-05T06:04:47.427Z weekly 0.7 https://www.humanexasignals.com/signals/tyra-biosciences-initiates-phase-2ab-trial-of-dabogratinib-for-low-grade-upper-t 2026-07-05T06:04:14.330Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-respiratory-muscle-strength-training-in-breast-cancer-surgery-patients 2026-07-05T06:04:03.563Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-endometrial-peristalsis-impact-on-pregnancy-outcomes-in-hrt-fet-cycles 2026-07-05T06:03:54.721Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluates-intra-articular-ozone-for-knee-osteoarthritis 2026-07-05T06:03:43.937Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-incidental-thyroid-cancer-in-autoimmune-thyroiditis-patients-launched 2026-07-05T06:03:35.995Z weekly 0.7 https://www.humanexasignals.com/signals/nursing-led-mobile-health-study-aims-to-improve-outcomes-in-breast-cancer-chemot 2026-07-05T06:03:26.178Z weekly 0.7 https://www.humanexasignals.com/signals/continuation-of-numom2b-heart-health-study-to-address-cvd-in-women 2026-07-05T06:02:55.323Z weekly 0.7 https://www.humanexasignals.com/signals/neoadjuvant-therapy-trial-for-head-and-neck-squamous-cell-carcinoma-initiated 2026-07-05T06:02:45.600Z weekly 0.7 https://www.humanexasignals.com/signals/discovery-of-egfr-l858r-targeting-peptide-shows-promise-against-ovarian-cancer 2026-07-05T06:02:27.057Z weekly 0.7 https://www.humanexasignals.com/signals/novel-tumor-inflammation-score-predicts-outcomes-in-nsclc-patients-treated-with- 2026-07-05T00:34:46.110Z weekly 0.7 https://www.humanexasignals.com/signals/cenpi-identified-as-a-promoter-of-hepatocellular-carcinoma-progression-via-pi3ka 2026-07-05T00:34:07.728Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-tolvaptan-by-alkem-labs 2026-07-05T00:33:51.848Z weekly 0.7 https://www.humanexasignals.com/signals/torrent-pharmaceuticals-submits-anda-for-vericiguat 2026-07-05T00:33:36.936Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-dalfampridine-by-accord-healthcare 2026-07-05T00:33:22.513Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-pirfenidone-anda-submission-receives-ap-status 2026-07-05T00:33:08.581Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-zuranolone-zurzuvae-by-biogen 2026-07-05T00:32:55.747Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-fda-approval-for-enzalutamide-anda216068 2026-07-05T00:32:43.697Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-anda-for-canagliflozin-receives-approval-status 2026-07-05T00:32:31.635Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-idvynso-containing-doravirine-and-islatravir 2026-07-05T00:32:21.052Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tzield-teplizumab-mzwv-supplement 2026-07-05T00:32:10.461Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sodium-acetate-anda220274-by-extrovis 2026-07-05T00:32:00.308Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-ebus-tbna-with-suction-for-lung-cancer-sample-collection 2026-07-05T00:31:32.334Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-study-on-odevixibat-effectiveness-for-pfic-in-south-korea-initiated 2026-07-05T00:31:02.771Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-pembrolizumab-for-poor-prognosis-cup-patients-initiated 2026-07-05T00:30:54.522Z weekly 0.7 https://www.humanexasignals.com/signals/teikoku-pharma-initiates-trial-for-dmts-in-alzheimers-related-agitation 2026-07-05T00:30:45.931Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetics-of-familial-mediterranean-fever-and-related-disorders-launched 2026-07-05T00:30:38.316Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-repository-for-pediatric-and-adult-common-childhood-cancers-samples 2026-07-05T00:30:31.367Z weekly 0.7 https://www.humanexasignals.com/signals/nurix-therapeutics-initiates-nx-5948-study-for-relapsed-cllsll-post-btk-and-bcl- 2026-07-05T00:30:18.211Z weekly 0.7 https://www.humanexasignals.com/signals/viiv-healthcare-compares-two-drug-vs-three-drug-regimen-in-hiv-treatment-study 2026-07-05T00:30:10.512Z weekly 0.7 https://www.humanexasignals.com/signals/fea-guided-design-enhances-bubble-microneedles-for-rapid-drug-delivery 2026-07-04T18:33:20.408Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-calcipotriene-supplement-by-glenmark 2026-07-04T18:32:54.445Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-cosentyx-secukinumab 2026-07-04T18:32:41.985Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-carbamazepine-anda219072-by-yichang-humanwell 2026-07-04T18:32:12.543Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lamotrigine-supplement-from-glenmark-pharmaceuticals 2026-07-04T18:32:01.150Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-valproic-acid-anda090517-by-quagen 2026-07-04T18:31:52.195Z weekly 0.7 https://www.humanexasignals.com/signals/impax-labs-receives-ap-status-for-tetracycline-hydrochloride-anda060469 2026-07-04T18:31:42.535Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-brimonidine-tartrate-anda220398-by-mankind-pharma 2026-07-04T18:31:30.899Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-methotrexate-sodium-anda220225-receives-ap-status-from-fda 2026-07-04T18:31:01.870Z weekly 0.7 https://www.humanexasignals.com/signals/mydiamate-study-aims-to-alleviate-diabetes-distress-in-type-1-diabetes 2026-07-04T18:30:51.431Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-lsds-effect-on-serotonin-2a-receptor-occupancy-initiated 2026-07-04T18:30:43.308Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-pt010-study-targets-severe-asthma-in-adults-and-adolescents 2026-07-04T18:30:35.110Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-reverse-shoulder-arthroplasty-to-exercise-in-rotator-cuff-arthro 2026-07-04T18:30:28.035Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-ronovotm-robotic-surgical-platform-in-oncological-procedures 2026-07-04T18:30:20.340Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-endothelial-cell-dysfunction-in-pulmonary-hypertension-launched-by-nih 2026-07-04T12:32:01.468Z weekly 0.7 https://www.humanexasignals.com/signals/bms-initiates-trial-for-imzokitug-in-nsclc-with-pumitamig-and-chemotherapy 2026-07-04T12:31:50.071Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictive-model-for-pancreatic-cancer-prognosis-using-multimodal-data 2026-07-04T12:31:23.448Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-on-palliative-care-for-advanced-heart-failure-shows-innovative-metho 2026-07-04T12:30:49.601Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rtms-for-mood-shifts-in-bipolar-disorder-underway 2026-07-04T12:30:41.661Z weekly 0.7 https://www.humanexasignals.com/signals/shr-8068-trial-in-resectable-hepatocellular-carcinoma-shows-promise 2026-07-04T12:30:34.616Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-oxytocins-impact-on-trust-in-borderline-personality-disorder-patients 2026-07-04T12:30:19.385Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-orbital-atherectomy-for-critical-limb-threatening-ischemia-launched-in- 2026-07-04T12:30:11.209Z weekly 0.7 https://www.humanexasignals.com/signals/study-shows-no-autoantibody-induction-post-bnt162b2-boost-in-coronavac-primed-in 2026-07-04T06:34:53.967Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-diacomit-stiripentol-by-biocodex-sa 2026-07-04T06:34:18.364Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-zoledronic-acid-by-mylan-labs 2026-07-04T06:33:45.853Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-glycerol-phenylbutyrate-application-receives-fda-review 2026-07-04T06:33:31.145Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-dextromethorphan-polistirex-receives-ap-status-from-fda 2026-07-04T06:33:17.122Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-glycerol-phenylbutyrate-anda219540 2026-07-04T06:33:02.532Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-atropine-sulfate-anda219013-by-edenbridge-pharmaceutical 2026-07-04T06:32:49.810Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-buprenorphine-and-naloxone-from-dr-reddys-labs 2026-07-04T06:32:38.537Z weekly 0.7 https://www.humanexasignals.com/signals/baxter-healthcares-dexmedetomidine-hydrochloride-anda208103-receives-ap-status 2026-07-04T06:32:28.276Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sodium-bicarbonate-anda220788-by-aspiro 2026-07-04T06:32:18.045Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-blood-markers-for-early-detection-of-pancreatic-cancer-initiated 2026-07-04T06:32:06.384Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-femtosecond-laser-imaging-for-intraoperative-lung-diagnosis 2026-07-04T06:31:58.286Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-immune-response-after-sabr-in-stage-i-nsclc 2026-07-04T06:31:49.048Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-188re-sss-lipiodol-sirt-for-non-operable-liver-cancer-initiated 2026-07-04T06:31:39.989Z weekly 0.7 https://www.humanexasignals.com/signals/regeneron-initiates-trial-for-pozelimab-cemdisiran-in-pnh-patients-unresponsive- 2026-07-04T06:31:14.863Z weekly 0.7 https://www.humanexasignals.com/signals/brainchild-bio-initiates-car-t-therapy-study-for-dipg-patients 2026-07-04T06:31:07.346Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-on-locally-ablative-therapy-for-oligo-progressive-solid-tumors-ini 2026-07-04T06:30:56.391Z weekly 0.7 https://www.humanexasignals.com/signals/esketamine-improves-postoperative-emotions-and-immune-function-in-acoustic-neuro 2026-07-04T06:30:18.955Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-barriers-to-hpv-vaccine-uptake-in-south-quito-ecuador 2026-07-04T06:30:09.696Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vidutolimod-and-nivolumab-in-melanoma-treatment 2026-07-04T06:05:43.996Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-psoriasis-and-cardiometabolic-disease-relationship-launched-by-nhlbi 2026-07-04T06:05:26.960Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-comparing-ious-guided-margin-selection-in-crohns-disease-surgery 2026-07-04T06:04:50.975Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-19f-mri-in-children-with-mild-cystic-fibrosis-lung-disease 2026-07-04T06:04:36.685Z weekly 0.7 https://www.humanexasignals.com/signals/metformin-aging-study-to-assess-insulin-sensitivity-and-mitochondrial-function 2026-07-04T06:04:23.813Z weekly 0.7 https://www.humanexasignals.com/signals/nhlbi-study-on-dyslipidemias-evaluates-lipid-disorders-and-their-impact 2026-07-04T06:04:12.441Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-opioid-use-disorder-treatment-for-patients-with-serious-injection 2026-07-04T06:04:00.572Z weekly 0.7 https://www.humanexasignals.com/signals/ibr733-cell-injection-shows-promise-in-relapsedrefractory-acute-myeloid-leukemia 2026-07-04T06:03:49.102Z weekly 0.7 https://www.humanexasignals.com/signals/semaglutide-wegovy-approved-for-metabolic-associated-steatohepatitis-treatment 2026-07-04T06:03:38.333Z weekly 0.7 https://www.humanexasignals.com/signals/discovery-of-dp8-tregs-in-colorectal-cancer-reveals-new-immune-suppression-mecha 2026-07-04T06:03:07.096Z weekly 0.7 https://www.humanexasignals.com/signals/integrating-immune-landscape-insights-to-enhance-breast-cancer-management 2026-07-04T06:02:56.550Z weekly 0.7 https://www.humanexasignals.com/signals/study-links-age-and-mortality-in-men-with-testosterone-deficiency-and-impact-of- 2026-07-04T06:02:25.385Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-trial-shows-safety-and-immunogenicity-of-covid-19-influenza-combination 2026-07-04T06:02:17.033Z weekly 0.7 https://www.humanexasignals.com/signals/chimeric-ccl2-and-ccl8-peptides-show-antitumor-activity-in-breast-cancer 2026-07-04T06:02:07.362Z weekly 0.7 https://www.humanexasignals.com/signals/insights-into-rna-polymerase-ii-phosphorylation-dynamics-and-disease-implication 2026-07-04T06:01:58.843Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-ges-variants-impact-resistance-to-ceftazidime-avibactam-and-imipen 2026-07-04T06:01:48.839Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-shows-non-inferior-immunogenicity-of-pcv-free-rotavirus-vaccine- 2026-07-04T06:01:38.957Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-stelara-by-janssen-biotech 2026-07-04T00:34:36.365Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-buspirone-hydrochloride-anda075388-by-oxford-pharms 2026-07-04T00:34:23.990Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-anda215575-by-qilu-pharm-hainan 2026-07-04T00:34:13.783Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-ondansetron-hydrochloride-preservative-free 2026-07-04T00:34:04.021Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-ondansetron-hydrochloride-anda078257 2026-07-04T00:33:54.786Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-ontruzant-trastuzumab-dttb 2026-07-04T00:33:20.904Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-inavolisib-by-genentech 2026-07-04T00:33:12.427Z weekly 0.7 https://www.humanexasignals.com/signals/eisais-e6742-shows-promise-in-systemic-lupus-erythematosus-study 2026-07-04T00:33:04.332Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cd3-cd20-bispecific-antibody-with-cd19-car-t-cells-in-b-nhl 2026-07-04T00:32:56.641Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lilly-initiates-phase-1-trial-of-oral-idh-inhibitor-ly3410738-in-hematologic 2026-07-04T00:32:48.665Z weekly 0.7 https://www.humanexasignals.com/signals/mirtazapine-shows-promise-for-treating-methamphetamine-use-in-opioid-disorder-pa 2026-07-04T00:32:39.784Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-risk-stratification-in-infantile-hemangioma-with-minimal-growth-initiat 2026-07-04T00:32:31.673Z weekly 0.7 https://www.humanexasignals.com/signals/nimh-study-on-mri-and-mrs-techniques-for-brain-chemistry-imaging 2026-07-04T00:32:25.810Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-scb0020160-by-scbio-inc-underway 2026-07-04T00:30:17.138Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-of-restoreme-app-for-cancer-patient-nutrition-and-activity 2026-07-03T18:31:52.891Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-compares-iberdomide-to-lenalidomide-in-multiple-myeloma-mai 2026-07-03T18:31:23.368Z weekly 0.7 https://www.humanexasignals.com/signals/dizal-pharmaceuticals-initiates-trial-for-dzd8586-in-relapsed-b-cell-non-hodgkin 2026-07-03T18:31:15.057Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bottle-pep-device-effects-in-parkinsons-disease-patients 2026-07-03T18:30:49.510Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-evaluates-azacitidine-with-lenalidomide-or-vorinostat-in-myelo 2026-07-03T18:30:41.842Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-quercetins-impact-on-glucose-absorption-in-obesity-and-type-2-diabetes 2026-07-03T18:30:25.076Z weekly 0.7 https://www.humanexasignals.com/signals/astellas-initiates-first-in-human-trial-of-asp2246-for-post-stroke-movement-diso 2026-07-03T18:30:15.981Z weekly 0.7 https://www.humanexasignals.com/signals/ruthenium-based-metallodrug-shows-promise-against-cisplatin-resistant-osteosarco 2026-07-03T12:34:32.247Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplement-approval-for-datscan-ioflupane-i-123 2026-07-03T12:34:05.885Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-wainua-autoinjector-by-astrazeneca 2026-07-03T12:33:51.313Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-glycerol-phenylbutyrate-anda218738-receives-ap-status-from-fda 2026-07-03T12:33:37.369Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-alendronate-sodium-anda206387 2026-07-03T12:33:24.497Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-ramelteon-by-micro-labs 2026-07-03T12:32:51.214Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lactulose-anda074712-by-cumberland-pharmaceuticals 2026-07-03T12:32:38.501Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-bosentan-anda207760-by-zydus-pharmaceuticals 2026-07-03T12:32:24.491Z weekly 0.7 https://www.humanexasignals.com/signals/fda-investigates-neurologic-risks-of-general-anesthesia-linked-to-genetic-varian 2026-07-03T12:32:04.167Z weekly 0.7 https://www.humanexasignals.com/signals/cook-research-initiates-rct-for-evero-dcb-in-pad-treatment 2026-07-03T12:31:53.788Z weekly 0.7 https://www.humanexasignals.com/signals/sun-pharma-initiates-trial-for-deuruxolitinib-in-severe-alopecia-areata-in-japan 2026-07-03T12:31:25.197Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-trial-for-jdq443-in-kras-g12c-mutated-nsclc 2026-07-03T12:30:58.987Z weekly 0.7 https://www.humanexasignals.com/signals/bicycle-therapeutics-launches-continued-access-protocol-for-investigational-prod 2026-07-03T12:30:49.342Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-study-on-early-life-agricultural-exposures-and-cancer-risk 2026-07-03T12:30:38.469Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-ultrasonic-vs-conventional-spirometry-in-chronic-respiratory-dise 2026-07-03T12:30:30.124Z weekly 0.7 https://www.humanexasignals.com/signals/genentech-initiates-study-on-cevostamab-and-elranatamab-for-relapsedrefractory-m 2026-07-03T12:30:21.195Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-zanidatamab-with-chemotherapy-in-her2-positive-breast-cancer 2026-07-03T12:30:11.669Z weekly 0.7 https://www.humanexasignals.com/signals/milpharm-limited-issues-class-4-medicines-defect-notification-for-loperamide-hyd 2026-07-03T06:34:14.810Z weekly 0.7 https://www.humanexasignals.com/signals/modeling-hyperthermia-enhanced-delivery-of-doxorubicin-in-solid-tumors 2026-07-03T06:33:57.649Z weekly 0.7 https://www.humanexasignals.com/signals/fda-reports-increase-in-accidental-overdoses-of-apoquel-chewable-in-dogs 2026-07-03T06:33:20.066Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-recalls-impella-cp-sets-due-to-low-purge-pressure-risk 2026-07-03T06:32:47.717Z weekly 0.7 https://www.humanexasignals.com/signals/insulet-recalls-omnipod-pods-due-to-insulin-leakage-risk 2026-07-03T06:32:35.992Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-lidocaine-and-methylprednisolone-for-headaches-post-subarachnoid 2026-07-03T06:32:22.545Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-compares-continuous-vs-intermittent-dabrafenib-and-trametinib-in- 2026-07-03T06:32:11.639Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-edot-vs-traditional-dot-for-tb-treatment-adherence 2026-07-03T06:32:01.168Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ibii-trial-of-ipilimumab-nivolumab-and-nogapendekin-alfa-in-nsclc 2026-07-03T06:31:50.152Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-automated-parameter-optimization-for-adaptive-dbs-in-parkinsons-disease 2026-07-03T06:31:37.859Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predicting-migraine-attack-pain-using-hemodynamic-monitoring 2026-07-03T06:31:11.149Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-skyrizi-risankizumab-by-abbvie 2026-07-03T06:31:03.079Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-sarclisa-isatuximab-irfc 2026-07-03T06:30:54.926Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1b2a-trial-of-cnp-103-for-stage-3-type-1-diabetes-initiated 2026-07-03T06:30:21.307Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pelvic-congestion-syndrome-prevalence-in-varicose-vein-patients-and-qua 2026-07-03T06:30:12.057Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-applications-for-trelstar 2026-07-03T06:05:43.872Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-zevtera-ceftobiprole-medocaril-sodium 2026-07-03T06:05:27.828Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-romvimza-vimselitinib-by-deciphera-pharmaceuticals 2026-07-03T06:05:13.030Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-bla761530-lumvoa-from-viridian-therapeutics 2026-07-03T06:04:58.707Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-argatroban-by-teva-pharmaceuticals 2026-07-03T06:04:46.094Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-pembrolizumab-and-trastuzumab-in-her2-positive-esophagogastric 2026-07-03T06:04:13.540Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-mtp-101p-for-safety-in-colon-resection-patients 2026-07-03T06:03:59.291Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-aki-prevention-in-liver-cancer-patients-undergoing-therapy 2026-07-03T06:03:47.618Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nivolumab-and-ipilimumab-before-surgery-in-sarcomatoid-mesothe 2026-07-03T06:03:36.788Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-aberrations-in-wild-type-gist-patients-in-taiwan 2026-07-03T06:03:24.462Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sacituzumab-tirumotecan-and-pembrolizumab-combo-trial-in-nsclc-underway 2026-07-03T06:02:54.690Z weekly 0.7 https://www.humanexasignals.com/signals/ipsen-initiates-trial-for-elafibranor-in-primary-sclerosing-cholangitis 2026-07-03T06:02:43.201Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-her2-imaging-as-biomarker-for-t-dm1-in-advanced-breast-cancer 2026-07-03T06:02:09.961Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-afimkibart-shows-promise-for-ulcerative-colitis 2026-07-03T06:01:57.703Z weekly 0.7 https://www.humanexasignals.com/signals/inotuzumab-ozogamicin-combined-with-chemotherapy-in-young-adults-with-b-all 2026-07-03T06:01:43.327Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-abreva-by-haleon 2026-07-03T00:34:59.129Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-sonazine-chlorpromazine-hydrochloride 2026-07-03T00:34:44.300Z weekly 0.7 https://www.humanexasignals.com/signals/breckenridges-milnacipran-hydrochloride-anda205071-receives-ap-status 2026-07-03T00:34:31.661Z weekly 0.7 https://www.humanexasignals.com/signals/amneal-pharmaceuticals-submits-anda-for-milnacipran-hydrochloride 2026-07-03T00:34:03.282Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-rytello-imetelstat-sodium 2026-07-03T00:33:51.090Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-danziten-nilotinib-tartrate 2026-07-03T00:33:09.649Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-canagliflozin-by-apotex 2026-07-03T00:32:42.374Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lamotrigine-supplement-from-alembic-pharmaceuticals 2026-07-03T00:32:31.908Z weekly 0.7 https://www.humanexasignals.com/signals/pharmacogenomics-trial-for-alectinib-in-nsclc-examines-snp-impact 2026-07-03T00:32:21.014Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iib-trial-of-autoantibody-reduction-therapy-for-progressive-ipf-initiated 2026-07-03T00:32:03.501Z weekly 0.7 https://www.humanexasignals.com/signals/biosensics-to-validate-digital-health-tech-for-psp-and-dlb-monitoring 2026-07-03T00:31:25.654Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-hipec-with-cisplatin-and-paclitaxel-for-high-risk-gastric-canc 2026-07-03T00:30:59.238Z weekly 0.7 https://www.humanexasignals.com/signals/dapagliflozin-trial-for-renal-protection-in-heart-transplant-recipients-initiate 2026-07-03T00:30:49.175Z weekly 0.7 https://www.humanexasignals.com/signals/apogee-therapeutics-initiates-long-term-safety-study-for-apg777-in-atopic-dermat 2026-07-03T00:30:40.076Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-yzj-5053-tablets-in-advanced-solid-tumors-initiated 2026-07-03T00:30:30.927Z weekly 0.7 https://www.humanexasignals.com/signals/novel-gacdvdc-nanovehicle-enhances-oral-bioavailability-of-cholecalciferol 2026-07-02T18:32:37.008Z weekly 0.7 https://www.humanexasignals.com/signals/estrogen-fluctuations-linked-to-increased-depression-in-postmenopausal-women 2026-07-02T18:32:24.603Z weekly 0.7 https://www.humanexasignals.com/signals/bruceine-d-inhibits-stat3-mediated-glycolysis-suppressing-nsclc-progression 2026-07-02T18:32:14.635Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-of-inhaled-cromolyn-sodium-in-locally-advanced-lung-cancer 2026-07-02T18:31:36.024Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-moxifloxacins-impact-on-qtc-interval-in-t2dm-patients-initiated 2026-07-02T18:31:26.226Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-tislelizumab-and-surufatinib-in-unresectable-stage-iii-nsclc 2026-07-02T18:30:56.226Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-trop2-car-nk-cells-for-platinum-resistant-ovarian-cancer 2026-07-02T18:30:45.496Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-mk-2870-study-targets-advanced-gastrointestinal-cancers 2026-07-02T18:30:36.710Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-safety-of-cardiac-mri-in-high-risk-patients-with-implanted-leads 2026-07-02T18:30:28.963Z weekly 0.7 https://www.humanexasignals.com/signals/eisais-fycompa-injection-safety-study-for-epilepsy-underway 2026-07-02T18:30:20.902Z weekly 0.7 https://www.humanexasignals.com/signals/sava-technologies-initiates-pilot-trial-for-continuous-glucose-monitor-in-type-1 2026-07-02T18:30:11.560Z weekly 0.7 https://www.humanexasignals.com/signals/fda-to-terminate-emergency-use-authorizations-for-covid-19-drugs 2026-07-02T12:32:51.886Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-approves-gemcitabine-delivery-system-for-high-risk-bladder-cancer 2026-07-02T12:32:30.062Z weekly 0.7 https://www.humanexasignals.com/signals/exosome-based-delivery-of-wedelolactone-shows-promise-for-sepsis-induced-liver-i 2026-07-02T12:31:57.950Z weekly 0.7 https://www.humanexasignals.com/signals/genentechs-vixarelimab-shows-promise-in-moderate-to-severe-ulcerative-colitis 2026-07-02T12:31:45.496Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-azacitidine-and-gemtuzumab-ozogamicin-in-older-aml-patients 2026-07-02T12:31:34.446Z weekly 0.7 https://www.humanexasignals.com/signals/blinatumomab-plus-low-dose-dli-in-high-risk-b-all-post-transplantation 2026-07-02T12:31:09.086Z weekly 0.7 https://www.humanexasignals.com/signals/washington-university-launches-multi-site-trial-on-care-tool-for-cancer-cost-nav 2026-07-02T12:30:56.886Z weekly 0.7 https://www.humanexasignals.com/signals/epizymes-tazemetostat-shows-promise-in-follicular-lymphoma-trial 2026-07-02T12:30:38.593Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-personalized-supportive-care-for-cancer-related-fatigue-in-lymphoma-pat 2026-07-02T06:31:23.798Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mfolfox6bevacizumabpd-1-in-local-advanced-mss-crc-initiated 2026-07-02T06:31:13.635Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-bypass-techniques-in-thoracoabdominal-aneurysm-repair-initiated 2026-07-02T06:30:59.161Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-pacritinib-with-venetoclax-and-azacitidine-for-myeloproliferati 2026-07-02T06:30:49.055Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-pap-therapy-dental-device-and-atomoxetine-oxybutynin-for-osa-trea 2026-07-02T06:30:13.019Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-hepzato-kit-and-opdualag-for-metastatic-melanoma-initiated 2026-07-02T06:05:25.663Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-ultrasound-and-tcm-for-keloid-treatment-shows-promising-result 2026-07-02T06:05:08.260Z weekly 0.7 https://www.humanexasignals.com/signals/vyvanse-evaluated-for-weight-management-in-children-aged-6-12 2026-07-02T06:04:34.651Z weekly 0.7 https://www.humanexasignals.com/signals/rna-modifications-as-key-regulators-in-cancer-translational-control-and-therapeu 2026-07-02T06:04:21.361Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-nintedanib-dpi-in-idiopathic-pulmonary-fibrosis-initiated-by-ma 2026-07-02T06:04:03.241Z weekly 0.7 https://www.humanexasignals.com/signals/gsks-belantamab-mafodotin-study-targets-multiple-myeloma-with-renal-impairment 2026-07-02T06:03:36.697Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-atezolizumab-post-surgery-for-stage-i-nsclc-shows-promise 2026-07-02T06:03:21.529Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-compares-ibrutinibrituximab-vs-chemo-in-cllsll 2026-07-02T06:02:55.741Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-compares-rituximab-and-mosunetuzumab-in-low-tumor-burden-follicu 2026-07-02T06:02:43.698Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-casgevy-for-young-children-with-sickle-cell-disease 2026-07-02T06:02:29.690Z weekly 0.7 https://www.humanexasignals.com/signals/roches-divarasib-shows-best-in-class-potential-in-phase-iii-nsclc-trial-1 2026-07-02T06:01:59.417Z weekly 0.7 https://www.humanexasignals.com/signals/roches-divarasib-shows-best-in-class-potential-in-phase-iii-nsclc-trial 2026-07-02T06:01:42.705Z weekly 0.7 https://www.humanexasignals.com/signals/flamingo-pharma-recalls-flucloxacillin-capsules-due-to-incorrect-patient-informa 2026-07-02T00:32:09.033Z weekly 0.7 https://www.humanexasignals.com/signals/hologic-recalls-biozorb-markers-due-to-patient-complications-risk 2026-07-02T00:31:13.504Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-study-of-lbl-024-in-advanced-malignant-tumors-initiated-by-nanjing-lea 2026-07-02T00:31:03.680Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-neoadjuvant-dapagliflozin-in-high-risk-prostate-cancer 2026-07-02T00:30:53.900Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-cbt-and-sound-therapy-for-chronic-tinnitus-management 2026-07-02T00:30:41.061Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-low-dose-atropines-effects-on-pupil-size-and-accommodation 2026-07-01T18:34:21.355Z weekly 0.7 https://www.humanexasignals.com/signals/mobile-technology-may-enhance-cardiac-rehabilitation-participation-post-acute-co 2026-07-01T18:33:52.602Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-pediatric-study-for-asciminib-in-chronic-myeloid-leukemia 2026-07-01T18:33:37.870Z weekly 0.7 https://www.humanexasignals.com/signals/novo-nordisks-nnc0487-0111-trial-targets-heart-failure-with-obesity 2026-07-01T18:33:13.873Z weekly 0.7 https://www.humanexasignals.com/signals/zetroz-initiates-trial-for-litus-in-knee-osteoarthritis-pain-relief 2026-07-01T18:32:59.398Z weekly 0.7 https://www.humanexasignals.com/signals/nimh-launches-genetic-study-to-understand-schizophrenia-neurobiology 2026-07-01T18:32:29.215Z weekly 0.7 https://www.humanexasignals.com/signals/dexmedetomidine-esketamine-combo-may-reduce-delirium-in-icu-patients 2026-07-01T18:32:18.525Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-besremi-ropeginterferon-alfa-2b-njft 2026-07-01T18:31:55.805Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-trelstar-by-verity 2026-07-01T18:31:46.355Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-childrens-advil-flavored-supplement-by-haleon 2026-07-01T18:31:23.486Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-argatroban-supplement-receives-fda-acceptance 2026-07-01T18:31:13.212Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-sarclisa-isatuximab-irfc-by-sanofi 2026-07-01T18:30:50.022Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-zevtera-ceftobiprole-medocaril-sodium 2026-07-01T18:30:40.945Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-romvimza-vimselitinib-by-deciphera-pharmaceutic 2026-07-01T18:30:31.602Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-haloperidol-decanoate-anda214507 2026-07-01T18:30:22.380Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-ferric-carboxymaltose-anda212572-by-mylan-labs 2026-07-01T18:30:14.752Z weekly 0.7 https://www.humanexasignals.com/signals/fluticasone-propionate-nebulized-suspension-trial-for-infant-wheezing-shows-pote 2026-07-01T12:34:57.341Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-external-pancreatic-stent-to-prevent-fistula-post-pancreatoduodenectomy 2026-07-01T12:34:24.495Z weekly 0.7 https://www.humanexasignals.com/signals/rituximab-and-low-dose-mycophenolate-mofetil-trial-for-pediatric-lupus-nephritis 2026-07-01T12:34:08.753Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-betamethasone-for-pprom-in-pregnant-women-aims-to-reduce-neonatal-morbi 2026-07-01T12:33:48.401Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-multi-epitope-vaccine-in-triple-negative-breast-cancer-shows-p 2026-07-01T12:33:34.338Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-psychological-treatments-for-youth-with-disruptive-mood-dysregulation-d 2026-07-01T12:33:05.283Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-florida-tests-pinpoint-intervention-for-cervical-cancer-prevention 2026-07-01T12:32:27.660Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-daridorexant-for-ptsd-under-adaptive-platform-design 2026-07-01T12:32:17.592Z weekly 0.7 https://www.humanexasignals.com/signals/strides-pharmas-piroxicam-anda206136-receives-ap-status-from-fda 2026-07-01T12:32:07.437Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-arikayce-kit-by-insmed 2026-07-01T12:31:38.771Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-bicillin-l-a-by-king-pharmaceuticals 2026-07-01T12:31:29.152Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-dapsone-anda213414-by-alembic 2026-07-01T12:31:20.586Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-gabapentin-anda077661-by-rubicon-research 2026-07-01T12:31:10.425Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-xeomin-incobotulinumtoxina-by-merz-pharmaceuticals 2026-07-01T12:31:01.161Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-piroxicam-anda210347-by-strides-pharma 2026-07-01T12:30:51.850Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-iohexol-supplement-application-by-amneal 2026-07-01T12:30:26.890Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-levomilnacipran-hydrochloride-anda210732-receives-ap-status 2026-07-01T12:30:12.278Z weekly 0.7 https://www.humanexasignals.com/signals/study-identifies-sall2-as-a-potential-therapeutic-target-in-breast-cancer-progre 2026-07-01T06:34:51.268Z weekly 0.7 https://www.humanexasignals.com/signals/rising-research-on-ici-associated-cardiotoxicity-2016-2025-bibliometric-analysis 2026-07-01T06:34:35.643Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-trial-of-aftx-201-in-bag3-associated-dilated-cardiomyopathy-initiated 2026-07-01T06:34:03.139Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-voicing-my-choices-tool-for-advanced-care-planning-in-young-adults-with 2026-07-01T06:33:47.619Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-suction-mini-pcnl-to-standard-pcnl-for-kidney-stones-launched 2026-07-01T06:33:30.653Z weekly 0.7 https://www.humanexasignals.com/signals/mobile-health-intervention-trial-for-aya-leukemia-adherence 2026-07-01T06:33:18.688Z weekly 0.7 https://www.humanexasignals.com/signals/deep-brain-stimulation-study-for-movement-disorders-including-parkinsons-disease 2026-07-01T06:32:47.474Z weekly 0.7 https://www.humanexasignals.com/signals/new-prospective-cohort-study-on-acute-cardiovascular-referrals-launched 2026-07-01T06:32:37.083Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda217769-for-ferric-carboxymaltose-by-mylan 2026-07-01T06:32:24.208Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-valproic-acid-anda073229-by-catalent 2026-07-01T06:31:42.961Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methylprednisolone-sodium-succinate-by-amneal 2026-07-01T06:31:32.911Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-oseltamivir-phosphate-anda-submission-receives-ap-status 2026-07-01T06:31:23.739Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levonorgestrel-and-ethinyl-estradiol-anda202970 2026-07-01T06:31:15.155Z weekly 0.7 https://www.humanexasignals.com/signals/glenmark-pharmaceuticals-receives-fda-acceptance-for-ciclopirox-anda090273 2026-07-01T06:31:06.524Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-supplemental-anda-for-imiquimod 2026-07-01T06:30:58.551Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-fluocinolone-acetonide-supplement-by-sun-pharma 2026-07-01T06:30:51.632Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-carbidope-and-levodopa-supplement-by-rubicon-research 2026-07-01T06:30:29.671Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-animated-video-and-booklet-to-enhance-breast-cancer-awareness-in-palest 2026-07-01T06:30:12.490Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-aciclovir-anda210401-by-yiling 2026-07-01T06:06:33.258Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-aciclovir-anda212173-by-yiling 2026-07-01T06:06:14.432Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-allogeneic-t-cell-immunotherapy-for-hematologic-malignancies 2026-07-01T06:05:56.688Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tregzi-for-chronic-gvhd-in-blood-cancer-patients 2026-07-01T06:05:41.870Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-lisocabtagene-maraleucel-targets-minimal-residual-disease-in-la 2026-07-01T06:05:13.205Z weekly 0.7 https://www.humanexasignals.com/signals/quell-therapeutics-initiates-phase-12-trial-for-qel-005-in-autoimmune-diseases 2026-07-01T06:04:46.091Z weekly 0.7 https://www.humanexasignals.com/signals/ltr-as-novel-target-for-cancer-immunotherapy-mechanisms-and-therapeutic-potentia 2026-07-01T06:04:31.673Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-phase-iii-study-of-ytb323-in-non-active-progressive-multiple- 2026-07-01T06:04:08.113Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-digital-solutions-in-cardiac-rehabilitation-for-ascvd-patient 2026-07-01T06:03:41.330Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-rotavac-5d-vaccine-in-chilean-infants-underway 2026-07-01T06:03:31.392Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-c1-esterase-inhibitor-for-acute-hereditary-angioedema-by-octaph 2026-07-01T06:03:21.809Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-navenibart-for-hereditary-angioedema-initiated-by-astria-therap 2026-07-01T06:02:51.983Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-ixazomib-and-lenalidomide-in-solitary-plasmacytoma-post-radia 2026-07-01T06:02:41.148Z weekly 0.7 https://www.humanexasignals.com/signals/merck-partners-with-adap-to-enhance-access-to-idvynso-for-hiv-treatment 2026-07-01T06:02:30.224Z weekly 0.7 https://www.humanexasignals.com/signals/deep-learning-model-enhances-prognostic-prediction-in-stage-iii-colon-cancer 2026-07-01T00:33:18.171Z weekly 0.7 https://www.humanexasignals.com/signals/sex-based-differences-in-tlr-agonist-efficacy-for-early-stage-melanoma-treatment 2026-07-01T00:33:07.729Z weekly 0.7 https://www.humanexasignals.com/signals/innovative-targeted-proteoform-degradation-enhances-precision-drug-design-and-de 2026-07-01T00:32:43.998Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-brimonidine-tartrate-anda216772 2026-07-01T00:32:05.014Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lidocaine-hydrochloride-anda040078 2026-07-01T00:31:55.688Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-mk-1045-combined-with-rituximab-in-follicular-lymphoma-trial-launched 2026-07-01T00:31:48.375Z weekly 0.7 https://www.humanexasignals.com/signals/spi-1005-trial-for-menieres-disease-evaluates-safety-and-efficacy 2026-07-01T00:31:24.551Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-mother-daughter-des-system-for-pci-bifurcation-lesions 2026-07-01T00:30:48.150Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-peposertib-with-radiation-and-temozolomide-in-glioblastoma 2026-07-01T00:30:38.851Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-study-on-surabgene-lomparvovec-for-neovascular-amd 2026-07-01T00:30:31.107Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-emgality-galcanezumab 2026-06-30T18:34:37.545Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-sotalol-hydrochloride-anda207429 2026-06-30T18:34:21.104Z weekly 0.7 https://www.humanexasignals.com/signals/raloxifene-identified-as-potential-inhibitor-for-pediatric-acute-myeloid-leukemi 2026-06-30T18:34:00.202Z weekly 0.7 https://www.humanexasignals.com/signals/licensed-viral-vaccines-show-promise-as-anti-cancer-therapies 2026-06-30T18:33:32.025Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-adjuvanted-influenza-vaccine-in-older-adults-in-the-nether 2026-06-30T18:33:19.480Z weekly 0.7 https://www.humanexasignals.com/signals/nitazoxanide-shows-potential-as-a-ferroptosis-inducer-in-triple-negative-breast- 2026-06-30T18:33:03.746Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-mtx-439-in-diabetic-kidney-disease-patients-initiated-by-mediar 2026-06-30T18:31:54.005Z weekly 0.7 https://www.humanexasignals.com/signals/dana-farber-initiates-cv-care-program-for-prostate-cancer-patients-on-adt 2026-06-30T18:31:31.175Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-radiation-planning-aims-to-reduce-neurocognitive-impairments-in-pediatr 2026-06-30T18:31:20.729Z weekly 0.7 https://www.humanexasignals.com/signals/biohavens-bhv-1300-trial-for-graves-disease-underway 2026-06-30T18:31:08.664Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ib-trial-of-aldesleukin-with-nivolumab-for-gastric-cancer-with-peritoneal- 2026-06-30T18:30:58.258Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-hiv-treatment-strategies-for-opioid-users-in-malaysia 2026-06-30T18:30:33.441Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vagus-nerve-stimulation-in-parkinsons-disease-underway 2026-06-30T18:30:12.287Z weekly 0.7 https://www.humanexasignals.com/signals/brancaster-pharma-issues-class-4-medicines-defect-notification-for-benzylpenicil 2026-06-30T12:32:54.648Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-social-risk-informed-care-for-opioid-use-disorder-in-ed 2026-06-30T12:32:13.916Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-of-mobile-app-for-binge-eating-in-adolescents 2026-06-30T12:32:03.172Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-vr-device-for-anxiety-and-pain-in-interventional-radiology 2026-06-30T12:31:45.080Z weekly 0.7 https://www.humanexasignals.com/signals/non-inferiority-trial-of-trigr-for-ptsd-shows-promise-against-standard-therapy 2026-06-30T12:31:24.338Z weekly 0.7 https://www.humanexasignals.com/signals/vitamin-d-supplementation-may-improve-iron-status-in-ibd-patients 2026-06-30T12:31:15.521Z weekly 0.7 https://www.humanexasignals.com/signals/fenofibrate-trial-aims-to-prevent-worsening-of-diabetic-retinopathy 2026-06-30T12:31:07.095Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-eliquis-apixaban 2026-06-30T12:30:40.690Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-orserdu-elacestrant-hydrochloride 2026-06-30T12:30:33.650Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-propranolol-hydrochloride-anda217238 2026-06-30T12:30:27.190Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tryngolza-autoinjector 2026-06-30T12:30:19.252Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-ibrance-palbociclib-by-pfizer 2026-06-30T12:30:10.415Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-phenotyped-diffuse-interstitial-lung-disease-launched-in-france 2026-06-30T06:32:35.149Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-keytruda-qlex 2026-06-30T06:32:09.033Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-ibrance-palbociclib 2026-06-30T06:31:58.402Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-keytruda-pembrolizumab-by-merck 2026-06-30T06:31:49.591Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-trodelvy-sacituzumab-govitecan-hziy 2026-06-30T06:31:40.641Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-anda218949-for-icosapent-ethyl-receives-ap-status 2026-06-30T06:31:15.970Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-spravato-esketamine-by-janssen 2026-06-30T06:31:06.340Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-navitrux-by-avyxa-holdings 2026-06-30T06:30:59.035Z weekly 0.7 https://www.humanexasignals.com/signals/fda-drug-trials-snapshot-for-palsonify-in-acromegaly 2026-06-30T06:30:32.240Z weekly 0.7 https://www.humanexasignals.com/signals/fda-drug-trials-snapshot-yartemlea-approved-for-ta-tma 2026-06-30T06:30:24.449Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-hrs-7450-injection-for-acute-ischemic-stroke-initiated-by-fuji 2026-06-30T06:30:17.423Z weekly 0.7 https://www.humanexasignals.com/signals/immunomic-therapeutics-initiates-phase-i-trial-of-iti-1001-for-newly-diagnosed-g 2026-06-30T06:30:09.662Z weekly 0.7 https://www.humanexasignals.com/signals/triastek-initiates-phase-1-trial-for-octreotide-acetate-tablets-t25-bioavailabil 2026-06-30T06:06:32.410Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ib-trial-of-m1774-and-zen-3694-in-recurrent-ovarian-and-endometrial-cancer 2026-06-30T06:06:03.036Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-managing-hyperlipidemia-in-alk-nsclc-patients-on-lorlatinib 2026-06-30T06:05:42.467Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-dose-escalated-mr-guided-radiotherapy-for-prostate-cancer-init 2026-06-30T06:04:57.729Z weekly 0.7 https://www.humanexasignals.com/signals/study-links-chronic-psychological-stress-to-outcomes-in-pancreatic-cancer 2026-06-30T06:04:45.132Z weekly 0.7 https://www.humanexasignals.com/signals/rucaparib-monoclonal-antibody-trial-for-lorlatinib-induced-hypercholesterolemia- 2026-06-30T06:04:32.877Z weekly 0.7 https://www.humanexasignals.com/signals/comparative-study-of-emr-and-esd-for-barretts-neoplasia-initiated 2026-06-30T06:04:14.381Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-lentiviral-gene-transfer-for-xscid-in-children-over-two-years 2026-06-30T06:03:50.833Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluating-levofloxacin-for-infection-prophylaxis-in-mds-and-aml-patients 2026-06-30T06:03:38.450Z weekly 0.7 https://www.humanexasignals.com/signals/cabozantinib-plus-nivolumab-shows-promise-in-advanced-non-clear-cell-rcc 2026-06-30T06:03:26.668Z weekly 0.7 https://www.humanexasignals.com/signals/enhertu-secures-eu-approval-as-first-tumour-agnostic-her2-therapy 2026-06-30T06:03:02.853Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-roches-enspryng-in-thyroid-eye-disease-1 2026-06-30T06:02:53.673Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-roches-enspryng-in-thyroid-eye-disease 2026-06-30T06:02:41.892Z weekly 0.7 https://www.humanexasignals.com/signals/mbd2s-role-in-silencing-sfrp1-identifies-potential-crc-therapeutic-targets 2026-06-30T00:34:59.175Z weekly 0.7 https://www.humanexasignals.com/signals/altered-immune-cell-interactions-with-bacterial-lps-in-colorectal-cancer-reveale 2026-06-30T00:34:30.613Z weekly 0.7 https://www.humanexasignals.com/signals/microneedle-delivery-of-amphotericin-b-shows-promise-for-american-cutaneous-leis 2026-06-30T00:34:16.894Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-ajovy-fremanezumab 2026-06-30T00:34:00.789Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-epidiolex-by-jazz-pharmaceuticals 2026-06-30T00:33:49.929Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vyepti-eptinezumab-jjmr-by-lundbeck-1 2026-06-30T00:33:39.920Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-aciclovir-supplement-application-receives-standard-review-stat 2026-06-30T00:33:30.000Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-childrens-allegra-hives 2026-06-30T00:33:19.851Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-dipyidamole-anda074521-receives-ap-status-from-fda 2026-06-30T00:33:10.804Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-ramelteon-anda215485-by-hibrow-healthcare 2026-06-30T00:33:02.715Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-haloperidol-anda214470-by-alembic 2026-06-30T00:32:39.731Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-tofacitinib-citrate-by-aurobindo-pharma 2026-06-30T00:32:32.311Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tioprinin-for-treatment-of-cystinosis 2026-06-30T00:32:24.992Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tbi-assessment-using-tms-and-delphi-md-device-initiated 2026-06-30T00:32:18.484Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-botulinum-toxin-a-for-temporomandibular-myofascial-pain-outcomes 2026-06-30T00:32:12.763Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-astx727-with-paclitaxel-and-pembrolizumab-in-metastatic-tnbc 2026-06-30T00:31:50.746Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-spect-ct-bone-scintigraphy-for-characterizing-solitary-bone-lesions 2026-06-30T00:31:39.635Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-app-based-incentives-for-older-adults-with-substance-use-disorders 2026-06-30T00:31:32.623Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-nerve-function-in-piezo2-deficiency-syndrome-launched 2026-06-30T00:30:09.718Z weekly 0.7 https://www.humanexasignals.com/signals/fda-orders-azurity-pharmaceuticals-to-halt-distribution-of-unapproved-compoundin 2026-06-29T18:31:54.306Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-prone-position-in-acute-bronchiolitis-aims-to-reduce-ventilation-needs 2026-06-29T18:31:20.994Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-vnotes-and-laparoscopy-on-respiratory-and-hemodynamic-outcomes 2026-06-29T18:31:13.873Z weekly 0.7 https://www.humanexasignals.com/signals/nhlbi-launches-study-on-18f-fapi-74-petct-imaging-for-early-detection-of-fibrosi 2026-06-29T18:31:07.444Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tactile-feedback-training-for-stress-urinary-incontinence-in-pregnant-w 2026-06-29T18:30:57.980Z weekly 0.7 https://www.humanexasignals.com/signals/omega-pharma-recalls-napralief-250mg-tablets-due-to-pil-deficiencies 2026-06-29T12:33:25.182Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-issues-update-on-automated-impella-controllers-due-to-software-error 2026-06-29T12:32:38.874Z weekly 0.7 https://www.humanexasignals.com/signals/ge-healthcare-issues-correction-for-infant-resuscitation-systems-due-to-oxygen-c 2026-06-29T12:32:30.147Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-oxycodone-hydrochloride-supplement-by-sun-pharma 2026-06-29T12:32:19.393Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-methadone-hydrochloride-by-thepharmanetwork-llc 2026-06-29T12:32:10.470Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-tramadol-hydrochloride-and-acetaminophen 2026-06-29T12:31:48.361Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-morphine-sulfate-supplement-by-actavis-elizabeth 2026-06-29T12:31:40.407Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-letrozole-and-l-carnitine-for-sperm-quality-in-oligoasthenoterat 2026-06-29T12:31:28.378Z weekly 0.7 https://www.humanexasignals.com/signals/mi078-capsules-show-promise-in-treating-postpartum-depression 2026-06-29T12:31:20.572Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-near-fatal-asthma-in-children-to-inform-future-clinical-guidelines 2026-06-29T12:30:58.040Z weekly 0.7 https://www.humanexasignals.com/signals/scotiaderm-initiates-trial-for-novel-barrier-cream-against-moisture-associated-s 2026-06-29T12:30:50.888Z weekly 0.7 https://www.humanexasignals.com/signals/akero-therapeutics-initiates-study-of-efruxifermin-in-nashmash-patients 2026-06-29T12:30:38.947Z weekly 0.7 https://www.humanexasignals.com/signals/defect-notification-for-hiprex-1g-tablets-due-to-braille-embossing-error 2026-06-29T06:33:39.365Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-tramadol-hydrochloride-by-sun-pharma-1 2026-06-29T06:33:16.777Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-oxycodone-hydrochloride-by-epic-pharma 2026-06-29T06:33:05.800Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-nucynta-tapentadol-hydrochloride 2026-06-29T06:32:56.211Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-methadone-hydrochloride-intensol-by-hi 2026-06-29T06:32:46.062Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-butalbital-aspirin-caffeine-and-codeine-phosphate 2026-06-29T06:32:36.469Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-oxycodone-hydrochloride-supplement-by-actavis-elizabeth 2026-06-29T06:32:05.948Z weekly 0.7 https://www.humanexasignals.com/signals/novo-nordisk-tests-ubt251-for-type-2-diabetes-in-new-clinical-trial 2026-06-29T06:31:51.717Z weekly 0.7 https://www.humanexasignals.com/signals/lenvatinib-evaluated-for-invasive-thyroid-cancer-surgery-outcomes 2026-06-29T06:31:31.920Z weekly 0.7 https://www.humanexasignals.com/signals/natural-history-study-of-cadasil-launched-by-nhlbi-to-monitor-disease-progressio 2026-06-29T06:31:23.661Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-vasopressor-agents-for-pulmonary-hypertension-crisis-initiated 2026-06-29T06:31:16.593Z weekly 0.7 https://www.humanexasignals.com/signals/new-device-for-bladder-control-in-men-with-sci-shows-promise 2026-06-29T06:30:52.450Z weekly 0.7 https://www.humanexasignals.com/signals/tirabrutinib-vs-r-tmz-in-relapsedrefractory-pcnsl-ignite-study-launched 2026-06-29T06:30:46.084Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-18f-fdopa-pet-for-non-invasive-glioma-characterization-initiated 2026-06-29T06:30:39.774Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-anda090964-for-oxymorphone-hydrochloride-receives-ap-status 2026-06-29T06:05:37.139Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-hydrocodone-bitartrate-and-ibuprofen-by-amneal-pharmaceu 2026-06-29T06:05:22.212Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-hydromorphone-hydrochloride-by-hikma 2026-06-29T06:05:07.864Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-oxycodone-hydrochloride-by-vistapharm 2026-06-29T06:04:53.863Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-of-oxycodone-hydrochloride-anda203823-by-lannett-co-inc 2026-06-29T06:04:28.325Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-buprenorphine-by-watson-labs-teva 2026-06-29T06:04:15.818Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-methadone-hydrochloride-by-hikma 2026-06-29T06:04:02.807Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-of-oxymorphone-hydrochloride-supplement-by-actavis-elizabeth 2026-06-29T06:03:53.168Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bariatric-endoscopic-antral-myotomy-beam-for-obesity-underway 2026-06-29T06:03:44.338Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-pha130-hemoadsorption-in-kidney-failure-patients-shows-potential-for-im 2026-06-29T06:03:35.581Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-sitagliptin-in-glioblastoma-patients-to-enhance-immune-response 2026-06-29T06:03:24.237Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-phase-1-study-of-ml261-in-rr-sclc-and-necs-initiated-by-moonlight 2026-06-29T06:02:53.206Z weekly 0.7 https://www.humanexasignals.com/signals/e-virtue-trial-to-evaluate-enfortumab-vedotin-with-pembrolizumab-in-rare-genitou 2026-06-29T06:02:43.142Z weekly 0.7 https://www.humanexasignals.com/signals/roche-launches-axelios-1-next-generation-sequencing-platform-1 2026-06-29T06:01:44.546Z weekly 0.7 https://www.humanexasignals.com/signals/roche-launches-axelios-1-next-generation-sequencing-platform 2026-06-29T06:01:34.830Z weekly 0.7 https://www.humanexasignals.com/signals/datroway-recommended-for-eu-approval-as-1st-line-treatment-for-tnbc 2026-06-29T06:01:24.423Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-of-iv-contrast-enhanced-cbct-in-radiotherapy 2026-06-29T00:35:20.277Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-dietary-oxalates-impact-on-kidney-stone-disease-and-immunity 2026-06-29T00:33:17.685Z weekly 0.7 https://www.humanexasignals.com/signals/spi-1005-trial-for-adults-with-cochlear-implants-shows-potential-for-side-effect 2026-06-29T00:33:11.104Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-adverse-effects-of-medications-in-periodontology-clinics 2026-06-29T00:31:07.020Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-evaluates-karxt-for-bipolar-i-disorder-manic-episodes 2026-06-29T00:30:59.575Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-extended-release-buprenorphine-for-opioid-use-disorder-inducti 2026-06-29T00:30:29.177Z weekly 0.7 https://www.humanexasignals.com/signals/crescent-pharma-recalls-ramipril-10mg-capsules-due-to-manufacturing-error 2026-06-28T18:33:32.245Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-percocet-anda040330 2026-06-28T18:33:16.405Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-tevas-morphine-sulfate 2026-06-28T18:33:02.837Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-xtampza-er-by-collegium-pharma 2026-06-28T18:32:39.345Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-oxycodone-and-acetaminophen-supplement 2026-06-28T18:32:14.482Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-oxycodone-and-acetaminophen-by-lannett-co-inc 2026-06-28T18:32:04.968Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-morphine-sulfate-supplement-by-actavis-elizabeth 2026-06-28T18:31:55.403Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-application-for-oxycodone-hydrochloride 2026-06-28T18:31:47.270Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-to-reduce-hepatitis-b-vertical-transmission-in-africa 2026-06-28T18:31:27.016Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-p-cab-vs-gi-protection-in-ami-patients-undergoing-pci 2026-06-28T18:31:19.158Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-dual-vs-triple-lipid-lowering-therapy-in-type-2-diabetes-patient 2026-06-28T18:31:12.353Z weekly 0.7 https://www.humanexasignals.com/signals/mink-therapeutics-trials-agent-797-for-severe-pneumonia-with-ahrf 2026-06-28T18:30:51.149Z weekly 0.7 https://www.humanexasignals.com/signals/nevros-hf10-therapy-study-for-non-surgical-refractory-back-pain-underway 2026-06-28T18:30:44.762Z weekly 0.7 https://www.humanexasignals.com/signals/nih-investigates-exoskeletons-for-children-with-mobility-impairments 2026-06-28T18:30:37.522Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-digital-psychosocial-screening-for-cancer-survivors-launched 2026-06-28T18:30:29.895Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-tramadol-hydrochloride-and-acetaminophen-combination 2026-06-28T12:35:06.563Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-oxycodone-hydrochloride-anda204979 2026-06-28T12:34:37.248Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-hydrocodone-bitartrate-and-acetaminophen-by-strides-phar 2026-06-28T12:34:10.371Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-morphine-sulfate-supplement-by-strides-pharma 2026-06-28T12:33:56.655Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-application-for-hydromorphone-hydrochloride-by-hi 2026-06-28T12:33:44.175Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-methadone-hydrochloride-by-vistapharm-1 2026-06-28T12:33:32.214Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-nda-for-ms-contin-by-knoa-pharma 2026-06-28T12:33:11.280Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-hydrocodone-bitartrate-by-alvogen 2026-06-28T12:32:56.710Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iia-trial-of-dca-in-recurrent-glioblastoma-multiforme-initiated 2026-06-28T12:32:46.687Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-focal-cryoablation-to-rf-ablation-for-bradyarrhythmias 2026-06-28T12:32:34.845Z weekly 0.7 https://www.humanexasignals.com/signals/fostamatinib-trial-for-lung-transplant-patients-with-donor-specific-antibodies 2026-06-28T12:32:01.891Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-evaluates-pumitamig-vs-pembrolizumab-in-nsclc-trial 2026-06-28T12:31:52.439Z weekly 0.7 https://www.humanexasignals.com/signals/gilteritinib-study-launch-for-alk-positive-nsclc-patients-by-astellas-pharma 2026-06-28T12:31:41.133Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-surgical-approaches-for-carpal-tunnel-syndrome-relief 2026-06-28T12:31:21.019Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-ivonescimab-and-irinotecan-liposome-in-relapsed-sclc 2026-06-28T12:31:11.912Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-evaluates-agn-151586-with-botox-for-glabellar-lines-in-new-trial 2026-06-28T12:31:01.743Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-computerized-tool-for-faster-brain-scan-diagnosis-initiated 2026-06-28T12:30:40.649Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-inspiratory-muscle-strength-training-for-obesity-related-hypertension 2026-06-28T12:30:31.003Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-acetaminophen-and-codeine-phosphate-anda211610 2026-06-28T06:35:13.182Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-nucynta-er-by-collegium-pharma 2026-06-28T06:34:57.778Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-hydromorphone-hydrochloride-supplement 2026-06-28T06:34:30.559Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-oxycodone-hydrochloride-by-genus-lifesciences-1 2026-06-28T06:34:15.327Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-nda-for-oxycodone-hydrochloride-by-genus-lifescie 2026-06-28T06:33:44.856Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-of-hydrocodone-bitartrate-and-acetaminophen-supplement 2026-06-28T06:33:29.534Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-oxycontin-by-knoa-pharma-1 2026-06-28T06:33:14.111Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-tramadol-hydrochloride-supplement-by-strides-pharma 2026-06-28T06:33:00.318Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-morphine-sulfate-supplement-by-tris-pharma 2026-06-28T06:32:37.376Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-morphine-sulfate-by-upsher-smith-labs 2026-06-28T06:32:17.350Z weekly 0.7 https://www.humanexasignals.com/signals/durvalumab-and-cetuximab-combination-trial-for-head-and-neck-cancer 2026-06-28T06:32:06.618Z weekly 0.7 https://www.humanexasignals.com/signals/nevro-corp-launches-global-study-on-scs-therapy-for-painful-diabetic-neuropathy 2026-06-28T06:31:48.609Z weekly 0.7 https://www.humanexasignals.com/signals/xya02-trial-initiated-for-advanced-solid-tumors-by-xyone-therapeutics 2026-06-28T06:31:36.230Z weekly 0.7 https://www.humanexasignals.com/signals/bmss-navlimetostat-in-nsclc-trial-vs-placebo-and-pembrolizumab 2026-06-28T06:30:56.926Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-tyra-300-shows-promise-for-fgfr3-altered-nmibc 2026-06-28T06:30:44.189Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cthpvdna-response-adapted-chemoradiation-with-retifanlimab-in-anal-canc 2026-06-28T06:05:16.746Z weekly 0.7 https://www.humanexasignals.com/signals/zoll-medicals-hfms-device-trial-aims-to-enhance-heart-failure-management-post-ho 2026-06-28T06:05:03.327Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-inflammatory-biomarkers-for-diagnosing-multiple-sclerosis 2026-06-28T06:04:35.057Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rtms-therapy-for-neuropathic-pain-in-spinal-cord-injury-patients 2026-06-28T06:04:02.877Z weekly 0.7 https://www.humanexasignals.com/signals/review-highlights-inflammations-role-in-cancer-and-small-molecule-therapeutics-d 2026-06-28T06:03:24.612Z weekly 0.7 https://www.humanexasignals.com/signals/hexavalent-dtap-ipv-hb-hib-vaccine-shows-immunogenicity-in-preterm-infants 2026-06-28T06:03:13.292Z weekly 0.7 https://www.humanexasignals.com/signals/gut-proteobacteria-influence-cocaine-addiction-via-glycine-metabolism-in-mice 2026-06-28T06:03:00.369Z weekly 0.7 https://www.humanexasignals.com/signals/microperimetry-predicts-outcomes-in-diabetic-macular-oedema-treated-with-anti-ve 2026-06-28T06:02:42.410Z weekly 0.7 https://www.humanexasignals.com/signals/abhd17c-identified-as-a-regulator-of-lenvatinib-efficacy-in-hepatocellular-carci 2026-06-28T06:02:21.103Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-compares-transdermal-and-oral-hrt-effects-on-bone-density-in-turner- 2026-06-28T06:02:06.276Z weekly 0.7 https://www.humanexasignals.com/signals/capivasertib-plus-abiraterone-approved-for-pten-deficient-prostate-cancer 2026-06-28T06:01:38.076Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-issues-class-4-medicines-defect-notification-for-apixaban-tablets 2026-06-28T00:35:29.510Z weekly 0.7 https://www.humanexasignals.com/signals/quadrant-pharmaceuticals-issues-class-4-medicines-defect-notification-for-vesomn 2026-06-28T00:35:12.847Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-oxycet-anda087463-by-specgx-llc 2026-06-28T00:34:47.365Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-acetaminophen-and-codeine-phosphate-by-pharmobedient 2026-06-28T00:34:32.986Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-oxaydo-by-zyla 2026-06-28T00:34:07.293Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-hydrocodone-bitartrate-and-acetaminophen-by-specgx-llc 2026-06-28T00:33:43.942Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-nucynta-tapentadol-hydrochloride 2026-06-28T00:33:32.593Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-anexsia-75325-by-specgx-llc 2026-06-28T00:33:21.806Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anexsia-5325-submission-by-specgx-llc 2026-06-28T00:32:59.494Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-oxycodone-and-acetaminophen 2026-06-28T00:32:49.955Z weekly 0.7 https://www.humanexasignals.com/signals/novitium-pharmas-butalbital-combination-receives-fda-submission-approval 2026-06-28T00:32:40.229Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-acetaminophen-and-codeine-phosphate 2026-06-28T00:32:22.442Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-noom-programs-impact-on-glp-1-medication-users 2026-06-28T00:32:01.180Z weekly 0.7 https://www.humanexasignals.com/signals/plerixafor-vs-g-csf-trial-for-whim-syndrome-a-comparative-study 2026-06-28T00:31:53.060Z weekly 0.7 https://www.humanexasignals.com/signals/tirzepatide-evaluated-for-cannabis-use-disorder-in-proof-of-concept-study 2026-06-28T00:31:44.678Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-bern-trials-remote-cognitive-training-for-alzheimers-disease 2026-06-28T00:31:36.338Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-sx-682-and-docetaxel-in-advanced-head-and-neck-and-prostate-can 2026-06-28T00:31:18.828Z weekly 0.7 https://www.humanexasignals.com/signals/nikang-therapeutics-initiates-study-of-nkt5097-in-advanced-solid-tumors 2026-06-28T00:31:11.196Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-behavioral-program-for-weight-loss-after-glp-1-discontinuation 2026-06-28T00:31:04.074Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-for-lb-dtk-mv-in-antiviral-resistant-infections-post-anticancer-t 2026-06-28T00:30:56.434Z weekly 0.7 https://www.humanexasignals.com/signals/mlnlycke-health-care-recalls-hibiwash-due-to-microbial-contamination 2026-06-27T18:34:49.236Z weekly 0.7 https://www.humanexasignals.com/signals/curaleaf-laboratories-recalls-curaleaf-oil-due-to-low-thc-content 2026-06-27T18:34:34.886Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-tapentadol-hydrochloride-anda205057-receives-ap-status 2026-06-27T18:34:21.583Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-oxycodone-hydrochloride-and-acetaminophen 2026-06-27T18:34:09.808Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tapentadol-hydrochloride-by-novitium-ph 2026-06-27T18:33:36.961Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-morphine-sulfate-by-ani-pharmaceuticals 2026-06-27T18:33:26.163Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-binimetinib-application-by-alembic-pharmaceuticals 2026-06-27T18:33:15.940Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-oxycodone-hydrochloride-supplement-by-abhai-llc 2026-06-27T18:32:54.792Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levorphanol-tartrate-anda213906-by-sun-pharma 2026-06-27T18:32:30.875Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-tramadol-hydrochloride-by-sun-pharma 2026-06-27T18:32:19.424Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-dual-bronchodilator-in-copd-patients-undergoing-lung-cancer-surgery 2026-06-27T18:31:17.088Z weekly 0.7 https://www.humanexasignals.com/signals/moderna-initiates-safety-and-immunogenicity-study-for-rsv-vaccines-in-infants 2026-06-27T18:31:07.480Z weekly 0.7 https://www.humanexasignals.com/signals/study-aims-to-enhance-minority-representation-in-prostate-cancer-trials 2026-06-27T18:30:59.040Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-phase-iii-trial-of-ytb323-for-treatment-resistant-generalized 2026-06-27T18:30:50.201Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ultimaster-stents-evaluates-real-world-effectiveness-and-safety 2026-06-27T18:30:31.238Z weekly 0.7 https://www.humanexasignals.com/signals/bayer-plc-issues-class-3-recall-for-various-products-due-to-impurity 2026-06-27T12:33:16.621Z weekly 0.7 https://www.humanexasignals.com/signals/trimelvax-vaccine-shows-neutrophils-as-key-regulators-of-antitumor-immunity 2026-06-27T12:32:53.003Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-impact-of-blood-flow-on-microwave-ablation-efficacy 2026-06-27T12:32:40.822Z weekly 0.7 https://www.humanexasignals.com/signals/sec61g-identified-as-a-pan-cancer-biomarker-and-potential-therapeutic-target 2026-06-27T12:32:20.479Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-pediatric-long-term-follow-up-study-for-dabrafenib-and-tramet 2026-06-27T12:31:51.355Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-mazdutide-shows-promise-in-alcohol-use-disorder-study 2026-06-27T12:31:41.407Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iia-trial-of-metformin-for-preventing-oral-cancer-in-premalignant-lesions 2026-06-27T12:31:32.581Z weekly 0.7 https://www.humanexasignals.com/signals/swedish-study-on-infective-endocarditis-aims-to-improve-treatment-outcomes 2026-06-27T12:31:14.721Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-rivaroxaban-and-ticagrelor-against-clopidogrel-for-stroke-prevent 2026-06-27T12:31:05.971Z weekly 0.7 https://www.humanexasignals.com/signals/vir-biotechnology-initiates-phase-2-trial-for-chronic-hepatitis-d-with-vir-2218- 2026-06-27T12:30:58.091Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-paclitaxel-cyclophosphamide-withwithout-trastuzumab-in-breast- 2026-06-27T12:30:32.389Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-topical-infliximab-for-autoimmune-dry-eye-disease-in-sjgrens-syndrome 2026-06-27T12:30:23.260Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-osteopathic-intervention-for-fibromyalgia-patients-initiated 2026-06-27T06:31:25.251Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ketamine-vs-fentanyl-for-pain-management-in-laparoscopic-cholecystectom 2026-06-27T06:31:04.873Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-botox-alone-vs-combined-treatment-for-chronic-anal-fissure 2026-06-27T06:30:55.840Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-calderasib-and-durvalumab-trial-for-kras-g12c-nsclc-enters-phase 2026-06-27T06:30:47.958Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-trodelvy-sacituzumab-govitecan-hziy 2026-06-27T06:30:23.013Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tryngolza-autoinjector-submission 2026-06-27T06:30:15.202Z weekly 0.7 https://www.humanexasignals.com/signals/sys6010-in-combination-with-anti-pd-l-1-for-nsclc-study-launched 2026-06-27T06:06:07.696Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-ibrance-palbociclib 2026-06-27T06:05:40.074Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-supplemental-anda-for-pregabalin 2026-06-27T06:05:25.501Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda220768-for-fluvoxamine-maleate-by-micro-labs 2026-06-27T06:05:01.984Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-bupropion-hydrochloride-by-macleods 2026-06-27T06:04:48.324Z weekly 0.7 https://www.humanexasignals.com/signals/rubicon-researchs-anda220869-for-promethazine-and-dextromethorphan-receives-ap-s 2026-06-27T06:04:33.154Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gabapentin-anda203611-by-actavis-elizabeth 2026-06-27T06:04:10.843Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-bosentan-by-natco-pharma 2026-06-27T06:03:59.905Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-adrenalin-epinephrine-nda204640 2026-06-27T06:03:49.741Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-brimonidine-tartrate-and-timolol-maleate-anda219166 2026-06-27T06:03:31.767Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-mrd-guided-zanubrutinib-and-sonrotoclax-in-high-risk-cllsll-pa 2026-06-27T06:03:08.147Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluates-alpha-interferon-for-adjuvant-skin-melanoma-therapy 2026-06-27T06:02:57.526Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-neuangio-ct-impact-on-acute-ischemic-stroke-intervention 2026-06-27T06:02:39.697Z weekly 0.7 https://www.humanexasignals.com/signals/ipilimumab-vs-high-dose-interferon-in-high-risk-melanoma-trial 2026-06-27T06:02:29.987Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-phase-2b3-trial-of-surabgene-lomparvovec-for-diabetic-retinopat 2026-06-27T06:02:21.565Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-keytruda-and-trodelvy-combination-for-first-line-tnbc-treatment 2026-06-27T06:02:03.437Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-jaypirca-recommended-for-eu-approval-in-cll-across-all-therapy-lines 2026-06-27T06:01:53.449Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-for-platform-trial-in-intracerebral-haemorrhage-patients 2026-06-27T00:33:15.865Z weekly 0.7 https://www.humanexasignals.com/signals/rising-bone-cancer-incidence-highlights-need-for-improved-surgical-outcomes 2026-06-27T00:33:04.756Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-gait-biofeedback-for-fastoa-shows-potential-for-early-intervention 2026-06-27T00:32:42.193Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-patient-navigation-models-for-hiv-treatment-in-criminal-justice-populat 2026-06-27T00:32:23.129Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-gynecological-complications-post-stem-cell-transplantation 2026-06-27T00:31:57.197Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-rifapentine-anda217042-by-macleods-pharmaceuticals 2026-06-27T00:31:38.829Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-prolia-denosumab-by-amgen 2026-06-27T00:31:30.110Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-anda219324-for-junel-fe-receives-approval-status-from-fda 2026-06-27T00:31:21.139Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-brimonidine-tartrate-by-regcon-holdings 2026-06-27T00:31:12.746Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-copaxone-glatiramer-acetate 2026-06-27T00:30:54.662Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda075972 2026-06-27T00:30:47.802Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-codeine-sulfate-by-hikma-1 2026-06-27T00:30:30.051Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-butrans-by-knoa-pharma 2026-06-27T00:30:22.514Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-twirla-by-agile 2026-06-27T00:30:15.533Z weekly 0.7 https://www.humanexasignals.com/signals/age-and-treatment-modality-impact-survival-in-atypical-meningioma-patients 2026-06-26T18:34:45.660Z weekly 0.7 https://www.humanexasignals.com/signals/axitinib-and-survivin-vaccine-enhance-pd-1-therapy-in-renal-carcinoma 2026-06-26T18:34:11.834Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-fibroblast-derived-cell-lines-for-gene-therapy-in-immune-disorders 2026-06-26T18:33:53.483Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-aflibercept-8-mg-for-refractory-age-related-macular-degeneration 2026-06-26T18:33:30.150Z weekly 0.7 https://www.humanexasignals.com/signals/niaaa-launches-study-on-addictions-neuroclinical-assessment-for-alcohol-use-diso 2026-06-26T18:33:15.848Z weekly 0.7 https://www.humanexasignals.com/signals/bayers-study-on-nitroglycerin-and-nurandociguat-safety-in-cad-patients 2026-06-26T18:33:01.913Z weekly 0.7 https://www.humanexasignals.com/signals/viridian-therapeutics-initiates-trial-for-vrdn-003-in-thyroid-eye-disease 2026-06-26T18:32:48.008Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-trials-upadacitinib-for-moderate-to-severe-atopic-dermatitis-in-dupilumab 2026-06-26T18:32:24.589Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ustekinumab-for-ibd-patients-switching-from-anti-tnf-due-to-psoriasis 2026-06-26T18:32:09.089Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-belbuca-by-bdsi 2026-06-26T18:31:39.588Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-fioricet-with-codeine-supplement 2026-06-26T18:31:29.546Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-percodan-by-endo-operations 2026-06-26T18:31:20.526Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-codeine-sulfate-by-hikma 2026-06-26T18:31:09.983Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-dilaudid-by-rhodes-pharmaceuticals 2026-06-26T18:31:02.022Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-qdolo-tramadol-hydrochloride 2026-06-26T18:30:43.487Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-roxybond-by-protega-pharmaceuticals 2026-06-26T18:30:35.202Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-cysview-kit-by-photocure-asa 2026-06-26T18:30:28.482Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-application-for-nucynta-by-collegium-pharma 2026-06-26T18:30:21.062Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-binimetinib-with-mfolfox6-in-advanced-biliary-tract-cancers 2026-06-26T12:34:56.803Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-s-esp-vs-ficb-for-postoperative-pain-relief-after-hip-arthroplas 2026-06-26T12:34:33.739Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-zonulin-and-lbp-as-biomarkers-in-uc-and-liver-disease 2026-06-26T12:34:04.776Z weekly 0.7 https://www.humanexasignals.com/signals/new-esophageal-string-test-for-diagnosing-helicobacter-pylori-under-investigatio 2026-06-26T12:33:36.053Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-abbv-722-shows-focus-on-safety-and-pharmacokinetics 2026-06-26T12:33:13.066Z weekly 0.7 https://www.humanexasignals.com/signals/innovative-model-for-treatment-sequencing-in-relapsing-remitting-multiple-sclero 2026-06-26T12:32:52.640Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-oxycodone-hydrochloride-by-vistapharm 2026-06-26T12:32:28.852Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lunsumio-mosunetuzumab-axgb 2026-06-26T12:32:15.759Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-morphine-sulfate-by-hikma 2026-06-26T12:32:03.736Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-xtampza-er-by-collegium-pharma 2026-06-26T12:31:51.690Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-roxicodone-by-specgx-llc 2026-06-26T12:31:23.350Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-ms-contin-by-knoa-pharma 2026-06-26T12:31:11.711Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-zegalogue-supplemental-application 2026-06-26T12:30:53.116Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-nucynta-er-supplement-application-by-collegium-pharma 2026-06-26T12:30:40.218Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-oxycodone-hydrochloride-by-genus-lifesciences 2026-06-26T12:30:23.170Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-oxycodone-hydrochloride-by-genus-lifesc 2026-06-26T12:30:13.009Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-oxycontin-by-knoa-pharma 2026-06-26T06:35:11.625Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-oxaydo-by-zyla 2026-06-26T06:34:45.943Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-nucynta-tapentadol-hydrochloride 2026-06-26T06:34:23.378Z weekly 0.7 https://www.humanexasignals.com/signals/indicus-pharmas-metformin-hydrochloride-anda079148-receives-ap-status 2026-06-26T06:34:10.040Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-demerol-meperidine-hydrochloride 2026-06-26T06:33:50.337Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-conzip-by-cipher-pharmaceuticals 2026-06-26T06:33:37.232Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-synalgos-dc-by-sun-pharma 2026-06-26T06:33:25.196Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-bla-for-ocrevus-zunovo-by-genentech 2026-06-26T06:33:14.274Z weekly 0.7 https://www.humanexasignals.com/signals/rna-lp-vaccine-study-for-pediatric-high-grade-gliomas-and-adult-glioblastoma-ini 2026-06-26T06:32:43.109Z weekly 0.7 https://www.humanexasignals.com/signals/bms-986504-trial-initiated-for-recurrent-glioblastoma-patients-with-mtap-loss 2026-06-26T06:32:22.800Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-compares-weekly-vs-every-three-weeks-cisplatin-in-advanced-hea 2026-06-26T06:32:04.827Z weekly 0.7 https://www.humanexasignals.com/signals/akkermansia-muciniphila-muct-shows-potential-in-improving-insulin-sensitivity-in 2026-06-26T06:31:48.991Z weekly 0.7 https://www.humanexasignals.com/signals/digital-health-tools-show-promise-in-accelerating-lifestyle-habit-formation-for- 2026-06-26T06:31:21.726Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-hypofractionation-trial-for-recurrent-glioblastoma-patients 2026-06-26T06:30:58.683Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-phase-3-extension-study-for-tozorakimab-in-copd-patients 2026-06-26T06:05:24.440Z weekly 0.7 https://www.humanexasignals.com/signals/biontechs-pumitamig-phase-iii-trial-in-triple-negative-breast-cancer-underway 2026-06-26T06:04:55.458Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-radiprodil-in-grin-related-neurodevelopmental-disorder-initiate 2026-06-26T06:04:29.934Z weekly 0.7 https://www.humanexasignals.com/signals/preempt-trial-evaluates-radiation-therapy-for-high-risk-asymptomatic-bone-metast 2026-06-26T06:04:10.931Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-compares-stereotactic-radiosurgery-to-ha-wbrt-in-brain-cancer-pa 2026-06-26T06:03:27.283Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-deep-cervical-lymphovenous-anastomosis-for-severe-alzheimers-disease-in 2026-06-26T06:03:06.743Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-elecoglipron-phase-iii-trials-target-obesity-and-t2dm 2026-06-26T06:02:49.359Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-obesity-medicines-accessible-to-medicare-part-d-patients-via-new-program 2026-06-26T06:02:22.491Z weekly 0.7 https://www.humanexasignals.com/signals/sbrt-combined-with-ql1706-shows-promise-in-second-line-hepatocellular-carcinoma- 2026-06-26T06:01:54.335Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-of-morphine-sulfate-supplement-by-novel-labs 2026-06-26T00:34:49.143Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-oxycodone-and-acetaminophen 2026-06-26T00:34:26.541Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-tramadol-hydrochloride-by-graviti-pharms 2026-06-26T00:34:09.897Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-hydromorphone-hydrochloride-supplement-by-actavis-labs 2026-06-26T00:33:48.010Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-morphine-sulfate-by-rhodes-pharmaceuticals 2026-06-26T00:33:36.439Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-acetaminophen-caffeine-and-dihydrocodeine-bitartr 2026-06-26T00:33:15.928Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-conzip-tramadol-hydrochloride 2026-06-26T00:32:55.788Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-morphine-sulfate-anda200812-by-strides-pharma 2026-06-26T00:32:45.941Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-synalgos-dc-by-sun-pharma 2026-06-26T00:32:30.714Z weekly 0.7 https://www.humanexasignals.com/signals/janssens-guselkumab-trial-targets-skin-of-color-patients-with-psoriasis 2026-06-26T00:32:09.165Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-initiates-long-term-study-of-nerandomilast-in-pulmonary-fib 2026-06-26T00:32:00.019Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-cooling-treatments-for-neonatal-hypoxic-ischemic-encephalopathy-initiat 2026-06-26T00:31:51.503Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-electroacupunctures-impact-on-bowel-motility-in-healthy-subjects 2026-06-26T00:31:35.966Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-trial-of-acp-501-for-familial-lcat-deficiency-initiated 2026-06-26T00:31:19.032Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-factors-regulating-mast-cell-proliferation-in-mastocytosis 2026-06-26T00:31:01.314Z weekly 0.7 https://www.humanexasignals.com/signals/bayers-study-on-darolutamide-in-japanese-men-with-low-volume-mhspc 2026-06-26T00:30:53.115Z weekly 0.7 https://www.humanexasignals.com/signals/japet-medical-devices-evaluates-japetw-for-low-back-pain-management 2026-06-26T00:30:42.546Z weekly 0.7 https://www.humanexasignals.com/signals/trial-to-compare-bleeding-risk-of-rivaroxaban-vs-apixaban-in-acute-vte-treatment 2026-06-26T00:30:28.341Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-air-pollutions-impact-on-cystic-fibrosis-severity-in-hispanic-children 2026-06-26T00:30:18.086Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-oxymorphone-hydrochloride-by-hikma 2026-06-25T18:35:15.270Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-tevas-tramadol-hydrochloride-supplement 2026-06-25T18:35:03.024Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-tramadol-hydrochloride-by-specgx-llc 2026-06-25T18:34:43.930Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-codeine-sulfate-by-hikma-1 2026-06-25T18:34:35.493Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-oxycodone-hydrochloride-supplement-by-rhodes-pharmaceuticals 2026-06-25T18:34:23.360Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-butrans-by-knoa-pharma 2026-06-25T18:34:15.991Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-eloralintide-trial-targets-insulin-sensitivity-in-obesity 2026-06-25T18:34:08.907Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tgf-betas-role-in-asthmatic-susceptibility-to-rsv-initiated 2026-06-25T18:34:01.888Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mannitol-for-delirium-prevention-in-myocardial-infarction-patients 2026-06-25T18:31:08.465Z weekly 0.7 https://www.humanexasignals.com/signals/isometric-resistance-exercise-may-improve-bp-control-in-hypertension-patients 2026-06-25T18:31:00.172Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-her2-expression-in-breast-cancer-using-99mtctc-zher24107-initiated 2026-06-25T18:30:44.061Z weekly 0.7 https://www.humanexasignals.com/signals/psilocybin-assisted-psychotherapy-trial-for-cancer-survivors-launched 2026-06-25T18:30:35.120Z weekly 0.7 https://www.humanexasignals.com/signals/long-read-sequencing-to-enhance-neurogenetic-diagnoses-in-neurological-condition 2026-06-25T18:30:26.420Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-hydrocodone-bitartrate-and-acetaminophen-1 2026-06-25T12:34:19.580Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tapentadol-hydrochloride-by-epic-pharma 2026-06-25T12:34:07.658Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-twirla 2026-06-25T12:33:42.499Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-mylans-fentanyl-supplement 2026-06-25T12:33:31.656Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-sacituzumab-govitecan-hziy-for-first-line-triple-negative-breast-ca 2026-06-25T12:33:12.505Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tryngolza-for-reducing-acute-pancreatitis-risk-in-severe-hypertrigl 2026-06-25T12:32:53.531Z weekly 0.7 https://www.humanexasignals.com/signals/oliceridine-shows-potential-to-reduce-ponv-in-thyroid-surgery-compared-to-sufent 2026-06-25T12:32:35.055Z weekly 0.7 https://www.humanexasignals.com/signals/obecabtagene-autoleucel-trial-for-mrd-negative-b-cell-all-initiated 2026-06-25T12:32:22.973Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-tests-vicadrostat-with-empagliflozin-in-ckd-patients 2026-06-25T12:32:11.523Z weekly 0.7 https://www.humanexasignals.com/signals/vironexis-biotherapeutics-initiates-phase-12-trial-for-vnx-202-in-her2-positive- 2026-06-25T12:31:54.852Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pelvic-pain-in-women-with-endometriosis-to-explore-treatment-approaches 2026-06-25T12:31:34.722Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-pediatric-study-of-risankizumab-for-ulcerative-colitis 2026-06-25T12:31:19.450Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ketamines-impact-on-anaesthesia-depth-consistency-in-laparoscopic-surge 2026-06-25T12:31:04.918Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-nicardipine-for-rapid-bp-control-in-ich-patients-initiated 2026-06-25T12:30:35.036Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-epinephrine-auto-injector-needle-depth-for-anaphylaxis-treatment 2026-06-25T12:30:25.905Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-palbociclib-with-trastuzumab-for-hr-positive-her2-positive-breast-c 2026-06-25T06:34:57.045Z weekly 0.7 https://www.humanexasignals.com/signals/trial-protocol-for-liposomal-bupivacaine-in-shoulder-arthroscopy-pain-management 2026-06-25T06:34:39.985Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-surgical-treatment-efficacy-for-ascending-aortic-aneurysm 2026-06-25T06:34:20.214Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheims-survodutide-trial-for-nashmash-with-cirrhosis-underway 2026-06-25T06:34:06.115Z weekly 0.7 https://www.humanexasignals.com/signals/new-registry-for-recurrent-gynecologic-cancer-treatment-insights 2026-06-25T06:33:44.457Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-medical-cannabis-impact-on-opioid-use-in-chronic-pain-patients 2026-06-25T06:33:23.794Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-duodenal-pulsendo-for-type-ii-diabetes-and-liver-disease-initiated 2026-06-25T06:32:59.912Z weekly 0.7 https://www.humanexasignals.com/signals/prospective-study-on-skull-base-osteomyelitis-management-initiated 2026-06-25T06:31:58.632Z weekly 0.7 https://www.humanexasignals.com/signals/uk-wide-endo1000-study-aims-to-advance-endometriosis-diagnosis-and-treatment 2026-06-25T06:31:46.055Z weekly 0.7 https://www.humanexasignals.com/signals/efficacy-and-safety-of-cdk46-inhibitors-in-hrher2-advanced-breast-cancer-across- 2026-06-25T06:31:35.687Z weekly 0.7 https://www.humanexasignals.com/signals/amino-acid-infusion-shows-no-benefit-for-aki-post-aortic-surgery-subgroup-sugges 2026-06-25T06:31:10.820Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-nephrotoxic-risks-in-ckd-patients-using-sglt2-inhibitors 2026-06-25T06:30:55.734Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-adjuvant-chemotherapy-in-non-metastatic-sarcoma-analyzed 2026-06-25T06:30:45.685Z weekly 0.7 https://www.humanexasignals.com/signals/immunostimulatory-adjuvant-reverses-vaccine-response-decline-in-aged-models 2026-06-25T06:30:35.401Z weekly 0.7 https://www.humanexasignals.com/signals/insights-on-hpv-vaccine-hesitancy-to-enhance-global-vaccination-strategies 2026-06-25T06:30:22.583Z weekly 0.7 https://www.humanexasignals.com/signals/mir-6833-3p-promotes-prostate-cancer-progression-via-numb-notch-pathway-inhibiti 2026-06-25T06:30:13.505Z weekly 0.7 https://www.humanexasignals.com/signals/otud5-slc7a11-axis-identified-as-novel-target-in-aml-progression 2026-06-25T06:05:35.338Z weekly 0.7 https://www.humanexasignals.com/signals/hydroxytyrosol-loaded-hydrogel-shows-promise-for-cartilage-regeneration-in-osteo 2026-06-25T06:05:15.646Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-utero-ovarian-transposition-in-pelvic-malignancies-to-preserve- 2026-06-25T06:04:58.841Z weekly 0.7 https://www.humanexasignals.com/signals/study-identifies-biomarkers-for-immunotherapy-response-in-advanced-cervical-canc 2026-06-25T06:04:22.202Z weekly 0.7 https://www.humanexasignals.com/signals/v116-shows-safety-and-immunogenicity-in-high-risk-children-for-pneumococcal-dise 2026-06-25T06:03:58.345Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-sargramostim-and-vaccine-therapy-for-melanoma-recurren 2026-06-25T06:03:46.500Z weekly 0.7 https://www.humanexasignals.com/signals/sanofis-venglustat-phase-3-trial-targets-left-ventricular-mass-in-fabry-disease 2026-06-25T06:03:27.531Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-pazopanib-in-metastatic-kidney-cancer-post-surgery 2026-06-25T06:03:07.674Z weekly 0.7 https://www.humanexasignals.com/signals/long-acting-growth-hormone-shows-transient-bmi-increase-in-children-raising-trea 2026-06-25T06:02:51.738Z weekly 0.7 https://www.humanexasignals.com/signals/cadonilimab-targets-pd-1pd-l1-blockade-refractory-msi-hdmmr-colorectal-cancer 2026-06-25T06:02:39.768Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-acquires-centessa-pharmaceuticals-to-enhance-sleep-wake-disorder-treatment 2026-06-25T06:02:16.457Z weekly 0.7 https://www.humanexasignals.com/signals/european-commission-approves-keytruda-plus-padcev-for-cisplatin-ineligible-bladd 2026-06-25T06:02:00.566Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-pfizers-ibrance-for-hr-her2-metastatic-breast-cancer-maintenance 2026-06-25T06:01:38.885Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-belbuca-buprenorphine-hydrochloride 2026-06-25T00:34:57.571Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-oxycodone-hydrochloride-by-novel-labs 2026-06-25T00:34:40.898Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-amneals-tramadol-hydrochloride-supplement 2026-06-25T00:34:29.649Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-fioricet-with-codeine 2026-06-25T00:34:19.313Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-morphine-sulfate-by-alkem-labs 2026-06-25T00:34:09.390Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-oxycodone-hydrochloride-supplement-by-strides-pharma 2026-06-25T00:33:52.651Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-psmacd70-bi-specific-car-t-cell-therapy-initiated 2026-06-25T00:33:44.771Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ib-trial-of-niraparib-and-copanlisib-for-recurrent-gynecological-cancers 2026-06-25T00:33:36.301Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-rademikibart-for-acute-asthma-exacerbation-initiated-by-connect 2026-06-25T00:33:17.952Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bupivacaine-dilution-impact-in-infraclavicular-block-outcomes 2026-06-25T00:33:09.150Z weekly 0.7 https://www.humanexasignals.com/signals/jnj-68284528-cilta-cel-vs-standard-therapy-in-multiple-myeloma-study-initiated 2026-06-25T00:33:02.624Z weekly 0.7 https://www.humanexasignals.com/signals/xtx301-phase-12-trial-initiated-for-advanced-solid-tumors 2026-06-25T00:30:43.243Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-initiates-phase-1-study-of-bi-1831169-in-advanced-solid-tum 2026-06-25T00:30:28.924Z weekly 0.7 https://www.humanexasignals.com/signals/universal-car-t-cells-show-promise-in-multiple-myeloma-study 2026-06-25T00:30:20.160Z weekly 0.7 https://www.humanexasignals.com/signals/iron-dep-study-evaluates-iv-vs-oral-iron-for-postpartum-depression-in-anemia 2026-06-25T00:30:12.166Z weekly 0.7 https://www.humanexasignals.com/signals/crescent-pharma-recalls-ramipril-5mg-capsules-due-to-manufacturing-error 2026-06-24T18:33:16.389Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-oxycodone-and-acetaminophen-supplement 2026-06-24T18:32:51.881Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-methadone-hydrochloride-by-sun-pharma 2026-06-24T18:32:40.303Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-hydromorphone-hydrochloride-by-osmotica 2026-06-24T18:32:23.531Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-roxicodone-by-specgx-llc 2026-06-24T18:32:13.669Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-methadone-hydrochloride-by-hikma 2026-06-24T18:31:57.463Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tramadol-hydrochloride-anda209404-by-macleods 2026-06-24T18:31:35.088Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-percodan-by-endo-operations 2026-06-24T18:31:25.248Z weekly 0.7 https://www.humanexasignals.com/signals/merck-initiates-trial-for-mk-1045-in-lupus-and-rheumatoid-arthritis-patients 2026-06-24T18:31:10.364Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sacituzumab-tirumotecan-trial-targets-high-risk-breast-cancer 2026-06-24T18:30:55.551Z weekly 0.7 https://www.humanexasignals.com/signals/olaparib-investigated-as-neoadjuvant-treatment-in-ovarian-cancer-study 2026-06-24T18:30:47.497Z weekly 0.7 https://www.humanexasignals.com/signals/aavb-039-shows-promise-in-stargardt-disease-with-ongoing-safety-and-efficacy-stu 2026-06-24T18:30:39.332Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-conducts-safety-study-of-iptacopan-in-pnh-patients-using-registry-data 2026-06-24T18:30:24.502Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-on-olfactory-stimuli-in-vr-for-alcohol-dependence-patients 2026-06-24T18:30:12.062Z weekly 0.7 https://www.humanexasignals.com/signals/rayner-pharmaceuticals-issues-class-4-medicines-defect-notification-for-dropodex 2026-06-24T12:34:12.371Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-roxicet-anda089351-receives-abbreviated-approval-from-fda 2026-06-24T12:33:49.783Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-oxycodone-hydrochloride 2026-06-24T12:33:34.465Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-codeine-sulfate-by-hikma 2026-06-24T12:33:10.836Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-fentanyl-75-supplement-by-difgen-pharms 2026-06-24T12:32:58.457Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-methadone-hydrochloride-by-vistapharm 2026-06-24T12:32:40.105Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-dilaudid-by-rhodes-pharmaceuticals 2026-06-24T12:32:24.312Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-qdolo-by-rosemont 2026-06-24T12:32:15.169Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tramadol-hydrochloride-by-rubicon-resea 2026-06-24T12:32:01.429Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-roxybond-nda209777 2026-06-24T12:31:52.053Z weekly 0.7 https://www.humanexasignals.com/signals/neurocrines-nbi-1065845-shows-promise-as-adjunctive-treatment-for-major-depressi 2026-06-24T12:31:37.447Z weekly 0.7 https://www.humanexasignals.com/signals/entrectinib-phase-12-study-in-pediatric-solid-tumors-and-cns-tumors-initiated 2026-06-24T12:31:15.245Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ozone-injection-therapy-for-knee-osteoarthritis-outcomes 2026-06-24T12:31:07.043Z weekly 0.7 https://www.humanexasignals.com/signals/epcoritamab-shows-promise-in-high-risk-burkitt-lymphoma-with-da-epoch-r-in-phase 2026-06-24T12:30:59.880Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-keymaker-u01-study-explores-pembrolizumab-in-nsclc-with-chemotherapy 2026-06-24T12:30:46.227Z weekly 0.7 https://www.humanexasignals.com/signals/hoffmann-la-roches-enicepatide-trial-targets-obesity-and-type-2-diabetes 2026-06-24T12:30:37.634Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-carbohydrate-intake-impact-in-type-1-diabetes-with-advanced-hybrid-clos 2026-06-24T12:30:24.090Z weekly 0.7 https://www.humanexasignals.com/signals/sanofis-nirsevimab-study-to-assess-rsv-immunisation-rates-in-queensland-infants 2026-06-24T12:30:15.993Z weekly 0.7 https://www.humanexasignals.com/signals/sterling-pharmaceuticals-recalls-kidnaps-melatonin-due-to-stability-issues 2026-06-24T06:33:08.265Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-generic-of-priftin-rifapentine-tablets 2026-06-24T06:32:23.282Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-trial-for-inclisiran-in-acute-coronary-syndromes 2026-06-24T06:32:03.315Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-trial-for-ubrogepant-in-menstrual-migraine-treatment 2026-06-24T06:31:53.139Z weekly 0.7 https://www.humanexasignals.com/signals/gilteritinib-vs-midostaurin-trial-for-flt3-mutated-acute-myeloid-leukemia 2026-06-24T06:31:38.935Z weekly 0.7 https://www.humanexasignals.com/signals/dianthus-therapeutics-initiates-phase-2-trial-for-claseprubart-in-multifocal-mot 2026-06-24T06:31:30.621Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-lentiviral-gene-therapy-for-hemophilia-a-initiated 2026-06-24T06:31:09.852Z weekly 0.7 https://www.humanexasignals.com/signals/nutritional-screening-study-aims-to-link-nutritional-status-to-surgical-outcomes 2026-06-24T06:30:59.262Z weekly 0.7 https://www.humanexasignals.com/signals/hoffmann-la-roche-initiates-study-on-ro7663498-for-diabetic-retinopathy 2026-06-24T06:30:45.274Z weekly 0.7 https://www.humanexasignals.com/signals/agios-pharmaceuticals-mitapivat-shows-promise-in-non-transfusion-dependent-thala 2026-06-24T06:30:35.083Z weekly 0.7 https://www.humanexasignals.com/signals/kif18a-inhibitor-shows-promise-against-osteosarcoma-growth 2026-06-24T06:05:14.692Z weekly 0.7 https://www.humanexasignals.com/signals/mrna-lnp-vaccine-tp0435-shows-promise-against-syphilis-in-animal-models 2026-06-24T06:04:43.750Z weekly 0.7 https://www.humanexasignals.com/signals/adar1-circrab5a-bip-axis-linked-to-radiotherapy-resistance-in-colorectal-cancer 2026-06-24T06:04:07.624Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-targeted-temperature-management-to-reduce-delirium-in-cancer-surgery-pa 2026-06-24T06:03:48.955Z weekly 0.7 https://www.humanexasignals.com/signals/purinergic-activity-in-extracellular-vesicles-linked-to-melanoma-progression 2026-06-24T06:03:30.344Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-bevacizumab-with-chemotherapy-in-her-2-positive-metast 2026-06-24T06:03:17.648Z weekly 0.7 https://www.humanexasignals.com/signals/va-study-to-test-values-based-intervention-for-veterans-in-buprenorphine-treatme 2026-06-24T06:02:54.863Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-durvalumab-post-surgery-in-early-stage-nsclc-shows-potential- 2026-06-24T06:02:43.587Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-mc2-01-cream-for-plaque-psoriasis-shows-efficacy-and-safety 2026-06-24T06:02:29.336Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-axelopran-with-pembrolizumab-in-head-and-neck-cancer 2026-06-24T06:02:07.960Z weekly 0.7 https://www.humanexasignals.com/signals/pfizer-reports-phase-3-results-for-sigvotatug-vedotin-in-nsclc-no-overall-surviv 2026-06-24T06:01:42.379Z weekly 0.7 https://www.humanexasignals.com/signals/aspar-pharmaceuticals-recalls-ibuprofen-200mg-tablets-due-to-foil-perforations 2026-06-24T00:33:54.542Z weekly 0.7 https://www.humanexasignals.com/signals/syrimed-recalls-baclofen-oral-solution-due-to-crystallisation-issues 2026-06-24T00:33:35.909Z weekly 0.7 https://www.humanexasignals.com/signals/accord-healthcare-recalls-carmustine-due-to-out-of-specification-test-result 2026-06-24T00:33:17.978Z weekly 0.7 https://www.humanexasignals.com/signals/charm-copd-program-evaluates-post-discharge-care-for-copd-patients 2026-06-24T00:33:07.831Z weekly 0.7 https://www.humanexasignals.com/signals/intismeran-autogene-plus-pembrolizumab-trial-for-nsclc-initiated-by-merck-and-mo 2026-06-24T00:32:53.922Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-trial-for-drug-repurposing-in-advanced-thyroid-cancer-initiated 2026-06-24T00:32:44.781Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-enlicitide-study-aims-to-enhance-ldl-c-reduction-with-rosuvastatin 2026-06-24T00:32:29.230Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-apl-like-acute-myeloid-leukemia-and-vascular-complications-initiated 2026-06-24T00:32:12.945Z weekly 0.7 https://www.humanexasignals.com/signals/regeneron-initiates-study-of-regn13335-for-pulmonary-arterial-hypertension 2026-06-24T00:31:52.061Z weekly 0.7 https://www.humanexasignals.com/signals/ani-pharmaceuticals-submits-supplemental-application-for-oxycodone-and-aspirin 2026-06-24T00:31:29.714Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-levorphanol-tartrate-by-acertis-pharmaceu 2026-06-24T00:31:22.440Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-oxycodone-and-aspirin-combination 2026-06-24T00:31:14.725Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-oxycodone-hydrochloride-by-pharmobedient 2026-06-24T00:31:03.284Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-hydrocodone-bitartrate-and-acetaminophen 2026-06-24T00:30:50.618Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-tramadol-hydrochloride-supplement-by-sun-pharma 2026-06-24T00:30:42.617Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-diphenhydramine-hydrochloride-anda219470 2026-06-24T00:30:34.970Z weekly 0.7 https://www.humanexasignals.com/signals/viatris-reports-quality-defect-in-arixtra-pre-filled-syringes 2026-06-23T18:34:59.348Z weekly 0.7 https://www.humanexasignals.com/signals/novel-psma-targeted-imaging-and-sabr-for-recurrent-prostate-cancer 2026-06-23T18:34:36.173Z weekly 0.7 https://www.humanexasignals.com/signals/trial-to-compare-bowel-prep-methods-for-reducing-surgical-site-infections-post-c 2026-06-23T18:34:21.030Z weekly 0.7 https://www.humanexasignals.com/signals/iap-overexpression-may-predict-recurrence-in-locally-advanced-cervical-cancer 2026-06-23T18:34:02.390Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-transcranial-electrostimulation-for-pain-relief-in-osa-surgery 2026-06-23T18:33:41.122Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-malaria-infection-factors-in-pregnant-women-and-children-in-mali 2026-06-23T18:33:18.589Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-sim0689-for-advanced-solid-tumors-initiated-by-jiangsu-simcere 2026-06-23T18:33:07.231Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-elexacaftortezacaftorivacaftors-impact-on-cystic-fibrosis-microbiota 2026-06-23T18:32:54.720Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-olaparib-and-pembrolizumab-in-advanced-uveal-melanoma-initiate 2026-06-23T18:32:39.139Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rifampin-for-cyp24a1-related-hypercalcemia-and-hypercalciuria-initiated 2026-06-23T18:32:24.566Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-continuous-glucose-monitoring-in-gestational-diabetes-outcomes 2026-06-23T18:32:14.922Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-epcoritamab-epkinly 2026-06-23T18:32:01.286Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-anda-for-solriamfetol-hydrochloride-receives-approval-status 2026-06-23T18:31:46.795Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-fluoxetine-hydrochloride-by-sciegen-pharmaceuticals 2026-06-23T18:31:31.235Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-utebzi-tebipenem-pivoxil-by-glaxosmithkline 2026-06-23T18:31:23.479Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-paricalcitol-by-hikma-pharmaceuticals 2026-06-23T18:31:14.827Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-eltrombopag-olamine-anda208815 2026-06-23T18:30:59.533Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-fostamatinib-disodium-anda217329 2026-06-23T18:30:48.641Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-solriamfetol-hydrochloride-by-alkem-labs 2026-06-23T18:30:41.506Z weekly 0.7 https://www.humanexasignals.com/signals/fda-draft-guidance-aims-to-accelerate-gene-therapy-development 2026-06-23T18:30:33.839Z weekly 0.7 https://www.humanexasignals.com/signals/restoregi-study-evaluates-regenerative-therapy-for-benign-gi-fistulas 2026-06-23T12:34:55.849Z weekly 0.7 https://www.humanexasignals.com/signals/elevar-therapeutics-evaluates-lirafugratinib-in-solid-tumors-with-fgfr2-alterati 2026-06-23T12:34:20.366Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-pain-medicines-pregabalin-and-naproxen-in-healthy-adults 2026-06-23T12:34:05.348Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-risk-factors-for-acute-pulmonary-hypertension-crisis-launched 2026-06-23T12:33:40.284Z weekly 0.7 https://www.humanexasignals.com/signals/sp16-trial-aims-to-prevent-acute-kidney-injury-in-ckd-patients-undergoing-cardia 2026-06-23T12:33:22.306Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-baloxavir-marboxil-for-anda217449 2026-06-23T12:33:07.463Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-atomoxetine-hydrochloride-anda218875 2026-06-23T12:32:52.308Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levonorgestrel-and-ethinyl-estradiol-anda200492 2026-06-23T12:32:39.741Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-sun-pharms-ganirelix-acetate-supplement 2026-06-23T12:32:14.408Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-anda091440-for-levonorgestrel-and-ethinyl-estradiol-receives-ap-status 2026-06-23T12:32:03.315Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-argatroban-by-sandoz 2026-06-23T12:31:45.448Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-isotretinoin-by-upsher-smith-labs 2026-06-23T12:31:35.458Z weekly 0.7 https://www.humanexasignals.com/signals/fda-review-status-update-for-aprepitant-nda218754-by-azurity 2026-06-23T12:31:19.240Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-cabergoline-anda220309-by-renata 2026-06-23T12:31:02.306Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-pantoprazole-sodium-supplement-by-meitheal 2026-06-23T12:30:52.444Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-dual-target-combination-therapies-for-inflammatory-bowel-disease-initia 2026-06-23T06:34:44.814Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sac-tmt-trial-for-advanced-ovarian-cancer-aims-to-improve-maintenance-tre 2026-06-23T06:34:29.223Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-hysteroscopy-vs-aspiration-for-early-miscarriage-management 2026-06-23T06:34:06.438Z weekly 0.7 https://www.humanexasignals.com/signals/safety-and-tolerability-study-of-nmn-in-dhdds-cdg-patients-initiated 2026-06-23T06:33:51.853Z weekly 0.7 https://www.humanexasignals.com/signals/abbotts-study-compares-novel-spinal-cord-stimulation-techniques 2026-06-23T06:33:37.217Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-targeted-physical-activity-in-pancreatic-cancer-patients-undergoi 2026-06-23T06:33:19.799Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictors-of-functional-capacity-improvement-post-tavi 2026-06-23T06:33:01.333Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-divalproex-sodium-anda202419-receives-ap-status 2026-06-23T06:32:43.881Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-mylans-liraglutide-anda213155 2026-06-23T06:32:33.168Z weekly 0.7 https://www.humanexasignals.com/signals/bayer-healthcares-nda219627-receives-approval-from-fda 2026-06-23T06:32:20.182Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-bosutinib-monohydrate-for-market 2026-06-23T06:32:11.518Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-yervoy-ipilimumab 2026-06-23T06:31:53.178Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-capivasertib-receives-ap-status-from-fda 2026-06-23T06:31:44.232Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-pokonza-by-genus-lifesciences 2026-06-23T06:31:31.076Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-anda218359-for-acetaminophen-and-ibuprofen-receives-ap-status 2026-06-23T06:31:17.308Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-ocu500-vaccine-shows-safety-and-immunogenicity-in-adults 2026-06-23T06:31:01.613Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-vr-and-dual-task-training-for-balance-in-parkinsons-disease 2026-06-23T06:30:51.927Z weekly 0.7 https://www.humanexasignals.com/signals/chemoimmunotherapy-shows-promise-in-mss-colorectal-cancer-pooled-analysis-insigh 2026-06-23T06:04:38.254Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluates-adaptive-dbs-for-parkinsons-disease-management 2026-06-23T06:04:14.008Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2a-trial-of-kds2010-in-obesity-shows-promising-efficacy-and-safety-profile 2026-06-23T06:03:59.328Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-limb-cryocompression-system-to-prevent-chemotherapy-induced-neuropathy 2026-06-23T06:03:43.931Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-lnf2105-shows-promise-in-advanced-solid-tumors 2026-06-23T06:03:28.706Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-virr-vs-vdcie-in-metastatic-ewing-sarcoma 2026-06-23T06:03:03.350Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-ipilimumab-and-nivolumab-in-nasopharyngeal-carcinoma 2026-06-23T06:02:31.273Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-dalcetrapib-in-acs-patients-with-aa-genotype-initiated-by-dalco 2026-06-23T06:01:50.433Z weekly 0.7 https://www.humanexasignals.com/signals/sanofi-and-regeneron-launch-phase-3-study-on-itepekimab-for-chronic-rhinosinusit 2026-06-23T06:01:35.058Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-cemiplimab-in-nsclc-post-surgery-shows-promise-for-disease-fr 2026-06-23T06:01:16.101Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-tulisokibart-achieves-key-endpoints-in-phase-3-uc-study 2026-06-23T06:00:56.209Z weekly 0.7 https://www.humanexasignals.com/signals/cadila-pharmaceuticals-issues-class-4-defect-notification-for-mirtazapine-30mg-t 2026-06-23T00:33:07.113Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-tevas-risedronate-sodium-supplement 2026-06-23T00:32:43.842Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-succinylcholine-chloride-anda217873 2026-06-23T00:32:31.892Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-macitentan-anda211187-by-teva-pharmaceuticals 2026-06-23T00:32:21.985Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-risendronate-sodium-anda-submission-receives-ap-status 2026-06-23T00:32:10.315Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-real-world-effectiveness-of-rozanolixizumab-in-myasthenia-gravis-patien 2026-06-23T00:31:58.294Z weekly 0.7 https://www.humanexasignals.com/signals/registry-launched-to-evaluate-thrombectomy-for-pulmonary-embolism 2026-06-23T00:31:34.183Z weekly 0.7 https://www.humanexasignals.com/signals/phase-trial-of-rilvegostomig-in-her2-positive-gastric-cancer-initiated-by-astraz 2026-06-23T00:31:26.489Z weekly 0.7 https://www.humanexasignals.com/signals/mastelli-srl-initiates-study-on-pnha-for-skin-hydration-improvement 2026-06-23T00:31:13.125Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-unipolar-voltage-mapping-for-personalized-atrial-fibrillation-ablation- 2026-06-23T00:31:02.086Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1b-study-of-cx11-tablets-for-obesity-by-corxel-pharmaceuticals 2026-06-23T00:30:55.101Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-patient-satisfaction-and-efficacy-of-laser-treatment-for-varicose-veins 2026-06-23T00:30:48.559Z weekly 0.7 https://www.humanexasignals.com/signals/challenges-in-rotavirus-vaccine-efficacy-in-low-and-middle-income-countries 2026-06-22T18:34:34.709Z weekly 0.7 https://www.humanexasignals.com/signals/advances-in-bacteria-based-cancer-immunotherapy-via-synthetic-biology 2026-06-22T18:34:21.243Z weekly 0.7 https://www.humanexasignals.com/signals/ret-fusion-partners-influence-aggressiveness-in-spindle-cell-sarcomas 2026-06-22T18:34:06.030Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-labetalol-hydrochloride-by-epic-pharma 2026-06-22T18:33:37.057Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-macitentan-by-amneal 2026-06-22T18:33:25.794Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-atovaquone-by-hetero-labs 2026-06-22T18:33:05.877Z weekly 0.7 https://www.humanexasignals.com/signals/glenmarks-atovaquone-anda209685-receives-abbreviated-approval 2026-06-22T18:32:52.409Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-provocholine-methacholine-chloride 2026-06-22T18:32:43.476Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abiraterone-acetate-anda208371-approval-status 2026-06-22T18:32:30.542Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-tofacitinib-citrate-application-by-zydus-pharms 2026-06-22T18:32:20.055Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-rabeprazole-sodium-anda204237 2026-06-22T18:32:02.220Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-pfizers-marstacimab-bla761369 2026-06-22T18:31:48.427Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-tamsulosin-dose-escalation-vs-silodosin-switch-in-bph-related-uri 2026-06-22T18:31:41.363Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-on-immunotherapy-toxicities-in-cancer-patients 2026-06-22T18:31:26.529Z weekly 0.7 https://www.humanexasignals.com/signals/nalfurafine-hydrochloride-shows-promise-for-treating-pruritus-in-hemodialysis-pa 2026-06-22T18:31:14.867Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-remote-physiologic-data-collection-in-cancer-by-msk 2026-06-22T18:31:07.597Z weekly 0.7 https://www.humanexasignals.com/signals/abcellera-initiates-phase-1-trial-for-abcl575-assessing-safety-in-healthy-partic 2026-06-22T18:30:59.875Z weekly 0.7 https://www.humanexasignals.com/signals/new-non-aqueous-rotavirus-vaccine-shows-promise-for-ambient-shipping-and-stabili 2026-06-22T12:35:50.319Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-launches-ai-sandbox-to-enhance-medicines-development-and-safety 2026-06-22T12:35:23.382Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-epidiolex-by-jazz-pharmaceuticals 2026-06-22T12:35:08.824Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda219395 2026-06-22T12:34:45.640Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda219530-by-macleods-pharmaceutica 2026-06-22T12:34:34.925Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-anda-for-tofacitinib-citrate 2026-06-22T12:34:24.474Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-tofacitinib-citrate-by-msn 2026-06-22T12:33:24.359Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-dapagliflozin-by-inventia 2026-06-22T12:33:09.833Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-cyclobenzaprine-hydrochloride-supplement 2026-06-22T12:32:55.946Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-211at-bc8-b10-in-high-risk-acute-leukemia-and-myelodysplastic 2026-06-22T12:32:38.749Z weekly 0.7 https://www.humanexasignals.com/signals/new-strategy-for-identifying-unstable-coronary-plaque-in-emergency-chest-pain-pa 2026-06-22T12:32:12.914Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pet-imaging-in-gaucher-disease-and-parkinsonism-launched 2026-06-22T12:32:04.494Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-baiobit-sensor-reliability-for-gait-assessment-in-stroke-survivors 2026-06-22T12:31:57.270Z weekly 0.7 https://www.humanexasignals.com/signals/ipsc-derived-rpe-transplantation-trial-for-geographic-atrophy-in-amd-initiated 2026-06-22T12:31:40.884Z weekly 0.7 https://www.humanexasignals.com/signals/tirzepatide-trial-for-metabolic-alcohol-associated-liver-disease-in-aud-patients 2026-06-22T12:31:33.144Z weekly 0.7 https://www.humanexasignals.com/signals/isatuximab-trial-for-relapsedrefractory-cd38-positive-t-all-initiated 2026-06-22T12:31:21.706Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-pimicotinib-study-targets-tenosynovial-giant-cell-tumor-in-japan 2026-06-22T12:31:14.998Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vr-mirror-therapy-for-stroke-patients-shows-promise 2026-06-22T12:31:03.863Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-edinburgh-investigates-innate-immunity-mechanisms-in-copd 2026-06-22T12:30:57.535Z weekly 0.7 https://www.humanexasignals.com/signals/nipocalimab-imaavy-approved-for-generalised-myasthenia-gravis-treatment 2026-06-22T06:33:11.552Z weekly 0.7 https://www.humanexasignals.com/signals/study-identifies-malignancy-risk-factors-for-pulmonary-nodules-in-bronchiectasis 2026-06-22T06:32:57.393Z weekly 0.7 https://www.humanexasignals.com/signals/sbrt-and-il-12-in-pdac-local-therapy-alters-bone-marrow-hematopoiesis 2026-06-22T06:32:45.105Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-eua-for-nitenpyram-tablets-to-treat-new-world-screwworm-in-pets 2026-06-22T06:32:24.936Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-issues-correction-for-automated-impella-controllers-due-to-safety-concer 2026-06-22T06:32:12.281Z weekly 0.7 https://www.humanexasignals.com/signals/exploratory-trial-of-lurbinectedin-and-radiotherapy-in-sclc-progression 2026-06-22T06:31:58.307Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-obesity-and-heart-disease-risk-factors-in-african-americans-launched 2026-06-22T06:31:47.515Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-alcohols-impact-on-pde4b-imaging-in-healthy-adults 2026-06-22T06:31:39.285Z weekly 0.7 https://www.humanexasignals.com/signals/development-of-pediatric-cgvhd-symptom-scale-to-enhance-patient-reporting 2026-06-22T06:31:30.275Z weekly 0.7 https://www.humanexasignals.com/signals/web-based-nurse-support-program-improves-cancer-screening-knowledge-and-attitude 2026-06-22T06:31:20.316Z weekly 0.7 https://www.humanexasignals.com/signals/deucravacitinib-shows-promise-in-pityriasis-rubra-pilaris-study-by-mayo-clinic 2026-06-22T06:31:05.668Z weekly 0.7 https://www.humanexasignals.com/signals/novel-diclofenac-potassium-lollipop-for-pediatric-postoperative-pain-management 2026-06-22T06:30:57.738Z weekly 0.7 https://www.humanexasignals.com/signals/slc22a4-variants-influence-fusobacterium-nucleatum-in-colorectal-cancer 2026-06-22T06:05:04.966Z weekly 0.7 https://www.humanexasignals.com/signals/weight-loss-reduces-antihypertensive-treatment-in-type-2-diabetes-patients 2026-06-22T06:04:46.353Z weekly 0.7 https://www.humanexasignals.com/signals/semaglutide-tablet-approved-in-the-uk-for-weight-loss 2026-06-22T06:04:26.643Z weekly 0.7 https://www.humanexasignals.com/signals/baxters-volara-system-faces-air-leak-issues-impacting-patient-therapy 2026-06-22T06:04:14.743Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tzield-for-pediatric-stage-3-type-i-diabetes 2026-06-22T06:03:59.033Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-otc-continuous-glucose-monitor-for-children 2026-06-22T06:03:47.575Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-capivasertib-with-abiraterone-for-pten-deficient-prostate-cancer 2026-06-22T06:03:29.389Z weekly 0.7 https://www.humanexasignals.com/signals/beekeepers-naturals-recalls-saline-nasal-spray-due-to-microbial-contamination 2026-06-22T06:03:16.402Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-video-monitoring-for-heart-failure-patients-launched 2026-06-22T06:03:01.480Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-glp-1-and-lifestyle-interventions-in-pediatric-obesity-management 2026-06-22T06:02:50.253Z weekly 0.7 https://www.humanexasignals.com/signals/ai-system-for-enhanced-detection-of-colonic-sessile-serrated-lesions-in-colonosc 2026-06-22T06:02:35.682Z weekly 0.7 https://www.humanexasignals.com/signals/opioid-free-anesthesia-strategy-may-improve-outcomes-in-aaa-repair 2026-06-22T06:02:20.760Z weekly 0.7 https://www.humanexasignals.com/signals/viiv-healthcares-cab-ula-and-rpv-ula-study-for-virologically-suppressed-hiv-pati 2026-06-22T06:02:09.613Z weekly 0.7 https://www.humanexasignals.com/signals/prevent-all-als-study-launches-to-collect-data-on-genetic-risk-for-als 2026-06-22T06:01:54.327Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-initiates-long-term-study-of-spesolimab-for-hidradenitis-su 2026-06-22T06:01:45.010Z weekly 0.7 https://www.humanexasignals.com/signals/viatris-initiates-trial-for-cenerimod-in-active-lupus-nephritis 2026-06-22T06:01:33.851Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-icg-for-enhanced-visualization-of-ureters-in-deep-infiltrating-endometr 2026-06-22T06:01:24.683Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-belzutifan-with-pembrolizumab-for-renal-cell-carcinoma-treatment 2026-06-22T00:34:42.590Z weekly 0.7 https://www.humanexasignals.com/signals/medline-issues-correction-for-bupivacaine-hydrochloride-kits 2026-06-22T00:34:32.563Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-neuroimmune-diseases-in-reproductive-age-to-inform-pregnancy-management 2026-06-22T00:34:16.038Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-urinary-alkalinizations-impact-on-uric-acid-in-type-1-diabetes 2026-06-22T00:32:00.711Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-on-single-fraction-interstitial-brachytherapy-for-breast-cancer-sa 2026-06-22T00:31:52.483Z weekly 0.7 https://www.humanexasignals.com/signals/eko-devices-initiates-study-on-detecting-pulmonary-hypertension-with-electronic- 2026-06-22T00:31:43.473Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-atezolizumab-with-chemotherapy-for-peritoneal-mesothelioma 2026-06-22T00:31:35.627Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-oxygen-saturation-targeting-in-preterm-infants-with-pulmonary-hypertens 2026-06-22T00:31:26.023Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nivolumab-and-ipilimumab-for-rare-tumors 2026-06-22T00:31:05.689Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-8-chloroadenosine-and-venetoclax-in-relapsedrefractory-aml 2026-06-22T00:30:57.693Z weekly 0.7 https://www.humanexasignals.com/signals/ftobcl6-axis-identified-as-therapeutic-target-in-gastric-cancer-progression 2026-06-21T18:34:16.220Z weekly 0.7 https://www.humanexasignals.com/signals/targeted-pegylated-plga-nanoparticles-enhance-hesperidin-delivery-in-ovarian-can 2026-06-21T18:33:59.320Z weekly 0.7 https://www.humanexasignals.com/signals/advancements-in-subcutaneous-drug-delivery-for-high-concentration-antibody-produ 2026-06-21T18:33:44.263Z weekly 0.7 https://www.humanexasignals.com/signals/progress-on-ebv-vaccine-development-critical-for-ms-prevention 2026-06-21T18:33:27.651Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-fluorescite-by-alcon-labs 2026-06-21T18:33:13.934Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-depemokimab-by-glaxosmithkline 2026-06-21T18:33:01.525Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-doxylamine-succinate-and-pyridoxine-hydrochloride 2026-06-21T18:32:50.388Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-clindamycin-phosphate-anda064050-by-padagis-us 2026-06-21T18:32:39.627Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-propranolol-hydrochloride-anda219165 2026-06-21T18:32:29.599Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-nda-for-argatroban-in-sodium-chloride-receives-ap-status-from-fda 2026-06-21T18:32:17.795Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-fosaprepitant-dimeglumine-anda212143 2026-06-21T18:32:08.906Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vorasidenib-voranigo-by-servier 2026-06-21T18:32:00.545Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-malarone-pediatric 2026-06-21T18:31:44.467Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-dorzolamide-hydrochloride-anda205294 2026-06-21T18:31:37.417Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-chronic-e-cigarette-usage-and-microvascular-health-initiated 2026-06-21T18:31:30.239Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-transnasal-microstream-etco2-monitoring-in-elderly-post-surgery-patient 2026-06-21T18:31:22.612Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-low-dose-antihypertensive-therapy-in-prehypertensive-chinese-population 2026-06-21T18:31:02.809Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-m6620-and-gemcitabine-in-recurrent-ovarian-cancer 2026-06-21T18:30:40.993Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-iovera-cryoneurolysis-to-radiofrequency-ablation-for-chronic-low- 2026-06-21T18:30:34.188Z weekly 0.7 https://www.humanexasignals.com/signals/ubiquitination-signature-identified-in-neuroendocrine-prostate-cancer-with-thera 2026-06-21T12:34:02.732Z weekly 0.7 https://www.humanexasignals.com/signals/dual-ligand-cantharidin-nanoparticles-show-promise-for-hepatocellular-carcinoma- 2026-06-21T12:33:47.917Z weekly 0.7 https://www.humanexasignals.com/signals/innovative-strategy-combining-cryoablation-and-immunotherapy-for-triple-negative 2026-06-21T12:33:25.439Z weekly 0.7 https://www.humanexasignals.com/signals/high-resolution-multi-omics-map-of-dlbcl-reveals-cd3-b-cell-role-in-tumor-microe 2026-06-21T12:33:07.130Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-terlivaz-by-mallinckrodt 2026-06-21T12:32:56.798Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-valacyclovir-hydrochloride-by-hetero-labs 2026-06-21T12:32:39.285Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-argatroban-in-sodium-chloride 2026-06-21T12:32:28.831Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-tofacitinib-citrate-by-yaopharma 2026-06-21T12:32:12.116Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda219830-by-orient-pharma 2026-06-21T12:31:57.968Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-cephalexin-receives-fda-approval 2026-06-21T12:31:49.688Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-capecitabine-by-accord-healthcare 2026-06-21T12:31:39.619Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-tofacitinib-citrate-by-auson 2026-06-21T12:31:31.519Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda218821-by-concord-biotech 2026-06-21T12:31:21.162Z weekly 0.7 https://www.humanexasignals.com/signals/baricitinib-trial-for-job-syndrome-patients-with-lupus-like-disease-or-atopic-de 2026-06-21T12:31:11.058Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-of-low-dose-colchicine-in-ckd-aims-to-improve-vascular-and-bone-outc 2026-06-21T12:30:59.612Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictors-of-ptsd-relapse-in-children-and-families 2026-06-21T12:30:50.377Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mri-findings-and-executive-functions-in-preterm-infants 2026-06-21T12:30:43.986Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-venetoclax-combination-in-t-cell-acute-lymphoblastic-leukemia 2026-06-21T12:30:36.070Z weekly 0.7 https://www.humanexasignals.com/signals/amgens-amg-691-phase-1-study-targets-safety-in-asthma-patients 2026-06-21T12:30:24.170Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-inqovi-by-taiho-oncology 2026-06-21T12:30:18.566Z weekly 0.7 https://www.humanexasignals.com/signals/hpv-associated-cancers-impose-significant-burden-on-peruvian-men-highlighting-ne 2026-06-21T06:33:32.652Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-linezolid-in-sodium-chloride-09-for-hospira 2026-06-21T06:33:18.733Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-applications-for-zyvox-by-pfizer 2026-06-21T06:33:03.883Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda218900-by-saptalis-pharmaceutica 2026-06-21T06:32:45.079Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-lebrikizumab-by-eli-lilly 2026-06-21T06:32:35.627Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-vancomycin-hydrochloride-in-plastic-container 2026-06-21T06:32:21.013Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-azacitidine-anda204949-by-pharmobedient 2026-06-21T06:32:10.776Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-losartan-potassium-anda090382-by-strides-pharma 2026-06-21T06:31:59.705Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gallium-ga-68-gozetotide-anda216410 2026-06-21T06:31:51.677Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-anda078232-for-losartan-potassium-receives-ap-status-from-fda 2026-06-21T06:31:39.985Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gadobutrol-anda219146-by-zenara 2026-06-21T06:31:26.663Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-ly4268989-study-with-mirikizumab-in-ulcerative-colitis-underway 2026-06-21T06:31:18.913Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-tev-56286-trial-for-multiple-system-atrophy-underway 2026-06-21T06:31:10.076Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-gut-microbiota-and-cachexia-in-breast-cancer-patients-under-home-care 2026-06-21T06:31:03.098Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sleep-quality-improvement-with-cpap-in-obstructive-sleep-apnea 2026-06-21T06:30:54.423Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-abemaciclib-with-gemcitabine-for-advanced-soft-tissue-sarcoma 2026-06-21T06:30:45.980Z weekly 0.7 https://www.humanexasignals.com/signals/takeda-initiates-continuation-study-of-zasocitinib-for-psoriatic-arthritis 2026-06-21T06:30:39.680Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-temozolomide-with-or-without-veliparib-in-glioblastoma-mult 2026-06-21T06:30:22.550Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-exercise-programs-for-women-with-pcos-initiated-by-biruni-university 2026-06-21T06:04:37.210Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sleep-regularitys-impact-on-glycemic-control-in-type-1-diabetes 2026-06-21T06:04:24.814Z weekly 0.7 https://www.humanexasignals.com/signals/new-observational-study-on-treatment-adaptation-in-status-epilepticus 2026-06-21T06:04:06.823Z weekly 0.7 https://www.humanexasignals.com/signals/alnylams-aln-bcat-study-in-hepatocellular-carcinoma-evaluates-safety-and-efficac 2026-06-21T06:03:51.777Z weekly 0.7 https://www.humanexasignals.com/signals/dulce-digital-20-study-aims-to-enhance-diabetes-self-management-via-digital-tool 2026-06-21T06:03:34.127Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-core-stability-and-functional-capacity-in-pediatric-demyelinating-disea 2026-06-21T06:03:13.495Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-non-invasive-vagus-nerve-stimulation-in-ibd-remission 2026-06-21T06:03:04.135Z weekly 0.7 https://www.humanexasignals.com/signals/targeting-macrophage-cytokine-circuit-offers-new-strategy-against-tnbc-metastasi 2026-06-21T06:02:54.378Z weekly 0.7 https://www.humanexasignals.com/signals/study-optimizes-immunotherapy-for-pancreatic-adenocarcinoma-treatment 2026-06-21T06:02:44.222Z weekly 0.7 https://www.humanexasignals.com/signals/budget-impact-of-single-inhaler-triple-therapy-for-asthma-in-saudi-arabia 2026-06-21T06:02:37.423Z weekly 0.7 https://www.humanexasignals.com/signals/circkpna2-promotes-colorectal-cancer-via-rin1-ras-pathway-activation 2026-06-21T06:02:28.338Z weekly 0.7 https://www.humanexasignals.com/signals/emerging-trends-in-car-t-immunotherapy-research-for-breast-cancer-identified 2026-06-21T06:02:21.341Z weekly 0.7 https://www.humanexasignals.com/signals/lactobacillus-reuteri-promotes-ferroptosis-resistance-in-esophageal-cancer-via-s 2026-06-21T00:33:10.686Z weekly 0.7 https://www.humanexasignals.com/signals/novel-krasg12v-targeting-peptide-shows-potent-activity-against-colorectal-cancer 2026-06-21T00:32:56.857Z weekly 0.7 https://www.humanexasignals.com/signals/nmr-reveals-key-excipient-interactions-affecting-mab-viscosity-in-formulations 2026-06-21T00:32:44.311Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-levetiracetam-anda204754-by-aiping-pharm 2026-06-21T00:32:33.681Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-estradiol-by-mylan-technologies 2026-06-21T00:32:22.503Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-ap-status-for-irbesartan-and-hydrochlorothiazide-anda 2026-06-21T00:32:09.998Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-risperidone-anda077494-submission 2026-06-21T00:31:57.816Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-opdualag-by-bristol-myers-squibb 2026-06-21T00:31:47.502Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-provocholine-methacholine-chloride-by-methapharm 2026-06-21T00:31:37.024Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-pfizers-marstacimab-hympavzi-supplement 2026-06-21T00:31:29.555Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-emgality-galcanezumab-by-eli-lilly 2026-06-21T00:31:21.081Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-ajovy-fremanezumab-by-teva-pharmaceuticals 2026-06-21T00:31:13.718Z weekly 0.7 https://www.humanexasignals.com/signals/dapagliflozin-evaluated-for-right-ventricular-pulmonary-artery-coupling-post-opc 2026-06-21T00:31:03.237Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-remternetug-study-in-healthy-chinese-participants-initiated 2026-06-21T00:30:37.948Z weekly 0.7 https://www.humanexasignals.com/signals/ncis-match-trial-evaluates-genetic-testing-for-targeted-therapy-in-advanced-canc 2026-06-21T00:30:31.382Z weekly 0.7 https://www.humanexasignals.com/signals/fremanezumab-trial-for-acute-mountain-sickness-shows-potential-for-cgrp-blockade 2026-06-21T00:30:23.511Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-anti-inflammatory-diets-impact-on-type-2-diabetes-management 2026-06-21T00:30:15.906Z weekly 0.7 https://www.humanexasignals.com/signals/ezetimibe-atorvastatin-spc-approved-in-china-economic-value-assessment-needed 2026-06-20T18:33:03.594Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-mavacamten-in-obstructive-hypertrophic-cardiomyopathy-asse 2026-06-20T18:32:53.052Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vyepti-eptinezumab-jjmr-by-lundbeck 2026-06-20T18:32:38.379Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-acetazolamide-sodium-anda202693 2026-06-20T18:32:27.156Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-imuldosa-by-accord-biopharma 2026-06-20T18:32:13.898Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-dextromethorphan-hydrobromide-and-quinidine-sulfate-by-sun- 2026-06-20T18:32:04.057Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-darzalex-by-janssen-biotech 2026-06-20T18:31:55.128Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-thalidomide-anda213267-by-natco 2026-06-20T18:31:44.139Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-albuterol-sulfate-anda219409-from-cipla 2026-06-20T18:31:34.947Z weekly 0.7 https://www.humanexasignals.com/signals/novel-oral-nanoemulsion-targets-hepatic-stellate-cells-in-liver-fibrosis-treatme 2026-06-20T18:31:25.477Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-intestinal-trm-cells-and-hiv-1-persistence-during-art-launched 2026-06-20T18:31:03.879Z weekly 0.7 https://www.humanexasignals.com/signals/managed-access-program-for-del-zota-in-dmd-patients-announced-by-avidity-bioscie 2026-06-20T18:30:56.415Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-amxt-1501-and-dfmo-for-neuroblastoma-and-cns-tumors 2026-06-20T18:30:41.392Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-trial-for-telisotuzumab-adizutecan-in-mcrc-with-folfox-and-beva 2026-06-20T18:30:31.991Z weekly 0.7 https://www.humanexasignals.com/signals/ravulizumab-shows-promise-in-reducing-delayed-graft-function-in-kidney-transplan 2026-06-20T18:30:23.493Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-compares-pre-and-post-surgery-chemotherapy-for-gallbladder-can 2026-06-20T18:30:16.293Z weekly 0.7 https://www.humanexasignals.com/signals/limited-fda-approved-antihypertensive-therapies-for-pediatric-patients-highlight 2026-06-20T12:32:22.349Z weekly 0.7 https://www.humanexasignals.com/signals/hpv-vaccination-linked-to-decline-in-high-grade-cin-consultations-in-brazil 2026-06-20T12:31:55.114Z weekly 0.7 https://www.humanexasignals.com/signals/shikonin-induces-ferroptosis-in-dlbcl-via-lncrna-adpgk-as1-downregulation 2026-06-20T12:31:43.287Z weekly 0.7 https://www.humanexasignals.com/signals/network-meta-analysis-compares-minimally-invasive-treatments-for-uterine-fibroid 2026-06-20T12:31:28.096Z weekly 0.7 https://www.humanexasignals.com/signals/draeger-issues-correction-for-a350-and-a350xl-anesthesia-machines-due-to-ventila 2026-06-20T12:31:20.738Z weekly 0.7 https://www.humanexasignals.com/signals/regeneron-and-sanofi-study-dupilumab-for-bullous-pemphigoid-in-adults 2026-06-20T12:31:11.632Z weekly 0.7 https://www.humanexasignals.com/signals/venetoclax-dexamethasone-trial-for-t1114-relapsedrefractory-amyloidosis-initiate 2026-06-20T12:31:02.973Z weekly 0.7 https://www.humanexasignals.com/signals/gene-transfer-study-for-giant-axonal-neuropathy-initiated-by-ninds 2026-06-20T12:30:54.412Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-lutetium-lu-177-dotatate-in-advanced-bronchial-neuroendocrine- 2026-06-20T12:30:45.880Z weekly 0.7 https://www.humanexasignals.com/signals/kiora-pharmaceuticals-initiates-phase-ii-trial-of-kio-301-for-late-stage-retinit 2026-06-20T12:30:34.669Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-corticosteroids-for-healing-ring-enhancing-lesions-in-multiple-sclerosi 2026-06-20T12:30:25.726Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-mobile-health-platform-to-improve-adherence-in-metastatic-breast-cancer 2026-06-20T12:30:18.382Z weekly 0.7 https://www.humanexasignals.com/signals/mitf-driven-plasticity-in-melanoma-key-to-overcoming-therapy-resistance 2026-06-20T06:32:13.404Z weekly 0.7 https://www.humanexasignals.com/signals/fcgr2b-targeting-enhances-anti-tumor-activity-of-macrophages-in-melanoma 2026-06-20T06:32:03.003Z weekly 0.7 https://www.humanexasignals.com/signals/analysis-of-oral-nirmatrelvirritonavir-utilization-in-spain-for-covid-19 2026-06-20T06:31:54.316Z weekly 0.7 https://www.humanexasignals.com/signals/systematic-review-on-egfr-alterations-in-recurrent-glioblastoma-therapy-response 2026-06-20T06:31:45.408Z weekly 0.7 https://www.humanexasignals.com/signals/rbms1-identified-as-a-key-factor-in-multiple-myeloma-malignancy-and-macrophage-p 2026-06-20T06:31:38.370Z weekly 0.7 https://www.humanexasignals.com/signals/role-of-gsh-and-h2s-in-cancer-metabolism-implications-for-anticancer-strategies 2026-06-20T06:31:28.318Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-neuropsychological-changes-in-brain-metastases-patients-undergoing-radi 2026-06-20T06:31:12.332Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cancer-related-fatigue-in-chinese-cancer-patients-launched 2026-06-20T06:31:04.061Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-covid-19-vaccine-safety-in-cancer-immunotherapy-patients-launched 2026-06-20T06:30:54.316Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-sms-platform-to-prevent-malnutrition-in-hiv-exposed-children-in-kenya 2026-06-20T06:30:37.064Z weekly 0.7 https://www.humanexasignals.com/signals/heartfelt-study-evaluates-remote-monitoring-device-for-heart-failure-management 2026-06-20T06:30:16.385Z weekly 0.7 https://www.humanexasignals.com/signals/yale-university-launches-digital-health-initiative-for-heart-failure-in-uganda 2026-06-20T06:02:59.956Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-hemato-immunological-parameters-in-immune-thrombocytopenic-purpura 2026-06-20T06:02:33.397Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-targeted-temperature-management-to-reduce-delayed-neurocognitive-recove 2026-06-20T06:02:22.801Z weekly 0.7 https://www.humanexasignals.com/signals/study-initiated-to-collect-samples-for-eye-disease-research 2026-06-20T06:02:13.501Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-liposomal-bupivacaine-for-pain-management-in-vats-partial-pneumonectomy 2026-06-20T06:02:01.048Z weekly 0.7 https://www.humanexasignals.com/signals/cefazolin-infusion-study-aims-to-reduce-surgical-site-infections-in-orthopedic-p 2026-06-20T06:01:53.014Z weekly 0.7 https://www.humanexasignals.com/signals/study-links-blood-brain-barrier-disruption-to-cognitive-impairment-in-lung-cance 2026-06-20T06:01:40.009Z weekly 0.7 https://www.humanexasignals.com/signals/genetic-variants-erbb4-and-shbg-linked-to-pcos-risk-in-south-indian-women 2026-06-20T06:01:30.384Z weekly 0.7 https://www.humanexasignals.com/signals/high-intensity-thermal-stress-boosts-nk-cell-cytotoxicity-in-hcc 2026-06-20T06:01:23.329Z weekly 0.7 https://www.humanexasignals.com/signals/maged4-promotes-hcc-progression-via-jak2stat3-pathway-activation 2026-06-20T00:32:20.818Z weekly 0.7 https://www.humanexasignals.com/signals/cxcl13-expressing-cd4-t-cells-enhance-anti-tumor-immunity-in-nsclc-through-lymph 2026-06-20T00:32:09.019Z weekly 0.7 https://www.humanexasignals.com/signals/lidocaine-enhances-efficacy-of-sorafenib-and-gw5074-in-colorectal-cancer-cell-li 2026-06-20T00:32:00.707Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-otc-naloxone-nasal-spray-rextovy-for-opioid-overdose 2026-06-20T00:31:48.923Z weekly 0.7 https://www.humanexasignals.com/signals/fda-alerts-providers-to-supply-disruption-of-breast-biopsy-needles 2026-06-20T00:31:37.367Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-absorica-by-sun-pharma 2026-06-20T00:31:20.130Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-yervoy-ipilimumab 2026-06-20T00:31:10.562Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tzield-teplizumab-supplement 2026-06-20T00:31:03.186Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-welireg-supplement-from-merck 2026-06-20T00:30:56.574Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-orforglipron-study-in-adolescents-with-obesity-underway 2026-06-20T00:30:48.880Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-tirzepatide-study-targets-adolescents-with-obesity-and-comorbidities 2026-06-20T00:30:40.002Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-disorders-of-the-immune-system-launched-by-niaid 2026-06-20T00:30:34.208Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-bgb-45035-in-healthy-adults-and-autoimmune-patients 2026-06-20T00:30:15.533Z weekly 0.7 https://www.humanexasignals.com/signals/guidance-on-distinction-between-angioedema-types-for-ace-inhibitor-users 2026-06-19T18:33:35.481Z weekly 0.7 https://www.humanexasignals.com/signals/orbit-pharma-recalls-cyclizine-lactate-due-to-gmp-deficiencies 2026-06-19T18:33:22.562Z weekly 0.7 https://www.humanexasignals.com/signals/gut-microbial-markers-linked-to-immunotherapy-response-in-melanoma-identified-in 2026-06-19T18:33:09.979Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methylprednisolone-anda210985-by-ingenus-pharms 2026-06-19T18:32:52.047Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-divalproex-sodium-anda209286-receives-abbreviated-approval 2026-06-19T18:32:44.129Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-anda-for-empagliflozin-and-metformin-hydrochloride 2026-06-19T18:32:33.123Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-divalproex-sodium-anda217358-by-mankind-pharma 2026-06-19T18:32:23.789Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-anda215230-for-brimonidine-tartrate-and-timolol-maleate-receives-ap-sta 2026-06-19T18:32:15.819Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-hydroxyzine-hydrochloride-anda220271-by-saptalis-pharmaceuticals 2026-06-19T18:32:05.219Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-alecensa-alectinib-hydrochloride 2026-06-19T18:31:56.043Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-methylprednisolone-sodium-succinate-anda202691-receives-ap-status 2026-06-19T18:31:49.329Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-growth-of-skin-neurofibromas-in-neurofibromatosis-type-1-initiated-by-n 2026-06-19T18:30:53.486Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genotype-phenotype-correlation-of-morc2-mutations-in-charcot-marie-toot 2026-06-19T18:30:45.386Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-deep-brain-stimulation-for-opioid-use-disorder-initiated 2026-06-19T18:30:32.084Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-factors-in-fungal-infection-susceptibility-launched 2026-06-19T18:30:24.454Z weekly 0.7 https://www.humanexasignals.com/signals/pentoxifylline-and-tocopherol-study-for-rili-in-stage-iii-nsclc-patients 2026-06-19T18:30:18.016Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda216272-for-norepinephrine-bitartrate-by-nephron 2026-06-19T12:33:19.133Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-generic-of-xofluza-for-influenza-treatment 2026-06-19T12:33:11.212Z weekly 0.7 https://www.humanexasignals.com/signals/advancements-in-nk-cell-based-immunotherapy-for-cancer-treatment 2026-06-19T12:33:03.287Z weekly 0.7 https://www.humanexasignals.com/signals/ulk1-modulation-shows-promise-in-cancer-therapy-with-dcc-3116-in-clinical-evalua 2026-06-19T12:32:53.895Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-oral-carbapenem-for-complicated-utis 2026-06-19T12:32:46.119Z weekly 0.7 https://www.humanexasignals.com/signals/fda-launches-national-priority-voucher-program-to-accelerate-drug-review-times 2026-06-19T12:32:36.612Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-spermatic-abnormalities-in-fabry-disease-patients 2026-06-19T12:31:38.578Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-factors-of-enlarged-vestibular-aqueducts-and-hearing-loss 2026-06-19T12:31:31.322Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-tev-53408-trial-for-vitiligo-focuses-on-safety-and-efficacy 2026-06-19T12:31:23.460Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-emotional-wellness-in-stroke-rehabilitation-initiated 2026-06-19T12:31:10.819Z weekly 0.7 https://www.humanexasignals.com/signals/nimh-study-on-brain-function-in-pediatric-bipolar-disorder 2026-06-19T12:31:02.714Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-venetoclax-and-hma-in-flt3-mutated-aml-patients 2026-06-19T12:30:47.294Z weekly 0.7 https://www.humanexasignals.com/signals/tislelizumab-and-zeprumetostat-show-promise-in-nkt-cell-lymphoma-phase-ibii-tria 2026-06-19T12:30:35.919Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-to-present-positive-phase-3-results-for-pirtobrutinib-in-cll-at-eha-2026 2026-06-19T12:30:16.464Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-and-oscor-warn-of-catheter-introducer-leakage-risk 2026-06-19T06:32:21.275Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cardiovascular-abnormalities-in-children-with-adhd-launched 2026-06-19T06:32:11.972Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cardiac-rehabilitation-in-hypertensive-rheumatoid-arthritis-patients-in 2026-06-19T06:32:03.401Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-trial-for-abbv-932-in-bipolar-disorder-depressive-episodes 2026-06-19T06:31:55.507Z weekly 0.7 https://www.humanexasignals.com/signals/crlx101-and-paclitaxel-combination-study-in-ovarian-cancer-initiated-by-newlink- 2026-06-19T06:31:45.616Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-resistance-trainings-impact-on-womens-health-during-menopause 2026-06-19T06:31:04.692Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-study-on-natural-history-of-cns-tumors-to-enhance-treatment-options 2026-06-19T06:30:56.542Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-yanjiu-needle-for-pharyngeal-dysphagia-shows-promise-in-stroke-patients 2026-06-19T06:30:48.351Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-evaluates-xen63-gel-stent-for-glaucoma-via-two-surgical-approaches 2026-06-19T06:30:40.102Z weekly 0.7 https://www.humanexasignals.com/signals/medline-industries-expands-catheter-recall-due-to-infection-risk 2026-06-19T06:03:43.994Z weekly 0.7 https://www.humanexasignals.com/signals/tego-science-initiates-study-on-tpx-115-for-partial-thickness-rotator-cuff-tear 2026-06-19T06:03:27.923Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-leads-study-on-dlbcl-treatment-patterns-in-mea-region 2026-06-19T06:03:13.111Z weekly 0.7 https://www.humanexasignals.com/signals/edinburgh-study-investigates-pancreas-lipotoxicity-and-weight-loss-in-type-2-dia 2026-06-19T06:03:01.487Z weekly 0.7 https://www.humanexasignals.com/signals/amgens-xaluritamig-plus-abiraterone-trial-targets-metastatic-prostate-cancer 2026-06-19T06:02:48.695Z weekly 0.7 https://www.humanexasignals.com/signals/establishment-of-pulmonary-hypertension-biorepository-for-future-biomarker-disco 2026-06-19T06:02:37.962Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-ildr-plus-immunochemotherapy-in-borderline-resectable-esophage 2026-06-19T06:02:29.586Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-early-treatment-in-high-risk-cllsll-shows-promise 2026-06-19T06:02:16.670Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-to-assess-cognitive-function-changes-in-rett-syndrome-during-trofine 2026-06-19T06:02:05.628Z weekly 0.7 https://www.humanexasignals.com/signals/fruquintinib-study-in-metastatic-colorectal-cancer-patients-in-poland 2026-06-19T06:01:53.724Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-chidamide-for-mrd-positive-dlbcl-in-first-complete-remission 2026-06-19T06:01:39.472Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-capvaxive-for-at-risk-children-and-adolescents 2026-06-19T06:01:28.898Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-ntsr1-targeted-imaging-in-prostate-cancer-shows-promise 2026-06-18T18:32:35.963Z weekly 0.7 https://www.humanexasignals.com/signals/risdiplam-study-to-assess-real-world-outcomes-in-type-i-and-ii-sma 2026-06-18T18:32:17.644Z weekly 0.7 https://www.humanexasignals.com/signals/biogens-felzartamab-study-targets-immunoglobulin-a-nephropathy-in-adults 2026-06-18T18:32:08.481Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-dispepril-efficacy-in-functional-dyspepsia-vs-proton-pump-inhibi 2026-06-18T18:31:58.881Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-text-based-contingency-management-for-smoking-cessation-engagemen 2026-06-18T18:31:42.649Z weekly 0.7 https://www.humanexasignals.com/signals/decipheras-vimseltinib-study-evaluates-interaction-with-oral-contraceptives 2026-06-18T18:31:30.133Z weekly 0.7 https://www.humanexasignals.com/signals/st-judes-protocol-for-long-term-review-of-childhood-cancer-survivors 2026-06-18T18:31:19.124Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-riociguats-impact-on-right-heart-function-in-pah-and-cteph 2026-06-18T18:31:09.487Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-host-pathogen-interaction-with-staphylococcus-aureus-using-lymphoid-org 2026-06-18T18:31:00.412Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-frailty-in-young-adult-survivors-of-childhood-cancer-highlights-long-te 2026-06-18T18:30:48.763Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-rextovy-by-amphastar-pharmaceuticals 2026-06-18T18:30:40.003Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lacosamide-anda217596 2026-06-18T18:30:31.293Z weekly 0.7 https://www.humanexasignals.com/signals/taros-anda219052-for-perampanel-receives-approval-status 2026-06-18T18:30:23.425Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-3d-printed-vs-ready-to-wear-insoles-for-diabetic-neuropathy 2026-06-18T12:32:39.593Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-mucus-plug-dynamics-in-copd-patients-and-ex-smokers 2026-06-18T12:32:28.508Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-topiramate-by-aiping-pharm-inc 2026-06-18T12:32:15.790Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-keytruda-qlex-supplement-application 2026-06-18T12:32:05.698Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-yervoy-ipilimumab-by-bristol-myers-squibb 2026-06-18T12:31:53.188Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-nda-for-capivasertib-by-astrazeneca 2026-06-18T12:31:43.194Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-skyrizi-risankizumab 2026-06-18T12:31:35.150Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-clonazepam-by-rubicon-research 2026-06-18T12:31:25.348Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-welireg-supplement-nda215383 2026-06-18T12:31:16.329Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-skyrizi-risankizumab-by-abbvie 2026-06-18T12:31:06.092Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-doxycycline-anda204234-receives-ap-status-from-fda 2026-06-18T12:30:55.995Z weekly 0.7 https://www.humanexasignals.com/signals/alembic-submits-anda-for-bosutinib-monohydrate 2026-06-18T12:30:46.512Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ibii-trial-of-qlc5508-and-qlh12016-in-advanced-prostate-cancer 2026-06-18T12:30:34.606Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-epro-follow-up-for-oncology-patients-post-hospitalization 2026-06-18T12:30:26.349Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-anda214209-for-sumatriptan-receives-abbreviated-approval-from-fda 2026-06-18T06:33:11.691Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-divalproex-sodium-by-mylan 2026-06-18T06:32:57.876Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-absorica-ld-by-sun-pharma 2026-06-18T06:32:47.216Z weekly 0.7 https://www.humanexasignals.com/signals/bayers-nda219627-receives-approval-from-fda 2026-06-18T06:32:33.845Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-divalproex-sodium-by-unichem 2026-06-18T06:32:21.563Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-treatment-patterns-for-nivolumab-in-community-oncology-settings 2026-06-18T06:32:08.042Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-proton-therapy-for-craniopharyngioma-shows-feasibility-and-saf 2026-06-18T06:31:57.284Z weekly 0.7 https://www.humanexasignals.com/signals/digital-management-improves-outcomes-in-early-cardiogenic-shock-patients 2026-06-18T06:31:44.454Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-de-escalation-of-radiation-therapy-in-node-negative-breast-cancer 2026-06-18T06:31:31.365Z weekly 0.7 https://www.humanexasignals.com/signals/act-vs-cbt-trial-for-psychological-distress-in-hivaids-patients 2026-06-18T06:31:20.795Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-olaparib-and-durvalumab-combinations-in-recurrent-endometrial- 2026-06-18T06:31:07.896Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-selumetinib-and-olaparib-in-ras-pathway-mutant-ovarian-and-end 2026-06-18T06:30:54.546Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nivolumab-for-persistent-cervical-cancer-shows-potential-effic 2026-06-18T06:30:43.153Z weekly 0.7 https://www.humanexasignals.com/signals/raptor-trial-evaluates-radiation-therapy-with-atezolizumab-in-extensive-stage-sm 2026-06-18T06:30:26.200Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gadobutrol-anda219287-by-viwit-pharm 2026-06-18T06:04:48.072Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tretinoin-anda214590-by-alembic 2026-06-18T06:04:37.909Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-enspryng-satralizumab 2026-06-18T06:04:27.441Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-endoscopic-gastric-mucosal-ablation-for-class-iii-obesity-initiated 2026-06-18T06:04:17.955Z weekly 0.7 https://www.humanexasignals.com/signals/genentech-initiates-study-on-progression-of-intermediate-age-related-macular-deg 2026-06-18T06:04:01.562Z weekly 0.7 https://www.humanexasignals.com/signals/combomatch-trial-targets-genetic-mutations-in-advanced-solid-tumors 2026-06-18T06:03:48.680Z weekly 0.7 https://www.humanexasignals.com/signals/nivolumab-phase-iii-trial-for-high-risk-stage-ii-iiib-anal-cancer-initiated 2026-06-18T06:03:36.492Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-nivolumab-post-surgery-in-non-small-cell-lung-cancer 2026-06-18T06:03:26.687Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-atezolizumab-with-chemotherapy-for-metastatic-colorectal-canc 2026-06-18T06:03:14.628Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-radiotherapy-with-dual-immunotherapy-in-locally-advanced-rectal- 2026-06-18T06:02:58.138Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-pembrolizumab-timing-in-nsclc-treatment 2026-06-18T06:02:43.653Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-pembrolizumab-plus-doxorubicin-in-aggressive-sarcomas 2026-06-18T06:02:32.869Z weekly 0.7 https://www.humanexasignals.com/signals/sintilimab-and-ipilimumab-show-promise-in-first-line-therapy-for-advanced-biliar 2026-06-18T06:02:17.512Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-zyrtec-hives-by-kenvue-brands 2026-06-18T00:33:36.298Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-methylprednisolone-sodium-succinate-anda203125-receives-ap-status 2026-06-18T00:33:27.642Z weekly 0.7 https://www.humanexasignals.com/signals/alembic-pharmaceuticals-submits-anda220639-for-review 2026-06-18T00:32:24.355Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-inc-submits-anda-for-ruxolitinib 2026-06-18T00:32:16.164Z weekly 0.7 https://www.humanexasignals.com/signals/teva-pharmaceuticals-submits-anda219413-for-fda-review 2026-06-18T00:32:05.670Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-baxfendy-baxdrostat-from-astrazeneca 2026-06-18T00:31:52.115Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-educational-intervention-for-breast-cancer-patients-adherence-and-sexua 2026-06-18T00:31:41.523Z weekly 0.7 https://www.humanexasignals.com/signals/dabrafenib-and-trametinib-rollover-study-for-continued-patient-access 2026-06-18T00:31:31.171Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-investigates-vitamin-ds-impact-on-menstrual-cycle-health 2026-06-18T00:31:20.820Z weekly 0.7 https://www.humanexasignals.com/signals/evolve-study-to-assess-real-world-effectiveness-of-tezepelumab-in-severe-asthma- 2026-06-18T00:31:10.950Z weekly 0.7 https://www.humanexasignals.com/signals/cardiff-oncology-and-pfizer-assess-onvansertib-in-metastatic-colorectal-cancer-t 2026-06-18T00:31:00.828Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-optimizing-crt-lead-placement-for-non-lbbb-patients-using-advanced-imag 2026-06-18T00:30:51.757Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-acs-geriatric-surgery-programs-impact-on-older-cancer-patients 2026-06-18T00:30:34.916Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-on-sensory-changes-in-pediatric-oncology-patients-undergoing-t 2026-06-18T00:30:24.640Z weekly 0.7 https://www.humanexasignals.com/signals/fda-proposes-exclusion-of-semaglutide-tirzepatide-and-liraglutide-from-503b-bulk 2026-06-17T18:32:32.154Z weekly 0.7 https://www.humanexasignals.com/signals/fda-lists-quinacrine-hydrochloride-for-compounding-in-cutaneous-lupus-erythemato 2026-06-17T18:32:14.228Z weekly 0.7 https://www.humanexasignals.com/signals/robin-trial-to-explore-rt-effects-on-immune-system-in-rectal-cancer 2026-06-17T18:32:00.446Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-early-rehabilitation-protocol-for-breast-cancer-surgery-shows-promising 2026-06-17T18:31:52.669Z weekly 0.7 https://www.humanexasignals.com/signals/sillajen-initiates-phase-1-trial-of-bal0891-in-advanced-solid-tumors-and-aml 2026-06-17T18:31:42.312Z weekly 0.7 https://www.humanexasignals.com/signals/norm-hf-study-to-evaluate-fire1-norm-system-in-heart-failure-management 2026-06-17T18:31:28.597Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-durvalumab-bevacizumab-and-tace-for-advanced-hepatocellular-carcinoma 2026-06-17T18:31:19.548Z weekly 0.7 https://www.humanexasignals.com/signals/nemtabrutinib-study-vs-ibrutinibacalabrutinib-in-1l-cllsll-initiated 2026-06-17T18:31:07.632Z weekly 0.7 https://www.humanexasignals.com/signals/zilovertamab-vedotin-shows-promise-in-rrdlbcl-with-standard-care-in-phase-23-stu 2026-06-17T18:30:56.551Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-adipose-derived-stem-cells-for-burn-scarring-initiated-in-den 2026-06-17T18:30:45.334Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-s-icd-implantation-without-defibrillation-testing-shows-non-inferiority 2026-06-17T18:30:34.418Z weekly 0.7 https://www.humanexasignals.com/signals/r-mvst-cells-show-promise-for-treating-refractory-viral-infections 2026-06-17T18:30:25.604Z weekly 0.7 https://www.humanexasignals.com/signals/fda-draft-guidance-aims-to-reduce-animal-testing-for-cancer-drugs 2026-06-17T12:32:25.451Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-inqovi-nda-212576-by-taiho-oncology 2026-06-17T12:32:12.732Z weekly 0.7 https://www.humanexasignals.com/signals/stard10s-role-in-her2-breast-cancer-progression-and-lipid-metabolism 2026-06-17T12:32:03.447Z weekly 0.7 https://www.humanexasignals.com/signals/otac-trial-evaluates-anti-covid-19-immunoglobulin-in-outpatients 2026-06-17T12:31:53.003Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-psb-pacing-to-prevent-atrial-fibrillation-in-sinus-node-dysfunction-pat 2026-06-17T12:31:43.576Z weekly 0.7 https://www.humanexasignals.com/signals/boomerang-medical-initiates-pivotal-trial-for-device-in-ulcerative-colitis 2026-06-17T12:31:34.267Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-tqb2868-and-anlotinib-in-metastatic-pancreatic-cancer-initiated 2026-06-17T12:31:23.972Z weekly 0.7 https://www.humanexasignals.com/signals/db-1303bnt323-trial-in-her2-low-metastatic-breast-cancer-initiated 2026-06-17T12:31:13.137Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-exercise-programs-impact-on-quality-of-life-in-prostate-cancer-patients 2026-06-17T12:31:02.843Z weekly 0.7 https://www.humanexasignals.com/signals/large-study-on-breast-phyllodes-tumors-in-china-aims-to-enhance-treatment-guidel 2026-06-17T12:30:54.117Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-aur103-calcium-in-advanced-neuroendocrine-tumours-initiated 2026-06-17T12:30:44.707Z weekly 0.7 https://www.humanexasignals.com/signals/kshb002-trial-shows-equivalence-to-orencia-in-pk-safety-and-immunogenicity-for-r 2026-06-17T12:30:35.529Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-outcomes-after-discontinuation-of-btk-inhibitors-in-cll-patients 2026-06-17T12:30:25.533Z weekly 0.7 https://www.humanexasignals.com/signals/polyploid-giant-cancer-cells-drive-aggressiveness-in-ovarian-cancer-and-indicate 2026-06-17T06:34:16.574Z weekly 0.7 https://www.humanexasignals.com/signals/lactylation-related-biomarker-predicts-prognosis-and-therapy-response-in-cutaneo 2026-06-17T06:34:03.216Z weekly 0.7 https://www.humanexasignals.com/signals/novel-pra-peptide-hydrogel-shows-promise-for-treating-ocular-inflammation 2026-06-17T06:33:48.630Z weekly 0.7 https://www.humanexasignals.com/signals/gut-microbiota-impairs-flutamide-efficacy-in-prostate-cancer-treatment 2026-06-17T06:33:35.927Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-risk-factors-for-second-primary-cancer-in-colorectal-cancer-surviv 2026-06-17T06:33:22.615Z weekly 0.7 https://www.humanexasignals.com/signals/gene-amplification-adjacent-to-f3-linked-to-poor-outcomes-in-pancreatic-adenocar 2026-06-17T06:33:10.613Z weekly 0.7 https://www.humanexasignals.com/signals/e7-mrnalnp-vaccine-shows-promise-in-treating-early-stage-hpv-tumors-in-mice 2026-06-17T06:32:59.505Z weekly 0.7 https://www.humanexasignals.com/signals/tebentafusp-establishes-first-line-treatment-for-hla-a0201-positive-uveal-melano 2026-06-17T06:32:42.643Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-socio-aesthetics-care-impact-on-cancer-patients-quality-of-life 2026-06-17T06:32:29.127Z weekly 0.7 https://www.humanexasignals.com/signals/launch-of-alzheimers-disease-neuroimaging-initiative-4-to-validate-biomarkers 2026-06-17T06:32:17.340Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-pembrolizumab-with-chemotherapy-in-non-small-cell-lung-cancer 2026-06-17T06:32:05.835Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-gammatile-vs-standard-care-in-gbm-surgery-initiated 2026-06-17T06:31:54.859Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-l606-in-patients-with-ph-ild-shows-safety-and-efficacy-potentia 2026-06-17T06:31:45.014Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-compares-6-vs-12-months-of-her2-targeted-therapy-in-breast-cance 2026-06-17T06:31:34.783Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-orelabrutinib-in-secondary-progressive-ms-underway 2026-06-17T06:31:22.792Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-herceptin-hylecta-or-phesgo-with-chemotherapy-for-her2-positi 2026-06-17T06:31:10.984Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-medi5752-in-unresectable-pleural-mesothelioma-launched 2026-06-17T06:30:57.596Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-giredestrant-vs-endocrine-therapy-in-er-her2-early-breast-can 2026-06-17T06:30:43.569Z weekly 0.7 https://www.humanexasignals.com/signals/ifinatamab-deruxtecan-receives-priority-review-for-es-sclc-in-the-us 2026-06-17T06:30:25.574Z weekly 0.7 https://www.humanexasignals.com/signals/analysis-reveals-key-trends-in-als-immunotherapeutics-research-and-collaboration 2026-06-17T06:04:50.928Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-study-of-durvalumab-domvanalimab-in-stage-iii-unresectable-nsclc-initi 2026-06-17T06:04:40.353Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-cemiplimab-with-surgery-for-advanced-skin-cancer 2026-06-17T06:04:29.780Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-hemay005-in-chinese-patients-with-ulcerative-colitis-initiate 2026-06-17T06:04:19.564Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-osimertinib-and-bevacizumab-in-egfr-mutant-lung-cancer 2026-06-17T06:04:08.143Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-blu-5937-shows-promise-for-refractory-chronic-cough 2026-06-17T06:03:58.365Z weekly 0.7 https://www.humanexasignals.com/signals/acadia-pharmaceuticals-initiates-acp-204-trials-for-alzheimers-disease-psychosis 2026-06-17T06:03:48.692Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-syha1813-shows-promise-for-high-grade-meningiomas 2026-06-17T06:03:39.485Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-dinutuximab-in-high-risk-neuroblastoma-shows-promise 2026-06-17T06:03:28.190Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-phase-3-study-of-tofacitinib-in-pediatric-ulcerative-colitis-underway 2026-06-17T06:03:15.654Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-acquisition-of-terns-pharmaceuticals-advances-as-hsr-waiting-period-expir 2026-06-17T06:03:03.342Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-pelvic-radiotherapy-with-adt-in-node-positive-prostate-cancer 2026-06-17T06:02:50.549Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-enflonsia-approved-in-eu-for-rsv-prevention-in-infants 2026-06-17T06:02:41.035Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-keytruda-and-keytruda-qlex-in-mibc-treatment 2026-06-17T06:02:30.307Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-mercks-idvynso-for-virologically-suppressed-hiv-1-patients 2026-06-17T06:02:20.733Z weekly 0.7 https://www.humanexasignals.com/signals/merck-and-eisais-litespark-012-trial-fails-to-meet-primary-endpoints-in-rcc 2026-06-17T06:02:08.432Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-roches-gazyva-for-systemic-lupus-erythematosus-treatment 2026-06-17T06:01:58.624Z weekly 0.7 https://www.humanexasignals.com/signals/roches-enspryng-shows-68-relapse-reduction-in-phase-iii-mogad-study 2026-06-17T06:01:48.623Z weekly 0.7 https://www.humanexasignals.com/signals/roche-reports-strong-q1-2026-sales-growth-driven-by-innovative-medicines-and-dia 2026-06-17T06:01:38.319Z weekly 0.7 https://www.humanexasignals.com/signals/mrna-1083-shows-durable-immune-response-and-safety-in-adults-50-years 2026-06-17T00:32:17.258Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-durvalumab-with-chemotherapy-in-stage-ii-iii-breast-cancer 2026-06-17T00:32:07.341Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-hormone-therapy-and-chemotherapy-in-invasive-breast-ca 2026-06-17T00:31:57.981Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-triapine-with-cisplatin-for-advanced-cervical-and-vagi 2026-06-17T00:31:48.790Z weekly 0.7 https://www.humanexasignals.com/signals/calderasib-and-pembrolizumab-study-in-kras-g12c-nsclc-shows-promising-efficacy 2026-06-17T00:31:39.582Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-compares-folfox8-and-mfolfox6-in-metastatic-colorectal-cancer 2026-06-17T00:31:30.954Z weekly 0.7 https://www.humanexasignals.com/signals/neoadjuvant-therapy-trial-for-tnbc-sacituzumab-govitecan-pembrolizumab 2026-06-17T00:31:21.789Z weekly 0.7 https://www.humanexasignals.com/signals/overview-of-antibody-drug-conjugates-in-cancer-therapy-and-clinical-development 2026-06-17T00:31:04.371Z weekly 0.7 https://www.humanexasignals.com/signals/merck-acquires-terns-pharmaceuticals-enhancing-oncology-pipeline-with-tern-701 2026-06-17T00:30:54.395Z weekly 0.7 https://www.humanexasignals.com/signals/merck-receives-fda-approval-for-idvynso-expands-oncology-pipeline-and-animal-hea 2026-06-17T00:30:43.182Z weekly 0.7 https://www.humanexasignals.com/signals/roche-presents-new-data-on-vabysmo-and-susvimo-at-arvo-2026 2026-06-17T00:30:34.270Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-elrexfio-shows-significant-pfs-improvement-in-rrmm-patients 2026-06-17T00:30:23.482Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-bizengri-for-nrg1-fusion-positive-cholangiocarcinoma 2026-06-16T18:32:38.060Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tzield-for-pediatric-patients-with-stage-3-type-1-diabetes 2026-06-16T18:32:23.118Z weekly 0.7 https://www.humanexasignals.com/signals/cmp-001-and-nivolumab-show-promise-in-advanced-melanoma-phase-23-trial 2026-06-16T18:32:12.027Z weekly 0.7 https://www.humanexasignals.com/signals/ashwagen-shows-efficacy-in-managing-stress-and-anxiety-in-hypertensive-patients 2026-06-16T18:32:02.988Z weekly 0.7 https://www.humanexasignals.com/signals/fda-odac-vote-against-camizestrant-for-hr-positive-breast-cancer-raises-concerns 2026-06-16T18:31:42.702Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-reports-strong-q1-2026-revenue-growth-and-positive-nme-readouts 2026-06-16T18:31:32.574Z weekly 0.7 https://www.humanexasignals.com/signals/merck-acknowledges-daiichi-sankyos-adc-manufacturing-update 2026-06-16T18:31:23.032Z weekly 0.7 https://www.humanexasignals.com/signals/merck-publishes-method-for-scalable-synthesis-of-oral-pcsk9-inhibitor-enlicitide 2026-06-16T18:31:14.327Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-present-phase-ii-data-on-enicepatide-and-petrelintide-at-ada-2026-1 2026-06-16T18:31:02.941Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-acquire-pathai-for-750m-to-enhance-ai-driven-diagnostics-1 2026-06-16T18:30:53.801Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-acquire-pathai-for-750m-to-enhance-ai-driven-diagnostics 2026-06-16T18:30:44.179Z weekly 0.7 https://www.humanexasignals.com/signals/cvs-caremark-to-cover-foundayo-and-zepbound-enhancing-access-for-obesity-treatme 2026-06-16T12:32:38.624Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-expands-infectious-disease-portfolio-with-three-strategic-acquisitions 2026-06-16T12:32:28.752Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-foundayo-shows-significant-weight-loss-in-menopausal-women 2026-06-16T12:32:20.769Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lillys-ebglyss-for-atopic-dermatitis-with-unique-dosing-regimen 2026-06-16T12:32:11.906Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-present-phase-ii-data-on-enicepatide-and-petrelintide-at-ada-2026 2026-06-16T12:32:01.874Z weekly 0.7 https://www.humanexasignals.com/signals/nextcove-trial-shows-mrna-1283-vaccine-elicits-higher-nab-responses-than-mrna-12 2026-06-16T12:31:49.891Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-breakthrough-therapy-designation-for-calderasib-in-kras-g12c-mutant-n 2026-06-16T12:31:41.859Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-verve-102-shows-significant-ldl-c-reduction-in-phase-1b-trial 2026-06-16T12:31:32.802Z weekly 0.7 https://www.humanexasignals.com/signals/merck-reports-promising-long-term-data-for-keytruda-and-intismeran-in-oncology-a 2026-06-16T12:31:23.265Z weekly 0.7 https://www.humanexasignals.com/signals/saphnelo-self-administration-approved-in-the-us-for-sle-treatment 2026-06-16T12:31:14.113Z weekly 0.7 https://www.humanexasignals.com/signals/roches-elecsys-ptau217-blood-test-receives-ce-mark-for-alzheimers-detection 2026-06-16T12:31:01.005Z weekly 0.7 https://www.humanexasignals.com/signals/roches-elecsys-ptau217-blood-test-receives-ce-mark-for-alzheimers-diagnosis 2026-06-16T12:30:48.590Z weekly 0.7 https://www.humanexasignals.com/signals/european-commission-approves-pfizers-hympavzi-for-hemophilia-a-and-b-treatment 2026-06-16T12:30:40.597Z weekly 0.7 https://www.humanexasignals.com/signals/fda-extends-decision-date-for-astrazenecas-camizestrant-in-hr-positive-breast-ca 2026-06-16T06:34:14.993Z weekly 0.7 https://www.humanexasignals.com/signals/roche-launches-liver-disease-panel-to-enhance-chronic-liver-disease-management 2026-06-16T06:34:06.112Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-foundayo-shows-superior-a1c-reduction-and-weight-loss-in-pivotal-diabetes 2026-06-16T06:33:56.091Z weekly 0.7 https://www.humanexasignals.com/signals/truqap-approved-in-us-for-pten-deficient-metastatic-prostate-cancer 2026-06-16T06:33:46.468Z weekly 0.7 https://www.humanexasignals.com/signals/5-year-data-shows-intismeran-autogene-keytruda-reduces-melanoma-recurrence-risk- 2026-06-16T06:33:24.794Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-retevmo-shows-83-reduction-in-disease-recurrence-for-early-stage-ret-fusi 2026-06-16T06:33:12.517Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-foundayo-shows-superior-results-in-phase-3-trial-for-type-2-diabetes 2026-06-16T06:33:02.524Z weekly 0.7 https://www.humanexasignals.com/signals/imfinzi-gains-us-approval-for-early-bladder-cancer-with-bcg-combination 2026-06-16T06:32:53.274Z weekly 0.7 https://www.humanexasignals.com/signals/enhertu-gains-fda-approval-for-two-new-her2-early-breast-cancer-indications 2026-06-16T06:32:44.404Z weekly 0.7 https://www.humanexasignals.com/signals/fda-odac-recommends-truqap-for-pten-deficient-prostate-cancer 2026-06-16T06:32:32.027Z weekly 0.7 https://www.humanexasignals.com/signals/foundayo-shows-significant-weight-reduction-in-older-adults-with-obesity-in-new- 2026-06-16T06:32:22.100Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-to-present-phase-3-study-of-retevmo-in-ret-fusion-positive-nsclc-at-asco-2 2026-06-16T06:32:11.973Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-retatrutide-shows-significant-weight-loss-in-phase-3-obesity-trial 2026-06-16T06:32:01.949Z weekly 0.7 https://www.humanexasignals.com/signals/datroway-approved-in-us-as-first-trop2-directed-adc-for-1l-triple-negative-breas 2026-06-16T06:31:51.490Z weekly 0.7 https://www.humanexasignals.com/signals/gilead-and-merck-report-positive-phase-3-results-for-once-weekly-hiv-treatment-i 2026-06-16T06:31:41.775Z weekly 0.7 https://www.humanexasignals.com/signals/imfinzi-ev-shows-significant-survival-benefits-in-muscle-invasive-bladder-cancer 2026-06-16T06:31:31.676Z weekly 0.7 https://www.humanexasignals.com/signals/roche-advances-obesity-portfolio-with-promising-phase-ii-data-on-enicepatide-and 2026-06-16T06:31:22.496Z weekly 0.7 https://www.humanexasignals.com/signals/roche-advances-obesity-portfolio-with-promising-phase-ii-data-for-enicepatide-an 2026-06-16T06:31:11.369Z weekly 0.7 https://www.humanexasignals.com/signals/camizestrant-recommended-for-1st-line-er-positive-breast-cancer-in-eu 2026-06-16T06:31:00.877Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-keytruda-plus-padcev-receives-positive-eu-chmp-opinion-for-muscle-invasiv 2026-06-16T06:30:51.981Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sacituzumab-tirumotecan-shows-os-and-pfs-improvement-in-endometrial-cance 2026-06-16T06:30:40.934Z weekly 0.7 https://www.humanexasignals.com/signals/roche-and-nurix-collaborate-on-btk-degrader-bexobrutideg-for-b-cell-malignancies-1 2026-06-16T06:05:30.126Z weekly 0.7 https://www.humanexasignals.com/signals/roche-and-nurix-collaborate-on-btk-degrader-bexobrutideg-for-b-cell-malignancies 2026-06-16T06:05:14.101Z weekly 0.7 https://www.humanexasignals.com/signals/tozorakimab-shows-positive-phase-iii-results-in-copd-reducing-exacerbations 2026-06-16T06:04:57.466Z weekly 0.7 https://www.humanexasignals.com/signals/ultomiris-meets-primary-endpoint-in-phase-iii-trial-for-igan 2026-06-16T06:04:42.021Z weekly 0.7 https://www.humanexasignals.com/signals/merck-and-gilead-discontinue-phase-3-study-of-trodelvy-and-keytruda-in-nsclc 2026-06-16T06:04:26.877Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-25vpnc-vaccine-shows-strong-phase-2-results-advancing-to-phase-3 2026-06-16T06:04:11.835Z weekly 0.7 https://www.humanexasignals.com/signals/pfizer-and-innovent-collaborate-on-12-early-stage-oncology-programs 2026-06-16T06:03:56.766Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-berobenatide-shows-promising-phase-2b-results-for-monthly-dosing-in-obes 2026-06-16T06:03:42.162Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-present-promising-giredestrant-data-at-asco-2026-for-early-breast-cance-1 2026-06-16T06:03:28.576Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-present-promising-giredestrant-data-at-asco-2026-for-early-breast-cance 2026-06-16T06:03:06.243Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-lorbrena-crown-trial-reports-longest-progression-free-survival-in-advanc 2026-06-16T06:02:51.045Z weekly 0.7 https://www.humanexasignals.com/signals/talzenna-plus-xtandi-shows-52-rpfs-improvement-in-metastatic-prostate-cancer 2026-06-16T06:02:35.354Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-roches-giredestrant-in-early-stage-er-positive-breast-cancer-1 2026-06-16T06:02:19.790Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-roches-giredestrant-in-early-stage-er-positive-breast-cancer 2026-06-16T06:02:04.190Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-braftovi-regimen-nearly-doubles-progression-free-survival-in-mcrc 2026-06-16T06:01:50.639Z weekly 0.7 https://www.humanexasignals.com/signals/non-coding-rnas-as-regulators-of-aerobic-glycolysis-in-pancreatic-ductal-adenoca 2026-06-15T18:00:37.814Z weekly 0.7 https://www.humanexasignals.com/signals/nanomaterial-based-vaccines-show-promise-for-improved-rotavirus-protection 2026-06-15T11:55:36.199Z weekly 0.7 https://www.humanexasignals.com/signals/novel-cd2-targeted-bispecific-antibody-enhances-t-cell-engagers-for-solid-tumors 2026-06-15T11:55:27.900Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-maridebart-cafraglutide-in-obstructive-sleep-apnea-patients 2026-06-15T11:55:18.163Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-duvakitug-for-moderately-to-severely-active-ulcerative-colitis- 2026-06-15T11:55:08.806Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-zepbound-tirzepatide-targets-moderate-obstructive-sleep-apnea-in-national 2026-06-15T11:54:58.429Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-tr115-vs-investigators-choice-in-relapsedrefractory-periphera 2026-06-15T11:54:45.509Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-jaypirca-shows-45-reduction-in-disease-progression-risk-in-cllsll 2026-06-15T11:54:28.604Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-presents-promising-phase-1-data-for-first-in-class-type-ii-jak2-inhibitor- 2026-06-14T12:00:27.358Z weekly 0.7 https://www.humanexasignals.com/signals/gsks-as03-adjuvanted-h5n8-vaccine-shows-promising-immunogenicity-and-safety-in-p 2026-06-14T12:00:17.411Z weekly 0.7 https://www.humanexasignals.com/signals/rivaroxaban-trial-for-antithrombotic-prevention-in-hypertrophic-cardiomyopathy-p 2026-06-14T06:00:18.632Z weekly 0.7 https://www.humanexasignals.com/signals/new-biobank-established-for-cutaneous-melanoma-and-non-melanoma-research 2026-06-14T00:01:10.724Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ultrasound-guidance-for-central-catheterization-in-obese-icu-patients 2026-06-13T18:00:15.311Z weekly 0.7 https://www.humanexasignals.com/signals/covac-2-vaccine-shows-safety-and-immunogenicity-as-covid-19-booster-in-phase-1-t 2026-06-13T12:00:56.818Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-keytruda-combinations-for-adjuvant-treatment-in-clear-cell-rcc 2026-06-13T12:00:46.215Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-sal0140-shows-promise-for-primary-aldosteronism 2026-06-13T12:00:34.132Z weekly 0.7 https://www.humanexasignals.com/signals/roches-ventana-pten-assay-receives-fda-approval-for-prostate-cancer-companion-di 2026-06-13T12:00:20.007Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-mri-guided-sbrt-for-liver-metastases-aims-to-establish-safe-dose-levels 2026-06-13T06:00:18.545Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-cu-20101-shows-promise-for-glabellar-lines-compared-to-botox 2026-06-13T00:00:45.698Z weekly 0.7 https://www.humanexasignals.com/signals/mri-guided-radiotherapy-trial-for-hpv-positive-oropharyngeal-cancer-initiated 2026-06-12T18:00:57.390Z weekly 0.7 https://www.humanexasignals.com/signals/surufatinib-trial-initiated-for-adjuvant-therapy-in-pancreatic-neuroendocrine-tu 2026-06-12T12:01:33.824Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiia-trial-of-mc1r-targeted-therapy-with-nivolumab-in-advanced-melanoma 2026-06-12T06:00:42.581Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-silicone-barrier-spray-to-zinc-oxide-for-incontinence-associated- 2026-06-12T00:00:49.822Z weekly 0.7 https://www.humanexasignals.com/signals/dapagliflozin-vs-metformin-for-antipsychotic-induced-weight-gain-in-clinical-tri 2026-06-11T18:02:04.334Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluates-prs-ck-storm-for-cytokine-storm-in-respiratory-infectio 2026-06-11T18:01:55.329Z weekly 0.7 https://www.humanexasignals.com/signals/4cmenb-and-menacwy-crm-vaccines-co-administered-safely-in-adolescents 2026-06-11T12:01:42.641Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-timing-of-midazolam-in-pediatric-adenotonsillectomy-to-assess-stress-an 2026-06-11T12:01:30.729Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-cxd-and-ketogenic-diet-for-masld-shows-structured-approach 2026-06-11T12:01:21.546Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-roches-tecentriq-in-stage-iii-colon-cancer-1 2026-06-11T12:01:11.515Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-roches-tecentriq-in-stage-iii-colon-cancer 2026-06-11T12:00:57.741Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-behavioral-activation-to-relapse-prevention-for-veterans-with-au 2026-06-11T06:01:28.210Z weekly 0.7 https://www.humanexasignals.com/signals/fda-clears-bridge-device-for-opioid-use-disorder-treatment-efficacy-under-evalua 2026-06-11T06:01:16.361Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-of-digitally-enhanced-stepped-care-for-depression-in-primary-care-in 2026-06-11T00:02:01.609Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-image-guided-cancer-treatments-using-spectral-angio-ct 2026-06-11T00:01:50.076Z weekly 0.7 https://www.humanexasignals.com/signals/ai-driven-nutrition-study-for-type-2-diabetes-shows-promise-for-glycemic-control 2026-06-10T18:00:41.446Z weekly 0.7 https://www.humanexasignals.com/signals/pridopidine-phase-3-trial-initiated-for-als-efficacy-and-safety-evaluation 2026-06-10T18:00:32.582Z weekly 0.7 https://www.humanexasignals.com/signals/lipus-and-microbubbles-enhance-amphotericin-b-delivery-for-cryptococcal-meningit 2026-06-10T12:01:18.493Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-pe-therapy-pharmacotherapy-and-combination-for-ptsd-in-veterans 2026-06-10T12:01:05.430Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-venetoclax-and-rituximab-in-older-patients-with-mantle-cell-ly 2026-06-10T12:00:52.749Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-pfizers-hympavzi-for-expanded-hemophilia-a-and-b-indications 2026-06-10T12:00:41.077Z weekly 0.7 https://www.humanexasignals.com/signals/torrents-lurasidone-hydrochloride-anda-receives-ap-status-from-fda 2026-06-10T06:00:25.356Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-spravato-esketamine-hydrochloride 2026-06-10T06:00:15.823Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-artesunate-by-amivas 2026-06-10T00:01:51.882Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-filspari-sparsentan-by-travere 2026-06-10T00:01:41.400Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-pimozide-anda219897-by-novitium-pharma 2026-06-09T18:00:49.515Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-olmesartan-medoxomil-and-hydrochlorothiazide-anda206371 2026-06-09T18:00:39.768Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-concerta-by-janssen 2026-06-09T12:00:32.833Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lidocaine-hydrochloride-04-in-dextrose-5 2026-06-09T12:00:21.418Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-lidocaine-hydrochloride-04-in-dextrose-5 2026-06-09T06:00:23.567Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-diltiazem-hydrochloride-anda216327 2026-06-09T00:00:14.930Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-mycophenolate-mofetil-by-strides-pharma 2026-06-08T18:01:07.009Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-methylprednisolone-acetate-by-sandoz 2026-06-08T12:01:09.205Z weekly 0.7 https://www.humanexasignals.com/signals/sandozs-methylprednisolone-anda040194-receives-ap-status-from-fda 2026-06-08T00:00:20.306Z weekly 0.7 https://www.humanexasignals.com/signals/glenmark-pharmaceuticals-submits-supplemental-application-for-lamotrigine 2026-06-07T18:00:33.652Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-doxycycline-hyclate-supplement-by-impax-labs 2026-06-07T12:00:23.605Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-retatrutide-shows-significant-weight-loss-and-pain-reduction-in-triumph-1 2026-06-07T06:01:53.253Z weekly 0.7 https://www.humanexasignals.com/signals/south-african-hcps-support-dual-prevention-pill-but-highlight-key-challenges 2026-06-07T06:01:43.998Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-mesna-anda203364-submission-by-rising 2026-06-07T06:01:36.684Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vabysmo-by-genentech 2026-06-07T06:01:28.328Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-losartan-potassium-by-micro-labs 2026-06-07T00:00:24.901Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-duloxetine-hydrochloride-supplement-receives-ap-status-from-fda 2026-06-07T00:00:16.620Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-deflazacort-supplement-application-by-upsher-smith-labs 2026-06-06T18:00:40.324Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-lamotrigine-anda-submission-receives-ap-status 2026-06-06T18:00:31.331Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-levetiracetam-by-chartwell-rx 2026-06-06T12:01:41.453Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-cosopt-pf-supplement-by-thea-pharma 2026-06-06T12:01:32.591Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-phenylephrine-hydrochloride-by-baxter-healthcare 2026-06-06T06:00:47.187Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-ondansetron-hydrochloride-anda078127 2026-06-06T06:00:35.737Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-tyvaso-treprostinil 2026-06-06T00:00:51.990Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-dapagliflozin-by-jiangsu-hansoh-pharma 2026-06-06T00:00:40.603Z weekly 0.7 https://www.humanexasignals.com/signals/comparative-study-of-spsipb-vs-thoracic-paravertebral-block-for-opioid-reduction 2026-06-02T03:09:28.046Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-geniculate-artery-embolization-for-knee-osteoarthritis-initiated 2026-06-02T03:09:23.745Z weekly 0.7 https://www.humanexasignals.com/signals/imfinziimjudo-shows-significant-pfs-improvement-in-early-liver-cancer-trial 2026-06-02T03:09:20.953Z weekly 0.7 https://www.humanexasignals.com/signals/efzimfotase-alfa-shows-positive-phase-iii-results-in-hypophosphatasia 2026-06-02T03:09:15.835Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-pulmonary-artery-catheters-in-cardiac-surgery-aims-to-compare-recovery- 2026-06-02T03:01:35.313Z weekly 0.7 https://www.humanexasignals.com/signals/tapur-study-evaluates-targeted-therapies-in-advanced-cancer-with-genomic-variant 2026-06-02T03:01:32.508Z weekly 0.7 https://www.humanexasignals.com/signals/tozorakimab-achieves-primary-endpoints-in-phase-iii-trials-for-copd 2026-06-02T03:01:29.578Z weekly 0.7 https://www.humanexasignals.com/signals/enhertu-recommended-for-eu-approval-in-her2-metastatic-solid-tumours 2026-06-02T03:01:25.861Z weekly 0.7 https://www.humanexasignals.com/signals/zhuochuming-trial-evaluates-3te-vs-3prn-in-diabetic-macular-edema 2026-06-01T19:50:47.438Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-nmes-for-functional-recovery-in-copd-and-pneumonia-patients 2026-06-01T19:50:43.736Z weekly 0.7 https://www.humanexasignals.com/signals/fda-issues-guidance-on-postapproval-pregnancy-safety-studies 2026-06-01T19:50:38.722Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-baxfendy-receives-us-approval-for-hypertension-as-first-in-class-tr 2026-06-01T19:50:35.739Z weekly 0.7 https://www.humanexasignals.com/signals/breztri-gains-us-approval-as-first-triple-therapy-for-asthma 2026-06-01T19:50:32.737Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-001 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-002 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-003 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-004 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-005 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-006 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-007 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-008 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-009 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-010 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-011 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-012 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-013 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-014 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-015 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-016 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-017 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-018 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-019 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-020 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-021 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-022 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-023 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-024 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-025 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-026 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-027 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-028 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/95569e37-4691-4627-9f2d-140a13958dac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/beeb1234-0827-4921-9155-a1a690b5ff6d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7aae7ac1-3095-4769-aa6a-043247e500aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d3155fd-c04a-4887-a6bb-8abc6cb01429 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0555f23-570c-4208-8fc4-6a2e01eb7bf1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9bf4592-cab0-4f3f-8646-95ac380b64db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8eceb56b-fd3b-4baf-9b00-498c7f5d79b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d63eca8-2d58-49b9-8bbc-70ed236b7da8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2035f9ad-3759-4888-9f81-f8e50e3bdb1e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/92d1fd8e-f3c7-4ac2-9c31-a0a8e8ae10e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/844e1a51-6307-430a-aa9c-df731feb7695 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6493c8d6-9c83-4a92-8479-6a4761f027be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/48e739d9-d2c6-4cd1-97c0-eaba5cec3059 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c745c1bf-fbcf-476e-9767-d4424fd7f944 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/02ca615a-0eb1-41d6-b141-2a89f723d0f8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/77047bea-9116-443d-ae68-0d05f757c586 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0869ff22-f009-4e3a-bc1c-dacbe1233105 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0afb58d9-d647-455c-8b90-d5ff59432e21 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8cccb1bd-aba6-43e0-a338-b1723550eeaf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ddaf3e14-60c2-4224-a0a2-b0e16bd5b84b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f53267cf-6b97-478e-a771-ad0b81e611fa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7399f326-8368-41bd-bfcf-342b80709c48 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/568663a6-1280-4490-b15c-337845cb6823 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ef18be7-aa8a-4aa2-a39c-4c62b1098c38 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/57bb8f4c-c3c2-4930-853a-1f32bdcd11e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb0de5fc-46c6-4e7d-b38a-9a9e385ab83f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/15abb925-1662-45a7-ac1a-5432e5c4384b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/88d69831-34dd-4827-9287-043d1bfa3404 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4832333e-6f61-4e20-8460-777859a085d6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23f3864d-4c4b-4399-a1cc-f430e1091dfd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d072fee4-451d-4032-8f2b-3054fa30e654 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ada0db9-788d-4f99-b30b-593db07dd179 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/43999cef-6a5c-4454-979c-62115bbfd0b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6dca4c3e-c26d-4369-81f4-82273771e3c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e29ffdb1-d148-4f13-89fc-5307263d4843 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/435393b6-b077-4bd0-afbc-689819e1f7ad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/099fb505-9b80-4d4c-b920-2766eafcd665 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71d1c885-ae70-4f0a-999c-a8e9e18b41ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d90f4949-7d1f-451d-9da4-48473cee8266 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/79978d36-50bc-4618-87a1-e6d6727ea234 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4ce9a48-0a43-477e-96ae-07455c32d14d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4e29b078-5bf2-4c6f-8042-28c13bb87fc6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b185360-55a1-41fe-88b2-0cfde7da597d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b6d4bf4d-9930-4850-a16d-9f38762236af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2197ff7a-a514-4c1b-bebb-045773b23708 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/af2fa75d-2442-420b-90ee-48832d2f6f29 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/06c1e313-0194-4d51-b9fd-d1972d070d30 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b9b4f7b-319c-486b-a0ba-13fc3e372aa0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c5d69110-673e-4fcc-afae-06373342aec5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/413cdc2b-2674-4a33-b73b-f414aca5c3e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5b1c673-52aa-4374-801d-72a32d69549a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/377d6602-3612-43cb-bfbf-7b6f58a33a48 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4274febf-b122-4503-945d-67a6d6e67625 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a35a0b7-2cc2-4137-9c34-36f4b9e7cafa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86614f45-3cf1-4729-bbd3-bc0f99da5cdd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ba2b322-7ba6-49ec-b844-bddd708ae926 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e16142e-5bce-43ef-86d2-8c4ca10bff2c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1bc1152-8d3c-4d8d-8b4c-48398ec83700 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e96f179f-9cde-4e3b-8431-ec211705fd63 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d233861-5dac-4634-a1af-a88e39d4a7e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d759e90b-917f-47ae-9bde-a77e869f728c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6cc07928-84d6-4252-8cdf-13f6c617fbc7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b04c8a1-1b89-43e0-bdde-127c4095ac0e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8495b9f6-c062-40fe-8100-b8b50dbce369 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e10d6188-8b89-4bc6-90fe-46ac54621eb7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dc820a18-0420-44fc-8f14-414f3391f815 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc83c0df-1593-4ed6-9a07-8781bb687132 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b69b07e-ffc9-4746-a58a-6172091ae206 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31caa965-cd62-44bc-9410-d09a0f585fc8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5942de35-3ee6-407f-b467-eff39741c573 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6784b70c-0d1b-4fb1-ad14-5ebd5a692dfb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/714932a2-7d9c-4a61-9874-38d7c1adc233 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/17094173-eb19-4f50-a085-ac3944eff514 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9b6ff4f-95f9-46e4-8258-f185e9440b66 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ff584aa-59c4-4f05-bf85-f77c9a74fa4c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0faaaa1-f6d3-4848-9d2f-ff442ff69f3b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9fa08a02-c15c-4529-ac90-e38b3cd394e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2edf2eb-6121-49a3-8a67-7e50c2d5a8e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6d9e808a-9619-47ef-8e50-438b9a6697ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fc870c8a-f38f-4c8e-9319-b93008aeda46 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8bb4c48-4ba4-43a4-bc11-9f74cd98aae8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab444103-cb4e-465b-a9c2-69343405f7fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/306abe40-955c-496c-af8a-34392cbb65da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d42bb705-2195-4f6f-aa35-4507cd178c3a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a938470-32eb-459e-adbe-b6527eeca820 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/220c91f7-5b9e-4fb7-beee-1be056429ab2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bed0e015-ff68-4448-bc60-ac88d25b1d7a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed6a9ac5-3f1f-4e0e-9d6f-baf90fb8678b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/747a9356-d160-49dd-8cfd-cf2645d8b0a8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe9ac731-b8b9-4f21-acc3-41e431b36e4c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/60d72edc-c1b4-44ab-ab0d-b08e5c25eba3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d941f27-c9e0-4afa-8f21-ca263e5c0ae0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a9b6acf-cdff-4bd2-976c-619f2a318019 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4042e4cd-c48a-44dd-b588-b031ab39542a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b5da5eb-33ef-4d51-9f14-fa58928048af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4dc1fd20-4a24-48e9-bca1-5fd9a665e40e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/924f6d10-b330-4780-8ff3-a2e2b6a88e51 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0caa65f-e3e0-4825-b1c6-65d8732324e1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/417de9a9-c957-4450-9c8b-58f481bc604d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f8357a1-d22d-40ca-aea8-5d1ec9b2ef61 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/371c104d-5b26-43eb-b67c-0765794829f9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c73c13fe-acd3-4b13-8c44-a06920538191 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7264cb6d-576c-48c0-9010-9d97763daf94 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4a7c4cc9-93ca-477b-8374-161477d68a45 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/480fdea4-e24c-4287-b668-4bcf4458cbc6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/29bf8d69-9a21-44d8-8fb5-563d12584458 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8074946a-2de3-42f9-bfa7-e77b443c9549 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae9e2103-f94c-40ac-b92c-bb8b29cecb10 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/58241153-b485-4eb3-9c2c-9f40f32f761b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/300107af-85e0-45a4-b967-3386ad041dc2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab713b4b-8623-4e1d-8440-aa9a74a12a42 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2c5bbeeb-3bc2-4a95-9407-7d82c3a4edac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a4afb86-e6f7-45fd-ab92-9a6f09275a2d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae871d65-d6db-4de8-a321-2914c9940467 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/618204f1-9f03-4e77-8a42-6a7f3bc30b9e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/392767da-027d-470e-ae85-9335c82211e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cfb7ec4d-d984-46c7-93ff-bef97d9840d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87640501-46c4-43d2-a7b9-aea38e9cf8b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad520949-e4cc-43e3-b8a0-e28faa1ee422 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09d7d22b-560b-4dc2-9b37-00e54bafde9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ad0a10d-bf13-496a-8873-5c2123b9eaa9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9562184-ecda-4436-bd34-0048d7933848 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9b49a7c-d48a-4417-b16c-2f07f5a9fce1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c0ee6411-fd05-443f-b900-521743693f8b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7bea453-48c3-41fe-bf22-2e3ba34479d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0fb68ff1-bef1-4019-9053-65a1ebe3f581 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/74b0f125-e986-4005-81b9-f3e6693f3f0c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/baa96591-0691-46f0-b7b1-5115fab1de1a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dc4853c2-6009-42b2-890c-2771911b6bb3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6bbf5164-32bd-4a3a-ba8a-ff70a46f4035 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59f5e82c-003a-4ead-8be7-44e1ebe568e0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aef88680-7319-4cb5-8d9d-b735fbdd38a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a1c700e-3f4c-4ef5-9773-20d02b1f67f9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/408ba6fa-9f75-4692-87aa-ca7be712ad5a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4a550cd-098a-4e4e-a45a-c8900a3d072b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4562e12e-b6fd-4e00-93f3-53e190156064 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a54d10d2-0fbc-494d-b6a8-4f46504f0007 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d4b8694b-a06b-46e5-bb46-3fcfe625015f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/660d66fc-62f0-4434-b533-7cf563ea48ac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f34e0c7-14e6-4530-9260-76293ed13a29 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd6bff35-951e-4763-bb80-e3cfb2154e9c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec3f4deb-cdac-4e86-9447-2e0e22124b18 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9df45e33-7528-4add-8de3-f204fb02456f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fb8341c7-94a0-43a2-a1f3-0822f124a1bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c2a6ade-81fc-4c2b-8110-41230c890285 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/486b764b-e55e-45bd-af56-e9e729ed860c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b55c1641-f4e1-4b05-bf69-a8a6b258fcdf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f75ba589-af98-407d-9cb4-8405b7495765 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2e15bbf-f8a0-49d4-b088-0e6895fe0ac8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b964c493-1dfb-4014-8431-4a6ea8481588 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c9a2d1b-f49c-455d-942c-043407902fd1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81c7c354-9a56-4c23-8f11-59c0713b35f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/de64409f-e519-41c9-992d-bc06c6264573 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4486f84f-2561-46b7-bd15-dc9c76a2f4ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/017d5aae-1ed1-4211-9880-727e311208cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a3a16cf-8646-40bc-8678-ddd8745851cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/940847d9-c4b6-4552-adec-960f346322a6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e9b60b0-b20a-46b2-8531-009148f2603c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/416c758e-3e58-4da7-bc72-7c599bb4434e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ca67c84-8e21-452a-bb91-e0a0be4022bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f63c85ed-63a7-4111-bb34-021853e8a209 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ffbd26c-eb1f-4e55-86c1-97caa5352310 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/70753730-bc97-45e2-9194-8b2d74297436 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec7d874e-a0d9-4a79-bbba-e2245c4a3b9c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed55e736-2b51-4ce6-a456-16583c1235e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1053146-1da6-41c3-9c6d-7fc6a4c5d305 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c98329ec-678c-43cc-8793-69972e7c3317 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a847f2e-6e30-4862-94bc-71724d4a3ca7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/371cf823-45de-4d3f-9bdd-1d2d68b28be7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f03b04bf-41c4-4ec5-95c1-f96d5e26a21d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf92fb46-66f6-4076-9a48-673bca6c8832 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2438ffc-2228-460c-9fd8-3bed401bc983 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3cc689b8-0c0b-471c-9161-07297941a6c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9eb818fc-fdf1-4f9f-804f-d52b8da9818b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/812922e2-179b-4ef3-a56d-53f130040181 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dcd85dce-43e9-479d-b326-b2914165d301 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/550488d8-a3fe-4092-8f2c-1fba568e2573 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/43aee697-8eba-40ea-bfab-7a19d5333efd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5189a433-9f6f-4119-9b5e-9cc2317ffb75 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8e3f532-9290-4bb0-9c66-ff1379f76924 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b7d9040-8b94-40d0-9530-99be475cd599 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81c4d0e5-6b94-4f03-b755-1792bdbd65e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75bc8151-646c-4161-9a97-59e1ddd00c75 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/086b2a11-09e5-4798-ba68-78364835d8a0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b705f756-eb57-4b9d-b353-f7b6657d7f90 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bdad722b-cede-4300-b776-4239ab5aaacd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/579b02ff-2863-4f8b-95e6-75a0d47fd8b4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4adbe8ee-c753-4b6d-9081-5443919a0b18 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/46f6ae62-339a-46f6-9aba-31ba6fb7f65e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3985269f-8b0f-4f60-9768-d042208fc94f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/167ebeda-9318-45ac-9c89-df9bb6bc7e6b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/37c2ca8a-3d38-411f-b263-a32d133fe199 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/781c518c-61cb-4390-bd53-a79b9485ff08 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/20f917f9-2a43-4739-9e16-4a7ff31ee58a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c4ee060-e2db-4f33-8d1d-88a4ece5cd9c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/367022dc-6882-486d-8151-4497240444e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b2aafca-8200-477a-b7e5-1728d2ea59e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1832dd7-aa6a-4e33-a294-211666a0b8fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e875e11-f51d-4898-9742-738b3ce16b09 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/70f53945-0140-4c83-89b9-d60906ea6bcd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5042a308-2664-45c9-a7d7-e83329b2732f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a3d0c8d9-db84-43fd-a58a-448fa216fa65 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b591d356-a639-47a4-8f69-8be132def184 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7477807d-8299-4b11-83f8-7cffe3900054 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c332e41e-63c2-4f92-8df5-8673e560e605 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53a94a59-cf3c-470a-8f1b-2ec3a08696dc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/598b6149-f5a0-4ba5-abd1-c2553122a783 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a7d4c6b5-cf91-4630-ac6e-0bbb4dfeaaad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/61c480e0-7cd3-4255-88e7-4d41007858b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/968a85a1-97e2-45eb-937f-97158fd717be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0649c4a9-785d-411c-b432-83e021e3ccdc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/673cee70-7a19-4924-a03c-9ed83fb299b0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/740e5cc0-748e-4776-ae2b-cb1e54910c8a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b395ca7-5118-4cf4-a3fe-20e63d3eddcd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3db585fb-f56f-4ac9-9bdd-d6d59beb1d11 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8fa09a94-0b05-4e22-ad6b-0ff87a993731 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ecbb6a9f-9c4c-4131-9459-4e82b0220adc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f2190ea-ab40-4a0c-996b-f63fca2bd8ac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb9114a4-9523-407d-b53b-191609dd919f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ae9666c-a0dc-4eca-b729-580385b6ac47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/672fdaa3-fdc4-422c-83f3-f7defd061773 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6aaed22d-f54b-4d82-a135-5e6ecb7241a7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/484af344-e652-4de3-8093-18dc76f76d1b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f000220-80da-4d2f-b6b3-ce48718627c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa277490-fb43-4844-be20-ff12b8a0aec6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9687370-d9e0-4dbc-bc08-e76b3597f236 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3217262-bd6e-4ab3-ab8f-e506e23f3d94 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fadd0e8c-6b3f-439c-af9e-02cf61bf5325 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/58eb9aa7-45ba-42ec-9be9-a5b49d2da3d6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2c0d0474-571d-4532-89b3-fae4359708b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81007f69-d432-4706-a4e6-8534a5a8808b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd6ca341-f95f-46a6-80d5-aef01df72a84 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/89ec3968-c9cf-4c49-9422-4fdb4b75bdbd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/68538662-f764-4423-b7f4-21fb9a6f6e9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7bc9b3a-508a-49ec-8746-9438fbe68c83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d670925-8fce-41f7-901f-40b6b2686eaa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/97811f86-c2c8-4e11-84c7-0c54242c852a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0dc203d2-1116-4e58-8eeb-8357a23f0807 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f495c242-2d2a-4883-89b2-ca31f296e9f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8b35ee7-c893-4d7b-849c-6340317df8c3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1441d43-391a-44d8-bc63-40d847d6e54d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63ed7f3e-ee07-4e7b-b268-42eee3178c8e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/98cc8cff-1e1e-4108-abc0-1dd7fd7c41b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7b7aac0-bf1d-4ab5-9495-55ddb6124b44 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1cb36b85-2ea2-4dd6-8d0e-78f50972f96a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec7828af-00d3-4f31-b546-89f73d6eb876 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82ca496c-927a-4f82-8559-3fad3bda8727 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f5bbd3b-3c13-4bee-90ac-8ab18f069dff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c1eb458-7a8c-4396-8568-4b459ca58005 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/76fd6c6e-fe3d-4850-9893-dbf5738f5edc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f15d753-576f-43e5-9493-a8e5997b20e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0990fcf6-7eae-46ab-9eaf-49c5996f0c63 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/13a326c9-c42a-4445-986b-aa091eb9fe83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5b015f95-e2ae-4648-bca5-a59dc84a9f7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4e17f9f-1a5e-46e6-ae98-6d4fb0fcd208 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b59efd25-6658-4213-acb7-57ea36fffeb5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86e3737d-6ffa-4316-a749-3826f2cd01a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9a0eac67-1956-4ce2-b80e-f70779dbdc61 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5e5b318-f533-4c03-a350-6a2c9cb91487 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b821e18-5cbe-43da-a947-2bcaf430e5ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/26f06248-6093-4e08-b97c-44b34f00be22 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f3ebfaf-7b9e-4fbc-8d45-4750065786de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ee59ef4-0a5f-477b-b6dd-0f0ec9def734 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/daff62fc-7d91-49fc-be2c-157a278bfe28 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3174c123-d6ec-4548-8a74-a781dc9b5b5f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1500557-a6fe-4dee-a33b-403c5f07362f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/91cd0aea-747b-485f-a8d8-0e772985f779 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc0d6d69-b255-4d1b-837f-56f7980a3598 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae9ec062-816d-4875-a554-d64e1ec65aaf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/679b2e84-1b63-40a3-80d4-850240b04093 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1cbe342d-d442-4aae-9e00-2e91864dc49d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93737daf-6995-40f6-bdbb-f323e84cce52 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f909dd84-ff33-4192-b789-4c742253ce54 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bb35a2a7-8702-421c-a931-f594f47432df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fb579bb-93b6-4d73-9e3d-68c7f21dd0aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d1df9499-938b-4d63-a295-c0b42a222091 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/64e6ea36-71a7-4592-a4ba-1b98684c8894 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/65e0bbcf-bd47-4c21-ab63-a113f3728867 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc6cdd9c-e353-4f44-8fe1-a103e1b4a13e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0997e587-b52c-4262-9927-d20a2c3ecd1d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/34995ab6-f4de-4ddf-8fd0-2576b8864f76 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba6a8d99-12cd-4d27-89c0-1b1fc2e9be77 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6dc045fd-f60a-4503-851b-6b0216038fc9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f61800c-0145-42e3-a2d0-3be776b53f9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/810a49bb-497a-4dd0-9d38-aa5d583e0555 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/34a0f4b0-dfab-41e2-a67e-346e51f13c53 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e53ef29c-c93e-45c4-96e6-3f03b211bfbc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb61f5fa-2169-4122-8a86-fb57dd755c55 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c5d2998-96b2-4e85-b1f1-7ba021c3f978 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a706957b-a993-4169-8c3d-9ee6043063c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b212c3b6-ed2f-426c-8e75-b6b440d24ed3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09722019-c5c2-4d30-aca5-d97bdf02234b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da7383b5-d505-4aba-9c7a-15ace5d688fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b0d322c7-5cfd-42c9-8bbf-06884754c888 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dcdefcee-1631-4791-9c20-c8bf239425f7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/534c5e6f-2e37-43f6-987c-a16c830c9680 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d08af269-37f0-4d65-a5ba-62a9f971a0a5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c22f483-cbd4-486b-bc9d-4ee765477bb2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8aecf182-a4ca-41d1-8319-3446b5c2ab7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/66fe9478-a7ad-4970-9d96-5b6e0610b8e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b1221a1-9c2e-490d-8c69-5fb4a0de0abf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5df9b02b-575e-4d82-a469-c4d9a86061b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b160c38-533c-4c73-a694-b2b42c40f97e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c6e02032-06f0-4d83-9464-d191dee5c562 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ffdce1d-b478-41e8-a7e3-6f5482753f65 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75ae30de-5b9f-4575-bc13-385dad9683f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a42d11a-d844-47aa-9360-59305f5051fc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0fddbb7c-3103-410d-ba6d-896144b70012 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d03e7d03-7832-4b96-a1ad-cad2f3ce19fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f14e1a8-016f-4e20-8763-cfd0fbda21cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5a435ea-4a09-4d2a-a295-5c71356dfae3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/37c75d36-7b2f-44eb-80be-1ec7eb1aa0de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7775f021-0628-47e7-8aed-cad349b20259 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/532eb6b8-6175-4569-8f03-c059eae06f66 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f15672b3-9919-4519-9409-77437ae44fdc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0de10238-6311-4934-8760-78d36db50323 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5c9803a-765b-40a3-928c-666f283e1815 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/35a237ec-8450-4e15-bb27-19770937778d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4111c71a-1be3-4fed-bdae-d9c0afdc1663 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a0ab15a1-0710-44e9-b326-00fe1f51288e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/908466fc-0294-4563-bdbf-42b00ecdf203 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e94eb0e6-871a-4bfb-8880-14676c167e14 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bb8e21b4-8de1-4133-af99-a95874e87ae3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d1bc007-d091-4d52-80e1-6a2fc5662745 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c4e3897-ce1e-4703-9c44-b0f725fd628e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e787659c-53c4-4380-90fd-ed18d662a789 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53c4ddda-6f0b-4e21-b397-c36125b0b45a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f91f2b6-387d-4e04-90bd-a07a4843e77f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2c8e818-5b9f-4981-a529-2c215749f7c3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8113f219-6384-4e43-a291-f5d195bca1c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/653c8d4f-c3fb-46e6-b03b-73139d454e23 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/73cd4e28-fb29-4ec1-8a79-dd017a6d3ca8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ccb53b6-8342-44d3-b329-5140b2edea76 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fb459e7c-d321-4897-a6d0-f90c9ee48439 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/32fc7d86-5099-448a-b3bb-7c9e9079acf3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3ba3ece-388b-4e4d-965e-55b442d2f561 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3bbcc74e-bb38-498f-b584-35718dc7c503 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/85b54695-d931-4c98-a83d-4ea6c2b1b8cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/79ebdafe-347f-44b0-9241-14b48dadc7d4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b817c4d4-e9cc-4af8-9503-0f34673572a6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/21d75d57-97d4-4ad0-81df-c97bd3af7ccb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/adecebf3-423e-479c-ba4c-0bc5718a77c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee4d57ed-99db-4e4e-be48-c63feea1ccd9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/216ce3af-d572-4872-b37d-450782efa5da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82a0fbe4-5f40-4cf5-8456-39ab82b187f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/64bc22a5-9371-451b-827b-46a2aafd6a37 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4041676-b6fc-46df-ac5e-c6813220b793 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2c4b9f10-90bd-4e1d-bfd4-83d2fad51322 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6473029a-b5c1-431f-be50-1c9d8e9f9793 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a3c5c7d-20b6-45ba-8986-35788ede02c8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc55685d-3a9a-4796-a020-cc198be66419 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f274c411-9163-4228-a89c-e78eafed2a41 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9081a64-495e-461e-af9f-fb4ec5659d92 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/db0c1b88-3bb0-48ab-9620-14c9c36bed99 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1e37ff22-4ac8-4206-b947-2d6d1425f125 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a7adc13-85fd-481d-b948-d6758423b1fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea8f757a-0a36-4496-8fd0-aca0f08055f6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d7e7aeb-25b9-4cb1-9786-3e15227cac87 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7eda19fc-aced-407b-bd28-a4bddf4e4da8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c733bc45-3010-41f6-b081-d72f6f9d780c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3477a8ea-e243-40db-92bd-960a3d68f458 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd226df8-50c8-4643-ac66-372b67701701 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4268736-be0c-4375-9794-83517c553657 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/88f868ee-53a9-430f-9e24-2797ecd0ec97 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/181c42ef-8c31-47d3-804f-055e8bfdea71 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f1917ae-ebc1-4d10-8cfa-ffcf30c1d39e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e2740f6-52bf-414e-9066-846d3558b2d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e0d4978-51ab-456c-8a66-eb0784f1fb03 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3a50dc0-4309-4b7a-b5b2-34ee6a5bca17 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/be4b2d37-3578-4c15-a82a-e04f0a50588b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf3c3ccc-0438-478d-8101-ab09431ec671 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6eed132a-953a-416c-adff-6cb7397a4ed6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4ff5519-4a1c-43a9-96b5-a7bf3144b24c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/25a6563b-66e1-48d4-9b4f-47dd650ad530 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ca1c4f59-c1a6-47e9-91e5-64245a84e9e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ab2a4b7-a85c-4281-871b-72621b9dddc5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/575b1da2-61c6-4655-ada0-58a7f9abe7da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e406ed3-b726-4dfb-83b0-d508db35f2b0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d70cb7e-1c4d-450f-acd0-0d5947dfea34 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c155c4d4-a686-45ae-a35a-9ab79eba09e0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5008bdcc-a3fe-4dc8-ad35-0e23125c7c5d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2c741402-eb48-4c2a-951d-bba95c572c01 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/43c8587e-0444-434d-825b-5334b74c8d89 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5947ed0e-0a15-458b-86d4-b495438436df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd1f5a20-6dd0-438d-914f-3c4ddd30f5c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a2ce596-6eec-408c-bb1d-d46fd827974e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99518e45-d6e2-40e2-9c23-d8ffc5008458 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5b8ce3d-655d-447f-8fc0-86b958cf6110 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/806b906d-162b-4159-a1c4-21db0c2b19ee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0547902f-506f-459b-a254-bef70146904d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/01a6194b-7fc2-4405-a852-2dce7d7cf0b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c3860dc-6101-4af6-8de9-b66d76fc449d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4398f6d0-4bd7-4247-a691-d36158816a37 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d70e84dd-fbe6-454d-b51e-6e5c2099b336 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a6b9ea1-dc0a-44c8-8a5e-88070435f6fa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9094d95-6ab6-43ad-a271-7c0a751ba74d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8cd95d38-d620-42c8-8789-5980011cf836 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27bc48c7-a938-4432-b68b-12b8ff5c8446 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da56fda6-f952-4789-8699-e6809cf9aa41 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/42617dd7-0f1b-423d-8a1a-3b28243930e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a346b8cb-9bca-4bc0-8f02-f9f481f71576 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/537bbdf2-5ed6-4feb-a9f8-788acc5a6be6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b7eed35b-e460-47a9-bf74-dfffa0656c03 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a290804-3635-49c6-986d-d493b1e2bd10 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/978c9ede-7fa5-41f6-b227-a584d7ea1f2f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/32450444-157e-4e1d-8d27-ffc4b517d447 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b5981df-d253-4ee6-ac13-8a89591a1307 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/98c19f3f-acf7-418b-826a-ce43f20dd8be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4afaa428-9c5e-44f3-8fe2-a6bd295cfaa3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/337a5817-3175-42db-8141-efb4036bedea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e8de24a8-0f5d-404a-890a-e29207b16f8b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3e1ac61c-df73-4a59-b7a3-283572e403cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/69fe6f9f-5c0a-4f19-8f6c-9f41b6b66fbe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/70765ddb-4da6-4828-a78f-f73db23eeed8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/959cd493-6755-47be-a1cd-e51a8ed22b7b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e87e9eb9-199d-41c7-ae9d-f276589ba33d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8378a53f-9933-44eb-8351-f4d15f5374c7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a6ec331-df60-4435-91c2-0ce824499965 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b47f3963-8509-4f73-b3a2-8549542649b1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae1b5c3f-a7a3-4c32-a074-413b78d673c3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2cca92d-6b29-40ab-875b-11b61f2326ff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/238e8046-b1e9-4024-bd74-0cde098d7e01 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e19c8f26-2034-4950-849c-6bf210c3afb1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f8a96de-b2fc-4550-92dd-4b8039b2db04 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/72d3b122-f354-4e5b-9c3f-4acac7847050 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d2c8f68-217a-42f4-9c36-1a7790ef304f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/22fcc1c6-3106-46c0-8dda-d8efea220875 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a83247a9-1974-48cf-96a9-95638a37a5cd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef3f52a4-14db-4b1a-a4f5-20596b30b81a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/18935d03-922a-4e35-a047-1c1a1cb69cc1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5c837ca-3e92-4e6b-86cd-32d64a91a679 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c091091f-c04d-4769-8523-34d786f4e65a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6cbda4fe-e084-4165-b297-2bbfd90d207b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0034b408-5a95-496a-8d7e-2f1c7c9eebde 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/298f72bc-6d52-4227-b753-1377766abe31 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/450ce18a-661c-425e-9b91-3272255ed991 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b962af9-ff52-468c-be6f-72e095d4f50d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f24cd8b0-9322-473c-a55c-5f96cb7408ad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b55f62d3-17c7-4127-915e-33d694f32bd7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0a80d27-7361-4b3a-866d-34ae978b1a81 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b9561e2-2add-4148-840e-191e8f785c7e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5bb3bc9-0a29-45be-a380-4d2f89b9c8cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/620466a4-853c-4f78-96c3-dc2f4be1e600 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/77d7503e-3ff6-457f-be14-1ab1ced4abe7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da132aff-c72e-4f1b-9b10-8b63259d069a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81b861b1-abeb-4ca7-a7cd-ec54ad08bd0c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c8fc06f-280e-49bd-91a2-765890ed6a35 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/65fd6d2f-f7cb-4ef3-8fee-d0fd547a56ff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9571731c-69c5-4400-af65-6b3aace2a0be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e1306e9-b9ea-4de7-9f9b-e5264c98a726 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c6da078c-301b-41d2-ac32-42772a4beac5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f22950e6-baae-4c58-941f-a428b999c2e0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d5077cc-307c-464f-a090-58e1b6204630 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e28dedb-67dc-457d-afaa-2b82aa09be45 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/286f5d98-845b-449f-a58e-50bbd9f5aa26 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8ee772f-1961-441f-b89d-a60e4802721f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac8a4fdb-df99-424c-8795-b0212182acfd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7ae5f69-6c40-49c4-975d-90db85ee8367 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c333a1d8-6703-4fa4-a223-9d0a63f57f79 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d0ba4b8-d100-4094-97f7-6a951ce6c756 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e229a3a-ccb8-4682-ae23-51164ec72d11 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9856f5e6-79e5-4961-a416-2bfe5561bf45 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8bf763a-c5d8-4a40-b9f6-0f2f9ebeaf6b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f86d428-a7fb-42ae-acc7-2646773ea3da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aab6379b-1ab8-4c05-a7e0-7958a3cbf53c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1a79a8d-fe98-4cd1-bffe-9ba4a43f78df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7967fd0a-f174-4b88-9496-753eeace5ca1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2c258ebe-ee5d-49e1-a360-39e94b673be6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3f9f340-8d97-4901-a56d-eec27ceb6cdb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/472356e8-bc7d-4f96-b21a-127279cbaef5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8712e980-383e-4395-b960-1e600857b481 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d8e3909-3c71-4af3-beef-8cc9e13f3134 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3fcaf832-727a-4fa9-bd0b-6ea2258265d2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f6df840e-91cc-4641-bdf2-790481f645de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a88bacc-e231-4c4f-8b36-47ac64844aac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c17a035e-1295-47e4-bcc0-7ef308a53922 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/080262ed-1038-41f5-9e61-6c4649c7a59a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e8931bf-d040-4589-a3e7-98a8c7a0dbe2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a479c087-f38e-4deb-ab48-88774e2b4721 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/338e650c-9f67-4897-b052-2939d6bcb242 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8129490a-06ae-4875-925a-e957203cab07 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/058df77f-6d56-4bf5-ae72-d4c14a210f53 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7f04562-230b-4146-972a-ddedd6c47b21 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/15487cb5-d43e-4670-8d23-0498a342b56a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c12ffdb9-d103-450d-94b1-a88beeb37aed 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/85ddcacd-a463-4432-812a-41636bb14bde 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/949d8c7c-49bd-4d46-8c15-ab07af1131ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7bc93085-875d-4109-a633-7d13334be01c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9c10a17-3a05-460b-95ef-1463413f28c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f4e2e0a-6583-4a7f-b1d3-8ff8048faaff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d2136dc-63b7-4121-b80e-44c2f40f705d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1b50de6-bd34-4b87-b1ec-0636580c9baa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d987de7-a934-48c6-b327-d15556029949 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ded6eb11-fd04-4537-8d17-aeb93ffb5100 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9faab3c-40da-4d96-8f1a-97024e9f9728 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/993e9dd9-aa51-4330-af0b-fd3465d53fe4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/627b46c2-61d3-439a-8d83-0312df36e2f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c41cfc5-3b21-4be4-97f0-890993a28526 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27efc6d0-010b-402f-833a-bcffd2b047a5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c5c64dc6-d405-4244-8c55-b121eb529587 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cedeb741-2638-4e7c-b8a2-b0d3b10925be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/399103d5-2f20-4def-bb4e-0037094b321b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b4c381e-85b8-4c38-9100-be86367bd6e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7afc0bd5-e337-4679-abab-ceceec0a1cc2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0854a043-9d80-4587-84e7-ea88f7fd6635 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4fab76a-f943-4556-84c4-30ed1ac12caf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1a4945e-7781-49a4-8032-2a562731fa52 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae99fd3c-3b6e-4fa2-b621-ad6a987adb95 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/20d3ff5e-28e2-4c8b-9ff1-646b2d1307a6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa6f2340-dec4-49ae-86cb-66846af62fe5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/61b27ba4-e351-4244-94b9-6afb48a22264 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d3bbe33-4d5f-4190-b0ed-e2f1fb870f45 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/62513640-32c8-4d66-8939-bd6225793941 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8557d8e-3224-448d-9c9f-a6b4ab04d2d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8863e8e1-8c8a-46bc-9908-5644103beea9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/497a30d8-e9cc-4a61-b8c5-a63bed6b886f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0222ee3-202f-4382-bc1b-8931c73559ff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d278960-0d1a-48ad-86d4-353f69dfd002 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/529eb7fd-c1d1-4402-b6e6-abf860eb06a3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe7c2ac7-21fc-48b5-908b-0482612a0f39 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4bd96972-7d13-4591-8a55-a03f17f1e530 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/48b96b91-8c63-47c9-b3c3-ebbafc7cc133 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93b8ebc1-7d6d-4ab4-8996-b471f0631c82 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b24b25a0-2aa6-4941-accb-561a711f0759 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6e62b608-23e1-40e8-95a6-3d212b5dafb4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da0a72b0-6fef-447b-925a-97932f5031e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d5029b6-1ff8-4e8a-b2b8-6f33ab2fb298 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b6f8468-ba96-442d-8108-1a77f304be71 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1471f645-09b7-4a3d-93c5-330b7131caeb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f6d77baa-29a4-44d0-abb0-2d765bd8d06e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/195e0a2e-72ee-47db-9989-73ad0bdda2e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/be41dc61-a9f7-4940-85aa-c41a4db67648 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7533a3ca-8f11-4129-8a8d-07594e7e35cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e331de5e-f3ee-4220-9722-f5d41405f2a3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/54f9ef67-67d8-4d35-b23d-8d325c3a56c3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/46149568-79be-4332-8dc1-b3dc32470a95 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5de60774-3698-4242-b395-c8eb75847452 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/24a45bdc-09ce-4eb6-8a63-cedc599ba652 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b46881b-071c-4696-a3d7-45144fcd4bfc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cbdd5f24-f2f0-4166-8c30-b2ea9e0d559a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/151279e8-9c7c-4796-8393-3c8d1a6e60fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c7f45e27-f212-4d41-8579-b80cb68a63fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5fa99a3-8414-4c9c-88d8-4ac35d335e0a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8166d33d-bb3c-4386-b8f3-a33f082aa58c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63ee5da1-fb9c-4716-881d-682d20657c7a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a709a1d8-5a69-40ba-8f6f-eadd2d7a51df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7def38a6-3584-45f4-b0ea-d41dacbe72df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b430a96e-4525-4365-a3e3-147716e5a6f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09ceb06a-6b98-4ff6-ae67-44c64d08f49d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59c7462e-d572-4562-9f52-ddfb8a48d829 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b52c709-2067-484c-8af4-93bfd189d015 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1aaa7906-de70-4c20-b728-0d36035019cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5395d23-2193-49fb-a5ee-21e83800c27a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e138164-7f86-4c34-8f2d-c512a9e91645 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4494e228-edc8-427c-ab6f-eb2520a55a68 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1eb8333b-d8d7-4bac-9626-08f22bfa615d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67170812-da0d-45d0-b1a5-99f0d2f81393 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/256346d7-b002-4b28-888e-74426615f864 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e301c438-a767-46b1-b3b1-f065804ea23f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c2343aa-254e-4dac-b1a0-9df74d986795 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/194e5185-1518-49c1-bd93-644573291a3d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63d44c7a-b3df-4449-ba92-11da5d1634d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a2f733c0-17cf-410c-b0df-3b704eede16c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/001003e3-4859-4f13-bac3-73e0beb62f0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1287e9aa-a54a-4c9b-87a5-ad982b9952d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef9fb8e7-c16f-4298-9841-12a3d1ac4483 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56e9f5fa-1e61-4c3b-9d8b-e36fdd100d20 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/366af9cf-841f-47e8-b9d8-cbab728e2414 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b100cb1a-f7cc-4e93-808d-c57e7f97bcd8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e62bd81a-0232-4ab2-b775-f91afe8a155d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a45d1fab-f397-4626-b8c9-07bcca5aacb0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/05023c4c-7aad-4851-b6e5-33718fa44db1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cca70c47-6907-4acc-82b6-769bf9294007 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/706771aa-ec81-4215-8012-68b28140959c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/17fe11ac-b28e-442e-a4aa-9d9f89121334 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4983907a-88f5-442d-9801-35dd22467601 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e297e23f-c2c0-49b3-b687-bfdd69ef98e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/690e57c4-60a6-47d2-8422-25c043c5081a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08f2945a-e285-4673-882f-f5e10b2ab290 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5d5b944-f258-4a70-8869-3f2ab646663b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/094409da-de70-4b76-9f42-40d457ecbbb2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9f37b3c-b566-4737-897e-ca03206cb77a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2516698-3be2-46b9-931f-5bde3b7c8541 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/00ba570b-a03a-4d9e-90fd-12e0baab1e85 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f81614e3-a6e4-459c-a009-3160bebb5a04 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/05f2a034-5513-4514-aa5f-9ca245c2ea14 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/01168456-0b26-4535-b03b-2725b9935f67 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f17040d-4456-493b-bba0-ffc64c20e8ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09dd6a37-a4ce-4a3f-bb32-f5b89250883b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3ff2847-421e-4f4d-91e3-4c42ca7fdbb1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/496d4224-ef8d-45fe-9926-2024bd5da80a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/de3e4853-86e8-4918-9180-cce361ba91c0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ef3beb1-188c-4081-a130-06b7110b8491 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fb844f2c-607e-4358-a7d6-e7d15fc0cc0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e898090-e5bc-4f4e-8456-2f5844d58c6e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/327e21bc-cac8-4a7d-bbbc-b2986fa9ec6e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c62473c-ba24-4ebe-9e54-0465bc301058 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffac042a-a52d-4f0d-90c6-df426e6005f1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2be22992-d90a-45e6-b989-fe99c5925833 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/267e168d-30fd-48f0-8201-856bd867135d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef687271-5f47-4c87-a721-82be5c276360 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/561f2e31-ae09-45d1-9782-61248b8998c7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9cadb13-81b6-41b3-94fd-208ed2fcb362 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9aa4086f-f764-400e-91c9-b0d351e19b68 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/37abb2c0-b6b3-421d-84d5-93d21f17a63a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fcd5100b-c41e-4974-9c5c-3dba9b88fe9f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d92b6d2-2107-45f3-b198-250163168059 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e26bbe89-e0af-402a-a06d-410fc2c9c68f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/60c9c04d-a3b2-410c-96d0-77909a635f80 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/273b80df-018c-4898-b17f-fc30ebb43c4e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef9c4efa-1c53-4496-85e7-3e0092a5e4d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da04149f-a2fa-436d-adc2-e460603fbd46 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ec2183b-7185-4e84-a612-428fef5eec66 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/915e5078-1085-4364-a3cb-e461e484be11 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cbcaa212-46cf-4bff-aaf7-b1f350c930ac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c556825e-1b12-404d-aa85-ade22fd865d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/97dd6237-690f-4a12-8e35-95a2bbc45e53 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b4c6706-e791-4b9f-8b1e-4a60f365b42c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/803ec85c-458b-480a-9cb9-2f57ee8e89ad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e34a4d8-78be-4a66-82e7-5b07e26a5105 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bea76dd9-7100-4fe9-a201-8b37befe381d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4a0d86e-be42-4047-bb5a-5496142309bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/402dd1e9-2524-4fc2-a55a-929093815798 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eec46444-8012-45a2-8b4a-f394ee839c8d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3314f39e-40f5-4f74-8c22-e8d7d36b777d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f28c3561-8289-4f5d-9c6f-052e66359937 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2f3f92f-eac0-4784-b768-54cb0df733e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94aeea45-a4c3-413e-8543-3e36699a656a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81d5b272-f993-4981-ba6f-38138cf1d017 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/29b05251-a980-404a-8831-3062bf82158d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7dfbe66f-0c4c-4428-ae45-b23e35492f5f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/52e656d7-b46b-454c-ad17-33338a511feb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27191ebd-b338-41fb-97c2-89c4f7f0ab56 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7052608f-f43d-4a1c-acaa-d9a22ef7615d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/84bace64-778a-4145-85da-17cb9e20555c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/113e6a2c-8079-4188-b52f-29cf8113ea57 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94738bae-9fb3-4fde-88b7-baf2cec00f8e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba41d573-b687-471d-a259-2e8b8954df25 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4178d11-aa73-4098-804f-23f6517719b4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/43871040-6c7b-4cf5-861e-6aec1c4fbe33 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/177956f3-69ae-43d2-af20-d7801eec7e12 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f43e89c-0db1-4fae-b9c7-06717d4d7573 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1a7501e-8119-48b6-b5d0-34c2b3340958 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/151e9f62-8ad1-4aa7-b857-c0af1f715bc8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b8534c98-7bb8-4197-8ee6-959b0f776eae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/95e7dda9-50e0-4e8c-8cff-5151de754447 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c044038-41b7-4384-8808-a337315a63bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bbcebfe2-4659-4a54-bc19-873d550813d2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f397331e-4b10-4b6e-9dfa-e2cc154b7055 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b58e52cd-9b6f-4999-9e8a-7b3f3869e90b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ee0f79c-74fe-4d5e-b711-95beef954e93 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3e5fd543-342f-4a38-8462-770f041b3dea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c666990-51d4-46d1-973a-575293f9253b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/165ff0a8-abca-40f4-b3e3-e6e6aa03e734 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3d8176a-d614-4005-a1d4-d4613022e6ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/69c3051a-f53d-4b6c-8944-5af687dfaae4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/44ed218d-ae42-4182-aa72-4e2e57a19440 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87026e53-a21f-4a43-8e06-981ee0c5e8f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4b3462d-9fe9-4e54-beaf-2dba84d7fcd0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff97958e-4c2f-4678-905b-e429a78b4f2a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c381dd0f-5db6-4d6d-b09e-082a0b6030bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b198e76f-8040-432d-8700-a15cecf99f49 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/879757f6-8ead-452a-8047-69f421a100da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/622d883d-74b1-4d23-978a-5fe125a70526 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/40c19ba7-fbbd-4c40-a2f8-cc78fe8a171e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a507085f-2f40-4cea-bc0e-4f868cfe27bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5dccc539-5057-4709-8b78-9920bfb1e612 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08a5d3ce-ca75-44a9-86f1-4198205379d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec0b41fa-2d3e-4271-980b-1a41a18af838 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1ed8d0c-b4c5-428c-9982-3e11cbab734d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4dbb0871-5ab5-4022-9456-30771ab013f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/60f8a932-323e-4403-8e56-f68abeb918fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a64f2e60-c747-4dac-b51e-ec7dd8e6a72c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36ffcb21-79fb-4f85-b3d2-ed8a8e4dce43 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd748c69-f319-45ba-b92d-79f9a96b8be8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2faf7207-4b8e-4251-ad9f-020ab649f8db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2905465a-9ce3-4b76-885d-d77c847532e0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b827784c-fd8f-4e30-ac30-26fde2fb929a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a07c0dad-993f-4aaa-8b91-9f950c08079b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63b89769-3f93-4c78-9c31-6cc7d3af279e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c01984ab-36d1-4090-9ad5-1c631989c9d4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03caf7f1-1dd9-431c-bdb2-a7e4d806c419 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/46cb3489-12e2-452b-a61f-afcfe37c2a35 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9fa4cca0-80da-4044-8db5-48eb9c6c73c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/930f42f4-8053-4eeb-b491-5fe7d922b68c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c53663b-7499-4988-abfc-792754b3f4ed 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cf3ffa3-171d-4e90-9ace-187fdac170af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ef693fa-c932-4370-a307-4fef7183bdbe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/65f317a0-e7a6-45f5-8fbc-578bf2d18f6d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b3d6e2a-f8e5-4a30-91fd-0567aa93f32d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5ec04e1-d0bb-4015-8fa6-e53c60ac9543 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71848486-d9e8-4fdb-84ff-e8077d2aefbb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da368a6d-01b2-4137-ae7c-66156982b081 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1469eb7c-96a6-49c1-80ed-8c429aafe091 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3dee9a32-a54d-47e5-b7ff-d43ad79dd0cd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/374beba5-03e0-4956-9b17-8279b0650ca9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8c609d7-a85a-43eb-8701-2640b2471227 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a1a7eaf-874d-45f2-99a2-f65893c30c43 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5cf226d6-6f36-4435-9331-3f267c273926 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ee7cb20-57ca-4693-9c7c-fb828a87428c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/527b3c38-b512-4449-aada-6d47510ed955 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/101abe0d-13fc-4f54-a1eb-de187db47b9e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1e222dc9-21a5-475e-8f90-99ed8133d294 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f654afd0-1f18-4424-baa6-064823be5be8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba825aa0-0d82-48ac-ac6e-14cde7251c02 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27c8d6d0-c716-46d1-93a0-a6b8fdc94504 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/66698014-0e28-4529-bfcd-85110cd8489b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c9266e5-9b93-4de2-ad21-7068f86d5bde 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5b0715c8-ea52-4780-8129-e9096a9869b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08c83094-45fa-4b4b-9194-8ae459bd44bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/862130db-7af2-4426-a081-5efbde203da3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9522b121-481b-4182-b99c-40ecdeae1942 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cee2d052-c0af-4d5c-9499-cb3c982549a2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1bff4647-9bab-4434-9067-4603c3e0deb0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c71f6a4a-230c-4bbe-a22b-151bf4e11499 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82cfda5b-c998-4f06-ba23-7e335b1f6fc0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/563c05eb-0734-419f-ba88-fdec3f968bda 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/19115230-368c-4f87-8d50-c5a7efa80ef3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/17d5e162-e320-4b35-82dd-6336cce1c883 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6bc4848d-50d0-4b97-8555-3201c1aea0e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2858112a-8c0b-4f33-8b8f-442c91db0993 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c07183e9-2445-42b0-a8f3-2ab0da91347a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0514156-5199-4115-9a1c-ca054a6716c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/287df822-4d95-4867-b5ad-7434fc1d1660 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/74ebca91-c020-4135-8363-9557fe031253 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bfb847af-40a9-4950-aadd-fcb3b8a92dd8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86d137a5-1d06-4455-a913-a8b3548282be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ac446b8-1ba4-4aa8-85f6-d0bb63f00f9e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23592944-e5e0-49bd-b2f5-eb4028daaed2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/258e45cb-fa2b-4fcc-9533-3863244d23e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/62c766d1-44fb-43ab-a8cf-276df35ee6cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a27b8945-d19c-4a01-a50b-09f397437288 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce595065-fef2-462e-bd54-b5e231370317 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99ceeefd-b546-4b7b-b6c9-d6dcda8cd8a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cfec606b-cb1d-4f9a-b725-242f6f593fa9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d89ea4b-27a3-480c-8814-d43c9c7f5bf2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36c2df57-2fdd-4898-bd14-1fb1e4f8a6b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ddb40c7-1c00-4c5d-9049-789845a837dd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b8b15700-b616-421c-a0c2-465f0276659f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/83876044-2756-4c15-811f-f95d504d5aa9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e136bec4-363d-4e40-9e2f-ba4619912b92 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f0cc79f-4da8-4d13-a345-f24db5044231 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e37aecb5-10df-44db-83e4-24803b52894a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/536d7ecf-74e5-4561-8303-6137a184f23f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/295ce124-d00b-4b1b-ad45-3786c0cdb5a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2173507b-0d37-4212-8337-1915b2f2b105 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e79b32ff-3944-43f2-a066-32ef05a38fd1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb72e9d5-3924-4eee-bd74-baf30ec04cdc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cbbb9da5-056b-44a8-b7db-46a5433a1744 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c5089ad-6381-47f8-af46-461e70de562e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3048cefd-dab1-4bd3-b942-3e93155cc8dd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5c2ed91-0073-4238-bfdf-00ac433fe6f8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba5d35d2-d7b7-4f48-9b9b-1a5d751122ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/750a5d28-0013-43e4-a5f0-7b232d9747b0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b387317e-72bb-4d2c-87ab-c9a433fc605c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87d7186c-1345-44f2-9575-1ce66313d04c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a655ca6-b79b-4855-8fde-875dc0011088 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/78cdf52d-99d9-48e2-94f8-300fc5828c51 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63f34b63-3064-4040-8896-a866bc1fd706 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a6127977-0d3c-4052-82bb-0d1e01fb9df2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3577d37-058a-4a45-93de-2321be5e174f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eeae3c01-5949-46a1-8dc3-36885671d4d6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cd45116-20c8-4c93-882a-a1885e09928c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d52f94ac-82f6-4d86-aba9-d666ebb5a135 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a99a18c1-1318-4a89-991d-fcc96efb0052 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e8af2070-822a-4408-85e5-3351c58095b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/97ce2407-4e8a-47a5-8bbb-cfbfe51eb188 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3061af7e-ea33-4740-aad5-6acd634e620a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8df71724-f6ed-4874-bbc7-1c1e869576b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f6fd75d6-5472-4a1f-9d95-88278733d562 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c591b7ac-190c-4af9-ba95-8d9d209e65ab 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0f6cb32-5f79-4f12-99d6-da4a4fbdd781 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8963b4f-9fcc-4c00-8ba5-0bf35b2ae54f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d911d51e-1fd7-4923-9b3d-ab8b0f40161e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d619d1fe-400a-48bb-a176-a3f1175207aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/302331fd-59e8-4ea9-939f-62e03df9599d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f69010f-aed3-4b4b-8b5f-27d4512cf118 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/49bea37b-c26a-4c1c-833b-092b85cf34db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f768eff9-be3e-47ac-bc42-2145f04fc5c1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/20293d58-e702-4852-8f39-db18eb2cbde1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7263ff02-11f4-4d20-81f5-df3f45e923d2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae508f8b-8992-412a-b89d-bc42691e2572 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6597cd13-15f6-4e64-bbae-4135a301e0de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc2a8e02-c0c4-4422-a207-56183a94a51d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6da614af-fe8f-4ea4-96f6-7e727c05c043 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8e95005-ef16-4ead-bd2f-2cc22f1e42b4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/172ca609-917a-433d-ada5-0e1acb3b0a4a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c7d12b0-b95f-4eb5-b81e-2054475e8265 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/505b3ff2-905b-41f8-b0d2-55171a21c289 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90c1186f-3453-4f54-8fdc-836756019fa7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/736af226-0de0-4ca5-827a-e166a1beb363 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ac5b7d4-8615-4d0e-a24a-b9dddac99ae6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/54e4301f-df29-4538-968d-58e02018ca57 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94a86973-5e58-4b0e-8cf5-a8b23019f13d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8160e390-cf47-4065-b625-8df7e0ca4b03 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3376eeb2-86c5-4b95-b05f-69172c27a22e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5580f2e-7163-4b63-a493-a9c1daa2208c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a994bdb-fc86-4c3e-8045-343f36ef7689 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d6bf7acc-3d47-4ce0-91a0-217d0fbebe94 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/78ef9879-c4bd-414d-b340-9258a8e525ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9447ab4d-11c6-418c-8930-2d775245962b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d71af69e-7afa-4030-9f51-8764bedf4c6c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d73eda08-d2e6-422a-8480-fa1543fefed9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/189b71b4-09a4-4cef-9568-b9748c12cccc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99fb9326-c068-4f35-b91c-095f5e7fd5b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da54d829-c965-4ed7-b853-f69ea61a6a3c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/07ffd63e-51e0-4d0f-a092-73b9c2349156 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f3f091dd-a34c-4a9c-b8d8-d37ebd24d60e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09568a3f-bf08-4698-90f0-18a0e8024d65 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/40461af0-a2d1-49ec-ba3e-9a54bd6842ea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa277054-ef29-45a2-97c6-26d43d41f2cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ff2e6c0-6d9e-4530-a574-03087cec3cde 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1da3595f-9533-4377-aa64-ee58b870b9e0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/64e2cebf-8a13-4916-9208-eeefda35a4d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d09dae50-d5d4-4b35-ad8f-de468d736ade 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6031d49b-592f-4fe5-9ba1-053b3fa06eef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ebc186d9-abd9-46c7-ae5f-fd11eb7316eb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bd0cec1f-e9a4-4b0f-8c16-8a17684c1af0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59b3d4b2-5b9d-4266-bca5-ddf51cc34035 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/70220119-05ad-49e8-9e33-00a721678881 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b08bc3c-84e6-4f23-bb1c-dfbf28ab6959 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1940739-4934-47a0-bf19-6a7be844c7c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/72978120-a356-40d2-a97c-f6c9f90b2b2c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3eec1e0f-e4cc-4bb7-9e72-f22af3ba98bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c037f8ce-4fc5-4bc6-9461-eb2aeeb7e62c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c79e7684-a040-4e60-b07e-5ce3655cffb8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c640968-cae6-4c3e-ba2d-23e5a1d352af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81d164a4-772d-43c5-9d55-97bafeec2cc2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fef83997-2a5c-4b49-b51e-d0cce9c8b109 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f2c197d-3261-4891-b304-63e8ffa1b6cd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/50c3b186-5b0d-45cd-a338-dbc9a3636949 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d25e20d9-0076-40e3-a289-e0c5fc172978 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4bb82ed-dfc4-4d5e-8d10-f35e240831d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd71ea53-02d5-47d7-bf4c-470b54e90f4e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7437031e-8395-44ec-8ad4-954bb04fb644 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a5e3a44-1a85-436a-91b9-69a37737e568 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f37e17f-f983-40d6-9a5a-ab017699778b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/76202ec2-782b-48e9-9ae5-614147f09133 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ebe4a617-cf91-4e28-96b0-6784767111f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee97a0c0-d570-43f1-a600-3d750f0aa348 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5740473d-349a-4f42-8514-a99c736cacf2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/801102a0-cfcb-4a00-830c-7d347835ecfb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6e491265-2864-46e7-b42e-d655cc18de8f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b56f7be-a1fa-4425-b520-f0b346654d5d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a954d271-c8cc-4e40-b9f7-3afd16b85543 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6364373-f058-44de-9228-304c78dbe136 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a7004a8-5a6e-4f8c-981b-4da2760eeb42 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9a999947-e8da-4c85-9154-db2261e3cbbc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/30b3a31f-d022-4937-8bfc-5356983d05d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8423aff-35f5-4c1b-8053-e6920547b020 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c3263c6-deb1-4b4c-aae6-a6dc302a6a1c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/121c4b83-de77-47b8-9255-5e8c3e8e49f0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/21e67843-2edc-48fc-87fa-f0f8c26ff9c8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d487120-e7f0-43e1-ad23-6e8532077269 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d870a26-7550-43b1-a413-1587234541ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/65cf144a-e694-4266-b904-5df340f93cab 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/89734250-887f-47e7-ab7f-5cedcc545ab1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ee66193-a1d1-4f3d-b9e6-0b4c824a9b39 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d3eecda-af59-403a-aa61-65bbe27bcf7b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c07e3487-9fa0-409b-9c6f-01d27971418a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e73751f-508c-42df-9407-5d0515612449 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d05a4e04-c3a6-4d7b-ab31-28a53c83285f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75f52a86-37d4-491f-9ef5-efbef890e0cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09101347-776e-490a-bd13-baa747f8aded 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9253ece8-4e48-46cc-8135-79b6652ca70a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31725d1d-8fab-4e08-9901-cd6172d4c6d6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce826f6d-640a-47df-9f2c-2f802f1f2e67 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b4f625a-2668-4623-9af2-3a6b47940b41 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/deeaea71-3f34-4cd2-8694-0e7586966cf9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f0c7ee6-f457-4d26-a95d-65a7e1fa8569 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0cd307e3-03f5-4bfc-886a-24eb46534f6f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b6f01dc-79d3-458b-ae99-7142a416d7b1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/28212996-c6b3-41b9-9be2-b7571db8beb8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea2b39b3-a19b-44d5-acc1-debea3a618ed 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b705e2c-d43b-4cde-b17a-5bf96f280e3e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/926c35b1-d97c-4ae0-862e-fb35871693b4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4591408c-84fd-4390-a3f9-6acf7982889c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1006d54b-22ba-4338-bcff-b83c978f989e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/43bde469-90ce-4185-a79e-2aaaca46a7e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/519455e4-3f0e-433e-816e-6dce587c6446 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea12d1a9-7b03-4d43-a948-b9611ca5e116 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f8c282d-eef3-461e-ba53-3ac3113c0144 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/118bf93b-0b36-4e53-8e14-1d5fff829ab7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1367f87b-b0f4-4697-8558-91a7c8edfaeb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/661ef425-4b5d-4983-9142-df2e95ecca30 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa892039-1885-4530-8047-ac3548aa1aea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee58262f-1fa2-4621-bd4c-c1c00728ee60 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5bdebf8d-412d-4db0-82ca-e4425ba9f88e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce38ceb9-0223-4c6b-80da-3576318b25a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ae8fe1c-29f2-4789-b4da-e5cd84d559fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6096fbde-e8e9-4d18-8339-3d9659965dd1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a45cae4-14e6-40aa-8dd3-2c021f8dd491 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99383a22-9a2a-4296-b5ca-b49f5e32dc24 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a731bb9d-4cfa-4c51-b9ea-431fceec0791 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ffb3972-51e2-415d-b771-e39e1e9f8b3d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6d00f9d8-1bcb-49c7-b1c2-09942aa41e57 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e03eb3d6-b76c-4553-90ed-c8a725369d7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2da541bd-0abb-407e-bc5a-68b8264e2b50 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2de1c183-d005-4128-99b6-e8dd77311822 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04b151bb-16d1-4751-98e7-85ebd558ab4e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed11c69c-275c-4b4d-a614-dba0c44c75bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bca4b858-dbf5-47cf-b6b4-ead88aa65b82 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/107213d1-4b6f-4f97-9c5b-3a0b3eca6b70 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5687d448-fd14-46d6-9600-8f713e5d40bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ab3e56b-95a8-4219-9abf-7a46d6837b0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4825e18f-d0f9-4dd7-9e81-c2fb7cb15ddf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/13776c98-f44e-4c50-a656-e8b93b09c99a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5b5687b-7ee6-4970-9dd3-5fc7c4cf26af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a2023ac-7cdb-4d60-ba0f-7f515d23a28e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/69c6e819-e2bd-4fbb-b14e-7e436c23b7fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c0829ba-0c81-41e1-966d-40e9f401f9cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/38c02a8e-19b1-486e-9cd5-d34ac0862bb0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9634887-ff88-4d8e-bcdb-9e7f025c5ad9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ccc3dae4-a359-472d-9294-5ad0c1cf6210 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82f9bcd6-7ccd-410a-8e36-1359cb483686 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a989cbe7-d672-4d1b-8916-00833d48ffb7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/673eb865-6f87-4ba4-a82c-c37db1839f13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/908a96e8-0786-41e1-8b37-8f5631e665d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/307a6e79-52f9-466e-b0ed-f699a96d92d1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c604813-992e-4d5b-9f8f-880291f476a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56fed5a2-453c-42cb-ae71-d25a386479db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d79bdad-a540-4861-bc83-92d1e40fc374 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/708f1f4f-c2a3-4a60-a196-74e14db8cec6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5eaf549-195c-48f4-a24b-1ff212d8314e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f86fab7-4250-454b-ba7e-489dae93ce62 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/25f0b3dc-b7f8-4365-9bd8-5b9b452f7460 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/76f10929-2816-45c6-93c6-990de009d09b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bb81a8e8-7dc9-4b7b-8e3a-88d12a5e7a18 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d62439d8-ed25-4208-9f6d-b1a440cf4884 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd6bb7b4-8f83-4b70-86fc-ef084b39d1f4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9cbc9777-664a-4ce5-980f-6aecb235f589 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bd45cb90-1d4c-4d02-9b18-68b0fba9f9e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e03a977f-71f9-4b16-9f0b-e3f46f0e170c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7778598c-5749-48d0-a725-b769cc2e59a6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9087f1e9-854c-46c6-89cf-3400480a4a17 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5fed11c5-2dff-4440-a59c-823e1ea78a8b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/29a8de20-28d9-4d3d-9fbb-0c1571bf10ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7926851f-a73c-42e5-ab26-1f233e8b7689 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e58199b7-cd5f-460a-987b-888d5e591589 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6522580d-c7e0-4642-a435-9c0371c26865 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b7bbc1fd-34ab-47a9-b034-99db6e198fd7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6cbf7f77-446c-4dc1-b84e-59f87addec26 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/258bc555-a759-4c7a-be94-dfca58e655a0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9e84144b-2d5f-438e-b3da-930fdd8c550e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/144ba6a7-573c-4c8d-8707-01b2b412e97f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/056536b8-7d48-4d4f-af00-f24eb3a0524b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e057190b-ae3d-499d-b651-0f34bb28d141 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c75cf46-fc09-478b-8c18-2942943c6a9c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d82b83c-ded7-4403-9946-d90fa26f84b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1aa59cf-b16e-4acf-af17-189840d1b566 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d663bf54-1373-45de-91fc-0ad0898acec2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ed4e65b-c25a-4cb1-b3be-6868be85709c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f43b23d6-a995-4f65-bf48-9423eadf8108 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3201e7cf-d3a8-4bd8-a415-cd5a9ab2e864 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/739b7c04-3cf4-4bb6-bde6-9fa618d79189 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/20d03822-d80c-458e-aaa9-f512848a0ae4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9dcc0825-6369-407d-a53f-42426d12e434 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/be7b44e9-683b-49db-bc58-6293e6bff14c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7290ac45-76ac-4db9-9311-4f9f06be7582 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c7e3ff2-39c5-49b3-8dfa-757bdcfdf300 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/34244ad5-52eb-4142-9797-fe4020e895bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a873e1fd-b7c7-46fc-b445-ae49bc77c15d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23c208a4-af3e-401f-becf-dd5118efa7e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c35e1a49-df10-46f7-8fc4-e7589d4af26a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/368102f6-023b-4241-b891-a81c5e2a8115 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f1eca8f-ebe4-452b-916e-fecca7aff31e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9238bc05-bfc2-4190-82f6-0c47ae2b59b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ce9c1ee-dfb9-4f32-849c-750ac18fc564 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09d995f4-5ee1-46c5-aef2-38e5b6278257 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ffbab0a-6399-46b6-8e31-1e92374076e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5b0835bb-f6ba-477d-872e-fb5aa926a349 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf1bc6e6-b201-491f-817c-73984b799e11 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/976c77b2-7582-48fb-83cb-73eafefd82cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/78ed5199-0d80-49f2-9fb3-f5c6ce82b5e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/25ed816f-75ea-4357-af07-2539e631a668 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d228359-a7dc-4332-8e4b-b539f44df4e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/44c2c1c8-15b7-44d1-b7b8-1e996f770572 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/60ad579f-1c75-4f7b-90e2-4aed81028574 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87d1a38d-daee-40d3-849e-c12fe9d2caab 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4f1dde7-214b-4d95-8cad-a5e91b60846c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef239123-2db5-49f2-974a-309a5287909d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ab4cf21-3265-48f8-8ba9-cd421e61eaeb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f745bc4-ee60-4127-b7e4-1ffdade48623 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9dd7f8bb-e78c-43d8-af8e-e6988334d15d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0546d338-477b-448f-9f93-498037af90e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8587a01-ad11-42fd-b644-01b92bad23e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/98166820-d8e7-42d3-88bb-0178c8f41267 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/35e71497-33ba-4278-af81-014058cbc5fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/98d4510a-7ec6-40ef-a954-0d5b8aea447b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d101b91f-764d-4a69-9168-a40a2f2c2b05 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/197508e4-1ca8-4e43-a823-dd9aa91d2eba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/841797ba-f54f-4247-b838-79e1249bffa0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8122f0bc-c9fc-4e98-b0e7-969ee69d1e25 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/32c9cea9-7548-48f7-bc23-7c1b08a482b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/74e6ba79-0eba-44ae-ab54-92b7265a6c59 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f04f8de7-4d76-4f60-aaa5-4e99857414ee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c6239ae0-966e-4f32-87a7-4bd45d8b3a57 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8aebf4e2-ce86-4772-8e23-8e50d4643fb2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/55787302-5e65-46f4-ae8d-8a92202d0568 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eab783a9-6601-4735-9668-82e72b2aa82c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4821a01f-e86e-473b-8755-1327006f21cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6188f6b4-6255-4d16-9e97-b15056077ec1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b57b70c0-d8ab-41f9-81a2-722888caea70 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b7da05c6-5397-460a-81e6-610d2f6e14c3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/66deb659-7aae-49e5-b400-9ec0ed31e7b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d396c9e6-e872-4ffd-99bc-d799fdff7634 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba15abfc-1f3f-4925-9652-32ca0a90dc6d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5527fec-3992-406d-b943-15079a64d929 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d2d7bbf-c87f-49bd-9a4b-d4eaa12292ef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee9c68fa-cb66-4778-8810-4cfea98d525b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d25cc1ac-a293-4514-8282-b736435fa758 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d7ab982-dd4c-4700-b392-578c7ab5200e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c49557d-605c-4584-8130-0a1482c44218 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7202de24-328b-4f91-8536-da90cb888812 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/042d22e2-2d58-483a-85ed-a6fe7639f5f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bafe4490-5385-44cc-b3e6-783dd2d20e73 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/17ddfedc-4b1a-4f21-a829-663efe92452d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b3e8abb-3169-4923-be40-637cea1cf634 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d32a4faa-9008-45c8-92f8-2dadef87a689 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ceb93d0f-3d7f-47b4-87e9-e945fc1c8e7b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/661dc08b-afc5-4902-9a8c-d7035537bb9c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c343cfc-4daf-4d01-9d4a-2204f477c28a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3c485f7-6987-49da-ad95-0123be272454 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/de3f11e2-7161-475f-969e-61e2dd98d87e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b35d71d5-9a83-45eb-9afe-119182a2b9bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae1619e5-c105-4b24-b146-4a77ffbe850a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/39afd2df-3978-400a-bb3b-b14135ffd182 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8dc736dd-9799-4ac9-9b38-4daa19dff9d9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a3529fa0-fa57-4c28-8d64-27fb92118e6e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7155b88d-f156-4c10-a39d-aff96bd66da8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/30711ebb-cf0a-4fba-8997-ef319a4366a6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/83077033-4031-43c0-a657-2ffbaaae2e8d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2659f474-204e-4e04-9632-f2a0a8aa15fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa8b76a1-fc91-413d-b9ca-53ca2052e4b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9727f38-b704-4a83-b200-43231b41a909 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/20b13206-1344-40b8-a406-78c411bc31d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4521727-100b-4fc6-8141-ce7619937c90 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/48e3328d-4cf6-4a65-9d4a-52849a672121 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d711fdf3-6354-4a18-a7a7-16e7143799d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a394aa0-d60c-4272-8543-f0800c34c840 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe767ad3-febf-43da-8c19-37f1abe2d1d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a3f987e9-9aa9-42ec-9988-0dc591cdbc26 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/07ff603a-a13f-453b-9e9e-54136cc9f646 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba2016ce-73d4-4a21-82a5-731007a80ab2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/230904a2-5ff5-4353-8aba-e44c5f0045a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ca0b35b3-d1c9-4419-9fb5-50b8ec27d09f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/458b8541-d509-4bae-8f20-b4f2f4c7e549 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2272287-c52c-4dc3-928e-7b2edb455a3d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71a383cf-9a81-4352-9382-772b3aa4fec7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e55953d0-3c87-4889-94f3-9630ee0ea2fa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/16a10492-baa6-4cd6-91b7-2e5de731e077 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8735b370-491c-4810-8725-e549745326fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd082856-b6e7-48a1-b001-3a35aedfbeff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8b14373-41ef-46e5-b892-a1b9b717902d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ddb1e549-6630-4dbc-b5c7-a5576e303bd4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8bfe6b6-2ea7-4010-8c10-9f5161e44e7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fb2b4d3-10db-493d-9001-746f8dc598a3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/02f67bbb-e25b-4759-8b0f-a3d4cf6cecc0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2afa6bb8-f8c4-4694-a18b-699e70d78c84 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8ceb79b-5d53-4a06-9f8b-38e1e3ed3beb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/261d0319-b612-40b0-9bca-298c25f13c74 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2c5295ca-c388-41d1-9eb0-dd4867bfd69d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc670ddb-39c9-4770-aaac-ef6f7a1f5092 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0d8af65-ec16-4f9c-8222-0252604a1638 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6501c68f-ef1b-4823-84db-105b463b0d8a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/32e76cb1-12ed-4ede-aea3-08835de2ea48 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e973777a-bb00-49e3-86c3-fc4a362a0141 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67ccd7ed-f4fb-490c-a54f-21f5bbf4070b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f95267e7-6a5c-4e0d-8301-5c214b1eb3c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/79f3c2c3-4acf-4d89-abc0-a240955fbcc9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5f86e9a-027b-4c81-99af-133d05545da0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d3d8ac2-d755-4376-bd22-f3f4a4dfc92b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93fa0382-bd9e-42b1-bc7f-f44f58b6b55d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/474c7f15-f832-4d65-9e27-213c12566f75 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/016c35d2-4619-4a1d-b322-caab4177cf5b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d6c740b9-03c6-4751-92a5-133a59968a30 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/49e9d679-1352-4038-ba48-678ad73c87f8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab4d1592-55de-4767-92a6-bf9b33847c47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b77c0acc-7097-48a5-a590-3d97f9ec6979 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1d47384-c514-40e0-b952-764a8a9f263e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c5e84c3d-9f2f-47a9-b54b-9bd3b6286a77 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81f8375d-ce88-452d-86ee-a6e2efacd104 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d1204e2-188e-4503-9c33-608e21a63c89 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/df3bf984-8fe0-4dc9-b4d5-4d91c5b9103c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3e63590d-a0d6-4c3e-b234-475258a96881 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b724d452-7406-45ed-a73a-3ca30b57e457 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9e96c2f-2bb5-4687-a37c-8726f80f6f50 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/92334557-4f2a-42e6-9541-98d747fd4b67 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/503830f1-d1f0-400e-9185-01d343a8184c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/543a1d3b-a088-4d0a-9f69-3fd4ae6f2af8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63624ae8-1a40-4e46-9ccc-b4a0666bf15a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d054d374-68d1-429f-af7f-dfcd6df7b8b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90f492fb-08a5-45bb-a038-599c074fded4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a5d793c-7317-4d3f-83e6-a760bfbc349a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/38de3407-7665-460a-91a1-36f03c46bf83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f9b2e9a-2ef2-42bb-87c2-402491a7dd51 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/db01706c-c026-427c-926e-5d37324c783c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef25011b-1dde-4fec-adad-ba6a28c6aedc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a935fb9-6783-4c9e-b20a-a97733d5067a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3275091e-826c-4d6a-a704-05e3b4664893 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/498b478a-d8f7-488e-a49a-4366259dbf86 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cbc698ee-5468-4360-a52a-72d4bfd26e43 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c13ee784-4f12-4683-bc95-752e63156bad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3369057a-0625-49e8-8581-9e01c6a42989 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/913a7051-88eb-482b-bdeb-e5aae884463c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e8ba7ef6-b977-4938-bc69-2aed23a49472 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a7129a2-3e5f-4ea8-945e-29779ba12a40 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82405eb5-2c7e-4912-a5a9-8de66b18a446 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94fd2cad-67e1-407d-9091-3ff4b75c0b0e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8cd45cf4-4962-41be-bb50-4ea695c1abcf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/18b3fea4-af95-4df6-befd-151b76e9220d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9da6e036-315f-4d8d-bfbf-c5c423c53b78 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/820c2036-3cd4-4d2e-b776-3b9c38419e56 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/edadec9e-242c-4671-8e07-d804ef6b7a31 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/24d217a3-edf3-4b90-b9c1-5558e33365be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/51aabd7c-e4cf-4521-b599-ac97f325cd43 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5be5218b-7858-4312-90b6-bd96d664a5b7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e1319cb-556f-4378-a8e8-d1c74ee874ae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/13fd3549-095a-4821-b3f4-4c62705bdabc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1111d6cc-fb76-4714-befd-fb4dfa62873e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/479002ed-a4b1-4c36-b655-57ea71507ea0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6aa1e5ea-a00f-48f9-9559-49fe7a75910b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1fcded13-7c54-4a59-8db9-a9afb2d20b14 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e13785f-c697-4f89-a4a2-b76bf5cc7360 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a2b85387-0dfc-4402-8e95-fd692b312951 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/42f9db4b-fb60-4eab-afba-bdad7ae69bbe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fddf880-91bd-49aa-b9d8-cf9b0798c347 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a6ec8e4-0a48-42b0-b5a8-55600dd5a3d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/348b7092-501b-4a4e-819f-878f4c13f3cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/19e2999c-3523-40d0-af1e-aa554ed463fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1484a372-2867-4827-865c-87b324a7386d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/998312d6-f5a9-4e0c-b391-a305b18029e9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c69907b4-b47e-4809-aad8-8a9ac7e689c8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3951c991-0bd2-4315-a665-dbec759d2ff7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1073e28e-2bcb-4623-9eef-050b14e245c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d370a9b0-e223-461c-a37d-0ccbc240b7c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/91562947-1a84-4180-b3dc-fe169cc0daae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/202f3fd9-853b-4d76-af9e-05d360faa6ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd87350e-cfb3-416e-8986-4c106cd26f00 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/35c1aa0d-6535-459f-9384-a0954deb3fe7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8db815b8-fab6-47ee-ab8f-8dd0ae940bee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3baf162d-68ec-48bb-959a-c04046403e92 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2dd82c9c-99d8-4e79-be68-a2ba69a89b5a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d53ac7a-3689-4e2b-9d82-f036cf28bbd0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/558caec9-650b-4453-a41a-31e6451acb4e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2b231ef-4f05-40c1-b166-2a794ec09527 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c726963-89c9-4ba7-86d0-ad0a96772639 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a7f6a737-a333-4348-8ce2-4899fbdfd0e1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef0cdf4f-894e-48dd-a7be-7b6fef219c90 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f44bef6-ce4d-4b11-a95b-8933668cf035 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f3c9735-7738-4be2-b576-4f62170cc731 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d39a8dc1-29f5-4d45-9a62-335f222f38fa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3e058b2-1864-497e-9738-9880aaafd638 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/472d77b8-f0ca-4b0b-b966-a8605dcc67a2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9dc240e6-5f43-4084-9349-0eb47e1008df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/51974c5d-827f-410b-a9ff-d2112f162003 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d14311c-8646-4866-aaa8-49d4d42260de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4815ec0-90de-4321-b60c-c704dbfa970e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f081fe1f-ae97-4592-b5ad-21d331c1fbef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f19df04-0d9c-40b8-8cb6-f852c872dcc1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/44024a70-3796-4419-8131-b37084298bd4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f804a21-fb05-473b-94e6-21af034a49c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d413266a-d93d-44e4-b705-3062b9390cef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/19ed2778-8d9b-4d7c-8ef7-90b06077c32e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7176466c-a82b-4faf-8142-cba1035e2041 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/776e208e-9a26-4f0c-9325-c25178a29653 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8906511-0389-4ff4-ae02-e7eede02cc13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c868b765-5dc9-4317-b452-9b80fa99624f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/626bd83f-e697-48e2-adbd-e57c3d874656 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9855a0db-08fd-4bcd-8426-bd36607b2aed 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f12f8721-fdc7-4685-ad75-f4e68efe8868 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/381ec08a-0066-483c-ae9c-eeea17df6452 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1977a2ed-eaa9-40c2-9c9d-a5decdce7cba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4621b740-97e9-46a7-80f6-02c84f6efbc0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75c46a37-c3ca-41eb-9887-ca40a173c9e0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d482e6b-0a9a-4da3-bfb7-6592458e6b63 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/199e458c-d4a5-4f41-9281-295bbfe24638 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/80fc4eb1-a4a4-4e2c-b4ec-a8bb668d5753 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/39ea9b96-e7e6-438e-87b9-3af7ad6fc161 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/049cb4a3-cae9-44b6-8000-193ba10035ef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/646221fa-429d-42a7-a8ff-e89dd206cb13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/988b429f-358f-461b-bb95-f9c80381f2f8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d76bdaa7-8037-4e87-8045-435b87652f7e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c299e4db-707a-492f-bfef-36da99b1c17d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ace8539-44a7-44a3-a48e-b81c15f77dee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f39f6e3-7cb0-49d6-a39c-e74b95a1e735 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f28c153-8386-4bab-80af-480e7636a676 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/acbdd50e-e7b5-48cb-9760-0b28ff53531d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b35fe5f0-1574-4aa4-8c4f-8d58a96c5e57 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/672d0d76-2cd7-41d3-8b74-6aaccc932624 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b16b037-a7c5-40a2-8a29-5423b9896a48 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/abafdb53-732e-45bc-a23c-780cd60d0618 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/abd457c4-724c-4726-8ad9-3b2f036c1f5b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e13246d1-1515-42d6-89f6-175a18f41ebf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4d35bbf-769e-48ab-bbbb-41d4bcb14783 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7508c620-fae9-4003-9944-4b1d36113cad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9358cc5-e118-47c6-9570-659b5d4dff5a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a42ebad1-893b-4cd7-928a-ec8a8ffbd27f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/33842f85-5358-49b5-b475-6adcbb172e73 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/740d1fe4-0dc8-45b0-877d-b0aacefd181a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f7e4f36-a047-4532-87e7-2ec2312fdfb6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff80cbc8-8fc7-4617-9c85-5d32fea32579 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a096ba0f-fbbe-4460-91fe-07145cd92a9b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f963318-e0bb-47e9-9c99-5628eca60f30 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/72cda19c-6127-41f8-9645-ddd2b8f6bdba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c0d49852-41ea-4bac-88e3-41a182601b13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee4a4141-e651-4fc1-9f38-2aea6c689c48 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a351796c-30b3-42ff-aae6-d616fb53321f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9d4045d-18d0-4325-a440-71c465cc33b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e251d45b-f612-443b-a62a-d90e6ae7b4e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5275a283-b9d1-4b37-b955-aa46d1c0cea9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e235458-0890-49db-9611-46c9db8a7d01 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4524658-57bd-452f-ac1f-2e72d62c32e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/132371a7-547d-4e9a-97a3-12238bbf7a17 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a772131c-6e18-42ac-bb65-b0b29ecea18e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1087f19c-af5e-4c89-9616-40b39fc2186d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7077f720-41d0-43e5-95c2-5e9b0512ca1b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b7b47be8-201c-497d-84bd-14b7de368804 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/92b32353-ed2b-482f-ac3e-401115f38378 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f46e0362-80a3-4198-9ea4-055382dcc9a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/76665aea-f562-45f1-9870-c6f3128c52a5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8b6fa34e-2dd2-4f3f-9128-1b5a0f0c6190 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/47e51a3a-1f89-40cb-a3e7-76126e791f13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f530be6-5935-434a-b328-9c0b42e9bd61 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dcf46ca8-67ff-430f-9ddd-cc745e675e8b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/552e30dd-080b-4655-8f38-c2d5e659b580 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f455610-1cc7-4ce7-9f7d-c11ec5d1af0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f831223-f499-4955-9e27-6d2f7211d268 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/df8fa847-b8d4-4e2a-9b09-bb2e07629c97 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/69605701-7087-4979-949d-97627a79c4cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7365dcf0-cad5-4e55-b5e2-d0bac3c07cd2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04443a2d-3bc6-4b1a-ba9c-5710a6dde846 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/42ccb09f-a565-4e71-afd4-374a1b0f8d58 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3edaee3d-586d-44c1-ba34-24f4ff965dee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f058123a-e600-4299-b39e-da2b792f2103 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/57b08934-60fa-42d9-9835-8628d5a4096b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5099202c-14d1-42d6-b4f1-5a9984465651 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/baf63c99-3998-4b35-b356-14a36bae8412 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/faed45b9-710a-4fe8-ba3e-15919d165d22 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c62583e-c676-4fe9-b59d-3b07fedfad53 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc0da722-695c-40f7-b443-ef07058f0d55 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fbc3d19c-7efc-4569-be21-02a04e802cbc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b67c3671-1012-42b1-a7c3-6c3cc7f5bfef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3375401-5e0e-4477-ac84-4a811d6be2f7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bb93f190-3fa2-4023-8a4a-fe6c7be3faeb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a41e5d0-233e-4e75-b9c6-7f6b8f6f4e8a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2a97494e-a176-4cd0-becf-7a37c4483169 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e45b82b0-3535-42a9-9784-3604a4361aaf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b6cbd58-8cd5-4143-9c57-951a28341068 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a4108b9-67cd-43d5-b06d-cf0b4dad742b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f064b0b-9ee3-4839-8582-973d567d749e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bd1e243e-377a-4ef9-a8bb-885c83b4137c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4dbf0879-f42d-4241-8cc2-00ef77e5cbe5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/10c76709-0422-499b-9301-c299bfa78e86 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7652d883-8451-44fa-beab-7e53c3498d46 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/47470b6f-7444-46c9-909e-4c9aa08e1072 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/749e03e3-19a4-4fde-9842-969a967b76f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b67375a8-d518-445a-9ae8-7ca7af52fb66 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/43f26881-459d-432e-ad05-5121bd60c8dd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31ba8b42-0e5a-488a-91a9-e68e7c842ab5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2ca97dcf-244f-4a9e-a0a2-5a8e841d4cb7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2da5767b-bdde-454b-b322-af6d53cd71e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e9bc8a2-83c6-4fca-9e93-4112f9dd1e8c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2abad7f7-6924-4b0d-bb12-aba94565c9b0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/26dc9395-1a4e-4a1f-aa10-dbb8d113496e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f1b13b4-ed71-4f08-a10c-51b2aa108593 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c32a969-fe03-476a-ac38-abba94c1c7fc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce751734-35ba-4a90-93a7-a46b690daad3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2cfdc89-b6af-4a2d-9ac2-bb743c08a54b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/936792e3-9efe-46a4-aaeb-c92946ca6b91 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/459701ab-dd8e-41c9-9bdd-9d2324ee8200 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/34e21ec9-2bb3-4763-8610-08b8cb23f969 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59b82a80-007a-4b82-b42a-b8a5b1a94a48 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/40b3cafc-fe9f-47c9-af86-16aee08e1821 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9dd77c1d-1e45-4d9f-9595-6a9d91f57371 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f2367ce-d7d7-48c1-8ebf-643e823f2d56 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d23f2fba-6f98-4232-9d9d-ea8e2dee161b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/857c8fc2-835f-4f9c-9db9-307acfa5b7d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c953c7d-79dc-4c9d-aaf6-4eb8afe797a7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e628b9eb-0fd0-4ea2-85c3-040dbc037a0e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd279724-d477-49e9-9ee5-82b1d2cceac8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/74811905-a17e-4bbc-8c69-b4ecb878968c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6704b4bc-6b56-4906-b621-0e2eab2c54f4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b81e7ff-1050-442d-89f2-4ed466fdeffe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad994ce9-7ce3-43be-adc4-826cd3906f7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/075708eb-7099-4b80-a2fb-fbcef87bb360 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/02e6b0f0-d03c-4bf8-bbd7-ca9859b9cc57 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a26739d-0641-4f32-8a9c-1a902cc17e9d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bfc7abbe-f86f-4ead-b799-0fb7fa4e726c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/de2103e6-42cc-4e49-8fa2-9b8767ce3479 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/500a63bc-b4a5-43fa-bffd-be35139b40e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/55d90bcd-5482-4633-9b75-c27b1e23295b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3af0fea-d32b-45c7-911e-818c50b2bc9b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5b70c692-eb14-416b-99ea-57c7926c8d60 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d3df170-79ec-4f83-a5e7-1160704bcf12 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5bad38fd-656f-4e38-86a4-4bd4e26b55f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f22cf599-74a0-430c-a469-4aa23acc07b4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/89ffdd23-8b0e-4151-88fc-1262d65bebc5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2863a3a-29aa-4f5c-bbc7-20dcc9b8cf87 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/deb31d2c-2fb8-4bd9-90df-ef281b699081 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7b34769-e037-472e-9254-9cc770828ef7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a290c52b-3ca3-4b1a-b7b7-0f789c907f68 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0349979d-afe5-458f-b20f-719abf8a2056 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1be66ba6-cb26-4e42-8d4a-0d0ed6d17272 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/85f5b803-6548-4607-8c53-76605ac67ddd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/85206422-be78-4bf2-b5ac-202d20ea61b7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/797112b5-6517-4fcd-9fb6-ade98ab06d05 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a7a5aabb-9bc7-44f8-b2dd-02911abff7fc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31cac1c3-be6c-4e22-8214-6203099e167e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/621a97b3-0ce6-4d79-a889-b2eccc303ac1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04df928e-2413-40f3-a751-63edac9cd1df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/78e7ae26-124d-4507-bc7e-8fe4682f291b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71fa0e4f-5b76-4728-94be-9fc5c2af2b7e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f20737a7-bf83-4a36-a21a-8e498fe210d4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04eebce4-dfee-42a7-8fa6-8272a3e35e18 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cecf174-ebf0-4aff-8aa1-118493b40d1d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed45af1f-79ac-4553-b2b2-66f2f92cc9b0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f752869d-94a4-436f-a4ac-95f59c5dce03 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e000bc9-ec32-49e5-ab51-cd03afd5337f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b6805c2-c921-4a12-9899-9e3738c64a70 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5cf6091a-8160-42c8-9c62-e2b575d327a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a02ec41d-c6f6-4494-9737-4ecbbd2c338a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/46fed487-bed3-4744-aa6b-c91c00a42e53 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/465a7bee-18e3-492b-8773-ea75f40bf5f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b8ddf111-147d-4fc2-a55f-15ea26d71b84 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3597381a-0f00-4eb2-af1d-4f1fc3d6b06a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5522e5d-dd14-4e9f-ad0f-0bb8a7a279c3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f43a0b9-582d-4c0c-ad6f-130c03692ac5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53b159d0-ad85-4b42-a5e4-57d4ce50645e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/10c4eee2-d9a4-413e-9e86-4d0947c7c4e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/42f06e9f-b347-4209-a5dc-b4afaa42be30 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/210d2cd7-c69a-42ea-bccf-21e5aee4a7d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/400ec443-50e7-4676-ae0d-e2ffdc4f663d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/185e65f5-755e-4d1f-b9cd-5de6eb5d6cd9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5abb71fb-221b-47d1-848d-a91af3b20dc1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/41529767-aeee-4b86-8729-5c3283d5cf1b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd63308d-af29-4fab-87f7-1adbe04e0f03 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71ee5839-0cf6-4f19-a5d1-c97813407584 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8338efe6-1463-4431-b87f-6ce60344bd5c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5206be04-03f8-4e78-ab6d-4cbcb63d8aa7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9bcfb34a-403f-4bc3-ad2b-11305357910b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf972baa-2350-41de-a7c2-f39d66dcbfc5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/506396c4-f972-414f-b044-b19cc8d23515 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb4c01f1-5497-48fb-8350-c69adeb6dd26 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f241c9c4-e20f-4ef4-8b2d-7ef9dfd984bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc5c9b5c-a616-4ab7-bf27-a205eca1da80 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/58f5d209-5b95-470d-86e7-926fb0e168c8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8272691f-558a-48ab-b2e7-3d3111d55d82 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d086eac2-14a5-48d1-ad93-227e6cccbde9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/96642efb-3731-4f12-8daa-892fe0cb5f45 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/76e33449-0e66-482b-8681-1026419ea592 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1e90bdd1-39e4-47e0-b32c-a59883e04b28 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/efd05524-7347-424b-af9a-000e8fa31606 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0033463f-8448-4812-8317-b9d08baaf227 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d7665d7-bb2d-40bb-a4dc-28fa5688ec2a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/24adbe56-4b66-4e2e-b7af-9f3b97742a6d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d4bee30-2b24-435d-b57d-f56d8ea25b0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa8e151a-e87c-4e42-b3fa-823c63052f9c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e523a00-1f37-4873-a65d-62f94b237f3e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4bab7711-33ca-42d8-84e1-cccf7f681f82 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/40e78158-c100-452b-8865-b7c439332771 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7da47675-29f9-4b12-a9c2-0e097050e962 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f3a83551-b686-4358-9379-2bff0867fa1c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/428faa46-63b4-4452-87d9-7194a9673458 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3cb5e025-33d9-4bff-895a-c777c2ca960b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc5de659-9fab-4c19-a5c3-ac0bd08145a5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/84cbaead-c1f9-4507-b548-27a8d51f7947 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/552cdc56-0abb-4c34-ba15-0a7e31588321 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09ae43b7-4fe3-411b-84bf-0028e82d161c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/741e648a-8c81-4d87-9531-4ffd2f430867 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/96a95c23-5650-4efb-9e51-b790057b8555 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/74590db9-f9da-4fa9-81be-394201e06504 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/819d1ee3-b08e-4b31-9e94-53e74e74ec32 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a0c7efa9-dda2-475d-a22b-eb546fee16aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7416207c-9ffd-4040-87c0-c41d4d6f167a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/11967de6-357b-4071-ad43-fcc320cb4941 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1f53453-f3e6-4367-b4fd-eb2d56a43646 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ceefb8ee-44c8-4fcd-963d-18fd21ebb5ad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e29cc762-5022-49f3-ba70-1168453137f8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1bfd188-67de-4d60-adde-1512a6557e96 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56ce86b5-473c-490d-83cc-86c90ce798f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/060395f3-645d-400f-bde5-c731b6731658 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b44b8738-ed7d-41cb-b33b-86f5ec6b060f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ba32c0b-5946-449f-b41b-4fc2939cc3f9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f37e22b2-6c25-4810-bd0b-86de35034090 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bce57c55-072a-40a9-84b8-384191fc85dc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/503b41e6-b559-4b80-9a55-adfeed16a09d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/37f7c46a-813d-48e9-8c3b-9681140e8750 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/762652a9-9235-4116-abda-66754ea184e9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c89917f-2190-45f1-95ad-fca01c9cc295 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90ac17f9-53ed-4911-8ef5-a6259b77e1f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2c21b1d-e0d1-4bfb-affc-ff5cfb5e72e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/be157136-1dab-462f-b5f9-82a289bdda1b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b296f7d-3597-4cda-a9df-bab0479666f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99cfe6d9-ef8e-4974-ba67-4603a125f0a5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a57fe244-93e4-4796-9673-403f8eb132d1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4726f8f4-c9ab-4886-99d3-3d528cbd88b0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b40ecd9c-8826-47ed-820a-e03acb6ec831 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/124f868c-8700-4c9e-b4df-f68814852c37 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8b22bff3-38af-4cd4-8ea5-6027d4997426 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a771cd1e-9cb6-4a1d-a4b2-1bcf98e35884 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d0bfbb2-99c8-4bb2-b6da-f19a8a95632e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba7f8ca8-7cb4-4469-a344-01f5fd16ef4b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2908b896-9d2d-4650-a85f-cec7dacac5d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4ff4588-0e51-421b-84aa-7f80e5b0ad06 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59958a82-ce04-486d-a620-e3a4180470e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e104c09-7c29-4fdf-8baf-345945c46dfe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f6a8ddf-0084-4add-bfa4-7c4100ff253c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d74a16ff-b980-4757-9cd1-defc1d7ab77f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a47acf5e-1e8e-441a-8cf0-c581a176f2ea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27e5e395-9a4e-4d7f-82d0-5e20721bf0cd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/425e3afd-d57a-4bab-af8a-0fc4d1a7c0e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/24bae7f9-cc7b-46cd-a8a7-f81e7d4da529 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5aaa9b7b-3c5e-40cd-b2eb-c9eab4da3f54 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/49f9fd7b-161e-4d6e-befb-15b0795ea51c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6e0e82b4-8626-408d-9d64-e6eec6533caa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1970e703-406f-4e04-acfa-b7fd0208847c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c861096e-d2da-4eb2-9f6f-7e337542a80a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94e31a4d-f06d-49ac-b169-018132c8a8e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/728d1900-cf28-4fb5-8a7d-6ce42718ffbb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b0ce47bd-423c-49e7-b0ba-76d0405af605 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f4303c7-b4ca-4c9b-8f44-16d9e9649663 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a097aca2-4ca7-4f24-8ef6-580c3a1e5209 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4a37259-56c9-4a58-b93f-46cb52d777c7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ab888e4-d839-4441-aebc-cc2ebbad011a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1191ef8f-92e0-4ef6-a945-c5e94b6bb3ab 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/578d6391-4902-4a24-927e-71f8c471f79e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f72f825-c6cc-46d0-b10f-dff17d183f6f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/267fa3f9-35a4-47c2-a12d-ed8ecdcfb0ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd666f4e-e200-4489-9891-6fd36ed689b7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/043409f8-ed0d-4ef9-9953-27a6ec3cb235 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f4e3a23-cdf6-41bd-b3d0-bc7982addb46 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/922d418c-229c-4118-91f4-6dc463d06e3a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bbd5ec07-662f-4118-9383-357dd9683221 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/549b05d2-8e7c-4230-ade1-8126a439ee90 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d001da11-61c8-43ac-aea2-de1f9fa2ddd8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/049e48bb-8793-42e5-b384-8c28b7ce98c0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0efccd91-4de0-478d-a18c-1138cee6a327 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff1c51ee-dbdf-4365-b51b-564266d26a47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a439ee5d-1680-4a92-b637-6add928d6a04 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ca02721-2bb0-4b96-bfc9-89adbfb11a42 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3834d4d2-ec42-4bee-a8b2-eedac9e94ff5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/398843ab-ec72-48d5-b6c0-c3d74fcb108b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/89e452c4-21a5-4f04-93e1-870f4307b6c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c913d766-2e3e-4a9c-ad1c-3500955161d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a96f93e2-c928-45db-ad3d-7563c238be0e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3b97332-bf5c-46bd-aa26-8881845f3df3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/696997b4-9a12-42ba-a6b8-18ae955d8312 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/465611c6-9c51-4bdc-b205-968e0b24e783 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ebc880d-0be7-4786-a8ff-3026fef9b87d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0413c55a-4df4-4624-8a0b-7a7fe4d408f0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/084ae248-192e-4288-9997-5ec532f77bb0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dc5234cd-c815-4786-8182-0bc1208793d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/530f13a5-e58d-46a1-bb48-c03190b72edc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4242226-1641-4237-8491-1633c26b4a2a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b4bacff-0db1-4e17-ba86-83d7724b68f6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f164407c-a50d-4cff-b70b-02030199387a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/793999c7-a001-4c2b-ab4e-feeab6a88e81 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0262addc-304e-486e-8537-1ff8ea0f1fed 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d979009c-f979-46dc-8909-72c811ce2977 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/467c405f-03d6-48be-a230-10e042711ffa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/38a1d987-6163-4456-849f-b180adb55ac5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b4df867-2707-4744-a7f9-296b0e1483a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e052f5e-d301-442f-a47b-d8a7e5d76946 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c528f43d-ac6b-4483-9c7f-ac005eb150ed 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2cfae8b-ae4e-4a8e-93c5-ec52bd3bc93d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6cafd86f-5abd-4e1b-9172-ec15fbb9d98c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b18022e-db05-4432-b189-4abd5ecc253e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4eaa18fe-20e8-4a80-b362-05016d572fa7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1453e462-fc52-4018-88d7-0138c330a470 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/656e4781-ae47-445d-a146-1324bd325e57 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f88ec11-fb96-44e3-85e8-dc42cd264232 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/441e6f39-a20f-49d5-bf98-4d6b9d23a608 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd5e234c-4a1d-479e-8585-03222c207c96 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/16049a01-2262-41fe-b8ed-4b8d7da36b7b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4fcfbc17-c595-44b5-a2e8-9924b4a538dc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b183d0a1-8ecc-4eef-a109-5d8e4aef386e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b8d94cc5-c383-455a-8ad3-2d053169f043 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b9cd7b7-4301-4c85-8654-29c4929a037a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8694a062-8f65-47dd-98e3-d42648136733 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da381ab5-8874-4202-a83f-373010aad448 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b565c051-cf52-4f06-8081-233b5d7ae9c8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/62b8d996-8852-4eec-848f-59ffd84620c6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1497b6ab-abd0-4e33-9034-49e18c209068 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f9b0d84-0a4d-40e0-b9e7-578ef62308c6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3fd6f70c-111a-4017-a22e-9796770f6265 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f4035ad-f28d-49b8-b49d-079f43f7aa27 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/375bb92c-87f1-404d-a12f-3832c405cf17 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/89d645b7-1956-476e-88d7-a0dc01cb75b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fc1060a3-d437-4588-ad5d-93d52ef5c8e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc96410d-43b2-4485-890b-97e7413a41b4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/48c610bf-d199-4ec5-b0de-eee70f914d06 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d1fb5ef-1ff8-4fb9-ae26-8a516bd3847c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/70cd005c-bdd5-4434-8ab9-c5ad36dc42fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2204d60-23cb-4d2e-a44f-119578b5dd47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e47a0e55-50e2-48b7-9ece-680d33c5f892 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93c6cc47-95a0-4d95-a978-c3ff599c82a3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/269ed787-2282-4490-9afb-3cc6031c3550 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/95bd87bb-9442-4fed-8643-85d50e6869b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/019f0fcc-ba76-4a13-97d2-721c9e814b7b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a2f44e5-afc9-4e03-81ff-13d4195d7619 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cbb161ff-43e5-4312-9f43-131fbe8c5f4c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c0ee406-58d6-42ae-8ac4-0e1ff17f27a6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a3cfa34-9172-4450-815a-95441413c03e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a704826f-5801-48ab-b07c-60331dda8841 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f577e404-80d1-42a3-bc31-5f24973b42f7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75cb368b-21b6-4a65-8e8c-5eb6be41e2a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da9fc7a2-0d08-436e-972f-16e5a0c9033d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ad4a613-c662-48ee-8498-ec7c247d4f6b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7189a52-7ba5-4e68-9186-251de3f6eb43 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3204993-cd6d-48cc-87e3-d8ce3ee42722 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5acb70e7-ce17-4ac5-82ec-b8069c71b4ca 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c9b924e-c5e0-41b3-b8c4-f7c754880aea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3228dce8-1d47-4a13-93ab-503c879d4e95 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e21b4097-1f44-4510-96ee-fc051615a17c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2229f923-0a2b-4b7d-a64e-1fc217b79106 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5fe63bc2-5bc5-413e-9593-899da178aa1d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71d3f3aa-a7da-4f69-bd71-6fad133434a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e70998eb-d694-4294-8ab8-e1a3f28dff91 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3fc6750f-e605-44fc-91b2-d540edf91378 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d122608-6a61-406b-8b81-93d239be1177 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/92063abc-ddfd-47fb-b0b3-1575984248be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed939294-2d26-4add-9019-ebe2307199f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b67d923a-7691-4f92-8166-6a11a2e7a9e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/29a80b05-6453-4c85-a8b7-891c4abfcc24 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/18877ec6-2673-4301-8ee6-cb9302f8e0ca 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/394d57e5-787a-4fc6-8cb3-cc20560be8da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0976dac2-0d06-490c-a3b5-2d3b3fafc13c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9328508-1ee5-4bee-a7d4-b6241775155b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59b4a639-9cb6-43fa-8792-148f766d5568 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c24ef53b-e476-417b-a102-3d96ab48569a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c9a2ce8-65c4-49fd-bb8e-5cef6b0936bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1fbfecd6-04d1-4cee-8d44-e2e5dd40fb3b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d820fb3c-7c7c-44eb-afab-2158a02e5bbb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eeab92d4-a661-4065-81cd-5c69227b218e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/735db79a-cbf0-4007-8603-9bb5723d9ab5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/466330c9-468a-4104-8073-6611be64effe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a779dcf-91ce-4462-9ec5-16756a407436 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c7e275c2-c298-42ca-9326-9047f3863538 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a6577bd7-4550-420f-80b5-4988d96851cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/17df63db-9047-4070-b97d-9ea5ed08f60a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/653e16f1-5016-4def-95aa-d2e372eaa8e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee8bb20c-1956-433f-bd90-fa6f6ae88eeb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1cb1b7a0-1193-434d-a8c9-08dffd20eaac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2621536d-62e1-41a1-9b3e-3da1112ff436 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/83966f00-830f-47f1-878a-4de64c4cdd15 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/654abdde-2472-4585-b96e-38ec5fcff0e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc91fe0f-ad98-4bd3-af6d-1e4118ea3cae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c5cea43c-4e7b-413e-a075-3dc62e91f439 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ed77070-7842-4fe5-b4a3-f8163c74575e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/02c25fb3-ce33-41c2-8ecb-23fd6f0cd3bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f63d694-2035-4678-8867-5809f79ef185 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/de2a3fd8-1edd-4f16-8605-c072b829f8b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/786c1e12-51af-4f6e-813c-d9240a1b3480 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e290e670-160c-459c-8807-2578c8e41c6f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/165ef138-219a-4b9d-aa67-89789ec029d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f01327f-5280-4cfa-82f1-2fdbd4f71888 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0944ec4-4fd6-4770-8a76-cd5bdf750894 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2c92b2c-b135-4685-be16-c9ddf6df14b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86a71c96-b794-4141-8289-ba6156c637b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/91b862e4-d532-427d-9458-124698ae95fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/06bb5694-8135-493e-8cee-853105bdeea1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e5a8807-f970-4b96-985c-e98397228e3e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/95edd1b6-2831-4832-b1d4-0b324bc056f4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8954bb11-fbae-49b4-9fed-7acdb6a6b665 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/343cb843-dbd3-4518-9ee3-f0faf979dd33 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0fcd18b4-6e84-4f38-97e2-df9052488a97 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d1899d62-cad7-4873-8b82-13567f788a30 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf59a8ee-b017-43ab-b39a-2cfe16d4d200 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94ee5dbb-93f2-417c-87cb-37247b563596 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8de4c54a-c6ed-42e0-92d6-0a2ff34dacad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/db392df5-d83c-4c30-a4b5-24ecd5293eb1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9682425a-e6af-4150-a1ca-4e60b6903a6c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/410f431d-e3b7-4489-89ed-f8df291cd6e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fc26f090-85e3-483a-a549-34c709cf5d0b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b70da55-0c4e-4975-b7da-e6e1bce956ff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/64fcfa4b-8081-4e62-97b2-1befe79bebdd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d42f1a0a-347b-46bc-ac33-5be575d8573b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/14fea5dd-bc4d-440c-9d6b-4b6632fa4c1a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/54438b48-2d07-48e1-a04e-66c6678ad86a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9bb1c376-0b3e-402d-8fc9-1538293d40b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0666213e-6b5c-4933-ba13-13016ce80c33 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/01247984-bf58-4c4d-9d07-1b08ce491821 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b652dc3-bca2-4a68-896e-e68a1e674a3e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5fe2c1d-1cf3-4300-b3c1-09c6a197ec10 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f36040b-ab2e-4bbc-9489-61321188a7aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d81e657-280b-48e2-8d1b-1ca631786294 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d47f7c0-510e-44cd-8be9-4839b7126c05 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c81c5b9-3e44-443c-96bb-a17afa672bf4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bba6d5e3-7a53-444b-abe7-e5e4aeb370de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d6f53b52-95db-49bc-836b-cdd4c956337e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a7025590-887c-4303-a497-98d0727d16b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6184e0d8-7398-4fc3-b37d-598f86f180ee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c42d0baa-c851-49a5-a95c-c8379b14f3b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82f546d4-ed73-4eae-813f-00a19fc4863a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90cc98f4-43b2-476b-acb5-c1fdfa939942 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/40642327-e9c9-4583-bc3b-f6c4664f42e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03547878-7e7f-4f70-b663-acf4573da97a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b43431af-9809-416a-a4d8-46f385e3f70b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f30a04ad-25d1-4891-9cbf-7aa5ec57d849 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/32e70a84-3892-4e28-ac36-68edd8501b06 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e76f4db-282a-481e-ae6e-c2bf82e5959d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/382b14f8-101f-46da-992b-f9d07ec23b74 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/69861a7a-15ae-4fcb-b58f-d667735b8dea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3595ab44-09ba-4939-b62e-d1cc7cafb495 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/093628ae-0168-49cd-9146-14d52366adef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d33e5fd-f70a-402c-a423-c5a75c0fb4f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cfb0bf5a-832e-4e88-a0bf-53d4159bdc62 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b1adcae-7bf6-40c6-9da6-03ffe20f8333 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2a6430c3-9f99-45ef-9f55-47f5373c408e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/595a0b77-f2b9-4381-bfa3-a78b141ed92a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ebeaacc-8333-41c6-b374-5a31260510b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/048a099b-fa4e-44fd-aba6-f7b813b161ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac4dd19a-aa42-409c-b55b-870a616b9e7e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e744936-4277-4fc1-b136-525b4a704972 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e0aca5a0-9e92-45be-9aef-066bda013710 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87a0eeea-049a-42eb-92bf-287375f33502 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d80427df-68e3-4378-9359-d39fb8773bdc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e8024c1-42a0-453b-9768-54c89bd26ee1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9e68de0-55a7-4194-b1ab-150718a34473 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5695aace-6e77-4ca3-8ac6-844891534cec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04bbd6e4-c5b2-4bb4-b0cf-52692cf32a44 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/477ef5f2-0323-4f40-9917-2badef9d0200 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4aadde56-f6b0-459b-ad55-76007b33c7b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08053df0-1da7-4823-93fa-2f6abfa08ef5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/10140e76-0ef3-4787-9044-71cff7ee8faf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23fa7422-0eb1-42f3-8160-04d0bc2c5ff6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/032fe4a1-d6f7-47a9-9dfe-2d87fe58eb1d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/17182773-6ba7-4660-90ac-c67ce1991917 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2bd675c3-9109-406b-b14b-2fb26ddeb0c1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/33f8a1b4-ccb0-45ba-9388-645a2849ae72 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/275b56ad-f86f-453e-b081-57a53808c653 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f63b5cbb-8831-4af4-8ca0-d1fdcf82faec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/787b6028-232e-4684-be04-229eeabed7ca 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3af6dbf1-981c-41f9-8fc1-cb5dfe0c3fff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/314ed619-4fec-4694-8d55-eff5433b9889 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/205b3e89-51f7-4a86-8113-9a96945aad24 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bfb398d5-feaf-4f69-a650-caaffe1b1baa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cda38e3b-6c88-4869-a274-970bf9d64728 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/44cea9b7-fdba-41b9-8af5-1fdd1f2dbce6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2e7b3e2-0eee-4865-8258-311982e265c3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e06ed699-20dd-4b20-bfcc-e309fe3ce6f1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8fcc78d4-50a7-43a5-9f90-dc96339272d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27d4dc76-c5b8-42b1-abff-d95114bbde56 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c0886eb0-ebd2-4140-b261-6d81ab32f4cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1e57afa0-7381-47d4-a844-d3d586ea276f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/65e9e1a1-8a12-4d0d-a2df-4bc3cb4bf232 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d3ddfea-9e7d-4570-b690-8592f31b988e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/15d96014-81ee-41c0-8d6d-862e794877e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7bd9e732-a79c-4be4-91ea-7db114a7fd04 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9fd2193b-c2b6-4bc9-b36c-ff393fccca5f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/efa04d50-a7cc-4899-8a4d-ac6a1df25492 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/176c78a2-f990-4ee1-9bc0-87eab19d71f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb34b974-9f22-4991-85fe-9a47ca527533 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bfddbdcc-ce04-492e-96b5-5067681c1cfc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9fe69bed-08a3-4fa8-9433-855ba1da35b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d197b500-0230-451f-adfe-cbfc047359be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3acf6e70-f65c-4f4b-b809-031d7113e8d1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99204667-d646-48b7-9396-682316ebb9f6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99e5a240-9c15-4183-9971-c5df1eb8d236 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ffb4470-2bf4-441f-9b0f-4cbf6d95fb38 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b972fd5-d625-4adb-8a35-9a1d8d381d5c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dfbfb32a-e3b1-49bb-93cb-b7a5a772e9ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f2d5155-9068-45d8-88a1-a9b59e0c0d2a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad641d03-01d4-484f-b417-11a6db1af0a7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/703c6144-c27f-4e78-ad79-d1ee98c9df71 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/658e963e-29e9-4ac6-a5c5-306655da7388 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/79d9b76f-d691-47c3-a6bf-7d654ae5419a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa4fab0d-abf2-4aa1-b839-c9783d4c34bb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f5ab09f-89e8-4ccf-8751-0810bf91d0da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ec92179-76b4-42c9-b1e0-2eae95bb5956 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dc23be35-b045-449e-82f9-c47a7fabaed0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9abd962-5b50-4622-b36d-2421eb5875f1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b6e35c3d-1bb3-4d39-8f30-293a593d2a47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b8cf9b4-3f98-4acf-8344-b36578d2bcff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d68d8356-39f3-4e1f-866a-9c1d82a46582 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/22f4bed7-aaaa-42d6-a369-7109f0a04048 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b0213071-9dc9-45a9-b130-19e0c4f109c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed07feac-35a0-46e3-a898-1e231a7e28a7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27d27407-942f-4619-8f16-336c7c857a04 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a105921e-fe3b-428d-9349-66cc8bad5303 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/afc2b750-62ae-444f-8031-271c641a6ac1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/51d406b5-d687-44eb-8024-21b062684518 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9115cb08-11c5-46b2-934c-c0564b8f7561 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1cee8591-3bcd-4d52-a903-a7c839734766 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81089ead-5949-4b24-b45c-ec4d2fa6977c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa146806-16be-48c8-a334-4946d75e21b7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4603c5b1-c73f-4ec2-b2da-029dbe79d967 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0a4fc32-3f94-4a4a-9d19-06be2b9a6a45 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef351039-256d-4926-8c8f-071bfbeecca4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/51c6e437-3c05-4c2f-8f1a-bce7a355388c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99c97897-281d-4609-a229-b5c1c9d5fc40 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c0ee569-a426-4aef-a36d-e988f6b7181c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e40a266-a828-48b1-b9e2-5ca5350bede1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1bf85168-3da8-470d-bcb6-e5a65bbfbead 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b0dffe48-dc0f-4036-a379-26dde65ccd55 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75e8f665-a63b-431d-bcdc-f2446459b480 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dca55ceb-66e6-4b43-9f54-0853033a6d75 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9361bf7-5cc6-4ce5-a58f-7384b3ac77f6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/330b918f-abda-499b-9a20-54fcf4a817ca 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/46c961ab-056a-4998-a76f-3c1687473fc6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad7f6f2e-244a-4495-9465-ed271b337895 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5edeb81b-c4d9-491b-990b-0af18800e659 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9593f06f-ead6-43f1-8fbb-ef38b1aad23c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ece9af7-fe3b-4f7d-964c-111c52c288b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5150b46e-fd5e-4813-add2-27a7e6e827ab 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d20fc81d-fa40-4f63-abc4-645337458d27 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f5cfabf-f192-493a-8904-0837c6a137fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce7fb637-a547-4d9c-929a-a838c30109d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fec2594-a6a7-4ef7-b96f-139b2f99d60b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1e73559-2650-4b96-b6b1-1785130e5898 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aac4260e-4560-454a-8cf2-185f692d654e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/79e1f7ac-e69e-4f5e-a2b4-336c5eb76f93 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/79e8e16a-b358-4000-a772-1ca85ff67a63 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cfc5d489-cbd7-4c8e-9abb-f56fa2b6dea6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0026c8cc-0eed-4d99-802e-9dbd5431a764 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/25c3d252-0856-4a36-ac64-6873526e5114 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56031b2a-9199-43a6-846b-40151dff4d4e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1cacafe0-b78e-4e80-9770-35e9924721e7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad167bfc-fa5a-469e-9e9d-72ceb850dc39 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c30c10bd-0059-49b9-9821-aeab3eac0702 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/29a73deb-7bc0-41b3-8a98-f50c05474dbc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8af79622-7b5e-4f59-abe7-dcde513de0ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f5eca80-4802-4488-a254-fc9a9a476caf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5547cdd-da15-4159-956e-ae941cffd07a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/340fb020-b100-4f4e-b8c2-f0fc8754c9b1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b6bf8514-a51a-4ca6-9ca6-936ec8ab1fd5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9036f795-ce19-4fcf-a675-0cfbca744c9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82b2af8b-2c6b-4f16-8f81-37a0ff2d0261 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9fc6982-5faf-47eb-9a87-00021fad701f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/934caae3-fbf6-4041-80e3-635446dea618 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/26bb4d62-0364-483c-a9f7-420a7a07d935 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/956e6883-88d7-4a21-a168-229a961f77f6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/edb4b1b0-54c7-466a-977b-530fdbf48129 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3eddd669-389b-42f8-b6fe-3771ed9d8092 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/de29cc15-71ea-4e28-ab64-f313fda40d84 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d701b36-3cb1-467a-a1a9-6416ea3fe12f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03eacff3-6bed-484e-b6a4-722ea4828725 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f5fdac7-2b91-458c-9cd8-f51a95de7022 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f3d27d5-9526-404e-8cdf-5378bae6a2c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/518153f1-b00a-4732-b8ae-f39487c1c125 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ac82a89-ca0e-4e4d-96e6-4655f49e419c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/95bea029-5934-40e3-bdd4-d332ed17d6af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d77e072-1868-47de-b76c-86a9aae9eefe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b7e9b7c0-ac3b-459e-9437-17296104d865 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86452806-fd03-4392-b2d3-5838d533a9cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87255351-5c97-4a45-8550-f7b5255557f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8853fe85-9d92-4830-90b5-8f1e077eaff2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1984140d-84d6-4b5c-b56f-28fd4bbe6397 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/583b93ba-33fd-45c0-a8f2-180c4c7065ad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36d65db4-e2f3-4373-a3f6-71f88c2f99a5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/92404da4-9da2-4577-a346-b78687800011 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf6865b6-d36c-4208-89da-03cc84e27cf6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/910f7a7e-396a-4ca4-85dd-ec2375c78395 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9965fe3-7a93-47bc-b33e-959770a63a03 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/921d1205-c624-41a2-aba9-e5733d481c9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d346c0b-1039-46a3-b76b-dfcf5b55d48c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/784f3d73-4143-437d-8cbb-20543e4286a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d174a6e6-48df-463c-b83d-508e28642281 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/14623ff5-e52a-4a21-9215-9fb1dfab3d5f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c743de1e-1126-4baa-99d7-b96a429025d6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/879ff37d-205f-49f8-a7a9-15950499733f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3610ce82-88d5-494c-8cf2-a5ff53ab06a5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/db836372-bd46-4ae1-a6e3-8efaa660f3a3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0fda8920-4979-48d6-b65e-5ff3a6228634 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9106710c-8cd9-459e-b2df-dd8b544e83c0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4452b2c-3263-46f9-9f82-96ccc76a94d6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cb86033-9bf6-4f25-a634-758092ef3365 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9292393a-0e0d-43cb-af0e-2b1c62a897c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/40b3f045-2ca9-4476-bfec-7789a6fc9345 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/366b2eca-3aed-45c9-ab1a-48d145143593 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd7655f9-44d9-473d-9f21-2ca8cac4ef0b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/58faf64e-cdbc-4bf7-b72d-52f02414a0e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90a421dd-e94f-4938-8df6-de613596817e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c0ce51d-0b51-4750-aebe-2f5a5eb27151 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23142989-a070-43d0-8826-ebcf6b7c7c90 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fffa0d50-8e31-43b8-a432-15bd756cd0b4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2797c49d-87cf-4d9b-a365-178a27957447 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63f66110-e293-4014-b6b1-7f6b1220b1d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d1920a9-557d-4d41-895b-6dde4e584c80 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5fa48256-4448-4b5f-b846-1589fafdf56c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8befd124-7eb7-4764-96c0-998ddb689138 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f694311d-c0c9-4428-a7fd-17dc5de3dbdd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86fa9284-c09d-4809-85fd-1ed5ec7be74b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1812393a-b2e3-48c6-ba47-1f57aea99f94 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/449eac3f-776b-4826-9bc6-427efc39c505 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d3de164-ad90-4398-a8b7-7a047c259663 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a3dc809b-d4ef-43eb-8c49-13020f1e7dab 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c93dfe01-f592-4143-b6c8-a1eb2fe665da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1fa3cc7-6d4f-435e-bd81-6a1103fa9b8a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0095778a-8d74-4d66-94e1-60a806ff7a3c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb359616-b1be-49dc-8fca-9036cd2f3076 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d673495f-09b8-4463-88c8-46e71617b61b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71c38817-aa72-4960-8cb8-48dc4d9c6ea4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c7d61c7e-d42d-46a3-9d11-840f443da87a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b4452e0-c1eb-4e65-9da3-ecd42b6a5189 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/819fa4c3-f628-47ac-825c-45d4c4468c68 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7efcad9-f3c3-4bf3-b680-18c265adc661 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dfd2dab1-ac5e-4fc8-a989-e7884aaec038 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f24439a5-ca16-449a-bea4-cec35ffdcdf8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d36cc2a-d81a-48f1-b6cd-6e882dd8af60 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/270a3ae0-313a-4baf-9c46-f7fe618c460a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc8e6a58-0583-4992-9ea3-b0f1c9fc4adc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5668d281-af98-4e57-8bf2-dc7f2b8f2f0c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e93164aa-4c0a-4770-96a2-420201229729 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8354e9af-4a7d-47fc-a694-da3413e9f38d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/578017d1-2768-4191-bbaa-b2c989982d13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eccf4e5a-da87-4edb-bd07-8391cf50c2f0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8a4397b-1219-427a-8823-cdca3cc29080 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82b5dc48-b95a-4207-9821-40a2d7a33ac6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5114c175-6a79-47f1-8e09-263249d09487 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b0df246-d33b-484d-86be-1222d181b09a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7be8a8cb-7a89-43a4-99f0-3de12d77d5dd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c80ed39a-5238-45cf-8487-059dc5422d0a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5b0c45a4-f7b6-4833-85f5-6fdd45bca3c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75129188-79aa-44ed-b5e7-9a7f6e289f45 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/96895e7a-13a8-4a4f-9afe-0114398b956e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e300b0c4-8898-41a1-ad06-49d861b0f7b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90f4f248-ce45-4f02-abe4-3765d9c62ad9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6530e909-deb6-49cb-b75d-4c596f66eba0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2a7a1df-e761-4b90-8db5-992d72a656a2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc8c03cb-cfd3-4d21-8dbe-682164e8d39c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2786438c-8cc4-4cfc-b6a8-52a66eb1fb7d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0adbf1cb-4caf-418a-9482-fa2cbe60864a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ef0a4a1-e618-4ee6-996e-23c74bdd4e43 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b3499e2-47f5-40df-ad0f-09627d590662 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56c35265-732c-4d13-bd86-f810309af184 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/659464b5-6247-4718-9c34-ae0d7027ecd5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3625b010-952f-4e7c-90b6-b144bc82ea64 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82c914b3-a509-4311-b014-67e5782a31f1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9820f22-9c43-40a6-8c82-fd24a39f1e0b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a64e6c68-a7b1-4b8b-a19a-2491901b232a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8ce6358-311e-4919-bb62-9f049baaedf2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e57e259-7d30-4d80-a7f6-619a7b6ab158 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9fc059a0-f952-4e12-a35b-47427fa46f9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/074e0013-46ba-41a4-82f1-571975f92ad8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3cc77756-44ca-4b86-8784-1fcbea221657 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/47ebb9e8-ca38-4f48-9448-3d49c281f0e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe1f2a9e-a628-4ee0-b667-225f4eb02223 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b438f2f8-4c86-4f64-baad-8b15667242db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc68de68-cbd6-46b4-8515-f92ed17702c8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe393f21-ffb7-4685-9b41-c0c8ab012600 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5aeb47e9-f732-4278-aed8-41b6ad906201 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d64fc321-906f-41f2-b99a-3361fd9fcdd5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3fd7d528-0a2b-4f55-9f4b-191fe2ee2d22 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed661574-9a7f-46a3-b384-261424b25ee7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/78c5893a-4512-4133-977e-cc243aa2f762 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dcfb17a6-b991-40c7-8c25-17c27167c383 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/027bc34c-ee38-43ca-9402-5ee91d2b8880 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/557078d1-ea11-4004-8e8a-b6f9523f22f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c8f3395-6eb7-4142-bdfb-c4073484100b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/00934029-4333-4689-a2f8-4494501d6e66 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eea74fcf-f4ab-4307-b2da-b3ce840ffaaf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2a1ab8ca-a784-4aea-aed2-aaeb7b10e1bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e654c3c3-1669-4b10-a1d4-0f5d3f78f8c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/588819f9-69c1-4bcb-9253-fc32011d8101 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9f909d2-a645-4517-92cb-45470c5dc230 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aba2c825-a526-4c25-bb1b-171dc24b2b6c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/537970f9-b2bc-4500-bd72-f1bced7a62ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e28a3f92-53b5-4c56-b783-5907da61985f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3bc30d74-1079-46ce-a0ea-af9e85f60234 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc06e8d3-1238-4eb9-836a-b09174f3495c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08ff96ff-68e9-4816-98f8-c81151869e1d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d8895c5-ae93-4c18-9545-d92c69660af9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/166971c4-aa77-4d40-874d-adb4c498d024 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b7b88578-d689-4365-acfe-3c0c4ea350c7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/662f169f-e611-4a9a-b49e-f049deb3bef2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d4a9f2f9-95d0-4945-be01-b0692536301f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/83897460-606c-404a-b4f4-e4ccaf87604a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d210b44-f18f-42cc-8cd9-170eb3bd7cc6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9793e6c1-c4a2-4fb8-96ac-d06d30072f4a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/76d1d491-33c3-4e0c-a13d-f45a501a7d20 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c7282520-6ddf-48be-bbb7-4f965c737237 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/61040ac7-e5c1-4c9e-856c-b9d870c84ea4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5fa7d4c4-3cfc-4257-9e86-5e054f77df74 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/338f20cc-b8bc-4288-819f-ef7b0f1cad45 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87f22c48-8008-4214-8c78-3ef4adf4fef8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/80ebcc8a-33b7-4924-8f76-e6dde0521753 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6830bab0-7052-406d-8ea3-c25c80964225 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/10e23841-73c3-49d3-9391-0b8fa863b4bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/236ce523-cd3e-4527-9925-e95d76de9daa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3333d607-b10d-4394-9c8a-cb712471a651 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c5b5e3c1-5953-4ca8-9bb4-605c3f28f30b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/48b186c9-2136-452f-9758-d13b12ab3f8b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/72b48ee5-a5cb-43bb-836b-5e9facfa91f9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b38bee2-fb3c-4f27-a35c-03affa31a375 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7332f60d-fee8-4830-9ffc-e2df5d59c457 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/88d9d4af-b05d-4883-a835-a9d028c5c34a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c7eca6b-5312-45b2-8bfb-a9f1d0f6a194 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c9962bf-72e7-4b29-896d-0684ef50035a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b38f9ac-9555-4ca5-9602-1e42844d70cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/358dab50-8fa0-4b56-a317-f747fd3c8ecf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8499ef78-81a1-4282-a151-0d70dd7cea9d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f9f1e6c-e61b-45fd-807f-ca3e8e7a26c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2bb60858-60f7-4cbc-8a31-e571acf0168b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/07cef061-e198-481d-ba6d-27e394684ab7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8fbc08f0-fe5b-4707-a206-b34ae1b7efee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/39590dea-a06e-418e-ab27-cd9f86216117 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aee33025-7a2d-48a0-90ee-c0c90130eb2c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a803c37b-e5ca-466a-9569-0e48d2fc98b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5b98eae0-c7c1-4705-b18f-33db16ea1448 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9078802f-5bad-4f6e-a8fa-465b6a6d0185 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c6f6597-086d-4617-9ffa-8c9bbdfbf53f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fd06d5a-ba36-4913-9556-27d84ca0397a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b45eaf32-fb34-4981-bc65-11646b2c7a85 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/16cfe80a-2399-48fe-83bc-51e1f2910693 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a25ea290-5e2b-4b13-83b8-8685341ec957 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f68bb62b-294e-48d4-8b7f-efab26bdea14 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d06d7d6-bfc1-49b2-bac7-52372172c6f4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b50db22-5a9b-44da-88a2-7392d7809f4b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/45290c73-c7e5-4ce3-891c-d5ae9413c26b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b715146b-24e6-4370-a81b-b002591f26f8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5fe017a-ff15-4793-9d39-ce546528e7c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eec3b7d0-ffa5-4d01-9eb0-629109e5784a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/be74bfe3-b7f7-4a1d-919b-30def7c3bfff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/50285ea1-865d-4f77-93a9-a3c4a2b6d7a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/472b3108-d1b5-4d8c-9cc1-33d16215966d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/70c14d61-4dcb-4433-9e44-3535a1fd907f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c33029b-47e8-47ae-9748-a492526b8af8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c382dff6-f3c5-40f8-8a81-ddc2be14712e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/13f76a16-1032-4c18-a107-540ffa3f0b47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/270f314e-a6cb-41a5-939f-181efaa900b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9a8b3cd-3c63-4c55-9404-75d4c9d72630 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3308872-b53c-49e5-a402-112a3597df0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a43d674e-8f8c-4833-9dea-29699e89e285 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ed35337-b680-4e57-8f42-055e299e2379 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aabd8856-ac51-440e-8381-2377ca1e7bf9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4f59ce4-0a10-49f4-bf81-8664c71ef81c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3233dd9a-1378-4919-9bfd-32ca2333d627 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a22e5189-64e5-4d9e-a7e3-e0781592558a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c72fc1c4-d846-48d1-b77b-18f2f28e87ae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/621e9598-15aa-402a-9800-a0f56c70aa0b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b7718df-c036-4698-831f-a0770a59a40a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d614aab5-a79e-448a-9260-605e8f714579 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56eef106-265a-4cd6-abb3-94eb93b45388 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f421864-3e1f-4ab7-82ea-ca73c8bbcf83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/45ec8c8d-d2ae-47fe-be22-8d720fa125bb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f28644d8-ff7f-4c7b-99c2-14b176291457 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f5af4f6-3714-49eb-9730-7801227c210d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/43c86e35-26d9-4152-b413-548901d117c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/668b8be9-78c3-4eeb-ad69-6d6ce5b566dd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e70c1132-c501-46a1-af09-f51848b68dee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f78eff9-dc2b-4661-84ca-126e84a3671d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59bcea77-4bab-42d3-bb4a-e221118e6e4e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6cf3e7ee-a9de-44c5-afef-a3c37e30aa8f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff752846-98d8-4ad5-b052-18ed4c940da1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9119980e-47e7-45e1-81d3-360966f9d699 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e2fd780-7414-4a5c-b8e8-ac4328fb8707 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4be52bb5-c982-4b39-b1e1-6918671c3a86 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d458d6e6-1b50-4e3e-91f2-6e3fd2de2606 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8d7f0a5-943f-4821-8448-eeb6fe823201 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fc86da06-6eb5-4c31-a8ca-c2b66777b6a0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b87b41c6-dd1a-4cea-b40f-9509312c82f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1e89d21d-71b8-445d-8cd4-abe2a3807318 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aeba4131-fc66-468e-88ed-c55d8b3a0dcb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/35cb24fc-7d4e-48c8-a662-3ad1f285c1c7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3237caf-5de3-44f7-9cd9-92471fa316b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71f6f21a-fe82-467a-adc3-fcd49d97dc0e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed10301e-2d31-4681-9427-69712acf2733 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff352add-3503-4d7e-8906-292ee16580d2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/54562295-bf7b-442a-b935-d2d625332d02 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e594a280-2db1-42bf-806d-05fbb305aafd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/db39e3fa-e611-47d8-bc72-27a2de1c9334 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0b07ee6-7499-451f-86b8-da45d5acf374 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5a9ca1c-8818-4a60-8051-938597a3ac92 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d114806e-e07f-4dc6-85ec-29ea6ece5d55 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ac108f7-8ff8-4b63-b09b-8080fe5cd6a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb8b294c-e299-401a-a275-aeaaf26e4ce4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d4fd135-6127-497f-bc1d-89faf317d002 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87e6c83c-38e4-4dde-9d75-1860a81f7327 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/df202309-9187-4108-a02f-bc9311fcd5f1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0931cb03-06a3-415a-919d-8213a4a53160 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d96d736-44ff-4981-b290-5fdbfbb1f339 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7629fa4-7eb3-4287-aabb-22fa620c624b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2440b9a7-d66d-48ff-b561-3f3182e56632 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/496e9eac-4eee-4cc5-9bb2-ffb85ec9bdbd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/22e3e618-16ed-4135-857b-9c4b8a1cc4d6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/802f4965-465e-42ef-a74c-ae986ffde0a0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3965d6fb-e0b7-4bdb-902c-e91cbcf5e73a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/84237eab-dc66-4cd4-affb-7b69d1821e78 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dedb6bdb-bbe0-4bd8-93d8-209b999bc756 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a2f09a5-199b-4083-9caa-ea33dca0267b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e757e271-bffe-4dfe-b2ff-fef0068b3636 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/65f532fc-8550-42c2-9c76-c59e91dd6ebf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2f7c4ce-9e19-46ae-a528-2d417e2adc7a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/92f8ea17-798c-4699-90e2-01a34163304c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56eede67-d263-41fe-9e91-be14f82da02b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad0d2c8f-21d5-4b2e-a049-cdb7cfb468da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9960c57d-ad12-49be-9ea1-1d0bee49bf65 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1241364-cdb8-4a34-8838-e5b913a6ec33 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/21e52530-f580-4845-8fe7-bf4a5ad47d00 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3aad42cc-06d6-4349-9cf7-91751fb410f0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e528ebb6-27bd-4d6b-9d8f-5eb6b703a5ef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8242a95c-6f0d-4d02-a5eb-7d731bc4bdd0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5c913a1-11a7-49fb-8b92-a4200758d53f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/822869ae-b479-488f-832a-cb9969bb2e0a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c4f94e0-797f-448f-86f0-9c5fd6c359f4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/df57b1bf-0e9b-40f3-9b13-a670f5f95b1a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8ab1e47-0b99-4192-8886-21160357f225 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/100ad286-98e0-4af2-a5f9-3c527fbfc3e7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b544aef-a99a-4ec1-bff1-637b73c0712c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c31ab8f-7642-42b0-84c0-99d736816c8d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/633b50a3-7122-4a87-8732-dd0e36a80f12 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f3367d20-8bd6-4f07-9369-163353ea8904 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/89459a30-c272-4945-8b55-40025194ca76 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc7d1b64-c5d4-4057-987f-e96fdcf10e72 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/187cb15e-0746-49ad-8685-2e786efabe78 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/097a8b56-83b6-40a9-ba78-6af53b9a7e08 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3669511c-5a90-4970-acd7-970bdc6f4d69 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8575b72c-3c92-4396-9b75-8614c65e78b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e68078b5-544a-4182-800c-65bcaf0f0459 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2107b42f-1761-4dea-805c-40f5ddec3f68 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e5fc8f8-a3fb-4a80-9300-2928cf77ad58 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b1beee7-e131-4c37-9f5e-fe3152885bd4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87929719-22ff-4cda-9cc2-451f03659d82 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b954f1e-db7b-4e2e-a6be-0037860d5198 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e66221e-2f30-4f12-b56b-5d38396d5941 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d40c5d20-905b-4724-ae2f-7719589ab4ae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ce856ca-dfbb-44f5-abd0-afd79d261e1d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/68d48cea-a941-4fee-8b4f-cb085cc2ae27 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0135ca9-d0e3-4369-a371-d294c4d795bb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/107c2285-e115-4a26-80f9-9ad2dc1c4e0e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c23ab96-47d1-41a5-a44d-a902f3b076f0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f1d53ff-be7f-468c-9fba-a60ed7bed38c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a69727e6-18a8-4e4e-ae19-e9c46829b388 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c0182170-bbd8-48f0-8ff3-c08371a78e08 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f15d683-c06f-41ed-be3f-32dcd9f34cee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9a6e806-a546-44d8-a269-6c44709a1160 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f08041f9-4fbc-4f87-ac00-c6e7bbbef9bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c47fd67-15f2-4635-b33c-bce895718d34 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce54cc28-ad01-4330-97eb-c15643296ffc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3fae1b1-e599-439a-b16a-3404206ae911 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1357ad20-770b-41e3-b26f-ca66c1b43b5d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d9ea9ae-9ff5-40e4-9a63-2e1b35ed3b26 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ee01266-99c8-42be-adad-28c81824a8ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/974408d4-33c7-4f26-addf-7dfb4dbd96d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/656db10c-5432-4f52-b9f0-74dbe2c366c6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c6422df-37e8-476d-a1ab-70f8b8308d62 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/96b82897-bb61-4e7c-bd59-4c8b304e1ee8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/feb37e12-1d01-4363-a5ac-200bdd38e545 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3488d164-0b80-473b-89a7-32668c78dc45 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/64541ccd-7925-44a9-b043-1b155db29979 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed16dbcd-0b7f-494d-a759-32c49714028c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eca2ccb2-2763-4a56-a776-7fed4a32d083 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67b50c40-c221-43d5-be37-2c8c32c44f34 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b85374df-20cb-4a5d-b51c-ef04b25edb8c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b834c83-4e2e-4363-a399-03e65fbf4953 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dc99f498-7681-465c-b6a1-1fc925481189 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56866bd3-9fbb-4c00-8fa2-30594f02f6a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3db9c325-de6f-422f-88bc-25013b046c1a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/677452c1-ac7c-4775-8b4e-b26658582149 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ba2a528-0f85-4b30-8720-bac47340073b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1503be85-45eb-4b86-b527-be1aade2fed9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d6e8829c-a273-49a5-96b4-d1aaeec206a3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fed58407-7760-4c8c-be1d-d1ee07a9ca22 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3667e5b1-90e5-4da0-87ed-e2519015b3e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b441e05-b9a7-48dd-97ec-af8ca4cc7a6e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/83c58421-ba52-4c12-ac80-49ad1328de73 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/df46410d-44d0-440b-8c18-1c019952b668 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/581a2a20-9e7c-4227-b628-0f9b4534e3e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a15fef40-9df8-42cc-a0b1-66faa1f4146c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93cedc23-f638-439c-b1ef-635b2cd020b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ceff8df-ce22-4533-9994-ea7b82d16a53 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cb3823a-2454-4c4d-a741-3c4532440b5c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/939ad303-e795-456a-8568-b2c6fcccc2fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d48d172-a0c4-4df0-a75f-00458fa504f8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/581199e4-109a-4dd9-87ad-6abfa28142ff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a38306e-825f-4999-b444-84b873bab079 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56c52608-ce1c-4c28-b368-680247577a22 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/98294925-05b0-4890-acc9-015b7efa9cea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/415f04cb-3960-4a4a-9235-a12854429744 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/faec8def-f32c-4328-ac5b-441de68e9c85 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b0ac156-97ef-4303-9054-105fd7cd1bb2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a49d199e-a5ad-4bcb-9dc3-b67a15742eeb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7bc8927e-9f73-4360-86d4-87175d18877a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b746668d-d887-45c9-a2a7-a5dd6f23e391 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/264f7318-bf88-4551-8698-c3284a7f5624 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e26c9603-e4ab-419e-93b1-18b633fe229e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/925755f4-6c57-4d66-a160-94b81ba0713c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed108a84-ecc3-495c-8b6c-966ffccf7de7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6640e073-58c6-4e7a-99df-5d1701131c90 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d8108b9-3904-467e-a23d-25a25a7bbc29 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/911d5f37-8363-4d1b-8435-145e6765294f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5df17391-2fc9-4d78-9f60-2ab68e67960b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9bc64ee-5849-4214-b9d7-ce8bb58dc317 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ef25878-3845-47c6-b5ad-4067f5cfa7da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c83a646b-2cf4-4d75-8438-f2b3b4ee1ba2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1107676-7871-4946-9efb-03dde421ca46 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb32983b-1650-4626-a836-bb02cc825f78 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03d1af73-f821-4025-abff-c63eaecb725d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3bc09e3e-a5bd-4c84-818b-ef615d404c8e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b7419a4-e066-40b9-85ac-fcd0450a8cb5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/738bb424-48c3-40da-ba63-3309874b81c3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/97ff1bf5-2d26-4efc-8dd2-41e009a7391e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3fa96cd5-52d4-4871-9807-dc34e2b2f4e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6496551-047a-4f30-b05c-6a29772f150c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5db9504d-a200-407f-ac4c-3d1f98061a5f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8cfec531-8f87-4c65-8882-9a8f6083f208 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/42e47400-099b-4426-8c90-3388b3ef48e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee504edf-6239-4e41-b9ff-1698f2557bf1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5069a7ea-868b-4914-a925-d8ac7b59f2e7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/66febca3-f6fd-4520-a3b1-786eabb1ae77 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/525407ba-70ba-4dd2-90c5-89be7ff517fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab201ac7-5b94-48d9-bc69-3801db4e6fca 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1cb16dd2-a7f3-4625-a165-c10de6d7dbbc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d52623a1-0b9e-4a59-b4bd-0198c192dcc1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c93276d9-a5a3-45e0-aa7b-903938aadbd6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82b86f22-78da-4d15-9166-95d09b4e2d13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/285d0065-e79a-4197-bdc5-f5f7248855bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/987f12ff-8947-4898-916c-5895d50616be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f97ff436-fc90-4ddb-8bde-0ecbc357ea84 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4fa0ab53-34ac-49a5-abec-22733a70ed54 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e26b17ad-32c0-4722-8eee-adc9b16e301f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/202c1c91-7a7a-4c11-a634-be522d991d2e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb2c096a-72e0-4f61-80dd-de083aa272b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b28b1516-f508-4372-83af-9f549c881c8b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea36bbe1-2bb5-46d2-b6bc-9f4a77f8fdd1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/76f7924f-c2f5-46bf-b706-41c304574887 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c42fcad-5eb4-435c-821b-e674d6ffc66c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/00f734d0-1ef3-4919-a28c-1a3c1ff7d7de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/803d818f-89c0-4ed3-853c-a870459ccaa7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6399ec1a-37df-4d75-9e7a-4a2d8524fc16 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f3440afa-81ee-4221-9668-7621627a00d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/25da3efe-62ee-435f-990b-83dc59c6ede4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a903ea4-6cba-4f65-be5b-b41004ee61cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1943feb5-d921-4b56-8fe8-5c6fa6a5c183 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/95bd87aa-0680-4702-bb04-4771704895f0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63037945-468d-4482-a6c5-910208513a32 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0248d123-24b8-4677-b092-31a633f3363b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c130af84-4028-4194-a001-015397d640d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/43745bd9-c244-4759-ab0d-59177183f7ac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dccbfcd4-8d47-4aad-8617-c308aa3a9304 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ebaf716-e6cf-4baf-81de-b03325cb79d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c317345-9343-4668-9342-3c1e922cf0a7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eca73fde-2c1e-4bfa-9712-c43fb388942c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/feabaa3d-5fe0-4e6f-96a1-5b5e9736a754 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67a7121d-5b5c-4822-8236-5274e50861a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b506e10-1796-4593-8a3b-d3bb6e2b4b9b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8fc37a4f-9eef-4c54-8ca6-ab612ab4ea81 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c7038b0-4bab-45fb-8163-9cfa80cc2485 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a31b287c-5054-43e5-b6ec-2345da008e5e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/702d96e4-ccc5-47c7-8499-62819fdfa071 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e30ae356-c095-4b8d-ab19-551947e6b4af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1fe94379-f680-4928-a489-1672ff3c11f0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab7a0baf-6077-4d03-a56e-5a8d16e8d26a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5f68f69-392f-4c4b-9478-bf5197e3224b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a862872-67b7-4eeb-b1ab-a0ca02a0bee5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1414408b-21ef-4ff3-a0f8-e9ed52708943 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/119b2b19-6c4a-4067-827d-95d90249f815 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75349431-8148-48b6-868c-a6eaa09fa5fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ddd1490-db7b-4b6b-bb14-fcba421fe1bb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/afcaa30e-32be-460e-b10b-6a5a6d7b68c7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/636d0e79-6ced-4521-95bf-ec5755e7227c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a0d9842c-8c28-49f2-96a8-38e0c66eb5a0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a0fcfe99-6c8b-4001-977c-a950d157e414 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f205e1ac-438f-49e7-87e8-9df3343a2db5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffccda44-1498-4769-968d-b5e88dbcb057 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/958a6af3-b1be-45d5-a182-5e6ff421f4f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ee6458c-fead-46e1-80f5-36918bd598aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d13a124-b0f2-4b29-96cf-7a655c794bef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad4fa44d-4b2c-4309-9aa5-80155c35fba4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3aed92b-b56a-4b80-b95c-a6180add5b10 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a1517ed-b11d-4d1d-adf1-17ee69113507 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dbda47da-6d6d-425e-9452-a733d95d8e6b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0731412f-edd5-4ae8-bd0b-53c3f03ce16d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a1d9a08-4c8b-4be1-a8d6-5f962e97c2e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87613b8b-b623-47b5-bd40-73a5cd307c53 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a2e9d85-7978-41ad-a393-dcc4593748b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75be8bb4-2ebe-46f4-a88a-d108b655eaca 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e035fc1e-5595-47cb-a6a8-765ab19c322d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/55d34271-5be4-4727-aab8-f7fdceb0e312 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4f1f47d-9dfd-47cd-a9e9-b436a5f34893 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b44fb0b3-dbc6-4fce-934d-5e8e585a3fff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/864f0df2-227c-45b4-8e65-59fb5abcaf52 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/650e092e-cfef-4f2b-87c3-f102923a321f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/211a12d9-062a-468a-9e5f-f63643d446b4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e2c8b9f-b697-4523-93e1-dbe2c24416de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da72f132-ebd5-4a9e-93d6-5a0f0fc19359 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3daf7d8e-7140-489e-aaad-e4c58bc70d87 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3bd4a745-1660-4011-b691-3f16aeb57f96 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/11c541f0-4492-4941-85ad-bdcd20c0f4d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/133078b6-a90a-4e27-9d8d-5fbb21ea003a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0afbd2e4-69f2-4064-bea9-de3c8bbcba83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/97dfe566-4a6f-4cf6-bdd6-f223710f24f4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/61a6c688-6184-4409-947a-63298774c5a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc9d2b6b-8cf4-4ff3-be10-53e85c13ff0d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/58ee31a3-7fa9-4da1-a63f-70784ba39cdf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c29147be-a9bb-4127-93bf-b68fcad98b05 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2a36d166-0085-44d7-8636-78384e3ef9fc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f493734f-58f6-49cd-8185-90b3f8fe1a51 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c2aef9d-2094-408e-b747-fed7dd97b76f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8603066c-2b1d-4c4e-acb6-e58b4ede764c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab8f7b89-cae0-4893-a9bc-df7e00d7ecd6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03c3b108-2b37-4575-b2d4-b6c47c352a2f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/62607921-9d06-4807-8a2a-9ae75804b89b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/41280cf5-5da8-4a05-8aaa-b95715ffecc7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/deaee155-ae4c-4e26-bb50-ee4f64171462 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/baf6d61d-606f-4339-b473-d3fcd0e14f35 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fc7db278-3f43-4195-827f-138bb166b0f9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d655de1-e856-45bd-8136-fe278bdde204 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/10de49d3-13bf-4525-b552-83b8f529e8dd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5187522c-8ef9-48ad-8e7d-806358bd04b0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c490b54e-58ea-48e2-802a-5435013483b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8e7681f-8bea-4d65-a6fc-3bbcff465b73 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ca00ae7e-6d6a-4171-a80e-b8dea51852af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4527d8c5-fd85-4fe4-86f0-d65c9390cd36 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5b38532a-8ebc-48fc-a2d8-670412823b22 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c7392955-2ccc-47e2-b1e8-3f2bae085a02 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/af63ff41-5a8d-49e3-aac1-ef8f9cefb466 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f9942b3-014a-4ac8-8bf3-d22f486b5fec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/249fe2a6-5941-4b6a-8e96-9751e1d2a443 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5b4f8de9-2342-4b8a-9202-0c80853e3de6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dbaba0a3-aabd-41c6-88ef-236f83068c2e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ee2bf0f-ddff-4d11-abda-1af2c2722ae8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0cfb9e59-440e-470c-95f1-f1fe1cf92eb0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1882ecd0-bf4d-4cb5-b22a-481090501a13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f3abc8e-ce05-4c86-a2f4-9e3456b012b1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/39a7b259-9948-4b85-afbd-13e06d9822e9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/083f1935-a8f1-4000-971d-1308f22a4e83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59ba191a-fe4e-4aaf-8f12-6dfcbf80f090 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e979116-99ec-4928-bd64-839fd21adc51 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0de2b549-b754-4aa5-b817-ea1567dff63c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/053bbb82-7d25-4d00-8503-f1ba1157c607 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac6a12ce-033e-4194-a1dc-02b76b87b953 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75b6144b-ce07-4a6c-aa16-5fe1b66ddff6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4d2c74f-e65f-46f1-8a70-aa0ec9f64570 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fad3cc2-2455-4475-aaac-1202aef6bae9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9009ddc-4705-494f-8467-373aabe4b7b1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8da91265-6362-4299-8176-2335bff2a4eb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d328c595-037a-42c5-b1bf-8c2b91ae912d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04c62698-e85f-4406-9320-18f43e352c65 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab6a0254-06ff-482f-b755-fbb78581d66c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/49dd6dbc-3eaf-4fcb-829f-a70c80e6d87c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/21521db0-69c2-48e9-9669-50b99a7a40bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4459d7e-db32-47a0-bdd4-6477177dd963 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cfc208df-0a87-4e28-9e61-a2397839f219 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/793879ed-09c0-4acb-8b28-072fe30b6336 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/41eb5ba5-5aa3-433f-bf10-0bb2180ff8d9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f3045bd-00a8-4301-8ac1-877f141bad98 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dacea90d-bfdd-4528-a7e5-98a782145dea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27c83fa4-89dd-43f9-8acb-f05abc1b2f88 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c71a80d9-c8b3-44b5-9bd8-63e8c29d285a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a0ebcfa9-1ec1-436f-a9b6-652d448c5d02 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a21430b2-f662-40b5-ab01-d650b830d489 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/29998bef-cfb3-49a0-aa03-86afdc010bb3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c76992df-5ca2-496f-b004-5beafc449ac5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb9f8f37-e8ed-4488-8625-53e1c1c3b860 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c898954d-fe5f-4b9a-a3d4-431d5131eacb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/198ac78b-1d40-44a9-aade-90601aeb3b9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8dca52f1-a28f-4ce2-8dd7-d24116e32e3a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea56b4fb-5fff-4e21-ad1b-4bf9c1addabc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/196740aa-c616-4645-9568-d17717042d61 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53f7908a-2df8-435d-bc68-31060743a42e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c320068c-0186-4924-b8f5-fc50ec2f9a06 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6e177bfe-4401-44e4-b490-65fd98e8f859 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2a63e3d-6f07-4847-a777-12fc37ac2c2d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2c5f115c-6efe-4a21-b446-55e222e1132f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fd949f3-1443-4335-b0c1-50bdaa5f4562 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/537ab9af-34a9-4075-9c11-e6ea47c807df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/80c803c0-81f9-4fc4-8cbe-6a69cb0ad672 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/df00795c-4e34-4c85-8d3e-509b6804cf20 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a0c8c54-2e9f-4db7-9eb3-ac294fbeda77 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0996471-a958-4394-aba7-1712b108345c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59d3650a-7508-437e-bb1f-1b21a17a31e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae65d8bd-0ac6-4800-a7c6-69e3a2d34de3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff516501-ad53-4792-95c0-59e3ca48f843 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dcfb8005-b5ca-427a-aa21-7aeff2317b59 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a930e7d0-4f0f-456e-ba32-b62344cb9883 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1967588d-a736-416a-bec8-7e8d92b0e8c6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/06562d53-aacf-42dc-a58d-a5025d959f9c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9004b7c-1ac4-430a-b06f-c9aa5b9ca56f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c4984dc-3786-45d6-9201-80d7831cbd83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/079b0ba3-e2a3-4524-8646-a549d7b24fbe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1406f76-e7cd-41fc-b88d-56aff52d81da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a384fb99-52bc-4444-a75d-07c44c8ca229 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f021988e-edb4-4a98-b7bd-733d5499dc56 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f677f2c9-3329-4a1f-97f9-a62ffc5d6ef2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/96da3074-dd54-4fe5-a82d-c644000f89d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8b92ac7-4828-4018-8d74-e9be725c6e7c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb0fb5b6-fed5-47ff-8a06-60b2fa8c6a0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1ada1bb-6de4-4a78-b243-5f5fbe69686e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67490966-2eda-4067-8742-76dde62d6eeb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7df6f430-e50b-4484-b436-7cf988b649e1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/91e23af3-1a49-4677-98eb-cdc3d28d0fd3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82d31a83-1b6d-4f44-86f6-d46a0d1e64b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6063b0cb-91d8-42dc-b618-edc1c13339e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff6a6264-81ba-4429-a5d3-1c25f1400182 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee91ae53-8a85-4818-9b5b-c8079f81caab 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f208358b-e1a7-4a4e-a130-172ec28f138c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/51daad97-6ce0-449d-9d57-129aae2f7d49 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8fcbe925-c5ef-4a3a-b6b1-8d7832b6a91c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/37b5ca61-8eb7-427b-a719-be157a2e1c4d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/140b83eb-d33e-4115-b7d7-ce913052add2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf60f0fc-e97e-4cee-8e6f-e92fd7a94817 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/455600b7-65eb-4cdd-b201-2606131cc228 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7abf9e4-18a7-4afa-9847-4e199d6835e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b38cc0bf-4300-4519-a36c-57466a0387b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2bc610c8-f805-4e88-97b8-21c8529acb63 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/79f220b5-c1f2-4d9d-a1cc-4e627df6f8b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c6cb2c66-8bf8-4ee7-b3f0-8e16a27eee11 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fcc5983e-01dc-445f-aa33-d0b58c2a9c2f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d15fd78b-8407-4d07-8dc4-ec77e73780ff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/509a8686-4f76-4a88-8634-ec2f99324c36 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d9d3bae-0343-4375-a058-c1d8b5ab9553 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea810ba1-2d0f-4763-84c5-f5e2767b95ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d30bea04-5c8b-42d8-a0d3-114a0477bd56 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e736a8ec-5581-4e57-bbdd-df120a1e6a8a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bfb28592-4113-471c-a7ae-d7faf2a7d7b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/384d01ad-fbe5-41e4-90cd-ee58ccbe5107 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8338ce17-3550-44f3-b7b3-289efca62907 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/391d8036-cb56-40e8-83a7-05ad423e9c69 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/45ba5c47-bee7-4949-a289-ad70cc1595aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a573f68d-ea82-4695-be60-4ec6c88d2d5f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b86cf81a-9241-4547-811b-0bc0bd7ae309 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bec5fcc2-d02d-484d-b825-f00491f68f87 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3e27deb-99f7-4b18-ba13-7c9fa6e4ae6b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b299993f-9526-4c8e-81b7-8d2c52d35456 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82232136-d3fe-475f-8d9c-11578de1d685 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1843107-d6d6-446e-a00b-effd48bd1d56 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed3f1e89-989c-4f4a-9d2b-c6c47a2b00a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f668947-4cdf-4b03-94d7-f86fd7fad2ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0904f9af-10a2-409c-9aab-d215fd8c84cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef48cc3e-0ed0-4049-aaf3-67f03750b70c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/26de1087-b39b-4da9-9d4e-d077e4ad90b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b7765c2-2835-4953-ad06-5aa60c6199d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/15a7ed3a-a2f6-4b78-90d9-a0c43efe44d1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5498d1e-ee46-4124-a90d-a54e79a3e524 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d6cb63f-72e1-403a-808d-e0ed34af2ca0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2d2e049-0874-4458-a9eb-96ac7dfd463c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5bbe2d4-ab71-44c6-8650-cab9267130d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4d498cf-aa48-4b54-b1d7-f9473edd48ac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2277a95b-f51f-4fe9-860c-0f7e1fc63422 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27cb62b9-cfc8-4f8c-ba21-e301825b08df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eed89fec-5546-4002-b385-455f2080ff10 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/612d5b14-8ca1-4266-ac4a-c7ef3dc81541 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f381c659-0948-4fce-a1f7-ae469bdcadf3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9798ef23-4c6d-4f78-9533-d7c78d939785 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3a21359-b373-4fa5-b2c7-3844d55bf213 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7f256ba-7353-41c6-ad4c-35aec163a1a0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9337e410-d922-49d6-aa51-af1dede6c89c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/734c5865-b198-489e-8faa-2f933312e6a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e645f39-a3cd-4fcf-a5a3-c9883378beaf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c702b641-2c78-463f-aa65-6a50d247fa33 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/038d824c-d0da-4007-b18a-d39a4b4ffa1c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f126f41-3558-4036-ac48-0112648a334d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fef66acf-e8c6-4532-874c-a264ca2170e7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf365fba-3f64-4ff6-ad1e-f13276e257e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/db8c265b-ffc9-4959-8181-cc1bb72d41aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c7671945-7445-4f51-9c3a-33708010fd93 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04641308-2975-4db6-9727-041eb2f5b3b7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e4e9f82-9525-4e12-9e82-6ad2d76fd812 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4dfa9531-5966-4006-a6f1-3816e3e93316 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/843e8365-d089-41a9-911e-4e1c06e6662f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fb72ddcc-7606-4145-8351-b7c10fd4d684 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3df5091a-1884-404c-b2a4-66fd832390af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8024104-4d60-467a-9258-0bc8bfc611a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1075ba84-8b11-4464-a1be-e7dc46f11c4f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e8465433-7cd8-4289-a3ff-14e0ee725a64 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5559a6e-de56-46e1-8c52-bfcc8de326b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a3d711d9-2c68-44a2-861d-18cfa61e4276 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a704747-c579-4f71-bd1d-8256b24ee4c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a9f1281-a736-4ca2-9874-bd38716cf398 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ceba3d44-9c15-41c6-ba92-86f4ff730379 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f148d0dc-4041-4ba6-b2dc-f62247612576 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63b4203e-4fe8-407d-94d3-7d52864c19eb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6907e123-104f-42ff-b704-0a8a272ca0e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c7c1fa9-1888-4c69-8bd0-0b323d36be8a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e06f4186-c89f-4268-b1dd-47a4bd244840 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/80031694-947b-4841-ad74-11cd92944db9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/266429ae-560d-427b-b180-f790d56f84e1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/32d0d217-bc83-4d54-b3db-e0e298d7f9ae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/101b83e9-2da6-4f8a-a9f2-20d8a21c6e93 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/91e8e1d1-d6ba-4943-863c-392f56c7a3a8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4a11ac6-188e-4c59-8f62-d75f933500bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/973855c7-b047-493f-89a8-b6f564462c38 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c728657f-d085-4140-be3d-5f7dfca6684d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9234ce5-f3c6-47b6-8adb-e42cabc16ba7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a6980292-1123-463a-ae3b-f1dea6bd629e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2993466c-e162-4b19-9b1c-3302839f3344 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cb7fcab-9b4f-48e4-aca4-8618dfac7e07 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8311daf9-aef1-4dcd-ad58-413cf2b4df53 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4e382e74-c909-4fdb-baa9-cc46018115d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c49b66b0-0730-4d86-a781-12d3c599a387 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/83b69a36-5f9a-4607-a455-8895ed21ae80 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9a42ce90-9f3f-47a9-8ecb-7e21db56520f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4811f508-24fa-4170-8b69-13b521bd157a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fb069e99-42e8-41f5-9b82-b9c65531e576 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fd425a9-a702-4b02-af51-527047ccf7c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb6af320-fba5-4700-ab5a-0833d589c209 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d31fcbbf-b2ca-4c25-b5a6-9cc8b2cfbc78 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f93d9f9-45e5-4196-8961-f0431f928e5e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b491ae3-04aa-4f72-a760-deda65adf900 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d028b78e-e745-4dd2-badb-c74982a56abc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/49595b7f-fa1d-4ee0-9711-ce5f5619c268 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f966617-d85c-453f-b9a2-433d1688cc78 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fff7be4a-7e96-4874-a7e8-a45f05000189 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3488eb0a-feb0-42ea-83a9-028806f222b7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8bfcd62a-ae83-41b7-b651-15a4de41f7ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b864d526-2d3c-4809-bd34-ecfd15f8a1fc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f21a81a9-dabd-48b2-83fe-a6ef01222533 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e21c4d96-181b-4c75-b651-9923ef5e0210 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a441f6fa-dffc-4c57-9ab0-d86e99429803 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fc55d39c-a210-4bb2-9b13-0cd6054dae44 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/61d5b320-581e-4fd2-bbb9-1b10c96df2a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/46e8166a-5d0b-4af9-ba66-19ee5e4048c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27aa72d4-bcf1-41e5-8afe-8eb6e3aea99b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6bb668df-a8ca-487d-adcb-0fb735efbd2c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23176527-3481-46f7-affb-d1d63bdf2859 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63ea8f77-a239-4ecb-b976-18a71ce1e98f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/990f5861-86f8-4015-b996-0565dc21ee94 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b0594b84-2e44-4b22-a38e-b4bdd217fae1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/89fcc0b3-024f-46c3-ba86-c8d12793d018 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94c422a6-fe45-4f02-8640-e90dcba6f02e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ccd003da-bb46-4b41-8d45-80af1439f05d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fc0d8df-e4e5-4e4c-b7de-c9701164b297 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba189949-3016-483f-8965-8eca5e9c9745 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2cc8887-50be-4678-a791-c5a60bfb2491 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/420dc1f6-63e6-43d3-9786-ca34829d006e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7602445c-6327-43ac-b7b9-e5336a5a2944 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f240f037-7e64-42f9-bb8f-e3de694dab2a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ef9ca8f-5c19-4f49-a88d-1b809dce6643 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/12606227-32f3-48df-b4b5-b21cfbf4840e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/00648f98-3d00-4b38-b18f-3f3b54a2c67b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/550979fc-4133-423e-a2a4-10a8d8ab82bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5351c28-eb2a-4f59-8da8-6629e5172e77 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2835eff0-eb84-4324-a232-64777e9b5dd8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/827fe99a-0c1a-41f9-a68b-b5e205610559 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/293f4c6f-054d-4651-b286-4f8c1e45bbd5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d28ad3e4-1df9-4920-87fb-b01c6797b7a8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef84d266-ffaf-43ac-b74f-615f8830a9bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/57cddde1-9e2d-44b0-b801-ff9b00d2f2f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb8db648-9dc1-40da-83da-e21eb23b5f50 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a7a0e0d3-ed84-4911-ab43-38a8ac7f196b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1bb919b-1966-4f04-93db-946ca4302a39 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5dccf6a4-e323-45bb-b47a-8efed4d8aad0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1346adc-eeab-4e53-9408-14ed3e36be59 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f467bd2-f574-46ff-bbfc-35cd4b2f6e6d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/051be64d-8b16-439d-a11e-dacf829c0ff0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eac4f70b-6195-4cb6-ab92-6cac5e874f49 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0aac300-620f-49b2-813c-d833f81a42c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/02aaf8d2-8f80-48f2-af62-e0f27a6c1dbd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/42e6099a-ac57-4a97-81d1-88b2ade47dc2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f786131-a732-43bb-88d6-36c8e586cae5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53c8821c-1d39-469c-a555-45adaa16815d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd8d8298-561b-410e-b451-d67e247497e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6620892f-ffd6-4705-af1b-ca3d6701d6f6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa12d6e1-1390-4f57-a345-38f728ecbfdb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8cb1bc0a-b5ad-4eb2-82a8-f217d8ef412a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f6f6fd4-0249-428f-8d92-80b941a9be54 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5641e1d4-1e52-46f8-9eca-cd94465aaaa5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ab892d3-25ae-4d89-98df-43df736f142f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6971d075-5a9d-4554-b788-98429e415e69 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ebcd4fc6-1e65-44df-ad22-ffc00b3d09df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/18c51d02-1be1-4e1d-93b0-9f38ce0975d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/35ea2cd9-6dc7-4029-8ac7-126438d670d6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5c6127a-a9b9-484a-ad54-bb9aa16a1441 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c34fcc5e-fd0b-444c-85cc-6161ad9875d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/77031319-72e8-406d-8097-fdddd246c8fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b2c64d7-4882-475a-b074-eed5c55ff9e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/05f15385-29bb-4d8a-9669-73001afa6fd7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7355b0e1-8726-4f5b-816d-4cc6962d55c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/07476e39-bc3f-4c5c-a9af-cdbcdb0d3fa7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e61fe447-c566-462c-98f7-b3018c8f9fe7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90441aed-fbb2-4914-803e-87d0997ddc85 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d373affd-4bed-4f08-9768-f056c1f51f82 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5dcae937-2168-4b00-9fb4-c59312e1af19 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf7b3505-0154-4c9a-994d-5e5716fe93cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2e1b8c9-2815-4aa1-957e-a1197b4fb3c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2790c2e0-04de-4d67-8f03-7457e0fa12d9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/652b5a15-e0a2-49c0-8dee-fb6da79651a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8ef98c8-919f-4c9c-bc27-3106b3dcced1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bdb78967-d78b-45c3-beff-e97ba4a7293f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dacafa8d-d70d-422d-a017-2489c389d03a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9fb9dcb9-05c6-47d9-81f6-80c60b04c376 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8b22a7e-199b-4917-a156-7ae27587a7f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c29b7310-19ed-491c-9aa8-4f634d2a2589 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36ee431b-8f91-40e8-bc14-ac668d6e14a6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9520db45-568d-4ef1-b7ae-9d4f348517f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c339484a-3245-4bef-bf56-7ef47f8651a5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f64e14b-56a7-42df-b33d-37f41f1fe77e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/966f2ca7-f96b-45d9-b95d-91d89579ca5c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/be62806e-cf01-4ac6-b287-9b86c7cca93e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a2fb52d-f2b7-49da-8577-14a22ce85481 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/813f498b-563a-4d6a-b3b2-acc469e659f8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd4302f9-fd53-4e63-8a55-d975780628d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a01f46a-1832-48d3-95a1-0d10521d8e89 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf47396e-b1c1-4924-9aea-f7c508756e13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81bb90f1-4869-485e-9eee-7321630c3a42 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c69a19ba-ef61-489d-b4df-01c79345cf50 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c595f2c3-0cf5-41a0-a1e9-3cfd47f06d68 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/db5c0d0a-97bb-4464-95e5-e48d0e7b4e18 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c231472-8dca-4d16-a4f7-488ef97c34da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/137f7e14-3c7d-4cd1-9765-626322f3d624 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3acccc4c-48eb-4214-b19b-68a1eeac2d64 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffe62b4c-33d6-455c-8ae8-3ba4f40ffdda 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d1807552-b57e-4f90-845d-07e97dba545c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7fa2ad0-d623-488a-b38c-42351da76317 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a75df761-1612-4fb1-91f5-013c1d09cacc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67a91014-022e-457e-b935-9adcbe3fddfe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9dd1194-08ef-4df3-86bd-701a2d6704b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e94a9ad-7f62-4378-aa5f-51e315042294 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8bc6c684-6185-4a25-9265-cec720a2baf6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4bfd9b37-fe9d-4332-b924-438cc4f23665 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe800ceb-2eb1-4f89-81c4-71b237b11394 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23ad71fd-a1de-49fc-88e7-11b7ff61012b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2eba3173-3ebf-43b6-842b-c93805f51e79 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ddb5736-8389-4bc7-a490-368e9b2ae9ee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e36d10ff-5d23-413e-b434-68984c3c87c0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/70368d92-56d2-40d8-8363-536373e4b755 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2db02017-d589-4dfd-b72f-4036ca36baba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/11dcc010-ca37-4dff-b97d-12cea9074023 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aeee210b-41e4-400b-8336-2b6fd3c6e707 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8b6e4f90-a55b-4447-9861-d2c8d44c1146 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b040a060-df2c-4a44-bebb-e5cc39eda2fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31404432-dea7-4cca-8bf1-747f0b476295 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b152cd5e-e7dc-4e96-90a6-1a38fe39a7e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a068947-4d71-4c15-bf59-38fbdbc9d726 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2702471c-9d63-41e5-a8f6-5a25eb83d609 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/527f7334-8c1f-4286-88f5-b3e364d5b7d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/772f9df2-b611-4c85-b969-4693d69562da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1e423a4a-f5ce-48bf-bbb5-0d814ebe9734 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/07f127d4-1346-45fc-b4e1-13e9e84f47d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c3cfedf-6be0-4227-adee-949fadc7dd8b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e931c73-d3cb-472f-89af-aa3205bbff61 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a11e9fac-1a9e-49ca-af88-41e6b8a237b4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/62cfc3da-ac42-4e58-9b5e-fffad0490eac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7850dabf-f788-4932-a959-a5a27a6974a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e324189-5fb6-4e77-b509-ae8c121fc69a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/85dfef03-cf56-4729-a0ae-d7dd3928d206 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eed080de-dc22-44b1-8075-8242135b82e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/713fd5fc-30e8-4be6-99a3-f6b0752c1d8d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad39937c-bb96-44ab-a509-cca26ce45443 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/49296eed-ede8-4555-aa01-259b64b6036c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/60b1a93a-11ff-45a6-b949-8f61094e8904 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f700fd8-6df3-4a5c-a164-9f8d796340a2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/561daf0d-3cee-451c-be28-dfce9896dca5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b1a6505-da5d-45dd-bdb9-fea6e360c638 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/34471723-b223-4c95-9754-9ecc388c8e1c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b6f252ef-712a-4046-8910-7c47bd36c461 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4e660260-a2a2-474f-b993-1404b308054e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9edc436-b69f-41b6-a7de-ded7cefde23f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c96c3c99-300c-490d-9c94-2fa57cac6229 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3cdaf686-7f1a-47a3-b365-dcbb43ac028e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82c3aeca-5887-4fe0-8d3c-db664bc67236 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b8679f3c-5979-4eb9-aa75-3e3a975e0146 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f6f7a486-daa1-4186-8156-e563299b6c3a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c35b401-1d43-40d1-926f-fa7f26c8a168 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/385554b7-c406-4795-a875-b9a741f0890d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/79aa9e89-370b-4fdf-8aee-d792fe2faaf4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c148fdd-3fdd-42ef-bb75-fca7e9c26410 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/52402fdb-3862-44ca-b2c0-7f81a00a5768 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb602e6a-a566-4ef6-8eed-5e0ba37e078a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b7c8f201-a0b9-41a7-b577-6c2c8fe4cc2a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f75d2abd-8563-4973-8690-cf51ceca9236 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d88a64c-19d2-4c1f-9ec8-4688b71d647f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/881f1044-4a44-4793-b1d8-c50f78bccf52 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e4c6244-9d59-425e-86a5-e6d1eb4d36af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad93198e-a3d3-4340-9cbb-110930b0e986 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cebfdb7e-5bc9-436b-8fcc-cc5a324baf91 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/24d89c86-c4ab-4f09-a138-05b5ec7ea0fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5ef4f45-d214-4b05-8e05-07f6700a8c0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2c5ee8e-d543-43ff-a95c-87596c271866 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c5c0b6ba-3099-4a34-be9d-df8bb4968191 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/66abf9a7-629c-4e46-ae55-0072d534b7da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/26b61598-a1fc-40bc-a9ff-704a0ecd9251 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/84d37a5e-05fd-4648-b3a6-38897a355267 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1800ec5-3627-4dce-836c-5cd3dbeab70d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ef860ef-cea4-4428-88af-5d364b1e2a68 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ab8141c-d515-4fd4-900c-466d58b596dc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99d0445b-ae27-4178-a196-2ad6acfa1716 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/010bf15b-6ccd-4513-9acd-75391d4a889c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/29ce6df7-928a-4ea6-80e4-fb363b2e8040 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bd39a4c4-7734-4f09-84e5-dfb733cd2143 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f45a87c-2f92-4029-9154-44b5728bd376 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a2bacc6-ae88-43bb-9e81-30f4503ade89 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7fb6695-342c-463a-99e5-e157c0fc2a4c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eecd9a9d-fa08-4b5a-b6a3-5162216e9df4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3fd52cb-8f1d-45f0-ac21-22f0de8ac0a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0abc6425-2309-497e-a9c3-79855451919d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/736f920a-86e7-4a46-bc58-4c12f699fdff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a2e7e1b0-6238-4c07-9add-60d9f4cdadb6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c434da1-3a47-44dd-97b6-5ad48187223d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/120c48ef-3fd3-48a6-bc99-cf818488d92c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d7e70ef-19c6-4888-8281-294f93c73020 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8df730f7-736b-4dc0-b1db-4f03d4a44a43 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/68e2dd0e-ae67-45fd-8587-0cd5ce5d4d47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67740138-e653-4ef8-90fc-6b2005002579 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fff0ef75-1628-4a58-81f7-56123b3ed5d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7ca6009-3e04-4ed8-a454-f29ae61b32ca 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f800c1a-9fa6-41f1-9395-8465bf5c55b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa3e9763-a79f-4345-8a96-66b03d6c43a3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f7caa44-642d-47ca-a960-8fa68cbfd444 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/db3f8b92-5449-4bd4-ae2c-23733a96bfe9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/22b7f5b3-a4c2-431a-8de4-aac828f37926 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/51f831dc-d07d-45bb-b6e1-3903dbeebc35 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8dd350b6-8d0f-4b18-962f-032c0e9f4d2b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4a9cee21-32d6-42d7-98e5-1b45e217fa3a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/14004a97-b882-488b-b735-ba26dfe886c8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/30230176-d772-4e6e-9455-3aa80fe73e9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/42715105-566d-47e8-9e3c-dccdc6fcefaf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c9bd6fd-4b97-429d-9d31-38de091902f6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/080e24bf-ddeb-4929-a9cd-053f1ab82b7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac3b6ac5-dcd4-4bc8-a24f-c235c7c00ef0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/15da69e7-41fe-46aa-8d1f-304b8cedb041 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ed93596-62aa-4807-9130-a0781b458409 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4770a72-e7d7-4152-800b-b707ce156e59 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1bcb772-75a7-40a9-81b1-7c2d85a76a93 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03d36d73-9384-428d-b606-37c3d5092ebd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5695f310-2aa8-40ed-808e-643d0d3d1974 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/18394b94-0f82-480f-9b4b-3e66885e96aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3140f18f-2b40-438a-9c83-5d42da3f7383 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71fe3a6e-a739-4ccc-b22c-1a07673c4e24 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/33a1f7a2-65eb-449a-bc93-324411581b55 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/827cf4ca-7d9c-48a5-ac74-8ea911865c18 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb7f612b-6cbe-4cdc-a375-0efe13b07ef0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffce82af-f440-472b-b2e4-e9d6ec94b6eb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7af06a03-2efe-4e6c-830a-258f38b2f993 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ee2907e-ccec-4f4d-8da1-69775f51d1b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d16ceee9-3611-4e1c-a2b3-6ca56c5e05e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/64b7e4cd-d17d-4d5f-ac7b-ea6430502074 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f60f0c3-38b9-4864-a4ca-b6b4a913a3b1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2ca765b2-d065-4eb3-ac79-265763e9c8cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53856d28-cf0d-49f5-817b-81ebf99a2d69 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/357b7b15-605c-406c-812f-b867fe86155d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b408027-89b8-4400-abc5-f32912f31678 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27f0d3dc-080e-4512-bcc0-44eda74d7917 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9a191fa-839b-4b0c-bc90-00a5025e4dc4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e72f083d-3d87-4387-b21f-787a4e771eaa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7fb8cc75-6167-442e-995d-066fa4f172ef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/21df1283-bbe7-41c6-9aad-d382529f7eef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9eabcf0-5947-44da-a39a-d1ec15f577da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/927379bb-122d-4a6a-b4d6-58d3179c05fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/12ea56bb-cc84-4a24-bd80-0b63daad43d3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1876b9e2-076a-421f-986d-5d507af2ea0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5fefe33-e103-4845-8482-e9ae54643550 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb26afa5-a411-4e5e-860a-7ea0cb18f477 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce1bd396-5b86-4805-9439-3b227a74ea83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f4442ed-d62e-415c-9363-f82c38f22caf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/22951771-a308-49e6-97a3-ce4c7bda92d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c8a8cfe-11df-4de3-bee7-6cd134b59c2d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fcd9286-ab97-42f7-9a78-30b09b20700a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b19e47d7-3059-4d57-b63d-7d959a70b077 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b187fbef-8cd5-4b0e-a74f-c5545863d5b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7c38db1-9a9b-4f0a-8c43-bdf7ad075487 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/33029db9-981b-4a58-9ced-9076e0878a83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53c7749b-788a-45b9-806f-f02f4f1c2569 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac956563-ecd7-4669-ba99-ef0b9a924004 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63809392-ee0c-4ba0-a81c-b557fe39728d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27a8b551-0820-4339-a9b0-7d4f1dbf3f1a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/893fecdb-8c40-42bf-9cda-f758a518a9e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08effcdf-bebb-4cbd-ac79-9563911c0966 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7997c242-8b82-4dbb-b951-40570a7043c1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/661837d6-8e7b-4f43-8273-9c2fba8bba9d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/92d49ff9-2866-4c05-87b3-483515a124e9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/77ea6f39-4e36-4139-b48f-b5363c1b90e6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf36852a-d2a5-46a6-bcf6-1836d8e604ee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56957487-a5eb-44ec-ade0-c74b3edce90a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7b8cd81-01e5-4a2f-8a53-e9b042a49581 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/76b0937b-a11d-4a4f-97ad-58e84418a7e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/47340c2b-4aab-454e-a13d-5035a3544209 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8bcf81c0-5d84-4c03-b090-59011da24e65 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c6e1bc4b-4f29-430c-ad49-17aeef376f36 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d78707a-74bd-4b16-85dd-f1f01c3fbdc2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0491fc80-d766-4b6e-950a-9ab2d74ab80d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b188ce3-bfce-479d-8138-b7a4b0b5d56f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/babe9719-7252-49c2-b2aa-2459a8d48fb5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e94b22e8-5134-4ff3-b62a-b25095c1222c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/54175ed0-aec9-406f-83cb-31636430825e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b607ae17-1ebd-4336-b21a-00e7eee2eb28 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f1a5a47-338d-4772-a7e1-8c88e2546bf0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bab250db-ce97-45e1-bc73-8e87a7ff71c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b88aa49-90d1-420b-8a06-06c7701dfd51 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f51cf781-09c2-430d-89b9-95789c7b9f04 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6118c4ff-ebcc-4781-ab12-c01366b5d175 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e24aa04f-3459-4a1f-afb7-cb782c31fb9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b2eddb0-ddc9-4f44-afcf-eb210f2f9c0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c9f3ae7-f2f5-41d0-87a0-c6671377b68c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1d210ed-1bbf-40b4-a32b-5022e1effe21 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c43123fd-0085-4e1f-9d04-c554cd6cfa3c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cdd869c4-924e-4d4f-9f54-0f01fd299e38 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f38e832d-4cda-489c-b908-9585f9cfe6e7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7ea4f67-b352-40fb-8d86-8fa7c7144d24 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a45cb26-7e27-4746-bacf-357839979253 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/128e5575-1b10-42e3-911e-e4d4a9086ffd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56a9dda4-da4c-4430-a194-f2edc6168b28 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f3375d3-208e-4d65-9b5d-e74d1e20d577 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f37640dd-6ddd-4e94-af06-4e1ab5524058 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c25c5b65-74c8-4ea9-82fe-bd50be15e230 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9618a533-291e-4f87-a889-ad40c46e5bf8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/85d93d0f-d56e-426f-b156-09c34968aa2b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5faad5c-c89d-4625-aa22-8a329b2b3e24 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b0e1b99b-a5c0-4097-8956-f22466915eb9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c6a046e-9aa3-4ead-8875-521096c008e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d7508fc-862b-4ca9-bc2e-b321b8d03317 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23f72e49-3634-48b7-a0a1-6cb07e4211c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/847ed0c5-79cd-45a0-8f44-2780c4800bae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea37c715-dda3-428e-8cd5-fb585f7e1329 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d2bf2cda-082a-4e5e-bd8d-255291096c32 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93247191-d15c-4dbb-a99b-c7452d7c8e38 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fc65d3fc-7c8a-4282-ad1d-fcf00e90f8dd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/64a46729-0fc2-4116-8395-d02415f1ce09 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1721d569-ef37-4c66-89b3-5c99d55351c7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae606138-4a60-40bc-ad15-316e591c486c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d54b4d7c-4aab-4eeb-9dde-b1d3097c5a24 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/850727e3-e682-42bf-bcf6-c25cd93417c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4696d76-5b7a-40d8-9d76-d38366cecdaa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9df8b964-2fd0-412c-ab75-25f6301bb8df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ed5b5c7-ff1e-4c9e-8539-96556241d03c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fceb94e-ba9c-4e86-aa98-e087eba49b60 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99d356c4-a8e3-499a-a21f-63e7b49aff5c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/05c7dfc1-21e0-4b8f-9368-b52f08984210 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f27323a1-92c4-48b8-b034-53269baff76c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8100a94e-0e23-450d-803f-e7d5862f8f7e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f650107-4faf-4eba-8f90-458e1e8857d4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3f14610-995a-4145-b506-f594ff91f584 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a3014ee-b847-4266-9aa4-f764c7466a7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/327a4750-f943-4e1e-b0a6-f04145537713 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/796585fd-fc9d-40d7-8f3f-00b55718dbfa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f63f82f3-1b60-41ed-bd52-67dd9c1755f1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dc00d64b-b574-4e35-a276-a9dd39cd4fab 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4327f939-4670-436d-be5a-f614085e47b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27f4c882-4305-4f2b-b3da-f4ba88d0c471 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/49bc408a-30f0-4878-b966-07e21ce2449c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bb0333db-9f82-4c8d-beda-28355eeb6c5e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e99e83b3-411b-4aca-bdbd-ed70e0fed294 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa4c6b66-7bd5-4e81-8550-104678e25473 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d68ae8b0-bc62-4d9d-97b2-32402b81381d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b91f9c91-fedb-414a-89ed-0faf291de501 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/29c7a2da-5b3e-4dc4-baa2-e5b3e472a1ee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ccb562a-27df-4209-8df3-0a5f85c15ee0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e94f3cdb-c1a3-40b5-8aa8-fc42a97b37d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/114264bb-381f-47cf-bc38-82c652039562 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03dc7604-4b1f-4a8e-a652-54aa666357d1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fdf6bce3-488d-452c-abab-82e9974814fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/255bb32f-184c-4d53-bda3-df9a0331b88a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/89d9b2c8-a150-4e76-95ad-434c647ef0c6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/30c0e57e-d150-41b4-a646-76239e8b10f4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f7f3c9b-ffa1-4213-bed0-68168950f903 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8f104a9-7ec6-4599-9054-a11987fb9b4f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2b3a181-d567-4fc5-8711-718d6821b76a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd32b0e8-d034-4169-92a1-d93edf3f26ef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a653a60-9cd4-4fce-9ca4-2b43635aebdd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d684ae4-4a8a-48b9-bb26-da9b5a61d393 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7fcfb07-c8c9-4266-bf56-ef97bb278d2e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f689e4ac-a0f8-4651-9645-f93953f7f39b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae61190c-8e51-43d9-96f3-9ae03ef274df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ed28a1a-08d0-48cf-b273-cebe00c7cf9b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe8e3238-310e-4410-83cb-9bf1a9e4e9cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/66ea53b0-6b65-4874-bb88-2016eac394c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d1e6ef6-0f9a-4846-a0c9-66d283e99a21 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9869cfd-8b05-43de-8686-90ba85bbeb49 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b28e6c30-6ee8-4d3e-8eac-13f4eef0bc44 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cca6374a-48c8-4e87-8f28-33b9eefb7d16 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2a08990d-b50a-4cb5-a499-962677f0b295 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a0fa8fd9-a73a-47b4-ae70-f85491077473 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/35cf3b2a-a546-40c1-ba17-e282f2c21b40 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/425360c4-ecc0-4338-b666-1a968c7d36b7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d567d63-928b-4369-bbfc-c91f0f56c248 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/51d8768d-5c09-4efc-ad5d-e5f008bd900c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5d6066e-1f80-4db4-a8e5-3664eeda8b0a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4550f93-b082-41ca-bdd9-cbc91e2e80c4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c76069e1-0177-4856-9fcd-af3f73450991 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36b57a1b-3fcc-4f2f-80b6-f2b357f21a36 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/60ac7b6e-34ef-4bab-a06a-930d26a4a8c0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f4e039f-39da-4d83-8394-73e2c23be55e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb64a5a7-f2a2-4bb3-92b4-5f76ab4648c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0290a55c-f876-4435-8d32-25baf2eefe6f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03e6b8ac-7ca4-4d15-92fa-db8c4259ebaa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/534c8f6a-dc40-468b-93f6-ecf98810bb0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c9f7f52-b48b-4764-a9df-29bbe2726f68 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0b6975a-2193-492a-993a-b7cf8295d746 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/646f5cb8-ba9a-44e7-9b5c-04af6c1aa481 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b785ca5-db39-4ada-94e2-52a7e4b09383 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f7054ca-2004-4a19-ad06-bc7a30f6abc6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/087e34dc-8ecb-47c2-b645-438a5931bc0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b23a22af-0caf-4cde-8707-1c9c378adfc1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0df291b-7f34-44e4-b7b2-9435b7dec40b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a33cc9eb-31bf-4073-89b8-04829ef8040c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82cdf92d-a271-4c88-a10e-a17345457f3a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba08389c-6768-41b5-89e1-48439c17955b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4b454a6-7ccf-43c6-9733-16c4f9a53a82 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/41f4e26b-b91a-4234-b9db-0f1fba824cda 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6d0689a-b4eb-4a1f-a5ad-8ca073ad1763 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f98b634c-1f03-495b-aa57-3d208bca162f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b61e4b6-639d-4d38-b4dd-49468ba65947 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f6ebaf9-eee7-4614-8930-c59103b3385b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a8939cd-3be2-4e21-af82-0f3213c8946d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/77143e12-79d9-43b8-aa55-8f3ae6959249 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59fbabe5-33d7-45aa-bdb7-c4e2d3117cb7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c64ab62-2605-4374-8e41-ec347c366297 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf6ea756-108a-45ea-ab04-9fe96ae36eea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/77875af0-f448-4959-bc46-a5dfa9d988d9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/878fea07-a413-46c4-85b4-3ea092b659dc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb2e63a7-d38f-4179-8949-4c73bb47714d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/402bd6c3-efaa-4245-96ec-87ee4d3eedb3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5756f012-f23c-49c8-a559-2fa2d0ec3a7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b101090-b6a7-4576-b88a-0758c2880ea3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f51f3ef-2d4a-44a3-878c-b5e042f4c024 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b683c3f5-96b8-4115-b53a-84df88a7c33a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/14742006-c7ca-41f2-96b4-75fced424518 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2389df6-2894-4ce4-9272-f0230c81f3b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/060caf07-e60d-4a23-87e5-9466a74d2b70 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/41d23d24-5e98-45f7-b2e3-40b63b2fcdd1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c928a3d-0124-45c8-a304-8fc58b785bf1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ee649fc-edad-41ae-ad07-0214a560de58 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/79fc43d1-4319-4280-8a52-516e775bd403 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c1bb1759-03d4-42ee-b4e1-b109e7536abc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a745533-0d19-436c-a110-1613e835b449 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/af03bbc4-c97b-4d7e-b710-841086802f19 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7b15e9f-844d-49f3-b990-9c13888a175d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a7adf724-24a6-4765-891e-29d787a977ed 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3466a596-9d2d-4448-a01f-1b8439a6cc2c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/121bfc3c-4206-4319-a136-917fe0e7c95c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d07eb577-fd44-4cc8-8a58-0bdc5168c3f9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9865a0ff-75b1-4651-8163-b19c33d9d183 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f99da602-fdba-4546-8dcb-de0a7d62541c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6955eaee-7624-4700-9b95-40f4ca1a0cd5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93a395dc-c6fb-431e-a605-06073ee348d5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ddf70b7-0853-4762-8c21-a5183e1f6008 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8cc06d88-f53b-4fba-bbe3-2b3c36cdc1eb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4cebcc75-e710-47fc-875c-4547d6c97964 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce697d30-e84c-4a98-ad6c-312b0e453df8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b15b6bbe-d780-461e-9bbc-3da2e30614db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ff0a70d-fd00-4c8b-a6d8-622e0d0327cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b7063aef-1280-4b0d-91a5-87949dd86ef5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d19b2a9-0a35-4dd5-8dbd-2874e7c5d9c7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a44bd247-1011-4c55-b19e-5e3630f7153a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe9b77cc-34e8-458d-a344-d28d96231202 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a575f039-e508-424f-abd4-1a2d9a6c7b6b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9e0c938a-65e3-4533-8432-7265df5ae8c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8829028-24b9-40dd-b424-cecba0391b02 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b254f5c3-b8ed-4a00-81f6-c402e7c6bdec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/51d101d2-0a26-4552-87e4-e25234cd3c93 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bb94cde0-a7f9-43ec-9d74-8446c962b2d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0087db6b-e02e-4157-b3d0-ac6fd91cd7d1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/97404d40-b1a6-4366-bdb7-b94790106ee2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c6634eb-9bf1-4aac-a351-67e834ba2026 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c172a0a-c12c-4846-86fc-fdbc106bd4a0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/27aeacea-7e50-4a56-b548-46ff9db112aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d57f09e-1bad-488b-b629-cb80d4f7ec22 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d101866-747b-4c2e-ac14-ffbaad2b1f93 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b0897444-a71c-46dc-8da4-569f7d035df0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7202b7b-93d2-42f6-9dd6-a08a0dbe5cf1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c5a81df-7bcc-409d-a8ae-41a512e7c28a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90360a53-b5ac-4f03-ba03-0d1be37e9a01 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/18a08fe4-9761-42fd-97bc-f1a0150b22a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ae28de1-bdbc-4f85-a9c3-cc30c79d36e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab933334-3359-47a4-9b98-06c8202ee704 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8099b733-5e9e-4e5e-9058-7481e29d4d97 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5b76f5d-0018-4bcd-adc2-6d57bbf782ea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ff76974-fac8-499c-bbc4-ed55bf47c83c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7fb852a4-8760-42af-bc4e-b6ac3ee26a06 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5854cef5-36fa-4ad3-beb5-bc5d49709014 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad0fa7c5-cccd-43e0-95c0-bf2b004caae8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a6c23fe-5c7e-4a05-b19f-4969927ebd0e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2133c675-d6ce-4d8b-8f9c-1a4bebd11949 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bfc8dcc0-47f1-4af1-8d75-c1164073e6dc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cba2d69d-3456-4da7-980b-9ce0a6894f32 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/88644336-60a5-425a-9b38-2eda965b1647 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/30e526dd-54b6-4fdf-a53c-075850f3049f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/69574fb8-4bf0-4ffa-a5f0-1869a2e57c79 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82e91877-152e-4dd2-bab4-e14ae1079496 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3f1c3c4-0701-457f-99b7-1290d71d96cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/373fb49c-7540-48ee-9f18-28110bc1a73c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/06b619aa-ccac-4fbc-84a7-6d8ce6218e38 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c309b99-f8ec-4592-abba-3bbb08fae160 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/250701d8-e8f2-44d9-8c1d-ddf7c716b89b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ca1917b-30c5-45e7-a3ea-a1a99a57d6be 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/999d7bc4-c042-425e-b3a4-a61dd6e4b171 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f1edacb-3188-4863-8bb7-8314bbcf6a47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d0a574c-3566-45b5-8e07-0e5e55f3715e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/af835c9e-6808-4480-8fba-d4244f205c48 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eab87db8-ffa7-423d-a5e0-32eb2780ea2a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce12b4f4-5ce1-42ab-8c10-e11379decab9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f79dc0a4-7f0e-41ad-a3f5-089c96edc4eb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/89c86f5a-42b4-4426-9c4f-e702eee3bddb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e17e47b-a8ff-4402-ba09-e7803ba678a3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e247b8c5-16a9-4071-9458-be868b1c718f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/19778964-62c7-452d-bac6-c0c4f409f1c0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad34d6ad-146f-4f86-b0d6-4b93e30448d1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b06708d-616c-41b2-a780-0d84406a0e71 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3aa27fac-4184-4fac-b1c1-a74a306d9611 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04154cca-e030-477a-acea-e7df779bbb10 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad73fade-d1d2-49ed-a0a4-25b8a419581b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/105d99e1-c8cb-4a10-be61-e0f5d73f81ca 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0f8eed8-3290-4114-b241-2c7384471acc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9db52c3e-e2bd-4105-8a59-8609e6f23295 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3374da7e-e99f-4f34-aeb4-3eeef773c7de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0bf6f2e1-27fa-47b0-bcde-71587a3782ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/54fd7bf9-0f70-4fa7-909c-d63ac88cd26d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/57a81f6b-fb1d-4af0-8691-370a16d37959 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/975f29cc-2127-4196-a8d9-510e869a3d29 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/59b0eb6f-4940-4c62-bfb5-c44dea95d05a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae764a5a-ff24-4ab5-932b-a36448d1d197 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce96c55f-065c-4c8f-b126-08c44cf40307 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ef61011-f7d1-49cb-bc67-5d2ea43c8eb1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eccbb42b-7c6a-4fbc-8752-750b5d509439 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4008d1fc-9673-4e0e-9a18-da49e1c54fd6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f951581c-f4ac-4557-81ef-4d744e95f6a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d6cdcd83-4c5f-4c88-893a-7f85232a2f0b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f6fbecd-8824-4ca6-9532-2fc1685cfd4a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/064a7302-f847-4c6b-a2ff-88c7c28fb51e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94cbff89-eea1-4520-8023-d5893e744916 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d5169df-edad-4e0f-90b5-edc168e0d2c3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/335c3030-e1dd-4542-b20e-28bb025de97a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9b370e1-9be3-4a01-b257-a4672b1e1401 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a8fb87f-05e7-4a5a-a046-aa8f5a1b8b7c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/daf5f47e-8c1e-431f-a950-43d12060a9fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/72ca35d6-d240-49de-8176-b965d63743bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e979889b-4631-4d4a-a83e-617d467678e8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6250ce94-457e-4bc1-a5b0-c8bc398ce54f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/32fa3dc3-f740-4ae9-89a7-d9adb8ffc37e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e44c31b2-fa1e-4749-9867-42b839c0c937 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/71bea5ad-a116-46df-8bd5-0674ca2a94c7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4f85b2d-bf15-43b4-8d1a-d4c3f677bf2e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5184e85-1c6c-4b10-b2f2-82ad8580be87 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1588277c-3cfd-434a-a5dc-dd91bc918dbd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b8029855-000c-414e-94fb-6542578bb410 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cff6f212-37a4-4291-baae-709897114334 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3d43c85-a35e-4fdb-a7c6-f4c1ef38833a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/caca798e-00e4-4a65-8bdc-eec4427fe201 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/106d1dc4-b8cb-4b22-97ad-175e052a1efc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3cf425d3-de82-4004-910d-0288c31dffd8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c959e716-2fac-495f-8fdf-233680c4c7c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e357d8d-eb5f-4171-8a78-414c6aa7152d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/401bd159-4675-42c9-8ebe-87b91d95d9bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1df6af86-cd16-4435-9b62-8d3e6f4245ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d4fef2b-525b-4457-a664-b28459b1ce57 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d28ef894-f8c2-4329-8cf0-0ef88d810243 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75de0474-e8b2-4b9d-84d7-35e680c27b3e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e01226da-6931-43f0-b6b4-c58d45c25639 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d33c4dbf-50f0-4e2d-be7b-b2928e5437d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f77f7a7b-fe69-4f09-8708-22fa0b0bc322 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b3f5d15-adb7-4300-b6ba-a84d79d646ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56944f08-8a3b-4795-9bda-ced1544ba8f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/96564b5a-327f-4363-9f22-4d040591feb9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc63f702-3771-4520-b833-bc73b3f18c06 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5fc42409-f48f-49cb-b38c-8398779715b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3772827-0ce0-4c35-8082-8be6c11bde99 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82ec9dfe-decb-4cb9-a0db-03360b121ca1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/50233408-4138-4379-be3f-7abefc665cf9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/34eb37b0-4c1b-4fa7-945c-00fa9395c14f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31d8b305-f9d7-45b3-98cd-96324a2df1fc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc103f49-acb3-492c-8f74-2c05813fbc03 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c90eaa1c-a598-410e-b017-dfce8905a44b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a459f3a-495c-4d06-b454-d55ef90c67b0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9fadaa1-b219-484a-bcba-069814dd5a5d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ca102b5-5ae1-4af8-8ca8-74cad4c4f15c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3acf2def-870d-4a36-808b-de9f1a36d1f4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/10a19728-876d-4e2a-9764-da36c02e6652 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2bd7e6ec-bac2-4160-8bc5-0a1bac148f0d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1348252b-a9f0-46b7-8486-56c8c4f4a715 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/50eeacee-2cb6-44ce-800c-130b405d88d9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c020cbe-708e-4f1f-86ce-2a748855c8d9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/13e8a86c-57c5-4f3c-9860-9b0811a84e1d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/78d7a797-325a-4132-9e94-e0e3ab823b7a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93eaf703-7e90-4331-bf36-ed1167de60ea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a8df449-a979-465f-888f-0e3947876b9d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31f30e06-1dfe-469e-b676-931949c54a62 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1461dd50-4f55-48a7-a2c5-edbba407676b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/561a90bc-4935-44c6-8577-a24b36be70c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b398503-c759-41d0-af18-d6ff6ca465c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b536435-08ee-4d8f-b590-da494c557d85 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d17d8be2-6511-4811-a37f-04854d3026d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d51ee92d-88f0-40e2-bfd6-ddb6a87d37c1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/52ecf015-5703-414c-a72f-b327c08989b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/42686f03-dcb0-438f-a4d5-146117f47355 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4e174ed0-f78e-46e3-90ea-f41bd9a721df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94febeb1-8e32-4795-9711-10d366bd4d94 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7d38e12-c44c-4b53-b8c4-d3074a6d5981 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e4400f2-5bd0-4f31-b948-ba2eab5fafec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a8cb051-1099-4378-9b73-2a57db8464d4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82d40581-e7c6-4842-b698-501c4e9ff04a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd314e99-c87f-4277-86ae-583769e4ccec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/840a98ee-5e50-4852-82a8-bc8388a8861b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/94458b19-2709-4d12-b0c1-f6e0ca303fb4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04c0b503-f3df-4501-85dd-143af42ceba7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc0a47e1-ae75-4871-adb3-b09cc98cc6c1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2bfc7f93-f9f4-4b23-bffe-9561e1584018 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c39b07c5-22c4-4c96-95ee-9634b577632a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90a5ab5e-4f8d-4c09-8257-bb2ec6fb93d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8391c897-c463-436b-9192-1bcf47bf75c6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a781a10-060e-4a15-ae74-a1cafa2797e9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc3d49d0-84bf-410b-af7a-04e2547b377e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ac37487-e3e9-460b-ad46-20cc4e8d0450 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f6d401fd-53d0-4970-addf-8bd350b45525 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c13f909b-f956-4de5-993e-dd9e7b2341b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/158bbcbd-0f32-4ad2-af05-b020641f9ea8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a98edefd-1d5f-4d52-a2fc-d1ed3090fa12 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb7c87ba-f614-4a9c-86b6-b98c6fdb3922 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/05bfda06-264a-49c6-b184-33275fa132b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a578c129-8809-4c51-be77-56d3901d5749 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5d79b10-8d76-41be-ab85-40cd60b0a5ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/05373f61-4d41-45fe-a8e8-cf5c1dd922bd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d20fb4c-2086-4107-8fcc-16d620fac6db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93763882-5fe0-4237-9be3-5448cfab1536 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/07414301-0a3a-46a0-95ae-ba88a76aadef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9356db4-fa26-4b93-b591-6cc211171c9f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/20477cbf-10ae-4bb6-9790-72ccbbea6c83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4a17a1ef-6a9f-4ce0-8c47-b6f01e59543a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/164d3d4e-82e5-4f1d-a93c-6c4f3b721ce0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae917952-0e09-4c39-923a-6bb5dfce7b5e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6f550ce-e5c1-4466-b858-93b6d4556d29 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dbfe9d3a-d6ab-47d2-8ea6-e40734921930 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/425a7764-a10b-48db-9d15-6e6bff0eaf0b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3762ef92-3957-4a31-8364-870578faffcb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ab48b07-b9ec-467b-9651-63160d213ba1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/885d20eb-896d-4785-892b-097d124c7e62 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac89a716-d893-450d-a78a-ffd433608deb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e42485c1-5d79-43fd-a6e3-f71372594488 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c057730b-c2dc-45af-b3c2-3b05753088fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8018b514-71d7-4c65-a2ff-05d57813131c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4034ac00-7224-40aa-8e8e-b2524d7543d2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31af7e81-70fd-4e08-8231-4116d562be4d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6d64a919-ec27-4447-9d3c-a8c76c66170f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff47244c-84da-43c4-94b6-261be9a2872b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/97a69614-dd50-4bf8-bd10-1df46b03b1cd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c807a49e-8437-4ef1-9cfc-0a8eef6cc951 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0fb77b2f-ffdf-45d4-8422-02d1dc7024db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/34fe7c50-8577-487a-b51d-5e0685d65c47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5db95548-9db0-4b34-8d2c-3017d53dffd6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/96ce0de6-7e66-4e22-b5f3-b217e8c57af8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/95ca4eb2-8c7f-4edf-b332-ff83ade6efa0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9e12e499-c139-49ef-aaf6-1704bb90fc9f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fef85531-5490-4e38-948e-0c7183e2de05 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ffad458-93eb-49e1-9068-df7be4626856 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d20e98a0-f7ba-439f-bd34-7432eb73e79b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ccf7519-03cb-4cdc-9358-05b696bb1ae0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ea7001d-5c93-40b1-a1ba-d153f7c3aa90 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b0184c9d-a341-4f86-8613-c2d22cd78468 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ab802a8-df8a-48b5-bd74-130510ca5038 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7fb00b28-5c66-4939-9a4e-4aa033d49c0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c5b1a0d1-4eda-4e4c-a499-71fdcefd3405 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c28745b2-7458-4a3d-bb8d-948060f18848 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f93ee6f-9fd3-41d2-9c9a-80424f3b572f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8bc30bcc-904a-4b96-960c-472a110307ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d166648b-06c2-4d3f-a41b-68ba2d180cb8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7e7b57a-fb3d-41ef-a902-d886cf8354ea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a02f0957-35ef-4fc3-adc1-e8e47537357c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bbb250e0-46a1-403d-9873-22be4965ffa8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5cdd822f-6ccf-4dde-b749-9faadb005740 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a5bd773-167d-4f25-9b4f-70fac7377e05 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d774524c-3ba7-4f03-a1a5-5a4700c10aa3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/63d09266-5afd-4654-8f4c-43db5118a45b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6db80ead-6fac-4e7f-a30e-60cf8ad92c55 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3e8f0da1-3cfc-49ea-8105-4791cc704643 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/91832078-3601-4817-842d-c4d4d80ce00a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/592f05c2-e346-4062-9968-65391fd4314b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1a9be9c-aaf3-4cc5-8a2e-953940b3dfd9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f4f0da4-2f63-4158-b03e-195e96b7bc49 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7110e62-9481-4020-b0ae-8ddee67c2df1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08e8675e-7e47-4a12-9648-e712a92542df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/781f9c5e-66c5-425d-ab47-c6a8c1cf7159 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eca3f836-308b-43f5-abe4-7b8910198609 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d50b6038-9eb2-4168-aa77-9e981af2b7f7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c7475dc4-bf1b-4595-932e-c7ff25d84b95 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2ae0ae6b-f0f5-48cd-af12-35a19a107719 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ce032a0-d236-4a0f-bc49-7cecbdfd1297 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/19532a53-267c-4ec2-813f-6d2d0fb29541 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b22eb2b-1d92-4f22-ac8a-b1f9c1ee6d4c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/131aea2c-0efe-41a9-a7ee-60579704d296 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c57d23c-87e7-49a7-9664-330be470321d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5efa64d3-41fc-4846-9ed6-150f1d4205c6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8aa7bef4-de13-43a2-8616-b0c55a3330a3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd415022-7870-4403-8408-0623e460aed4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5345220-bdc1-4c6a-ab7e-3fab5fb59281 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7b88c96-e945-4cf0-af35-439d23361576 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cffa2bad-3028-4e52-848b-d3b9e8755586 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/33fa08fc-c4bf-4ae4-b5fd-ad88da884722 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/66e0c813-e79e-475d-8994-521c28ec6af4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/83dea7b6-654c-4325-ae11-be8803023b6b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b80edf52-30a7-49b8-88e1-87849e5d32ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/10870aa2-31c1-4efd-93be-088313bd4201 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3032f15a-3998-4ce5-a0ea-0be748b52c0a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5fe65e87-9198-462e-b990-014a03096a6e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/909ad2b1-7541-4411-a55e-9d6c53b63cc1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/550db755-09d2-4552-b23e-3d7e63bced3a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4457425f-566e-4305-b1e2-2ae260a4e6cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8bc8d95d-9b2a-4bf2-ac34-294d1daff2fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6354f3a5-a96a-4ca7-8475-188395e35bd6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d274c01c-5e1c-467f-add1-621216b6ac33 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4a226902-1e9f-42d6-881d-a8515b2cd441 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1cc7a73b-682a-4547-9e60-090c8c5bbace 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e87884c7-d6cd-4b4c-bc0b-619f6312a958 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/91f66251-4850-4e53-bcfe-4f48ffe6d71b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2a9c90e-e9ae-4ec4-95fb-b8b8a6596f67 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/14a5db58-a64b-46a7-9730-6efef7cc7df2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/37df45e0-7616-4af6-bc67-712f268b1488 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c597754f-9cb7-4b2d-9aa9-6a964505f83e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ed37e3d-966c-4ce5-9d42-5fbc6b55bf83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c5316f1d-755f-4f83-95f7-c318b415dd78 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93586bd8-85e1-4380-a6cb-67161c53702b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f93099f0-15af-476f-8c9e-6ca95ec3b7f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ca27cb68-28bf-4b11-bb48-ee5f5ea058d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba653abe-b69d-4307-98f7-30667260937f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9e16e52-3b10-42f0-800e-d15eaf5673ab 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/034d1b5a-f97b-4209-a411-263784eaf610 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c43aec5-5bb8-4548-9b22-1b21fb9c1f85 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/499781fe-b6b9-4c82-a882-134714fb1b41 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2a091ee9-6832-42c0-85a2-af0dd802534b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f564af29-d1cd-4053-bcfb-083adfdd2778 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d84845e-e2b1-4110-98b1-eb80873aaba4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/45b870b9-2824-41db-9aa8-b6e3495a8f4e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf65a901-79c3-4db2-8154-582cc5071865 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c4010db-103f-42e5-8fed-80aa00450e3d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/64b9ef2c-6bf2-4033-8803-99d679a3e732 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab8c3fe1-a46f-48a3-a90e-b1ed4beda13a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36218c12-11f2-477c-927f-aa6ed789c893 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae219a2c-34c2-49b7-9fa8-cf582f4cda7b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/69a4fcb0-c800-493c-a5db-e0b2180fe6af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8075bd3b-5fd3-4106-9a6d-610d1bb87a14 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86831444-8924-4d7e-a116-6eaaef6723c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/42fa5cd7-41f8-40df-8d4c-8296ab3edd54 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/db5d6f0c-5149-463f-a557-ee471be0035b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/14b99b35-cfb8-457a-b532-b35c5eaf604a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a737b0ee-f6b7-49ca-abec-4622d44c104f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/83a386dc-1fc4-4f02-afdf-2a4491379c5c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e02d6d1-d071-41fa-96a6-cb5044d465de 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a61d5cd-93e1-46cf-b349-339de4c0cef1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ea17f98-04b3-450b-aa10-5f78861b2413 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/33a6ccd4-6700-4968-b75d-dfc47aee07c9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2770da4-c624-4ec2-9288-4a1815e22d1c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d4f5f121-a12d-4282-bfeb-8ee6ed46826c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4376cc1-20e0-405c-aab2-db3f853b12d9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/57fae3d4-7cd7-49e0-bb27-fdfb9c1a281e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4c6894b-5484-4875-8dc3-21a27503f920 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1df67c8-0af1-4ca6-888f-ab37cf5bd185 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0739d5d0-9533-4802-93fe-1c802121c8ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09e72f2b-9d4d-4ed2-84b2-62e8a9b49116 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/757b4bfd-7534-462c-a152-e9c31dfd0144 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/313edeb8-3300-4c42-96e1-bda3f8593055 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/335f8726-69e8-4955-9e7b-5578269b574d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bba25c12-d66c-4640-9937-a2574bad009d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/398900e6-7bd9-492d-b2fc-aae55c68bfee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82c28eaa-d99b-4301-89ec-8d119ef002b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f03c4c00-486b-4356-81b1-821c0af5c923 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d135d4f-c9fd-4493-bed7-0c710414177c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c85aee4-16ae-47ba-aba2-d87f3261fcec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/15dc9edf-ad72-4776-a3ce-b1f9fbb839a2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ee19169-4e9f-4838-9271-b747575c7321 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3567ec7e-18a5-4975-8ece-f0840e33bad8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8244724a-c233-4cfb-a069-0d3313c08cc9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93ef131d-bcf0-4f2a-b79e-5424268c3fd3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/28954b5d-9c37-4e39-9229-44951b132cb5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b717707a-b5aa-46a9-9c78-645d45a88bc0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2de6f9c3-58b6-4bdd-b70a-5f4503f7b26c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f4b6e53-0998-42c0-84c0-1eda1f92217a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d4f07549-b00e-4b21-8517-6a4b7e7d1fff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f20b645-1c3f-4d91-9251-0e6a70700e75 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ca8f5a54-5b20-4e72-9f03-fe00cc8eb3b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2dc122e0-a008-44bc-bf23-3a18195cf126 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e59710e1-759e-483f-9191-4e0d19b0b97c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c979de48-7c24-4870-9dd9-fd7b9d1a389b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d45ddb2e-7380-4729-ab90-6830b40e5290 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f774059c-1dfa-4258-9932-f3a540cd1dfa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bac53677-b755-4b09-b2b5-5a1b16a1700f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/511aaaf4-596a-41a0-b526-8323f9cc19b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5ea007d-9a09-4bb4-a296-5290df08204e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3c7f313-e0ed-4ff0-b0c7-8ef4f396979a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23b99d7e-ea14-4147-a89e-7a8e12e9b8bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec484632-7837-449c-bca9-69effb37ff14 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bde6784d-5699-45bd-8bc9-733179007950 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f99af5f4-24ae-4547-8b61-2ebd35a27460 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90dabb5c-dc72-4cc8-b6f5-87a0e0c620c6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9d582b9-2f33-4e52-b2ce-26966d26923d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8791567d-2af3-425b-bc8e-a81edde4d804 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5dff28e0-145c-4ed0-9a59-6baaae65c66b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/17dcd4e4-7870-4a91-8c0e-da410098859c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a6275ac1-af9f-4d33-9071-0ae69e764252 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c6d5b93-9170-4b46-987f-839689929c6c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c50e2395-3e2c-44ea-a578-d64e4fa7bf56 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ec8f366-4dbb-4d8b-bff2-fe905fbfe968 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e898cba5-3104-4b7e-a78d-3c64e2af42a6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4fe72c21-5fba-4db1-a686-5171fba4c0b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd7055bd-b683-4ec2-84ca-d2ad98828a87 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf4fba91-1c39-4c25-b48f-4a453d28f88a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7ea2c78-fe50-40ee-bd50-28c24eded657 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23e0fc78-4b3f-47a8-9d4c-4def917826ca 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/180899b9-55fb-47d1-be4c-f48bf4a52b80 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/11cf7445-ffc7-4931-bc16-6f9f1ee85747 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2b8cb68-796e-40ca-b20a-e1c1d5497797 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac530132-a9b6-431b-8c90-7105b95ab903 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/88cc39a2-f6f4-490a-930f-e77eac9763a0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/46fd0c61-8a15-45f3-9d91-e68d8b526506 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ddea3bd1-4743-4fe3-af40-b738f5663a25 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8addb02-9025-4481-bf37-9ea0734a4e1f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6532e205-193d-493f-b3b4-1a31a1420910 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/da418331-2859-409b-80b3-87349fd47660 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea16bdc0-f05c-41a1-8a1b-299b59e7652c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/713ae752-b553-4181-a994-17b9bb379819 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ae7131d-c4df-4979-b3d5-8e9e14e2a6a7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a78e6c5-23a0-4eca-9c69-746375f9bb6a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36c2db4c-30f0-4dbe-a14f-202443444ba5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8b585224-ba1d-42b8-965a-7d4d447df261 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7b1b9b6-da41-4997-bcd6-f1c6832e9d4e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d309971-8707-4c73-93cc-90e46d5c8013 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f7c5bad-ae82-4e71-a2bd-ad1359ee1dc8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9171c77-f278-4478-80d1-8bbf29428798 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08fa0302-5bd2-4480-8f07-b0e96fa935e1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ac1b7ce-909d-4cc0-a26a-6bfdacc63dea 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e882cd9-3b32-4f0f-9d49-0c72f40af8fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cdf7a389-38b6-451a-9702-ac3fd026152f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/41c49b24-4dbd-45c6-a3e6-07769617f861 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ebab6c0-aa1f-4046-8982-13f05c9fecfc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08ed8e29-468b-4ada-b7b4-5870ead64215 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d53c3b7-861b-409c-85b6-156a1f8a0a1f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa4b1787-432d-4194-a636-7bf5492a5016 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c028bc09-28b9-4a80-be29-e39383745ab3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b33704a-1492-464e-889d-fa470920c1f6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cac63c2b-0da1-4165-81af-ec121e2bd0b0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d395f25e-ca65-44e0-aeeb-2aaa58336653 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b4b7108-01da-42d6-9152-7164b191ec36 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba9e2af3-8f06-4e37-9b58-9c4d0ec48019 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ebf1684-f040-43f1-a173-2b59ec79a24d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e40e321-1283-4749-86b0-2ee5856b4104 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f0fd960-c205-4f9c-a823-c1e453a32259 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1de6629-4f34-4ebf-818b-a2841fe3c081 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f222a0b6-de49-4a3d-92f2-20b40cd64e99 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b891f54a-003c-4413-bbd0-e54c67af0d49 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d530ab4-2c68-44af-bf3e-9c07ff85ae3f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/18d26ff4-2f93-4ff7-a324-5ea3905d8c28 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce6154cb-740a-4429-b658-985b576c4324 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7500d8ca-0a2a-4dce-9559-dd3575e0635e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc0dd1ef-7fe5-42a7-9be8-97abecd94bcc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a2b2c45-5ffb-4757-b047-0d47d023b70d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/13a8f0f4-99c7-43fb-8fb6-31459f02cc03 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/06447646-f5b3-4724-96d3-b4fafd93c9aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d880e15f-eaa1-4c27-922c-4fc2e9ee0a8b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/60ace017-ca28-4892-bd55-989691ca77b6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/232c2148-41c1-4105-91f9-c7a5d085632f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d4d348f-acbb-46b4-b26d-b2b054608665 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2422807b-6c80-4970-be14-64a53134294a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23744870-073b-43ee-a354-2e5fb967f9ee 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/942b3ac7-f35b-4b1d-8b0d-d76e09a07c3c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b99db26-736e-40b6-b22b-3512f4a6fa86 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8fb3873-00da-40f9-b0ca-772ffd608488 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3f48cff-7d53-4e98-a3c3-e1a52997c59d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ff4e718-a3ea-4ba9-be97-2e793c82e582 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5db27fe3-8404-448f-86b7-2e72aad20480 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8716e520-6405-48c7-846a-371b945b811d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff01cbbd-cbf1-486f-8151-e52911a7cd98 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a0bf8fd9-80ae-47de-a120-5189011a9cc2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3879e5b3-14c2-44f0-908f-db8d6f8890cd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/be4efe78-498f-45cd-829e-88afc25f567b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0cfb0835-786f-4593-9fef-a64d6e808570 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75ef406f-8e6a-4228-8d1c-35052f950936 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4368c43-a410-42d3-8a4b-084da3461a37 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d9762cc-65b6-4c9e-a6ca-8f5619ad0ad2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec3f2105-206c-495a-ba03-3e22a145d856 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/69ce7bf4-322d-47ca-8659-1b84a0bcaa7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/557d65b0-2e69-483e-bf4f-e95fe439c719 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f310d08e-315e-413e-ae60-5632fe262452 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67c92068-b1e9-4340-b592-4c12d67199a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0bcd34e1-0e6f-45f1-a795-41d46d09a145 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/839815ac-517b-4f1f-8a24-3fd49fcb4232 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4ce37ff-dd57-4dd3-8142-1c218fcfae9e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7fd58708-01b0-4285-a7e6-ed5e4deae37a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d554f10-730c-49dc-8fe6-f41ca08f6c98 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1ad2654-4adc-4fb0-ab34-4b2680d308f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8beaa81d-ceb4-46a2-81b8-bac30359bddf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0646a9d1-b433-40ed-9c20-0457c3495b22 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d30ffc95-9b65-4ddd-844d-570f1b19e7f0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/079d0377-1c1d-4d97-808f-03d8fd119edb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b1baec2-2a65-4e79-8caf-425af936d7fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2ff9347-084f-4587-a3a7-2737823aeeed 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fbbed14-a406-4ad2-b2d9-54cd1f6380ff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/368404c1-e59b-43de-a8b7-e2582095a652 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba7fc24c-66cf-4cee-acb8-e060e85b1182 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f82f4abb-4a95-4a72-8732-a8bfb429e21f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b1a6fb3-23f4-4617-baf8-d70375d5db7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/12f4ec08-0220-487d-b6b3-21840793f62f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4fa67dfc-9f66-4252-8015-8c29cf538c90 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/61e80d34-d677-441b-970a-fb008da17fc5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3b5ddd3-18c8-40cf-8873-d64d698e93a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e8927610-bda3-4780-8f2e-0e693bd983f8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/510551c8-0792-471a-8233-f483826d46e2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/47af43b2-ec3d-48fb-bb87-58e28a95ffa1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86fb979e-feb4-47aa-a5b4-645f78358030 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/082d84dc-3f25-4e20-b037-f489de2e6826 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/28ff6d97-7254-48d0-b161-f6695b205e41 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03456b01-1ad3-484d-be48-24f865630149 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/132ac79a-236f-4292-950c-eda8f931082e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/012360c3-f3ad-44d7-8205-781e5255b335 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c6fc33ae-115f-4962-8de4-29625c29dc24 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/70a1d8c2-83c6-4628-8716-9803a7846097 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5a2a726-ccff-4fc1-9a99-5ad5bd09f5b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/225c4c8b-c89c-4963-ae86-a7f6efa06a9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc610dee-9f99-4b0f-bef0-ae83a4ac5e10 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/765c4026-23c8-4974-ad6b-98ebb09d3856 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3414e1b6-cdd3-48b5-aea6-1429229426ec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b22441d4-239c-4470-a8df-cd53390bef86 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23550de1-62c6-4073-b615-e7fc593a17ce 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8888a65-5dbe-49b2-9bda-cc4f3976a8da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/22962bd5-b637-4b56-b209-3a002ab8c2b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7bfc8a07-db91-4ffe-b15b-aa24dfd9422b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c494d8d-23d7-4fd3-aee1-d037608c8d02 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f466a588-1394-4d34-b194-ec2aae4b642b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/98be78b3-b618-4963-86b9-be429d10fbbc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1b8ef73-1f95-4bea-8add-203248d819e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/21173365-8f17-453a-8a2d-89b9662c46b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/07f2e283-b6c9-4fbb-96d3-0b2ccaf167c2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e903ca2-489a-4e35-ba78-d1130f42387a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4379adc9-0c6a-47b5-baa1-8baa0c5a7409 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c56354af-6c90-418b-9e14-add49b08122a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e661468f-beae-4128-b755-9580e68ccddd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/95ba3611-972a-4aba-8e7e-cd4e9fb16b34 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7401257d-92f7-4299-80fa-cde53dc6b8cf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/03768a9c-dd5e-46c4-a2fd-a5babe5a3f3a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc173543-1850-49d7-bb64-0634140cb1e3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d063544-9385-4ac6-b216-827d007d2119 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bd955f1f-a0e2-4a16-817b-e2d6bb07ba39 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa4f961e-7fe4-4c74-a65a-b43f8b4137f2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fafdf37-68d4-485f-ab80-634cf045acb9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f761a3e-63f0-46b2-a2e7-a12236564a98 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/44be3749-5f7f-4ca3-a283-0e6a95c9f077 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/10374db0-3afe-448f-bb7a-e1f14d231f8e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/39eca2a5-e18a-4e2d-b2cd-c1d7b1667f49 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7777b25-e558-40ec-bdba-8e803056229d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec6e80e0-cca3-4fa9-96f2-69c3427afccd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/746c2bff-9b7b-45cf-b075-ef96ada9dc29 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4da30bc-abc7-46d0-b7c5-a2142ecd3a49 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/168eefa9-98b8-4b01-a813-36eb1cb2d2a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86659110-dfb7-42c1-88ca-3a315db2f98a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/25c1d8dc-12c7-44a1-9d2a-2b0288e5eed8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/885e1127-a670-4e25-bc1a-f4ba51d19381 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9dead41-6737-4131-8059-d14bf542c1fa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/11445234-79c9-4d6b-b070-b90648907e8f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/342cd08c-e821-4d69-9e89-53c8f61ecadc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c27c18a4-b3ea-4563-9fc6-8bc06818c31d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eda55868-64d0-42b1-ac7d-49241c4d9166 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f92c12e9-4990-4fe5-b005-e2b50e5a3e16 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/01345419-d07c-4a37-90d2-69615d719896 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/20d7742e-0c74-4991-990e-18375e855be6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b28d900-4d2f-4de8-83b7-43c1a7b28947 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/679c272d-2acd-453e-9724-695a372461b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba0b36e7-170e-420b-82f6-9582bdbff370 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d3ff7c1-0080-4046-8440-0a67cc4c3ca4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/49fd39d4-5655-4dca-9ce5-4431b7c1a249 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/06470f91-a36e-4caf-81fc-c3042e86ce43 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1e98f7d6-54d7-400a-a793-adefe4fd9dc9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6dd8333d-47bb-4e2a-b850-2c52b77d8d61 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f0ffe73-3bd9-43a4-a317-83d13d4fe927 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/20837f9e-c2f3-47df-a141-e5f549e39d01 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4399b0ef-1962-43a5-a3b3-e46418587cd5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5803b844-9efd-4217-a5dc-d0133d6e45e1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53144ed0-4694-4fec-9735-2dc476e6ef9d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/38134e35-a0b8-4acb-ba06-66da14c5df05 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1458974d-a936-4428-852b-03f0e1d7a7f1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c792c72-ff4b-40ad-b229-69e379d89dec 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ff24e71-5e54-4ae1-b6fb-06edead84e8e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67526a71-395f-49bd-acf4-bbb5a1343606 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f460a667-6965-4feb-aa9e-2153e9b8bbf1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef2dda98-157a-42cb-aae0-4fd25816bb72 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f79cc77-7dc0-4b70-9d18-2252ef451d95 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2a786df-5b36-40ce-ab3b-3b11220c1103 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc2d1b7e-be4b-4661-bce5-3684707bf5db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/93f69427-16c5-4bec-8900-aabb26fee7ef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/308117cf-c872-4438-864e-5ec4a0fb6214 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/10d5d8be-9f8a-4b94-a6bd-eedd484c7b87 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9127f1f8-834a-48a9-93ab-19290c9fdcb7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c46911fb-8d8c-49e6-97b4-66ba0b07e8e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dfbc3fd6-3664-4721-859a-53b4de3e2a5f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec168b06-6d6d-4330-9989-4afb17586cd7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/888c796f-7711-4998-8a58-3cd3ccde0a86 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c42a0277-0531-46e9-9081-cb19f50fc104 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/322a6c4d-f63a-4f0d-990a-75a24f3e4a0f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9158be06-d554-40aa-9e7e-e75d0992c5a8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e3836d0-2f1c-4c36-858c-5206cb85e3f3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/96a8f480-a573-441b-8397-c5dcfb2a4fe3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2f704b7-7dc3-4aac-88e8-63322dc06147 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b806e097-69e8-41b4-a719-a1ef62edd8ed 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/75ea6b74-af0b-418a-8c17-a9b2235bb73c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f91dcb1b-5540-492a-8338-13978e614c8f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffe13509-119b-43b0-bde7-5d71d870953b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/39cd7abf-e9b4-478f-854b-cc98cd01bc47 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7362bc3-fc69-4ba7-b632-67dbb5b68148 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/41812a54-be31-4bb0-982f-2404635b9e9b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd19cc74-50cc-48d3-ad64-60053d4e72d0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc0b95ef-4fea-4dc7-8e61-a95682cc5ec2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/104248ee-225d-4965-8d80-c8c029cd0278 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/09497733-19ae-4bf6-a33e-9ff09c3c349a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac330f3d-e092-45b0-a226-d03b7b48ba13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/786f7b3c-986c-40e8-9adb-e8a9ffaecc01 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b46310b-4edb-4fc2-9928-3023af1ba8d6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ca925fe8-5b72-41ca-9c48-34d3357c29db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b72443e0-036e-4ee6-b2e9-aaa3b907309b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2eadac1-fff5-4d10-a3ec-703d2430c2a4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a00f8d2a-7408-4c2e-be2d-08cdd21ed9ff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36a84572-672a-4a71-a797-0f7c0f8cdfbd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/37a6aa77-7e43-4df4-9647-03fc61911941 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31c4b5a8-74b7-4721-8362-9494294cc62f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce285039-22f2-4380-b855-25e565302312 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c992219-a9dd-4599-8d63-09ea52b987b5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82965336-6d82-4934-8e38-1fe214622af2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d33c4683-a897-46fc-8a53-6162abcb2a1a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ddd7870-7ae4-49c5-b8df-bcef93823917 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/091968b7-e28b-4a4d-815f-10a2a888418d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ddb86f6b-57ee-4efb-a48d-f62b5262e290 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3435a34e-bfd4-415a-a5a3-1b1b50a56cf1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f1e17cc-4bdf-4eb3-b530-f97a4107ba3b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa7cbd25-08ef-4cd1-a69d-e254ffc20824 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d75a67cc-4709-4f7d-a0a7-c68e98ed1f3d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7776899a-997c-4ee8-bad5-71268fc8169e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1efd1c71-cd4c-4b5b-8bab-6fbb98bcc305 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d0b9601-67f8-4fc1-a01f-2f6c72f5e7e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/237529a5-3765-4968-8c7a-8adaef677b28 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2cb835cf-cca8-4f0e-9daa-62d66c22ca0d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b285cedf-afe3-4340-b2f4-25b21260362f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0024c06-bec2-4dd8-8774-32efa5ec3147 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4542009c-840e-4be3-9187-1f9bb6f311b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/26d4ff93-8e84-428e-981e-6c7d7e2f641c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53325c6e-c548-4464-ac1e-4063e843034a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b9c7148-4038-492d-beec-c8c5ae2283b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c165dd1e-7ea6-4ab7-9e0c-613d3e95a150 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7f608e2-1ff0-4058-a294-aeeb8b782a17 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/39b5a061-be39-44cd-b965-6bcc662d4b92 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dbd1e651-aaca-4bf3-a042-31ab10003a31 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0416e6f-e914-4ef8-a4b5-c04953b44bfb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3d4bd70-8dee-4441-b4d1-3184f0436de3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8791c60-ed2d-47e9-bd9e-24521df0e97b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23c5a7ff-c56e-4365-9941-07419a16a3d1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8312b355-0700-47e7-a2a7-9a4a7f5c2832 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c0af75e-2188-4802-a2cc-18c7aa8195d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f70ac9c-4e22-4acf-aa60-144966f5a0c1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/51d00593-17b8-4da5-9194-48d977f2ac72 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a721640e-7d0b-4f24-b7c0-7777e47fdaae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9ff37cc-a0f5-4a68-b4f2-61ca561e5d5d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac76d3f7-dbff-43bb-a581-2e182aed89ad 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/413dcb94-60e9-495c-98cd-554d6b7e6131 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a01e6b90-01b0-4214-a041-02289f3c06bb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c80aa421-62e7-4e14-8cdd-49ad78fb53f6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e607b042-1e67-463b-ad8e-761d054654f9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1137149e-a2dd-4123-b8cf-b34d2a5523db 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f949f39-3e24-496b-b526-88af9c397c75 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/41b438ca-cf0f-4ac7-8f02-4759005646d9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7710bd9-44d6-4077-a3be-3fa4b6c79f39 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/88ee3574-14be-4229-8fbb-73bce1937b36 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1954e49a-aac1-417c-875c-1e95660c3549 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/af235b55-8bce-4fa0-a8a2-4d365ab3815a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d4f71f2-7abd-45de-afe3-86e6cd12449e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ccc4ecb5-9d91-44ed-9e58-7fd8d11d7326 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e0c23a98-29eb-4b51-8507-c5a4f47cefc5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a899ffb3-0f93-4006-8fbc-aeca446f480f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc624644-c71d-4888-b6fa-930619f627fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b3a9d20-3a56-4084-841e-5b094059e8e7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b5b6e30-b96f-473f-9a0e-50b83671977a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/252897c2-38b3-4ef4-8e30-795637a36912 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa81e2a3-0a71-4fb0-9f71-1b735d3471d7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/99a38200-d013-4cc0-b12a-87e355a4672a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/027e79f6-6ae4-41e5-bae5-8fd5c7668c53 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f21edb1e-102b-4991-ab6e-0995bd570486 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/73d9855c-93fe-47c9-9c9b-9a5fb372977d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/502db431-bb40-4f50-9819-fdd3ca5ef2f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/92dcf37a-0c84-4ae7-83c8-72091be7b1fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a60e185-cc85-452f-8d4e-e192ee99860d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ba54468-e9a6-4f71-9b1f-c98c1481c73a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5cdb8560-1a08-43c3-b3a4-73e3603a4286 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a4200b8-59ef-4ff2-9680-9775ae6a890a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/535ada57-4e31-4274-90bb-a0cc6cfd1d39 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1df35228-6b4f-4709-a611-f7e44b8e3390 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea314645-a651-4021-b8a1-36cc6c257d3e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/80dbe390-4959-4e0c-9d50-674e12137180 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ccd37e82-32fd-4f7e-bb91-1794741e2ee5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6bb47cb9-8cd2-4505-bc34-54fd30b972da 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/74ac80d4-756a-46b9-b8e1-65fffce2f5a1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ade25fca-c211-40f0-acb2-dba82ace321e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dae730fc-a0a3-4e84-b57a-31c7c8309029 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f3b8f05-2a01-4128-9aa7-7e68fdd6d79f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a50b81e5-e232-4092-a30c-c22d62b5fec0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/65452b24-4e76-4d6d-a9f0-a2c997dc644b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/90474bd0-8474-4df7-851b-e5178e79a4fa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c70aa1c-9390-464f-b835-aed796d36100 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/28aa4754-349a-45d7-8801-6fce16ca295a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b245ac0a-22f3-4280-be91-01745ae04a9a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8e6dbfa-4a99-4c8a-a88f-72e49ee10fa3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a68fce87-c518-458f-9407-43d1ea4db4f5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/54743d56-0140-4386-97eb-2867b4ca48ff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/86e7e6d8-c74a-4fed-97a3-107ea01cba65 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a83dbc7-4aa7-4cfa-b326-11c167c17a6c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/53268356-6ef0-4793-9769-763cd956d803 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5bcbfe55-5005-44c0-ab9a-2b4f0e469698 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1253f8e-5cd6-4ae8-ba94-cfdd812c2117 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/67615b67-d3ad-46a3-a77c-c3dfcef09bd9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/30626aa5-430d-4dc9-aa3e-bdbbaa84f05e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ab2e322-e35d-4330-b4cd-dc9c874db6e0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/abd85d2e-c7d7-4a3a-88e9-770d33ebd279 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ef28b61-47f5-49a2-8897-026ea0364dfe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b24a136-1aed-49ef-aae6-322d3e7a1b0c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/dfe14eef-a039-4488-8d81-06ff94bdb584 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/563f06fa-b405-4882-8a01-12fb16f83cc3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/13f27bfc-91f4-40dd-bca5-ae1a3b1c26aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b1012c7-a53f-448e-b282-2ffb214083e0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/aec066aa-3cd3-49de-b906-f33e21a077b1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bfddb8af-2824-4618-b16d-deb18f00748e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9195a8ba-648b-4e38-807a-13bbc8889ff9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d3f2ab7-da15-47c2-b4d2-13a1e7d1099a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/941c46fe-581e-4715-a38f-5ce7e3aee5a5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ae29881-2b6f-4ef3-813b-2ebd1a52be12 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3d8c5c4-358b-470f-a44d-dde0e001d8b9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/113cd90a-e949-4493-8ea8-3f453b30dc32 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c5bbeab-648e-4b8d-9b7d-22c66f2e7608 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed607c7f-2c89-4dbb-84fa-997fd86468f7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ccca8a6-4d1f-48ed-a2ee-fe34505e543f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf3876e1-cf21-45b9-a71d-54b432f49466 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/43166be7-0de3-444a-a34a-d2e691907111 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9b2761b-f5b0-4a33-8646-0c54c47ad4d8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/15aad6b5-0806-4cd7-a9cd-e00d70db45b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/45dfb0f3-2261-42b4-accf-81bc473f6e80 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b9d4444-85ee-48af-b4ba-7fe296949ee2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2bc4e9fb-1bae-4cea-a1a3-ea6cf9c602cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a32978e-bbcd-4037-82df-d634b9a1ff8f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c500b143-6bd0-4477-81f0-128c3efb8a3c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d25af25-658e-4f74-9d02-c440791bb0e5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/48600ce6-8adb-4ea3-a6bf-9ec1a59a40b3 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/178ab4e7-8104-420a-ab08-397485fb9997 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/64c9b681-40ca-437c-a0f7-dfb9acb6f2e9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9827ce13-c981-4292-8103-4bcf8aa776bb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1cc0ae5d-010b-46e9-a092-90ed28025c33 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/50a4e08f-e407-43bb-a4a3-51fe9c485cd5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b6faffb5-a6d1-41ca-be20-c34bec9d8c4d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/093ae12b-4f20-4500-87de-8d1051fe9e8e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/791d6a94-c6c2-4a47-a97c-e386915f10b8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4990502f-515a-4769-bace-655d5a1ab34d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0109cd2e-3d67-416e-8ac0-c079b90fb4e4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c3197ee-c2b4-4fb3-9c64-30c83dd7fd39 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e818db0f-40a9-4e19-8fed-e3ee83fe4a56 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fce34de6-7466-4e44-b212-e5f4853e9c34 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d913723-40db-4b47-8caa-c62dfc6646cc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd17ecd4-6ee9-4b18-9923-c93a2d9e82fd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5eb0884-4705-4989-b5ed-c904267d8611 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/446605fa-edb9-4bd0-8b84-920536ce6832 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4cd9c98c-bcb2-4d10-9a68-6a8addc2501c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/eec6f065-5e2a-469f-8383-1090f494ffc4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/854987c0-f890-4ea9-a411-4f9b3db9bb6d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3373dbf0-8900-4845-87d0-2897f2e9cfae 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56ad7b61-54ac-4505-8ee1-3040c40b6502 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/39a64d0f-7a05-40e4-a5fd-5b248ad6217e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/886e68d0-0c4f-421b-95a1-d36a3c9c0422 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/04edc447-066c-4c7a-a8b5-ab9b492b6b3d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d06c63a-b049-46d9-b01c-4d54565fe77d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a8aec56-dd72-4add-a2c7-3474ddc21c93 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3161fd01-1fce-44f9-9442-ee7427b859bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b75e8c5b-cfbc-463f-9c7e-23708e3e513b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e81d6ed0-b953-429c-a2b9-24f679fe3a6f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4800319e-41cb-4fa9-9012-af1675414f86 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b6175c5-0ea1-405f-b217-82ef4ae9f788 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/57bf7b89-52e8-41a3-b2c2-3e5ff02430bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c67977bc-6b87-451d-abf4-8a8a7bc4909c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a12423f4-ecea-4c41-ad7d-fa95075bacdd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/333c3f13-ce2c-4eac-a1ad-0fa2b6ffd9b1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/090fa625-adfc-45a4-a6ae-d31789e6258c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4dc8864-9345-4147-b201-12bd89a27974 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe92db47-8a08-43cf-89bb-c18ee0464470 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/065836d3-5f1b-4d8d-be02-74fe1568ad48 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/62e01b19-d436-4af5-b4b9-458a1fff8121 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/be4c69b2-f7c7-4e1a-8604-6f7ca40183bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f778a75-3e22-4458-862d-db493b683a15 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/87c1f37a-8ef1-4d47-8d16-413ca67b3fe1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc7c3465-1ed0-48cd-827b-990ff1346dfc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/be79bc3d-c956-4492-946a-2f02eeff9202 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/514c6bc3-0e96-4c68-923e-60807f03f9b2 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff1e68da-0e37-4574-8902-e0c3eb76be1c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6636fa0e-d10d-4f9d-9746-18ceac1229fe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/80862b7b-f7e8-4bdd-9770-ca6f263e25ba 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4b5d221-b540-43e9-874e-16445c03624e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f79255b-9ffc-4897-b399-36cc765ae551 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a7076b48-73b1-46af-bf7a-760be6350467 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c5ae227-4a3c-4fa2-8c89-f52707a58eff 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef5e34d3-edb4-4110-a5a7-079f4137685f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e24109ac-5941-46a3-839f-c8df418741b7 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/80a91be8-a37b-43bb-85d2-20732ca65dc5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/616b0d38-ea98-43f7-ad1d-c7c9c3cc327b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2174872-e237-472d-8a7b-a17b3cb30435 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6e088442-75fc-4d91-ab20-b15c65bc881a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23f7aeaf-3913-49c4-a526-f72947767996 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac854325-3267-40e8-9d8f-3eab4b0d5e5d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0960219-08f9-49b3-b70b-8f3ae4ce4bd1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf931769-37d5-411e-9d45-d87e48241857 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/075889ce-5b46-4738-af9d-2c7e89b86ae1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/73c819e6-b98c-4169-8d9c-9d9cb3c69293 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5462479-e3b9-4f75-9e2d-44d22cc5489b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2cc19f9a-fa5c-433f-b7a7-529db4b49656 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4332051e-c5fd-412d-a15e-bc8edbe180df 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a11014e1-0675-4fd8-899c-57c5e713a1bb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8160e132-51f8-4b94-a35d-f4124c9a0dbd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f784871a-8523-45f3-8f0f-2b852f8225ef 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b542a1b1-eb58-4998-9b05-a87266e91b54 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/23eb7e6e-2120-4af3-a647-74943f419962 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/daaaaac0-91d0-4489-9f50-9c407c194ee8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b674411f-3d7c-4782-ba97-f092a5dfc83a 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36c72d18-6be6-43e5-94ac-8acf408e36cb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d3a967d-0b9e-47e2-ae59-b24a1715f537 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/34c23dda-d20f-41f0-bc05-fd79aa642ec6 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc177d55-e867-44bd-9e8a-bb4958acc727 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9324ec7b-6f46-4e17-9198-c1a8eaadb438 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/36d476e0-ab34-4928-8cbe-4a3fed3e77af 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c0a68b8a-af67-430c-a149-c7fe284356a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/206927f1-a02a-4895-986b-65cc09b7feb9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ecf78e23-fe66-4f87-ac0d-69c1188f0e99 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d308484b-7448-45a7-98c6-39404dd500bc 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fed22bf0-0226-496d-8021-b4045dd6b985 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c48e833-6798-4ee3-8156-2f403a467732 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8949242-c79b-4274-820d-e74191cca009 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9e66bac4-a372-41fd-8736-4eb6bbdc73ac 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fb239c6-34d8-4b69-87f2-c83ed2e314c5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/734bc795-7a05-4bd7-bed1-5110cf9ae7dd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e120c40-6972-48c8-b64f-82a9ba0da2f1 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/56cebf9e-ade5-45fd-beed-07dac4b60ffe 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9ddaa1a-c9ef-45aa-ae4f-e31e60985df5 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4fe7fc67-a0e1-4adb-841f-0038107e23a9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/22f3110d-5f52-46a1-9948-d88d3553fc6e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7c97e02-21e4-4395-89e1-713c3d573559 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/cde6cfff-f5b0-435c-9fb5-1f1da9230d83 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee458652-d9d9-4bfc-842c-5f5e02cf1b4f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3188eca-4fe9-4fdc-93f6-dfab9637b3fb 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d4cbd90-1004-4d9c-b081-e75cce132bcd 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ae18c35-8d85-476e-82bb-703efcbad757 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b58a4c0-553e-4eb6-83de-9583fd4156e0 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d426a440-eeb6-4011-87fc-93e2fcea3303 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/6105499f-0470-4c12-8a5a-d55d3c871be9 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0487724d-e5d2-4f56-9273-b323bd611833 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fef8719a-edb3-45c4-a948-620302dcdf5f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5387c223-30ff-4333-be22-609b7cb8e4bf 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffc60942-b6e4-4504-ab37-3e366cf06d25 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a70a4ef-d1b7-46ac-bd1a-6ac3fd5ca41c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/7501ce75-dc19-4c69-90a8-bf58b49a5e87 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/65b421f2-c8e1-4ef0-9585-803e0be65a9e 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/a6e6cd66-dfa3-412e-8181-d01d431c3e7c 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/82e3be0d-1971-45f0-b1c6-de1b68504bb4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/31ad16f5-deda-4a86-89d2-b6b0ce92587b 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b27e599-3634-409a-884f-2dcb904f2763 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/445f5379-002c-43b0-9277-c38b22d2fbf4 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/f3d37798-b39c-4144-9e6c-15fbf34f99aa 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/08eb72b0-f36f-4845-8636-3880b506db7f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8576eabc-484c-486c-a50a-0ee193d3ce3f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd56dc6a-2063-42aa-ab25-40d6361e9b19 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ca0b149-8211-40ae-ba65-dd4fa941a04d 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f7d4632-673f-4ab5-9bc4-27f851713d13 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/386f1f03-ad5b-4ec8-b875-be29929a3f6f 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f219ea2-82eb-45d0-8a2d-fc9e64792024 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/81afa127-42bc-4dec-8c8d-b4dd08a69ce8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/c28c7719-56b1-4a51-8d82-50bd75506ded 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/9bfc9f6c-cdfb-4ead-b9be-1b0d36510784 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/e424d0c4-f54f-4013-8dfe-f913370c2c37 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/57079ff9-1714-4e77-87f9-152b2a79e780 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/3799a4b2-3b54-41f0-8af5-08cfcb8ef001 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/daf0cc1c-fd12-48cd-ac23-fe1220e189a8 2026-08-16T18:43:39.159Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0c26d86-ef8d-4afa-85ff-050885dee889 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee43ef85-414a-461c-b980-3d0a77d7a420 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8001ac59-71e0-4312-b2ea-a6d27bfa2c7b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/261910f7-91b8-4c9f-8a1a-479d23d14c9a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4810e26-6b56-40d6-a4b1-bc1f9ac21ca9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/31a6d32a-9955-4d35-a8e0-dcfa63b4c61a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4752d7e-8c90-4056-b552-971d5213dde8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/502b78ac-cc21-4b4f-b66f-a1a14672c999 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b1ff9ae-4fe1-41d1-8b78-64e3d4e92163 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/382c9211-0042-4464-af40-b3b9b089e645 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9fd9991-e30b-4703-9f52-0f5b7e7a68ce 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9cdc411-5f31-4b8d-874f-004547999b64 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/598f902c-a66a-4a53-9c8c-82fc2986508c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9cf66775-2247-49f0-a6c1-2c69238582d3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4381c3f-016f-4451-8c4c-9d6088840b5d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3496da7a-5e89-4e14-95dd-784eabf191a2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0724531-c94c-443f-8b1f-88eedb9a66a2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/780c9783-9c6c-4d85-91d0-27246c7fc018 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/19edf4f3-6265-4cef-af5d-6390db9ee315 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cebb078-9997-401f-a627-3b2390cf4e10 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2baa4ce9-e10f-4e0a-ac1c-b79432d08950 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/37a7659d-98e3-457a-b611-0bd1fe42dbad 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/85ee829d-f930-4e92-a63a-83f615c5cf89 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9097983-136d-4a87-b023-3a88f46aa14d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fc716354-28ec-4057-a917-d5162dbd6650 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7709d0f7-2784-42c2-b0e7-13591c0fd6cd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6ae5092-bce9-472f-90f4-2891cfc446e1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e4e391c-109a-4a3a-9fd7-27602432d163 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/997e9c8c-9cfc-4ead-b488-20335727e233 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6bb905d5-ef69-4640-82be-2129cbaa4bec 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f21760b5-931e-465e-9985-b22e35aa5fbf 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec780a81-978e-4b69-93ff-c33649831c3a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/04a2fa3e-ff62-48d6-a47b-e010d7685bd7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a2113785-9fa5-469d-824a-ae3d543d1512 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c744824e-53d9-4601-a769-235ba0f227d0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2d5a14a-3997-4621-8769-3e3fd5177dc6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e8171c04-533b-44c8-9288-85388abe4695 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e6ab4e9-5071-4bbf-9d64-cdc01301fa02 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/11e9e16d-6019-4af4-9c95-f5e0651d4ee1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/71193126-c41b-497b-8ffd-105b52a34574 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d246a8d-29a5-4f8c-afe4-a0972d9cc7d9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d022281-c5a4-4917-b14f-d8f78836bf9a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f43efae-1d0b-4d4f-b155-daaa5037ac7f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/213760c6-f956-4dbd-9842-46b2e257a024 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/922c2628-a04c-4fe5-ac1d-91ad776e1267 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f86d99a-c75e-4f6d-9514-98cde65ec4c9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d4d731c8-c04c-46c5-b84c-9f45aa76ce0b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f20f665-77a9-48a2-b7d0-a276b9110023 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/98491b81-b1e4-49e5-be6c-b46d48ca4340 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b52c635-0914-408f-a8e0-6073de4cc661 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5105b9df-2714-4477-b4a7-71016bd0bdda 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6d0aea57-51c2-4928-aafa-5e55b83de63d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cdf9ede2-9446-42af-a61c-b2b95a6a6972 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d22497c-3ba5-4968-80b6-aca03aa9950f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/80bee5b0-e38a-4c82-a422-dfd058401cf4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6a93acb-df11-470d-b304-e5acdec1e2b2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1590b4ac-7c4d-4543-94b5-97a58cce6f95 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/375be78b-bb6e-4291-b092-574988e4e477 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e38d256d-f464-4608-821b-09910c449dc9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f41f5738-0a12-431b-badb-eed654d7c364 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b75722d8-7d0d-4c93-b8aa-a4b273b20c27 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/718c9121-2c85-456b-8f03-ad11f59bb393 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff5eb49c-fd54-43ed-8c0c-7fb36b21f0d7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/97cf2d69-4740-46b5-999d-ba08f845c910 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff2e4477-7443-40cc-826a-dccb427e14ac 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6d3bea0e-f614-47e8-9180-ba0b1b3126f2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/63e14dad-d1b3-4a38-afe7-6072b29f53a4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/01b114e8-dfbe-43eb-a611-79540dd3d223 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9bce1976-9835-4a9e-9941-d0fa128dffe6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/95b32e11-f202-42a5-8837-f980cb71c585 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c8c20c6-6f3a-4394-a27a-93d2eb8a3963 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad5d7f07-2a50-4ae6-9542-059952d47730 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee326d42-e537-4b4a-8921-82628f54e917 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8dfde72-1903-47db-8d0b-6282f672e645 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2603c836-94d9-4623-a37d-139c62783841 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6914fc65-82e0-4bf5-bfe0-33e99d54d43f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/742c851b-e67b-4e10-bf0c-cbb13f43aff5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f3597da0-b269-40cb-ab9f-29773c00e8aa 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ba717b7-f418-4758-a53c-6a6f04a28035 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f73326fd-24b7-49b2-9eb9-1bc963329969 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9cbc70d-cd06-47cc-ad80-52f33da2cdb8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4e45148b-ee5c-4eff-b06a-b6db462cc5f7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/46d6f8b0-540a-4e43-8dbe-5dd0f5085e96 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/376c9399-0382-47f0-b528-5f6a7f8d89f6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f78b7e9-3e6f-4205-b0f3-775b72c0f9f3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/91d27bc7-c6d4-4bce-8a4b-6a65d06c7304 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ce3cac2-b694-49d3-a6e4-1c2b64cc94e1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6cade542-5081-44ab-9c41-1d16fd543815 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/38155632-88d0-42fe-9dc1-4bffe0f7e4a7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a46cc17-f9db-4522-851e-6488a5aeaf21 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8f1b75c-495d-4ec2-aeb2-e7235647c33f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b1337d4-2327-4c21-9654-2df1ebf31e68 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4db947c-4c48-430a-b35e-44a80f90ee6a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8e5c8ee-b2c3-4dd5-abf6-9612fff81453 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ede62f93-05e7-4d12-9862-779b9c8ceed2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3691e089-ffc0-4752-99cc-184d5c0ff7b6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/11955032-e20c-4371-9594-d6dd2a24f5b0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef33bfbd-c9df-4c91-ad58-793e6487399f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/44ee3240-4858-46ee-8f8b-6609558c6e47 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3893695-9fb0-49dc-92f2-f16b70f74b5e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b8cce68-e904-4c9b-812d-ee0de307b64e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c386b55-d308-4510-ab0c-3b2402e5f01d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ea755da-d5a5-4839-9ba3-84af66f90258 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/088be628-c5b3-43a8-9724-e7a8c684e4af 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/34828018-e7d7-4d84-b4e9-9f00a5919b5c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8b3d393f-1833-4d8f-82d8-16c0f33cf7ae 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/247d5d7a-9681-4787-a0d4-a2b86fb3a292 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/be45f22c-080f-4fb8-bd9f-be94783ae561 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a012e47-a0e3-4dce-9245-abba9dc29ca9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f083e448-19db-4a47-bba4-9a83d9765e0a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3041233-74c8-498a-b49c-119dda88efd8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ebf1fe14-3056-444e-92d8-de0246d16000 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/21002f66-ef49-4f47-9860-fb859fbf1077 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9363af2-d09c-4d8e-b632-070921767148 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0698d450-8f62-403d-bb66-b56e4f12d34f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/324ae6dd-df94-4900-a4f6-f547dfd55874 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c867d41-87c0-4e42-82da-421eed99a0b2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3160cb1-2335-46c8-af94-aebbe347bfa8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9a5529a5-8478-42ca-b707-273e21719224 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e506e2e0-62d2-40fa-8153-9411b5bad4af 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cda67526-91df-43f9-b522-e4e5d923b733 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d84ec42-d1c7-4229-baec-9e4e2328edbf 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff9f342b-1431-475d-aae8-145bd1d6ec68 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8b0113a-d316-4499-82f7-1312fbf74294 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f59e4824-e8d6-4f4b-ae18-9dcd6db70e1b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/61570aaf-cdeb-41f3-8b36-4e74f35c5a5d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e70bd1f-44da-40c3-951f-3bd1f1201542 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/582ba77d-74d7-4eae-850f-b7c23da10b94 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd46aaf4-8744-4706-b605-c379809fbffe 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/33790ce7-6952-40a2-8b47-5d63e706db28 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/58160b3f-8823-49d7-9aa8-35106214fcfa 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2797d261-afe4-46c4-ba0c-7efb5769eab9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/37d29fb0-ffeb-44b2-9e60-0746cbb0ceb6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab37db6b-d479-475c-a8d9-af4c29fca742 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/880925b8-ce50-477b-b9e2-8ff51bb6f158 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/55dd2933-5df2-4807-9437-ae8340db0530 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/39ef6cbf-3811-466a-b56f-1d9bc30753f5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5389b21a-5291-42a8-aed3-1b6a0a55557c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c1f0721e-92a7-4854-8b03-82f7a4f92d55 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f3f47b6-d33d-4875-9d59-3d5a66452ac5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9e48654-7455-46eb-9746-6f0ca000acdf 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a9f3852-75e6-4c34-8940-c0ac0a230e8c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5664bcfb-57c1-4616-84f9-ba52b3eff887 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9901f33f-ab87-42b6-8644-a5480b54b467 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4bdfbc7a-4073-4d30-9acc-5ec0f013d413 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c0b6ac6a-7904-4a0c-a539-bdd49e8852f7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4db334c0-3453-4fc9-a59b-149adcc2ae63 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a5956ae-d4d2-4b89-a7d3-48408c9ff43c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a3d7be42-5b2f-4a70-98eb-ae7c1a10a081 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/03f234f1-af03-49ba-bf00-27d514a34676 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e8aee41-382d-4715-a09a-b63ffd127464 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/35cc77dd-fb26-443e-a2c3-0ab9bc4dbfb1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/66d61063-7d9e-4a2c-8630-802e02d77707 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c4050f7-1ea4-4c57-8d0a-c65799888085 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/03107708-1d19-4313-a267-bf46bc24f5d2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6afb2404-df9d-4999-a835-6870edd0289f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2613edb7-0a7d-40b5-b054-aa63f0bce7c6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b566550b-96c6-49e8-a501-6ce616641b25 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3cdd24d0-3083-4030-939b-32e6fb7a615a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/11c188f2-811b-4738-8762-a9f6bba042a3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/740f4146-6a10-4a75-b056-bd4ca8b7d76e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea9bab8d-5c3d-4be5-b62f-aff64a572bdf 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d17a0848-ca39-4eea-a354-baa2de2524d7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d96227b-7368-43a9-9244-dcb0bb4405e9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/655ea09a-2939-4ac9-81d9-894ebd2b6a9a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b26b09a3-5dda-442b-a404-1450d7d290b4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/30147744-d147-41ca-8d2c-9f05298f87fe 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/85807023-412c-4d2e-968a-9b30113ebcbe 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6684b8ff-ee21-4b37-8173-219aa4041cc6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea6f0ccb-79cc-473b-b45b-7a5d5362779a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6cb1b043-9145-44ee-815c-3253f3a7ac94 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1de11e0b-59cd-442b-9a99-a1b193072a0e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7476dbdd-18b6-421e-b6b2-700fa0bbf827 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/752e0d11-073d-4a7b-81fc-7e1a60f977e0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/535acd5b-74a0-49fd-b3a3-23d8d62eff09 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3980223-058f-4241-b918-43ceac07bdfb 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/375e77b8-a0dd-4d5e-bb32-d8710d8b7ca8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/72591ea8-0045-43f0-bdb8-3c75c095893a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/caa139eb-5e6e-4115-8923-064662daabcc 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f16bf79-f15f-4a7f-abcc-0c9344f983e0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/204e612d-ed2b-4a82-9d51-e5e71d7642ff 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f8c99d3-98f1-4db0-812a-f96a3053012b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a54574d-2b88-43b1-8120-13feeb005ff4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3bcee8f-2071-4f71-bc15-6821b7b948c8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f6e55b9-0aea-493c-b825-a45c513b6336 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/73b7a388-297f-41be-a61e-506cd0098cf0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b16e4fd-ffef-4986-824a-6223e78e12cd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/600dc368-2b72-4ca5-a121-5e0c30b7dd77 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/adfc9072-86e5-48da-a866-f6ea4dbf7d74 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/60997d77-93f8-4fa9-9a42-aa7532e77b4f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/30e7f923-9e0f-4d94-8d87-8802fd81146a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/531bffcc-ed1c-4be0-825c-6d75ca0229db 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a47a1791-d8f3-4e9c-b573-f0d626caa762 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d9123d9-16b3-469a-9e2e-cf024242fa73 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/04ca3c7c-efbf-4d85-ba0f-eff688396331 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d43592ef-078b-42c8-8fd3-2d141a74e7bc 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7fd51ad2-e205-48b3-b6ac-9272f4b7d214 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd81c567-20ce-460e-aacc-6591ab6c7acc 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d247a965-7955-484d-b73d-17227ffd1260 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2108d9b6-a9f2-4056-973e-a9c46869bd8c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d85f964-d4c4-4e9a-8d31-4f04e89766d0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7787b2f5-46ca-413e-bc3d-1352295974b8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f639fb2-a0de-4672-8265-8ad67ab7f984 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cad9d1bc-e43a-4e42-b017-31a72a5c1365 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5c731ba-7fa5-4ec3-8959-bfe8409db71d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/758501a4-b958-461d-b02f-c92d14f8d6c3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/52a7ba05-6950-4f87-852c-e044153a7cde 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/01c2851e-b312-4947-a007-9984928a1ccf 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a44f9644-321e-4436-b0e2-bd6a1d918386 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/54e2c285-30df-4238-af25-256a379a9658 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6416a248-deb8-46fd-ad3a-042126fa14f7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c110e982-b434-43c3-aeba-64188e785221 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/00b58382-cdba-4307-a19d-64f652d7d71e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/196f3225-ddf1-47bf-a880-17f6b75d21b9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/27d53388-0b25-49d1-9e68-87013843b36b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb205108-f8fc-4ece-b1fd-ff33dec40724 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/226f9ac5-aca5-4a20-b839-8762fe089406 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d97d13be-d72e-457a-8678-910c108234f4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/56df4a6c-08bd-4627-b79a-24cde6f574c3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/30816347-04db-4d07-ae82-181f7e32ff83 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d06ade56-c0de-4436-a364-4b91dcd3872e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/636219de-16b9-4932-8ca9-c9271cd12fc7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/90457446-647c-49bf-b907-20b95d1ed037 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab306be7-2366-4864-a23c-5ec31e803795 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c772d10e-e028-4252-b7f2-d66a5ba45b04 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e98563c6-33b8-422a-9d0d-d1b475d9c0d4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8da3cf4f-68d3-4e71-9ea8-3da643da6e91 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ab628d3-852b-4032-93bd-1a6fc058b319 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/90ee8f01-f777-46df-b99e-fdaf569f284e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d593dcf-02ce-4ee5-8789-9abdd77af198 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/468075dd-8520-4141-936d-cf5c373a15b2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f4c4dd4-d6fd-4bc5-b74f-d45a38c6cb11 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a39f293e-548d-4b04-8a89-6e9b32b8a0c8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/674ae9e7-c65c-487a-8026-57810487f86f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/97f834b2-1d5c-4bc7-a36b-39094ed4b1cb 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/931d53e3-b08a-4a51-aaf7-1f0f7c95da85 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/876cd35f-bd6e-406c-b16f-6dd203eafc5f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/44941184-2c5a-43ce-a739-1b2318f171e4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/516d33bf-cc93-4bd6-9e15-23c0cc3597bb 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4768d929-c5d4-44cf-afa9-9f94d69d75ec 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/88f09c0e-08a1-4b85-9f83-5d118c4a6d38 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9418343f-8899-4e62-832d-0976ed7e2f41 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fbdf2369-0753-4abb-a09a-198caaa24315 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/292f441c-66a1-4e0c-ac3e-876c6018dc1f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e280d4ca-cb03-4a7d-aedc-419a16403964 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1ebea52-510c-4705-abbd-86e97e8ba87c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/141eafb3-ee7c-4fb6-a5dc-c0c13105a128 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9080512f-af4f-4cd1-8075-82c735f6e27b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6d49131f-ee8a-45cd-95f7-a380c70da08e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ad0945a-1973-4ca3-a85f-4bef36d361f5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/90bb69a8-4e91-4b24-a649-26a427399e15 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/93760927-2676-46e1-a7e3-b015e3d4eadd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6975f31-82db-463b-81f4-15a4c30a8ba6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2ec5c315-ec56-4ce4-8aa4-934f9e1d37e4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a30b1fa8-3476-49ec-8277-eaa2be761cf7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f711844c-5aaf-4ad1-a1d2-a35118e82d9b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0e14251-58a1-4561-92c5-c6f75f986928 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/360e05d2-4f43-4a98-8ee3-2efeaa0a9326 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2ef4e9c-14c0-4142-856d-179b1a9d484e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/29f5b51b-ab60-49ca-bdce-06c1644f44e9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6c451f2-3e0a-42a8-9b76-8dfbee64a8b0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a368fcc4-0ca7-4d19-9468-8b85475b69d4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ba4898e-b5e2-457c-a14d-8257dcbb1d50 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a3b5dd0-01ca-430a-9279-12f83428bee4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/79730c8e-d752-443a-8e74-41bb29ac4f70 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fd8ec4e-206f-4da9-9ba7-b7b5b809ec33 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1dfa70d-83b3-47c1-92c7-e45d981e23bf 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d702add0-2554-44cb-b2bc-d6aacd816034 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/87cd1bbb-94dc-4945-a0ce-e7f019f32d19 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f0e0ef5-c0fb-4f72-855a-cd83cf9fc07e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4269fcb6-41e7-4f1d-a041-45bcb3b761ec 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c17e72b-97b8-43b1-937d-ceef5e2e9bae 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/602421e3-8410-4397-a92f-240120fee263 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ce1dfb0-e24f-40b2-8394-9023e22f8a89 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c637d33-880a-4410-b5b6-3e4290652742 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e23c9a8a-8e76-4ae6-a803-5d14fcfa0b20 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f74ff5d-9e91-4558-97bb-d39b01387ecb 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e563c6b-f2cf-40f6-880b-e44b399935d6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/467dc831-5c5f-4459-8ae1-bf5273b41ac5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7fc5544-73eb-4375-b934-fa334c96dc96 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f30496b7-5fc4-45a1-8508-d07d4aa663fd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/01d5c284-cda0-4118-acdf-9349940a9eb7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/47febfed-0977-4af7-8bfd-2cea6b19688f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b1dbf19-6fb5-488f-b982-0fc59ef7b77a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3962c072-8e38-4575-8a54-bfa12cd90fb6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/08de508c-f7a0-45b2-9561-a2bfbc97046c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ebe26ec-ea21-4618-8b50-e496f0d0e97c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/af74b661-ad85-4918-b1d0-9e09ff29ce1a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9ebcf66-eda6-4520-9b24-94c05f7fe1de 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f7aa599-80fd-4dea-a2dd-c9885539ccf9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/de894d4f-89db-407c-9c29-7a8569aac3bf 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/911d7cc2-bd0a-4028-9c7a-c902c91f417a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d581352f-99af-45c9-97a7-68de81bc2b58 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/413cf4cf-04d6-4a49-8f2f-472b4a426113 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9b6073c-871c-4094-aca1-7dbc067d3966 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bab45ade-79d1-404f-952b-9549bc8477a5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/21585a89-5f01-4db6-ba6c-0b798524ddb1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa87d294-e07c-4719-a84c-b969dce2a40d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/65ca1368-3e13-47f5-b733-6a9164db58fe 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a4045e1-8aea-473f-973d-662304550908 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/083b7bd1-a58b-43fb-98f0-1dd4dab993ce 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/197c8f7b-42c8-4864-94de-e3c59fbc0712 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/deb2f293-1d19-4f0d-8631-4f960bd1a449 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1741a515-44f0-4ef9-aaa7-9b44ba53e9ba 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/811cd564-1612-4500-8059-8138899a6a18 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/72596372-a46a-47ea-bf50-b7d298f5c8b0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff7b175b-6ea1-4739-98d6-4b7700fdd778 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9acfeb0e-9a01-49c3-a70c-0f7a2e46496d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/de6aad48-b30e-4785-90d9-e8c34260866a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d6948c62-c8e2-4ec5-80ce-e9446e920471 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/52361038-6e0e-4690-bcc8-0453dd98f4c2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6beba610-25a1-4a8c-9e0c-4ad04bf9c97e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a690de5-61f0-4f51-bb00-ea7a087cd0f0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/96d9908c-db45-4125-bb8b-e6b80efdd9f1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5af502f3-5834-47a0-92bb-751c9c1c59c6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cdb1b7b-02fe-44f2-81bc-164177e09901 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0f7fb12-fb62-455d-a16e-d38648a63822 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd05e64f-2b59-4c8e-bc78-df41dd70fc41 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1dd903d-2413-45cb-8352-5696a90eed17 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd234acd-fa24-4a18-8f0b-a040ce5cc02c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/476797db-810a-4130-a209-bc050f75ee27 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8724ea6-be25-4dfe-a1e5-5c1a15129121 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b6a1632-30b5-4afa-98a9-b99499a77f3e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1de19fb-22f5-4713-9a91-c3e9d75f9cbd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa9c6363-288a-411b-9b96-bc9ffaeeffe6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3b8ef02-457b-4381-87f2-e7fcc30eec81 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6e6b3128-fe11-46cc-a83f-8afa085d7826 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3753fe3-6907-4baf-87bd-dbde38c58ac0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c651e41-77c2-4f56-94f5-fc0e8c49a17b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/46d3bb8c-17ac-4a9b-8db5-2cd958c54ada 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/33635f18-19d7-4822-a708-15b6de202669 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bac0e10f-a634-425a-b1fc-f7b3c503b9c0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/785c4487-622b-47fd-b89e-754285d61672 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf66147d-3268-415a-8618-3c290639f5ff 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/908a3789-dec5-498e-b9e7-c0aeb2649240 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4247128-7f0b-4e89-9cd3-a47fc58d3718 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/53fb14e6-cee3-40eb-8291-f45e32563191 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bb77cbfb-f22b-4fb9-a60b-a8a22cfb241d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd993263-26f4-43ae-bd96-8293d9a99c1b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f09bf240-e0d5-4881-9390-9da787d0b699 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5107e0fa-890c-46c1-b88e-298162ce1e8a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/020d7091-0025-4559-94de-76447070254a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a86cc974-9edb-49a1-bd72-27462348d25d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c6a74db-2396-4a22-bd11-312d8c7a7e99 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a019c76f-e973-462c-9608-db993331d73a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c87d6ad-dc51-4086-9a0f-d4ed4816fff2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ed8e2c5-07f0-4294-b941-bdbf18a2cd7a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3908bf0-51b9-418c-ab89-8d792c189da1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1ecab6d-6bfc-4011-bf0d-3fe8682b162f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef762a21-240d-437e-8c0f-c7834f966303 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5cd3759-6fd6-458a-9b72-c95c7bd8146a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/48e64aba-dc83-4c1c-9066-1a92c3b54289 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b3d1341-cf07-4bb1-964d-f86f3ae04e74 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/869737e5-c0d2-4de3-abc1-f740885e2b63 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5317829-1020-440a-ab55-cce36dc89963 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/47eb8353-5b37-4150-ada1-865c7add6cba 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1475a69e-b0d0-4565-b095-9409a7190302 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f00aba5-9a1a-4b4c-a2b0-d5b94e6da818 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2175156-cc79-40be-a0f8-4770797455e2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f0da057-25c8-4709-a226-027982576d90 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/52013a27-12db-47f6-8ba1-ecf902eee8bd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/83b20831-fa95-4e5d-be4c-a2306534e47a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/70281070-39a9-439d-acee-a94c71a877c3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3863a232-ad6c-4932-998f-9557f674f26d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/69ea27a8-b0ef-4259-9b23-74d3855f4195 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ba42043-4cf7-4e2b-832d-9dc35878efaf 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/37a53ef0-fe2a-4247-9268-ae03e121561d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6260fe9a-7cff-46a0-bc6e-d3bd97bb55cd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/de945c13-7f3e-4022-a58c-7b6ca0b4e6ee 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/76357332-292c-48b1-a8a5-160803746a15 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ec76405-ead7-4c3b-9f3d-35f7a49d58d4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e769fbb7-d702-4975-a69d-daf347a02d54 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/92e5115b-05c7-4b0d-9c5a-7d486b8a03ee 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/da48d54e-2f0e-4265-9871-840207d5abca 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c436015e-b8ba-411f-a10e-49b865eeb6bf 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffab620c-8309-4f62-9ffc-b93d4d8f686e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/26a32a1a-a444-4843-94b9-01e9a29541a5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/799eabc4-5445-4807-b781-3d3b88c7650d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2fa17c9-c842-4027-bf0f-164d9a16866d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/24f4dca5-99ca-4999-b576-d8a9cef18dfa 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e3721b4-6e71-4bf7-9945-ea1dc32f750e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/38866817-b37e-463c-9f96-5268715ee1ff 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e13c2f00-5acb-4c69-b559-0fbd487a64c0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/758c10ad-654f-4f4a-b3d4-50d6be540cd2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/17aa58ea-957b-4811-8a87-301bbff910c3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a43f5f03-c749-432d-8217-df130f638d4e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa4913a8-976b-428b-b8df-533bfba2e7c3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/327432a6-f0b2-459f-b8a9-238342e830e7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8648ff57-3b5b-459a-a52a-46b10a5827d4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/acd96430-31d5-4a12-8994-0c4a051f8e2a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/94984357-08e6-48b3-bc7a-dde7790a0dbc 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/885b31f6-1003-4c59-acb9-971576826bc2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8dc015c-d869-4339-8cc6-b7d149a17010 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c19c694a-1e04-452a-98ab-ef8f8cf35dcd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b81bd636-a1bc-4993-b0af-aaae55b0c2dd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c112ea12-1106-4616-9d30-f8166425c8ee 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c32cabf-1c4d-4c08-ad51-8462b00c78f0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/784c303a-f07b-4403-ba39-62a5a2cce326 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/12f0ad4d-ac01-42c9-b3c5-19cfbb0ea49a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b7c6ce1-d450-4bab-89e3-7bc3844cde15 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/38662ccf-2dc4-46fb-8030-14c2d25cf59e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/94bc32f9-0d1c-43b6-8a3a-12290e3c293a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9e1bde13-36df-4e5b-a9cb-73df92e109ec 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/14d51f0f-8d64-402a-bac7-a2f1934797eb 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f8bb355-f548-4ccf-9221-2f236149e8b9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ca03177-72ed-4dd6-83ab-e2bbe622a231 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bec274ca-3ad2-4006-ab2e-020e1b36531f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/78258d9e-d8d2-43d0-a2a0-d2deda15817f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7025d454-66e6-4fa3-9d23-cc6028456d43 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5759a25-e202-4fc9-ac90-01885772e095 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7215e8e-d404-4805-bb10-8c3817e89fa5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/46afbba6-6fdc-4e80-ba27-45e59d7aef47 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/55b1ef96-c87d-4f0f-b537-9595198b54b7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc56e1ea-697e-4771-9c8c-641391f91796 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/db5a0789-bd22-4b51-947b-98abd53bffb4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9481b15a-3e8e-4a84-887a-1402406d9fac 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1dcfb63c-7827-40f6-a736-ca09e5779978 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2661477b-46d3-4999-bbf8-56cf4877a8d2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/25f76e9b-b0a3-46a0-a2bf-386f104c0cf4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/94a6ae9f-7c1c-47d3-8121-c727185fcd02 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ecfc8717-f4e3-4bea-bf84-2fced0d8b98e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3e0b9ea5-5d24-4a8e-9663-e4e520b875af 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cab62176-c186-4b57-9056-2dc166834c6d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/01ed9767-d939-4959-a959-ef666ca57ba0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6699b8db-2c28-432f-b77a-130d954fee7c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d72f380-afa6-48f4-9808-4a8b5a5a29ba 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/09a3d599-f39b-40ac-bcab-fa3ea74968d0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9728aa56-82f9-4e0f-a2fe-d36251a2069a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f41b9358-793d-49e3-8abc-ed0cd20030ab 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4a12ff2-9e61-4464-806b-48fff86484af 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3438a012-82a6-4d83-beb3-6f524dc07bfd 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fec58e40-2916-4d3f-93dd-bb0c40e3f87f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4e03b44-54a7-4009-8844-9e0b166626d5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a762249-c902-44c0-b26e-d576dc9b0cde 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fbc9438-1254-4a55-9320-4227680a3c62 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b52ffa91-c3bc-4b5e-951d-c881cc9c0131 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/87c5db4e-b6fb-4062-9c37-cc674255dace 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/667f0955-f191-4ba5-80a5-8c98c398ee08 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/81ab3675-bbe5-42fb-9090-831a345dee08 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/987eb0ba-c88a-45ec-8bb0-3e0b2ed913b3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0057dc98-b827-4fe4-a9f1-48f024a01da8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5d166fe-320a-4870-a9b6-621c788f128e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ff41456-2255-45ad-ac9d-c04e2e60bc81 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8f4d8b7-8467-41ec-8ad5-fd78fa2fda6b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/51d5c49e-f82a-4496-82ed-0ab2a7694a53 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4dffc16c-e8d8-4dc4-b5b0-bc47c919c47a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/47d0b334-41fa-4934-a526-f3b48ad8cbb5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5dc4b93b-af68-4c96-a6fd-5488bd6aa64a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/090e2665-3ee8-4d85-bbda-a1386197a941 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c3064ab-f9cd-40a4-97ad-cc4df5fe132c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a679105-f82f-4b03-9b1f-321150f24cbe 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1bfd1ad-6526-460e-922c-2cedf08d6752 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f531119e-56d5-4919-89ab-9dd44abfa009 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/9fe09fd6-70ac-425b-8eb0-ee87b9bca7f5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b278b08a-3dab-4ffc-97bf-6cde0e90a543 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8a5e368-c40e-4f3b-a6e8-591d11c50ed1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7108eb15-34c2-4987-a739-1761a76be133 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c73de3f-de21-43aa-9126-45f584545e8a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c37bf67e-6e9d-424f-b52b-ea5fa288f6e3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b90ab1e2-31d7-4098-982d-dc1c93e6a56b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b2d31f0-528b-437a-9cec-b66b8dc19095 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/549e7fba-9a14-4660-aec0-22dbbb379d5a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a2c75d37-b66f-4910-8a9f-cebe2278c129 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bab71d82-77d7-42a0-89ce-c64809823c4e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/43b4aca6-2c70-4ea6-90ce-e2c7e6d51e45 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8831d8ef-4014-4947-a9c6-9ba290c2c055 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/70c30f2c-62b9-46ea-9d12-762e3ccce917 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0843873b-5aaf-4b6b-96d1-e1d67a706975 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/92d6590e-9f56-442b-8bc8-dca7357e49a0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/27478586-885e-4749-948f-23b960a670f9 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/234cf7ab-477d-4a93-b235-3355962ff70c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e0f892e-1c68-4d2f-974b-1e227504b7d0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0dd2dac7-4433-4f81-b9b1-1b923b426d7c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/20fe268d-4221-4a1a-b00c-3930a8812b31 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9bcfce7-2339-4242-8574-ff02f0483dc3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/38917e05-d2e6-4fcb-a65a-ae743b11b229 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/58100a57-025f-4776-9ba8-d16c07c22710 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cfeef1ba-774e-49c4-b967-db22f08099c8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cda7b1ca-5de0-4b4b-8ec8-e5b147e5a22c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4fe00c7-2df8-4818-9af9-4d4b82eb457f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/29606583-72cf-48f7-a181-f4ab648dc667 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/84accf23-09e1-41fa-91cb-dcf11511831f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/85984069-fdda-42ba-a640-4751d53b71da 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/697670ab-2e0f-4f09-b895-2ebd313d3810 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c6f206d-55a7-4a18-a0d3-c6d2a8bbeca8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/12e5b436-ed94-46d0-a221-25b694e9a964 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/56f1d78c-390c-4943-9e9b-a8331a129efc 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cbed0ced-6810-44af-9a34-5449539a9099 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/733bbd90-91a4-4467-9cb2-64d85a759e17 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab1b822d-6dcc-4f08-bdf8-93313d3c736b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e0cff3a6-68c1-4a12-9de0-c2d98421c00f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6bc72fe6-5371-49bf-aa71-2a0ab5e5794e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a118faa-23c8-4174-b549-ff7cd2fc8246 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/feb126e5-d914-4723-8a7a-3bb144b94445 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/606d12e6-85b4-4ab1-a0ca-ed6b2e3f8c1e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6acf18f2-7a83-48e4-b506-2b650d2355a7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3660ddc-0fc7-4a4e-a10f-06d3ae975601 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f72f30b2-ac39-4658-8f29-80cfc82d70d1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b81dcf8b-39a5-48ed-abfa-fdd6a52de9f5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0cb9a8ee-904b-4293-8948-b8e4c08e3de4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd569fa7-0499-473c-8be0-00e220e941e4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf2b2d62-e358-4800-ab9b-90b444224eb6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3538e722-7fe2-4478-9732-89634f92c119 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5212aee9-f1c1-45e9-a528-fe2984c1df62 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f9222c6-7327-4b9c-80a1-7711bbca8d7f 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/43fa5799-4d6d-4663-a8d2-866f07dbfb35 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7aea0875-16db-47ff-93ad-e1b8a4a9c121 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc0dca5d-4b05-483d-b89a-a6eefec56b98 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/26946b27-2455-4dd6-b776-7a316a99efe0 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6038cc8f-6090-427d-9180-6a859dfc7c09 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/47bd8e55-1fc0-4ab9-bc05-184bf9bcaa7c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f11dbb5-3e9c-4612-95fe-fe6ffaa74e79 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/06f67a71-3b23-4348-b9aa-0b2bb09c579e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/595fc20d-4f0c-4421-9e22-dab2fcaab006 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/14ea6ce6-fb5a-456f-9d0a-722e9232d79c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/99e8cf91-6660-4bd3-82cf-d9bbcf0dadae 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c895894-0862-42db-bbda-3903dad13293 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b7aefdb-c569-4593-9406-6071aeefaeb3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb9ee077-e581-4cff-b687-18707a9194e6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/180cdb2e-8d92-482c-9cd0-090136f2995c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ccad9d4-68bb-4f11-81cb-d29fca33690e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/760dc3c7-b98c-4c9e-90c8-feb0540dada3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d8252d5-578c-4979-ae7c-37e730757518 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d9b8171-cdf6-4465-838c-26694eff3f19 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/39a1a16d-5f08-4266-ad19-a7de22252eca 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0616a19-d62d-4745-9198-3a37722cec12 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fab9dbd9-e186-4bcd-bc8a-2b7192e7e335 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac6747a0-8e0e-4930-8716-a2c758d76cb6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3de2b58-ef1e-49f4-ba73-cd6f994d3da3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/488f282b-eee4-481e-9489-2171b3c11a45 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f2fa824-7bc9-43e7-b37a-ad4940142cab 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b0a618b-8e19-4884-938c-cb499d24a2ad 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c73e2e9-c498-411b-999c-5b09253e952e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/23c8799e-322b-4066-a19b-3b54ca1ae877 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd8a8f0b-a2af-4817-9a2a-9ac798b09290 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2bbbac86-c6d8-4f3b-a93b-5936f0dbc4c8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef4775f8-fd7b-46b2-9cb4-14f15c9c1f29 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2754114-6b7c-48cf-afdb-eefa6d5058ed 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2a04b993-53fd-457b-9ea9-4680ccb91d33 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/40e1f6db-763d-45bc-a471-4bf497186608 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/d623b9a6-7f4f-4d6c-96ec-4347d7894eb1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bedcdc19-0d8e-4e3d-92fc-f8bdec953e8c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/0889eb1e-7f6b-4d13-918e-1e617f90ebe3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4024514b-14bc-4219-847b-d36b167337ee 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/25d5b9a2-7863-4c8c-ab1b-b6283f46e6ac 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4e531e4-1c66-474d-8724-8e7d24cf3473 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/967ee6f7-93cc-490c-b31d-94f936e7a88a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4af70c78-89a7-45c4-9fdd-ebe7d7450095 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf9f94ed-7eea-4eef-9acd-ee05c2087a47 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/94d8f861-e926-46a4-b268-fa3cf95300f3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5f1361a-7fb9-424d-9df8-b629675e5dde 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/1e5b1c6e-6ef3-476d-b417-82b6f8f639d5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf37c0e0-5463-4101-b848-1e0fa23a6f1b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb03d3dd-95d2-46a9-9f26-99a29bb354db 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d04674f-2ae1-405f-b1ff-3c950f79bea8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f07396f7-d7af-434c-8179-34204f72a54c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/05ec4d06-d54c-49f8-ba6a-1367ebe391e1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/075e13f5-646f-415a-80e3-d07fd0dadca4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6aac787-a44e-463c-8dbd-6003cf3e0585 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4fa94347-b8c3-4743-991c-ae5677201c09 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4dc794b5-e81d-447d-b814-1236b558a1a5 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae523699-f29c-43c5-a9f9-abbe6c129b8a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9594c76-5a48-49ed-bf21-78afb541793e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ebc29d8-4c8c-4d2a-8108-57e5a19a92d6 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8caa3163-0d61-4509-823c-b2752fe84796 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8495d8d5-eae7-4a5e-bd37-34a4dffa1a05 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/75d4d5a8-a578-40fe-a870-424ab173ef69 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fbb9ae48-0714-42a5-8a98-08d88641cf6b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/284383d2-ec18-4b8e-afee-4a73c419c762 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7fee14b6-293a-4468-b96f-02b02fa0b9f4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ecca4697-6e9d-4023-958d-10ab97f9d098 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/513c18c2-d7f6-4221-addd-abefe635d434 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1e5b87a-5b1e-41e5-bb04-975f5ff3bd16 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b230c245-91ac-4657-9e2c-7eeb53c7e3c4 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/58820776-8e5d-4df6-9af8-fa79f324cf23 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/30e9150f-d70c-448d-84d6-042a7926d9a8 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/353f13eb-968a-4d3d-8476-279fb7063c24 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8835939-2b20-4c7f-8e6a-c76050e0158a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ad5be40-0cc2-47ee-ac16-359ac59dc400 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c313fa56-d023-464e-a1c7-a9e2767d4b10 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/2a8fe203-4cdb-4ba8-9f03-8d5b295e6563 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/c88ad848-5961-40c6-97fa-09a5d4ae76b3 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc72e13e-117f-485a-b014-b05ce0b2d229 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/612ded08-c7c8-4c41-948b-0a1f90b6610c 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d465637-e7fe-401e-9622-24d4045f7622 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf3e394c-186c-4b41-a4b6-9c30aae91549 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b335f1ea-bc13-4f8e-a2be-4aba4d9f2afb 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/6168e930-011f-4e92-9cc7-a9c75d676c01 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8eeb1870-f493-4819-8900-d36fc87dc3c2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce0a6147-4bfd-4d69-80af-c45dd435dff7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/842648c3-79a8-4af5-8989-913646f80871 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/124ad2b9-6a2e-4ba6-bcf8-adb0c9599026 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce36575a-a3d8-417e-b174-dd3b3fed39cc 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/dcd39c8a-216d-4497-b43d-84be584cdb66 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/7570a1f5-d572-4efe-a92a-20fc1758e75d 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9db8918-08f4-446e-8d01-ea4234cce8cb 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/a131e217-4eda-475d-b0ec-9c0fa4776a0b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/93d12930-22e7-4fc0-9b5a-76a5f8fffe67 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/fb670c19-b5d6-4483-bcc6-c7dcb72e49fc 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/dea1bf4a-b34b-49ab-9227-39594dd14b89 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/de7133d4-8399-4888-b601-0d9da1e2480e 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/360ae186-4064-4be1-9c0f-8dcbd6f1fc2a 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/10dee78f-3e46-4763-96a7-7d285c5ecf06 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/dc3b7e8b-7af4-4762-ba0c-52b5beeb862b 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/96486b46-d076-4069-91e0-3e91c2f187b7 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd40a5a4-d372-477d-9567-fc93fb704f74 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/b89482aa-b538-40a4-bea0-cbbb079a60d1 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/8cad0135-2ef9-4773-b761-e0753257aefb 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba0783a4-ea7d-4eea-95b6-e1c14f9b81bb 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/33a0fdaa-c2b0-4013-8ccd-a10f559155f2 2026-08-16T18:43:39.160Z weekly 0.7 https://www.humanexasignals.com/catalysts/e537e480-52ce-44b7-a16b-f7fe8e612807 2026-08-16T18:43:39.160Z weekly 0.7